data_2kcx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kcx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 66.6 m . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.876 0.37 . . . . 71.420000000000002 110.771 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 72.4 m -100.03 172.99 6.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.862 0.319 . . . . 71.400000000000006 111.862 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.87 112.7 0.82 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.1 -0.5 . . . . 63.520000000000003 111.485 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.73 2.16 49.59 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.471 -0.395 . . . . 63.530000000000001 113.961 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 22' ' ' PRO . 3.6 t -107.04 122.46 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 122.462 -0.434 . . . . 71.150000000000006 111.373 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.88 110.18 21.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.49 0.662 . . . . 64.439999999999998 111.421 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 55.1 m -136.14 180.0 6.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.09 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.57 -91.1 0.25 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 54.229999999999997 112.752 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.67 88.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.848 2.365 . . . . 74.340000000000003 112.839 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.558 ' H ' ' HB3' ' A' ' 29' ' ' ASP . . . 83.92 12.89 76.15 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.104 -0.498 . . . . 61.439999999999998 113.372 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 51.4 mtmt -141.3 136.67 31.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.376 0.51 . . . . 75.230000000000004 112.376 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.08 51.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.882 -0.599 . . . . 53.310000000000002 109.962 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.586 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 18.3 p -122.78 143.2 49.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.364 0.505 . . . . 74.230000000000004 112.364 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 16' ' ' ARG . 40.2 ttp180 -143.74 148.8 36.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.086 -0.506 . . . . 72.030000000000001 110.259 173.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 69.5 mtp -80.99 120.39 24.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.185 0.517 . . . . 62.329999999999998 112.072 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.6 106.14 18.27 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.952 -0.567 . . . . 75.439999999999998 109.664 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.57 -94.5 0.13 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.929 -0.653 . . . . 43.25 112.007 -174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.64 -8.2 12.63 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.177 -0.535 . . . . 51.140000000000001 113.881 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 27.3 ptt180 -121.04 133.27 24.12 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 117.573 0.687 . . . . 75.430000000000007 112.285 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.688 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 2.5 Cg_endo -81.89 128.82 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.143 2.562 . . . . 74.340000000000003 113.42 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -111.85 152.49 27.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.457 -0.338 . . . . 73.329999999999998 111.07 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 6.6 t -120.15 137.25 54.28 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.584 0.231 . . . . 63.509999999999998 110.465 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -131.82 146.14 51.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.75 0.31 . . . . 61.109999999999999 111.544 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 96.5 m -60.14 100.22 0.09 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.998 0.427 . . . . 52.219999999999999 111.141 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.24 155.29 53.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 64.209999999999994 111.359 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.71 107.75 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.372 2.048 . . . . 75.219999999999999 113.069 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.558 ' HB3' ' H ' ' A' ' 12' ' ' GLY . 10.7 p-10 -79.12 84.12 5.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.839 0.828 . . . . 74.319999999999993 110.81 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.4 m -83.74 84.5 7.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.526 -0.761 . . . . 51.32 112.226 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t -78.76 -145.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.903 -0.589 . . . . 73.439999999999998 110.487 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.66 80.84 0.12 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.863 -0.684 . . . . 71.510000000000005 112.997 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 51' ' ' CYS . 3.9 pp -155.33 148.59 18.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 122.609 -0.347 . . . . 75.340000000000003 111.758 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.94 120.33 3.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.554 2.169 . . . . 70.299999999999997 112.533 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.59 16.79 0.45 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.583 0.586 . . . . 65.409999999999997 112.583 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -115.21 -18.14 11.2 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.848 0.356 . . . . 74.329999999999998 111.735 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 61.6 tp -83.64 105.86 14.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.855 0.36 . . . . 55.439999999999998 111.757 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -59.86 160.09 8.14 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.032 -0.531 . . . . 61.219999999999999 112.132 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -157.58 144.66 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.331 -0.395 . . . . 53.119999999999997 111.963 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.2 128.52 46.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.907 0.384 . . . . 55.399999999999999 110.755 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.506 ' HA3' HD22 ' A' ' 64' ' ' LEU . . . -90.35 177.52 42.55 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.257 -0.497 . . . . 73.230000000000004 113.541 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.698 ' HA ' ' HE3' ' A' ' 67' ' ' MET . 42.6 m -60.82 -19.26 59.39 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.159 0.429 . . . . 73.140000000000001 112.159 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.54 -42.88 64.25 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.511 -0.313 . . . . 73.409999999999997 111.282 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.59 -0.27 8.62 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.25 -0.5 . . . . 72.400000000000006 113.895 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.27 146.19 27.21 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.218 -0.577 . . . . 71.510000000000005 111.891 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.3 m -86.3 108.32 18.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.088 0.471 . . . . 72.310000000000002 111.39 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -78.68 160.13 27.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.899 -0.591 . . . . 75.329999999999998 111.115 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -57.48 -34.85 69.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.371 0.508 . . . . 64.120000000000005 112.371 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.9 p30 -167.66 174.74 7.48 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.855 0.687 . . . . 72.549999999999997 112.855 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -46.99 -47.44 21.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.175 -0.92 . . . . 70.530000000000001 112.394 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.465 ' HB2' HD12 ' A' ' 33' ' ' LEU . 33.7 t -70.25 -40.24 74.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.058 -0.519 . . . . 65.530000000000001 111.028 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -54.25 -40.66 67.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.336 0.588 . . . . 64.510000000000005 111.203 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 66' ' ' VAL . 9.0 tt -64.91 -45.98 83.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.084 -0.507 . . . . 74.140000000000001 110.501 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -59.74 -27.54 66.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.138 -0.483 . . . . 72.349999999999994 111.765 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.09 -55.87 5.9 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 62.439999999999998 111.594 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . . . -53.35 -33.16 52.47 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.129 0.49 . . . . 60.439999999999998 111.198 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -48.97 -50.3 36.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.616 -0.72 . . . . 73.219999999999999 111.421 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 45.4 t -77.99 -23.54 48.33 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.04 0.448 . . . . 64.219999999999999 111.033 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 35.2 mmt180 -78.04 34.85 0.2 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.591 0.589 . . . . 63.450000000000003 112.591 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.66 23.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.226 -0.512 . . . . 74.129999999999995 114.118 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -131.71 74.4 77.78 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.521 0.66 . . . . 74.299999999999997 111.055 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.05 -29.37 40.33 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.562 2.175 . . . . 61.119999999999997 112.608 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.53 -13.23 60.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.035 -0.53 . . . . 74.420000000000002 111.993 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.506 HD22 ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -65.96 112.07 3.64 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.266 0.555 . . . . 72.409999999999997 111.948 -171.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -134.59 157.58 46.21 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 110.691 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.437 HG21 HD11 ' A' ' 53' ' ' LEU . 97.2 t -71.97 127.43 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.56 0.578 . . . . 72.310000000000002 112.56 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.698 ' HE3' ' HA ' ' A' ' 42' ' ' SER . 56.4 mtt -94.81 -53.64 3.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.372 -0.377 . . . . 71.209999999999994 110.758 171.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -165.23 167.53 17.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.887 0.375 . . . . 74.219999999999999 111.568 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -85.8 172.02 11.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.649 0.611 . . . . 74.319999999999993 112.649 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.37 -154.22 53.13 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.549 -0.751 . . . . 41.549999999999997 113.863 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -70.2 138.78 52.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.847 0.356 . . . . 71.430000000000007 111.004 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.62 84.9 2.66 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.259 0.552 . . . . 72.019999999999996 110.29 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 112.923 0.712 . . . . 74.310000000000002 112.923 -173.063 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.576 0.227 . . . . 73.450000000000003 110.485 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.641 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 15.1 m -129.6 126.89 39.51 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.144 -0.348 . . . . 75.120000000000005 111.014 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.43 112.13 23.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.852 -0.158 . . . . 72.219999999999999 111.338 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.95 49.0 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 114.463 0.545 . . . . 73.510000000000005 114.463 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 50.7 t -107.09 109.58 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 117.247 0.523 . . . . 64.340000000000003 110.887 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -91.5 106.5 18.53 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.349 0.5 . . . . 75.430000000000007 112.349 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 94.7 m -148.25 138.38 22.58 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.17 -0.468 . . . . 50.119999999999997 110.613 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 -121.27 0.9 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.913 -0.66 . . . . 65.420000000000002 113.519 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.39 107.84 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.597 2.198 . . . . 74.420000000000002 112.744 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 118.0 -54.96 0.59 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.095 -0.502 . . . . 75.340000000000003 112.255 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -135.39 134.95 40.24 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.802 0.334 . . . . 74.239999999999995 111.215 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.42 138.95 42.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 110.476 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 20.2 p -100.15 125.21 46.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.124 0.488 . . . . 74.540000000000006 111.277 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -144.16 159.54 42.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 74.530000000000001 109.777 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 47.8 mtp -78.97 103.67 9.08 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.682 -0.636 . . . . 72.099999999999994 111.957 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.06 141.2 48.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 110.387 175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.47 26.29 64.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.819 -0.705 . . . . 55.329999999999998 112.743 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.61 84.71 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.515 -0.374 . . . . 71.219999999999999 113.824 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -133.79 140.32 36.22 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 117.549 0.674 . . . . 74.319999999999993 111.676 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 27.5 Cg_endo -61.2 115.38 2.69 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.455 2.103 . . . . 65.530000000000001 113.455 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 35.4 mmt180 -118.05 156.53 28.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.869 0.467 . . . . 74.450000000000003 110.93 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 98.6 m -118.18 121.09 39.62 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.877 0.37 . . . . 63.210000000000001 111.77 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -133.85 161.36 34.96 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.468 -0.333 . . . . 60.020000000000003 111.058 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 37.0 t -55.26 130.15 41.13 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.421 0.897 . . . . 54.439999999999998 113.421 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.76 118.53 31.87 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.939 -0.573 . . . . 74.430000000000007 111.059 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.91 147.53 68.5 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.311 2.007 . . . . 71.239999999999995 112.75 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.41 31.7 0.12 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.35 0.5 . . . . 70.319999999999993 112.35 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.605 ' HA ' HD11 ' A' ' 33' ' ' LEU . 24.3 p -90.16 15.34 10.47 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.581 0.956 . . . . 71.540000000000006 113.581 -171.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -69.17 75.88 0.35 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.446 0.641 . . . . 52.549999999999997 110.527 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.16 6.39 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.034 -0.53 . . . . 63.25 112.97 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 30' ' ' CYS . 67.6 mt -94.42 151.14 39.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 122.474 -0.427 . . . . 72.409999999999997 111.467 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.29 119.32 6.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.335 2.023 . . . . 75.319999999999993 113.006 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.68 -4.56 53.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.129 0.49 . . . . 62.149999999999999 111.57 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -101.07 -1.0 35.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.203 -0.453 . . . . 71.439999999999998 112.024 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 58.1 tp -116.73 119.11 34.43 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.218 -0.301 . . . . 72.010000000000005 111.775 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -64.32 163.42 13.05 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.165 0.507 . . . . 62.340000000000003 112.188 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.544 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 10.0 p -150.51 144.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.019 0.378 . . . . 62.450000000000003 112.019 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 95.8 m -100.62 128.79 46.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.977 0.417 . . . . 52.109999999999999 111.122 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 64' ' ' LEU . . . -101.62 177.65 27.06 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.241 -0.504 . . . . 65.549999999999997 113.467 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.404 ' HB3' ' HE1' ' A' ' 67' ' ' MET . 64.9 p -61.88 -14.64 35.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.948 0.404 . . . . 72.230000000000004 111.839 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.36 -16.64 61.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.235 -0.439 . . . . 64.120000000000005 111.241 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.09 -14.44 62.56 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.435 -0.348 . . . . 74.140000000000001 113.494 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.04 153.68 19.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.667 0.617 . . . . 74.109999999999999 112.667 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -86.17 145.74 26.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.053 -0.522 . . . . 72.120000000000005 110.887 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.58 160.89 21.59 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.552 -0.295 . . . . 73.510000000000005 111.302 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -51.39 -43.31 61.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.071 0.548 . . . . 74.219999999999999 111.857 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.471 ' H ' ' HB3' ' A' ' 52' ' ' GLU . 4.7 p-10 -159.85 177.46 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.894 0.378 . . . . 64.319999999999993 111.469 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -57.94 -47.79 81.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.145 0.498 . . . . 74.519999999999996 111.453 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.4 t -65.81 -39.57 91.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.548 -0.296 . . . . 72.519999999999996 111.055 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.471 ' HB3' ' H ' ' A' ' 49' ' ' ASP . 5.8 tp10 -52.28 -41.17 62.66 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.318 -0.401 . . . . 53.020000000000003 111.246 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' HD22 ' A' ' 64' ' ' LEU . 9.7 tt -56.79 -56.01 27.0 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.205 0.526 . . . . 74.329999999999998 110.484 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -64.33 -29.55 70.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.118 -0.492 . . . . 74.150000000000006 111.211 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.85 71.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.94 0.4 . . . . 52.399999999999999 111.158 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.65 89.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 70.519999999999996 110.559 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 28.1 ttt180 -55.11 -50.28 69.61 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.523 -0.762 . . . . 70.329999999999998 111.808 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 84.9 m -81.0 6.33 13.74 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.223 0.453 . . . . 50.299999999999997 112.223 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -106.35 51.69 0.74 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.161 0.505 . . . . 73.25 111.279 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.0 69.54 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.551 0.58 . . . . 73.219999999999999 114.551 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 66.4 t60 -135.44 72.93 64.01 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 117.767 0.784 . . . . 63.219999999999999 111.721 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.2 -7.46 20.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.03 2.486 . . . . 73.510000000000005 112.844 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -9.19 52.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 73.140000000000001 111.825 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.475 HD12 ' HA3' ' A' ' 41' ' ' GLY . 43.1 tp -85.49 129.05 34.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.002 0.741 . . . . 65.140000000000001 113.002 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -127.77 155.43 44.06 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.631 -0.713 . . . . 65.219999999999999 110.496 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.88 123.39 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.855 0.359 . . . . 71.349999999999994 111.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.404 ' HE1' ' HB3' ' A' ' 42' ' ' SER . 18.6 mmt -100.48 -59.42 1.71 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.037 0.384 . . . . 72.299999999999997 112.037 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.409 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 53.1 p90 -154.43 145.46 22.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.001 0.429 . . . . 74.409999999999997 111.584 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HE ' ' HG3' ' A' ' 50' ' ' GLU . 93.1 mtt180 -83.04 110.72 18.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.241 0.543 . . . . 71.329999999999998 111.664 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.544 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 151.82 179.24 27.31 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.84 -0.618 . . . . 63.439999999999998 112.028 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -83.24 140.78 32.32 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.64 -0.329 . . . . 72.409999999999997 111.266 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 91.3 m -61.78 104.92 0.49 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.233 0.539 . . . . 71.329999999999998 111.783 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 63.509999999999998 112.319 -177.448 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 109.484 -0.561 . . . . 75.450000000000003 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.76 130.45 45.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.049 0.452 . . . . 37.229999999999997 111.859 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.5 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 m-20 -69.91 112.16 6.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 112.239 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.24 37.39 38.4 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.09 0.396 . . . . 37.229999999999997 114.09 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -106.61 135.49 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 112.004 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.18 106.64 14.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.096 0.474 . . . . 71.209999999999994 111.278 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -124.72 -179.92 4.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.089 -0.505 . . . . 62.009999999999998 111.02 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.38 -104.57 0.26 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 120.723 -0.751 . . . . 37.229999999999997 113.551 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.95 85.71 0.97 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.543 2.162 . . . . 63.310000000000002 113.106 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 102.07 2.74 51.7 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.194 -0.527 . . . . 44.450000000000003 113.559 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.773 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 48.4 mtmt -135.83 137.59 41.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.495 0.647 . . . . 73.040000000000006 112.03 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.04 142.13 49.46 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.719 -0.673 . . . . 64.409999999999997 110.072 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 23.2 p -105.5 136.46 45.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.133 0.492 . . . . 72.299999999999997 112.112 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -127.86 139.14 52.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.888 -0.597 . . . . 64.120000000000005 110.896 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.576 ' SD ' ' HB3' ' A' ' 22' ' ' PRO . 94.2 mmm -76.6 113.43 14.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.854 0.359 . . . . 72.010000000000005 111.409 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.776 HD13 ' HD3' ' A' ' 23' ' ' ARG . 88.6 mt -122.74 114.43 20.53 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.12 0.486 . . . . 62.439999999999998 111.304 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.65 30.74 75.61 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 116.231 -0.441 . . . . 40.140000000000001 113.77 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.25 -15.19 63.75 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 54.140000000000001 113.712 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 21' ' ' ARG . 43.0 mtt180 -122.14 137.42 27.47 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 117.25 0.525 . . . . 60.119999999999997 111.681 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 93.4 Cg_endo -83.28 145.29 12.02 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.725 2.283 . . . . 71.129999999999995 113.657 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.776 ' HD3' HD13 ' A' ' 18' ' ' LEU . 66.6 mtp85 -124.55 132.19 53.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.905 -0.589 . . . . 75.209999999999994 110.607 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 14.0 t -102.9 118.85 37.74 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.502 -0.555 . . . . 63.520000000000003 109.502 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.09 161.3 35.72 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 62.240000000000002 111.828 -171.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 97.5 m -54.26 108.55 0.38 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.137 0.791 . . . . 63.439999999999998 113.137 -174.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.72 120.82 56.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 115.889 -0.596 . . . . 65.310000000000002 110.754 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 83.3 Cg_endo -81.6 131.25 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.648 2.232 . . . . 75.450000000000003 113.535 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.803 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -67.86 82.5 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 116.303 -0.408 . . . . 65.400000000000006 111.019 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.8 p -148.96 123.07 9.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.399 0.619 . . . . 65.420000000000002 112.163 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -145.65 -53.9 0.28 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.844 -0.617 . . . . 64.099999999999994 110.197 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 51.63 1.96 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.176 -0.535 . . . . 73.219999999999999 113.385 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -156.64 145.07 14.52 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 122.584 -0.362 . . . . 75.319999999999993 110.8 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.94 120.02 4.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.247 1.965 . . . . 72.099999999999994 113.705 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.29 38.8 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.495 0.664 . . . . 74.430000000000007 110.792 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -129.9 8.05 5.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.819 -0.628 . . . . 73.200000000000003 111.551 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 64.9 tp -136.88 127.37 26.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.237 0.215 . . . . 64.209999999999994 111.064 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 50.7 mt-30 -66.48 148.27 52.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 74.239999999999995 112.047 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 32.6 m -131.15 146.77 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 71.219999999999999 111.493 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.5 t -100.9 113.66 26.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.388 -0.369 . . . . 64.409999999999997 110.822 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.14 170.37 49.2 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.266 -0.492 . . . . 37.229999999999997 114.239 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.9 m -54.9 -26.78 38.2 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.201 0.6 . . . . 70.030000000000001 112.111 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.54 -23.79 61.83 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.966 -0.561 . . . . 71.439999999999998 111.937 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.45 12.02 54.74 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.477 -0.392 . . . . 73.430000000000007 112.652 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.28 141.76 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.721 0.296 . . . . 75.409999999999997 111.764 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 m -86.65 107.35 18.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.466 -0.334 . . . . 71.230000000000004 111.434 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.01 147.16 24.43 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 110.151 -0.314 . . . . 71.230000000000004 110.151 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.416 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 39.9 ptt85 -59.83 -25.14 64.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.612 0.597 . . . . 73.510000000000005 112.612 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.0 p30 -166.86 172.25 10.53 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.043 0.449 . . . . 63.329999999999998 111.646 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HA ' HG22 ' A' ' 39' ' ' VAL . 29.6 tt0 -69.28 -26.7 64.88 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 112.135 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 48.6 t -74.72 -39.14 62.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.959 0.409 . . . . 73.209999999999994 110.206 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -59.14 -43.83 92.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.216 0.531 . . . . 75.099999999999994 110.583 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.59 -51.3 67.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.107 -0.497 . . . . 74.510000000000005 110.736 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.803 ' HD3' ' HB2' ' A' ' 29' ' ' ASP . 94.1 mtt180 -70.82 -17.01 62.77 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.32 0.489 . . . . 73.109999999999999 112.32 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.18 -34.05 63.66 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.328 0.585 . . . . 72.099999999999994 110.154 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.02 -25.62 52.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.701 -0.681 . . . . 75.299999999999997 112.091 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 54' ' ' ARG . 16.4 ptt85 -66.5 -20.08 65.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.045 0.45 . . . . 74.150000000000006 110.886 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.4 t -72.27 -16.83 61.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.297 0.57 . . . . 60.340000000000003 110.634 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -91.66 85.04 5.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.943 -0.571 . . . . 75.439999999999998 111.112 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.89 -52.68 4.5 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 114.737 0.655 . . . . 75.140000000000001 114.737 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -114.58 93.62 33.37 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 117.806 0.803 . . . . 75.239999999999995 112.978 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.44 -16.48 47.7 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.556 2.17 . . . . 64.200000000000003 112.55 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -82.14 0.0 42.84 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.352 0.501 . . . . 75.430000000000007 112.352 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.9 tp -57.2 111.97 1.23 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 71.0 110.792 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -115.59 164.2 14.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.262 -0.426 . . . . 52.340000000000003 111.339 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.67 127.79 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.256 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -78.76 -45.32 21.34 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.307 0.575 . . . . 43.409999999999997 110.546 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -159.76 145.47 15.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.832 -0.622 . . . . 64.420000000000002 110.766 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.16 99.94 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.348 0.594 . . . . 72.510000000000005 110.925 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.505 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 164.57 -176.08 40.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.348 -0.842 . . . . 71.219999999999999 111.572 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -80.93 138.26 36.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.162 0.481 . . . . 54.350000000000001 111.3 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.9 m -61.9 94.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.208 0.528 . . . . 63.439999999999998 112.048 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.783 -0.644 . . . . 74.329999999999998 110.398 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.754 0.312 . . . . 42.310000000000002 111.251 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.12 130.38 45.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.902 0.382 . . . . 61.299999999999997 111.837 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.19 114.85 20.29 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.355 0.502 . . . . 61.350000000000001 112.355 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.31 8.2 58.71 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 114.274 0.469 . . . . 72.329999999999998 114.274 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.58 109.78 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 O-C-N 122.617 -0.343 . . . . 74.230000000000004 110.741 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.85 108.96 16.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.98 0.419 . . . . 41.5 111.315 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -148.76 138.49 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.285 0.564 . . . . 63.149999999999999 111.341 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.44 -60.92 0.09 OUTLIER Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.616 -0.72 . . . . 40.399999999999999 111.625 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.51 90.35 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.474 2.116 . . . . 70.329999999999998 112.322 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 88.68 -5.69 84.38 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.19 -0.529 . . . . 74.329999999999998 114.051 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 49.6 mtmt -141.14 138.05 33.17 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.583 0.691 . . . . 72.030000000000001 112.202 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.84 140.11 50.51 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.145 -0.479 . . . . 75.140000000000001 110.005 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.3 t -98.33 135.74 39.5 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.099 0.476 . . . . 75.109999999999999 111.774 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -142.62 137.03 29.73 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.824 -0.626 . . . . 74.299999999999997 110.808 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.9 mmm -76.46 104.55 7.03 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.009 0.433 . . . . 75.420000000000002 111.801 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 112.6 23.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.856 0.36 . . . . 61.43 111.02 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.05 31.7 72.51 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.448 -0.406 . . . . 36.140000000000001 112.882 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.81 -4.55 60.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.179 -0.534 . . . . 73.230000000000004 112.859 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -113.1 129.52 24.46 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.589 0.356 . . . . 45.409999999999997 111.053 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 115.52 4.28 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.493 2.129 . . . . 64.319999999999993 113.121 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -111.57 132.47 54.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.46 -0.336 . . . . 73.129999999999995 111.373 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 13' ' ' LYS . 87.0 m -103.28 119.98 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.993 0.425 . . . . 73.040000000000006 110.588 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -102.04 145.14 29.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.587 . . . . 73.219999999999999 110.006 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 20.4 p -80.48 123.2 27.87 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.142 0.496 . . . . 44.240000000000002 111.91 -175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.05 134.28 24.03 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 52.039999999999999 110.962 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.71 152.33 47.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.411 2.074 . . . . 54.109999999999999 112.891 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -78.35 41.49 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.483 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.744 ' HA ' HD23 ' A' ' 33' ' ' LEU . 25.1 p -77.49 89.79 3.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.189 0.519 . . . . 75.109999999999999 111.908 -174.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.3 t -138.79 132.49 30.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.954 -0.567 . . . . 63.200000000000003 110.857 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.35 39.42 51.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.187 -0.53 . . . . 73.540000000000006 112.9 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 30' ' ' CYS . 3.2 pp -151.8 163.6 23.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 122.7 0.4 . . . . 74.329999999999998 110.726 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.493 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 84.5 Cg_exo -49.9 118.96 4.26 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.526 2.151 . . . . 63.539999999999999 114.336 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.89 -10.43 14.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.678 -0.692 . . . . 75.129999999999995 110.818 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -125.55 -22.47 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 63.240000000000002 111.313 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 3.7 tt -90.19 119.83 30.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.767 0.318 . . . . 72.450000000000003 110.312 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 52.4 mt-30 -63.74 148.82 48.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.313 0.486 . . . . 64.120000000000005 112.313 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.455 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 34.0 m -129.81 151.91 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.213 0.53 . . . . 72.019999999999996 112.052 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.71 113.67 26.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.946 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.64 162.19 32.84 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.262 -0.494 . . . . 73.25 113.789 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.9 p -65.97 -9.43 29.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.336 0.495 . . . . 72.420000000000002 112.336 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.622 ' HB2' HD13 ' A' ' 64' ' ' LEU . 14.6 t70 -81.19 -4.98 57.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.149 0.5 . . . . 71.150000000000006 110.923 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 13.23 66.48 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.4 -0.429 . . . . 63.020000000000003 113.266 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.76 148.23 41.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 111.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.675 HG22 ' HG2' ' A' ' 71' ' ' ARG . 69.7 m -99.62 116.57 32.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.959 0.409 . . . . 63.439999999999998 111.209 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -96.66 156.88 16.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.414 -0.357 . . . . 75.209999999999994 111.664 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 78.9 mtm180 -56.96 -32.88 66.48 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.518 0.562 . . . . 74.329999999999998 112.518 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -162.97 176.43 10.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.031 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.638 ' HB3' HD12 ' A' ' 33' ' ' LEU . 32.7 tt0 -74.99 -30.89 61.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.279 -0.569 . . . . 72.510000000000005 111.599 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 t -65.4 -37.41 86.88 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.834 -0.541 . . . . 63.219999999999999 109.806 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.56 -52.89 63.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.543 -0.753 . . . . 74.239999999999995 110.421 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.26 -52.03 54.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.034 -0.984 . . . . 75.329999999999998 111.675 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 41.4 mtp85 -70.46 -27.17 64.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.841 -0.618 . . . . 75.340000000000003 111.657 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.11 -49.27 62.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.188 0.518 . . . . 62.210000000000001 110.67 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.83 -32.01 71.4 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.078 -0.51 . . . . 74.430000000000007 110.969 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -58.37 -51.63 69.0 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.944 -0.571 . . . . 72.540000000000006 110.921 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 32.2 t -71.78 -31.74 66.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.746 0.308 . . . . 71.25 111.432 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -60.14 -50.5 73.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.401 0.519 . . . . 74.239999999999995 112.401 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.49 16.78 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.993 -1.098 . . . . 65.540000000000006 114.959 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.0 m-70 -135.69 75.16 57.16 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 117.806 0.803 . . . . 72.340000000000003 111.564 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.64 -23.18 74.59 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.358 2.038 . . . . 63.200000000000003 113.273 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.3 -14.26 47.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.008 0.373 . . . . 74.030000000000001 112.008 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' A' ' 43' ' ' ASP . 55.0 tp -64.4 112.36 3.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.2 0.524 . . . . 75.439999999999998 112.144 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.1 m -132.73 162.04 32.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.486 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.31 129.98 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.172 0.511 . . . . 74.439999999999998 111.788 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 69.5 mtm -85.27 -55.33 4.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.277 0.56 . . . . 73.519999999999996 110.166 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.482 ' HE2' ' H ' ' A' ' 73' ' ' ARG . 16.6 p90 -151.5 140.03 20.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.714 -0.676 . . . . 74.209999999999994 110.743 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.51 125.52 29.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.272 0.558 . . . . 70.299999999999997 111.543 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 124.56 161.57 11.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.35 -0.841 . . . . 60.439999999999998 111.139 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.675 ' HG2' HG22 ' A' ' 46' ' ' THR . 65.4 mtt180 -63.14 138.82 58.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.747 0.774 . . . . 75.319999999999993 111.082 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.5 m -48.28 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.626 0.602 . . . . 70.329999999999998 112.626 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' H ' ' HE2' ' A' ' 68' ' ' TYR . 11.9 ptp180 . . . . . 0 N--CA 1.468 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.319999999999993 111.217 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.68 0.276 . . . . 63.25 110.655 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 p -140.43 130.91 25.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.764 0.316 . . . . 63.240000000000002 111.794 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.66 114.15 22.42 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.154 0.502 . . . . 72.239999999999995 112.329 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.87 27.21 66.45 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.987 0.755 . . . . 61.329999999999998 114.987 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.511 HG11 ' SG ' ' A' ' 9' ' ' CYS . 49.9 t -107.15 126.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 117.358 0.579 . . . . 74.140000000000001 111.588 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 10.5 pt-20 -79.0 105.93 10.69 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.407 0.622 . . . . 75.319999999999993 111.664 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.511 ' SG ' HG11 ' A' ' 7' ' ' VAL . 58.7 m -149.61 155.99 41.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.101 -0.374 . . . . 64.409999999999997 111.42 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.7 -65.24 0.31 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.942 -0.647 . . . . 71.349999999999994 113.009 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.14 90.53 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.66 2.24 . . . . 71.310000000000002 112.83 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.31 0.78 84.48 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.053 -0.594 . . . . 70.040000000000006 113.634 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.32 136.04 41.26 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.0 -0.706 . . . . 74.109999999999999 111.964 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.27 143.95 41.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.076 -0.511 . . . . 74.209999999999994 110.353 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 30.9 p -101.88 128.52 48.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.79 0.663 . . . . 74.200000000000003 112.79 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -138.52 145.62 40.96 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.417 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.41 ' HE1' ' HB3' ' A' ' 17' ' ' MET . 74.1 mtp -91.12 112.16 23.95 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.947 0.404 . . . . 44.009999999999998 111.8 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.09 112.19 24.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.243 -0.435 . . . . 61.420000000000002 110.634 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 36.11 58.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.375 -0.44 . . . . 72.519999999999996 113.861 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.28 70.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.168 -0.539 . . . . 52.140000000000001 113.51 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.6 111.26 63.66 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 117.346 0.573 . . . . 72.129999999999995 111.771 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.474 ' HB2' HG22 ' A' ' 7' ' ' VAL . 58.7 Cg_endo -71.86 106.99 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.218 1.945 . . . . 74.230000000000004 112.269 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -117.79 149.2 41.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.904 0.383 . . . . 75.420000000000002 111.534 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 91.2 m -129.0 125.55 37.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.017 0.437 . . . . 64.239999999999995 111.487 177.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -119.99 161.54 20.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.528 -0.305 . . . . 75.150000000000006 110.188 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.86 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.35 0.595 . . . . 64.439999999999998 111.072 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 120.0 60.27 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.479 -0.782 . . . . 38.189999999999998 110.493 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.595 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 11.0 Cg_endo -52.17 117.62 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.5 2.134 . . . . 60.030000000000001 112.499 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.66 36.22 0.13 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.233 0.539 . . . . 73.239999999999995 111.623 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 47.6 m -65.51 101.89 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.978 -0.556 . . . . 73.540000000000006 111.587 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -129.34 92.32 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 62.039999999999999 110.243 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.78 7.35 17.83 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.054 -0.521 . . . . 71.319999999999993 112.858 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.9 mt -100.83 114.89 65.84 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.619 -0.342 . . . . 73.450000000000003 111.142 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.63 153.09 26.34 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.761 2.308 . . . . 74.439999999999998 113.531 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 37' ' ' LEU . . . -77.26 163.16 26.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.156 -0.475 . . . . 71.310000000000002 111.2 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 69.33 -15.2 0.29 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.793 0.664 . . . . 71.420000000000002 112.793 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 35' ' ' ALA . 1.1 tm? -72.23 88.01 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.477 -0.564 . . . . 73.510000000000005 109.477 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 98.1 mt-30 -71.24 142.11 50.58 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.775 0.657 . . . . 75.439999999999998 112.775 -175.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 69' ' ' ARG . 33.4 m -137.02 157.28 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.819 -0.628 . . . . 64.129999999999995 111.003 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 90.7 m -101.12 132.01 46.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.89 -0.506 . . . . 65.299999999999997 111.839 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.541 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -82.85 173.5 52.46 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.918 -0.583 . . . . 64.310000000000002 113.422 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -64.38 -11.17 30.08 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.544 0.572 . . . . 43.109999999999999 112.544 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -87.17 -26.87 23.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.859 0.361 . . . . 73.230000000000004 111.094 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.26 -0.36 20.73 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.316 -0.469 . . . . 73.209999999999994 113.924 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.5 152.09 19.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.344 0.572 . . . . 74.420000000000002 112.268 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.8 m -90.91 120.08 31.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.051 -0.522 . . . . 73.109999999999999 111.975 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -87.49 140.64 29.33 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.283 -0.417 . . . . 75.239999999999995 110.814 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 18.0 ptp180 -59.65 -15.55 19.95 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.001 0.741 . . . . 73.409999999999997 113.001 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.5 p30 -167.26 160.68 13.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.556 0.343 . . . . 74.209999999999994 110.91 172.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -64.04 -30.83 71.87 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.088 0.403 . . . . 72.540000000000006 112.088 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.26 -33.99 72.26 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.031 0.444 . . . . 73.340000000000003 110.683 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -56.48 -50.9 70.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 110.662 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.541 HD11 ' HA2' ' A' ' 41' ' ' GLY . 6.5 tt -63.08 -46.7 86.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.818 -0.628 . . . . 61.310000000000002 110.328 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.424 ' HD3' ' SG ' ' A' ' 30' ' ' CYS . 16.8 ttt180 -55.39 -33.69 63.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.832 -0.622 . . . . 73.239999999999995 111.288 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.11 -31.68 23.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.059 -0.519 . . . . 75.049999999999997 111.655 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.08 71.11 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.191 0.441 . . . . 71.019999999999996 112.191 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.57 -34.01 64.39 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.242 0.544 . . . . 75.120000000000005 111.45 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.3 m -88.66 14.16 10.67 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.434 0.531 . . . . 75.329999999999998 112.434 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -98.27 8.24 45.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.058 0.392 . . . . 75.519999999999996 112.058 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.1 0.81 5.05 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.756 -0.735 . . . . 72.349999999999994 114.429 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -133.98 88.53 31.75 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 117.655 0.727 . . . . 72.209999999999994 112.132 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.94 -20.92 69.27 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.505 2.136 . . . . 75.319999999999993 111.59 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -20.95 58.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.947 -1.024 . . . . 73.120000000000005 112.436 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.81 111.57 3.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.287 0.565 . . . . 63.130000000000003 111.653 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -129.67 163.48 26.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.0 -0.546 . . . . 74.310000000000002 111.242 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.84 126.28 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.106 0.479 . . . . 61.340000000000003 111.394 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 72.1 mtm -80.33 -43.79 20.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.006 0.373 . . . . 73.120000000000005 112.006 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -164.19 155.83 16.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.949 0.404 . . . . 74.129999999999995 111.876 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.663 ' HA ' HG12 ' A' ' 39' ' ' VAL . 8.6 mpt_? -80.5 104.87 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.168 0.509 . . . . 70.450000000000003 111.243 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.92 170.43 16.63 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 116.061 -0.518 . . . . 65.25 112.192 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -75.57 149.98 38.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.866 0.365 . . . . 74.299999999999997 111.424 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 71.5 m -58.77 113.78 2.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.113 -0.494 . . . . 70.349999999999994 111.934 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 115.706 -0.679 . . . . 74.129999999999995 112.131 -176.646 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 112.106 0.41 . . . . 73.400000000000006 112.106 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.4 m -105.85 127.95 53.44 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.849 0.357 . . . . 73.299999999999997 111.605 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.634 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 11.5 m-20 -87.64 111.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.183 -0.323 . . . . 62.420000000000002 110.4 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.8 -39.78 0.79 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 121.004 -0.617 . . . . 53.140000000000001 114.016 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 10.7 t -66.08 146.28 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.962 0.505 . . . . 74.349999999999994 111.62 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.71 105.3 15.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.486 0.66 . . . . 75.239999999999995 110.218 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 97.9 m -149.52 179.41 7.99 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.502 0.556 . . . . 74.310000000000002 112.502 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.03 -67.54 0.56 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.259 -0.736 . . . . 63.009999999999998 111.259 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -93.01 131.1 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 73.209999999999994 111.96 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.37 -35.78 1.99 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.008 -0.615 . . . . 44.229999999999997 114.268 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HE3' ' SG ' ' A' ' 9' ' ' CYS . 48.5 mtmt -131.38 145.95 52.05 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.254 0.527 . . . . 74.209999999999994 111.286 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -122.09 132.04 54.28 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.455 -0.339 . . . . 74.420000000000002 110.634 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.791 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.2 p -100.12 121.83 42.02 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.479 0.657 . . . . 73.5 111.584 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.444 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -123.88 163.56 21.03 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.835 -0.62 . . . . 73.310000000000002 111.265 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.652 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 14.0 mmt -80.9 110.74 16.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.249 0.462 . . . . 74.420000000000002 112.249 -174.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.686 HD21 ' HD2' ' A' ' 23' ' ' ARG . 6.8 mp -115.48 102.72 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.825 -0.435 . . . . 74.230000000000004 109.825 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.51 27.94 72.49 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.132 -0.556 . . . . 54.219999999999999 112.57 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.95 -16.62 56.51 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.483 -0.389 . . . . 64.540000000000006 113.633 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -93.11 137.25 23.77 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 122.321 -0.517 . . . . 72.129999999999995 111.804 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.634 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 90.4 Cg_endo -77.95 101.85 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.918 2.412 . . . . 70.310000000000002 113.409 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.686 ' HD2' HD21 ' A' ' 18' ' ' LEU . 53.9 mtt-85 -105.7 139.03 40.91 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.132 -0.321 . . . . 71.420000000000002 110.132 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.791 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 17.8 m -103.36 144.3 31.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 74.230000000000004 112.118 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' OE2' ' HD3' ' A' ' 16' ' ' ARG . 48.4 mt-10 -129.03 158.23 39.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 65.230000000000004 110.636 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.0 p -62.82 99.83 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.149 0.499 . . . . 63.520000000000003 112.278 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.82 125.59 41.68 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.874 -0.603 . . . . 71.219999999999999 111.45 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.9 Cg_exo -78.28 111.8 3.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.865 2.377 . . . . 74.019999999999996 112.848 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.36 94.22 0.16 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.788 0.328 . . . . 71.409999999999997 110.298 173.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.1 p -130.35 22.63 5.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.494 0.924 . . . . 63.549999999999997 113.494 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.1 p -70.93 -23.82 62.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.53 0.681 . . . . 63.420000000000002 109.965 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.61 27.83 14.08 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.56 -0.745 . . . . 37.990000000000002 113.017 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 78.6 mt -124.44 148.22 57.73 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 116.719 0.259 . . . . 52.119999999999997 111.688 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 13.6 Cg_exo -70.72 120.27 6.96 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.671 2.247 . . . . 73.129999999999995 112.629 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.28 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.992 0.367 . . . . 75.340000000000003 111.992 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -93.5 1.52 56.74 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.979 0.363 . . . . 72.109999999999999 111.979 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.3 mt -118.35 114.09 22.42 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.072 0.397 . . . . 71.200000000000003 112.072 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.34 146.75 53.78 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.503 -0.317 . . . . 71.329999999999998 110.375 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 69' ' ' ARG . 32.6 m -129.51 149.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.96 0.409 . . . . 71.329999999999998 111.603 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 61.3 m -100.53 128.58 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.385 -0.37 . . . . 70.310000000000002 110.796 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -72.89 164.3 54.88 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.253 -0.499 . . . . 43.409999999999997 113.068 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 t -58.97 -16.97 20.54 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.079 0.399 . . . . 71.540000000000006 112.079 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -82.11 -38.73 24.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.902 0.382 . . . . 74.030000000000001 110.931 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 -3.52 4.99 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.365 -0.445 . . . . 73.299999999999997 113.842 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.58 142.74 29.76 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.465 0.543 . . . . 62.539999999999999 112.465 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 71' ' ' ARG . 32.1 m -90.19 113.12 24.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.446 -0.343 . . . . 73.200000000000003 111.478 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -97.62 167.59 10.87 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 73.430000000000007 111.745 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -44.2 87.21 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.647 0.61 . . . . 71.129999999999995 112.647 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -169.06 -179.29 3.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.63 0.252 . . . . 63.210000000000001 111.631 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -64.73 -36.22 83.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.752 0.31 . . . . 74.129999999999995 111.698 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.5 t -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.117 0.484 . . . . 64.239999999999995 109.974 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -56.92 -44.11 82.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.644 -0.707 . . . . 74.120000000000005 111.377 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.523 ' HG ' HG22 ' A' ' 66' ' ' VAL . 1.5 tm? -59.37 -50.05 75.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.735 0.302 . . . . 73.230000000000004 110.877 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -56.51 -41.83 77.36 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.867 0.365 . . . . 43.229999999999997 111.283 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -39.53 94.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.027 0.441 . . . . 54.119999999999997 110.741 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -66.24 -22.03 66.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 72.040000000000006 112.499 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -65.55 -47.31 76.29 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.542 0.687 . . . . 72.219999999999999 110.107 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.19 -30.59 65.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.464 0.649 . . . . 73.129999999999995 110.679 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.755 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 23.2 ttt180 -82.78 83.63 7.64 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.279 -0.873 . . . . 74.409999999999997 111.385 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.72 -54.01 4.06 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 114.798 0.679 . . . . 73.109999999999999 114.798 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -115.04 90.94 25.04 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 113.673 0.99 . . . . 73.120000000000005 113.673 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.71 -22.22 73.91 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.845 2.363 . . . . 71.329999999999998 113.072 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.05 -2.79 49.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.364 -0.38 . . . . 72.530000000000001 111.844 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 41' ' ' GLY . 24.3 tp -77.71 118.08 19.74 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.554 0.576 . . . . 63.43 112.554 -172.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -125.87 164.63 20.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.856 -0.611 . . . . 71.430000000000007 110.607 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 53' ' ' LEU . 44.0 t -80.13 128.57 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.955 0.354 . . . . 73.349999999999994 111.955 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 61.7 mtt -74.36 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.448 0.642 . . . . 72.299999999999997 110.273 171.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.45 161.17 24.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.409 -0.814 . . . . 75.510000000000005 110.841 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.573 ' HA ' HG13 ' A' ' 39' ' ' VAL . 78.0 mtt180 -81.62 107.36 14.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.259 0.552 . . . . 65.239999999999995 110.655 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.32 143.91 3.79 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.688 -0.687 . . . . 73.129999999999995 112.076 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.55 ' HG3' HG22 ' A' ' 46' ' ' THR . 65.2 ttt180 -72.36 74.91 1.02 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.814 0.34 . . . . 73.409999999999997 111.819 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 85.7 m 34.84 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.747 1.017 . . . . 71.409999999999997 113.747 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.038 0.447 . . . . 75.230000000000004 110.905 -178.261 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.831 -0.433 . . . . 63.520000000000003 109.831 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 39.4 m -98.22 127.4 44.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 65.409999999999997 111.392 -173.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 7' ' ' VAL . 13.3 t70 -85.77 111.1 19.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.455 . . . . 71.150000000000006 110.879 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 -23.01 0.3 Allowed Glycine 0 CA--C 1.535 1.285 0 N-CA-C 114.421 0.528 . . . . 73.150000000000006 114.421 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 23.6 t -73.98 125.32 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 117.043 0.421 . . . . 72.120000000000005 111.849 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -115.05 110.01 18.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.168 0.508 . . . . 62.409999999999997 111.895 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.3 m -149.1 139.24 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.492 -0.322 . . . . 74.439999999999998 110.878 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.19 -76.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.917 -0.658 . . . . 75.209999999999994 112.972 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.67 130.49 12.65 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.45 2.1 . . . . 62.439999999999998 112.692 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.34 -49.2 3.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.928 -0.653 . . . . 51.200000000000003 112.997 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -121.63 135.7 54.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.902 0.382 . . . . 74.299999999999997 111.433 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.92 145.57 41.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.784 -0.45 . . . . 62.43 109.784 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 31.9 p -99.08 113.38 25.56 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.41 0.624 . . . . 45.43 111.286 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -112.25 149.39 32.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.765 -0.652 . . . . 73.120000000000005 111.214 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 52.6 mtp -88.97 107.57 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 74.109999999999999 111.488 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.5 HD21 ' HG2' ' A' ' 23' ' ' ARG . 3.3 mm? -116.16 103.07 10.17 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.479 -0.328 . . . . 74.230000000000004 110.384 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.45 62.46 5.08 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 64.310000000000002 113.525 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.21 -46.4 3.39 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.203 -0.522 . . . . 64.329999999999998 113.953 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 21' ' ' ARG . 4.8 mpt_? -92.77 125.81 54.06 Favored Pre-proline 0 CA--C 1.541 0.611 0 O-C-N 122.328 -0.513 . . . . 70.049999999999997 111.969 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 96.5 Cg_endo -79.91 110.3 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.648 2.232 . . . . 73.329999999999998 112.094 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 33.6 ptt180 -99.11 158.28 15.78 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.164 -0.335 . . . . 73.319999999999993 111.079 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' CG1' ' A' ' 7' ' ' VAL . 78.2 m -103.14 120.69 41.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.081 0.467 . . . . 55.310000000000002 110.823 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.68 142.86 50.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.978 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' SG ' ' NH1' ' A' ' 59' ' ' ARG . 25.7 p -58.6 105.04 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.223 0.535 . . . . 73.349999999999994 111.562 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 135.9 19.35 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 51.219999999999999 111.174 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.893 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 74.2 Cg_endo -72.56 120.55 6.78 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.288 1.992 . . . . 63.420000000000002 112.486 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.6 -28.2 68.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.265 -0.425 . . . . 64.140000000000001 111.815 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HA ' HD13 ' A' ' 33' ' ' LEU . 79.2 m 73.4 -39.91 0.45 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.649 0.78 . . . . 61.130000000000003 112.609 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -54.12 112.62 1.0 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.109 -0.369 . . . . 75.140000000000001 111.797 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.07 -13.38 11.31 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.503 -0.38 . . . . 75.519999999999996 113.469 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 30' ' ' CYS . 2.5 pp -139.77 164.71 36.2 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 122.403 -0.469 . . . . 75.209999999999994 111.509 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 53.7 Cg_exo -53.96 119.61 6.56 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.548 2.165 . . . . 74.109999999999999 113.446 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.65 18.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 112.04 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.59 -39.08 3.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.849 0.315 . . . . 73.129999999999995 111.849 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -64.8 118.93 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.874 0.368 . . . . 62.340000000000003 110.671 -176.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.39 162.89 2.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.648 0.61 . . . . 64.310000000000002 112.648 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 50' ' ' GLU . 31.3 m -143.84 147.5 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.863 -0.608 . . . . 62.100000000000001 110.471 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.3 t -103.64 126.82 51.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.947 0.403 . . . . 72.219999999999999 110.829 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.47 165.52 44.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.257 -0.497 . . . . 62.039999999999999 113.686 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.602 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 17.2 m -50.61 -28.36 8.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.63 0.604 . . . . 65.5 112.63 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.82 -34.04 75.96 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.086 0.47 . . . . 73.049999999999997 111.947 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.31 -10.0 24.42 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.374 -0.441 . . . . 71.540000000000006 112.236 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.83 134.71 38.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.072 0.463 . . . . 70.019999999999996 111.621 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.0 m -86.66 112.6 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.332 -0.395 . . . . 71.540000000000006 111.337 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.66 160.95 16.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.796 0.332 . . . . 64.310000000000002 111.671 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -61.47 -40.32 94.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 111.783 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -165.91 174.52 9.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.058 -0.519 . . . . 74.200000000000003 110.552 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HA ' HG22 ' A' ' 39' ' ' VAL . 29.5 tt0 -71.74 -27.88 63.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.899 0.381 . . . . 74.209999999999994 111.498 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.893 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 9.1 t -67.56 -39.87 84.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.948 0.404 . . . . 75.310000000000002 110.262 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.42 -46.45 88.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.099 -0.5 . . . . 73.530000000000001 110.82 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -56.74 -42.2 78.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.377 -0.374 . . . . 72.209999999999994 110.739 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.407 HH11 ' HA ' ' A' ' 28' ' ' PRO . 29.6 ttt180 -57.16 -40.29 76.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.102 0.477 . . . . 75.230000000000004 110.899 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.504 ' O ' ' HG2' ' A' ' 59' ' ' ARG . . . -65.41 -50.41 65.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.283 -0.417 . . . . 64.420000000000002 111.019 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.35 -38.45 66.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.989 0.424 . . . . 63.200000000000003 111.728 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -52.9 -46.64 68.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.158 -0.474 . . . . 73.040000000000006 111.022 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.7 t -77.1 -34.01 56.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.349 0.5 . . . . 70.109999999999999 112.349 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 55' ' ' ALA . 37.8 mmt180 -58.33 -48.51 80.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.722 0.296 . . . . 75.140000000000001 111.555 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.14 32.31 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.221 -0.99 . . . . 73.129999999999995 114.26 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -132.39 81.93 59.06 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 117.216 0.508 . . . . 62.219999999999999 111.015 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.32 -34.8 26.06 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.614 2.209 . . . . 63.340000000000003 112.778 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.47 -11.59 60.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 111.978 0.362 . . . . 71.519999999999996 111.978 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.7 tp -77.21 110.35 11.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.518 0.562 . . . . 54.450000000000003 112.518 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -123.92 161.08 26.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.140000000000001 110.323 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 ' HB ' ' A' ' 39' ' ' VAL . 2.7 p -88.34 111.3 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.001 0.429 . . . . 61.200000000000003 111.628 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.602 ' HE1' ' HA ' ' A' ' 42' ' ' SER . 62.9 mtt -63.59 -58.82 5.75 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 110.659 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.2 172.56 17.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.886 -0.597 . . . . 74.019999999999996 110.361 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -78.9 158.65 28.02 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.214 0.53 . . . . 74.040000000000006 111.564 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.4 54.72 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.951 -0.568 . . . . 75.230000000000004 112.562 -174.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -83.61 158.28 21.95 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.541 -0.387 . . . . 73.319999999999993 111.567 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.8 m -67.01 98.16 0.55 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.158 0.504 . . . . 62.149999999999999 111.078 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 . . . . . 0 CA--C 1.541 0.609 0 CA-C-N 115.993 -0.549 . . . . 74.120000000000005 111.046 -177.142 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 120.825 0.345 . . . . 62.229999999999997 111.105 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 24.0 m -124.93 128.32 48.43 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.852 0.358 . . . . 62.409999999999997 111.956 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 7' ' ' VAL . 5.0 m-20 -87.42 110.66 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.442 -0.345 . . . . 72.25 110.429 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.26 -32.21 0.32 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.501 0.56 . . . . 72.120000000000005 114.501 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 38.5 t -65.61 131.7 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 117.194 0.497 . . . . 73.319999999999993 111.976 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -76.57 105.34 7.57 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.95 0.405 . . . . 54.119999999999997 111.648 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.543 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 65.7 m -138.3 179.49 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.932 0.396 . . . . 65.299999999999997 111.206 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.23 -85.3 0.39 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.161 -0.542 . . . . 70.510000000000005 112.574 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -61.23 92.13 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.358 2.038 . . . . 74.019999999999996 112.431 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.97 23.88 72.91 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 115.976 -0.556 . . . . 71.0 114.003 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.1 mtmt -144.26 146.66 32.77 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.655 0.728 . . . . 75.219999999999999 112.957 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.35 149.18 40.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.369 -0.832 . . . . 70.109999999999999 110.163 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 26.6 p -112.44 142.59 44.79 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.328 0.585 . . . . 73.109999999999999 112.499 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 15.2 mmt180 -129.1 163.22 25.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.974 -0.557 . . . . 74.409999999999997 111.332 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.7 mmm -85.68 102.33 13.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.964 0.411 . . . . 74.439999999999998 111.247 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.4 110.44 22.41 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.04 0.447 . . . . 45.340000000000003 110.536 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.85 71.75 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.133 -0.556 . . . . 52.549999999999997 113.188 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.36 -4.77 84.28 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.255 -0.497 . . . . 50.25 113.243 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 21' ' ' ARG . 9.1 mpt_? -114.97 126.24 28.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 122.383 -0.48 . . . . 74.219999999999999 111.361 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 70.9 Cg_endo -74.0 113.85 3.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.471 2.114 . . . . 72.109999999999999 112.901 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -120.77 152.28 38.52 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.121 -0.362 . . . . 64.030000000000001 110.941 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 2.0 t -103.41 140.05 37.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.633 0.605 . . . . 74.299999999999997 112.633 -169.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.54 160.51 33.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.679 -0.691 . . . . 73.109999999999999 109.874 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 p -76.16 140.7 41.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.028 0.442 . . . . 64.430000000000007 111.393 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -118.88 125.17 27.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.262 -0.426 . . . . 72.239999999999995 111.51 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 6.0 Cg_exo -79.59 24.45 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.269 2.646 . . . . 73.129999999999995 114.241 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 54.1 40.25 31.46 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.025 0.44 . . . . 71.319999999999993 111.859 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HA ' HD22 ' A' ' 33' ' ' LEU . 27.3 m -70.4 88.64 0.66 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.217 0.532 . . . . 73.0 112.254 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.8 t -150.93 137.63 18.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.727 -0.67 . . . . 74.120000000000005 110.445 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 -50.32 4.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.04 -0.6 . . . . 61.140000000000001 113.367 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 30' ' ' CYS . 1.8 pt? -66.98 151.87 96.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.821 -0.223 . . . . 73.219999999999999 111.304 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.45 119.3 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 74.040000000000006 112.912 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.85 8.99 11.19 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 73.230000000000004 111.373 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -129.26 15.12 6.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.119 0.485 . . . . 74.140000000000001 110.792 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -125.64 125.4 43.05 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.07 -0.514 . . . . 72.420000000000002 110.025 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -63.55 147.73 50.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.897 0.702 . . . . 54.310000000000002 112.897 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' A' ' 50' ' ' GLU . 35.4 m -138.62 146.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.301 -0.408 . . . . 72.239999999999995 110.676 176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 17.2 t -105.21 131.53 52.56 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.106 0.479 . . . . 74.510000000000005 111.853 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.91 177.82 40.31 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.127 -0.488 . . . . 63.450000000000003 114.015 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.61 ' HA ' ' HE3' ' A' ' 67' ' ' MET . 13.1 m -55.29 -27.79 49.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.695 0.628 . . . . 74.310000000000002 112.695 -177.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.87 8.0 11.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.43 0.53 . . . . 71.129999999999995 112.43 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.052 -0.594 . . . . 53.210000000000001 112.68 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 125.15 36.25 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.502 0.321 . . . . 52.539999999999999 111.072 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 61.7 m -91.38 104.91 17.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.161 0.505 . . . . 74.140000000000001 111.161 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -80.48 157.82 26.06 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.531 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.419 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 63.4 mtt180 -53.32 -33.43 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.66 0.615 . . . . 73.25 112.66 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -170.92 173.16 5.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.939 0.399 . . . . 54.520000000000003 111.54 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HA ' HG23 ' A' ' 39' ' ' VAL . 11.8 tp10 -58.08 -43.6 87.1 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.07 -0.514 . . . . 73.239999999999995 111.63 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.55 -39.95 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.973 0.416 . . . . 75.030000000000001 110.599 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.419 ' OE1' ' HD2' ' A' ' 48' ' ' ARG . 7.5 tp10 -63.25 -44.27 95.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.826 -0.624 . . . . 75.129999999999995 110.866 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.94 -51.66 68.33 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.809 -0.632 . . . . 70.510000000000005 111.269 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.26 -33.27 75.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.714 0.292 . . . . 73.120000000000005 111.74 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.41 65.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.043 0.449 . . . . 74.200000000000003 110.689 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.2 76.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.982 0.42 . . . . 54.049999999999997 111.187 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.524 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -60.64 -50.24 74.28 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.079 -0.51 . . . . 74.519999999999996 110.404 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.77 -35.47 80.15 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.113 -0.494 . . . . 62.219999999999999 111.749 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -59.55 -58.68 7.53 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.506 -0.315 . . . . 74.109999999999999 111.575 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.44 24.92 0.19 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.543 -0.837 . . . . 74.230000000000004 114.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 42.2 m170 -122.38 78.81 45.35 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 122.139 -0.624 . . . . 73.530000000000001 111.144 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.51 -43.49 33.01 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.756 2.304 . . . . 70.340000000000003 113.552 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.53 2.82 39.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.57 0.581 . . . . 74.310000000000002 112.57 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.439 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 66.4 tp -76.64 127.43 32.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.015 0.436 . . . . 75.109999999999999 111.975 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -142.64 152.16 42.18 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.59 -0.277 . . . . 62.340000000000003 110.696 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -81.39 124.73 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.135 0.493 . . . . 52.149999999999999 111.748 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.61 ' HE3' ' HA ' ' A' ' 42' ' ' SER . 62.2 mtt -82.36 -49.64 9.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.11 0.481 . . . . 72.340000000000003 110.783 176.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -159.84 164.29 33.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.916 -0.583 . . . . 73.299999999999997 111.258 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HA ' HG12 ' A' ' 39' ' ' VAL . 49.5 mtm180 -76.8 135.62 38.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 65.230000000000004 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.86 -172.88 20.4 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.271 -0.49 . . . . 65.140000000000001 112.71 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -86.72 149.34 24.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.56 -0.377 . . . . 75.439999999999998 111.675 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 35.3 m -66.08 83.78 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.622 0.725 . . . . 43.409999999999997 111.159 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 115.16 -0.927 . . . . 75.329999999999998 111.812 -179.306 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 109.453 -0.573 . . . . 73.310000000000002 109.453 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.5 m -135.87 127.68 29.26 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.927 -0.483 . . . . 72.010000000000005 111.987 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.514 ' O ' HG21 ' A' ' 7' ' ' VAL . 29.0 t70 -86.67 111.42 20.65 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.676 0.25 . . . . 71.109999999999999 111.676 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 48.65 30.93 9.13 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 114.564 0.586 . . . . 72.140000000000001 114.564 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 5' ' ' ASP . 89.1 t -106.74 122.47 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 117.337 0.568 . . . . 74.150000000000006 111.77 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -92.07 106.73 18.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.612 -0.267 . . . . 72.109999999999999 111.202 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 96.1 m -148.84 138.54 21.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.648 0.261 . . . . 73.040000000000006 111.348 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.98 -141.42 4.33 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 120.894 -0.67 . . . . 41.100000000000001 113.932 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 -13.5 5.58 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.357 2.705 . . . . 72.239999999999995 114.81 -173.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.8 -30.17 9.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.99 -0.624 . . . . 53.329999999999998 113.155 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.7 mtmt -148.5 136.31 20.77 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.609 -0.347 . . . . 54.530000000000001 111.228 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.16 136.07 48.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.577 -0.283 . . . . 74.400000000000006 110.634 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 7.2 p -99.79 122.08 42.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.141 0.496 . . . . 62.020000000000003 111.714 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -119.95 158.84 25.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.144 -0.48 . . . . 75.540000000000006 111.345 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.59 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 3.8 mmt -79.73 102.62 9.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.468 -0.333 . . . . 73.209999999999994 111.597 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 23' ' ' ARG . 6.6 mp -110.77 112.99 25.24 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.929 0.395 . . . . 65.239999999999995 110.118 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.39 29.84 75.77 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.84 -0.695 . . . . 71.209999999999994 112.252 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -0.12 69.17 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.522 -0.37 . . . . 41.299999999999997 113.721 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -115.1 138.44 23.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 72.219999999999999 111.502 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.71 124.33 7.47 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.949 2.432 . . . . 55.240000000000002 114.273 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 8.7 mtp180 -119.69 134.62 55.16 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.965 -0.561 . . . . 74.030000000000001 110.907 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.1 m -103.37 119.82 39.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.886 0.374 . . . . 60.200000000000003 110.987 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -123.07 160.38 26.49 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.935 -0.575 . . . . 63.049999999999997 111.117 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -52.18 106.74 0.16 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.84 0.352 . . . . 73.310000000000002 111.863 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.45 122.87 58.28 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 116.218 -0.447 . . . . 74.510000000000005 112.197 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HB3' ' HA ' ' A' ' 55' ' ' ALA . 72.8 Cg_endo -75.95 -18.81 16.47 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.366 2.044 . . . . 70.230000000000004 112.118 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.1 t70 63.36 96.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.693 0.797 . . . . 74.010000000000005 112.234 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.4 m -121.39 25.84 9.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.389 -0.823 . . . . 63.130000000000003 109.945 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -64.27 103.32 0.62 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.284 -0.871 . . . . 54.340000000000003 113.212 -171.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.75 2.1 88.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.355 0.902 . . . . 73.430000000000007 115.355 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 51' ' ' CYS . 3.7 pp -85.86 153.72 57.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 118.03 0.915 . . . . 75.340000000000003 111.396 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.08 119.4 6.43 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.317 2.011 . . . . 61.310000000000002 112.703 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 76.59 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.028 0.442 . . . . 71.340000000000003 111.06 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 177.51 15.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.991 -0.55 . . . . 74.209999999999994 111.561 -175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.632 HD23 ' HD3' ' A' ' 69' ' ' ARG . 50.9 tp -119.99 105.56 11.16 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.015 0.436 . . . . 73.310000000000002 111.867 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.35 145.18 56.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.029 -0.532 . . . . 52.130000000000003 111.984 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 50' ' ' GLU . 31.4 m -141.13 143.56 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.268 -0.424 . . . . 71.329999999999998 111.043 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.19 125.8 48.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 110.159 -0.312 . . . . 70.120000000000005 110.159 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.404 ' HA2' HD13 ' A' ' 53' ' ' LEU . . . -73.24 169.25 53.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.407 -0.425 . . . . 63.350000000000001 113.765 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 t -65.18 -6.39 9.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.155 0.428 . . . . 74.140000000000001 112.155 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.94 -31.15 14.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.356 0.262 . . . . 72.519999999999996 111.389 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.38 -11.39 7.18 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 121.357 -0.449 . . . . 50.409999999999997 113.778 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.98 134.58 36.26 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.014 0.435 . . . . 42.299999999999997 112.002 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 71' ' ' ARG . 45.8 m -97.17 107.76 20.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.871 0.367 . . . . 54.439999999999998 111.1 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.52 151.62 24.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.395 -0.366 . . . . 74.219999999999999 111.705 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.52 -30.45 65.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.575 0.583 . . . . 71.140000000000001 112.575 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 34.5 t70 -155.29 159.81 40.29 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.758 0.313 . . . . 73.409999999999997 111.548 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 39' ' ' VAL . 39.5 tt0 -58.92 -43.37 91.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.799 0.333 . . . . 64.530000000000001 110.994 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.487 ' HB2' HD12 ' A' ' 33' ' ' LEU . 36.1 t -57.23 -34.99 69.13 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.138 0.494 . . . . 64.519999999999996 111.032 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -65.66 -41.47 92.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.041 -0.527 . . . . 71.409999999999997 111.155 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.404 HD13 ' HA2' ' A' ' 41' ' ' GLY . 9.3 tt -65.03 -42.34 94.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.066 0.46 . . . . 52.530000000000001 110.172 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 54' ' ' ARG . 11.2 mmm180 -54.14 -49.72 68.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.294 0.569 . . . . 72.140000000000001 110.584 175.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . . . -61.13 -42.97 99.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.916 -0.584 . . . . 62.32 111.158 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -55.69 -36.94 67.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.052 -0.522 . . . . 73.340000000000003 111.938 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 76.3 ttt-85 -59.92 -38.16 81.56 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.104 0.478 . . . . 71.219999999999999 111.021 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.0 t -82.68 -15.68 51.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.06 0.457 . . . . 73.25 111.207 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.482 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.9 ttp180 -97.17 49.51 1.06 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.239 0.542 . . . . 74.129999999999995 111.619 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.46 58.97 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 115.068 0.787 . . . . 60.310000000000002 115.068 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 4.0 m-70 -126.76 77.74 73.9 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.144 0.972 . . . . 75.120000000000005 111.972 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.12 -22.87 61.12 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.67 2.247 . . . . 75.439999999999998 113.043 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.84 4.23 54.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.309 -0.405 . . . . 70.329999999999998 111.802 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 56.9 tp -80.46 125.77 30.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.27 0.557 . . . . 75.120000000000005 112.158 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.1 p -136.62 163.8 29.71 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.68 -0.691 . . . . 70.420000000000002 110.475 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.13 124.56 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.006 0.431 . . . . 71.230000000000004 111.194 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.5 mmt -89.59 -53.67 4.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.93 0.395 . . . . 74.549999999999997 111.044 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.98 152.66 42.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 73.25 111.276 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.632 ' HD3' HD23 ' A' ' 37' ' ' LEU . 96.7 mtt180 -82.55 134.73 35.19 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.189 0.519 . . . . 62.409999999999997 111.8 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.27 -161.82 12.83 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.944 -0.571 . . . . 71.409999999999997 112.422 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.554 ' HG2' HG23 ' A' ' 46' ' ' THR . 50.2 mtp180 -86.29 153.61 21.85 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.538 -0.39 . . . . 74.120000000000005 111.286 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.5 m -57.38 112.72 1.49 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.532 0.682 . . . . 71.310000000000002 111.42 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 115.286 -0.87 . . . . 74.200000000000003 112.265 -173.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.592 0.234 . . . . 71.099999999999994 110.461 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 7.4 m -97.86 127.0 43.52 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.793 0.33 . . . . 72.010000000000005 110.439 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.35 110.31 20.69 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 110.241 -0.281 . . . . 74.299999999999997 110.241 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -34.8 0.57 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.147 -0.549 . . . . 72.140000000000001 114.386 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 21.2 t -66.08 140.22 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.156 0.478 . . . . 74.540000000000006 112.2 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -89.65 107.95 19.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.279 -0.419 . . . . 73.140000000000001 111.546 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.3 m -144.65 138.88 27.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.258 -0.428 . . . . 72.319999999999993 111.333 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.24 -95.28 0.1 OUTLIER Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.486 -0.387 . . . . 73.540000000000006 112.336 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.12 111.18 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.368 2.046 . . . . 73.340000000000003 112.334 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.21 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.239 -0.505 . . . . 37.020000000000003 113.862 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.9 mtmt -129.51 160.59 32.72 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.474 0.637 . . . . 65.140000000000001 112.324 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.8 136.03 20.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.358 -0.837 . . . . 73.010000000000005 109.946 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.2 p -101.63 142.37 33.08 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.194 0.521 . . . . 63.420000000000002 111.648 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -132.76 143.92 49.92 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.971 -0.559 . . . . 63.549999999999997 110.629 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.404 ' HA ' ' HE3' ' A' ' 17' ' ' MET . 0.7 OUTLIER -80.25 101.92 9.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.996 0.427 . . . . 71.400000000000006 110.298 177.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.8 mt -125.48 116.07 21.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.408 -0.36 . . . . 75.310000000000002 111.385 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.42 32.75 82.18 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.297 -0.478 . . . . 64.400000000000006 113.019 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.02 77.03 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.429 -0.415 . . . . 72.0 113.077 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.88 135.68 24.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.6 -0.353 . . . . 74.099999999999994 111.548 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.93 98.22 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.444 2.096 . . . . 64.209999999999994 112.716 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 mtp-105 -95.96 123.17 39.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.608 -0.269 . . . . 74.420000000000002 111.0 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.573 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 9.5 t -104.06 120.19 40.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.68 0.276 . . . . 74.450000000000003 110.398 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -129.7 160.89 31.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 74.439999999999998 111.415 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.08 125.01 23.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 111.556 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.13 132.98 20.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 111.909 0.337 . . . . 72.200000000000003 111.909 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.0 112.87 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.923 2.416 . . . . 63.340000000000003 112.899 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.32 133.79 38.68 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.024 0.44 . . . . 62.109999999999999 111.108 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.1 m -124.33 45.09 2.58 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.937 0.399 . . . . 64.219999999999999 111.424 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.9 m -77.01 -76.44 0.17 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.23 0.456 . . . . 72.510000000000005 112.23 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 52.01 3.97 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.247 -0.502 . . . . 71.409999999999997 114.158 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.687 HD12 ' SG ' ' A' ' 51' ' ' CYS . 4.6 pp -155.83 151.56 22.16 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.44 -0.447 . . . . 63.520000000000003 111.497 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 7.3 Cg_exo -73.63 137.7 25.48 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.594 2.196 . . . . 64.230000000000004 112.479 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.77 134.33 56.11 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.224 0.453 . . . . 54.140000000000001 112.224 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 63.59 15.65 9.05 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.828 0.677 . . . . 75.319999999999993 112.828 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.5 tm? -82.71 104.11 12.71 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.851 0.358 . . . . 70.349999999999994 110.84 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.404 ' O ' HD13 ' A' ' 37' ' ' LEU . 80.8 mt-30 -61.12 150.18 34.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.022 -0.535 . . . . 62.43 111.804 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 69' ' ' ARG . 25.5 m -141.52 159.16 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.952 0.353 . . . . 64.349999999999994 111.952 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.568 ' SG ' ' HA2' ' A' ' 44' ' ' GLY . 51.5 t -106.31 122.18 45.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.856 0.36 . . . . 72.439999999999998 111.57 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.38 176.86 54.55 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.327 -0.463 . . . . 52.020000000000003 113.224 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.546 ' HA ' ' HE2' ' A' ' 67' ' ' MET . 29.1 t -58.51 -25.76 62.74 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.4 0.519 . . . . 73.040000000000006 112.4 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.01 -14.4 59.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.025 0.44 . . . . 63.310000000000002 111.688 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.568 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . 85.05 34.62 14.28 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.227 -0.511 . . . . 73.109999999999999 112.952 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.24 148.01 40.89 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.505 0.322 . . . . 51.219999999999999 111.405 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -93.76 115.35 27.77 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.012 0.434 . . . . 75.219999999999999 112.128 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.12 166.1 13.15 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.352 -0.386 . . . . 71.040000000000006 111.149 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -62.23 -38.06 87.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.948 0.404 . . . . 74.420000000000002 111.194 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -166.02 174.07 9.77 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.939 -0.573 . . . . 65.109999999999999 110.743 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HB3' HD21 ' A' ' 33' ' ' LEU . 33.9 tt0 -63.06 -29.48 70.84 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.779 0.323 . . . . 74.450000000000003 111.086 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.687 ' SG ' HD12 ' A' ' 33' ' ' LEU . 62.1 m -58.28 -43.0 87.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.873 0.368 . . . . 72.420000000000002 110.693 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.44 -36.67 76.87 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 111.688 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.4 tt -65.25 -49.29 70.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.883 0.373 . . . . 70.299999999999997 110.372 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -57.31 -46.67 82.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 73.140000000000001 110.29 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.29 87.26 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.778 -0.646 . . . . 51.149999999999999 111.534 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.12 77.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.802 0.334 . . . . 41.240000000000002 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 34.4 mtm180 -61.75 -43.32 99.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.392 0.615 . . . . 72.450000000000003 110.683 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.4 t -78.51 -21.4 48.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.358 -0.837 . . . . 61.399999999999999 111.605 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp85 -90.03 -29.0 18.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.604 0.594 . . . . 74.409999999999997 112.604 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.566 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . -169.9 -37.08 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 119.669 -1.253 . . . . 40.32 115.45 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 83.3 m-70 -110.28 81.78 2.4 Favored Pre-proline 0 N--CA 1.477 0.922 0 CA-C-N 118.059 0.929 . . . . 74.329999999999998 112.553 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 23.8 Cg_exo -64.37 -24.63 64.37 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.497 2.131 . . . . 74.140000000000001 113.405 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.38 -4.65 57.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.981 0.42 . . . . 74.200000000000003 111.609 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 61.4 tp -66.2 112.7 4.07 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.383 0.512 . . . . 72.319999999999993 112.383 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -105.95 151.79 24.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.395 -0.366 . . . . 72.439999999999998 111.166 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.86 127.66 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.846 0.355 . . . . 74.209999999999994 111.236 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.546 ' HE2' ' HA ' ' A' ' 42' ' ' SER . 62.1 mtt -84.69 -55.06 4.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.947 0.403 . . . . 74.109999999999999 111.621 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -147.91 154.9 40.97 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.054 0.454 . . . . 75.510000000000005 111.779 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.438 ' HA ' HG12 ' A' ' 39' ' ' VAL . 94.2 mtt180 -84.2 141.65 30.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.901 -0.59 . . . . 71.400000000000006 111.102 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.45 158.65 14.01 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.858 -0.61 . . . . 54.229999999999997 111.813 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.78 130.81 46.56 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 117.291 0.545 . . . . 73.310000000000002 110.612 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.06 142.84 56.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.942 0.349 . . . . 63.109999999999999 111.942 -172.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 112.209 0.448 . . . . 71.530000000000001 112.209 -174.416 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 m . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.72 0.295 . . . . 73.319999999999993 111.326 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.2 m -139.59 129.0 24.17 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 111.891 0.33 . . . . 72.340000000000003 111.891 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.9 112.26 22.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.056 0.391 . . . . 75.140000000000001 112.056 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.7 56.09 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 114.992 0.757 . . . . 73.400000000000006 114.992 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.4 t -107.24 120.97 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.103 -0.645 . . . . 74.109999999999999 111.004 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 8' ' ' GLU . 0.3 OUTLIER -96.63 109.38 22.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.625 0.726 . . . . 71.010000000000005 111.543 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 95.8 m -148.47 139.67 23.27 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.842 -0.617 . . . . 61.32 110.415 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.9 -98.15 0.17 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.091 -0.576 . . . . 61.420000000000002 113.723 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.12 -62.76 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.672 2.248 . . . . 70.209999999999994 113.962 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.5 58.89 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.144 -0.551 . . . . 54.32 113.922 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 48.8 mtmt -133.81 139.89 46.57 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.304 -0.527 . . . . 71.439999999999998 111.763 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -115.17 137.65 51.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.684 -0.235 . . . . 64.019999999999996 110.396 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 19.0 p -99.68 140.57 33.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.121 0.486 . . . . 75.230000000000004 111.704 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.404 ' HD3' ' OE1' ' A' ' 25' ' ' GLU . 9.5 ptm180 -143.23 163.13 33.8 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.121 -0.49 . . . . 63.43 112.086 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.468 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 1.9 mmt -79.76 104.14 10.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.297 -0.411 . . . . 54.140000000000001 111.526 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.566 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 93.6 mt -120.69 119.09 31.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.67 -0.241 . . . . 75.299999999999997 110.8 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.46 26.36 56.65 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.152 -0.546 . . . . 72.129999999999995 113.554 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.55 82.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.453 -0.403 . . . . 40.210000000000001 113.64 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 18' ' ' LEU . 11.0 ptp180 -128.75 138.15 32.51 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 117.496 0.648 . . . . 62.119999999999997 111.558 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.95 111.59 3.31 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.777 2.318 . . . . 75.219999999999999 113.426 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 97.6 mtt180 -116.34 144.81 43.78 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.342 -0.39 . . . . 71.150000000000006 111.585 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 76.9 m -103.82 135.19 45.83 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.441 -0.345 . . . . 75.049999999999997 111.549 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' OE1' ' HD3' ' A' ' 16' ' ' ARG . 9.7 pt-20 -129.89 161.08 31.64 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.565 -0.289 . . . . 74.439999999999998 111.601 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.7 t -55.03 114.51 1.78 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.37 0.507 . . . . 64.109999999999999 112.37 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -97.2 118.43 64.63 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.452 -0.34 . . . . 73.109999999999999 111.078 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 2.6 Cg_endo -88.16 21.19 1.04 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.217 2.611 . . . . 63.130000000000003 113.944 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 55.74 36.41 27.2 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.903 0.382 . . . . 74.030000000000001 111.951 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' HD23 ' A' ' 33' ' ' LEU . 60.4 m -65.52 78.62 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.458 0.647 . . . . 43.229999999999997 111.637 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -149.88 120.43 7.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.465 -0.788 . . . . 63.530000000000001 110.396 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.15 -40.11 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.134 -0.555 . . . . 63.0 112.679 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 30' ' ' CYS . 3.3 pp -66.09 153.35 92.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.592 -0.357 . . . . 64.5 111.263 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.13 120.42 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.613 2.209 . . . . 37.850000000000001 113.081 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.41 141.17 29.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 111.023 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 63.3 10.86 4.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.134 0.791 . . . . 64.420000000000002 113.134 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.27 110.64 22.69 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.169 -0.678 . . . . 74.340000000000003 109.169 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -54.18 153.94 4.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.804 0.668 . . . . 64.340000000000003 112.804 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 69' ' ' ARG . 22.5 m -136.54 143.06 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.869 -0.605 . . . . 63.25 110.876 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.86 113.44 25.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 62.310000000000002 110.728 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.17 164.96 48.33 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.146 -0.479 . . . . 37.850000000000001 113.937 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.424 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 24.9 p -58.66 -20.98 52.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.307 0.643 . . . . 73.430000000000007 112.393 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.67 -14.31 60.35 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.989 0.424 . . . . 72.049999999999997 111.755 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.1 10.82 59.34 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.128 -0.558 . . . . 64.120000000000005 113.052 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.61 144.58 40.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.866 0.365 . . . . 43.240000000000002 111.416 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.0 m -96.23 129.41 43.55 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.502 -0.317 . . . . 70.0 111.226 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -109.89 168.89 9.09 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.626 0.251 . . . . 75.409999999999997 111.669 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -47.57 -54.92 10.4 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.573 0.583 . . . . 74.129999999999995 112.573 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -164.27 -178.91 5.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.696 0.284 . . . . 74.549999999999997 111.459 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 tp10 -55.37 -45.01 76.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.427 -0.351 . . . . 74.409999999999997 111.185 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.16 -43.08 82.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.098 0.475 . . . . 73.099999999999994 110.915 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.55 -43.23 97.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 111.052 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.514 ' HG ' HD13 ' A' ' 64' ' ' LEU . 10.4 tt -62.4 -45.27 93.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.227 -0.442 . . . . 71.349999999999994 111.349 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.7 mmm180 -62.57 -37.82 87.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.395 0.617 . . . . 70.099999999999994 109.927 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.1 84.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 111.084 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.25 87.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.366 . . . . 65.519999999999996 111.424 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -64.79 -41.29 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.067 0.461 . . . . 75.209999999999994 110.601 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.53 -26.68 67.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.354 0.597 . . . . 52.439999999999998 110.686 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -89.51 58.12 4.23 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.723 -0.671 . . . . 73.129999999999995 111.299 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.78 36.24 93.06 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.926 0.73 . . . . 52.299999999999997 114.926 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 77.9 m80 -135.66 74.96 57.78 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 117.689 0.744 . . . . 72.140000000000001 111.607 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.04 -24.1 75.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.843 2.362 . . . . 53.520000000000003 114.114 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.16 -2.82 42.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.388 0.514 . . . . 74.530000000000001 112.388 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.514 HD13 ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -77.72 111.59 13.67 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.241 0.543 . . . . 63.119999999999997 111.051 -175.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -142.92 152.07 41.65 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.005 -0.543 . . . . 74.420000000000002 110.706 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 53' ' ' LEU . 7.2 p -77.46 132.34 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 121.162 0.506 . . . . 61.149999999999999 112.257 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.424 ' HE1' ' HA ' ' A' ' 42' ' ' SER . 56.9 mtt -92.51 -54.0 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.378 0.609 . . . . 61.32 110.25 173.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -143.36 150.49 39.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 109.909 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 39' ' ' VAL . 77.2 mtt85 -92.18 148.15 22.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.964 0.888 . . . . 72.409999999999997 112.487 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.16 -163.21 12.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 114.977 -1.01 . . . . 53.109999999999999 110.878 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -90.42 142.91 27.26 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.486 0.643 . . . . 70.239999999999995 110.795 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.85 102.49 0.06 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.405 0.621 . . . . 72.340000000000003 112.578 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 . . . . . 0 CA--C 1.54 0.585 0 CA-C-N 115.436 -0.802 . . . . 74.530000000000001 110.326 177.646 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 64.329999999999998 111.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 29.0 m -98.9 128.81 45.17 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.426 -0.352 . . . . 36.5 110.637 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.08 111.26 20.16 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.25 -0.282 . . . . 55.310000000000002 110.313 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.91 -39.62 0.97 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.373 -0.442 . . . . 65.209999999999994 113.932 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 6.2 t -66.62 146.06 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.397 0.517 . . . . 71.239999999999995 112.397 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -102.97 106.62 17.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.11 0.481 . . . . 65.019999999999996 110.554 176.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.26 178.78 8.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.719 0.637 . . . . 74.319999999999993 112.719 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.25 -82.88 0.29 Allowed Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.74 -0.664 . . . . 74.409999999999997 111.78 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.67 92.76 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.765 2.31 . . . . 71.310000000000002 112.854 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.4 -10.3 73.26 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.15 -0.547 . . . . 74.030000000000001 113.473 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 45.1 mtmt -135.29 136.3 41.5 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.273 -0.545 . . . . 72.200000000000003 111.761 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.81 133.52 55.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.206 -0.452 . . . . 70.129999999999995 110.132 173.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 23.8 p -97.92 119.71 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.299 0.571 . . . . 64.530000000000001 110.385 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.2 ttm-85 -124.67 143.8 50.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.73 -0.668 . . . . 64.040000000000006 110.577 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.672 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 3.2 mmt -73.68 100.31 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.203 0.525 . . . . 73.120000000000005 110.694 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 83.9 mt -125.38 107.5 10.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.822 -0.626 . . . . 73.439999999999998 110.104 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.39 -64.89 4.09 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.958 -0.639 . . . . 51.109999999999999 112.532 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.55 -22.48 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.584 -0.817 . . . . 53.329999999999998 114.154 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -98.65 138.67 20.77 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.42 -0.459 . . . . 73.430000000000007 111.425 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.75 93.8 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.991 1.794 . . . . 75.239999999999995 112.093 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.555 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 11.5 ptm180 -106.1 142.55 35.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.889 -0.596 . . . . 70.209999999999994 111.022 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 93.9 m -103.29 138.85 39.51 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 70.439999999999998 111.757 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.5 mm-40 -106.45 156.69 18.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.232 -0.894 . . . . 54.310000000000002 110.061 -175.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.1 t -68.42 97.82 0.79 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.267 -0.642 . . . . 64.0 109.267 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.75 137.67 20.61 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.157 -0.474 . . . . 75.430000000000007 112.238 -171.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 7.7 Cg_exo -73.8 55.25 3.24 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.06 2.506 . . . . 74.120000000000005 112.59 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.51 127.01 18.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.819 0.342 . . . . 74.019999999999996 111.257 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.784 ' HB2' HD12 ' A' ' 33' ' ' LEU . 29.4 p -169.6 40.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.278 -0.419 . . . . 72.540000000000006 111.445 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.9 t -60.38 102.29 0.17 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.913 0.387 . . . . 64.209999999999994 111.705 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.31 -9.28 5.93 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.414 -0.422 . . . . 62.539999999999999 113.027 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 30' ' ' CYS . 95.7 mt -95.32 126.08 47.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 O-C-N 122.64 -0.329 . . . . 63.039999999999999 111.325 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.87 125.15 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.501 2.134 . . . . 65.120000000000005 113.057 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.81 9.93 1.64 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.734 0.642 . . . . 65.25 112.734 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -113.18 9.66 18.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.961 0.41 . . . . 74.439999999999998 111.021 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 52.7 tp -106.83 97.91 7.64 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.755 0.312 . . . . 71.319999999999993 111.115 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.13 148.76 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.239 -0.437 . . . . 73.430000000000007 111.868 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 50' ' ' GLU . 25.0 m -137.21 161.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.359 . . . . 64.519999999999996 111.844 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.7 t -118.05 128.5 54.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.932 0.396 . . . . 74.140000000000001 110.627 173.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.33 177.54 37.91 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.103 -0.57 . . . . 74.439999999999998 114.207 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.633 ' HA ' ' HE2' ' A' ' 67' ' ' MET . 55.1 p -63.78 -14.59 54.04 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.098 0.475 . . . . 71.319999999999993 111.74 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -81.95 -22.55 36.61 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.139 0.495 . . . . 65.319999999999993 111.093 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.54 -8.67 60.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.431 -0.414 . . . . 70.310000000000002 113.294 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.47 134.16 39.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.152 0.427 . . . . 72.340000000000003 112.152 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -86.72 116.25 24.69 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.626 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -100.65 159.68 14.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.036 0.446 . . . . 72.349999999999994 112.116 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -56.9 -35.96 69.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.723 -0.671 . . . . 73.129999999999995 111.163 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.0 p-10 -164.14 169.49 17.68 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.328 -0.851 . . . . 74.010000000000005 110.183 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HB3' HD11 ' A' ' 33' ' ' LEU . 34.4 tt0 -65.36 -33.02 74.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.043 -0.411 . . . . 70.25 111.552 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 49' ' ' ASP . 28.2 m -65.41 -37.89 88.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.884 0.373 . . . . 72.209999999999994 110.435 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.99 -39.51 89.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.244 0.545 . . . . 62.100000000000001 110.603 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.97 -47.12 81.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.291 0.567 . . . . 61.450000000000003 110.31 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -65.26 -22.09 66.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.813 -0.63 . . . . 74.120000000000005 111.03 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.59 -43.42 31.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.055 0.455 . . . . 74.340000000000003 110.876 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.32 64.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.133 0.492 . . . . 71.319999999999993 111.217 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 16.0 tpp85 -54.18 -51.35 64.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.576 . . . . 74.530000000000001 110.273 170.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 62.2 m -68.58 -29.95 68.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.92 -0.582 . . . . 71.549999999999997 111.6 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.19 -32.32 73.68 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.903 0.382 . . . . 75.439999999999998 111.292 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.11 43.9 0.06 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.065 -0.588 . . . . 74.329999999999998 113.469 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -135.33 82.07 41.79 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.345 -0.503 . . . . 74.299999999999997 111.646 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.04 -22.33 41.74 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.795 2.33 . . . . 70.150000000000006 113.415 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -84.23 -19.31 34.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.881 0.372 . . . . 75.510000000000005 111.805 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.6 tp -68.16 112.14 4.92 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.367 0.603 . . . . 71.129999999999995 112.521 -172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.2 p -127.38 163.43 24.04 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.66 -0.7 . . . . 72.109999999999999 109.736 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.63 127.56 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.104 0.478 . . . . 70.420000000000002 111.814 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.633 ' HE2' ' HA ' ' A' ' 42' ' ' SER . 57.4 mtt -90.62 -55.71 3.47 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.093 0.473 . . . . 75.439999999999998 111.406 176.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -148.46 157.15 43.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.864 0.364 . . . . 74.129999999999995 111.217 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -101.49 107.73 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.523 0.677 . . . . 74.129999999999995 111.782 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.88 -179.5 29.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.325 -0.852 . . . . 75.519999999999996 111.514 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -60.33 127.55 32.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.748 0.774 . . . . 62.210000000000001 109.95 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.89 97.96 0.06 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.437 0.637 . . . . 72.109999999999999 111.503 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 . . . . . 0 CA--C 1.537 0.473 0 CA-C-N 115.831 -0.622 . . . . 54.509999999999998 112.114 -175.128 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 120.732 0.301 . . . . 75.230000000000004 111.718 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.8 m -100.1 130.7 46.27 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.781 0.66 . . . . 61.450000000000003 112.781 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.06 124.87 32.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.327 -0.397 . . . . 72.200000000000003 111.445 173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.72 -31.42 2.48 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.689 0.636 . . . . 52.509999999999998 114.689 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 22' ' ' PRO . 36.2 t -66.16 139.69 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 117.276 0.538 . . . . 74.129999999999995 111.626 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.94 103.36 14.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.092 0.405 . . . . 73.349999999999994 112.092 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 57.9 m -152.13 138.84 18.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.369 -0.378 . . . . 70.420000000000002 111.266 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . -139.43 -106.32 0.68 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.737 -0.744 . . . . 63.439999999999998 113.977 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 13.5 Cg_exo -70.8 -49.82 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.843 2.362 . . . . 71.430000000000007 113.415 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.68 66.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.045 -0.598 . . . . 72.430000000000007 113.304 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 49.7 mtmt -128.47 141.26 51.45 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.622 -0.34 . . . . 74.040000000000006 110.985 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.36 133.82 52.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.494 -0.321 . . . . 74.120000000000005 110.169 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.72 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.0 t -100.42 136.52 40.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.339 . . . . 65.329999999999998 111.272 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -134.83 163.67 29.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.08 0.467 . . . . 75.140000000000001 111.465 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.8 mmm -89.85 101.5 14.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.199 0.523 . . . . 72.329999999999998 110.964 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.08 115.48 30.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.215 -0.448 . . . . 65.239999999999995 110.763 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.58 40.54 92.63 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.202 -0.523 . . . . 71.230000000000004 113.418 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 5.92 81.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.9 -0.667 . . . . 62.140000000000001 113.766 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -124.42 129.85 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 117.173 0.486 . . . . 72.319999999999993 111.517 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 7' ' ' VAL . 61.1 Cg_endo -72.55 106.2 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.497 2.131 . . . . 62.409999999999997 112.787 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -115.33 142.81 46.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.881 0.372 . . . . 72.209999999999994 111.277 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 9.4 m -103.92 142.83 33.74 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.102 0.477 . . . . 72.109999999999999 112.203 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -143.6 153.38 42.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.74 -0.664 . . . . 73.030000000000001 110.684 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.6 t -52.83 128.23 26.13 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.176 0.512 . . . . 63.140000000000001 111.929 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.71 128.21 30.51 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.162 -0.472 . . . . 72.5 111.67 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.95 -2.84 12.39 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.264 1.976 . . . . 73.239999999999995 112.645 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.425 ' HB3' ' NH1' ' A' ' 54' ' ' ARG . 36.2 t70 62.14 7.22 2.08 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.633 0.73 . . . . 74.299999999999997 111.645 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.491 ' HA ' HD22 ' A' ' 33' ' ' LEU . 33.8 t -80.53 92.63 5.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.887 -0.597 . . . . 73.319999999999993 112.197 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 p -138.43 -83.01 0.3 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.205 -0.452 . . . . 70.140000000000001 111.1 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.19 49.52 2.71 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.966 -0.635 . . . . 72.319999999999993 113.123 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 30' ' ' CYS . 2.6 pp -132.71 159.05 74.11 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 122.46 0.304 . . . . 60.310000000000002 111.08 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.95 119.09 6.11 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.367 2.045 . . . . 64.219999999999999 113.502 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.17 66.35 8.46 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.886 -0.783 . . . . 74.049999999999997 108.886 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -143.87 -13.38 0.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.909 0.707 . . . . 73.319999999999993 112.909 -165.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 68.1 tp -128.05 116.83 20.61 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.712 0.634 . . . . 74.450000000000003 112.712 -168.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -58.57 154.74 13.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.156 -0.475 . . . . 72.530000000000001 111.405 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.6 m -140.79 148.5 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.236 0.541 . . . . 70.0 111.846 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.0 t -100.03 116.37 31.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.288 -0.414 . . . . 73.329999999999998 110.593 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.34 162.18 34.73 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.215 -0.517 . . . . 73.209999999999994 113.63 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 73.8 p -55.14 -28.0 49.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.117 0.484 . . . . 42.530000000000001 111.654 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.4 -47.47 83.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.869 -0.605 . . . . 74.319999999999993 111.817 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.13 -23.38 5.84 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.335 -0.459 . . . . 62.100000000000001 112.531 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.9 139.89 36.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.993 0.425 . . . . 74.099999999999994 111.824 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -86.68 122.75 31.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.008 0.432 . . . . 71.109999999999999 111.092 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.73 153.73 17.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.442 . . . . 73.209999999999994 111.331 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -62.16 -25.71 67.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.825 -0.625 . . . . 61.450000000000003 112.606 -173.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 25.0 t70 -170.45 159.89 7.19 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.595 -0.275 . . . . 73.439999999999998 110.782 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.67 -40.21 68.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.314 0.578 . . . . 62.509999999999998 110.538 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.8 t -52.99 -42.69 65.81 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.286 -0.87 . . . . 71.040000000000006 111.471 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.98 -43.73 57.11 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.336 -0.393 . . . . 71.340000000000003 111.336 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.47 HD21 HG22 ' A' ' 66' ' ' VAL . 69.2 tp -55.17 -58.33 8.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.137 0.494 . . . . 72.230000000000004 112.208 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 78.3 mtp180 -70.69 -25.05 62.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 111.781 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 59' ' ' ARG . . . -72.76 -45.28 59.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 70.420000000000002 111.146 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.93 68.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.087 0.47 . . . . 73.239999999999995 110.771 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 54' ' ' ARG . 31.6 ttp180 -56.03 -50.02 72.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.579 -0.737 . . . . 73.099999999999994 110.642 171.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -66.28 -22.38 66.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.744 -0.662 . . . . 62.229999999999997 112.129 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 55' ' ' ALA . 29.5 mtp-105 -84.99 30.31 0.59 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.205 0.446 . . . . 73.329999999999998 112.205 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.75 6.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.965 -0.636 . . . . 64.510000000000005 114.279 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -134.46 77.54 59.16 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 117.294 0.547 . . . . 74.530000000000001 110.974 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.88 -21.15 38.18 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.872 2.382 . . . . 71.099999999999994 113.526 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.91 -17.64 52.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.989 0.423 . . . . 54.240000000000002 111.418 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 tp -72.26 112.0 7.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.195 0.521 . . . . 74.109999999999999 111.527 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -135.13 164.46 27.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.017 -0.538 . . . . 65.040000000000006 111.356 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.47 HG22 HD21 ' A' ' 53' ' ' LEU . 39.8 t -79.45 119.24 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.841 0.353 . . . . 71.209999999999994 111.862 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.417 ' HE1' ' HA ' ' A' ' 42' ' ' SER . 15.3 mmt -81.92 -58.73 2.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.978 0.418 . . . . 73.049999999999997 110.579 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -161.58 160.91 29.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.801 -0.636 . . . . 70.340000000000003 111.2 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -77.78 137.59 38.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.271 -0.422 . . . . 75.129999999999995 111.569 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.61 172.27 30.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.264 -0.493 . . . . 72.519999999999996 113.127 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' ARG . 63.3 ttt180 -60.15 154.59 19.2 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.634 -0.333 . . . . 70.150000000000006 110.2 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.17 84.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 73.230000000000004 112.502 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' ARG . 57.8 mtp180 . . . . . 0 N--CA 1.469 0.524 0 C-N-CA 123.123 0.569 . . . . 64.439999999999998 111.319 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 120.999 0.428 . . . . 72.340000000000003 111.736 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.4 p -98.72 130.78 45.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.018 0.437 . . . . 70.239999999999995 112.169 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -80.51 126.46 31.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.081 0.467 . . . . 64.140000000000001 111.521 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.34 -2.2 16.05 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.002 -0.544 . . . . 73.129999999999995 113.945 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 10.9 t -107.17 145.83 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 117.118 0.459 . . . . 64.310000000000002 111.326 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.12 106.41 15.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.635 -0.506 . . . . 64.120000000000005 109.635 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 87.9 m -138.91 139.1 37.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.923 0.392 . . . . 75.430000000000007 111.048 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' LYS . . . 169.97 -64.05 0.17 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.393 -0.432 . . . . 63.32 113.076 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.36 42.83 1.3 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.154 2.569 . . . . 74.549999999999997 113.69 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.79 -45.01 0.43 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.158 -0.544 . . . . 73.409999999999997 112.424 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 36.8 mtmm -122.65 136.92 55.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.492 0.317 . . . . 75.140000000000001 110.263 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -107.23 134.35 50.45 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 122.381 -0.2 . . . . 42.340000000000003 111.108 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.857 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 31.5 p -114.77 139.64 49.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.668 0.618 . . . . 54.310000000000002 112.668 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.551 HH11 ' HG3' ' A' ' 16' ' ' ARG . 29.1 ttm-85 -142.5 160.52 40.13 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.958 -0.565 . . . . 72.200000000000003 111.152 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.517 ' HE1' ' HA ' ' A' ' 17' ' ' MET . 1.2 mmt -82.53 107.91 15.53 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.577 0.584 . . . . 72.010000000000005 112.577 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.584 HD21 ' HD2' ' A' ' 23' ' ' ARG . 6.3 mp -123.45 102.0 7.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.871 0.367 . . . . 75.200000000000003 110.938 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.65 52.57 52.22 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.403 -0.427 . . . . 43.530000000000001 114.018 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.45 -44.37 3.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.205 -0.521 . . . . 74.150000000000006 113.811 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.04 130.76 35.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 75.140000000000001 111.716 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.07 141.05 12.83 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.515 2.143 . . . . 52.32 112.922 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.584 ' HD2' HD21 ' A' ' 18' ' ' LEU . 97.3 mtt180 -113.79 123.32 49.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.764 -0.198 . . . . 65.019999999999996 111.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.857 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 94.9 m -107.36 120.1 41.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.647 0.261 . . . . 75.0 110.988 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -119.74 159.23 24.9 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.341 -0.225 . . . . 75.519999999999996 111.525 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 58' ' ' CYS . 8.9 t -58.72 95.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.293 -0.412 . . . . 74.319999999999993 110.869 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.8 130.99 24.6 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.329 -0.396 . . . . 75.409999999999997 111.887 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -82.68 -158.87 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.672 2.248 . . . . 72.510000000000005 111.842 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.27 102.14 14.81 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.854 -0.529 . . . . 75.450000000000003 110.994 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.7 m -102.87 3.96 37.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.159 0.504 . . . . 73.25 110.56 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -81.37 -35.28 31.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.953 -0.567 . . . . 75.040000000000006 111.99 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.93 9.08 78.81 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.919 -0.658 . . . . 53.420000000000002 114.389 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 51' ' ' CYS . 4.1 pp -128.62 156.36 77.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 117.578 0.689 . . . . 74.319999999999993 112.087 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.56 123.19 2.49 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.677 2.251 . . . . 74.120000000000005 112.963 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.87 14.68 0.48 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.77 0.656 . . . . 72.040000000000006 112.77 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.01 10.04 13.85 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.11 -0.369 . . . . 72.519999999999996 111.78 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -111.06 100.19 8.92 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.205 -0.31 . . . . 73.209999999999994 110.798 -177.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.22 139.36 57.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.877 0.37 . . . . 73.019999999999996 111.974 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.627 HG12 ' HG3' ' A' ' 69' ' ' ARG . 26.2 m -128.72 166.25 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.142 0.496 . . . . 72.329999999999998 111.811 -175.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.0 t -116.34 124.16 49.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.224 -0.444 . . . . 53.32 111.254 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.02 161.56 24.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.124 -0.56 . . . . 71.299999999999997 113.497 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 p -55.54 -24.13 30.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.404 0.52 . . . . 74.530000000000001 112.404 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.2 -2.5 28.22 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 120.877 0.37 . . . . 73.439999999999998 111.674 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.11 25.06 58.39 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.424 -0.417 . . . . 38.57 113.244 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.41 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.928 0.394 . . . . 72.200000000000003 111.832 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 71' ' ' ARG . 81.2 m -86.36 110.95 20.04 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.279 -0.419 . . . . 74.310000000000002 110.862 174.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -91.16 159.8 15.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 71.239999999999995 111.673 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 3.9 mmp_? -53.04 -39.68 63.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.112 -0.494 . . . . 74.120000000000005 112.223 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 5.5 p-10 -163.93 -178.48 5.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.281 -0.418 . . . . 75.530000000000001 110.821 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HB3' HD21 ' A' ' 33' ' ' LEU . 24.7 tt0 -68.85 -37.28 79.02 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.673 0.273 . . . . 75.25 111.589 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.585 ' HB2' HD12 ' A' ' 33' ' ' LEU . 25.3 t -65.5 -41.71 92.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.657 0.265 . . . . 64.420000000000002 110.667 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.25 -51.48 53.65 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.209 0.528 . . . . 63.240000000000002 111.122 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.4 -53.84 46.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.915 -0.584 . . . . 64.200000000000003 110.984 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' NH1' HD23 ' A' ' 33' ' ' LEU . 70.0 mtp180 -61.75 -29.86 70.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 111.977 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.32 -42.8 68.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.985 0.421 . . . . 63.329999999999998 110.812 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.35 88.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.862 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 36.8 ttt85 -63.39 -48.06 79.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.086 0.47 . . . . 52.43 111.236 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.486 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 5.6 t -55.47 -44.42 76.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.933 -0.576 . . . . 71.400000000000006 110.468 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -84.21 61.9 6.81 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.255 0.55 . . . . 64.450000000000003 112.147 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.05 25.28 49.51 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.58 0.992 . . . . 54.210000000000001 115.58 170.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.476 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 95.4 m-70 -134.81 74.88 63.27 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 118.222 1.011 . . . . 75.310000000000002 112.132 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.96 -19.76 17.64 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.608 2.206 . . . . 63.539999999999999 113.494 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.0 -22.52 42.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.083 0.468 . . . . 65.040000000000006 111.067 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.448 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 63.9 tp -75.12 111.74 10.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.184 -0.462 . . . . 62.200000000000003 111.264 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 p -124.75 141.97 51.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.003 0.43 . . . . 74.329999999999998 111.638 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.24 113.71 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.305 0.574 . . . . 75.329999999999998 111.289 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.64 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 28.0 mmt -77.01 -42.44 38.65 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.962 0.41 . . . . 72.030000000000001 111.416 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -169.03 163.0 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.085 -0.507 . . . . 75.230000000000004 111.217 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.627 ' HG3' HG12 ' A' ' 39' ' ' VAL . 1.3 mpp_? -93.34 153.72 18.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.387 -0.37 . . . . 72.549999999999997 111.336 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.99 49.69 2.42 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.366 -0.445 . . . . 38.57 113.514 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 46' ' ' THR . 59.7 mtp85 61.47 172.08 0.11 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.894 0.701 . . . . 75.400000000000006 112.894 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.2 m -81.32 112.28 18.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 72.510000000000005 111.646 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 . . . . . 0 CA--C 1.54 0.571 0 CA-C-N 116.053 -0.522 . . . . 74.209999999999994 110.765 178.104 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.832 0.348 . . . . 74.150000000000006 111.625 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 m -97.1 130.56 44.36 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.856 0.36 . . . . 71.450000000000003 111.173 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -84.21 112.1 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.738 0.304 . . . . 75.540000000000006 111.454 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.28 0.01 9.6 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 114.67 0.628 . . . . 74.439999999999998 114.67 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.551 HG11 ' SG ' ' A' ' 9' ' ' CYS . 2.3 t -107.41 137.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 117.691 0.745 . . . . 51.340000000000003 111.819 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.46 106.03 18.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.797 0.332 . . . . 71.329999999999998 110.195 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.551 ' SG ' HG11 ' A' ' 7' ' ' VAL . 59.0 m -142.96 177.35 8.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.848 0.356 . . . . 74.109999999999999 111.908 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.87 -88.07 0.3 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.495 -0.383 . . . . 51.210000000000001 112.272 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.66 93.64 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.482 2.121 . . . . 64.439999999999998 112.925 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.0 10.89 82.26 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.034 -0.53 . . . . 72.129999999999995 113.432 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -146.98 136.29 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.386 -0.479 . . . . 74.420000000000002 111.484 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.1 140.21 52.28 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.594 -0.275 . . . . 73.340000000000003 110.802 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 15.8 p -100.1 106.24 17.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.402 0.62 . . . . 64.510000000000005 111.942 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -106.69 122.14 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.655 -0.702 . . . . 73.099999999999994 110.253 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 54.2 mtp -80.54 106.71 12.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.394 0.616 . . . . 64.129999999999995 111.883 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD13 ' HD2' ' A' ' 23' ' ' ARG . 92.9 mt -116.75 112.94 21.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.81 -0.632 . . . . 65.109999999999999 110.995 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.59 22.85 74.42 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.964 -0.636 . . . . 40.219999999999999 113.101 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.97 -21.12 44.86 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.337 -0.459 . . . . 71.310000000000002 113.627 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -106.08 131.78 21.45 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 117.22 0.51 . . . . 73.420000000000002 111.98 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 59.0 Cg_endo -73.36 111.6 3.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.436 2.091 . . . . 72.430000000000007 112.418 174.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.66 ' HD2' HD13 ' A' ' 18' ' ' LEU . 95.2 mtt180 -96.06 146.42 24.65 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.242 -0.286 . . . . 74.310000000000002 111.4 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 21.8 m -132.67 133.07 43.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.101 0.477 . . . . 53.310000000000002 111.191 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.16 161.23 37.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.015 -0.539 . . . . 71.239999999999995 110.11 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.8 t -54.05 95.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.033 0.444 . . . . 70.0 111.855 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.26 136.59 24.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.678 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.45 90.84 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.421 2.081 . . . . 75.450000000000003 113.314 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.77 -70.5 0.25 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.921 0.391 . . . . 71.140000000000001 110.599 172.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.6 m 55.55 72.79 0.46 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.678 0.621 . . . . 72.230000000000004 112.678 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.8 m -85.28 -29.72 24.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.976 0.417 . . . . 70.439999999999998 110.893 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -65.52 1.54 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.28 -0.418 . . . . 62.439999999999998 113.333 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 33' ' ' LEU . 2.3 pt? -74.13 141.78 78.21 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.989 0.423 . . . . 75.239999999999995 111.993 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 16.1 Cg_exo -70.49 120.8 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.776 2.318 . . . . 71.530000000000001 112.574 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.15 60.35 1.04 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.345 0.593 . . . . 74.140000000000001 111.089 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -151.24 -35.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.578 -0.737 . . . . 71.019999999999996 110.937 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 66.3 tp -67.76 107.99 2.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.278 -0.419 . . . . 73.219999999999999 111.744 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.63 149.82 38.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.5 0.666 . . . . 70.420000000000002 112.744 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 69' ' ' ARG . 34.3 m -139.78 153.62 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 115.649 -0.705 . . . . 50.0 110.899 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.8 t -106.42 122.34 46.09 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.885 0.374 . . . . 74.209999999999994 111.256 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.6 165.12 40.21 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.05 -0.595 . . . . 60.240000000000002 113.648 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 p -53.53 -36.82 62.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.017 0.377 . . . . 71.209999999999994 112.017 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.06 -27.92 62.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 116.305 -0.407 . . . . 72.340000000000003 111.968 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.73 -3.0 34.05 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.174 -0.536 . . . . 55.140000000000001 113.099 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.28 142.73 27.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.98 0.419 . . . . 73.329999999999998 111.911 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.0 m -92.0 120.35 32.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.929 0.395 . . . . 72.409999999999997 110.33 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -97.12 148.55 22.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.529 -0.305 . . . . 64.140000000000001 111.11 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 19.9 ptp180 -49.51 -34.53 17.41 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.432 0.53 . . . . 74.140000000000001 112.432 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.2 p30 -160.75 176.69 11.22 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.885 0.374 . . . . 75.319999999999993 111.286 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HA ' HG23 ' A' ' 39' ' ' VAL . 35.2 tt0 -65.45 -33.61 76.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.412 -0.358 . . . . 73.049999999999997 111.885 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.32 -36.15 82.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.603 0.24 . . . . 61.009999999999998 111.1 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.63 -48.71 80.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.98 0.419 . . . . 74.010000000000005 110.818 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.6 -55.57 32.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.182 0.515 . . . . 74.510000000000005 110.397 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -58.8 -34.66 71.75 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.994 -0.548 . . . . 75.040000000000006 111.956 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.92 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.586 0.231 . . . . 73.239999999999995 111.485 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.57 86.09 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 73.439999999999998 111.348 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 1.6 tmt_? -59.42 -50.14 75.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.609 0.719 . . . . 73.25 109.99 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.76 -30.05 69.77 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.452 -0.794 . . . . 74.409999999999997 111.455 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.95 74.61 6.42 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.075 -0.512 . . . . 74.329999999999998 111.312 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.64 34.97 90.43 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 115.224 0.85 . . . . 73.420000000000002 115.224 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 77.8 m80 -135.04 89.05 25.07 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 117.96 0.88 . . . . 73.329999999999998 111.925 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.56 -18.18 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.01 2.473 . . . . 71.409999999999997 113.176 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -19.61 44.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.889 0.376 . . . . 74.219999999999999 111.916 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 tp -82.97 130.65 35.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.006 0.432 . . . . 74.519999999999996 112.001 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -146.72 161.26 40.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.283 -0.417 . . . . 74.5 110.78 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t -80.48 112.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 120.966 0.412 . . . . 64.040000000000006 111.372 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.62 ' HE1' ' HA ' ' A' ' 67' ' ' MET . 24.6 mmt -84.18 -55.91 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.21 0.529 . . . . 71.109999999999999 110.668 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -159.51 152.93 22.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.917 -0.583 . . . . 74.209999999999994 110.706 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HG2' HG12 ' A' ' 39' ' ' VAL . 91.3 mtt180 -79.57 150.48 31.07 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.062 0.458 . . . . 73.430000000000007 111.195 177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.84 -178.34 29.64 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.978 -0.555 . . . . 38.460000000000001 112.177 -173.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -75.03 161.91 29.03 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.265 -0.55 . . . . 73.219999999999999 111.388 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.42 93.68 0.24 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.159 0.799 . . . . 74.150000000000006 113.159 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 . . . . . 0 CA--C 1.538 0.51 0 CA-C-N 115.413 -0.812 . . . . 71.540000000000006 110.88 176.624 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 110.268 -0.271 . . . . 73.430000000000007 110.268 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.0 m -120.56 131.13 54.52 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.276 0.472 . . . . 63.350000000000001 112.276 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.415 ' O ' HG21 ' A' ' 7' ' ' VAL . 9.5 m-20 -83.45 112.13 19.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.21 -0.45 . . . . 75.319999999999993 111.726 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.72 32.08 16.87 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.757 0.663 . . . . 74.200000000000003 114.757 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 22' ' ' PRO . 93.1 t -106.96 122.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.541 0.67 . . . . 62.219999999999999 111.542 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -99.26 105.97 18.05 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.329 0.585 . . . . 72.140000000000001 111.747 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 80.9 m -148.34 137.95 22.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.002 -0.545 . . . . 52.409999999999997 110.127 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.74 -86.9 0.06 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 119.897 -1.144 . . . . 73.430000000000007 114.635 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.56 -35.64 80.47 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.12 2.547 . . . . 74.219999999999999 113.901 -172.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.96 -45.35 1.39 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.988 -0.625 . . . . 65.120000000000005 113.634 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.8 mtmt -123.63 146.87 47.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.489 0.552 . . . . 71.510000000000005 112.489 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -116.67 145.94 43.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 65.329999999999998 110.494 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.75 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 26.8 p -104.03 133.99 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.154 0.502 . . . . 64.310000000000002 112.198 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.474 ' NH2' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -118.86 164.26 15.68 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.987 -0.551 . . . . 73.430000000000007 111.161 176.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.633 ' HE1' ' HA ' ' A' ' 17' ' ' MET . 4.8 mmt -82.11 102.94 11.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.891 0.377 . . . . 64.120000000000005 111.274 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.83 103.41 12.66 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.871 0.367 . . . . 70.420000000000002 110.212 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.18 33.01 82.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.341 -0.457 . . . . 71.239999999999995 112.686 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.34 -12.97 57.27 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.369 -0.443 . . . . 52.200000000000003 113.047 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 94.9 mtt180 -99.19 129.31 29.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 O-C-N 122.616 -0.343 . . . . 72.200000000000003 111.602 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.645 ' HB2' HG23 ' A' ' 7' ' ' VAL . 1.9 Cg_endo -80.95 113.75 2.8 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.966 2.444 . . . . 73.109999999999999 112.877 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -123.14 140.62 52.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.789 0.328 . . . . 74.519999999999996 111.472 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.75 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.4 m -104.1 131.74 51.06 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.894 0.701 . . . . 74.519999999999996 112.894 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . 86.0 mt-10 -124.83 159.97 29.81 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.252 -0.431 . . . . 74.310000000000002 110.235 172.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.5 t -64.68 119.32 10.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.102 0.477 . . . . 62.210000000000001 111.415 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -108.82 138.38 20.31 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.794 0.664 . . . . 61.020000000000003 112.794 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.4 Cg_exo -77.74 130.69 10.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.952 2.435 . . . . 64.030000000000001 112.229 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 10.8 t0 -66.04 84.89 0.09 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.35 0.595 . . . . 71.329999999999998 110.816 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 87.4 m -105.18 39.66 1.68 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.19 -0.459 . . . . 75.349999999999994 112.074 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -69.12 83.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.12 0.486 . . . . 74.400000000000006 111.855 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.9 52.61 11.25 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.615 0.606 . . . . 64.219999999999999 114.615 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.758 HD12 ' SG ' ' A' ' 51' ' ' CYS . 4.4 pp -114.0 157.08 43.0 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 117.394 0.597 . . . . 61.43 111.258 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.81 119.92 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.264 1.976 . . . . 73.030000000000001 112.784 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.01 -9.96 59.37 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.297 0.48 . . . . 73.540000000000006 112.297 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -90.22 -9.63 47.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.538 -0.301 . . . . 72.450000000000003 111.795 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.3 tp -98.85 117.35 33.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.002 0.43 . . . . 73.019999999999996 112.113 -174.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 46.7 mt-30 -75.72 159.82 30.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 73.409999999999997 110.827 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.0 m -144.4 148.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 112.332 0.493 . . . . 73.129999999999995 112.332 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 34.2 m -104.67 126.7 52.01 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.347 -0.388 . . . . 42.219999999999999 111.676 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.27 162.91 22.84 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.174 -0.536 . . . . 74.540000000000006 112.711 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.624 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 46.9 t -57.36 -18.23 16.33 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.206 0.447 . . . . 72.510000000000005 112.206 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.4 -38.51 80.75 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.935 0.398 . . . . 53.439999999999998 111.607 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.0 4.3 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.106 -0.569 . . . . 73.109999999999999 113.041 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.82 148.5 29.96 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.123 0.487 . . . . 44.329999999999998 112.155 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 71' ' ' ARG . 96.2 m -86.18 137.38 32.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.714 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -106.68 143.66 34.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.474 -0.33 . . . . 74.430000000000007 111.452 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 68.5 mtt180 -43.71 -39.29 3.6 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.031 0.752 . . . . 74.109999999999999 113.031 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 38' ' ' GLN . 3.3 p30 -167.04 172.11 10.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.838 0.352 . . . . 75.129999999999995 111.278 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG3' HD21 ' A' ' 33' ' ' LEU . 13.4 tp10 -58.16 -34.12 69.95 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.491 -0.322 . . . . 71.230000000000004 111.765 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.758 ' SG ' HD12 ' A' ' 33' ' ' LEU . 62.9 m -71.05 -34.67 71.46 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.864 -0.523 . . . . 64.219999999999999 111.164 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.69 -46.86 87.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 73.129999999999995 110.65 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.82 -40.46 95.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 70.510000000000005 109.799 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -59.54 -24.76 63.97 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.706 -0.679 . . . . 65.109999999999999 111.084 175.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.09 -35.18 17.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.131 -0.486 . . . . 64.450000000000003 111.146 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.44 -29.41 69.0 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.191 0.441 . . . . 55.340000000000003 112.191 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 20.2 ptt180 -55.43 -29.09 57.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.843 173.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.5 t -82.65 -18.8 39.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.396 -0.82 . . . . 70.219999999999999 111.174 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -107.03 89.42 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.062 0.458 . . . . 63.32 111.481 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.78 -17.13 1.29 Allowed Glycine 0 CA--C 1.536 1.35 0 N-CA-C 115.321 0.888 . . . . 71.530000000000001 115.321 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.573 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 61.4 m80 -122.83 74.89 47.2 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 118.243 1.021 . . . . 71.019999999999996 112.2 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.1 -23.0 29.72 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.255 1.97 . . . . 71.319999999999993 112.957 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -96.21 10.38 38.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.456 -0.338 . . . . 75.120000000000005 111.742 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 tp -62.96 115.55 4.5 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.342 0.497 . . . . 54.149999999999999 112.342 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.2 m -114.14 163.76 14.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.251 -0.431 . . . . 73.25 111.344 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 53' ' ' LEU . 39.8 t -90.91 127.34 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.084 0.402 . . . . 73.319999999999993 112.084 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.624 ' HE1' ' HA ' ' A' ' 42' ' ' SER . 58.3 mtt -73.16 -53.77 10.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 63.299999999999997 110.483 173.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -168.01 167.82 12.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.804 -0.634 . . . . 74.120000000000005 110.462 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 150.06 25.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.186 0.517 . . . . 75.519999999999996 111.388 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.48 -162.0 15.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.849 -0.614 . . . . 64.519999999999996 112.456 -176.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' HG2' HG22 ' A' ' 46' ' ' THR . 73.3 mtm180 -98.41 147.25 24.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.938 0.399 . . . . 75.040000000000006 111.201 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 73.3 m -62.93 106.97 0.9 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.885 0.698 . . . . 62.409999999999997 112.885 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 . . . . . 0 CA--C 1.539 0.548 0 CA-C-N 116.066 -0.516 . . . . 71.319999999999993 110.863 175.656 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.809 0.338 . . . . 38.840000000000003 111.351 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.607 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 54.5 m -140.43 140.44 35.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.203 0.445 . . . . 71.450000000000003 112.203 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 7' ' ' VAL . 22.5 t70 -50.77 111.83 0.61 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.415 0.524 . . . . 75.219999999999999 112.415 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.68 10.92 26.98 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.375 0.51 . . . . 65.209999999999994 114.375 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.629 HG22 ' HB2' ' A' ' 22' ' ' PRO . 17.2 t -107.91 122.92 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 122.208 -0.583 . . . . 71.420000000000002 111.726 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.27 106.68 17.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.647 0.26 . . . . 75.510000000000005 110.416 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.594 ' SG ' HG11 ' A' ' 7' ' ' VAL . 47.8 m -148.9 163.05 38.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.975 0.417 . . . . 63.130000000000003 111.655 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.92 -84.02 0.11 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.138 -0.483 . . . . 75.109999999999999 112.493 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.6 108.76 2.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.56 2.174 . . . . 75.209999999999994 112.52 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.69 6.38 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.88 -0.676 . . . . 75.329999999999998 113.109 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -142.85 136.9 29.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 117.164 0.482 . . . . 53.439999999999998 111.479 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.86 146.58 32.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.194 -0.457 . . . . 71.319999999999993 110.54 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 52.7 t -104.25 141.03 37.0 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.568 0.581 . . . . 73.209999999999994 112.568 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -142.46 132.86 24.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.008 -0.542 . . . . 74.400000000000006 110.393 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 67.9 mtp -86.75 121.1 28.78 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.133 0.492 . . . . 73.549999999999997 112.245 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.7 mt -112.8 118.1 34.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.806 -0.634 . . . . 75.049999999999997 110.58 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.06 30.61 67.16 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.045 -0.598 . . . . 61.310000000000002 113.384 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.18 -8.99 78.84 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.235 -0.507 . . . . 75.420000000000002 113.553 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.496 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 95.9 mtt180 -113.46 120.55 39.49 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 122.424 -0.456 . . . . 74.530000000000001 111.091 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HB2' HG22 ' A' ' 7' ' ' VAL . 7.1 Cg_exo -75.29 143.69 28.45 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.037 2.491 . . . . 72.209999999999994 114.401 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 17.8 mmt180 -125.11 139.41 53.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.119 0.568 . . . . 73.140000000000001 110.814 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 89.4 m -122.28 118.97 29.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.986 0.422 . . . . 70.409999999999997 112.015 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -130.81 161.84 30.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.101 -0.5 . . . . 72.530000000000001 110.659 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 10.5 t -37.65 124.93 1.1 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.537 0.94 . . . . 72.549999999999997 113.537 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.02 143.84 27.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.779 -0.646 . . . . 74.040000000000006 111.306 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.15 52.7 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.469 2.113 . . . . 73.530000000000001 113.337 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.945 0.402 . . . . 52.5 110.456 173.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.544 ' HB2' HD22 ' A' ' 33' ' ' LEU . 24.8 p -134.37 23.4 3.76 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.795 0.665 . . . . 73.340000000000003 112.795 -171.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.2 t -65.19 106.38 1.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.874 0.368 . . . . 70.450000000000003 111.315 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.38 -42.87 0.92 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.758 -0.734 . . . . 73.409999999999997 113.499 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 50' ' ' GLU . 3.4 pp -67.66 152.51 96.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.359 0.503 . . . . 73.319999999999993 112.359 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 28.2 Cg_exo -62.77 137.67 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.677 2.251 . . . . 71.099999999999994 113.166 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 35.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.186 -0.461 . . . . 51.520000000000003 111.857 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 64.69 25.47 13.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.822 0.675 . . . . 70.120000000000005 112.822 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.1 tm? -84.85 102.8 13.37 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.672 -0.492 . . . . 75.129999999999995 109.672 174.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.656 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 64.2 mt-30 -66.26 145.89 55.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.726 0.639 . . . . 72.400000000000006 112.726 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.13 155.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.787 -0.642 . . . . 75.340000000000003 111.082 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.96 122.61 43.8 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.796 0.331 . . . . 63.229999999999997 111.603 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.485 ' HA3' ' HE2' ' A' ' 47' ' ' TYR . . . -83.01 176.0 53.14 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.182 -0.532 . . . . 51.009999999999998 113.549 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 64' ' ' LEU . 40.1 t -54.8 -40.43 69.49 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.914 0.709 . . . . 70.230000000000004 112.914 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.53 -20.01 65.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.923 0.392 . . . . 75.120000000000005 111.995 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 14.76 42.8 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.439 -0.41 . . . . 70.129999999999995 112.53 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.33 142.66 28.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.901 0.381 . . . . 72.329999999999998 111.752 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -87.14 117.29 25.79 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.083 0.468 . . . . 73.430000000000007 111.452 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HE2' ' HA3' ' A' ' 41' ' ' GLY . 83.6 m-85 -94.65 138.78 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 109.971 174.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.656 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -66.42 -6.9 16.16 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.559 0.578 . . . . 62.520000000000003 112.559 -175.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 4.8 p-10 -174.5 155.91 2.35 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.914 0.485 . . . . 60.310000000000002 110.934 172.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.697 ' HB3' HD21 ' A' ' 33' ' ' LEU . 41.7 tt0 -62.35 -30.79 71.43 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.172 0.434 . . . . 70.150000000000006 112.172 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.426 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 26.6 t -61.36 -40.19 93.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.223 0.535 . . . . 72.209999999999994 110.489 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -60.45 -44.01 96.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.675 -0.693 . . . . 71.120000000000005 110.784 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.56 -39.57 76.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 110.889 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -58.87 -49.43 77.79 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.989 0.423 . . . . 75.439999999999998 111.208 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.11 96.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.093 0.473 . . . . 72.209999999999994 111.211 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.3 96.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.143 -0.481 . . . . 74.030000000000001 111.548 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 23.2 ttt85 -61.82 -51.41 68.37 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.026 0.441 . . . . 73.140000000000001 111.342 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 74.7 m -75.47 -2.99 31.41 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.23 0.456 . . . . 64.239999999999995 112.23 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -78.88 -59.97 2.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.838 0.351 . . . . 73.430000000000007 110.112 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.47 27.31 0.32 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.962 -0.637 . . . . 63.329999999999998 113.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.683 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 37.8 m80 -134.53 76.33 61.61 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 122.233 -0.569 . . . . 72.430000000000007 111.668 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.34 -12.61 28.15 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.691 2.261 . . . . 64.450000000000003 113.45 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.82 8.07 26.49 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.843 0.312 . . . . 74.0 111.843 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 59.6 tp -73.44 111.34 8.48 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.154 0.502 . . . . 73.409999999999997 111.497 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.8 m -129.17 152.93 48.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 73.310000000000002 110.416 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.72 114.73 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.284 0.564 . . . . 64.430000000000007 111.579 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.564 ' HA ' ' HE2' ' A' ' 67' ' ' MET . 30.3 mmt -65.9 -41.57 91.3 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.012 0.434 . . . . 72.25 111.186 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.62 150.55 6.0 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.053 -0.521 . . . . 74.200000000000003 111.689 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.18 140.84 43.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.981 -0.554 . . . . 75.239999999999995 111.865 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.25 170.35 20.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.187 -0.46 . . . . 43.399999999999999 112.509 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.522 ' HG2' ' OE1' ' A' ' 38' ' ' GLN . 64.2 mtt-85 -61.0 132.11 52.79 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.612 -0.346 . . . . 73.239999999999995 110.454 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.49 96.99 0.73 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.197 0.522 . . . . 72.530000000000001 112.327 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 . . . . . 0 CA--C 1.539 0.544 0 CA-C-N 115.46 -0.791 . . . . 70.310000000000002 110.496 177.622 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.2 m . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 121.135 0.493 . . . . 61.130000000000003 111.734 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.665 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.7 m -98.68 130.73 45.19 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.18 -0.464 . . . . 65.310000000000002 111.388 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 7' ' ' VAL . 23.5 t70 -76.4 111.68 12.12 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.868 0.366 . . . . 54.520000000000003 111.191 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.76 -4.16 2.44 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.482 0.553 . . . . 38.600000000000001 114.482 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 14.1 t -97.49 126.25 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 117.408 0.604 . . . . 71.200000000000003 111.579 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.98 105.3 16.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.69 0.281 . . . . 74.430000000000007 110.985 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.0 m -149.05 158.78 44.45 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.374 0.509 . . . . 72.040000000000006 112.374 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.11 -107.67 0.2 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.107 -0.497 . . . . 71.430000000000007 112.758 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.83 102.69 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.323 2.015 . . . . 71.109999999999999 112.941 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.47 -3.88 56.57 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.958 -0.639 . . . . 62.549999999999997 113.813 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -143.22 136.12 27.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.316 0.579 . . . . 73.219999999999999 112.314 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -131.17 155.21 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.684 -0.689 . . . . 54.140000000000001 110.649 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.63 126.45 41.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.066 0.46 . . . . 50.420000000000002 111.209 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -123.5 137.32 54.8 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.138 -0.483 . . . . 53.520000000000003 110.465 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.9 mmm -85.79 102.58 13.79 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.113 0.483 . . . . 64.430000000000007 111.951 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.527 HD22 ' HG2' ' A' ' 23' ' ' ARG . 4.1 mm? -109.11 115.69 30.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.2 -0.455 . . . . 64.430000000000007 110.303 174.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.8 27.67 67.03 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.157 -0.544 . . . . 74.109999999999999 113.261 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.51 85.14 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.483 -0.389 . . . . 55.43 113.696 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -109.55 126.68 28.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.517 -0.402 . . . . 53.520000000000003 111.439 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.44 104.36 1.73 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.42 2.08 . . . . 73.209999999999994 113.253 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' HG2' HD22 ' A' ' 18' ' ' LEU . 7.5 ptp180 -97.18 157.65 15.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.477 -0.328 . . . . 71.219999999999999 110.839 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 30.2 m -111.11 120.36 42.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.21 0.529 . . . . 74.200000000000003 112.093 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -107.02 160.17 15.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.691 -0.686 . . . . 64.430000000000007 109.959 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.22 95.87 0.14 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.057 0.456 . . . . 64.209999999999994 111.179 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.7 119.26 59.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.129 -0.487 . . . . 53.399999999999999 110.764 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.491 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 22.4 Cg_endo -59.86 102.15 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.321 2.014 . . . . 62.539999999999999 112.932 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.46 100.34 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.001 0.429 . . . . 61.539999999999999 109.961 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.6 p -139.57 35.57 2.03 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.288 -0.415 . . . . 64.299999999999997 111.36 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.8 t -58.27 -37.89 75.88 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.242 -0.436 . . . . 74.430000000000007 111.842 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.41 43.16 1.75 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.365 -0.445 . . . . 40.210000000000001 113.151 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.433 HD12 ' NH2' ' A' ' 54' ' ' ARG . 87.9 mt -130.4 152.92 81.1 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.717 0.294 . . . . 74.209999999999994 111.428 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.09 119.94 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.211 1.941 . . . . 75.239999999999995 112.381 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.41 17.95 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.086 0.47 . . . . 60.420000000000002 111.65 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -120.84 -21.26 6.66 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.613 0.597 . . . . 71.439999999999998 112.613 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 69' ' ' ARG . 8.1 tt -93.2 120.84 33.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.832 0.349 . . . . 71.109999999999999 111.442 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.676 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 48.7 mt-30 -73.56 142.49 46.64 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.746 0.647 . . . . 74.200000000000003 112.746 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.93 159.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.109 -0.496 . . . . 74.329999999999998 111.577 -176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 51.8 t -106.13 127.46 53.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.887 0.375 . . . . 62.210000000000001 111.775 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.54 155.91 32.81 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 113.257 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 43.8 t -53.79 -32.3 52.07 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.981 0.734 . . . . 72.120000000000005 112.981 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.78 -2.95 52.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.055 0.455 . . . . 74.239999999999995 112.135 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.38 20.91 39.68 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.199 -0.524 . . . . 72.430000000000007 113.136 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.9 132.52 42.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.789 0.328 . . . . 64.019999999999996 111.309 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -85.78 122.44 29.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.963 0.411 . . . . 71.420000000000002 111.703 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -112.84 147.35 37.15 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.998 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.676 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 31.2 mmt-85 -75.29 -20.33 59.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.359 -0.382 . . . . 54.420000000000002 111.739 -173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -163.99 161.65 22.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.061 -0.518 . . . . 64.200000000000003 111.092 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.555 ' HG2' HG23 ' A' ' 66' ' ' VAL . 1.7 tm-20 -57.61 -40.38 79.02 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.175 0.512 . . . . 70.430000000000007 110.701 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 25.7 t -59.64 -38.23 80.83 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.974 0.416 . . . . 53.340000000000003 111.461 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.11 -43.88 90.57 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.069 0.461 . . . . 72.129999999999995 111.05 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.627 HD11 HG22 ' A' ' 66' ' ' VAL . 10.3 tt -64.83 -47.25 78.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.991 -0.55 . . . . 75.209999999999994 110.99 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' NH2' HD12 ' A' ' 33' ' ' LEU . 19.0 ttm180 -55.14 -37.25 66.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.079 0.466 . . . . 74.219999999999999 111.13 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.491 ' HB1' ' HG3' ' A' ' 28' ' ' PRO . . . -65.6 -47.65 74.96 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 111.262 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.91 -38.3 75.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.986 0.422 . . . . 62.240000000000002 111.633 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 76.2 ttt180 -60.74 -50.45 73.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.935 0.397 . . . . 75.209999999999994 111.085 175.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.27 -29.47 70.56 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.986 0.422 . . . . 75.319999999999993 111.664 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 59' ' ' ARG . 35.3 ttt-85 -61.8 -38.68 89.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.254 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.57 36.28 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.033 -0.603 . . . . 63.420000000000002 113.68 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.418 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 96.9 m-70 -134.31 78.13 58.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.297 -0.531 . . . . 70.209999999999994 111.507 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.62 -28.62 25.71 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.636 2.224 . . . . 71.319999999999993 113.186 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.24 -11.94 58.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.249 0.547 . . . . 64.329999999999998 111.328 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 5.8 tt -92.88 114.97 27.67 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.591 0.71 . . . . 74.319999999999993 111.331 -175.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' HD22 ' A' ' 53' ' ' LEU . 69.5 m -144.58 166.27 25.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.613 -0.721 . . . . 72.129999999999995 110.193 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 53' ' ' LEU . 75.4 t -69.07 111.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.018 0.437 . . . . 63.420000000000002 111.65 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.481 ' SD ' ' HA ' ' A' ' 42' ' ' SER . 66.1 mtm -81.69 -53.73 5.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.133 -0.485 . . . . 65.239999999999995 110.996 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.33 164.57 31.06 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 110.887 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HB3' HD23 ' A' ' 37' ' ' LEU . 98.9 mtt180 -96.77 151.68 19.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.987 0.423 . . . . 72.439999999999998 111.639 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 47.85 1.74 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.185 -0.531 . . . . 62.219999999999999 112.549 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.61 -177.54 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.351 1.061 . . . . 73.109999999999999 113.364 -176.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.4 m -89.51 105.36 17.74 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.789 -0.569 . . . . 62.240000000000002 111.078 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 116.068 -0.514 . . . . 74.310000000000002 111.75 -174.294 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.995 0.426 . . . . 73.420000000000002 110.134 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m -101.91 128.55 48.25 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.025 0.44 . . . . 74.109999999999999 111.721 -171.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.53 115.05 23.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.302 -0.408 . . . . 72.239999999999995 111.953 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.91 -31.74 1.07 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.217 -0.516 . . . . 70.420000000000002 113.538 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.531 HG22 ' HG2' ' A' ' 22' ' ' PRO . 12.1 t -67.94 105.07 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 122.545 -0.385 . . . . 72.340000000000003 110.985 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.8 105.78 17.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 71.409999999999997 110.844 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.1 m -133.33 137.33 45.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 74.329999999999998 111.396 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.16 -68.0 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.978 -0.555 . . . . 62.130000000000003 112.245 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.03 79.46 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.697 2.265 . . . . 72.299999999999997 112.408 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.77 54.99 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.356 -0.449 . . . . 73.329999999999998 113.68 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -145.53 148.87 33.67 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.627 0.713 . . . . 74.120000000000005 112.292 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.41 140.83 47.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.787 -0.642 . . . . 37.890000000000001 109.872 172.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.712 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 28.6 p -100.11 145.84 27.5 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.366 0.603 . . . . 64.239999999999995 111.422 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -129.78 133.74 47.17 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.629 -0.714 . . . . 65.329999999999998 110.826 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.86 103.13 4.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 70.150000000000006 111.325 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 98.0 mt -127.42 117.74 22.74 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.931 0.396 . . . . 71.129999999999995 111.788 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.6 26.34 66.52 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.562 -0.351 . . . . 73.109999999999999 113.826 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.07 -0.01 75.07 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.111 -0.566 . . . . 74.439999999999998 113.376 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -131.74 138.49 32.67 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 117.121 0.461 . . . . 73.409999999999997 112.014 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HG2' HG22 ' A' ' 7' ' ' VAL . 97.1 Cg_endo -80.81 118.97 3.52 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.735 2.29 . . . . 74.349999999999994 113.571 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -109.23 137.26 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.26 -0.275 . . . . 62.119999999999997 110.365 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -103.82 139.9 38.39 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.847 0.684 . . . . 74.349999999999994 112.847 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.42 160.68 34.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.895 -0.593 . . . . 63.140000000000001 110.606 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -57.72 112.87 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.22 0.452 . . . . 65.319999999999993 112.22 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.36 119.71 55.48 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.131 -0.486 . . . . 61.310000000000002 110.916 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 86.84 1.09 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.384 2.056 . . . . 74.0 113.266 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.68 100.23 12.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.271 0.557 . . . . 65.540000000000006 110.368 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.4 p -98.68 134.38 41.68 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.278 -0.419 . . . . 63.140000000000001 111.907 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.3 p -99.49 -76.01 0.55 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.269 -0.423 . . . . 75.310000000000002 111.356 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.27 39.51 3.0 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.217 -0.516 . . . . 74.549999999999997 113.598 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 34.1 mt -120.34 135.71 24.69 Favored Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 122.395 -0.474 . . . . 65.239999999999995 110.6 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.45 139.65 31.96 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.46 2.106 . . . . 72.450000000000003 113.239 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.75 141.91 30.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.793 0.33 . . . . 74.239999999999995 111.408 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 64.29 6.23 2.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.253 0.621 . . . . 72.319999999999993 112.545 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 2.4 tm? -93.19 95.41 9.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.412 -0.588 . . . . 71.5 109.412 176.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -54.79 137.06 45.63 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.718 0.636 . . . . 74.25 112.718 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 35.7 m -129.96 156.76 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.149 -0.478 . . . . 71.430000000000007 111.439 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -100.55 118.13 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.295 -0.411 . . . . 71.540000000000006 110.941 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.79 168.44 39.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.396 -0.431 . . . . 73.430000000000007 113.793 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.7 t -49.86 -37.05 29.29 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.792 0.664 . . . . 45.210000000000001 112.792 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.24 -33.9 68.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.038 0.446 . . . . 74.109999999999999 112.037 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.89 18.94 18.76 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.724 -0.55 . . . . 52.240000000000002 111.724 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.66 146.81 40.44 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.981 0.419 . . . . 74.209999999999994 111.444 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.468 HG22 ' HG2' ' A' ' 71' ' ' ARG . 38.6 m -86.05 120.23 27.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 111.414 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.76 157.51 16.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.429 -0.351 . . . . 73.420000000000002 110.982 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -49.2 -42.59 40.66 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.047 0.388 . . . . 73.049999999999997 112.047 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 51' ' ' CYS . 1.5 p30 -173.42 175.49 3.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.08 -0.509 . . . . 74.049999999999997 111.122 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -62.25 -31.5 72.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.892 0.377 . . . . 73.129999999999995 111.677 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.458 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 42.1 t -66.86 -40.53 87.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.213 0.53 . . . . 74.409999999999997 110.408 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -68.85 -38.02 79.51 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.797 -0.638 . . . . 75.109999999999999 110.941 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.648 HD13 HG22 ' A' ' 66' ' ' VAL . 10.4 tt -58.16 -43.4 87.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.872 0.368 . . . . 73.540000000000006 110.469 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -57.92 -38.77 76.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.383 -0.371 . . . . 74.450000000000003 111.227 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.99 44.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.382 . . . . 73.549999999999997 111.322 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.97 75.28 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 111.54 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 46.3 ttt-85 -64.58 -50.37 67.5 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.934 0.397 . . . . 63.509999999999998 110.659 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 37.1 t -63.11 -33.09 74.71 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 111.857 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -65.81 -31.65 72.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.501 -0.318 . . . . 75.129999999999995 111.612 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.23 37.2 0.02 OUTLIER Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.84 -0.695 . . . . 64.310000000000002 113.995 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.447 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 85.1 m-70 -135.56 82.62 38.88 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.213 0.506 . . . . 63.210000000000001 112.168 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.28 -25.93 49.28 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.452 2.102 . . . . 71.530000000000001 112.976 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.3 -20.02 60.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.361 . . . . 72.239999999999995 111.683 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.5 tp -69.63 112.54 6.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.521 0.677 . . . . 75.209999999999994 112.664 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.4 p -131.15 164.22 25.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.674 -0.694 . . . . 71.510000000000005 110.753 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.648 HG22 HD13 ' A' ' 53' ' ' LEU . 59.8 t -87.17 112.52 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.89 0.376 . . . . 64.439999999999998 111.544 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.0 mmt -81.16 -42.52 20.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.049 0.452 . . . . 72.140000000000001 110.979 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.421 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 45.9 p90 -169.4 156.75 6.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.021 -0.536 . . . . 53.100000000000001 110.812 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -82.82 125.54 31.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.023 0.44 . . . . 75.439999999999998 110.876 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 131.93 -175.79 19.58 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 112.105 -174.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HG2' HG22 ' A' ' 46' ' ' THR . 96.1 mtt180 -86.03 140.2 30.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.613 -0.345 . . . . 64.530000000000001 111.186 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.421 ' HA ' ' OH ' ' A' ' 68' ' ' TYR . 96.4 m -59.79 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.261 0.467 . . . . 54.340000000000003 112.261 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 . . . . . 0 N--CA 1.469 0.483 0 CA-C-N 115.895 -0.593 . . . . 65.439999999999998 110.326 174.323 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.739 0.304 . . . . 53.409999999999997 110.401 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.0 m -98.31 127.23 44.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.963 0.411 . . . . 64.319999999999993 111.515 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.514 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 14.4 t70 -86.64 112.54 21.71 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.09 -0.505 . . . . 73.219999999999999 110.973 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.9 -32.92 0.74 Allowed Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.156 -0.545 . . . . 72.230000000000004 114.21 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 18.3 t -66.19 117.45 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.96 0.38 . . . . 75.230000000000004 111.708 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -106.73 106.88 17.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.831 0.348 . . . . 71.340000000000003 111.28 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 71.5 m -140.03 142.61 36.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.031 0.443 . . . . 64.519999999999996 111.758 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.97 -52.88 0.04 OUTLIER Glycine 0 CA--C 1.532 1.103 0 CA-C-N 115.729 -0.669 . . . . 60.039999999999999 113.273 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.63 87.09 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 60.200000000000003 112.983 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.49 15.46 79.12 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.386 -0.435 . . . . 71.099999999999994 113.778 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -146.26 135.76 23.04 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.575 -0.368 . . . . 70.109999999999999 110.97 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.95 137.77 53.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.595 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.747 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.0 p -100.65 122.78 43.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.91 0.386 . . . . 45.140000000000001 110.342 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG3' ' HG ' ' A' ' 18' ' ' LEU . 10.7 ptm180 -129.2 160.55 32.57 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.079 0.4 . . . . 75.510000000000005 112.079 -172.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.608 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 3.9 mmt -76.25 101.89 5.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.88 0.371 . . . . 72.230000000000004 111.448 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.46 ' HG ' ' HG3' ' A' ' 16' ' ' ARG . 94.5 mt -133.36 111.62 10.94 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.828 0.347 . . . . 75.349999999999994 110.579 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.41 44.91 82.8 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.913 -0.66 . . . . 73.450000000000003 112.678 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.29 -49.48 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.003 0.361 . . . . 71.140000000000001 114.003 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -92.92 137.87 23.66 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.828 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.514 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 64.9 Cg_endo -72.51 129.74 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.516 2.144 . . . . 73.409999999999997 112.92 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -129.42 150.97 50.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.437 -0.347 . . . . 75.530000000000001 110.69 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 84.9 m -104.47 146.26 29.12 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.378 0.609 . . . . 63.43 112.262 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -143.94 161.44 38.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.881 -0.6 . . . . 73.349999999999994 110.535 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 12.7 t -64.17 84.04 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.209 0.528 . . . . 72.239999999999995 111.092 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.12 118.9 32.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 62.200000000000003 109.954 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.79 100.84 1.11 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.338 2.025 . . . . 70.200000000000003 114.276 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.21 98.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.546 -0.538 . . . . 75.349999999999994 109.546 166.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.627 ' HB2' HD13 ' A' ' 33' ' ' LEU . 6.3 p -121.87 91.82 3.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.444 0.535 . . . . 63.310000000000002 112.444 -172.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -107.98 166.11 10.96 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.921 -0.582 . . . . 71.329999999999998 110.861 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.97 -56.31 3.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.046 -0.597 . . . . 65.239999999999995 112.647 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 30' ' ' CYS . 4.5 pp -73.07 146.01 86.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.462 -0.434 . . . . 74.219999999999999 110.339 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.19 119.14 5.85 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 121.768 1.645 . . . . 50.210000000000001 113.509 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.23 15.22 6.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.829 0.347 . . . . 74.319999999999993 111.918 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -135.11 14.43 3.55 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.777 0.288 . . . . 74.219999999999999 111.777 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 38' ' ' GLN . 1.7 tm? -119.69 136.65 54.33 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.949 0.404 . . . . 74.150000000000006 110.645 -177.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 37' ' ' LEU . 37.6 mt-30 -63.74 137.67 58.17 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.352 0.501 . . . . 73.439999999999998 112.352 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.603 HG22 ' HA ' ' A' ' 50' ' ' GLU . 34.6 m -128.6 152.38 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.126 0.488 . . . . 75.430000000000007 111.56 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.8 t -101.01 128.66 46.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.962 -0.563 . . . . 51.109999999999999 111.739 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.02 152.95 19.96 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.495 -0.383 . . . . 53.340000000000003 113.074 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.6 t -57.25 -31.88 66.0 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.942 0.401 . . . . 62.119999999999997 111.996 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.33 -20.49 65.55 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.152 0.427 . . . . 71.450000000000003 112.152 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.4 14.77 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.306 -0.474 . . . . 65.129999999999995 112.732 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.38 135.15 54.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.775 0.321 . . . . 72.519999999999996 111.547 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 m -94.81 128.58 41.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.863 0.363 . . . . 73.329999999999998 111.439 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.06 154.83 21.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.745 0.307 . . . . 65.530000000000001 111.363 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -66.59 -20.14 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.956 0.408 . . . . 55.409999999999997 111.575 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -165.49 155.59 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.714 -0.676 . . . . 75.420000000000002 110.071 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.603 ' HA ' HG22 ' A' ' 39' ' ' VAL . 31.3 tt0 -60.03 -34.43 73.38 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.044 0.45 . . . . 72.299999999999997 110.976 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -58.99 -37.33 76.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.293 -0.412 . . . . 73.430000000000007 110.729 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.97 -40.21 91.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.868 0.366 . . . . 71.239999999999995 110.852 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.86 -47.98 82.99 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.094 0.473 . . . . 65.109999999999999 110.301 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 50' ' ' GLU . 2.2 mpt_? -64.19 -39.43 93.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.235 -0.439 . . . . 75.150000000000006 111.222 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.997 0.427 . . . . 62.200000000000003 111.517 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -34.96 76.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.406 0.622 . . . . 51.210000000000001 110.833 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.11 92.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.912 -0.585 . . . . 71.340000000000003 110.446 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 73.4 m -64.22 -26.74 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 111.822 0.304 . . . . 74.040000000000006 111.822 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -64.24 -34.07 77.25 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.977 0.418 . . . . 73.219999999999999 111.27 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.66 35.17 0.05 OUTLIER Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.275 -0.488 . . . . 42.439999999999998 113.082 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -128.65 79.05 75.03 Favored Pre-proline 0 CA--C 1.539 0.533 0 O-C-N 122.37 -0.489 . . . . 73.510000000000005 111.44 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.22 -28.26 72.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.461 2.107 . . . . 75.420000000000002 112.21 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.33 -22.9 66.88 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.918 -0.583 . . . . 73.120000000000005 111.994 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.02 111.71 8.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.476 0.655 . . . . 72.439999999999998 112.044 -174.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -127.75 161.17 29.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.295 -0.866 . . . . 75.200000000000003 110.594 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p -88.8 134.76 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.203 0.525 . . . . 74.109999999999999 111.956 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 16.7 mmt -90.65 -59.05 2.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.363 -0.381 . . . . 74.349999999999994 110.974 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -164.52 164.34 21.81 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.099 0.476 . . . . 73.219999999999999 112.006 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -75.65 111.98 11.54 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.828 -0.624 . . . . 71.549999999999997 111.057 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.36 161.23 8.65 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.337 -0.392 . . . . 63.409999999999997 112.147 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -72.58 134.85 45.39 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.249 0.525 . . . . 75.450000000000003 112.4 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.0 m -58.12 99.88 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.033 -0.53 . . . . 74.530000000000001 111.889 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 64.099999999999994 111.005 176.364 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.107 0.479 . . . . 71.109999999999999 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 33.7 m-20 -110.43 176.75 4.92 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.384 0.611 . . . . 60.420000000000002 112.492 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 66.6 m -142.59 146.03 34.15 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.471 -0.786 . . . . 71.420000000000002 110.771 176.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 72.4 m -100.03 172.99 6.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.862 0.319 . . . . 71.400000000000006 111.862 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.87 112.7 0.82 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.1 -0.5 . . . . 63.520000000000003 111.485 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.73 2.16 49.59 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.471 -0.395 . . . . 63.530000000000001 113.961 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 22' ' ' PRO . 3.6 t -107.04 122.46 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 122.462 -0.434 . . . . 71.150000000000006 111.373 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.88 110.18 21.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.49 0.662 . . . . 64.439999999999998 111.421 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 55.1 m -136.14 180.0 6.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.09 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.57 -91.1 0.25 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 54.229999999999997 112.752 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.67 88.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.848 2.365 . . . . 74.340000000000003 112.839 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.558 ' H ' ' HB3' ' A' ' 29' ' ' ASP . . . 83.92 12.89 76.15 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.104 -0.498 . . . . 61.439999999999998 113.372 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 51.4 mtmt -141.3 136.67 31.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.376 0.51 . . . . 75.230000000000004 112.376 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.08 51.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.882 -0.599 . . . . 53.310000000000002 109.962 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.586 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 18.3 p -122.78 143.2 49.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.364 0.505 . . . . 74.230000000000004 112.364 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 16' ' ' ARG . 40.2 ttp180 -143.74 148.8 36.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.086 -0.506 . . . . 72.030000000000001 110.259 173.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 69.5 mtp -80.99 120.39 24.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.185 0.517 . . . . 62.329999999999998 112.072 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.6 106.14 18.27 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.952 -0.567 . . . . 75.439999999999998 109.664 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.57 -94.5 0.13 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.929 -0.653 . . . . 43.25 112.007 -174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.64 -8.2 12.63 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.177 -0.535 . . . . 51.140000000000001 113.881 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 27.3 ptt180 -121.04 133.27 24.12 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 117.573 0.687 . . . . 75.430000000000007 112.285 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.688 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 2.5 Cg_endo -81.89 128.82 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.143 2.562 . . . . 74.340000000000003 113.42 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -111.85 152.49 27.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.457 -0.338 . . . . 73.329999999999998 111.07 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 6.6 t -120.15 137.25 54.28 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.584 0.231 . . . . 63.509999999999998 110.465 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -131.82 146.14 51.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.75 0.31 . . . . 61.109999999999999 111.544 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 96.5 m -60.14 100.22 0.09 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.998 0.427 . . . . 52.219999999999999 111.141 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.24 155.29 53.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 64.209999999999994 111.359 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.71 107.75 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.372 2.048 . . . . 75.219999999999999 113.069 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.558 ' HB3' ' H ' ' A' ' 12' ' ' GLY . 10.7 p-10 -79.12 84.12 5.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.839 0.828 . . . . 74.319999999999993 110.81 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.4 m -83.74 84.5 7.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.526 -0.761 . . . . 51.32 112.226 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t -78.76 -145.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.903 -0.589 . . . . 73.439999999999998 110.487 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.66 80.84 0.12 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.863 -0.684 . . . . 71.510000000000005 112.997 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 51' ' ' CYS . 3.9 pp -155.33 148.59 18.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 122.609 -0.347 . . . . 75.340000000000003 111.758 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.94 120.33 3.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.554 2.169 . . . . 70.299999999999997 112.533 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.59 16.79 0.45 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.583 0.586 . . . . 65.409999999999997 112.583 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -115.21 -18.14 11.2 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.848 0.356 . . . . 74.329999999999998 111.735 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 61.6 tp -83.64 105.86 14.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.855 0.36 . . . . 55.439999999999998 111.757 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -59.86 160.09 8.14 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.032 -0.531 . . . . 61.219999999999999 112.132 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -157.58 144.66 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.331 -0.395 . . . . 53.119999999999997 111.963 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.2 128.52 46.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.907 0.384 . . . . 55.399999999999999 110.755 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.506 ' HA3' HD22 ' A' ' 64' ' ' LEU . . . -90.35 177.52 42.55 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.257 -0.497 . . . . 73.230000000000004 113.541 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.698 ' HA ' ' HE3' ' A' ' 67' ' ' MET . 42.6 m -60.82 -19.26 59.39 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.159 0.429 . . . . 73.140000000000001 112.159 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.54 -42.88 64.25 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.511 -0.313 . . . . 73.409999999999997 111.282 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.59 -0.27 8.62 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.25 -0.5 . . . . 72.400000000000006 113.895 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.27 146.19 27.21 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.218 -0.577 . . . . 71.510000000000005 111.891 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.3 m -86.3 108.32 18.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.088 0.471 . . . . 72.310000000000002 111.39 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -78.68 160.13 27.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.899 -0.591 . . . . 75.329999999999998 111.115 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -57.48 -34.85 69.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.371 0.508 . . . . 64.120000000000005 112.371 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.9 p30 -167.66 174.74 7.48 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.855 0.687 . . . . 72.549999999999997 112.855 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -46.99 -47.44 21.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.175 -0.92 . . . . 70.530000000000001 112.394 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.465 ' HB2' HD12 ' A' ' 33' ' ' LEU . 33.7 t -70.25 -40.24 74.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.058 -0.519 . . . . 65.530000000000001 111.028 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -54.25 -40.66 67.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.336 0.588 . . . . 64.510000000000005 111.203 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 66' ' ' VAL . 9.0 tt -64.91 -45.98 83.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.084 -0.507 . . . . 74.140000000000001 110.501 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -59.74 -27.54 66.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.138 -0.483 . . . . 72.349999999999994 111.765 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.09 -55.87 5.9 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 62.439999999999998 111.594 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . . . -53.35 -33.16 52.47 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.129 0.49 . . . . 60.439999999999998 111.198 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -48.97 -50.3 36.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.616 -0.72 . . . . 73.219999999999999 111.421 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 45.4 t -77.99 -23.54 48.33 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.04 0.448 . . . . 64.219999999999999 111.033 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 35.2 mmt180 -78.04 34.85 0.2 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.591 0.589 . . . . 63.450000000000003 112.591 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.66 23.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.226 -0.512 . . . . 74.129999999999995 114.118 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -131.71 74.4 77.78 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.521 0.66 . . . . 74.299999999999997 111.055 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.05 -29.37 40.33 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.562 2.175 . . . . 61.119999999999997 112.608 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.53 -13.23 60.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.035 -0.53 . . . . 74.420000000000002 111.993 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.506 HD22 ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -65.96 112.07 3.64 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.266 0.555 . . . . 72.409999999999997 111.948 -171.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -134.59 157.58 46.21 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 110.691 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.437 HG21 HD11 ' A' ' 53' ' ' LEU . 97.2 t -71.97 127.43 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.56 0.578 . . . . 72.310000000000002 112.56 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.698 ' HE3' ' HA ' ' A' ' 42' ' ' SER . 56.4 mtt -94.81 -53.64 3.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.372 -0.377 . . . . 71.209999999999994 110.758 171.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -165.23 167.53 17.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.887 0.375 . . . . 74.219999999999999 111.568 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -85.8 172.02 11.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.649 0.611 . . . . 74.319999999999993 112.649 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.37 -154.22 53.13 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.549 -0.751 . . . . 41.549999999999997 113.863 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -70.2 138.78 52.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.847 0.356 . . . . 71.430000000000007 111.004 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.62 84.9 2.66 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.259 0.552 . . . . 72.019999999999996 110.29 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -88.73 136.43 33.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.923 0.712 . . . . 74.310000000000002 112.923 -173.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.693 -0.67 . . . . 63.310000000000002 110.536 172.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 120.411 0.148 . . . . 74.310000000000002 111.007 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.54 71.21 0.68 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.441 0.639 . . . . 73.150000000000006 110.478 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -166.04 -170.04 1.63 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.735 0.814 . . . . 73.450000000000003 110.485 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.641 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 15.1 m -129.6 126.89 39.51 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.144 -0.348 . . . . 75.120000000000005 111.014 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.43 112.13 23.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.852 -0.158 . . . . 72.219999999999999 111.338 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.95 49.0 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 114.463 0.545 . . . . 73.510000000000005 114.463 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 50.7 t -107.09 109.58 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 117.247 0.523 . . . . 64.340000000000003 110.887 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -91.5 106.5 18.53 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.349 0.5 . . . . 75.430000000000007 112.349 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 94.7 m -148.25 138.38 22.58 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.17 -0.468 . . . . 50.119999999999997 110.613 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 -121.27 0.9 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.913 -0.66 . . . . 65.420000000000002 113.519 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.39 107.84 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.597 2.198 . . . . 74.420000000000002 112.744 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 118.0 -54.96 0.59 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.095 -0.502 . . . . 75.340000000000003 112.255 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -135.39 134.95 40.24 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.802 0.334 . . . . 74.239999999999995 111.215 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.42 138.95 42.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 110.476 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 20.2 p -100.15 125.21 46.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.124 0.488 . . . . 74.540000000000006 111.277 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -144.16 159.54 42.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 74.530000000000001 109.777 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 47.8 mtp -78.97 103.67 9.08 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.682 -0.636 . . . . 72.099999999999994 111.957 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.06 141.2 48.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 110.387 175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.47 26.29 64.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.819 -0.705 . . . . 55.329999999999998 112.743 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.61 84.71 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.515 -0.374 . . . . 71.219999999999999 113.824 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -133.79 140.32 36.22 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 117.549 0.674 . . . . 74.319999999999993 111.676 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 27.5 Cg_endo -61.2 115.38 2.69 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.455 2.103 . . . . 65.530000000000001 113.455 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 35.4 mmt180 -118.05 156.53 28.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.869 0.467 . . . . 74.450000000000003 110.93 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 98.6 m -118.18 121.09 39.62 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.877 0.37 . . . . 63.210000000000001 111.77 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -133.85 161.36 34.96 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.468 -0.333 . . . . 60.020000000000003 111.058 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 37.0 t -55.26 130.15 41.13 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.421 0.897 . . . . 54.439999999999998 113.421 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.76 118.53 31.87 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.939 -0.573 . . . . 74.430000000000007 111.059 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.91 147.53 68.5 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.311 2.007 . . . . 71.239999999999995 112.75 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.41 31.7 0.12 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.35 0.5 . . . . 70.319999999999993 112.35 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.605 ' HA ' HD11 ' A' ' 33' ' ' LEU . 24.3 p -90.16 15.34 10.47 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.581 0.956 . . . . 71.540000000000006 113.581 -171.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -69.17 75.88 0.35 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.446 0.641 . . . . 52.549999999999997 110.527 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.16 6.39 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.034 -0.53 . . . . 63.25 112.97 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 30' ' ' CYS . 67.6 mt -94.42 151.14 39.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 122.474 -0.427 . . . . 72.409999999999997 111.467 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.29 119.32 6.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.335 2.023 . . . . 75.319999999999993 113.006 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.68 -4.56 53.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.129 0.49 . . . . 62.149999999999999 111.57 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -101.07 -1.0 35.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.203 -0.453 . . . . 71.439999999999998 112.024 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 58.1 tp -116.73 119.11 34.43 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.218 -0.301 . . . . 72.010000000000005 111.775 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -64.32 163.42 13.05 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.165 0.507 . . . . 62.340000000000003 112.188 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.544 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 10.0 p -150.51 144.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.019 0.378 . . . . 62.450000000000003 112.019 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 95.8 m -100.62 128.79 46.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.977 0.417 . . . . 52.109999999999999 111.122 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 64' ' ' LEU . . . -101.62 177.65 27.06 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.241 -0.504 . . . . 65.549999999999997 113.467 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.404 ' HB3' ' HE1' ' A' ' 67' ' ' MET . 64.9 p -61.88 -14.64 35.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.948 0.404 . . . . 72.230000000000004 111.839 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.36 -16.64 61.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.235 -0.439 . . . . 64.120000000000005 111.241 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.09 -14.44 62.56 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.435 -0.348 . . . . 74.140000000000001 113.494 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.04 153.68 19.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.667 0.617 . . . . 74.109999999999999 112.667 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -86.17 145.74 26.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.053 -0.522 . . . . 72.120000000000005 110.887 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.58 160.89 21.59 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.552 -0.295 . . . . 73.510000000000005 111.302 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -51.39 -43.31 61.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.071 0.548 . . . . 74.219999999999999 111.857 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' H ' ' HB3' ' A' ' 52' ' ' GLU . 4.7 p-10 -159.85 177.46 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.894 0.378 . . . . 64.319999999999993 111.469 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HA ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -57.94 -47.79 81.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.145 0.498 . . . . 74.519999999999996 111.453 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.4 t -65.81 -39.57 91.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.548 -0.296 . . . . 72.519999999999996 111.055 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.471 ' HB3' ' H ' ' A' ' 49' ' ' ASP . 5.8 tp10 -52.28 -41.17 62.66 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.318 -0.401 . . . . 53.020000000000003 111.246 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' HD22 ' A' ' 64' ' ' LEU . 9.7 tt -56.79 -56.01 27.0 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.205 0.526 . . . . 74.329999999999998 110.484 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -64.33 -29.55 70.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.118 -0.492 . . . . 74.150000000000006 111.211 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.85 71.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.94 0.4 . . . . 52.399999999999999 111.158 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.65 89.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 70.519999999999996 110.559 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 28.1 ttt180 -55.11 -50.28 69.61 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.523 -0.762 . . . . 70.329999999999998 111.808 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 84.9 m -81.0 6.33 13.74 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.223 0.453 . . . . 50.299999999999997 112.223 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -106.35 51.69 0.74 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.161 0.505 . . . . 73.25 111.279 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.0 69.54 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.551 0.58 . . . . 73.219999999999999 114.551 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 66.4 t60 -135.44 72.93 64.01 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 117.767 0.784 . . . . 63.219999999999999 111.721 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.2 -7.46 20.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.03 2.486 . . . . 73.510000000000005 112.844 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -9.19 52.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 73.140000000000001 111.825 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.475 HD12 ' HA3' ' A' ' 41' ' ' GLY . 43.1 tp -85.49 129.05 34.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.002 0.741 . . . . 65.140000000000001 113.002 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -127.77 155.43 44.06 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.631 -0.713 . . . . 65.219999999999999 110.496 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.88 123.39 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.855 0.359 . . . . 71.349999999999994 111.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.404 ' HE1' ' HB3' ' A' ' 42' ' ' SER . 18.6 mmt -100.48 -59.42 1.71 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.037 0.384 . . . . 72.299999999999997 112.037 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.409 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 53.1 p90 -154.43 145.46 22.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.001 0.429 . . . . 74.409999999999997 111.584 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HE ' ' HG3' ' A' ' 50' ' ' GLU . 93.1 mtt180 -83.04 110.72 18.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.241 0.543 . . . . 71.329999999999998 111.664 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.544 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 151.82 179.24 27.31 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.84 -0.618 . . . . 63.439999999999998 112.028 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -83.24 140.78 32.32 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.64 -0.329 . . . . 72.409999999999997 111.266 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 91.3 m -61.78 104.92 0.49 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.233 0.539 . . . . 71.329999999999998 111.783 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -91.17 131.41 36.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 63.509999999999998 112.319 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.492 ' NZ ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.639 -0.696 . . . . 71.120000000000005 110.95 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.756 0.312 . . . . 71.439999999999998 110.375 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -60.26 97.5 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.636 0.732 . . . . 74.0 112.954 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m -152.06 121.97 7.06 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.248 -0.887 . . . . 75.450000000000003 109.484 172.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.76 130.45 45.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.049 0.452 . . . . 37.229999999999997 111.859 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.5 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 m-20 -69.91 112.16 6.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 112.239 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.24 37.39 38.4 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.09 0.396 . . . . 37.229999999999997 114.09 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -106.61 135.49 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 112.004 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.18 106.64 14.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.096 0.474 . . . . 71.209999999999994 111.278 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -124.72 -179.92 4.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.089 -0.505 . . . . 62.009999999999998 111.02 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.38 -104.57 0.26 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 120.723 -0.751 . . . . 37.229999999999997 113.551 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.95 85.71 0.97 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.543 2.162 . . . . 63.310000000000002 113.106 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 102.07 2.74 51.7 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.194 -0.527 . . . . 44.450000000000003 113.559 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.773 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 48.4 mtmt -135.83 137.59 41.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.495 0.647 . . . . 73.040000000000006 112.03 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.04 142.13 49.46 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.719 -0.673 . . . . 64.409999999999997 110.072 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 23.2 p -105.5 136.46 45.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.133 0.492 . . . . 72.299999999999997 112.112 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -127.86 139.14 52.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.888 -0.597 . . . . 64.120000000000005 110.896 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.576 ' SD ' ' HB3' ' A' ' 22' ' ' PRO . 94.2 mmm -76.6 113.43 14.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.854 0.359 . . . . 72.010000000000005 111.409 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.776 HD13 ' HD3' ' A' ' 23' ' ' ARG . 88.6 mt -122.74 114.43 20.53 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.12 0.486 . . . . 62.439999999999998 111.304 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.65 30.74 75.61 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 116.231 -0.441 . . . . 40.140000000000001 113.77 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.25 -15.19 63.75 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 54.140000000000001 113.712 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 21' ' ' ARG . 43.0 mtt180 -122.14 137.42 27.47 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 117.25 0.525 . . . . 60.119999999999997 111.681 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 93.4 Cg_endo -83.28 145.29 12.02 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.725 2.283 . . . . 71.129999999999995 113.657 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.776 ' HD3' HD13 ' A' ' 18' ' ' LEU . 66.6 mtp85 -124.55 132.19 53.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.905 -0.589 . . . . 75.209999999999994 110.607 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 14.0 t -102.9 118.85 37.74 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.502 -0.555 . . . . 63.520000000000003 109.502 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.09 161.3 35.72 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 62.240000000000002 111.828 -171.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 97.5 m -54.26 108.55 0.38 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.137 0.791 . . . . 63.439999999999998 113.137 -174.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.72 120.82 56.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 115.889 -0.596 . . . . 65.310000000000002 110.754 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 83.3 Cg_endo -81.6 131.25 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.648 2.232 . . . . 75.450000000000003 113.535 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.803 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -67.86 82.5 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 116.303 -0.408 . . . . 65.400000000000006 111.019 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.8 p -148.96 123.07 9.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.399 0.619 . . . . 65.420000000000002 112.163 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -145.65 -53.9 0.28 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.844 -0.617 . . . . 64.099999999999994 110.197 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 51.63 1.96 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.176 -0.535 . . . . 73.219999999999999 113.385 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -156.64 145.07 14.52 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 122.584 -0.362 . . . . 75.319999999999993 110.8 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.94 120.02 4.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.247 1.965 . . . . 72.099999999999994 113.705 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.29 38.8 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.495 0.664 . . . . 74.430000000000007 110.792 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -129.9 8.05 5.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.819 -0.628 . . . . 73.200000000000003 111.551 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 64.9 tp -136.88 127.37 26.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.237 0.215 . . . . 64.209999999999994 111.064 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 50.7 mt-30 -66.48 148.27 52.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 74.239999999999995 112.047 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 32.6 m -131.15 146.77 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 71.219999999999999 111.493 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.5 t -100.9 113.66 26.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.388 -0.369 . . . . 64.409999999999997 110.822 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.14 170.37 49.2 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.266 -0.492 . . . . 37.229999999999997 114.239 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.9 m -54.9 -26.78 38.2 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.201 0.6 . . . . 70.030000000000001 112.111 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.54 -23.79 61.83 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.966 -0.561 . . . . 71.439999999999998 111.937 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.45 12.02 54.74 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.477 -0.392 . . . . 73.430000000000007 112.652 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.28 141.76 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.721 0.296 . . . . 75.409999999999997 111.764 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 m -86.65 107.35 18.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.466 -0.334 . . . . 71.230000000000004 111.434 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.01 147.16 24.43 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 110.151 -0.314 . . . . 71.230000000000004 110.151 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.416 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 39.9 ptt85 -59.83 -25.14 64.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.612 0.597 . . . . 73.510000000000005 112.612 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.0 p30 -166.86 172.25 10.53 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.043 0.449 . . . . 63.329999999999998 111.646 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HA ' HG22 ' A' ' 39' ' ' VAL . 29.6 tt0 -69.28 -26.7 64.88 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 112.135 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 48.6 t -74.72 -39.14 62.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.959 0.409 . . . . 73.209999999999994 110.206 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -59.14 -43.83 92.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.216 0.531 . . . . 75.099999999999994 110.583 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.59 -51.3 67.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.107 -0.497 . . . . 74.510000000000005 110.736 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.803 ' HD3' ' HB2' ' A' ' 29' ' ' ASP . 94.1 mtt180 -70.82 -17.01 62.77 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.32 0.489 . . . . 73.109999999999999 112.32 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.18 -34.05 63.66 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.328 0.585 . . . . 72.099999999999994 110.154 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.02 -25.62 52.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.701 -0.681 . . . . 75.299999999999997 112.091 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 54' ' ' ARG . 16.4 ptt85 -66.5 -20.08 65.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.045 0.45 . . . . 74.150000000000006 110.886 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.4 t -72.27 -16.83 61.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.297 0.57 . . . . 60.340000000000003 110.634 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -91.66 85.04 5.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.943 -0.571 . . . . 75.439999999999998 111.112 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.89 -52.68 4.5 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 114.737 0.655 . . . . 75.140000000000001 114.737 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -114.58 93.62 33.37 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 117.806 0.803 . . . . 75.239999999999995 112.978 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.44 -16.48 47.7 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.556 2.17 . . . . 64.200000000000003 112.55 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -82.14 0.0 42.84 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.352 0.501 . . . . 75.430000000000007 112.352 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.9 tp -57.2 111.97 1.23 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 71.0 110.792 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -115.59 164.2 14.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.262 -0.426 . . . . 52.340000000000003 111.339 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.67 127.79 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.256 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -78.76 -45.32 21.34 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.307 0.575 . . . . 43.409999999999997 110.546 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -159.76 145.47 15.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.832 -0.622 . . . . 64.420000000000002 110.766 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.16 99.94 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.348 0.594 . . . . 72.510000000000005 110.925 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.505 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 164.57 -176.08 40.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.348 -0.842 . . . . 71.219999999999999 111.572 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -80.93 138.26 36.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.162 0.481 . . . . 54.350000000000001 111.3 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.9 m -61.9 94.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.208 0.528 . . . . 63.439999999999998 112.048 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.04 105.49 15.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.783 -0.644 . . . . 74.329999999999998 110.398 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HB3' ' HZ1' ' A' ' 74' ' ' LYS . 4.3 ttpm? . . . . . 0 C--O 1.252 1.195 0 CA-C-O 118.696 -0.669 . . . . 72.0 111.072 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.723 0.296 . . . . 75.150000000000006 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.71 116.96 26.28 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.844 0.354 . . . . 74.439999999999998 111.069 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.5 p -102.31 108.55 19.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.754 0.312 . . . . 42.310000000000002 111.251 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.12 130.38 45.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.902 0.382 . . . . 61.299999999999997 111.837 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.19 114.85 20.29 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.355 0.502 . . . . 61.350000000000001 112.355 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.31 8.2 58.71 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 114.274 0.469 . . . . 72.329999999999998 114.274 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.58 109.78 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 O-C-N 122.617 -0.343 . . . . 74.230000000000004 110.741 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.85 108.96 16.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.98 0.419 . . . . 41.5 111.315 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -148.76 138.49 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.285 0.564 . . . . 63.149999999999999 111.341 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.44 -60.92 0.09 OUTLIER Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.616 -0.72 . . . . 40.399999999999999 111.625 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.51 90.35 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.474 2.116 . . . . 70.329999999999998 112.322 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 88.68 -5.69 84.38 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.19 -0.529 . . . . 74.329999999999998 114.051 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 49.6 mtmt -141.14 138.05 33.17 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.583 0.691 . . . . 72.030000000000001 112.202 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.84 140.11 50.51 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.145 -0.479 . . . . 75.140000000000001 110.005 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.3 t -98.33 135.74 39.5 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.099 0.476 . . . . 75.109999999999999 111.774 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -142.62 137.03 29.73 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.824 -0.626 . . . . 74.299999999999997 110.808 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.9 mmm -76.46 104.55 7.03 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.009 0.433 . . . . 75.420000000000002 111.801 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 112.6 23.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.856 0.36 . . . . 61.43 111.02 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.05 31.7 72.51 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.448 -0.406 . . . . 36.140000000000001 112.882 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.81 -4.55 60.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.179 -0.534 . . . . 73.230000000000004 112.859 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -113.1 129.52 24.46 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.589 0.356 . . . . 45.409999999999997 111.053 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 115.52 4.28 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.493 2.129 . . . . 64.319999999999993 113.121 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -111.57 132.47 54.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.46 -0.336 . . . . 73.129999999999995 111.373 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 13' ' ' LYS . 87.0 m -103.28 119.98 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.993 0.425 . . . . 73.040000000000006 110.588 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -102.04 145.14 29.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.587 . . . . 73.219999999999999 110.006 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 20.4 p -80.48 123.2 27.87 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.142 0.496 . . . . 44.240000000000002 111.91 -175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.05 134.28 24.03 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 52.039999999999999 110.962 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.71 152.33 47.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.411 2.074 . . . . 54.109999999999999 112.891 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -78.35 41.49 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.483 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.744 ' HA ' HD23 ' A' ' 33' ' ' LEU . 25.1 p -77.49 89.79 3.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.189 0.519 . . . . 75.109999999999999 111.908 -174.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.3 t -138.79 132.49 30.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.954 -0.567 . . . . 63.200000000000003 110.857 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.35 39.42 51.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.187 -0.53 . . . . 73.540000000000006 112.9 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 30' ' ' CYS . 3.2 pp -151.8 163.6 23.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 122.7 0.4 . . . . 74.329999999999998 110.726 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.493 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 84.5 Cg_exo -49.9 118.96 4.26 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.526 2.151 . . . . 63.539999999999999 114.336 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.89 -10.43 14.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.678 -0.692 . . . . 75.129999999999995 110.818 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -125.55 -22.47 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 63.240000000000002 111.313 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 3.7 tt -90.19 119.83 30.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.767 0.318 . . . . 72.450000000000003 110.312 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 52.4 mt-30 -63.74 148.82 48.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.313 0.486 . . . . 64.120000000000005 112.313 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.455 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 34.0 m -129.81 151.91 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.213 0.53 . . . . 72.019999999999996 112.052 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.71 113.67 26.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.946 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.64 162.19 32.84 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.262 -0.494 . . . . 73.25 113.789 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.9 p -65.97 -9.43 29.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.336 0.495 . . . . 72.420000000000002 112.336 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.622 ' HB2' HD13 ' A' ' 64' ' ' LEU . 14.6 t70 -81.19 -4.98 57.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.149 0.5 . . . . 71.150000000000006 110.923 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 13.23 66.48 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.4 -0.429 . . . . 63.020000000000003 113.266 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.76 148.23 41.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 111.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.675 HG22 ' HG2' ' A' ' 71' ' ' ARG . 69.7 m -99.62 116.57 32.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.959 0.409 . . . . 63.439999999999998 111.209 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -96.66 156.88 16.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.414 -0.357 . . . . 75.209999999999994 111.664 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 78.9 mtm180 -56.96 -32.88 66.48 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.518 0.562 . . . . 74.329999999999998 112.518 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -162.97 176.43 10.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.031 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.638 ' HB3' HD12 ' A' ' 33' ' ' LEU . 32.7 tt0 -74.99 -30.89 61.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.279 -0.569 . . . . 72.510000000000005 111.599 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 t -65.4 -37.41 86.88 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.834 -0.541 . . . . 63.219999999999999 109.806 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.56 -52.89 63.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.543 -0.753 . . . . 74.239999999999995 110.421 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.26 -52.03 54.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.034 -0.984 . . . . 75.329999999999998 111.675 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 41.4 mtp85 -70.46 -27.17 64.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.841 -0.618 . . . . 75.340000000000003 111.657 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.11 -49.27 62.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.188 0.518 . . . . 62.210000000000001 110.67 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.83 -32.01 71.4 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.078 -0.51 . . . . 74.430000000000007 110.969 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -58.37 -51.63 69.0 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.944 -0.571 . . . . 72.540000000000006 110.921 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 32.2 t -71.78 -31.74 66.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.746 0.308 . . . . 71.25 111.432 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -60.14 -50.5 73.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.401 0.519 . . . . 74.239999999999995 112.401 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.49 16.78 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.993 -1.098 . . . . 65.540000000000006 114.959 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.0 m-70 -135.69 75.16 57.16 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 117.806 0.803 . . . . 72.340000000000003 111.564 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.64 -23.18 74.59 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.358 2.038 . . . . 63.200000000000003 113.273 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.3 -14.26 47.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.008 0.373 . . . . 74.030000000000001 112.008 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' A' ' 43' ' ' ASP . 55.0 tp -64.4 112.36 3.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.2 0.524 . . . . 75.439999999999998 112.144 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.1 m -132.73 162.04 32.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.486 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.31 129.98 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.172 0.511 . . . . 74.439999999999998 111.788 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 69.5 mtm -85.27 -55.33 4.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.277 0.56 . . . . 73.519999999999996 110.166 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.482 ' HE2' ' H ' ' A' ' 73' ' ' ARG . 16.6 p90 -151.5 140.03 20.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.714 -0.676 . . . . 74.209999999999994 110.743 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.51 125.52 29.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.272 0.558 . . . . 70.299999999999997 111.543 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 124.56 161.57 11.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.35 -0.841 . . . . 60.439999999999998 111.139 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.675 ' HG2' HG22 ' A' ' 46' ' ' THR . 65.4 mtt180 -63.14 138.82 58.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.747 0.774 . . . . 75.319999999999993 111.082 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.5 m -48.28 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.626 0.602 . . . . 70.329999999999998 112.626 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' H ' ' HE2' ' A' ' 68' ' ' TYR . 11.9 ptp180 -117.64 128.03 54.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.319999999999993 111.217 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 C--O 1.258 1.545 0 N-CA-C 112.497 0.554 . . . . 72.120000000000005 112.497 176.422 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.741 0.305 . . . . 74.329999999999998 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -101.41 151.79 21.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.327 0.585 . . . . 38.189999999999998 112.52 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.1 p -147.49 154.17 40.43 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.753 -0.658 . . . . 63.25 110.655 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 p -140.43 130.91 25.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.764 0.316 . . . . 63.240000000000002 111.794 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.66 114.15 22.42 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.154 0.502 . . . . 72.239999999999995 112.329 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.87 27.21 66.45 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.987 0.755 . . . . 61.329999999999998 114.987 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.511 HG11 ' SG ' ' A' ' 9' ' ' CYS . 49.9 t -107.15 126.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 117.358 0.579 . . . . 74.140000000000001 111.588 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 10.5 pt-20 -79.0 105.93 10.69 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.407 0.622 . . . . 75.319999999999993 111.664 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.511 ' SG ' HG11 ' A' ' 7' ' ' VAL . 58.7 m -149.61 155.99 41.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.101 -0.374 . . . . 64.409999999999997 111.42 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.7 -65.24 0.31 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.942 -0.647 . . . . 71.349999999999994 113.009 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.14 90.53 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.66 2.24 . . . . 71.310000000000002 112.83 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.31 0.78 84.48 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.053 -0.594 . . . . 70.040000000000006 113.634 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.32 136.04 41.26 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.0 -0.706 . . . . 74.109999999999999 111.964 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.27 143.95 41.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.076 -0.511 . . . . 74.209999999999994 110.353 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 30.9 p -101.88 128.52 48.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.79 0.663 . . . . 74.200000000000003 112.79 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -138.52 145.62 40.96 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.417 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.41 ' HE1' ' HB3' ' A' ' 17' ' ' MET . 74.1 mtp -91.12 112.16 23.95 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.947 0.404 . . . . 44.009999999999998 111.8 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.09 112.19 24.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.243 -0.435 . . . . 61.420000000000002 110.634 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 36.11 58.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.375 -0.44 . . . . 72.519999999999996 113.861 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.28 70.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.168 -0.539 . . . . 52.140000000000001 113.51 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.6 111.26 63.66 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 117.346 0.573 . . . . 72.129999999999995 111.771 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.474 ' HB2' HG22 ' A' ' 7' ' ' VAL . 58.7 Cg_endo -71.86 106.99 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.218 1.945 . . . . 74.230000000000004 112.269 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -117.79 149.2 41.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.904 0.383 . . . . 75.420000000000002 111.534 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 91.2 m -129.0 125.55 37.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.017 0.437 . . . . 64.239999999999995 111.487 177.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -119.99 161.54 20.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.528 -0.305 . . . . 75.150000000000006 110.188 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.86 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.35 0.595 . . . . 64.439999999999998 111.072 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 120.0 60.27 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.479 -0.782 . . . . 38.189999999999998 110.493 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.595 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 11.0 Cg_endo -52.17 117.62 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.5 2.134 . . . . 60.030000000000001 112.499 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.66 36.22 0.13 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.233 0.539 . . . . 73.239999999999995 111.623 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 47.6 m -65.51 101.89 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.978 -0.556 . . . . 73.540000000000006 111.587 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -129.34 92.32 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 62.039999999999999 110.243 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.78 7.35 17.83 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.054 -0.521 . . . . 71.319999999999993 112.858 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.9 mt -100.83 114.89 65.84 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.619 -0.342 . . . . 73.450000000000003 111.142 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.63 153.09 26.34 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.761 2.308 . . . . 74.439999999999998 113.531 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 37' ' ' LEU . . . -77.26 163.16 26.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.156 -0.475 . . . . 71.310000000000002 111.2 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 69.33 -15.2 0.29 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.793 0.664 . . . . 71.420000000000002 112.793 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 35' ' ' ALA . 1.1 tm? -72.23 88.01 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.477 -0.564 . . . . 73.510000000000005 109.477 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 98.1 mt-30 -71.24 142.11 50.58 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.775 0.657 . . . . 75.439999999999998 112.775 -175.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 69' ' ' ARG . 33.4 m -137.02 157.28 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.819 -0.628 . . . . 64.129999999999995 111.003 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 90.7 m -101.12 132.01 46.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.89 -0.506 . . . . 65.299999999999997 111.839 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.541 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -82.85 173.5 52.46 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.918 -0.583 . . . . 64.310000000000002 113.422 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -64.38 -11.17 30.08 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.544 0.572 . . . . 43.109999999999999 112.544 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -87.17 -26.87 23.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.859 0.361 . . . . 73.230000000000004 111.094 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.26 -0.36 20.73 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.316 -0.469 . . . . 73.209999999999994 113.924 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.5 152.09 19.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.344 0.572 . . . . 74.420000000000002 112.268 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.8 m -90.91 120.08 31.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.051 -0.522 . . . . 73.109999999999999 111.975 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -87.49 140.64 29.33 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.283 -0.417 . . . . 75.239999999999995 110.814 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 18.0 ptp180 -59.65 -15.55 19.95 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.001 0.741 . . . . 73.409999999999997 113.001 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.5 p30 -167.26 160.68 13.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.556 0.343 . . . . 74.209999999999994 110.91 172.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -64.04 -30.83 71.87 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.088 0.403 . . . . 72.540000000000006 112.088 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.26 -33.99 72.26 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.031 0.444 . . . . 73.340000000000003 110.683 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -56.48 -50.9 70.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 110.662 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.541 HD11 ' HA2' ' A' ' 41' ' ' GLY . 6.5 tt -63.08 -46.7 86.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.818 -0.628 . . . . 61.310000000000002 110.328 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.424 ' HD3' ' SG ' ' A' ' 30' ' ' CYS . 16.8 ttt180 -55.39 -33.69 63.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.832 -0.622 . . . . 73.239999999999995 111.288 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.11 -31.68 23.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.059 -0.519 . . . . 75.049999999999997 111.655 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.08 71.11 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.191 0.441 . . . . 71.019999999999996 112.191 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.57 -34.01 64.39 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.242 0.544 . . . . 75.120000000000005 111.45 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.3 m -88.66 14.16 10.67 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.434 0.531 . . . . 75.329999999999998 112.434 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -98.27 8.24 45.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.058 0.392 . . . . 75.519999999999996 112.058 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.1 0.81 5.05 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.756 -0.735 . . . . 72.349999999999994 114.429 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -133.98 88.53 31.75 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 117.655 0.727 . . . . 72.209999999999994 112.132 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.94 -20.92 69.27 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.505 2.136 . . . . 75.319999999999993 111.59 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -20.95 58.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.947 -1.024 . . . . 73.120000000000005 112.436 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.81 111.57 3.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.287 0.565 . . . . 63.130000000000003 111.653 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -129.67 163.48 26.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.0 -0.546 . . . . 74.310000000000002 111.242 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.84 126.28 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.106 0.479 . . . . 61.340000000000003 111.394 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 72.1 mtm -80.33 -43.79 20.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.006 0.373 . . . . 73.120000000000005 112.006 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -164.19 155.83 16.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.949 0.404 . . . . 74.129999999999995 111.876 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.663 ' HA ' HG12 ' A' ' 39' ' ' VAL . 8.6 mpt_? -80.5 104.87 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.168 0.509 . . . . 70.450000000000003 111.243 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.92 170.43 16.63 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 116.061 -0.518 . . . . 65.25 112.192 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -75.57 149.98 38.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.866 0.365 . . . . 74.299999999999997 111.424 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 71.5 m -58.77 113.78 2.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.113 -0.494 . . . . 70.349999999999994 111.934 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -97.85 143.62 28.27 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.706 -0.679 . . . . 74.129999999999995 112.131 -176.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 C--O 1.253 1.269 0 CA-C-O 118.67 -0.681 . . . . 62.020000000000003 110.816 172.875 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.924 0.393 . . . . 63.520000000000003 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 156.12 36.75 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.968 0.413 . . . . 60.43 111.614 175.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 p -94.69 120.12 34.41 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.106 0.41 . . . . 73.400000000000006 112.106 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.4 m -105.85 127.95 53.44 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.849 0.357 . . . . 73.299999999999997 111.605 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.634 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 11.5 m-20 -87.64 111.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.183 -0.323 . . . . 62.420000000000002 110.4 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.8 -39.78 0.79 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 121.004 -0.617 . . . . 53.140000000000001 114.016 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 10.7 t -66.08 146.28 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.962 0.505 . . . . 74.349999999999994 111.62 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.71 105.3 15.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.486 0.66 . . . . 75.239999999999995 110.218 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 97.9 m -149.52 179.41 7.99 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.502 0.556 . . . . 74.310000000000002 112.502 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.03 -67.54 0.56 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.259 -0.736 . . . . 63.009999999999998 111.259 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -93.01 131.1 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 73.209999999999994 111.96 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.37 -35.78 1.99 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.008 -0.615 . . . . 44.229999999999997 114.268 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HE3' ' SG ' ' A' ' 9' ' ' CYS . 48.5 mtmt -131.38 145.95 52.05 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.254 0.527 . . . . 74.209999999999994 111.286 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -122.09 132.04 54.28 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.455 -0.339 . . . . 74.420000000000002 110.634 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.791 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.2 p -100.12 121.83 42.02 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.479 0.657 . . . . 73.5 111.584 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.444 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -123.88 163.56 21.03 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.835 -0.62 . . . . 73.310000000000002 111.265 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.652 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 14.0 mmt -80.9 110.74 16.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.249 0.462 . . . . 74.420000000000002 112.249 -174.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.686 HD21 ' HD2' ' A' ' 23' ' ' ARG . 6.8 mp -115.48 102.72 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.825 -0.435 . . . . 74.230000000000004 109.825 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.51 27.94 72.49 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.132 -0.556 . . . . 54.219999999999999 112.57 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.95 -16.62 56.51 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.483 -0.389 . . . . 64.540000000000006 113.633 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -93.11 137.25 23.77 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 122.321 -0.517 . . . . 72.129999999999995 111.804 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.634 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 90.4 Cg_endo -77.95 101.85 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.918 2.412 . . . . 70.310000000000002 113.409 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.686 ' HD2' HD21 ' A' ' 18' ' ' LEU . 53.9 mtt-85 -105.7 139.03 40.91 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.132 -0.321 . . . . 71.420000000000002 110.132 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.791 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 17.8 m -103.36 144.3 31.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 74.230000000000004 112.118 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.444 ' OE2' ' HD3' ' A' ' 16' ' ' ARG . 48.4 mt-10 -129.03 158.23 39.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 65.230000000000004 110.636 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.0 p -62.82 99.83 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.149 0.499 . . . . 63.520000000000003 112.278 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.82 125.59 41.68 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.874 -0.603 . . . . 71.219999999999999 111.45 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.9 Cg_exo -78.28 111.8 3.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.865 2.377 . . . . 74.019999999999996 112.848 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.36 94.22 0.16 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.788 0.328 . . . . 71.409999999999997 110.298 173.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.1 p -130.35 22.63 5.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.494 0.924 . . . . 63.549999999999997 113.494 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.1 p -70.93 -23.82 62.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.53 0.681 . . . . 63.420000000000002 109.965 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.61 27.83 14.08 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.56 -0.745 . . . . 37.990000000000002 113.017 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 78.6 mt -124.44 148.22 57.73 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 116.719 0.259 . . . . 52.119999999999997 111.688 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 13.6 Cg_exo -70.72 120.27 6.96 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.671 2.247 . . . . 73.129999999999995 112.629 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.28 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.992 0.367 . . . . 75.340000000000003 111.992 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -93.5 1.52 56.74 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.979 0.363 . . . . 72.109999999999999 111.979 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.3 mt -118.35 114.09 22.42 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.072 0.397 . . . . 71.200000000000003 112.072 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.34 146.75 53.78 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.503 -0.317 . . . . 71.329999999999998 110.375 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 69' ' ' ARG . 32.6 m -129.51 149.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.96 0.409 . . . . 71.329999999999998 111.603 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 61.3 m -100.53 128.58 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.385 -0.37 . . . . 70.310000000000002 110.796 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -72.89 164.3 54.88 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.253 -0.499 . . . . 43.409999999999997 113.068 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 t -58.97 -16.97 20.54 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.079 0.399 . . . . 71.540000000000006 112.079 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -82.11 -38.73 24.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.902 0.382 . . . . 74.030000000000001 110.931 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 -3.52 4.99 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.365 -0.445 . . . . 73.299999999999997 113.842 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.58 142.74 29.76 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.465 0.543 . . . . 62.539999999999999 112.465 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 71' ' ' ARG . 32.1 m -90.19 113.12 24.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.446 -0.343 . . . . 73.200000000000003 111.478 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -97.62 167.59 10.87 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 73.430000000000007 111.745 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -44.2 87.21 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.647 0.61 . . . . 71.129999999999995 112.647 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -169.06 -179.29 3.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.63 0.252 . . . . 63.210000000000001 111.631 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -64.73 -36.22 83.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.752 0.31 . . . . 74.129999999999995 111.698 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.5 t -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.117 0.484 . . . . 64.239999999999995 109.974 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -56.92 -44.11 82.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.644 -0.707 . . . . 74.120000000000005 111.377 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.523 ' HG ' HG22 ' A' ' 66' ' ' VAL . 1.5 tm? -59.37 -50.05 75.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.735 0.302 . . . . 73.230000000000004 110.877 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -56.51 -41.83 77.36 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.867 0.365 . . . . 43.229999999999997 111.283 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -39.53 94.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.027 0.441 . . . . 54.119999999999997 110.741 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -66.24 -22.03 66.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 72.040000000000006 112.499 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -65.55 -47.31 76.29 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.542 0.687 . . . . 72.219999999999999 110.107 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.19 -30.59 65.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.464 0.649 . . . . 73.129999999999995 110.679 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.755 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 23.2 ttt180 -82.78 83.63 7.64 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.279 -0.873 . . . . 74.409999999999997 111.385 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.72 -54.01 4.06 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 114.798 0.679 . . . . 73.109999999999999 114.798 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -115.04 90.94 25.04 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 113.673 0.99 . . . . 73.120000000000005 113.673 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.71 -22.22 73.91 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.845 2.363 . . . . 71.329999999999998 113.072 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.05 -2.79 49.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.364 -0.38 . . . . 72.530000000000001 111.844 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 41' ' ' GLY . 24.3 tp -77.71 118.08 19.74 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.554 0.576 . . . . 63.43 112.554 -172.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -125.87 164.63 20.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.856 -0.611 . . . . 71.430000000000007 110.607 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 53' ' ' LEU . 44.0 t -80.13 128.57 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.955 0.354 . . . . 73.349999999999994 111.955 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 61.7 mtt -74.36 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.448 0.642 . . . . 72.299999999999997 110.273 171.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.45 161.17 24.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.409 -0.814 . . . . 75.510000000000005 110.841 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.573 ' HA ' HG13 ' A' ' 39' ' ' VAL . 78.0 mtt180 -81.62 107.36 14.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.259 0.552 . . . . 65.239999999999995 110.655 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.32 143.91 3.79 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.688 -0.687 . . . . 73.129999999999995 112.076 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.55 ' HG3' HG22 ' A' ' 46' ' ' THR . 65.2 ttt180 -72.36 74.91 1.02 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.814 0.34 . . . . 73.409999999999997 111.819 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 85.7 m 34.84 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.747 1.017 . . . . 71.409999999999997 113.747 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -84.77 105.93 15.92 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.038 0.447 . . . . 75.230000000000004 110.905 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt . . . . . 0 C--O 1.251 1.137 0 CA-C-O 119.206 -0.426 . . . . 74.450000000000003 111.837 -176.732 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.592 0.234 . . . . 62.409999999999997 110.701 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -74.93 91.17 2.46 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.158 0.504 . . . . 62.240000000000002 111.573 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p -104.04 122.92 46.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.152 -0.476 . . . . 63.520000000000003 109.831 173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 39.4 m -98.22 127.4 44.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 65.409999999999997 111.392 -173.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 7' ' ' VAL . 13.3 t70 -85.77 111.1 19.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.455 . . . . 71.150000000000006 110.879 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 -23.01 0.3 Allowed Glycine 0 CA--C 1.535 1.285 0 N-CA-C 114.421 0.528 . . . . 73.150000000000006 114.421 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 23.6 t -73.98 125.32 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 117.043 0.421 . . . . 72.120000000000005 111.849 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -115.05 110.01 18.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.168 0.508 . . . . 62.409999999999997 111.895 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.3 m -149.1 139.24 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.492 -0.322 . . . . 74.439999999999998 110.878 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.19 -76.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.917 -0.658 . . . . 75.209999999999994 112.972 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.67 130.49 12.65 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.45 2.1 . . . . 62.439999999999998 112.692 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.34 -49.2 3.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.928 -0.653 . . . . 51.200000000000003 112.997 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -121.63 135.7 54.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.902 0.382 . . . . 74.299999999999997 111.433 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.92 145.57 41.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.784 -0.45 . . . . 62.43 109.784 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 31.9 p -99.08 113.38 25.56 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.41 0.624 . . . . 45.43 111.286 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -112.25 149.39 32.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.765 -0.652 . . . . 73.120000000000005 111.214 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 52.6 mtp -88.97 107.57 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 74.109999999999999 111.488 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.5 HD21 ' HG2' ' A' ' 23' ' ' ARG . 3.3 mm? -116.16 103.07 10.17 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.479 -0.328 . . . . 74.230000000000004 110.384 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.45 62.46 5.08 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 64.310000000000002 113.525 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.21 -46.4 3.39 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.203 -0.522 . . . . 64.329999999999998 113.953 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 21' ' ' ARG . 4.8 mpt_? -92.77 125.81 54.06 Favored Pre-proline 0 CA--C 1.541 0.611 0 O-C-N 122.328 -0.513 . . . . 70.049999999999997 111.969 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 96.5 Cg_endo -79.91 110.3 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.648 2.232 . . . . 73.329999999999998 112.094 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 33.6 ptt180 -99.11 158.28 15.78 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.164 -0.335 . . . . 73.319999999999993 111.079 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' CG1' ' A' ' 7' ' ' VAL . 78.2 m -103.14 120.69 41.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.081 0.467 . . . . 55.310000000000002 110.823 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.68 142.86 50.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.978 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' SG ' ' NH1' ' A' ' 59' ' ' ARG . 25.7 p -58.6 105.04 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.223 0.535 . . . . 73.349999999999994 111.562 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 135.9 19.35 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 51.219999999999999 111.174 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.893 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 74.2 Cg_endo -72.56 120.55 6.78 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.288 1.992 . . . . 63.420000000000002 112.486 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.6 -28.2 68.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.265 -0.425 . . . . 64.140000000000001 111.815 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HA ' HD13 ' A' ' 33' ' ' LEU . 79.2 m 73.4 -39.91 0.45 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.649 0.78 . . . . 61.130000000000003 112.609 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -54.12 112.62 1.0 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.109 -0.369 . . . . 75.140000000000001 111.797 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.07 -13.38 11.31 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.503 -0.38 . . . . 75.519999999999996 113.469 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 30' ' ' CYS . 2.5 pp -139.77 164.71 36.2 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 122.403 -0.469 . . . . 75.209999999999994 111.509 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 53.7 Cg_exo -53.96 119.61 6.56 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.548 2.165 . . . . 74.109999999999999 113.446 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.65 18.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 112.04 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.59 -39.08 3.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.849 0.315 . . . . 73.129999999999995 111.849 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -64.8 118.93 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.874 0.368 . . . . 62.340000000000003 110.671 -176.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.39 162.89 2.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.648 0.61 . . . . 64.310000000000002 112.648 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 50' ' ' GLU . 31.3 m -143.84 147.5 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.863 -0.608 . . . . 62.100000000000001 110.471 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.3 t -103.64 126.82 51.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.947 0.403 . . . . 72.219999999999999 110.829 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.47 165.52 44.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.257 -0.497 . . . . 62.039999999999999 113.686 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.602 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 17.2 m -50.61 -28.36 8.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.63 0.604 . . . . 65.5 112.63 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.82 -34.04 75.96 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.086 0.47 . . . . 73.049999999999997 111.947 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.31 -10.0 24.42 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.374 -0.441 . . . . 71.540000000000006 112.236 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.83 134.71 38.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.072 0.463 . . . . 70.019999999999996 111.621 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.0 m -86.66 112.6 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.332 -0.395 . . . . 71.540000000000006 111.337 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.66 160.95 16.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.796 0.332 . . . . 64.310000000000002 111.671 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -61.47 -40.32 94.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 111.783 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -165.91 174.52 9.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.058 -0.519 . . . . 74.200000000000003 110.552 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HA ' HG22 ' A' ' 39' ' ' VAL . 29.5 tt0 -71.74 -27.88 63.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.899 0.381 . . . . 74.209999999999994 111.498 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.893 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 9.1 t -67.56 -39.87 84.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.948 0.404 . . . . 75.310000000000002 110.262 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.42 -46.45 88.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.099 -0.5 . . . . 73.530000000000001 110.82 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -56.74 -42.2 78.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.377 -0.374 . . . . 72.209999999999994 110.739 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.407 HH11 ' HA ' ' A' ' 28' ' ' PRO . 29.6 ttt180 -57.16 -40.29 76.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.102 0.477 . . . . 75.230000000000004 110.899 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.504 ' O ' ' HG2' ' A' ' 59' ' ' ARG . . . -65.41 -50.41 65.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.283 -0.417 . . . . 64.420000000000002 111.019 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.35 -38.45 66.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.989 0.424 . . . . 63.200000000000003 111.728 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -52.9 -46.64 68.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.158 -0.474 . . . . 73.040000000000006 111.022 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.7 t -77.1 -34.01 56.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.349 0.5 . . . . 70.109999999999999 112.349 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 55' ' ' ALA . 37.8 mmt180 -58.33 -48.51 80.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.722 0.296 . . . . 75.140000000000001 111.555 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.14 32.31 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.221 -0.99 . . . . 73.129999999999995 114.26 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -132.39 81.93 59.06 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 117.216 0.508 . . . . 62.219999999999999 111.015 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.32 -34.8 26.06 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.614 2.209 . . . . 63.340000000000003 112.778 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.47 -11.59 60.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 111.978 0.362 . . . . 71.519999999999996 111.978 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.7 tp -77.21 110.35 11.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.518 0.562 . . . . 54.450000000000003 112.518 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -123.92 161.08 26.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.140000000000001 110.323 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 ' HB ' ' A' ' 39' ' ' VAL . 2.7 p -88.34 111.3 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.001 0.429 . . . . 61.200000000000003 111.628 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.602 ' HE1' ' HA ' ' A' ' 42' ' ' SER . 62.9 mtt -63.59 -58.82 5.75 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 110.659 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.2 172.56 17.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.886 -0.597 . . . . 74.019999999999996 110.361 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -78.9 158.65 28.02 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.214 0.53 . . . . 74.040000000000006 111.564 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.4 54.72 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.951 -0.568 . . . . 75.230000000000004 112.562 -174.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -83.61 158.28 21.95 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.541 -0.387 . . . . 73.319999999999993 111.567 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.8 m -67.01 98.16 0.55 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.158 0.504 . . . . 62.149999999999999 111.078 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -94.94 123.32 38.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.993 -0.549 . . . . 74.120000000000005 111.046 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.8 pttt . . . . . 0 C--O 1.255 1.393 0 CA-C-O 118.244 -0.884 . . . . 62.32 112.016 -178.719 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.853 0.358 . . . . 70.030000000000001 111.203 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.75 132.68 43.16 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.835 0.35 . . . . 71.120000000000005 111.623 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 t -128.58 134.25 48.56 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.436 -0.347 . . . . 62.229999999999997 111.105 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 24.0 m -124.93 128.32 48.43 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.852 0.358 . . . . 62.409999999999997 111.956 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 7' ' ' VAL . 5.0 m-20 -87.42 110.66 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.442 -0.345 . . . . 72.25 110.429 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.26 -32.21 0.32 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.501 0.56 . . . . 72.120000000000005 114.501 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 38.5 t -65.61 131.7 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 117.194 0.497 . . . . 73.319999999999993 111.976 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -76.57 105.34 7.57 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.95 0.405 . . . . 54.119999999999997 111.648 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.543 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 65.7 m -138.3 179.49 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.932 0.396 . . . . 65.299999999999997 111.206 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.23 -85.3 0.39 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.161 -0.542 . . . . 70.510000000000005 112.574 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -61.23 92.13 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.358 2.038 . . . . 74.019999999999996 112.431 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.97 23.88 72.91 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 115.976 -0.556 . . . . 71.0 114.003 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.643 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.1 mtmt -144.26 146.66 32.77 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.655 0.728 . . . . 75.219999999999999 112.957 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.35 149.18 40.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.369 -0.832 . . . . 70.109999999999999 110.163 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 26.6 p -112.44 142.59 44.79 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.328 0.585 . . . . 73.109999999999999 112.499 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 15.2 mmt180 -129.1 163.22 25.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.974 -0.557 . . . . 74.409999999999997 111.332 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.7 mmm -85.68 102.33 13.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.964 0.411 . . . . 74.439999999999998 111.247 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.4 110.44 22.41 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.04 0.447 . . . . 45.340000000000003 110.536 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.85 71.75 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.133 -0.556 . . . . 52.549999999999997 113.188 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.36 -4.77 84.28 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.255 -0.497 . . . . 50.25 113.243 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 21' ' ' ARG . 9.1 mpt_? -114.97 126.24 28.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 122.383 -0.48 . . . . 74.219999999999999 111.361 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 70.9 Cg_endo -74.0 113.85 3.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.471 2.114 . . . . 72.109999999999999 112.901 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -120.77 152.28 38.52 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.121 -0.362 . . . . 64.030000000000001 110.941 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 2.0 t -103.41 140.05 37.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.633 0.605 . . . . 74.299999999999997 112.633 -169.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.54 160.51 33.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.679 -0.691 . . . . 73.109999999999999 109.874 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 p -76.16 140.7 41.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.028 0.442 . . . . 64.430000000000007 111.393 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -118.88 125.17 27.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.262 -0.426 . . . . 72.239999999999995 111.51 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 6.0 Cg_exo -79.59 24.45 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.269 2.646 . . . . 73.129999999999995 114.241 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 54.1 40.25 31.46 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.025 0.44 . . . . 71.319999999999993 111.859 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HA ' HD22 ' A' ' 33' ' ' LEU . 27.3 m -70.4 88.64 0.66 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.217 0.532 . . . . 73.0 112.254 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.8 t -150.93 137.63 18.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.727 -0.67 . . . . 74.120000000000005 110.445 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 -50.32 4.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.04 -0.6 . . . . 61.140000000000001 113.367 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 30' ' ' CYS . 1.8 pt? -66.98 151.87 96.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.821 -0.223 . . . . 73.219999999999999 111.304 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.45 119.3 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 74.040000000000006 112.912 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.85 8.99 11.19 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 73.230000000000004 111.373 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -129.26 15.12 6.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.119 0.485 . . . . 74.140000000000001 110.792 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -125.64 125.4 43.05 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.07 -0.514 . . . . 72.420000000000002 110.025 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -63.55 147.73 50.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.897 0.702 . . . . 54.310000000000002 112.897 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' A' ' 50' ' ' GLU . 35.4 m -138.62 146.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.301 -0.408 . . . . 72.239999999999995 110.676 176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 17.2 t -105.21 131.53 52.56 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.106 0.479 . . . . 74.510000000000005 111.853 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.91 177.82 40.31 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.127 -0.488 . . . . 63.450000000000003 114.015 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.61 ' HA ' ' HE3' ' A' ' 67' ' ' MET . 13.1 m -55.29 -27.79 49.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.695 0.628 . . . . 74.310000000000002 112.695 -177.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.87 8.0 11.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.43 0.53 . . . . 71.129999999999995 112.43 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.052 -0.594 . . . . 53.210000000000001 112.68 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 125.15 36.25 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.502 0.321 . . . . 52.539999999999999 111.072 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 61.7 m -91.38 104.91 17.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.161 0.505 . . . . 74.140000000000001 111.161 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -80.48 157.82 26.06 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.531 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.419 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 63.4 mtt180 -53.32 -33.43 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.66 0.615 . . . . 73.25 112.66 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -170.92 173.16 5.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.939 0.399 . . . . 54.520000000000003 111.54 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HA ' HG23 ' A' ' 39' ' ' VAL . 11.8 tp10 -58.08 -43.6 87.1 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.07 -0.514 . . . . 73.239999999999995 111.63 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.55 -39.95 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.973 0.416 . . . . 75.030000000000001 110.599 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.419 ' OE1' ' HD2' ' A' ' 48' ' ' ARG . 7.5 tp10 -63.25 -44.27 95.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.826 -0.624 . . . . 75.129999999999995 110.866 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.94 -51.66 68.33 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.809 -0.632 . . . . 70.510000000000005 111.269 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.26 -33.27 75.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.714 0.292 . . . . 73.120000000000005 111.74 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.41 65.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.043 0.449 . . . . 74.200000000000003 110.689 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.2 76.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.982 0.42 . . . . 54.049999999999997 111.187 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.524 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -60.64 -50.24 74.28 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.079 -0.51 . . . . 74.519999999999996 110.404 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.77 -35.47 80.15 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.113 -0.494 . . . . 62.219999999999999 111.749 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -59.55 -58.68 7.53 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.506 -0.315 . . . . 74.109999999999999 111.575 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.44 24.92 0.19 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.543 -0.837 . . . . 74.230000000000004 114.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 42.2 m170 -122.38 78.81 45.35 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 122.139 -0.624 . . . . 73.530000000000001 111.144 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.51 -43.49 33.01 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.756 2.304 . . . . 70.340000000000003 113.552 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.53 2.82 39.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.57 0.581 . . . . 74.310000000000002 112.57 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.439 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 66.4 tp -76.64 127.43 32.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.015 0.436 . . . . 75.109999999999999 111.975 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -142.64 152.16 42.18 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.59 -0.277 . . . . 62.340000000000003 110.696 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -81.39 124.73 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.135 0.493 . . . . 52.149999999999999 111.748 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.61 ' HE3' ' HA ' ' A' ' 42' ' ' SER . 62.2 mtt -82.36 -49.64 9.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.11 0.481 . . . . 72.340000000000003 110.783 176.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -159.84 164.29 33.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.916 -0.583 . . . . 73.299999999999997 111.258 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HA ' HG12 ' A' ' 39' ' ' VAL . 49.5 mtm180 -76.8 135.62 38.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 65.230000000000004 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.86 -172.88 20.4 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.271 -0.49 . . . . 65.140000000000001 112.71 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -86.72 149.34 24.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.56 -0.377 . . . . 75.439999999999998 111.675 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 35.3 m -66.08 83.78 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.622 0.725 . . . . 43.409999999999997 111.159 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -77.2 140.28 40.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.16 -0.927 . . . . 75.329999999999998 111.812 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--O 1.252 1.21 0 CA-C-N 115.919 -0.582 . . . . 73.239999999999995 110.565 176.764 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.795 0.331 . . . . 63.210000000000001 111.651 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -142.9 102.76 4.08 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.626 0.727 . . . . 74.219999999999999 112.332 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m -157.09 166.31 33.64 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.826 0.85 . . . . 73.310000000000002 109.453 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.5 m -135.87 127.68 29.26 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.927 -0.483 . . . . 72.010000000000005 111.987 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.514 ' O ' HG21 ' A' ' 7' ' ' VAL . 29.0 t70 -86.67 111.42 20.65 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.676 0.25 . . . . 71.109999999999999 111.676 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 48.65 30.93 9.13 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 114.564 0.586 . . . . 72.140000000000001 114.564 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 5' ' ' ASP . 89.1 t -106.74 122.47 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 117.337 0.568 . . . . 74.150000000000006 111.77 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -92.07 106.73 18.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.612 -0.267 . . . . 72.109999999999999 111.202 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 96.1 m -148.84 138.54 21.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.648 0.261 . . . . 73.040000000000006 111.348 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.98 -141.42 4.33 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 120.894 -0.67 . . . . 41.100000000000001 113.932 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 -13.5 5.58 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.357 2.705 . . . . 72.239999999999995 114.81 -173.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.8 -30.17 9.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.99 -0.624 . . . . 53.329999999999998 113.155 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.7 mtmt -148.5 136.31 20.77 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.609 -0.347 . . . . 54.530000000000001 111.228 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.16 136.07 48.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.577 -0.283 . . . . 74.400000000000006 110.634 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 7.2 p -99.79 122.08 42.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.141 0.496 . . . . 62.020000000000003 111.714 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -119.95 158.84 25.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.144 -0.48 . . . . 75.540000000000006 111.345 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.59 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 3.8 mmt -79.73 102.62 9.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.468 -0.333 . . . . 73.209999999999994 111.597 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 23' ' ' ARG . 6.6 mp -110.77 112.99 25.24 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.929 0.395 . . . . 65.239999999999995 110.118 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.39 29.84 75.77 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.84 -0.695 . . . . 71.209999999999994 112.252 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -0.12 69.17 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.522 -0.37 . . . . 41.299999999999997 113.721 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -115.1 138.44 23.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 72.219999999999999 111.502 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.71 124.33 7.47 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.949 2.432 . . . . 55.240000000000002 114.273 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 8.7 mtp180 -119.69 134.62 55.16 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.965 -0.561 . . . . 74.030000000000001 110.907 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.1 m -103.37 119.82 39.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.886 0.374 . . . . 60.200000000000003 110.987 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -123.07 160.38 26.49 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.935 -0.575 . . . . 63.049999999999997 111.117 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -52.18 106.74 0.16 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.84 0.352 . . . . 73.310000000000002 111.863 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.45 122.87 58.28 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 116.218 -0.447 . . . . 74.510000000000005 112.197 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HB3' ' HA ' ' A' ' 55' ' ' ALA . 72.8 Cg_endo -75.95 -18.81 16.47 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.366 2.044 . . . . 70.230000000000004 112.118 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.1 t70 63.36 96.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.693 0.797 . . . . 74.010000000000005 112.234 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.4 m -121.39 25.84 9.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.389 -0.823 . . . . 63.130000000000003 109.945 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -64.27 103.32 0.62 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.284 -0.871 . . . . 54.340000000000003 113.212 -171.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.75 2.1 88.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.355 0.902 . . . . 73.430000000000007 115.355 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 51' ' ' CYS . 3.7 pp -85.86 153.72 57.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 118.03 0.915 . . . . 75.340000000000003 111.396 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.08 119.4 6.43 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.317 2.011 . . . . 61.310000000000002 112.703 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 76.59 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.028 0.442 . . . . 71.340000000000003 111.06 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 177.51 15.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.991 -0.55 . . . . 74.209999999999994 111.561 -175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.632 HD23 ' HD3' ' A' ' 69' ' ' ARG . 50.9 tp -119.99 105.56 11.16 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.015 0.436 . . . . 73.310000000000002 111.867 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.35 145.18 56.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.029 -0.532 . . . . 52.130000000000003 111.984 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 50' ' ' GLU . 31.4 m -141.13 143.56 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.268 -0.424 . . . . 71.329999999999998 111.043 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.19 125.8 48.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 110.159 -0.312 . . . . 70.120000000000005 110.159 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' HA2' HD13 ' A' ' 53' ' ' LEU . . . -73.24 169.25 53.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.407 -0.425 . . . . 63.350000000000001 113.765 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 t -65.18 -6.39 9.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.155 0.428 . . . . 74.140000000000001 112.155 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.94 -31.15 14.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.356 0.262 . . . . 72.519999999999996 111.389 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.38 -11.39 7.18 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 121.357 -0.449 . . . . 50.409999999999997 113.778 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.98 134.58 36.26 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.014 0.435 . . . . 42.299999999999997 112.002 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 71' ' ' ARG . 45.8 m -97.17 107.76 20.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.871 0.367 . . . . 54.439999999999998 111.1 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.52 151.62 24.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.395 -0.366 . . . . 74.219999999999999 111.705 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.52 -30.45 65.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.575 0.583 . . . . 71.140000000000001 112.575 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 34.5 t70 -155.29 159.81 40.29 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.758 0.313 . . . . 73.409999999999997 111.548 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 39' ' ' VAL . 39.5 tt0 -58.92 -43.37 91.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.799 0.333 . . . . 64.530000000000001 110.994 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.487 ' HB2' HD12 ' A' ' 33' ' ' LEU . 36.1 t -57.23 -34.99 69.13 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.138 0.494 . . . . 64.519999999999996 111.032 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -65.66 -41.47 92.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.041 -0.527 . . . . 71.409999999999997 111.155 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.404 HD13 ' HA2' ' A' ' 41' ' ' GLY . 9.3 tt -65.03 -42.34 94.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.066 0.46 . . . . 52.530000000000001 110.172 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 54' ' ' ARG . 11.2 mmm180 -54.14 -49.72 68.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.294 0.569 . . . . 72.140000000000001 110.584 175.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . . . -61.13 -42.97 99.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.916 -0.584 . . . . 62.32 111.158 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -55.69 -36.94 67.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.052 -0.522 . . . . 73.340000000000003 111.938 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 76.3 ttt-85 -59.92 -38.16 81.56 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.104 0.478 . . . . 71.219999999999999 111.021 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.0 t -82.68 -15.68 51.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.06 0.457 . . . . 73.25 111.207 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.9 ttp180 -97.17 49.51 1.06 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.239 0.542 . . . . 74.129999999999995 111.619 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.46 58.97 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 115.068 0.787 . . . . 60.310000000000002 115.068 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 4.0 m-70 -126.76 77.74 73.9 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.144 0.972 . . . . 75.120000000000005 111.972 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.12 -22.87 61.12 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.67 2.247 . . . . 75.439999999999998 113.043 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.84 4.23 54.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.309 -0.405 . . . . 70.329999999999998 111.802 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 56.9 tp -80.46 125.77 30.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.27 0.557 . . . . 75.120000000000005 112.158 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.1 p -136.62 163.8 29.71 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.68 -0.691 . . . . 70.420000000000002 110.475 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.13 124.56 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.006 0.431 . . . . 71.230000000000004 111.194 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.5 mmt -89.59 -53.67 4.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.93 0.395 . . . . 74.549999999999997 111.044 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.98 152.66 42.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 73.25 111.276 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.632 ' HD3' HD23 ' A' ' 37' ' ' LEU . 96.7 mtt180 -82.55 134.73 35.19 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.189 0.519 . . . . 62.409999999999997 111.8 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.27 -161.82 12.83 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.944 -0.571 . . . . 71.409999999999997 112.422 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.554 ' HG2' HG23 ' A' ' 46' ' ' THR . 50.2 mtp180 -86.29 153.61 21.85 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.538 -0.39 . . . . 74.120000000000005 111.286 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.5 m -57.38 112.72 1.49 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.532 0.682 . . . . 71.310000000000002 111.42 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -118.98 141.12 48.95 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.286 -0.87 . . . . 74.200000000000003 112.265 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.3 tttm . . . . . 0 C--O 1.251 1.141 0 CA-C-O 119.069 -0.491 . . . . 65.329999999999998 111.151 170.678 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.819 0.342 . . . . 71.120000000000005 111.235 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -122.35 125.16 45.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.014 0.435 . . . . 72.439999999999998 111.677 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 t -144.21 179.42 7.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.123 -0.489 . . . . 71.099999999999994 110.461 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 7.4 m -97.86 127.0 43.52 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.793 0.33 . . . . 72.010000000000005 110.439 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.35 110.31 20.69 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 110.241 -0.281 . . . . 74.299999999999997 110.241 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -34.8 0.57 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.147 -0.549 . . . . 72.140000000000001 114.386 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 21.2 t -66.08 140.22 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.156 0.478 . . . . 74.540000000000006 112.2 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -89.65 107.95 19.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.279 -0.419 . . . . 73.140000000000001 111.546 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.3 m -144.65 138.88 27.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.258 -0.428 . . . . 72.319999999999993 111.333 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.24 -95.28 0.1 OUTLIER Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.486 -0.387 . . . . 73.540000000000006 112.336 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.12 111.18 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.368 2.046 . . . . 73.340000000000003 112.334 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.21 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.239 -0.505 . . . . 37.020000000000003 113.862 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.9 mtmt -129.51 160.59 32.72 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.474 0.637 . . . . 65.140000000000001 112.324 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.8 136.03 20.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.358 -0.837 . . . . 73.010000000000005 109.946 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.2 p -101.63 142.37 33.08 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.194 0.521 . . . . 63.420000000000002 111.648 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -132.76 143.92 49.92 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.971 -0.559 . . . . 63.549999999999997 110.629 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.404 ' HA ' ' HE3' ' A' ' 17' ' ' MET . 0.7 OUTLIER -80.25 101.92 9.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.996 0.427 . . . . 71.400000000000006 110.298 177.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.8 mt -125.48 116.07 21.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.408 -0.36 . . . . 75.310000000000002 111.385 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.42 32.75 82.18 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.297 -0.478 . . . . 64.400000000000006 113.019 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.02 77.03 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.429 -0.415 . . . . 72.0 113.077 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.88 135.68 24.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.6 -0.353 . . . . 74.099999999999994 111.548 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.93 98.22 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.444 2.096 . . . . 64.209999999999994 112.716 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 mtp-105 -95.96 123.17 39.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.608 -0.269 . . . . 74.420000000000002 111.0 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.573 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 9.5 t -104.06 120.19 40.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.68 0.276 . . . . 74.450000000000003 110.398 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -129.7 160.89 31.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 74.439999999999998 111.415 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.08 125.01 23.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 111.556 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.13 132.98 20.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 111.909 0.337 . . . . 72.200000000000003 111.909 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.0 112.87 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.923 2.416 . . . . 63.340000000000003 112.899 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.32 133.79 38.68 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.024 0.44 . . . . 62.109999999999999 111.108 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.1 m -124.33 45.09 2.58 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.937 0.399 . . . . 64.219999999999999 111.424 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.9 m -77.01 -76.44 0.17 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.23 0.456 . . . . 72.510000000000005 112.23 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 52.01 3.97 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.247 -0.502 . . . . 71.409999999999997 114.158 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.687 HD12 ' SG ' ' A' ' 51' ' ' CYS . 4.6 pp -155.83 151.56 22.16 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.44 -0.447 . . . . 63.520000000000003 111.497 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 7.3 Cg_exo -73.63 137.7 25.48 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.594 2.196 . . . . 64.230000000000004 112.479 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.77 134.33 56.11 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.224 0.453 . . . . 54.140000000000001 112.224 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 63.59 15.65 9.05 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.828 0.677 . . . . 75.319999999999993 112.828 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.5 tm? -82.71 104.11 12.71 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.851 0.358 . . . . 70.349999999999994 110.84 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.404 ' O ' HD13 ' A' ' 37' ' ' LEU . 80.8 mt-30 -61.12 150.18 34.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.022 -0.535 . . . . 62.43 111.804 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 69' ' ' ARG . 25.5 m -141.52 159.16 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.952 0.353 . . . . 64.349999999999994 111.952 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.568 ' SG ' ' HA2' ' A' ' 44' ' ' GLY . 51.5 t -106.31 122.18 45.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.856 0.36 . . . . 72.439999999999998 111.57 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.38 176.86 54.55 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.327 -0.463 . . . . 52.020000000000003 113.224 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.546 ' HA ' ' HE2' ' A' ' 67' ' ' MET . 29.1 t -58.51 -25.76 62.74 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.4 0.519 . . . . 73.040000000000006 112.4 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.01 -14.4 59.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.025 0.44 . . . . 63.310000000000002 111.688 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.568 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . 85.05 34.62 14.28 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.227 -0.511 . . . . 73.109999999999999 112.952 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.24 148.01 40.89 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.505 0.322 . . . . 51.219999999999999 111.405 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -93.76 115.35 27.77 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.012 0.434 . . . . 75.219999999999999 112.128 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.12 166.1 13.15 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.352 -0.386 . . . . 71.040000000000006 111.149 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -62.23 -38.06 87.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.948 0.404 . . . . 74.420000000000002 111.194 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -166.02 174.07 9.77 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.939 -0.573 . . . . 65.109999999999999 110.743 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HB3' HD21 ' A' ' 33' ' ' LEU . 33.9 tt0 -63.06 -29.48 70.84 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.779 0.323 . . . . 74.450000000000003 111.086 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.687 ' SG ' HD12 ' A' ' 33' ' ' LEU . 62.1 m -58.28 -43.0 87.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.873 0.368 . . . . 72.420000000000002 110.693 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.44 -36.67 76.87 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 111.688 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.4 tt -65.25 -49.29 70.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.883 0.373 . . . . 70.299999999999997 110.372 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -57.31 -46.67 82.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 73.140000000000001 110.29 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.29 87.26 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.778 -0.646 . . . . 51.149999999999999 111.534 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.12 77.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.802 0.334 . . . . 41.240000000000002 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 34.4 mtm180 -61.75 -43.32 99.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.392 0.615 . . . . 72.450000000000003 110.683 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.4 t -78.51 -21.4 48.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.358 -0.837 . . . . 61.399999999999999 111.605 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp85 -90.03 -29.0 18.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.604 0.594 . . . . 74.409999999999997 112.604 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.566 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . -169.9 -37.08 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 119.669 -1.253 . . . . 40.32 115.45 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 83.3 m-70 -110.28 81.78 2.4 Favored Pre-proline 0 N--CA 1.477 0.922 0 CA-C-N 118.059 0.929 . . . . 74.329999999999998 112.553 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 23.8 Cg_exo -64.37 -24.63 64.37 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.497 2.131 . . . . 74.140000000000001 113.405 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.38 -4.65 57.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.981 0.42 . . . . 74.200000000000003 111.609 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 61.4 tp -66.2 112.7 4.07 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.383 0.512 . . . . 72.319999999999993 112.383 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -105.95 151.79 24.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.395 -0.366 . . . . 72.439999999999998 111.166 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.86 127.66 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.846 0.355 . . . . 74.209999999999994 111.236 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.546 ' HE2' ' HA ' ' A' ' 42' ' ' SER . 62.1 mtt -84.69 -55.06 4.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.947 0.403 . . . . 74.109999999999999 111.621 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -147.91 154.9 40.97 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.054 0.454 . . . . 75.510000000000005 111.779 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.438 ' HA ' HG12 ' A' ' 39' ' ' VAL . 94.2 mtt180 -84.2 141.65 30.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.901 -0.59 . . . . 71.400000000000006 111.102 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.45 158.65 14.01 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.858 -0.61 . . . . 54.229999999999997 111.813 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.78 130.81 46.56 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 117.291 0.545 . . . . 73.310000000000002 110.612 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.06 142.84 56.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.942 0.349 . . . . 63.109999999999999 111.942 -172.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -113.39 105.72 13.73 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.209 0.448 . . . . 71.530000000000001 112.209 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.5 -0.762 . . . . 43.140000000000001 110.919 172.031 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.96 0.409 . . . . 51.340000000000003 111.406 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 10.3 m-20 -74.62 87.8 2.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.352 0.596 . . . . 71.120000000000005 111.295 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 m -95.15 161.01 14.29 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.737 -0.665 . . . . 73.319999999999993 111.326 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.2 m -139.59 129.0 24.17 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 111.891 0.33 . . . . 72.340000000000003 111.891 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.9 112.26 22.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.056 0.391 . . . . 75.140000000000001 112.056 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.7 56.09 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 114.992 0.757 . . . . 73.400000000000006 114.992 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.4 t -107.24 120.97 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.103 -0.645 . . . . 74.109999999999999 111.004 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 8' ' ' GLU . 0.3 OUTLIER -96.63 109.38 22.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.625 0.726 . . . . 71.010000000000005 111.543 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 95.8 m -148.47 139.67 23.27 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.842 -0.617 . . . . 61.32 110.415 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.9 -98.15 0.17 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.091 -0.576 . . . . 61.420000000000002 113.723 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.12 -62.76 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.672 2.248 . . . . 70.209999999999994 113.962 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.5 58.89 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.144 -0.551 . . . . 54.32 113.922 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 48.8 mtmt -133.81 139.89 46.57 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.304 -0.527 . . . . 71.439999999999998 111.763 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -115.17 137.65 51.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.684 -0.235 . . . . 64.019999999999996 110.396 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.657 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 19.0 p -99.68 140.57 33.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.121 0.486 . . . . 75.230000000000004 111.704 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HA ' ' HB3' ' A' ' 2' ' ' ASP . 9.5 ptm180 -143.23 163.13 33.8 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.121 -0.49 . . . . 63.43 112.086 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.468 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 1.9 mmt -79.76 104.14 10.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.297 -0.411 . . . . 54.140000000000001 111.526 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.566 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 93.6 mt -120.69 119.09 31.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.67 -0.241 . . . . 75.299999999999997 110.8 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.46 26.36 56.65 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.152 -0.546 . . . . 72.129999999999995 113.554 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.55 82.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.453 -0.403 . . . . 40.210000000000001 113.64 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 18' ' ' LEU . 11.0 ptp180 -128.75 138.15 32.51 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 117.496 0.648 . . . . 62.119999999999997 111.558 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.95 111.59 3.31 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.777 2.318 . . . . 75.219999999999999 113.426 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 97.6 mtt180 -116.34 144.81 43.78 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.342 -0.39 . . . . 71.150000000000006 111.585 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 76.9 m -103.82 135.19 45.83 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.441 -0.345 . . . . 75.049999999999997 111.549 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' OE1' ' HD3' ' A' ' 16' ' ' ARG . 9.7 pt-20 -129.89 161.08 31.64 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.565 -0.289 . . . . 74.439999999999998 111.601 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.7 t -55.03 114.51 1.78 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.37 0.507 . . . . 64.109999999999999 112.37 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -97.2 118.43 64.63 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.452 -0.34 . . . . 73.109999999999999 111.078 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 2.6 Cg_endo -88.16 21.19 1.04 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.217 2.611 . . . . 63.130000000000003 113.944 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 55.74 36.41 27.2 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.903 0.382 . . . . 74.030000000000001 111.951 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' HD23 ' A' ' 33' ' ' LEU . 60.4 m -65.52 78.62 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.458 0.647 . . . . 43.229999999999997 111.637 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -149.88 120.43 7.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.465 -0.788 . . . . 63.530000000000001 110.396 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.15 -40.11 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.134 -0.555 . . . . 63.0 112.679 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 30' ' ' CYS . 3.3 pp -66.09 153.35 92.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.592 -0.357 . . . . 64.5 111.263 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.13 120.42 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.613 2.209 . . . . 37.850000000000001 113.081 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.41 141.17 29.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 111.023 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 63.3 10.86 4.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.134 0.791 . . . . 64.420000000000002 113.134 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.27 110.64 22.69 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.169 -0.678 . . . . 74.340000000000003 109.169 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -54.18 153.94 4.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.804 0.668 . . . . 64.340000000000003 112.804 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 69' ' ' ARG . 22.5 m -136.54 143.06 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.869 -0.605 . . . . 63.25 110.876 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.86 113.44 25.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 62.310000000000002 110.728 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.17 164.96 48.33 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.146 -0.479 . . . . 37.850000000000001 113.937 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.424 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 24.9 p -58.66 -20.98 52.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.307 0.643 . . . . 73.430000000000007 112.393 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.67 -14.31 60.35 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.989 0.424 . . . . 72.049999999999997 111.755 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.1 10.82 59.34 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.128 -0.558 . . . . 64.120000000000005 113.052 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.61 144.58 40.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.866 0.365 . . . . 43.240000000000002 111.416 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.0 m -96.23 129.41 43.55 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.502 -0.317 . . . . 70.0 111.226 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -109.89 168.89 9.09 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.626 0.251 . . . . 75.409999999999997 111.669 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -47.57 -54.92 10.4 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.573 0.583 . . . . 74.129999999999995 112.573 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -164.27 -178.91 5.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.696 0.284 . . . . 74.549999999999997 111.459 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 tp10 -55.37 -45.01 76.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.427 -0.351 . . . . 74.409999999999997 111.185 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.16 -43.08 82.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.098 0.475 . . . . 73.099999999999994 110.915 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.55 -43.23 97.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 111.052 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.514 ' HG ' HD13 ' A' ' 64' ' ' LEU . 10.4 tt -62.4 -45.27 93.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.227 -0.442 . . . . 71.349999999999994 111.349 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.7 mmm180 -62.57 -37.82 87.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.395 0.617 . . . . 70.099999999999994 109.927 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.1 84.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 111.084 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.25 87.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.366 . . . . 65.519999999999996 111.424 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -64.79 -41.29 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.067 0.461 . . . . 75.209999999999994 110.601 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.53 -26.68 67.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.354 0.597 . . . . 52.439999999999998 110.686 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -89.51 58.12 4.23 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.723 -0.671 . . . . 73.129999999999995 111.299 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.78 36.24 93.06 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.926 0.73 . . . . 52.299999999999997 114.926 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 77.9 m80 -135.66 74.96 57.78 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 117.689 0.744 . . . . 72.140000000000001 111.607 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.04 -24.1 75.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.843 2.362 . . . . 53.520000000000003 114.114 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.16 -2.82 42.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.388 0.514 . . . . 74.530000000000001 112.388 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.514 HD13 ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -77.72 111.59 13.67 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.241 0.543 . . . . 63.119999999999997 111.051 -175.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -142.92 152.07 41.65 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.005 -0.543 . . . . 74.420000000000002 110.706 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 53' ' ' LEU . 7.2 p -77.46 132.34 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 121.162 0.506 . . . . 61.149999999999999 112.257 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.424 ' HE1' ' HA ' ' A' ' 42' ' ' SER . 56.9 mtt -92.51 -54.0 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.378 0.609 . . . . 61.32 110.25 173.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -143.36 150.49 39.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 109.909 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 39' ' ' VAL . 77.2 mtt85 -92.18 148.15 22.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.964 0.888 . . . . 72.409999999999997 112.487 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.16 -163.21 12.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 114.977 -1.01 . . . . 53.109999999999999 110.878 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -90.42 142.91 27.26 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.486 0.643 . . . . 70.239999999999995 110.795 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.85 102.49 0.06 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.405 0.621 . . . . 72.340000000000003 112.578 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -118.6 110.96 17.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.436 -0.802 . . . . 74.530000000000001 110.326 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.254 1.302 0 CA-C-O 119.386 -0.34 . . . . 70.439999999999998 111.814 -173.761 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.771 0.32 . . . . 64.530000000000001 111.019 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.06 169.25 18.68 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.368 0.604 . . . . 74.209999999999994 112.336 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -88.29 128.95 35.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.799 -0.637 . . . . 64.329999999999998 111.881 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 29.0 m -98.9 128.81 45.17 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.426 -0.352 . . . . 36.5 110.637 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.08 111.26 20.16 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.25 -0.282 . . . . 55.310000000000002 110.313 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.91 -39.62 0.97 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.373 -0.442 . . . . 65.209999999999994 113.932 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 6.2 t -66.62 146.06 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.397 0.517 . . . . 71.239999999999995 112.397 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -102.97 106.62 17.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.11 0.481 . . . . 65.019999999999996 110.554 176.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.26 178.78 8.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.719 0.637 . . . . 74.319999999999993 112.719 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.25 -82.88 0.29 Allowed Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.74 -0.664 . . . . 74.409999999999997 111.78 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.67 92.76 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.765 2.31 . . . . 71.310000000000002 112.854 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.4 -10.3 73.26 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.15 -0.547 . . . . 74.030000000000001 113.473 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 45.1 mtmt -135.29 136.3 41.5 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.273 -0.545 . . . . 72.200000000000003 111.761 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.81 133.52 55.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.206 -0.452 . . . . 70.129999999999995 110.132 173.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 23.8 p -97.92 119.71 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.299 0.571 . . . . 64.530000000000001 110.385 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.2 ttm-85 -124.67 143.8 50.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.73 -0.668 . . . . 64.040000000000006 110.577 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.672 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 3.2 mmt -73.68 100.31 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.203 0.525 . . . . 73.120000000000005 110.694 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 83.9 mt -125.38 107.5 10.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.822 -0.626 . . . . 73.439999999999998 110.104 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.39 -64.89 4.09 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.958 -0.639 . . . . 51.109999999999999 112.532 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.55 -22.48 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.584 -0.817 . . . . 53.329999999999998 114.154 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -98.65 138.67 20.77 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.42 -0.459 . . . . 73.430000000000007 111.425 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.75 93.8 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.991 1.794 . . . . 75.239999999999995 112.093 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 11.5 ptm180 -106.1 142.55 35.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.889 -0.596 . . . . 70.209999999999994 111.022 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 93.9 m -103.29 138.85 39.51 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 70.439999999999998 111.757 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.5 mm-40 -106.45 156.69 18.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.232 -0.894 . . . . 54.310000000000002 110.061 -175.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.1 t -68.42 97.82 0.79 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.267 -0.642 . . . . 64.0 109.267 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.75 137.67 20.61 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.157 -0.474 . . . . 75.430000000000007 112.238 -171.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 7.7 Cg_exo -73.8 55.25 3.24 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.06 2.506 . . . . 74.120000000000005 112.59 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.51 127.01 18.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.819 0.342 . . . . 74.019999999999996 111.257 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.784 ' HB2' HD12 ' A' ' 33' ' ' LEU . 29.4 p -169.6 40.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.278 -0.419 . . . . 72.540000000000006 111.445 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.9 t -60.38 102.29 0.17 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.913 0.387 . . . . 64.209999999999994 111.705 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.31 -9.28 5.93 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.414 -0.422 . . . . 62.539999999999999 113.027 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.784 HD12 ' HB2' ' A' ' 30' ' ' CYS . 95.7 mt -95.32 126.08 47.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 O-C-N 122.64 -0.329 . . . . 63.039999999999999 111.325 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.87 125.15 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.501 2.134 . . . . 65.120000000000005 113.057 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.81 9.93 1.64 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.734 0.642 . . . . 65.25 112.734 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -113.18 9.66 18.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.961 0.41 . . . . 74.439999999999998 111.021 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 52.7 tp -106.83 97.91 7.64 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.755 0.312 . . . . 71.319999999999993 111.115 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.13 148.76 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.239 -0.437 . . . . 73.430000000000007 111.868 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 50' ' ' GLU . 25.0 m -137.21 161.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.359 . . . . 64.519999999999996 111.844 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.7 t -118.05 128.5 54.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.932 0.396 . . . . 74.140000000000001 110.627 173.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.33 177.54 37.91 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.103 -0.57 . . . . 74.439999999999998 114.207 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.633 ' HA ' ' HE2' ' A' ' 67' ' ' MET . 55.1 p -63.78 -14.59 54.04 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.098 0.475 . . . . 71.319999999999993 111.74 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -81.95 -22.55 36.61 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.139 0.495 . . . . 65.319999999999993 111.093 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.54 -8.67 60.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.431 -0.414 . . . . 70.310000000000002 113.294 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.47 134.16 39.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.152 0.427 . . . . 72.340000000000003 112.152 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -86.72 116.25 24.69 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.626 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -100.65 159.68 14.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.036 0.446 . . . . 72.349999999999994 112.116 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -56.9 -35.96 69.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.723 -0.671 . . . . 73.129999999999995 111.163 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.0 p-10 -164.14 169.49 17.68 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.328 -0.851 . . . . 74.010000000000005 110.183 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HB3' HD11 ' A' ' 33' ' ' LEU . 34.4 tt0 -65.36 -33.02 74.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.043 -0.411 . . . . 70.25 111.552 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.412 ' HB2' ' OD2' ' A' ' 49' ' ' ASP . 28.2 m -65.41 -37.89 88.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.884 0.373 . . . . 72.209999999999994 110.435 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.99 -39.51 89.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.244 0.545 . . . . 62.100000000000001 110.603 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.97 -47.12 81.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.291 0.567 . . . . 61.450000000000003 110.31 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -65.26 -22.09 66.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.813 -0.63 . . . . 74.120000000000005 111.03 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.59 -43.42 31.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.055 0.455 . . . . 74.340000000000003 110.876 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.32 64.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.133 0.492 . . . . 71.319999999999993 111.217 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 16.0 tpp85 -54.18 -51.35 64.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.576 . . . . 74.530000000000001 110.273 170.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 62.2 m -68.58 -29.95 68.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.92 -0.582 . . . . 71.549999999999997 111.6 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.19 -32.32 73.68 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.903 0.382 . . . . 75.439999999999998 111.292 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.11 43.9 0.06 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.065 -0.588 . . . . 74.329999999999998 113.469 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -135.33 82.07 41.79 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.345 -0.503 . . . . 74.299999999999997 111.646 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.04 -22.33 41.74 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.795 2.33 . . . . 70.150000000000006 113.415 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -84.23 -19.31 34.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.881 0.372 . . . . 75.510000000000005 111.805 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.6 tp -68.16 112.14 4.92 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.367 0.603 . . . . 71.129999999999995 112.521 -172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.2 p -127.38 163.43 24.04 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.66 -0.7 . . . . 72.109999999999999 109.736 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.63 127.56 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.104 0.478 . . . . 70.420000000000002 111.814 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.633 ' HE2' ' HA ' ' A' ' 42' ' ' SER . 57.4 mtt -90.62 -55.71 3.47 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.093 0.473 . . . . 75.439999999999998 111.406 176.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -148.46 157.15 43.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.864 0.364 . . . . 74.129999999999995 111.217 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -101.49 107.73 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.523 0.677 . . . . 74.129999999999995 111.782 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.88 -179.5 29.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.325 -0.852 . . . . 75.519999999999996 111.514 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -60.33 127.55 32.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.748 0.774 . . . . 62.210000000000001 109.95 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.89 97.96 0.06 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.437 0.637 . . . . 72.109999999999999 111.503 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -83.03 135.25 34.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.831 -0.622 . . . . 54.509999999999998 112.114 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm . . . . . 0 C--O 1.25 1.119 0 CA-C-N 116.086 -0.506 . . . . 73.340000000000003 111.309 177.172 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.528 0.204 . . . . 55.020000000000003 111.298 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -164.03 151.96 12.71 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.463 0.305 . . . . 53.43 111.046 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p -144.46 155.22 43.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 120.732 0.301 . . . . 75.230000000000004 111.718 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.8 m -100.1 130.7 46.27 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.781 0.66 . . . . 61.450000000000003 112.781 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.06 124.87 32.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.327 -0.397 . . . . 72.200000000000003 111.445 173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.72 -31.42 2.48 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.689 0.636 . . . . 52.509999999999998 114.689 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 22' ' ' PRO . 36.2 t -66.16 139.69 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 117.276 0.538 . . . . 74.129999999999995 111.626 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.94 103.36 14.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.092 0.405 . . . . 73.349999999999994 112.092 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 57.9 m -152.13 138.84 18.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.369 -0.378 . . . . 70.420000000000002 111.266 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . -139.43 -106.32 0.68 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.737 -0.744 . . . . 63.439999999999998 113.977 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 13.5 Cg_exo -70.8 -49.82 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.843 2.362 . . . . 71.430000000000007 113.415 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.68 66.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.045 -0.598 . . . . 72.430000000000007 113.304 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 49.7 mtmt -128.47 141.26 51.45 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.622 -0.34 . . . . 74.040000000000006 110.985 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.36 133.82 52.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.494 -0.321 . . . . 74.120000000000005 110.169 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.72 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.0 t -100.42 136.52 40.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.339 . . . . 65.329999999999998 111.272 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -134.83 163.67 29.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.08 0.467 . . . . 75.140000000000001 111.465 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.8 mmm -89.85 101.5 14.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.199 0.523 . . . . 72.329999999999998 110.964 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.08 115.48 30.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.215 -0.448 . . . . 65.239999999999995 110.763 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.58 40.54 92.63 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.202 -0.523 . . . . 71.230000000000004 113.418 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 5.92 81.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.9 -0.667 . . . . 62.140000000000001 113.766 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -124.42 129.85 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 117.173 0.486 . . . . 72.319999999999993 111.517 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 7' ' ' VAL . 61.1 Cg_endo -72.55 106.2 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.497 2.131 . . . . 62.409999999999997 112.787 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -115.33 142.81 46.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.881 0.372 . . . . 72.209999999999994 111.277 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 9.4 m -103.92 142.83 33.74 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.102 0.477 . . . . 72.109999999999999 112.203 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -143.6 153.38 42.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.74 -0.664 . . . . 73.030000000000001 110.684 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.6 t -52.83 128.23 26.13 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.176 0.512 . . . . 63.140000000000001 111.929 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.71 128.21 30.51 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.162 -0.472 . . . . 72.5 111.67 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.95 -2.84 12.39 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.264 1.976 . . . . 73.239999999999995 112.645 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.425 ' HB3' ' NH1' ' A' ' 54' ' ' ARG . 36.2 t70 62.14 7.22 2.08 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.633 0.73 . . . . 74.299999999999997 111.645 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.491 ' HA ' HD22 ' A' ' 33' ' ' LEU . 33.8 t -80.53 92.63 5.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.887 -0.597 . . . . 73.319999999999993 112.197 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 p -138.43 -83.01 0.3 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.205 -0.452 . . . . 70.140000000000001 111.1 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.19 49.52 2.71 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.966 -0.635 . . . . 72.319999999999993 113.123 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 30' ' ' CYS . 2.6 pp -132.71 159.05 74.11 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 122.46 0.304 . . . . 60.310000000000002 111.08 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.95 119.09 6.11 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.367 2.045 . . . . 64.219999999999999 113.502 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.17 66.35 8.46 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.886 -0.783 . . . . 74.049999999999997 108.886 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -143.87 -13.38 0.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.909 0.707 . . . . 73.319999999999993 112.909 -165.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 68.1 tp -128.05 116.83 20.61 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.712 0.634 . . . . 74.450000000000003 112.712 -168.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -58.57 154.74 13.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.156 -0.475 . . . . 72.530000000000001 111.405 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.6 m -140.79 148.5 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.236 0.541 . . . . 70.0 111.846 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.0 t -100.03 116.37 31.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.288 -0.414 . . . . 73.329999999999998 110.593 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.34 162.18 34.73 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.215 -0.517 . . . . 73.209999999999994 113.63 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 73.8 p -55.14 -28.0 49.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.117 0.484 . . . . 42.530000000000001 111.654 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.4 -47.47 83.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.869 -0.605 . . . . 74.319999999999993 111.817 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.13 -23.38 5.84 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.335 -0.459 . . . . 62.100000000000001 112.531 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.9 139.89 36.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.993 0.425 . . . . 74.099999999999994 111.824 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -86.68 122.75 31.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.008 0.432 . . . . 71.109999999999999 111.092 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.73 153.73 17.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.442 . . . . 73.209999999999994 111.331 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -62.16 -25.71 67.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.825 -0.625 . . . . 61.450000000000003 112.606 -173.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 25.0 t70 -170.45 159.89 7.19 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.595 -0.275 . . . . 73.439999999999998 110.782 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.67 -40.21 68.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.314 0.578 . . . . 62.509999999999998 110.538 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.8 t -52.99 -42.69 65.81 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.286 -0.87 . . . . 71.040000000000006 111.471 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.98 -43.73 57.11 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.336 -0.393 . . . . 71.340000000000003 111.336 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.47 HD21 HG22 ' A' ' 66' ' ' VAL . 69.2 tp -55.17 -58.33 8.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.137 0.494 . . . . 72.230000000000004 112.208 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 78.3 mtp180 -70.69 -25.05 62.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 111.781 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 59' ' ' ARG . . . -72.76 -45.28 59.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 70.420000000000002 111.146 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.93 68.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.087 0.47 . . . . 73.239999999999995 110.771 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 54' ' ' ARG . 31.6 ttp180 -56.03 -50.02 72.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.579 -0.737 . . . . 73.099999999999994 110.642 171.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -66.28 -22.38 66.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.744 -0.662 . . . . 62.229999999999997 112.129 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 55' ' ' ALA . 29.5 mtp-105 -84.99 30.31 0.59 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.205 0.446 . . . . 73.329999999999998 112.205 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.75 6.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.965 -0.636 . . . . 64.510000000000005 114.279 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -134.46 77.54 59.16 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 117.294 0.547 . . . . 74.530000000000001 110.974 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.88 -21.15 38.18 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.872 2.382 . . . . 71.099999999999994 113.526 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.91 -17.64 52.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.989 0.423 . . . . 54.240000000000002 111.418 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 tp -72.26 112.0 7.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.195 0.521 . . . . 74.109999999999999 111.527 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -135.13 164.46 27.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.017 -0.538 . . . . 65.040000000000006 111.356 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.47 HG22 HD21 ' A' ' 53' ' ' LEU . 39.8 t -79.45 119.24 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.841 0.353 . . . . 71.209999999999994 111.862 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.417 ' HE1' ' HA ' ' A' ' 42' ' ' SER . 15.3 mmt -81.92 -58.73 2.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.978 0.418 . . . . 73.049999999999997 110.579 172.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -161.58 160.91 29.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.801 -0.636 . . . . 70.340000000000003 111.2 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -77.78 137.59 38.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.271 -0.422 . . . . 75.129999999999995 111.569 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.61 172.27 30.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.264 -0.493 . . . . 72.519999999999996 113.127 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' ARG . 63.3 ttt180 -60.15 154.59 19.2 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.634 -0.333 . . . . 70.150000000000006 110.2 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.17 84.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 73.230000000000004 112.502 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' ARG . 57.8 mtp180 -119.25 142.86 47.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.123 0.569 . . . . 64.439999999999998 111.319 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.634 -0.698 . . . . 63.140000000000001 110.947 174.837 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 111.794 0.294 . . . . 73.409999999999997 111.794 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -81.66 133.29 35.35 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.25 0.548 . . . . 61.530000000000001 111.578 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m -123.76 -166.41 1.48 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.999 0.428 . . . . 72.340000000000003 111.736 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.4 p -98.72 130.78 45.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.018 0.437 . . . . 70.239999999999995 112.169 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -80.51 126.46 31.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.081 0.467 . . . . 64.140000000000001 111.521 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.34 -2.2 16.05 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.002 -0.544 . . . . 73.129999999999995 113.945 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 10.9 t -107.17 145.83 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 117.118 0.459 . . . . 64.310000000000002 111.326 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.12 106.41 15.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.635 -0.506 . . . . 64.120000000000005 109.635 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 87.9 m -138.91 139.1 37.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.923 0.392 . . . . 75.430000000000007 111.048 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' LYS . . . 169.97 -64.05 0.17 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.393 -0.432 . . . . 63.32 113.076 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.36 42.83 1.3 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.154 2.569 . . . . 74.549999999999997 113.69 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.79 -45.01 0.43 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.158 -0.544 . . . . 73.409999999999997 112.424 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 36.8 mtmm -122.65 136.92 55.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.492 0.317 . . . . 75.140000000000001 110.263 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -107.23 134.35 50.45 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 122.381 -0.2 . . . . 42.340000000000003 111.108 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.857 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 31.5 p -114.77 139.64 49.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.668 0.618 . . . . 54.310000000000002 112.668 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.551 HH11 ' HG3' ' A' ' 16' ' ' ARG . 29.1 ttm-85 -142.5 160.52 40.13 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.958 -0.565 . . . . 72.200000000000003 111.152 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.517 ' HE1' ' HA ' ' A' ' 17' ' ' MET . 1.2 mmt -82.53 107.91 15.53 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.577 0.584 . . . . 72.010000000000005 112.577 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.584 HD21 ' HD2' ' A' ' 23' ' ' ARG . 6.3 mp -123.45 102.0 7.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.871 0.367 . . . . 75.200000000000003 110.938 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.65 52.57 52.22 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.403 -0.427 . . . . 43.530000000000001 114.018 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.45 -44.37 3.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.205 -0.521 . . . . 74.150000000000006 113.811 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.04 130.76 35.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 75.140000000000001 111.716 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.07 141.05 12.83 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.515 2.143 . . . . 52.32 112.922 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.584 ' HD2' HD21 ' A' ' 18' ' ' LEU . 97.3 mtt180 -113.79 123.32 49.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.764 -0.198 . . . . 65.019999999999996 111.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.857 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 94.9 m -107.36 120.1 41.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.647 0.261 . . . . 75.0 110.988 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -119.74 159.23 24.9 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.341 -0.225 . . . . 75.519999999999996 111.525 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 58' ' ' CYS . 8.9 t -58.72 95.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.293 -0.412 . . . . 74.319999999999993 110.869 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.8 130.99 24.6 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.329 -0.396 . . . . 75.409999999999997 111.887 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -82.68 -158.87 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.672 2.248 . . . . 72.510000000000005 111.842 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.27 102.14 14.81 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.854 -0.529 . . . . 75.450000000000003 110.994 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.7 m -102.87 3.96 37.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.159 0.504 . . . . 73.25 110.56 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -81.37 -35.28 31.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.953 -0.567 . . . . 75.040000000000006 111.99 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.93 9.08 78.81 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.919 -0.658 . . . . 53.420000000000002 114.389 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 51' ' ' CYS . 4.1 pp -128.62 156.36 77.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 117.578 0.689 . . . . 74.319999999999993 112.087 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.56 123.19 2.49 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.677 2.251 . . . . 74.120000000000005 112.963 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.87 14.68 0.48 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.77 0.656 . . . . 72.040000000000006 112.77 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.01 10.04 13.85 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.11 -0.369 . . . . 72.519999999999996 111.78 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -111.06 100.19 8.92 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.205 -0.31 . . . . 73.209999999999994 110.798 -177.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.22 139.36 57.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.877 0.37 . . . . 73.019999999999996 111.974 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.627 HG12 ' HG3' ' A' ' 69' ' ' ARG . 26.2 m -128.72 166.25 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.142 0.496 . . . . 72.329999999999998 111.811 -175.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.0 t -116.34 124.16 49.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.224 -0.444 . . . . 53.32 111.254 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.02 161.56 24.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.124 -0.56 . . . . 71.299999999999997 113.497 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 p -55.54 -24.13 30.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.404 0.52 . . . . 74.530000000000001 112.404 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.2 -2.5 28.22 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 120.877 0.37 . . . . 73.439999999999998 111.674 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.11 25.06 58.39 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.424 -0.417 . . . . 38.57 113.244 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.41 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.928 0.394 . . . . 72.200000000000003 111.832 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 71' ' ' ARG . 81.2 m -86.36 110.95 20.04 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.279 -0.419 . . . . 74.310000000000002 110.862 174.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -91.16 159.8 15.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 71.239999999999995 111.673 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 3.9 mmp_? -53.04 -39.68 63.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.112 -0.494 . . . . 74.120000000000005 112.223 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 5.5 p-10 -163.93 -178.48 5.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.281 -0.418 . . . . 75.530000000000001 110.821 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HB3' HD21 ' A' ' 33' ' ' LEU . 24.7 tt0 -68.85 -37.28 79.02 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.673 0.273 . . . . 75.25 111.589 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.585 ' HB2' HD12 ' A' ' 33' ' ' LEU . 25.3 t -65.5 -41.71 92.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.657 0.265 . . . . 64.420000000000002 110.667 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.25 -51.48 53.65 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.209 0.528 . . . . 63.240000000000002 111.122 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.4 -53.84 46.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.915 -0.584 . . . . 64.200000000000003 110.984 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' NH1' HD23 ' A' ' 33' ' ' LEU . 70.0 mtp180 -61.75 -29.86 70.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 111.977 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.32 -42.8 68.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.985 0.421 . . . . 63.329999999999998 110.812 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.35 88.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.862 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 36.8 ttt85 -63.39 -48.06 79.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.086 0.47 . . . . 52.43 111.236 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.486 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 5.6 t -55.47 -44.42 76.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.933 -0.576 . . . . 71.400000000000006 110.468 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -84.21 61.9 6.81 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.255 0.55 . . . . 64.450000000000003 112.147 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.05 25.28 49.51 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.58 0.992 . . . . 54.210000000000001 115.58 170.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.476 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 95.4 m-70 -134.81 74.88 63.27 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 118.222 1.011 . . . . 75.310000000000002 112.132 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.96 -19.76 17.64 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.608 2.206 . . . . 63.539999999999999 113.494 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.0 -22.52 42.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.083 0.468 . . . . 65.040000000000006 111.067 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.448 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 63.9 tp -75.12 111.74 10.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.184 -0.462 . . . . 62.200000000000003 111.264 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 p -124.75 141.97 51.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.003 0.43 . . . . 74.329999999999998 111.638 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.24 113.71 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.305 0.574 . . . . 75.329999999999998 111.289 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.64 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 28.0 mmt -77.01 -42.44 38.65 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.962 0.41 . . . . 72.030000000000001 111.416 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -169.03 163.0 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.085 -0.507 . . . . 75.230000000000004 111.217 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.627 ' HG3' HG12 ' A' ' 39' ' ' VAL . 1.3 mpp_? -93.34 153.72 18.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.387 -0.37 . . . . 72.549999999999997 111.336 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.99 49.69 2.42 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.366 -0.445 . . . . 38.57 113.514 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 46' ' ' THR . 59.7 mtp85 61.47 172.08 0.11 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.894 0.701 . . . . 75.400000000000006 112.894 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.2 m -81.32 112.28 18.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 72.510000000000005 111.646 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -118.22 105.08 11.42 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.053 -0.522 . . . . 74.209999999999994 110.765 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? . . . . . 0 C--O 1.253 1.261 0 CA-C-O 118.575 -0.726 . . . . 72.329999999999998 111.547 -175.079 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.922 0.392 . . . . 64.439999999999998 111.699 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -91.7 134.41 34.73 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.509 -0.314 . . . . 60.219999999999999 110.32 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -66.92 127.89 34.23 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.832 0.348 . . . . 74.150000000000006 111.625 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 m -97.1 130.56 44.36 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.856 0.36 . . . . 71.450000000000003 111.173 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -84.21 112.1 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.738 0.304 . . . . 75.540000000000006 111.454 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.28 0.01 9.6 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 114.67 0.628 . . . . 74.439999999999998 114.67 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.551 HG11 ' SG ' ' A' ' 9' ' ' CYS . 2.3 t -107.41 137.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 117.691 0.745 . . . . 51.340000000000003 111.819 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.46 106.03 18.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.797 0.332 . . . . 71.329999999999998 110.195 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.551 ' SG ' HG11 ' A' ' 7' ' ' VAL . 59.0 m -142.96 177.35 8.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.848 0.356 . . . . 74.109999999999999 111.908 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.87 -88.07 0.3 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.495 -0.383 . . . . 51.210000000000001 112.272 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.66 93.64 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.482 2.121 . . . . 64.439999999999998 112.925 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.0 10.89 82.26 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.034 -0.53 . . . . 72.129999999999995 113.432 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -146.98 136.29 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.386 -0.479 . . . . 74.420000000000002 111.484 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.1 140.21 52.28 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.594 -0.275 . . . . 73.340000000000003 110.802 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 15.8 p -100.1 106.24 17.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.402 0.62 . . . . 64.510000000000005 111.942 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -106.69 122.14 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.655 -0.702 . . . . 73.099999999999994 110.253 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 54.2 mtp -80.54 106.71 12.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.394 0.616 . . . . 64.129999999999995 111.883 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD13 ' HD2' ' A' ' 23' ' ' ARG . 92.9 mt -116.75 112.94 21.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.81 -0.632 . . . . 65.109999999999999 110.995 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.59 22.85 74.42 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.964 -0.636 . . . . 40.219999999999999 113.101 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.97 -21.12 44.86 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.337 -0.459 . . . . 71.310000000000002 113.627 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -106.08 131.78 21.45 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 117.22 0.51 . . . . 73.420000000000002 111.98 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 59.0 Cg_endo -73.36 111.6 3.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.436 2.091 . . . . 72.430000000000007 112.418 174.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.66 ' HD2' HD13 ' A' ' 18' ' ' LEU . 95.2 mtt180 -96.06 146.42 24.65 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.242 -0.286 . . . . 74.310000000000002 111.4 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 21.8 m -132.67 133.07 43.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.101 0.477 . . . . 53.310000000000002 111.191 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.16 161.23 37.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.015 -0.539 . . . . 71.239999999999995 110.11 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.8 t -54.05 95.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.033 0.444 . . . . 70.0 111.855 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.26 136.59 24.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.678 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.45 90.84 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.421 2.081 . . . . 75.450000000000003 113.314 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.77 -70.5 0.25 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.921 0.391 . . . . 71.140000000000001 110.599 172.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.6 m 55.55 72.79 0.46 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.678 0.621 . . . . 72.230000000000004 112.678 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.8 m -85.28 -29.72 24.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.976 0.417 . . . . 70.439999999999998 110.893 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -65.52 1.54 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.28 -0.418 . . . . 62.439999999999998 113.333 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 33' ' ' LEU . 2.3 pt? -74.13 141.78 78.21 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.989 0.423 . . . . 75.239999999999995 111.993 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 16.1 Cg_exo -70.49 120.8 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.776 2.318 . . . . 71.530000000000001 112.574 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.15 60.35 1.04 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.345 0.593 . . . . 74.140000000000001 111.089 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -151.24 -35.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.578 -0.737 . . . . 71.019999999999996 110.937 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 66.3 tp -67.76 107.99 2.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.278 -0.419 . . . . 73.219999999999999 111.744 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.63 149.82 38.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.5 0.666 . . . . 70.420000000000002 112.744 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 69' ' ' ARG . 34.3 m -139.78 153.62 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 115.649 -0.705 . . . . 50.0 110.899 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.8 t -106.42 122.34 46.09 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.885 0.374 . . . . 74.209999999999994 111.256 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.6 165.12 40.21 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.05 -0.595 . . . . 60.240000000000002 113.648 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 p -53.53 -36.82 62.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.017 0.377 . . . . 71.209999999999994 112.017 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.06 -27.92 62.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 116.305 -0.407 . . . . 72.340000000000003 111.968 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.73 -3.0 34.05 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.174 -0.536 . . . . 55.140000000000001 113.099 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.28 142.73 27.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.98 0.419 . . . . 73.329999999999998 111.911 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.0 m -92.0 120.35 32.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.929 0.395 . . . . 72.409999999999997 110.33 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -97.12 148.55 22.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.529 -0.305 . . . . 64.140000000000001 111.11 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 19.9 ptp180 -49.51 -34.53 17.41 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.432 0.53 . . . . 74.140000000000001 112.432 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.2 p30 -160.75 176.69 11.22 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.885 0.374 . . . . 75.319999999999993 111.286 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HA ' HG23 ' A' ' 39' ' ' VAL . 35.2 tt0 -65.45 -33.61 76.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.412 -0.358 . . . . 73.049999999999997 111.885 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.32 -36.15 82.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.603 0.24 . . . . 61.009999999999998 111.1 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.63 -48.71 80.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.98 0.419 . . . . 74.010000000000005 110.818 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.6 -55.57 32.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.182 0.515 . . . . 74.510000000000005 110.397 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -58.8 -34.66 71.75 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.994 -0.548 . . . . 75.040000000000006 111.956 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.92 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.586 0.231 . . . . 73.239999999999995 111.485 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.57 86.09 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 73.439999999999998 111.348 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 1.6 tmt_? -59.42 -50.14 75.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.609 0.719 . . . . 73.25 109.99 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.76 -30.05 69.77 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.452 -0.794 . . . . 74.409999999999997 111.455 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.95 74.61 6.42 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.075 -0.512 . . . . 74.329999999999998 111.312 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.64 34.97 90.43 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 115.224 0.85 . . . . 73.420000000000002 115.224 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 77.8 m80 -135.04 89.05 25.07 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 117.96 0.88 . . . . 73.329999999999998 111.925 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.56 -18.18 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.01 2.473 . . . . 71.409999999999997 113.176 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -19.61 44.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.889 0.376 . . . . 74.219999999999999 111.916 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 tp -82.97 130.65 35.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.006 0.432 . . . . 74.519999999999996 112.001 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -146.72 161.26 40.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.283 -0.417 . . . . 74.5 110.78 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t -80.48 112.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 120.966 0.412 . . . . 64.040000000000006 111.372 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.62 ' HE1' ' HA ' ' A' ' 67' ' ' MET . 24.6 mmt -84.18 -55.91 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.21 0.529 . . . . 71.109999999999999 110.668 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -159.51 152.93 22.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.917 -0.583 . . . . 74.209999999999994 110.706 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HG2' HG12 ' A' ' 39' ' ' VAL . 91.3 mtt180 -79.57 150.48 31.07 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.062 0.458 . . . . 73.430000000000007 111.195 177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.84 -178.34 29.64 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.978 -0.555 . . . . 38.460000000000001 112.177 -173.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -75.03 161.91 29.03 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.265 -0.55 . . . . 73.219999999999999 111.388 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.42 93.68 0.24 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.159 0.799 . . . . 74.150000000000006 113.159 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -118.7 145.54 45.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.413 -0.812 . . . . 71.540000000000006 110.88 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.67 ' HZ2' ' HB3' ' A' ' 74' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.314 -0.851 . . . . 52.130000000000003 112.383 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 120.704 0.288 . . . . 54.130000000000003 110.665 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.53 118.19 18.11 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.35 0.5 . . . . 72.310000000000002 112.35 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 m -98.84 138.28 36.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.112 -0.495 . . . . 73.430000000000007 110.268 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.0 m -120.56 131.13 54.52 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.276 0.472 . . . . 63.350000000000001 112.276 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.415 ' O ' HG21 ' A' ' 7' ' ' VAL . 9.5 m-20 -83.45 112.13 19.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.21 -0.45 . . . . 75.319999999999993 111.726 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.72 32.08 16.87 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.757 0.663 . . . . 74.200000000000003 114.757 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 22' ' ' PRO . 93.1 t -106.96 122.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.541 0.67 . . . . 62.219999999999999 111.542 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -99.26 105.97 18.05 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.329 0.585 . . . . 72.140000000000001 111.747 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 80.9 m -148.34 137.95 22.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.002 -0.545 . . . . 52.409999999999997 110.127 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.74 -86.9 0.06 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 119.897 -1.144 . . . . 73.430000000000007 114.635 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.56 -35.64 80.47 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.12 2.547 . . . . 74.219999999999999 113.901 -172.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.96 -45.35 1.39 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.988 -0.625 . . . . 65.120000000000005 113.634 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.8 mtmt -123.63 146.87 47.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.489 0.552 . . . . 71.510000000000005 112.489 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -116.67 145.94 43.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 65.329999999999998 110.494 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.75 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 26.8 p -104.03 133.99 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.154 0.502 . . . . 64.310000000000002 112.198 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.474 ' NH2' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -118.86 164.26 15.68 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.987 -0.551 . . . . 73.430000000000007 111.161 176.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.633 ' HE1' ' HA ' ' A' ' 17' ' ' MET . 4.8 mmt -82.11 102.94 11.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.891 0.377 . . . . 64.120000000000005 111.274 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.83 103.41 12.66 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.871 0.367 . . . . 70.420000000000002 110.212 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.18 33.01 82.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.341 -0.457 . . . . 71.239999999999995 112.686 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.34 -12.97 57.27 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.369 -0.443 . . . . 52.200000000000003 113.047 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 94.9 mtt180 -99.19 129.31 29.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 O-C-N 122.616 -0.343 . . . . 72.200000000000003 111.602 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.645 ' HB2' HG23 ' A' ' 7' ' ' VAL . 1.9 Cg_endo -80.95 113.75 2.8 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.966 2.444 . . . . 73.109999999999999 112.877 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -123.14 140.62 52.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.789 0.328 . . . . 74.519999999999996 111.472 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.75 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.4 m -104.1 131.74 51.06 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.894 0.701 . . . . 74.519999999999996 112.894 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . 86.0 mt-10 -124.83 159.97 29.81 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.252 -0.431 . . . . 74.310000000000002 110.235 172.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.5 t -64.68 119.32 10.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.102 0.477 . . . . 62.210000000000001 111.415 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -108.82 138.38 20.31 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.794 0.664 . . . . 61.020000000000003 112.794 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.4 Cg_exo -77.74 130.69 10.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.952 2.435 . . . . 64.030000000000001 112.229 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 10.8 t0 -66.04 84.89 0.09 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.35 0.595 . . . . 71.329999999999998 110.816 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 87.4 m -105.18 39.66 1.68 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.19 -0.459 . . . . 75.349999999999994 112.074 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -69.12 83.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.12 0.486 . . . . 74.400000000000006 111.855 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.9 52.61 11.25 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.615 0.606 . . . . 64.219999999999999 114.615 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.758 HD12 ' SG ' ' A' ' 51' ' ' CYS . 4.4 pp -114.0 157.08 43.0 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 117.394 0.597 . . . . 61.43 111.258 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.81 119.92 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.264 1.976 . . . . 73.030000000000001 112.784 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.01 -9.96 59.37 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.297 0.48 . . . . 73.540000000000006 112.297 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -90.22 -9.63 47.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.538 -0.301 . . . . 72.450000000000003 111.795 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.3 tp -98.85 117.35 33.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.002 0.43 . . . . 73.019999999999996 112.113 -174.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 46.7 mt-30 -75.72 159.82 30.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 73.409999999999997 110.827 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.0 m -144.4 148.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 112.332 0.493 . . . . 73.129999999999995 112.332 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 34.2 m -104.67 126.7 52.01 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.347 -0.388 . . . . 42.219999999999999 111.676 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.27 162.91 22.84 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.174 -0.536 . . . . 74.540000000000006 112.711 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.624 ' HA ' ' HE1' ' A' ' 67' ' ' MET . 46.9 t -57.36 -18.23 16.33 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.206 0.447 . . . . 72.510000000000005 112.206 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.4 -38.51 80.75 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.935 0.398 . . . . 53.439999999999998 111.607 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.0 4.3 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.106 -0.569 . . . . 73.109999999999999 113.041 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.82 148.5 29.96 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.123 0.487 . . . . 44.329999999999998 112.155 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 71' ' ' ARG . 96.2 m -86.18 137.38 32.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.714 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -106.68 143.66 34.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.474 -0.33 . . . . 74.430000000000007 111.452 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 68.5 mtt180 -43.71 -39.29 3.6 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.031 0.752 . . . . 74.109999999999999 113.031 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 38' ' ' GLN . 3.3 p30 -167.04 172.11 10.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.838 0.352 . . . . 75.129999999999995 111.278 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG3' HD21 ' A' ' 33' ' ' LEU . 13.4 tp10 -58.16 -34.12 69.95 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.491 -0.322 . . . . 71.230000000000004 111.765 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.758 ' SG ' HD12 ' A' ' 33' ' ' LEU . 62.9 m -71.05 -34.67 71.46 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.864 -0.523 . . . . 64.219999999999999 111.164 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.69 -46.86 87.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 73.129999999999995 110.65 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.82 -40.46 95.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 70.510000000000005 109.799 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -59.54 -24.76 63.97 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.706 -0.679 . . . . 65.109999999999999 111.084 175.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.09 -35.18 17.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.131 -0.486 . . . . 64.450000000000003 111.146 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.44 -29.41 69.0 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.191 0.441 . . . . 55.340000000000003 112.191 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 20.2 ptt180 -55.43 -29.09 57.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.843 173.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.5 t -82.65 -18.8 39.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.396 -0.82 . . . . 70.219999999999999 111.174 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -107.03 89.42 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.062 0.458 . . . . 63.32 111.481 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.78 -17.13 1.29 Allowed Glycine 0 CA--C 1.536 1.35 0 N-CA-C 115.321 0.888 . . . . 71.530000000000001 115.321 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.573 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 61.4 m80 -122.83 74.89 47.2 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 118.243 1.021 . . . . 71.019999999999996 112.2 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.1 -23.0 29.72 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.255 1.97 . . . . 71.319999999999993 112.957 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -96.21 10.38 38.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.456 -0.338 . . . . 75.120000000000005 111.742 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 tp -62.96 115.55 4.5 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.342 0.497 . . . . 54.149999999999999 112.342 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.2 m -114.14 163.76 14.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.251 -0.431 . . . . 73.25 111.344 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 53' ' ' LEU . 39.8 t -90.91 127.34 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.084 0.402 . . . . 73.319999999999993 112.084 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.624 ' HE1' ' HA ' ' A' ' 42' ' ' SER . 58.3 mtt -73.16 -53.77 10.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 63.299999999999997 110.483 173.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -168.01 167.82 12.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.804 -0.634 . . . . 74.120000000000005 110.462 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 150.06 25.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.186 0.517 . . . . 75.519999999999996 111.388 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.48 -162.0 15.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.849 -0.614 . . . . 64.519999999999996 112.456 -176.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' HG2' HG22 ' A' ' 46' ' ' THR . 73.3 mtm180 -98.41 147.25 24.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.938 0.399 . . . . 75.040000000000006 111.201 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 73.3 m -62.93 106.97 0.9 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.885 0.698 . . . . 62.409999999999997 112.885 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -118.03 131.72 56.44 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.066 -0.516 . . . . 71.319999999999993 110.863 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 74' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.599 -0.715 . . . . 73.319999999999993 111.665 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 81.0 p . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 112.252 0.464 . . . . 72.549999999999997 112.252 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -73.75 108.48 6.61 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.18 -0.325 . . . . 65.310000000000002 111.561 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 t -150.49 164.27 36.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.809 0.338 . . . . 38.840000000000003 111.351 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.607 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 54.5 m -140.43 140.44 35.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.203 0.445 . . . . 71.450000000000003 112.203 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 7' ' ' VAL . 22.5 t70 -50.77 111.83 0.61 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.415 0.524 . . . . 75.219999999999999 112.415 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.68 10.92 26.98 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.375 0.51 . . . . 65.209999999999994 114.375 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.629 HG22 ' HB2' ' A' ' 22' ' ' PRO . 17.2 t -107.91 122.92 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 122.208 -0.583 . . . . 71.420000000000002 111.726 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.27 106.68 17.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.647 0.26 . . . . 75.510000000000005 110.416 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.594 ' SG ' HG11 ' A' ' 7' ' ' VAL . 47.8 m -148.9 163.05 38.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.975 0.417 . . . . 63.130000000000003 111.655 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.92 -84.02 0.11 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.138 -0.483 . . . . 75.109999999999999 112.493 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.6 108.76 2.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.56 2.174 . . . . 75.209999999999994 112.52 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.69 6.38 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.88 -0.676 . . . . 75.329999999999998 113.109 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -142.85 136.9 29.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 117.164 0.482 . . . . 53.439999999999998 111.479 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.86 146.58 32.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.194 -0.457 . . . . 71.319999999999993 110.54 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 52.7 t -104.25 141.03 37.0 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.568 0.581 . . . . 73.209999999999994 112.568 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -142.46 132.86 24.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.008 -0.542 . . . . 74.400000000000006 110.393 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 67.9 mtp -86.75 121.1 28.78 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.133 0.492 . . . . 73.549999999999997 112.245 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.7 mt -112.8 118.1 34.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.806 -0.634 . . . . 75.049999999999997 110.58 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.06 30.61 67.16 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.045 -0.598 . . . . 61.310000000000002 113.384 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.18 -8.99 78.84 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.235 -0.507 . . . . 75.420000000000002 113.553 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.496 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 95.9 mtt180 -113.46 120.55 39.49 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 122.424 -0.456 . . . . 74.530000000000001 111.091 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HB2' HG22 ' A' ' 7' ' ' VAL . 7.1 Cg_exo -75.29 143.69 28.45 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.037 2.491 . . . . 72.209999999999994 114.401 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 17.8 mmt180 -125.11 139.41 53.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.119 0.568 . . . . 73.140000000000001 110.814 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 89.4 m -122.28 118.97 29.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.986 0.422 . . . . 70.409999999999997 112.015 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -130.81 161.84 30.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.101 -0.5 . . . . 72.530000000000001 110.659 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 10.5 t -37.65 124.93 1.1 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.537 0.94 . . . . 72.549999999999997 113.537 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.02 143.84 27.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.779 -0.646 . . . . 74.040000000000006 111.306 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.15 52.7 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.469 2.113 . . . . 73.530000000000001 113.337 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.945 0.402 . . . . 52.5 110.456 173.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.544 ' HB2' HD22 ' A' ' 33' ' ' LEU . 24.8 p -134.37 23.4 3.76 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.795 0.665 . . . . 73.340000000000003 112.795 -171.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.2 t -65.19 106.38 1.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.874 0.368 . . . . 70.450000000000003 111.315 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.38 -42.87 0.92 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.758 -0.734 . . . . 73.409999999999997 113.499 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 50' ' ' GLU . 3.4 pp -67.66 152.51 96.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.359 0.503 . . . . 73.319999999999993 112.359 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 28.2 Cg_exo -62.77 137.67 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.677 2.251 . . . . 71.099999999999994 113.166 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 35.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.186 -0.461 . . . . 51.520000000000003 111.857 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 64.69 25.47 13.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.822 0.675 . . . . 70.120000000000005 112.822 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.1 tm? -84.85 102.8 13.37 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.672 -0.492 . . . . 75.129999999999995 109.672 174.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.656 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 64.2 mt-30 -66.26 145.89 55.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.726 0.639 . . . . 72.400000000000006 112.726 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.13 155.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.787 -0.642 . . . . 75.340000000000003 111.082 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.96 122.61 43.8 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.796 0.331 . . . . 63.229999999999997 111.603 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.485 ' HA3' ' HE2' ' A' ' 47' ' ' TYR . . . -83.01 176.0 53.14 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.182 -0.532 . . . . 51.009999999999998 113.549 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 64' ' ' LEU . 40.1 t -54.8 -40.43 69.49 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.914 0.709 . . . . 70.230000000000004 112.914 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.53 -20.01 65.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.923 0.392 . . . . 75.120000000000005 111.995 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 14.76 42.8 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.439 -0.41 . . . . 70.129999999999995 112.53 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.33 142.66 28.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.901 0.381 . . . . 72.329999999999998 111.752 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -87.14 117.29 25.79 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.083 0.468 . . . . 73.430000000000007 111.452 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HE2' ' HA3' ' A' ' 41' ' ' GLY . 83.6 m-85 -94.65 138.78 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 109.971 174.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.656 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -66.42 -6.9 16.16 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.559 0.578 . . . . 62.520000000000003 112.559 -175.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 4.8 p-10 -174.5 155.91 2.35 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.914 0.485 . . . . 60.310000000000002 110.934 172.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.697 ' HB3' HD21 ' A' ' 33' ' ' LEU . 41.7 tt0 -62.35 -30.79 71.43 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.172 0.434 . . . . 70.150000000000006 112.172 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.426 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 26.6 t -61.36 -40.19 93.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.223 0.535 . . . . 72.209999999999994 110.489 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -60.45 -44.01 96.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.675 -0.693 . . . . 71.120000000000005 110.784 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.56 -39.57 76.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 110.889 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -58.87 -49.43 77.79 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.989 0.423 . . . . 75.439999999999998 111.208 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.11 96.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.093 0.473 . . . . 72.209999999999994 111.211 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.3 96.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.143 -0.481 . . . . 74.030000000000001 111.548 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 23.2 ttt85 -61.82 -51.41 68.37 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.026 0.441 . . . . 73.140000000000001 111.342 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 74.7 m -75.47 -2.99 31.41 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.23 0.456 . . . . 64.239999999999995 112.23 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -78.88 -59.97 2.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.838 0.351 . . . . 73.430000000000007 110.112 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.47 27.31 0.32 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.962 -0.637 . . . . 63.329999999999998 113.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.683 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 37.8 m80 -134.53 76.33 61.61 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 122.233 -0.569 . . . . 72.430000000000007 111.668 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.34 -12.61 28.15 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.691 2.261 . . . . 64.450000000000003 113.45 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.82 8.07 26.49 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.843 0.312 . . . . 74.0 111.843 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 59.6 tp -73.44 111.34 8.48 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.154 0.502 . . . . 73.409999999999997 111.497 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.8 m -129.17 152.93 48.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 73.310000000000002 110.416 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.72 114.73 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.284 0.564 . . . . 64.430000000000007 111.579 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.564 ' HA ' ' HE2' ' A' ' 67' ' ' MET . 30.3 mmt -65.9 -41.57 91.3 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.012 0.434 . . . . 72.25 111.186 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.62 150.55 6.0 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.053 -0.521 . . . . 74.200000000000003 111.689 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.18 140.84 43.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.981 -0.554 . . . . 75.239999999999995 111.865 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.25 170.35 20.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.187 -0.46 . . . . 43.399999999999999 112.509 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.522 ' HG2' ' OE1' ' A' ' 38' ' ' GLN . 64.2 mtt-85 -61.0 132.11 52.79 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.612 -0.346 . . . . 73.239999999999995 110.454 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.49 96.99 0.73 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.197 0.522 . . . . 72.530000000000001 112.327 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -107.77 106.05 16.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.46 -0.791 . . . . 70.310000000000002 110.496 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? . . . . . 0 C--O 1.254 1.296 0 CA-C-O 119.114 -0.469 . . . . 63.439999999999998 110.734 -177.654 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.581 0.229 . . . . 62.32 111.27 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -109.66 174.55 5.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.845 0.355 . . . . 74.540000000000006 111.044 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.2 m -84.97 154.78 21.93 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.135 0.493 . . . . 61.130000000000003 111.734 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.665 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.7 m -98.68 130.73 45.19 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.18 -0.464 . . . . 65.310000000000002 111.388 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 7' ' ' VAL . 23.5 t70 -76.4 111.68 12.12 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.868 0.366 . . . . 54.520000000000003 111.191 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.76 -4.16 2.44 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.482 0.553 . . . . 38.600000000000001 114.482 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 14.1 t -97.49 126.25 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 117.408 0.604 . . . . 71.200000000000003 111.579 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.98 105.3 16.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.69 0.281 . . . . 74.430000000000007 110.985 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.0 m -149.05 158.78 44.45 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.374 0.509 . . . . 72.040000000000006 112.374 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.11 -107.67 0.2 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.107 -0.497 . . . . 71.430000000000007 112.758 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.83 102.69 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.323 2.015 . . . . 71.109999999999999 112.941 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.47 -3.88 56.57 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.958 -0.639 . . . . 62.549999999999997 113.813 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -143.22 136.12 27.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.316 0.579 . . . . 73.219999999999999 112.314 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -131.17 155.21 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.684 -0.689 . . . . 54.140000000000001 110.649 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.63 126.45 41.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.066 0.46 . . . . 50.420000000000002 111.209 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -123.5 137.32 54.8 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.138 -0.483 . . . . 53.520000000000003 110.465 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.9 mmm -85.79 102.58 13.79 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.113 0.483 . . . . 64.430000000000007 111.951 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.527 HD22 ' HG2' ' A' ' 23' ' ' ARG . 4.1 mm? -109.11 115.69 30.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.2 -0.455 . . . . 64.430000000000007 110.303 174.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.8 27.67 67.03 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.157 -0.544 . . . . 74.109999999999999 113.261 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.51 85.14 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.483 -0.389 . . . . 55.43 113.696 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -109.55 126.68 28.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.517 -0.402 . . . . 53.520000000000003 111.439 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.44 104.36 1.73 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.42 2.08 . . . . 73.209999999999994 113.253 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' HG2' HD22 ' A' ' 18' ' ' LEU . 7.5 ptp180 -97.18 157.65 15.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.477 -0.328 . . . . 71.219999999999999 110.839 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 30.2 m -111.11 120.36 42.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.21 0.529 . . . . 74.200000000000003 112.093 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -107.02 160.17 15.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.691 -0.686 . . . . 64.430000000000007 109.959 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.22 95.87 0.14 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.057 0.456 . . . . 64.209999999999994 111.179 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.7 119.26 59.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.129 -0.487 . . . . 53.399999999999999 110.764 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.491 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 22.4 Cg_endo -59.86 102.15 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.321 2.014 . . . . 62.539999999999999 112.932 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.46 100.34 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.001 0.429 . . . . 61.539999999999999 109.961 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.6 p -139.57 35.57 2.03 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.288 -0.415 . . . . 64.299999999999997 111.36 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.8 t -58.27 -37.89 75.88 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.242 -0.436 . . . . 74.430000000000007 111.842 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.41 43.16 1.75 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.365 -0.445 . . . . 40.210000000000001 113.151 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.433 HD12 ' NH2' ' A' ' 54' ' ' ARG . 87.9 mt -130.4 152.92 81.1 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.717 0.294 . . . . 74.209999999999994 111.428 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.09 119.94 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.211 1.941 . . . . 75.239999999999995 112.381 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.41 17.95 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.086 0.47 . . . . 60.420000000000002 111.65 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -120.84 -21.26 6.66 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.613 0.597 . . . . 71.439999999999998 112.613 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 69' ' ' ARG . 8.1 tt -93.2 120.84 33.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.832 0.349 . . . . 71.109999999999999 111.442 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.676 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 48.7 mt-30 -73.56 142.49 46.64 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.746 0.647 . . . . 74.200000000000003 112.746 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.93 159.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.109 -0.496 . . . . 74.329999999999998 111.577 -176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 51.8 t -106.13 127.46 53.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.887 0.375 . . . . 62.210000000000001 111.775 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.54 155.91 32.81 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 113.257 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 43.8 t -53.79 -32.3 52.07 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.981 0.734 . . . . 72.120000000000005 112.981 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.78 -2.95 52.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.055 0.455 . . . . 74.239999999999995 112.135 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.38 20.91 39.68 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.199 -0.524 . . . . 72.430000000000007 113.136 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.9 132.52 42.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.789 0.328 . . . . 64.019999999999996 111.309 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -85.78 122.44 29.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.963 0.411 . . . . 71.420000000000002 111.703 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -112.84 147.35 37.15 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.998 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.676 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 31.2 mmt-85 -75.29 -20.33 59.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.359 -0.382 . . . . 54.420000000000002 111.739 -173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -163.99 161.65 22.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.061 -0.518 . . . . 64.200000000000003 111.092 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.555 ' HG2' HG23 ' A' ' 66' ' ' VAL . 1.7 tm-20 -57.61 -40.38 79.02 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.175 0.512 . . . . 70.430000000000007 110.701 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 25.7 t -59.64 -38.23 80.83 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.974 0.416 . . . . 53.340000000000003 111.461 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.11 -43.88 90.57 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.069 0.461 . . . . 72.129999999999995 111.05 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.627 HD11 HG22 ' A' ' 66' ' ' VAL . 10.3 tt -64.83 -47.25 78.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.991 -0.55 . . . . 75.209999999999994 110.99 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' NH2' HD12 ' A' ' 33' ' ' LEU . 19.0 ttm180 -55.14 -37.25 66.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.079 0.466 . . . . 74.219999999999999 111.13 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.491 ' HB1' ' HG3' ' A' ' 28' ' ' PRO . . . -65.6 -47.65 74.96 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 111.262 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.91 -38.3 75.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.986 0.422 . . . . 62.240000000000002 111.633 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 76.2 ttt180 -60.74 -50.45 73.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.935 0.397 . . . . 75.209999999999994 111.085 175.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.27 -29.47 70.56 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.986 0.422 . . . . 75.319999999999993 111.664 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 59' ' ' ARG . 35.3 ttt-85 -61.8 -38.68 89.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.254 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.57 36.28 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.033 -0.603 . . . . 63.420000000000002 113.68 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.418 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 96.9 m-70 -134.31 78.13 58.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.297 -0.531 . . . . 70.209999999999994 111.507 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.62 -28.62 25.71 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.636 2.224 . . . . 71.319999999999993 113.186 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.24 -11.94 58.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.249 0.547 . . . . 64.329999999999998 111.328 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 5.8 tt -92.88 114.97 27.67 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.591 0.71 . . . . 74.319999999999993 111.331 -175.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' HD22 ' A' ' 53' ' ' LEU . 69.5 m -144.58 166.27 25.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.613 -0.721 . . . . 72.129999999999995 110.193 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 53' ' ' LEU . 75.4 t -69.07 111.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.018 0.437 . . . . 63.420000000000002 111.65 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.481 ' SD ' ' HA ' ' A' ' 42' ' ' SER . 66.1 mtm -81.69 -53.73 5.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.133 -0.485 . . . . 65.239999999999995 110.996 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.33 164.57 31.06 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 110.887 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HB3' HD23 ' A' ' 37' ' ' LEU . 98.9 mtt180 -96.77 151.68 19.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.987 0.423 . . . . 72.439999999999998 111.639 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 47.85 1.74 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.185 -0.531 . . . . 62.219999999999999 112.549 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.61 -177.54 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.351 1.061 . . . . 73.109999999999999 113.364 -176.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.4 m -89.51 105.36 17.74 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.789 -0.569 . . . . 62.240000000000002 111.078 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -115.95 132.49 56.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.068 -0.514 . . . . 74.310000000000002 111.75 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.196 -0.907 . . . . 53.509999999999998 111.596 175.194 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.742 0.306 . . . . 74.129999999999995 111.169 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -103.97 102.25 12.03 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.155 0.502 . . . . 72.420000000000002 112.063 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m -125.55 116.7 22.18 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.134 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m -101.91 128.55 48.25 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.025 0.44 . . . . 74.109999999999999 111.721 -171.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.53 115.05 23.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.302 -0.408 . . . . 72.239999999999995 111.953 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.91 -31.74 1.07 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.217 -0.516 . . . . 70.420000000000002 113.538 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.531 HG22 ' HG2' ' A' ' 22' ' ' PRO . 12.1 t -67.94 105.07 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 122.545 -0.385 . . . . 72.340000000000003 110.985 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.8 105.78 17.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 71.409999999999997 110.844 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.1 m -133.33 137.33 45.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 74.329999999999998 111.396 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.16 -68.0 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.978 -0.555 . . . . 62.130000000000003 112.245 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.03 79.46 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.697 2.265 . . . . 72.299999999999997 112.408 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.77 54.99 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.356 -0.449 . . . . 73.329999999999998 113.68 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -145.53 148.87 33.67 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.627 0.713 . . . . 74.120000000000005 112.292 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.41 140.83 47.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.787 -0.642 . . . . 37.890000000000001 109.872 172.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.712 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 28.6 p -100.11 145.84 27.5 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.366 0.603 . . . . 64.239999999999995 111.422 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -129.78 133.74 47.17 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.629 -0.714 . . . . 65.329999999999998 110.826 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.86 103.13 4.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 70.150000000000006 111.325 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 98.0 mt -127.42 117.74 22.74 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.931 0.396 . . . . 71.129999999999995 111.788 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.6 26.34 66.52 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.562 -0.351 . . . . 73.109999999999999 113.826 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.07 -0.01 75.07 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.111 -0.566 . . . . 74.439999999999998 113.376 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -131.74 138.49 32.67 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 117.121 0.461 . . . . 73.409999999999997 112.014 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HG2' HG22 ' A' ' 7' ' ' VAL . 97.1 Cg_endo -80.81 118.97 3.52 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.735 2.29 . . . . 74.349999999999994 113.571 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -109.23 137.26 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.26 -0.275 . . . . 62.119999999999997 110.365 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -103.82 139.9 38.39 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.847 0.684 . . . . 74.349999999999994 112.847 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.42 160.68 34.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.895 -0.593 . . . . 63.140000000000001 110.606 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -57.72 112.87 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.22 0.452 . . . . 65.319999999999993 112.22 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.36 119.71 55.48 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.131 -0.486 . . . . 61.310000000000002 110.916 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 86.84 1.09 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.384 2.056 . . . . 74.0 113.266 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.68 100.23 12.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.271 0.557 . . . . 65.540000000000006 110.368 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.4 p -98.68 134.38 41.68 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.278 -0.419 . . . . 63.140000000000001 111.907 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.3 p -99.49 -76.01 0.55 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.269 -0.423 . . . . 75.310000000000002 111.356 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.27 39.51 3.0 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.217 -0.516 . . . . 74.549999999999997 113.598 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 34.1 mt -120.34 135.71 24.69 Favored Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 122.395 -0.474 . . . . 65.239999999999995 110.6 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.45 139.65 31.96 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.46 2.106 . . . . 72.450000000000003 113.239 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.75 141.91 30.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.793 0.33 . . . . 74.239999999999995 111.408 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 64.29 6.23 2.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.253 0.621 . . . . 72.319999999999993 112.545 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 2.4 tm? -93.19 95.41 9.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.412 -0.588 . . . . 71.5 109.412 176.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -54.79 137.06 45.63 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.718 0.636 . . . . 74.25 112.718 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 35.7 m -129.96 156.76 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.149 -0.478 . . . . 71.430000000000007 111.439 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -100.55 118.13 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.295 -0.411 . . . . 71.540000000000006 110.941 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.79 168.44 39.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.396 -0.431 . . . . 73.430000000000007 113.793 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.7 t -49.86 -37.05 29.29 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.792 0.664 . . . . 45.210000000000001 112.792 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.24 -33.9 68.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.038 0.446 . . . . 74.109999999999999 112.037 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.89 18.94 18.76 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.724 -0.55 . . . . 52.240000000000002 111.724 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.66 146.81 40.44 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.981 0.419 . . . . 74.209999999999994 111.444 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.468 HG22 ' HG2' ' A' ' 71' ' ' ARG . 38.6 m -86.05 120.23 27.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 111.414 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.76 157.51 16.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.429 -0.351 . . . . 73.420000000000002 110.982 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -49.2 -42.59 40.66 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.047 0.388 . . . . 73.049999999999997 112.047 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 51' ' ' CYS . 1.5 p30 -173.42 175.49 3.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.08 -0.509 . . . . 74.049999999999997 111.122 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -62.25 -31.5 72.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.892 0.377 . . . . 73.129999999999995 111.677 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.458 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 42.1 t -66.86 -40.53 87.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.213 0.53 . . . . 74.409999999999997 110.408 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -68.85 -38.02 79.51 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.797 -0.638 . . . . 75.109999999999999 110.941 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.648 HD13 HG22 ' A' ' 66' ' ' VAL . 10.4 tt -58.16 -43.4 87.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.872 0.368 . . . . 73.540000000000006 110.469 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -57.92 -38.77 76.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.383 -0.371 . . . . 74.450000000000003 111.227 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.99 44.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.382 . . . . 73.549999999999997 111.322 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.97 75.28 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 111.54 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 46.3 ttt-85 -64.58 -50.37 67.5 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.934 0.397 . . . . 63.509999999999998 110.659 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 37.1 t -63.11 -33.09 74.71 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 111.857 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -65.81 -31.65 72.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.501 -0.318 . . . . 75.129999999999995 111.612 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.23 37.2 0.02 OUTLIER Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.84 -0.695 . . . . 64.310000000000002 113.995 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.447 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 85.1 m-70 -135.56 82.62 38.88 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.213 0.506 . . . . 63.210000000000001 112.168 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.28 -25.93 49.28 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.452 2.102 . . . . 71.530000000000001 112.976 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.3 -20.02 60.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.361 . . . . 72.239999999999995 111.683 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.5 tp -69.63 112.54 6.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.521 0.677 . . . . 75.209999999999994 112.664 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.4 p -131.15 164.22 25.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.674 -0.694 . . . . 71.510000000000005 110.753 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.648 HG22 HD13 ' A' ' 53' ' ' LEU . 59.8 t -87.17 112.52 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.89 0.376 . . . . 64.439999999999998 111.544 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.0 mmt -81.16 -42.52 20.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.049 0.452 . . . . 72.140000000000001 110.979 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.421 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 45.9 p90 -169.4 156.75 6.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.021 -0.536 . . . . 53.100000000000001 110.812 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -82.82 125.54 31.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.023 0.44 . . . . 75.439999999999998 110.876 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 131.93 -175.79 19.58 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 112.105 -174.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HG2' HG22 ' A' ' 46' ' ' THR . 96.1 mtt180 -86.03 140.2 30.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.613 -0.345 . . . . 64.530000000000001 111.186 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.421 ' HA ' ' OH ' ' A' ' 68' ' ' TYR . 96.4 m -59.79 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.261 0.467 . . . . 54.340000000000003 112.261 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -119.36 123.52 44.36 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.895 -0.593 . . . . 65.439999999999998 110.326 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.403 -0.808 . . . . 73.349999999999994 110.572 -178.844 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.834 0.35 . . . . 75.409999999999997 111.126 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.34 80.73 0.37 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.402 0.62 . . . . 71.430000000000007 111.802 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m -99.47 123.89 44.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.703 -0.681 . . . . 53.409999999999997 110.401 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.0 m -98.31 127.23 44.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.963 0.411 . . . . 64.319999999999993 111.515 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.514 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 14.4 t70 -86.64 112.54 21.71 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.09 -0.505 . . . . 73.219999999999999 110.973 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.9 -32.92 0.74 Allowed Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.156 -0.545 . . . . 72.230000000000004 114.21 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 18.3 t -66.19 117.45 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.96 0.38 . . . . 75.230000000000004 111.708 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -106.73 106.88 17.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.831 0.348 . . . . 71.340000000000003 111.28 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 71.5 m -140.03 142.61 36.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.031 0.443 . . . . 64.519999999999996 111.758 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.97 -52.88 0.04 OUTLIER Glycine 0 CA--C 1.532 1.103 0 CA-C-N 115.729 -0.669 . . . . 60.039999999999999 113.273 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.63 87.09 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 60.200000000000003 112.983 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.49 15.46 79.12 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.386 -0.435 . . . . 71.099999999999994 113.778 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -146.26 135.76 23.04 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.575 -0.368 . . . . 70.109999999999999 110.97 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.95 137.77 53.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.595 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.747 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.0 p -100.65 122.78 43.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.91 0.386 . . . . 45.140000000000001 110.342 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG3' ' HG ' ' A' ' 18' ' ' LEU . 10.7 ptm180 -129.2 160.55 32.57 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.079 0.4 . . . . 75.510000000000005 112.079 -172.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.608 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 3.9 mmt -76.25 101.89 5.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.88 0.371 . . . . 72.230000000000004 111.448 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.46 ' HG ' ' HG3' ' A' ' 16' ' ' ARG . 94.5 mt -133.36 111.62 10.94 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.828 0.347 . . . . 75.349999999999994 110.579 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.41 44.91 82.8 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.913 -0.66 . . . . 73.450000000000003 112.678 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.29 -49.48 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.003 0.361 . . . . 71.140000000000001 114.003 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -92.92 137.87 23.66 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.828 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.514 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 64.9 Cg_endo -72.51 129.74 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.516 2.144 . . . . 73.409999999999997 112.92 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -129.42 150.97 50.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.437 -0.347 . . . . 75.530000000000001 110.69 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 84.9 m -104.47 146.26 29.12 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.378 0.609 . . . . 63.43 112.262 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -143.94 161.44 38.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.881 -0.6 . . . . 73.349999999999994 110.535 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 12.7 t -64.17 84.04 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.209 0.528 . . . . 72.239999999999995 111.092 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.12 118.9 32.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 62.200000000000003 109.954 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.79 100.84 1.11 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.338 2.025 . . . . 70.200000000000003 114.276 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.21 98.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.546 -0.538 . . . . 75.349999999999994 109.546 166.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.627 ' HB2' HD13 ' A' ' 33' ' ' LEU . 6.3 p -121.87 91.82 3.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.444 0.535 . . . . 63.310000000000002 112.444 -172.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -107.98 166.11 10.96 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.921 -0.582 . . . . 71.329999999999998 110.861 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.97 -56.31 3.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.046 -0.597 . . . . 65.239999999999995 112.647 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 30' ' ' CYS . 4.5 pp -73.07 146.01 86.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.462 -0.434 . . . . 74.219999999999999 110.339 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.19 119.14 5.85 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 121.768 1.645 . . . . 50.210000000000001 113.509 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.23 15.22 6.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.829 0.347 . . . . 74.319999999999993 111.918 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -135.11 14.43 3.55 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.777 0.288 . . . . 74.219999999999999 111.777 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 38' ' ' GLN . 1.7 tm? -119.69 136.65 54.33 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.949 0.404 . . . . 74.150000000000006 110.645 -177.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 37' ' ' LEU . 37.6 mt-30 -63.74 137.67 58.17 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.352 0.501 . . . . 73.439999999999998 112.352 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.603 HG22 ' HA ' ' A' ' 50' ' ' GLU . 34.6 m -128.6 152.38 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.126 0.488 . . . . 75.430000000000007 111.56 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.8 t -101.01 128.66 46.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.962 -0.563 . . . . 51.109999999999999 111.739 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.02 152.95 19.96 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.495 -0.383 . . . . 53.340000000000003 113.074 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.6 t -57.25 -31.88 66.0 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.942 0.401 . . . . 62.119999999999997 111.996 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.33 -20.49 65.55 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.152 0.427 . . . . 71.450000000000003 112.152 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.4 14.77 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.306 -0.474 . . . . 65.129999999999995 112.732 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.38 135.15 54.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.775 0.321 . . . . 72.519999999999996 111.547 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 m -94.81 128.58 41.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.863 0.363 . . . . 73.329999999999998 111.439 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.06 154.83 21.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.745 0.307 . . . . 65.530000000000001 111.363 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -66.59 -20.14 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.956 0.408 . . . . 55.409999999999997 111.575 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -165.49 155.59 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.714 -0.676 . . . . 75.420000000000002 110.071 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.603 ' HA ' HG22 ' A' ' 39' ' ' VAL . 31.3 tt0 -60.03 -34.43 73.38 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.044 0.45 . . . . 72.299999999999997 110.976 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -58.99 -37.33 76.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.293 -0.412 . . . . 73.430000000000007 110.729 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.97 -40.21 91.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.868 0.366 . . . . 71.239999999999995 110.852 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.86 -47.98 82.99 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.094 0.473 . . . . 65.109999999999999 110.301 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 50' ' ' GLU . 2.2 mpt_? -64.19 -39.43 93.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.235 -0.439 . . . . 75.150000000000006 111.222 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.997 0.427 . . . . 62.200000000000003 111.517 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -34.96 76.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.406 0.622 . . . . 51.210000000000001 110.833 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.11 92.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.912 -0.585 . . . . 71.340000000000003 110.446 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 73.4 m -64.22 -26.74 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 111.822 0.304 . . . . 74.040000000000006 111.822 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -64.24 -34.07 77.25 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.977 0.418 . . . . 73.219999999999999 111.27 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.66 35.17 0.05 OUTLIER Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.275 -0.488 . . . . 42.439999999999998 113.082 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -128.65 79.05 75.03 Favored Pre-proline 0 CA--C 1.539 0.533 0 O-C-N 122.37 -0.489 . . . . 73.510000000000005 111.44 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.22 -28.26 72.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.461 2.107 . . . . 75.420000000000002 112.21 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.33 -22.9 66.88 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.918 -0.583 . . . . 73.120000000000005 111.994 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.02 111.71 8.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.476 0.655 . . . . 72.439999999999998 112.044 -174.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -127.75 161.17 29.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.295 -0.866 . . . . 75.200000000000003 110.594 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p -88.8 134.76 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.203 0.525 . . . . 74.109999999999999 111.956 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 16.7 mmt -90.65 -59.05 2.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.363 -0.381 . . . . 74.349999999999994 110.974 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -164.52 164.34 21.81 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.099 0.476 . . . . 73.219999999999999 112.006 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -75.65 111.98 11.54 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.828 -0.624 . . . . 71.549999999999997 111.057 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.36 161.23 8.65 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.337 -0.392 . . . . 63.409999999999997 112.147 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -72.58 134.85 45.39 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.249 0.525 . . . . 75.450000000000003 112.4 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.0 m -58.12 99.88 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.033 -0.53 . . . . 74.530000000000001 111.889 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -109.86 136.58 48.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 64.099999999999994 111.005 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.55 -0.738 . . . . 75.109999999999999 110.819 175.416 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 66.6 m . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.876 0.37 . . . . 71.42 110.771 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 72.4 m -100.03 172.99 6.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.862 0.319 . . . . 71.4 111.862 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.87 112.7 0.82 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.1 -0.5 . . . . 63.52 111.485 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.73 2.16 49.59 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.471 -0.395 . . . . 63.53 113.961 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' A' ' 22' ' ' PRO . 3.6 t -107.04 122.46 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 122.462 -0.434 . . . . 71.15 111.373 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.88 110.18 21.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.49 0.662 . . . . 64.44 111.421 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 55.1 m -136.14 180.0 6.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.195 -0.457 . . . . 75.11 111.09 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.57 -91.1 0.25 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 54.23 112.752 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.67 88.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.848 2.365 . . . . 74.34 112.839 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.621 ' H ' ' HB3' ' A' ' 29' ' ' ASP . . . 83.92 12.89 76.15 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.104 -0.498 . . . . 61.44 113.372 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.645 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 51.4 mtmt -141.3 136.67 31.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.376 0.51 . . . . 75.23 112.376 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.08 51.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.882 -0.599 . . . . 53.31 109.962 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 18.3 p -122.78 143.2 49.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.364 0.505 . . . . 74.23 112.364 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.434 ' HD3' HH11 ' A' ' 16' ' ' ARG . 40.2 ttp180 -143.74 148.8 36.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.086 -0.506 . . . . 71.51 110.259 173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 69.5 mtp -80.99 120.39 24.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.185 0.517 . . . . 62.33 112.072 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.6 106.14 18.27 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.952 -0.567 . . . . 75.44 109.664 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.57 -94.5 0.13 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.929 -0.653 . . . . 43.25 112.007 -174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.64 -8.2 12.63 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.177 -0.535 . . . . 51.14 113.881 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.459 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 27.3 ptt180 -121.04 133.27 24.12 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 117.573 0.687 . . . . 62.34 112.285 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 2.5 Cg_endo -81.89 128.82 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.143 2.562 . . . . 73.01 113.42 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -111.85 152.49 27.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.457 -0.338 . . . . 73.33 111.07 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 6.6 t -120.15 137.25 54.28 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.584 0.231 . . . . 63.51 110.465 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -131.82 146.14 51.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.75 0.31 . . . . 61.11 111.544 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 96.5 m -60.14 100.22 0.09 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.998 0.427 . . . . 52.22 111.141 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.24 155.29 53.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 64.21 111.359 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.71 107.75 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.372 2.048 . . . . 75.22 113.069 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.621 ' HB3' ' H ' ' A' ' 12' ' ' GLY . 10.7 p-10 -79.12 84.12 5.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.839 0.828 . . . . 74.32 110.81 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.4 m -83.74 84.5 7.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.526 -0.761 . . . . 51.32 112.226 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t -78.76 -145.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.903 -0.589 . . . . 73.44 110.487 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.66 80.84 0.12 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.863 -0.684 . . . . 71.51 112.997 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 51' ' ' CYS . 3.9 pp -155.33 148.59 18.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 122.609 -0.347 . . . . 75.34 111.758 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.94 120.33 3.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.554 2.169 . . . . 52.23 112.533 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.59 16.79 0.45 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.583 0.586 . . . . 61.4 112.583 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -115.21 -18.14 11.2 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.848 0.356 . . . . 74.33 111.735 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 61.6 tp -83.64 105.86 14.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.855 0.36 . . . . 55.44 111.757 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -59.86 160.09 8.14 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.032 -0.531 . . . . 61.22 112.132 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -157.58 144.66 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.331 -0.395 . . . . 53.12 111.963 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.2 128.52 46.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.907 0.384 . . . . 55.4 110.755 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 64' ' ' LEU . . . -90.35 177.52 42.55 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.257 -0.497 . . . . 73.23 113.541 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 m -60.82 -19.26 59.39 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.159 0.429 . . . . 73.14 112.159 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.54 -42.88 64.25 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.511 -0.313 . . . . 52.15 111.282 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.59 -0.27 8.62 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.25 -0.5 . . . . 72.4 113.895 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.27 146.19 27.21 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.218 -0.577 . . . . 65.11 111.891 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.3 m -86.3 108.32 18.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.088 0.471 . . . . 72.31 111.39 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -78.68 160.13 27.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.899 -0.591 . . . . 75.33 111.115 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -57.48 -34.85 69.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.371 0.508 . . . . 63.14 112.371 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.9 p30 -167.66 174.74 7.48 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.855 0.687 . . . . 72.55 112.855 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -46.99 -47.44 21.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.175 -0.92 . . . . 54.43 112.394 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.492 ' HB2' HD11 ' A' ' 33' ' ' LEU . 33.7 t -70.25 -40.24 74.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.058 -0.519 . . . . 62.14 111.028 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -54.25 -40.66 67.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.336 0.588 . . . . 64.51 111.203 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.461 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.91 -45.98 83.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.084 -0.507 . . . . 72.24 110.501 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -59.74 -27.54 66.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.138 -0.483 . . . . 72.35 111.765 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.09 -55.87 5.9 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 62.44 111.594 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . . . -53.35 -33.16 52.47 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.129 0.49 . . . . 60.44 111.198 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -48.97 -50.3 36.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.616 -0.72 . . . . 73.22 111.421 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 45.4 t -77.99 -23.54 48.33 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.04 0.448 . . . . 64.22 111.033 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 35.2 mmt180 -78.04 34.85 0.2 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.591 0.589 . . . . 63.45 112.591 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.66 23.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.226 -0.512 . . . . 74.13 114.118 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.403 ' HD2' ' HB1' ' A' ' 56' ' ' ALA . 27.9 m-70 -131.71 74.4 77.78 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.521 0.66 . . . . 74.3 111.055 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.05 -29.37 40.33 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.562 2.175 . . . . 61.12 112.608 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.53 -13.23 60.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.035 -0.53 . . . . 74.42 111.993 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -65.96 112.07 3.64 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.266 0.555 . . . . 72.41 111.948 -171.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -134.59 157.58 46.21 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.095 -0.502 . . . . 70.54 110.691 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.461 HG22 HD13 ' A' ' 53' ' ' LEU . 97.2 t -71.97 127.43 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.56 0.578 . . . . 72.31 112.56 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.4 mtt -94.81 -53.64 3.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.372 -0.377 . . . . 70.53 110.758 171.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -165.23 167.53 17.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.887 0.375 . . . . 74.22 111.568 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -85.8 172.02 11.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.649 0.611 . . . . 74.32 112.649 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.37 -154.22 53.13 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.549 -0.751 . . . . 41.55 113.863 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -70.2 138.78 52.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.847 0.356 . . . . 71.43 111.004 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.62 84.9 2.66 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.259 0.552 . . . . 72.02 110.29 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 112.923 0.712 . . . . 74.31 112.923 -173.063 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.576 0.227 . . . . 73.45 110.485 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 15.1 m -129.6 126.89 39.51 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.144 -0.348 . . . . 75.12 111.014 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.43 112.13 23.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.852 -0.158 . . . . 72.22 111.338 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.95 49.0 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 114.463 0.545 . . . . 73.51 114.463 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 50.7 t -107.09 109.58 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 117.247 0.523 . . . . 64.34 110.887 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -91.5 106.5 18.53 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.349 0.5 . . . . 75.43 112.349 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 94.7 m -148.25 138.38 22.58 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.17 -0.468 . . . . 50.12 110.613 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 -121.27 0.9 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.913 -0.66 . . . . 65.42 113.519 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.39 107.84 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.597 2.198 . . . . 74.42 112.744 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 118.0 -54.96 0.59 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.095 -0.502 . . . . 75.34 112.255 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -135.39 134.95 40.24 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.802 0.334 . . . . 74.24 111.215 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.42 138.95 42.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.825 0.345 . . . . 74.12 110.476 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.595 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 20.2 p -100.15 125.21 46.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.124 0.488 . . . . 74.54 111.277 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -144.16 159.54 42.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 74.53 109.777 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 47.8 mtp -78.97 103.67 9.08 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.682 -0.636 . . . . 72.1 111.957 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.06 141.2 48.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.067 -0.515 . . . . 74.11 110.387 175.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.47 26.29 64.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.819 -0.705 . . . . 55.33 112.743 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.61 84.71 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.515 -0.374 . . . . 71.22 113.824 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -133.79 140.32 36.22 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 117.549 0.674 . . . . 74.32 111.676 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 27.5 Cg_endo -61.2 115.38 2.69 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.455 2.103 . . . . 65.53 113.455 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 35.4 mmt180 -118.05 156.53 28.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.869 0.467 . . . . 74.45 110.93 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 98.6 m -118.18 121.09 39.62 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.877 0.37 . . . . 63.21 111.77 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -133.85 161.36 34.96 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.468 -0.333 . . . . 60.02 111.058 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 37.0 t -55.26 130.15 41.13 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.421 0.897 . . . . 54.44 113.421 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.76 118.53 31.87 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.939 -0.573 . . . . 73.44 111.059 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.91 147.53 68.5 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.311 2.007 . . . . 71.24 112.75 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.41 31.7 0.12 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.35 0.5 . . . . 70.32 112.35 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.597 ' HA ' HD12 ' A' ' 33' ' ' LEU . 24.3 p -90.16 15.34 10.47 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.581 0.956 . . . . 71.54 113.581 -171.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -69.17 75.88 0.35 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.446 0.641 . . . . 52.55 110.527 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.16 6.39 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.034 -0.53 . . . . 63.25 112.97 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 30' ' ' CYS . 67.6 mt -94.42 151.14 39.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 122.474 -0.427 . . . . 72.41 111.467 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.29 119.32 6.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.335 2.023 . . . . 75.32 113.006 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.68 -4.56 53.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.129 0.49 . . . . 55.41 111.57 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -101.07 -1.0 35.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.203 -0.453 . . . . 71.44 112.024 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 58.1 tp -116.73 119.11 34.43 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.218 -0.301 . . . . 72.01 111.775 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -64.32 163.42 13.05 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.165 0.507 . . . . 62.34 112.188 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.581 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 10.0 p -150.51 144.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.019 0.378 . . . . 62.45 112.019 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 95.8 m -100.62 128.79 46.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.977 0.417 . . . . 52.11 111.122 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -101.62 177.65 27.06 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.241 -0.504 . . . . 65.55 113.467 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.9 p -61.88 -14.64 35.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.948 0.404 . . . . 72.23 111.839 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.36 -16.64 61.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.235 -0.439 . . . . 64.12 111.241 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.09 -14.44 62.56 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.435 -0.348 . . . . 74.14 113.494 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.04 153.68 19.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.667 0.617 . . . . 74.11 112.667 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -86.17 145.74 26.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.053 -0.522 . . . . 54.24 110.887 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.58 160.89 21.59 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.552 -0.295 . . . . 73.51 111.302 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 48' ' ' ARG . 1.5 tmm_? -51.39 -43.31 61.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.071 0.548 . . . . 74.22 111.857 -175.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.554 ' H ' ' HB3' ' A' ' 52' ' ' GLU . 4.7 p-10 -159.85 177.46 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.894 0.378 . . . . 64.32 111.469 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' HG11 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -57.94 -47.79 81.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.145 0.498 . . . . 72.34 111.453 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.4 t -65.81 -39.57 91.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.548 -0.296 . . . . 72.52 111.055 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.554 ' HB3' ' H ' ' A' ' 49' ' ' ASP . 5.8 tp10 -52.28 -41.17 62.66 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.318 -0.401 . . . . 53.02 111.246 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' HD21 ' A' ' 64' ' ' LEU . 9.7 tt -56.79 -56.01 27.0 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.205 0.526 . . . . 74.33 110.484 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -64.33 -29.55 70.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.118 -0.492 . . . . 74.15 111.211 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.85 71.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.94 0.4 . . . . 52.4 111.158 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.65 89.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 70.52 110.559 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 28.1 ttt180 -55.11 -50.28 69.61 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.523 -0.762 . . . . 63.1 111.808 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 84.9 m -81.0 6.33 13.74 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.223 0.453 . . . . 50.3 112.223 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -106.35 51.69 0.74 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.161 0.505 . . . . 73.25 111.279 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.0 69.54 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.551 0.58 . . . . 73.22 114.551 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 66.4 t60 -135.44 72.93 64.01 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 117.767 0.784 . . . . 54.13 111.721 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 16.6 Cg_exo -69.2 -7.46 20.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.03 2.486 . . . . 73.51 112.844 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -9.19 52.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 73.14 111.825 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' A' ' 41' ' ' GLY . 43.1 tp -85.49 129.05 34.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.002 0.741 . . . . 64.3 113.002 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -127.77 155.43 44.06 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.631 -0.713 . . . . 65.22 110.496 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.88 123.39 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.855 0.359 . . . . 71.35 111.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.6 mmt -100.48 -59.42 1.71 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.037 0.384 . . . . 72.3 112.037 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 53.1 p90 -154.43 145.46 22.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.001 0.429 . . . . 74.41 111.584 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.46 ' HE ' ' HG3' ' A' ' 50' ' ' GLU . 93.1 mtt180 -83.04 110.72 18.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.241 0.543 . . . . 71.33 111.664 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 151.82 179.24 27.31 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.84 -0.618 . . . . 63.44 112.028 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -83.24 140.78 32.32 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.64 -0.329 . . . . 72.12 111.266 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 91.3 m -61.78 104.92 0.49 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.233 0.539 . . . . 71.33 111.783 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 63.51 112.319 -177.448 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 109.484 -0.561 . . . . 75.45 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.76 130.45 45.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.049 0.452 . . . . 34.24 111.859 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.543 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 m-20 -69.91 112.16 6.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.182 -0.463 . . . . 75.41 112.239 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.24 37.39 38.4 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.09 0.396 . . . . 35.21 114.09 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -106.61 135.49 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.083 0.468 . . . . 73.41 112.004 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.18 106.64 14.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.096 0.474 . . . . 71.21 111.278 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -124.72 -179.92 4.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.089 -0.505 . . . . 62.01 111.02 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.38 -104.57 0.26 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 120.723 -0.751 . . . . 34.22 113.551 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.95 85.71 0.97 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.543 2.162 . . . . 63.31 113.106 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 102.07 2.74 51.7 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.194 -0.527 . . . . 44.45 113.559 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 48.4 mtmt -135.83 137.59 41.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.495 0.647 . . . . 73.04 112.03 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.04 142.13 49.46 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.719 -0.673 . . . . 43.43 110.072 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 23.2 p -105.5 136.46 45.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.133 0.492 . . . . 72.3 112.112 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -127.86 139.14 52.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.888 -0.597 . . . . 64.12 110.896 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.564 ' SD ' ' HB3' ' A' ' 22' ' ' PRO . 94.2 mmm -76.6 113.43 14.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.854 0.359 . . . . 72.01 111.409 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.795 HD12 ' HD3' ' A' ' 23' ' ' ARG . 88.6 mt -122.74 114.43 20.53 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.12 0.486 . . . . 62.44 111.304 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.65 30.74 75.61 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 116.231 -0.441 . . . . 40.14 113.77 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.25 -15.19 63.75 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 54.14 113.712 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 21' ' ' ARG . 43.0 mtt180 -122.14 137.42 27.47 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 117.25 0.525 . . . . 60.12 111.681 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 93.4 Cg_endo -83.28 145.29 12.02 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.725 2.283 . . . . 71.13 113.657 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.795 ' HD3' HD12 ' A' ' 18' ' ' LEU . 66.6 mtp85 -124.55 132.19 53.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.905 -0.589 . . . . 75.21 110.607 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 14.0 t -102.9 118.85 37.74 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.502 -0.555 . . . . 63.52 109.502 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.09 161.3 35.72 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 62.24 111.828 -171.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 97.5 m -54.26 108.55 0.38 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.137 0.791 . . . . 63.44 113.137 -174.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.72 120.82 56.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 115.889 -0.596 . . . . 65.31 110.754 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 83.3 Cg_endo -81.6 131.25 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.648 2.232 . . . . 75.45 113.535 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.816 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -67.86 82.5 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 116.303 -0.408 . . . . 65.4 111.019 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.8 p -148.96 123.07 9.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.399 0.619 . . . . 43.03 112.163 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -145.65 -53.9 0.28 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.844 -0.617 . . . . 53.3 110.197 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 51.63 1.96 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.176 -0.535 . . . . 73.22 113.385 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -156.64 145.07 14.52 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 122.584 -0.362 . . . . 73.31 110.8 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.94 120.02 4.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.247 1.965 . . . . 72.1 113.705 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.29 38.8 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.495 0.664 . . . . 44.41 110.792 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -129.9 8.05 5.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.819 -0.628 . . . . 73.2 111.551 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 64.9 tp -136.88 127.37 26.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.237 0.215 . . . . 64.21 111.064 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 50.7 mt-30 -66.48 148.27 52.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 74.24 112.047 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 32.6 m -131.15 146.77 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 71.22 111.493 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.5 t -100.9 113.66 26.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.388 -0.369 . . . . 64.41 110.822 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.14 170.37 49.2 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.266 -0.492 . . . . 31.41 114.239 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.9 m -54.9 -26.78 38.2 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.201 0.6 . . . . 70.03 112.111 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.54 -23.79 61.83 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.966 -0.561 . . . . 71.44 111.937 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.45 12.02 54.74 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.477 -0.392 . . . . 73.43 112.652 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.28 141.76 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.721 0.296 . . . . 75.41 111.764 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 m -86.65 107.35 18.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.466 -0.334 . . . . 54.11 111.434 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.01 147.16 24.43 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 110.151 -0.314 . . . . 71.23 110.151 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 39.9 ptt85 -59.83 -25.14 64.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.612 0.597 . . . . 73.51 112.612 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.0 p30 -166.86 172.25 10.53 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.043 0.449 . . . . 63.33 111.646 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 39' ' ' VAL . 29.6 tt0 -69.28 -26.7 64.88 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.147 -0.479 . . . . 74.32 112.135 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 48.6 t -74.72 -39.14 62.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.959 0.409 . . . . 73.21 110.206 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -59.14 -43.83 92.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.216 0.531 . . . . 74.43 110.583 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.59 -51.3 67.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.107 -0.497 . . . . 74.51 110.736 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.816 ' HD3' ' HB2' ' A' ' 29' ' ' ASP . 94.1 mtt180 -70.82 -17.01 62.77 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.32 0.489 . . . . 73.11 112.32 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.18 -34.05 63.66 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.328 0.585 . . . . 72.1 110.154 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.02 -25.62 52.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.701 -0.681 . . . . 75.3 112.091 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 54' ' ' ARG . 16.4 ptt85 -66.5 -20.08 65.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.045 0.45 . . . . 74.15 110.886 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.4 t -72.27 -16.83 61.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.297 0.57 . . . . 60.34 110.634 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -91.66 85.04 5.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.943 -0.571 . . . . 75.44 111.112 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.89 -52.68 4.5 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 114.737 0.655 . . . . 75.14 114.737 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 36.2 m80 -114.58 93.62 33.37 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 117.806 0.803 . . . . 75.24 112.978 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 61' ' ' HIS . 43.6 Cg_endo -67.44 -16.48 47.7 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.556 2.17 . . . . 64.2 112.55 177.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -82.14 0.0 42.84 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.352 0.501 . . . . 75.43 112.352 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.9 tp -57.2 111.97 1.23 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 71.0 110.792 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -115.59 164.2 14.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.262 -0.426 . . . . 44.45 111.339 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.67 127.79 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.095 0.474 . . . . 71.54 111.256 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -78.76 -45.32 21.34 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.307 0.575 . . . . 43.41 110.546 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -159.76 145.47 15.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.832 -0.622 . . . . 64.42 110.766 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.16 99.94 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.348 0.594 . . . . 72.32 110.925 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.53 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 164.57 -176.08 40.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.348 -0.842 . . . . 71.22 111.572 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -80.93 138.26 36.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.162 0.481 . . . . 54.35 111.3 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.9 m -61.9 94.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.208 0.528 . . . . 63.44 112.048 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.783 -0.644 . . . . 74.33 110.398 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.754 0.312 . . . . 42.31 111.251 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.12 130.38 45.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.902 0.382 . . . . 61.3 111.837 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.19 114.85 20.29 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.355 0.502 . . . . 61.35 112.355 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.31 8.2 58.71 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 114.274 0.469 . . . . 72.33 114.274 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.58 109.78 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 O-C-N 122.617 -0.343 . . . . 74.23 110.741 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.85 108.96 16.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.98 0.419 . . . . 41.5 111.315 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -148.76 138.49 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.285 0.564 . . . . 51.02 111.341 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.44 -60.92 0.09 OUTLIER Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.616 -0.72 . . . . 40.4 111.625 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.51 90.35 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.474 2.116 . . . . 53.02 112.322 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 88.68 -5.69 84.38 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.19 -0.529 . . . . 74.33 114.051 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 49.6 mtmt -141.14 138.05 33.17 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.583 0.691 . . . . 72.03 112.202 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.84 140.11 50.51 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.145 -0.479 . . . . 75.14 110.005 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.3 t -98.33 135.74 39.5 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.099 0.476 . . . . 75.11 111.774 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 16' ' ' ARG . 12.5 ptm180 -142.62 137.03 29.73 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.824 -0.626 . . . . 64.41 110.808 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.9 mmm -76.46 104.55 7.03 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.009 0.433 . . . . 75.42 111.801 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 112.6 23.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.856 0.36 . . . . 61.43 111.02 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.05 31.7 72.51 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.448 -0.406 . . . . 30.33 112.882 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.81 -4.55 60.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.179 -0.534 . . . . 73.23 112.859 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -113.1 129.52 24.46 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.589 0.356 . . . . 42.15 111.053 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 115.52 4.28 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.493 2.129 . . . . 64.32 113.121 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -111.57 132.47 54.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.46 -0.336 . . . . 65.21 111.373 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 13' ' ' LYS . 87.0 m -103.28 119.98 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.993 0.425 . . . . 73.04 110.588 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -102.04 145.14 29.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.587 . . . . 73.22 110.006 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 20.4 p -80.48 123.2 27.87 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.142 0.496 . . . . 44.24 111.91 -175.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.05 134.28 24.03 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 52.04 110.962 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.71 152.33 47.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.411 2.074 . . . . 54.11 112.891 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -78.35 41.49 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.196 0.522 . . . . 73.1 111.483 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.758 ' HA ' HD21 ' A' ' 33' ' ' LEU . 25.1 p -77.49 89.79 3.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.189 0.519 . . . . 70.43 111.908 -174.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.3 t -138.79 132.49 30.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.954 -0.567 . . . . 63.2 110.857 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.35 39.42 51.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.187 -0.53 . . . . 73.54 112.9 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 30' ' ' CYS . 3.2 pp -151.8 163.6 23.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 122.7 0.4 . . . . 74.33 110.726 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 84.5 Cg_exo -49.9 118.96 4.26 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.526 2.151 . . . . 63.54 114.336 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.89 -10.43 14.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.678 -0.692 . . . . 75.13 110.818 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -125.55 -22.47 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 63.24 111.313 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 3.7 tt -90.19 119.83 30.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.767 0.318 . . . . 72.45 110.312 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 52.4 mt-30 -63.74 148.82 48.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.313 0.486 . . . . 64.12 112.313 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 34.0 m -129.81 151.91 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.213 0.53 . . . . 72.02 112.052 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.71 113.67 26.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.946 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.64 162.19 32.84 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.262 -0.494 . . . . 73.25 113.789 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.9 p -65.97 -9.43 29.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.336 0.495 . . . . 72.42 112.336 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' HD13 ' A' ' 64' ' ' LEU . 14.6 t70 -81.19 -4.98 57.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.149 0.5 . . . . 71.15 110.923 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 13.23 66.48 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.4 -0.429 . . . . 63.02 113.266 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.76 148.23 41.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.854 0.359 . . . . 74.34 111.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.687 HG21 ' HG2' ' A' ' 71' ' ' ARG . 69.7 m -99.62 116.57 32.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.959 0.409 . . . . 53.22 111.209 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -96.66 156.88 16.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.414 -0.357 . . . . 64.33 111.664 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 78.9 mtm180 -56.96 -32.88 66.48 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.518 0.562 . . . . 74.33 112.518 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -162.97 176.43 10.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.213 -0.449 . . . . 61.13 110.031 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.652 ' HB3' HD13 ' A' ' 33' ' ' LEU . 32.7 tt0 -74.99 -30.89 61.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.279 -0.569 . . . . 70.31 111.599 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 t -65.4 -37.41 86.88 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.834 -0.541 . . . . 63.22 109.806 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.56 -52.89 63.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.543 -0.753 . . . . 74.24 110.421 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.26 -52.03 54.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.034 -0.984 . . . . 73.43 111.675 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 41.4 mtp85 -70.46 -27.17 64.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.841 -0.618 . . . . 75.34 111.657 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.11 -49.27 62.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.188 0.518 . . . . 31.41 110.67 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.83 -32.01 71.4 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.078 -0.51 . . . . 74.43 110.969 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -58.37 -51.63 69.0 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.944 -0.571 . . . . 72.54 110.921 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 32.2 t -71.78 -31.74 66.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.746 0.308 . . . . 71.25 111.432 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -60.14 -50.5 73.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.401 0.519 . . . . 74.24 112.401 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.49 16.78 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.993 -1.098 . . . . 65.54 114.959 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.0 m-70 -135.69 75.16 57.16 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 117.806 0.803 . . . . 72.34 111.564 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.64 -23.18 74.59 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.358 2.038 . . . . 63.2 113.273 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.3 -14.26 47.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.008 0.373 . . . . 74.03 112.008 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 43' ' ' ASP . 55.0 tp -64.4 112.36 3.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.2 0.524 . . . . 73.34 112.144 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.1 m -132.73 162.04 32.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.486 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.31 129.98 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.172 0.511 . . . . 74.44 111.788 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 69.5 mtm -85.27 -55.33 4.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.277 0.56 . . . . 70.15 110.166 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.508 ' HE2' ' H ' ' A' ' 73' ' ' ARG . 16.6 p90 -151.5 140.03 20.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.714 -0.676 . . . . 74.21 110.743 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.51 125.52 29.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.272 0.558 . . . . 70.3 111.543 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.511 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 124.56 161.57 11.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.35 -0.841 . . . . 60.44 111.139 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.687 ' HG2' HG21 ' A' ' 46' ' ' THR . 65.4 mtt180 -63.14 138.82 58.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.747 0.774 . . . . 75.32 111.082 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.5 m -48.28 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.626 0.602 . . . . 62.02 112.626 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.508 ' H ' ' HE2' ' A' ' 68' ' ' TYR . 11.9 ptp180 . . . . . 0 N--CA 1.468 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.32 111.217 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.68 0.276 . . . . 63.25 110.655 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 p -140.43 130.91 25.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.764 0.316 . . . . 63.24 111.794 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.66 114.15 22.42 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.154 0.502 . . . . 72.24 112.329 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.87 27.21 66.45 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.987 0.755 . . . . 61.33 114.987 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.524 HG12 ' SG ' ' A' ' 9' ' ' CYS . 49.9 t -107.15 126.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 117.358 0.579 . . . . 74.14 111.588 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 10.5 pt-20 -79.0 105.93 10.69 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.407 0.622 . . . . 75.32 111.664 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.524 ' SG ' HG12 ' A' ' 7' ' ' VAL . 58.7 m -149.61 155.99 41.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.101 -0.374 . . . . 64.41 111.42 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.7 -65.24 0.31 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.942 -0.647 . . . . 71.35 113.009 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.14 90.53 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.66 2.24 . . . . 71.31 112.83 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.31 0.78 84.48 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.053 -0.594 . . . . 70.04 113.634 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.32 136.04 41.26 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.0 -0.706 . . . . 74.11 111.964 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.27 143.95 41.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.076 -0.511 . . . . 74.21 110.353 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.698 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 30.9 p -101.88 128.52 48.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.79 0.663 . . . . 74.2 112.79 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -138.52 145.62 40.96 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.558 -0.746 . . . . 75.42 110.417 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 74.1 mtp -91.12 112.16 23.95 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.947 0.404 . . . . 44.01 111.8 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 18' ' ' LEU . 6.0 mp -103.09 112.19 24.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.243 -0.435 . . . . 40.05 110.634 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 36.11 58.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.375 -0.44 . . . . 72.52 113.861 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.28 70.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.168 -0.539 . . . . 52.14 113.51 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.6 111.26 63.66 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 117.346 0.573 . . . . 72.13 111.771 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.502 ' HB2' HG21 ' A' ' 7' ' ' VAL . 58.7 Cg_endo -71.86 106.99 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.218 1.945 . . . . 74.23 112.269 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -117.79 149.2 41.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.904 0.383 . . . . 75.42 111.534 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 91.2 m -129.0 125.55 37.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.017 0.437 . . . . 64.24 111.487 177.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -119.99 161.54 20.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.528 -0.305 . . . . 75.15 110.188 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.86 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.35 0.595 . . . . 64.44 111.072 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 120.0 60.27 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.479 -0.782 . . . . 32.42 110.493 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 11.0 Cg_endo -52.17 117.62 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.5 2.134 . . . . 60.03 112.499 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.66 36.22 0.13 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.233 0.539 . . . . 73.24 111.623 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 47.6 m -65.51 101.89 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.978 -0.556 . . . . 73.54 111.587 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -129.34 92.32 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 62.04 110.243 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.78 7.35 17.83 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.054 -0.521 . . . . 71.32 112.858 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.403 HD11 HH11 ' A' ' 54' ' ' ARG . 83.9 mt -100.83 114.89 65.84 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.619 -0.342 . . . . 73.45 111.142 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.63 153.09 26.34 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.761 2.308 . . . . 74.44 113.531 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.26 163.16 26.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.156 -0.475 . . . . 71.31 111.2 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 69.33 -15.2 0.29 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.793 0.664 . . . . 71.42 112.793 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 1.1 tm? -72.23 88.01 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.477 -0.564 . . . . 73.51 109.477 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.496 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 98.1 mt-30 -71.24 142.11 50.58 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.775 0.657 . . . . 75.44 112.775 -175.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 69' ' ' ARG . 33.4 m -137.02 157.28 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.819 -0.628 . . . . 64.13 111.003 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 90.7 m -101.12 132.01 46.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.89 -0.506 . . . . 65.3 111.839 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -82.85 173.5 52.46 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.918 -0.583 . . . . 64.31 113.422 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -64.38 -11.17 30.08 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.544 0.572 . . . . 43.11 112.544 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -87.17 -26.87 23.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.859 0.361 . . . . 73.23 111.094 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.26 -0.36 20.73 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.316 -0.469 . . . . 73.21 113.924 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.5 152.09 19.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.344 0.572 . . . . 74.42 112.268 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.8 m -90.91 120.08 31.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.051 -0.522 . . . . 73.11 111.975 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -87.49 140.64 29.33 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.283 -0.417 . . . . 75.24 110.814 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 18.0 ptp180 -59.65 -15.55 19.95 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.001 0.741 . . . . 73.41 113.001 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.5 p30 -167.26 160.68 13.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.556 0.343 . . . . 71.43 110.91 172.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -64.04 -30.83 71.87 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.088 0.403 . . . . 72.54 112.088 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.26 -33.99 72.26 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.031 0.444 . . . . 73.34 110.683 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -56.48 -50.9 70.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.985 -0.552 . . . . 75.4 110.662 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.574 HD11 ' HA2' ' A' ' 41' ' ' GLY . 6.5 tt -63.08 -46.7 86.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.818 -0.628 . . . . 54.32 110.328 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HD3' ' SG ' ' A' ' 30' ' ' CYS . 16.8 ttt180 -55.39 -33.69 63.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.832 -0.622 . . . . 73.24 111.288 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.11 -31.68 23.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.059 -0.519 . . . . 75.05 111.655 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.08 71.11 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.191 0.441 . . . . 71.02 112.191 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.57 -34.01 64.39 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.242 0.544 . . . . 75.12 111.45 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.3 m -88.66 14.16 10.67 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.434 0.531 . . . . 63.14 112.434 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -98.27 8.24 45.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.058 0.392 . . . . 75.52 112.058 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.1 0.81 5.05 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.756 -0.735 . . . . 72.35 114.429 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -133.98 88.53 31.75 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 117.655 0.727 . . . . 72.21 112.132 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.94 -20.92 69.27 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.505 2.136 . . . . 75.32 111.59 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -20.95 58.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.947 -1.024 . . . . 73.12 112.436 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.81 111.57 3.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.287 0.565 . . . . 63.13 111.653 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -129.67 163.48 26.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.0 -0.546 . . . . 74.31 111.242 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.84 126.28 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.106 0.479 . . . . 61.34 111.394 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 72.1 mtm -80.33 -43.79 20.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.006 0.373 . . . . 73.12 112.006 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 44.0 p90 -164.19 155.83 16.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.949 0.404 . . . . 74.13 111.876 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.676 ' HA ' HG12 ' A' ' 39' ' ' VAL . 8.6 mpt_? -80.5 104.87 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.168 0.509 . . . . 70.45 111.243 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.92 170.43 16.63 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 116.061 -0.518 . . . . 65.25 112.192 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -75.57 149.98 38.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.866 0.365 . . . . 74.3 111.424 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 71.5 m -58.77 113.78 2.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.113 -0.494 . . . . 52.32 111.934 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 115.706 -0.679 . . . . 74.13 112.131 -176.646 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 112.106 0.41 . . . . 73.4 112.106 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.4 m -105.85 127.95 53.44 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.849 0.357 . . . . 73.3 111.605 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.646 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 11.5 m-20 -87.64 111.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.183 -0.323 . . . . 62.42 110.4 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.8 -39.78 0.79 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 121.004 -0.617 . . . . 53.14 114.016 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 10.7 t -66.08 146.28 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.962 0.505 . . . . 74.35 111.62 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -102.71 105.3 15.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.486 0.66 . . . . 75.24 110.218 177.02 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.632 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 97.9 m -149.52 179.41 7.99 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.502 0.556 . . . . 74.31 112.502 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.03 -67.54 0.56 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.259 -0.736 . . . . 63.01 111.259 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -93.01 131.1 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 73.21 111.96 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.37 -35.78 1.99 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.008 -0.615 . . . . 44.23 114.268 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HE3' ' SG ' ' A' ' 9' ' ' CYS . 48.5 mtmt -131.38 145.95 52.05 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.254 0.527 . . . . 74.21 111.286 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -122.09 132.04 54.28 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.455 -0.339 . . . . 74.42 110.634 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.2 p -100.12 121.83 42.02 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.479 0.657 . . . . 73.5 111.584 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -123.88 163.56 21.03 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.835 -0.62 . . . . 73.31 111.265 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -80.9 110.74 16.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.249 0.462 . . . . 74.42 112.249 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.699 HD22 ' HD2' ' A' ' 23' ' ' ARG . 6.8 mp -115.48 102.72 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.825 -0.435 . . . . 74.23 109.825 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.51 27.94 72.49 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.132 -0.556 . . . . 54.22 112.57 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.95 -16.62 56.51 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.483 -0.389 . . . . 64.54 113.633 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -93.11 137.25 23.77 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 122.321 -0.517 . . . . 72.13 111.804 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.646 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 90.4 Cg_endo -77.95 101.85 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.918 2.412 . . . . 45.33 113.409 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.699 ' HD2' HD22 ' A' ' 18' ' ' LEU . 53.9 mtt-85 -105.7 139.03 40.91 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.132 -0.321 . . . . 71.35 110.132 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 17.8 m -103.36 144.3 31.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 74.23 112.118 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' ' HD3' ' A' ' 16' ' ' ARG . 48.4 mt-10 -129.03 158.23 39.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 65.23 110.636 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.0 p -62.82 99.83 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.149 0.499 . . . . 63.52 112.278 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.82 125.59 41.68 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.874 -0.603 . . . . 71.22 111.45 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.9 Cg_exo -78.28 111.8 3.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.865 2.377 . . . . 65.5 112.848 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.36 94.22 0.16 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.788 0.328 . . . . 71.41 110.298 173.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.1 p -130.35 22.63 5.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.494 0.924 . . . . 63.55 113.494 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.1 p -70.93 -23.82 62.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.53 0.681 . . . . 63.42 109.965 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.61 27.83 14.08 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.56 -0.745 . . . . 31.42 113.017 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 78.6 mt -124.44 148.22 57.73 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 116.719 0.259 . . . . 52.12 111.688 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 13.6 Cg_exo -70.72 120.27 6.96 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.671 2.247 . . . . 73.13 112.629 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.28 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.992 0.367 . . . . 44.12 111.992 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -93.5 1.52 56.74 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.979 0.363 . . . . 72.11 111.979 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.3 mt -118.35 114.09 22.42 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.072 0.397 . . . . 71.2 112.072 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -67.34 146.75 53.78 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.503 -0.317 . . . . 71.33 110.375 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 69' ' ' ARG . 32.6 m -129.51 149.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.96 0.409 . . . . 71.33 111.603 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 61.3 m -100.53 128.58 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.385 -0.37 . . . . 70.31 110.796 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.516 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -72.89 164.3 54.88 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.253 -0.499 . . . . 43.41 113.068 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 t -58.97 -16.97 20.54 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.079 0.399 . . . . 71.54 112.079 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -82.11 -38.73 24.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.902 0.382 . . . . 74.03 110.931 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 -3.52 4.99 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.365 -0.445 . . . . 73.3 113.842 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.58 142.74 29.76 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.465 0.543 . . . . 62.54 112.465 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.583 HG21 ' HG3' ' A' ' 71' ' ' ARG . 32.1 m -90.19 113.12 24.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.446 -0.343 . . . . 54.12 111.478 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -97.62 167.59 10.87 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 71.5 111.745 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -44.2 87.21 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.647 0.61 . . . . 71.13 112.647 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -169.06 -179.29 3.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.63 0.252 . . . . 63.21 111.631 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -64.73 -36.22 83.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.752 0.31 . . . . 74.13 111.698 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 17.5 t -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.117 0.484 . . . . 64.24 109.974 174.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -56.92 -44.11 82.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.644 -0.707 . . . . 74.12 111.377 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.563 ' HG ' HG22 ' A' ' 66' ' ' VAL . 1.5 tm? -59.37 -50.05 75.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.735 0.302 . . . . 73.23 110.877 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -56.51 -41.83 77.36 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.867 0.365 . . . . 42.23 111.283 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -39.53 94.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.027 0.441 . . . . 54.12 110.741 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.786 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -66.24 -22.03 66.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 72.04 112.499 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -65.55 -47.31 76.29 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.542 0.687 . . . . 72.22 110.107 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.19 -30.59 65.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.464 0.649 . . . . 73.13 110.679 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.786 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 23.2 ttt180 -82.78 83.63 7.64 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.279 -0.873 . . . . 74.41 111.385 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . 88.72 -54.01 4.06 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 114.798 0.679 . . . . 73.11 114.798 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -115.04 90.94 25.04 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 113.673 0.99 . . . . 65.22 113.673 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 32.0 Cg_exo -61.71 -22.22 73.91 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.845 2.363 . . . . 71.33 113.072 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.05 -2.79 49.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.364 -0.38 . . . . 72.53 111.844 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.516 HD11 ' HA3' ' A' ' 41' ' ' GLY . 24.3 tp -77.71 118.08 19.74 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.554 0.576 . . . . 63.43 112.554 -172.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -125.87 164.63 20.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.856 -0.611 . . . . 60.44 110.607 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.563 HG22 ' HG ' ' A' ' 53' ' ' LEU . 44.0 t -80.13 128.57 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.955 0.354 . . . . 73.35 111.955 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 61.7 mtt -74.36 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.448 0.642 . . . . 72.3 110.273 171.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.45 161.17 24.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.409 -0.814 . . . . 75.51 110.841 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HA ' HG12 ' A' ' 39' ' ' VAL . 78.0 mtt180 -81.62 107.36 14.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.259 0.552 . . . . 61.14 110.655 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.32 143.91 3.79 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.688 -0.687 . . . . 73.13 112.076 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.583 ' HG3' HG21 ' A' ' 46' ' ' THR . 65.2 ttt180 -72.36 74.91 1.02 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.814 0.34 . . . . 73.41 111.819 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 85.7 m 34.84 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.747 1.017 . . . . 71.41 113.747 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.038 0.447 . . . . 75.23 110.905 -178.261 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.831 -0.433 . . . . 63.52 109.831 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 39.4 m -98.22 127.4 44.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 65.41 111.392 -173.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.501 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 13.3 t70 -85.77 111.1 19.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.455 . . . . 70.33 110.879 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 -23.01 0.3 Allowed Glycine 0 CA--C 1.535 1.285 0 N-CA-C 114.421 0.528 . . . . 73.15 114.421 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 23.6 t -73.98 125.32 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 117.043 0.421 . . . . 72.12 111.849 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -115.05 110.01 18.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.168 0.508 . . . . 62.41 111.895 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.3 m -149.1 139.24 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.492 -0.322 . . . . 74.44 110.878 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.19 -76.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.917 -0.658 . . . . 75.21 112.972 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.67 130.49 12.65 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.45 2.1 . . . . 62.44 112.692 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.34 -49.2 3.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.928 -0.653 . . . . 51.2 112.997 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -121.63 135.7 54.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.902 0.382 . . . . 74.3 111.433 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.92 145.57 41.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.784 -0.45 . . . . 62.43 109.784 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 31.9 p -99.08 113.38 25.56 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.41 0.624 . . . . 45.43 111.286 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -112.25 149.39 32.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.765 -0.652 . . . . 73.12 111.214 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.6 mtp -88.97 107.57 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 74.11 111.488 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.509 HD23 ' HG2' ' A' ' 23' ' ' ARG . 3.3 mm? -116.16 103.07 10.17 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.479 -0.328 . . . . 74.23 110.384 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.45 62.46 5.08 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 64.31 113.525 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.21 -46.4 3.39 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.203 -0.522 . . . . 64.33 113.953 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 21' ' ' ARG . 4.8 mpt_? -92.77 125.81 54.06 Favored Pre-proline 0 CA--C 1.541 0.611 0 O-C-N 122.328 -0.513 . . . . 70.05 111.969 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 96.5 Cg_endo -79.91 110.3 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.648 2.232 . . . . 73.33 112.094 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 33.6 ptt180 -99.11 158.28 15.78 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.164 -0.335 . . . . 73.32 111.079 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' CG1' ' A' ' 7' ' ' VAL . 78.2 m -103.14 120.69 41.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.081 0.467 . . . . 55.31 110.823 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.68 142.86 50.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.978 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' SG ' ' NH1' ' A' ' 59' ' ' ARG . 25.7 p -58.6 105.04 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.223 0.535 . . . . 73.35 111.562 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 135.9 19.35 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 51.22 111.174 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.906 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 74.2 Cg_endo -72.56 120.55 6.78 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.288 1.992 . . . . 63.42 112.486 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.6 -28.2 68.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.265 -0.425 . . . . 64.14 111.815 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HA ' HD11 ' A' ' 33' ' ' LEU . 79.2 m 73.4 -39.91 0.45 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.649 0.78 . . . . 61.13 112.609 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -54.12 112.62 1.0 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.109 -0.369 . . . . 72.44 111.797 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.07 -13.38 11.31 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.503 -0.38 . . . . 75.52 113.469 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 30' ' ' CYS . 2.5 pp -139.77 164.71 36.2 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 122.403 -0.469 . . . . 75.21 111.509 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 53.7 Cg_exo -53.96 119.61 6.56 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.548 2.165 . . . . 74.11 113.446 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.65 18.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.234 -0.439 . . . . 73.21 112.04 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.59 -39.08 3.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.849 0.315 . . . . 73.13 111.849 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -64.8 118.93 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.874 0.368 . . . . 62.34 110.671 -176.109 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.39 162.89 2.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.648 0.61 . . . . 64.31 112.648 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 66' ' ' VAL . 31.3 m -143.84 147.5 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.863 -0.608 . . . . 62.1 110.471 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.3 t -103.64 126.82 51.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.947 0.403 . . . . 72.22 110.829 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.47 165.52 44.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.257 -0.497 . . . . 62.04 113.686 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.2 m -50.61 -28.36 8.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.63 0.604 . . . . 65.5 112.63 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.82 -34.04 75.96 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.086 0.47 . . . . 73.05 111.947 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.31 -10.0 24.42 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.374 -0.441 . . . . 71.54 112.236 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.83 134.71 38.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.072 0.463 . . . . 70.02 111.621 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.0 m -86.66 112.6 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.332 -0.395 . . . . 71.54 111.337 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.66 160.95 16.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.796 0.332 . . . . 64.31 111.671 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -61.47 -40.32 94.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.142 -0.481 . . . . 71.41 111.783 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -165.91 174.52 9.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.058 -0.519 . . . . 74.2 110.552 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HA ' HG21 ' A' ' 39' ' ' VAL . 29.5 tt0 -71.74 -27.88 63.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.899 0.381 . . . . 70.4 111.498 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.906 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 9.1 t -67.56 -39.87 84.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.948 0.404 . . . . 75.31 110.262 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.42 -46.45 88.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.099 -0.5 . . . . 73.53 110.82 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -56.74 -42.2 78.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.377 -0.374 . . . . 72.21 110.739 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' A' ' 28' ' ' PRO . 29.6 ttt180 -57.16 -40.29 76.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.102 0.477 . . . . 75.23 110.899 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 59' ' ' ARG . . . -65.41 -50.41 65.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.283 -0.417 . . . . 64.42 111.019 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.35 -38.45 66.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.989 0.424 . . . . 63.2 111.728 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -52.9 -46.64 68.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.158 -0.474 . . . . 73.04 111.022 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.7 t -77.1 -34.01 56.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.349 0.5 . . . . 65.21 112.349 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 55' ' ' ALA . 37.8 mmt180 -58.33 -48.51 80.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.722 0.296 . . . . 75.14 111.555 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.14 32.31 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.221 -0.99 . . . . 73.13 114.26 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -132.39 81.93 59.06 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 117.216 0.508 . . . . 62.22 111.015 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.32 -34.8 26.06 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.614 2.209 . . . . 63.34 112.778 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.47 -11.59 60.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 111.978 0.362 . . . . 71.52 111.978 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.7 tp -77.21 110.35 11.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.518 0.562 . . . . 54.45 112.518 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -123.92 161.08 26.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.14 110.323 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 39' ' ' VAL . 2.7 p -88.34 111.3 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.001 0.429 . . . . 61.2 111.628 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.9 mtt -63.59 -58.82 5.75 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.112 0.482 . . . . 73.44 110.659 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.2 172.56 17.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.886 -0.597 . . . . 73.15 110.361 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 9.9 mpt_? -78.9 158.65 28.02 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.214 0.53 . . . . 74.04 111.564 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.4 54.72 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.951 -0.568 . . . . 75.23 112.562 -174.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -83.61 158.28 21.95 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.541 -0.387 . . . . 63.55 111.567 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.8 m -67.01 98.16 0.55 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.158 0.504 . . . . 62.15 111.078 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 . . . . . 0 CA--C 1.541 0.609 0 CA-C-N 115.993 -0.549 . . . . 74.12 111.046 -177.142 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 120.825 0.345 . . . . 32.32 111.105 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 24.0 m -124.93 128.32 48.43 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.852 0.358 . . . . 62.41 111.956 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -87.42 110.66 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.442 -0.345 . . . . 72.25 110.429 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.26 -32.21 0.32 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.501 0.56 . . . . 72.12 114.501 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 38.5 t -65.61 131.7 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 117.194 0.497 . . . . 73.32 111.976 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -76.57 105.34 7.57 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.95 0.405 . . . . 54.12 111.648 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.543 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 65.7 m -138.3 179.49 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.932 0.396 . . . . 65.3 111.206 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.23 -85.3 0.39 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.161 -0.542 . . . . 70.51 112.574 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -61.23 92.13 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.358 2.038 . . . . 71.2 112.431 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.97 23.88 72.91 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 115.976 -0.556 . . . . 71.0 114.003 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.656 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.1 mtmt -144.26 146.66 32.77 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.655 0.728 . . . . 75.22 112.957 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.35 149.18 40.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.369 -0.832 . . . . 70.11 110.163 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 26.6 p -112.44 142.59 44.79 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.328 0.585 . . . . 73.11 112.499 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 15.2 mmt180 -129.1 163.22 25.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.974 -0.557 . . . . 74.41 111.332 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.7 mmm -85.68 102.33 13.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.964 0.411 . . . . 74.44 111.247 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.4 110.44 22.41 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.04 0.447 . . . . 45.34 110.536 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.85 71.75 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.133 -0.556 . . . . 52.55 113.188 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.36 -4.77 84.28 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.255 -0.497 . . . . 50.25 113.243 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 21' ' ' ARG . 9.1 mpt_? -114.97 126.24 28.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 122.383 -0.48 . . . . 74.22 111.361 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 70.9 Cg_endo -74.0 113.85 3.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.471 2.114 . . . . 72.11 112.901 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -120.77 152.28 38.52 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.121 -0.362 . . . . 64.03 110.941 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 2.0 t -103.41 140.05 37.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.633 0.605 . . . . 74.3 112.633 -169.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.54 160.51 33.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.679 -0.691 . . . . 73.03 109.874 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 p -76.16 140.7 41.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.028 0.442 . . . . 64.43 111.393 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -118.88 125.17 27.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.262 -0.426 . . . . 62.3 111.51 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 6.0 Cg_exo -79.59 24.45 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.269 2.646 . . . . 73.13 114.241 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 54.1 40.25 31.46 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.025 0.44 . . . . 71.32 111.859 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.462 ' HA ' HD21 ' A' ' 33' ' ' LEU . 27.3 m -70.4 88.64 0.66 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.217 0.532 . . . . 73.0 112.254 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.8 t -150.93 137.63 18.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.727 -0.67 . . . . 61.44 110.445 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 -50.32 4.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.04 -0.6 . . . . 61.14 113.367 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' ' 50' ' ' GLU . 1.8 pt? -66.98 151.87 96.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.821 -0.223 . . . . 73.22 111.304 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.45 119.3 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 74.04 112.912 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.85 8.99 11.19 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 73.23 111.373 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -129.26 15.12 6.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.119 0.485 . . . . 72.42 110.792 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 5.7 tt -125.64 125.4 43.05 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.07 -0.514 . . . . 72.42 110.025 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -63.55 147.73 50.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.897 0.702 . . . . 54.31 112.897 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 50' ' ' GLU . 35.4 m -138.62 146.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.301 -0.408 . . . . 72.24 110.676 176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 17.2 t -105.21 131.53 52.56 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.106 0.479 . . . . 74.51 111.853 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.91 177.82 40.31 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.127 -0.488 . . . . 63.45 114.015 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.1 m -55.29 -27.79 49.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.695 0.628 . . . . 63.31 112.695 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.87 8.0 11.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.43 0.53 . . . . 71.13 112.43 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.052 -0.594 . . . . 53.21 112.68 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 125.15 36.25 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.502 0.321 . . . . 52.54 111.072 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 61.7 m -91.38 104.91 17.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.161 0.505 . . . . 74.14 111.161 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -80.48 157.82 26.06 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.531 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 63.4 mtt180 -53.32 -33.43 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.66 0.615 . . . . 73.25 112.66 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.4 p30 -170.92 173.16 5.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.939 0.399 . . . . 50.52 111.54 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' HD12 ' A' ' 33' ' ' LEU . 11.8 tp10 -58.08 -43.6 87.1 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.07 -0.514 . . . . 73.24 111.63 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.55 -39.95 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.973 0.416 . . . . 71.24 110.599 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE1' ' HD2' ' A' ' 48' ' ' ARG . 7.5 tp10 -63.25 -44.27 95.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.826 -0.624 . . . . 75.13 110.866 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.94 -51.66 68.33 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.809 -0.632 . . . . 51.4 111.269 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.26 -33.27 75.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.714 0.292 . . . . 73.12 111.74 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.41 65.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.043 0.449 . . . . 74.2 110.689 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.2 76.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.982 0.42 . . . . 54.05 111.187 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -60.64 -50.24 74.28 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.079 -0.51 . . . . 74.52 110.404 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.77 -35.47 80.15 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.113 -0.494 . . . . 62.22 111.749 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -59.55 -58.68 7.53 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.506 -0.315 . . . . 74.11 111.575 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.44 24.92 0.19 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.543 -0.837 . . . . 74.23 114.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 42.2 m170 -122.38 78.81 45.35 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 122.139 -0.624 . . . . 73.53 111.144 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.51 -43.49 33.01 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.756 2.304 . . . . 70.34 113.552 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.53 2.82 39.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.57 0.581 . . . . 74.31 112.57 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 66.4 tp -76.64 127.43 32.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.015 0.436 . . . . 75.11 111.975 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -142.64 152.16 42.18 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.59 -0.277 . . . . 54.0 110.696 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -81.39 124.73 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.135 0.493 . . . . 52.15 111.748 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.36 -49.64 9.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.11 0.481 . . . . 72.34 110.783 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -159.84 164.29 33.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.916 -0.583 . . . . 73.3 111.258 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 39' ' ' VAL . 49.5 mtm180 -76.8 135.62 38.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 65.23 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.86 -172.88 20.4 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.271 -0.49 . . . . 65.14 112.71 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -86.72 149.34 24.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.56 -0.377 . . . . 75.44 111.675 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 35.3 m -66.08 83.78 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.622 0.725 . . . . 43.41 111.159 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 115.16 -0.927 . . . . 75.33 111.812 -179.306 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 109.453 -0.573 . . . . 53.14 109.453 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.5 m -135.87 127.68 29.26 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.927 -0.483 . . . . 72.01 111.987 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 7' ' ' VAL . 29.0 t70 -86.67 111.42 20.65 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.676 0.25 . . . . 71.11 111.676 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 48.65 30.93 9.13 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 114.564 0.586 . . . . 72.14 114.564 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 5' ' ' ASP . 89.1 t -106.74 122.47 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 117.337 0.568 . . . . 74.15 111.77 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -92.07 106.73 18.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.612 -0.267 . . . . 72.11 111.202 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 96.1 m -148.84 138.54 21.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.648 0.261 . . . . 73.04 111.348 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.98 -141.42 4.33 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 120.894 -0.67 . . . . 41.1 113.932 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 -13.5 5.58 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.357 2.705 . . . . 72.24 114.81 -173.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.8 -30.17 9.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.99 -0.624 . . . . 53.33 113.155 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.7 mtmt -148.5 136.31 20.77 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.609 -0.347 . . . . 54.53 111.228 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.16 136.07 48.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.577 -0.283 . . . . 44.32 110.634 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.798 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 7.2 p -99.79 122.08 42.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.141 0.496 . . . . 62.02 111.714 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -119.95 158.84 25.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.144 -0.48 . . . . 75.54 111.345 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.8 mmt -79.73 102.62 9.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.468 -0.333 . . . . 73.21 111.597 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.578 HD13 ' HB2' ' A' ' 23' ' ' ARG . 6.6 mp -110.77 112.99 25.24 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.929 0.395 . . . . 42.11 110.118 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.39 29.84 75.77 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.84 -0.695 . . . . 71.21 112.252 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -0.12 69.17 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.522 -0.37 . . . . 41.3 113.721 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -115.1 138.44 23.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 72.22 111.502 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.71 124.33 7.47 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.949 2.432 . . . . 55.24 114.273 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 8.7 mtp180 -119.69 134.62 55.16 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.965 -0.561 . . . . 74.03 110.907 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.798 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.1 m -103.37 119.82 39.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.886 0.374 . . . . 60.2 110.987 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -123.07 160.38 26.49 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.935 -0.575 . . . . 63.05 111.117 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -52.18 106.74 0.16 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.84 0.352 . . . . 73.31 111.863 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.45 122.87 58.28 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 116.218 -0.447 . . . . 74.51 112.197 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 55' ' ' ALA . 72.8 Cg_endo -75.95 -18.81 16.47 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.366 2.044 . . . . 51.02 112.118 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.1 t70 63.36 96.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.693 0.797 . . . . 74.01 112.234 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.4 m -121.39 25.84 9.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.389 -0.823 . . . . 63.13 109.945 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -64.27 103.32 0.62 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.284 -0.871 . . . . 54.34 113.212 -171.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.75 2.1 88.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.355 0.902 . . . . 73.43 115.355 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 51' ' ' CYS . 3.7 pp -85.86 153.72 57.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 118.03 0.915 . . . . 75.31 111.396 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.08 119.4 6.43 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.317 2.011 . . . . 61.31 112.703 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 76.59 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.028 0.442 . . . . 71.34 111.06 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 177.51 15.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.991 -0.55 . . . . 74.21 111.561 -175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD21 ' HD3' ' A' ' 69' ' ' ARG . 50.9 tp -119.99 105.56 11.16 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.015 0.436 . . . . 52.3 111.867 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.35 145.18 56.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.029 -0.532 . . . . 52.13 111.984 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 50' ' ' GLU . 31.4 m -141.13 143.56 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.268 -0.424 . . . . 71.33 111.043 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -102.19 125.8 48.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 110.159 -0.312 . . . . 70.12 110.159 178.196 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -73.24 169.25 53.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.407 -0.425 . . . . 63.35 113.765 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 t -65.18 -6.39 9.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.155 0.428 . . . . 74.14 112.155 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.94 -31.15 14.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.356 0.262 . . . . 72.43 111.389 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.38 -11.39 7.18 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 121.357 -0.449 . . . . 50.41 113.778 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.98 134.58 36.26 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.014 0.435 . . . . 42.3 112.002 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.572 HG21 ' HG2' ' A' ' 71' ' ' ARG . 45.8 m -97.17 107.76 20.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.871 0.367 . . . . 42.43 111.1 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.52 151.62 24.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.395 -0.366 . . . . 74.22 111.705 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.52 -30.45 65.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.575 0.583 . . . . 71.14 112.575 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 34.5 t70 -155.29 159.81 40.29 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.758 0.313 . . . . 73.41 111.548 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' HG21 ' A' ' 39' ' ' VAL . 39.5 tt0 -58.92 -43.37 91.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.799 0.333 . . . . 64.53 110.994 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.507 ' HB2' HD11 ' A' ' 33' ' ' LEU . 36.1 t -57.23 -34.99 69.13 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.138 0.494 . . . . 64.52 111.032 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -65.66 -41.47 92.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.041 -0.527 . . . . 70.11 111.155 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.402 HD11 ' HA2' ' A' ' 41' ' ' GLY . 9.3 tt -65.03 -42.34 94.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.066 0.46 . . . . 52.53 110.172 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 54' ' ' ARG . 11.2 mmm180 -54.14 -49.72 68.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.294 0.569 . . . . 72.14 110.584 175.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . . . -61.13 -42.97 99.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.916 -0.584 . . . . 62.32 111.158 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -55.69 -36.94 67.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.052 -0.522 . . . . 73.34 111.938 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 76.3 ttt-85 -59.92 -38.16 81.56 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.104 0.478 . . . . 71.22 111.021 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.0 t -82.68 -15.68 51.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.06 0.457 . . . . 73.25 111.207 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.9 ttp180 -97.17 49.51 1.06 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.239 0.542 . . . . 74.13 111.619 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.46 58.97 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 115.068 0.787 . . . . 60.31 115.068 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 4.0 m-70 -126.76 77.74 73.9 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.144 0.972 . . . . 75.12 111.972 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.12 -22.87 61.12 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.67 2.247 . . . . 75.44 113.043 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.84 4.23 54.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.309 -0.405 . . . . 70.33 111.802 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 56.9 tp -80.46 125.77 30.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.27 0.557 . . . . 75.12 112.158 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.1 p -136.62 163.8 29.71 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.68 -0.691 . . . . 70.42 110.475 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.13 124.56 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.006 0.431 . . . . 63.32 111.194 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.5 mmt -89.59 -53.67 4.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.93 0.395 . . . . 74.55 111.044 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.98 152.66 42.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 73.25 111.276 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.649 ' HD3' HD21 ' A' ' 37' ' ' LEU . 96.7 mtt180 -82.55 134.73 35.19 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.189 0.519 . . . . 62.41 111.8 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 116.27 -161.82 12.83 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.944 -0.571 . . . . 71.41 112.422 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.572 ' HG2' HG21 ' A' ' 46' ' ' THR . 50.2 mtp180 -86.29 153.61 21.85 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.538 -0.39 . . . . 74.12 111.286 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.5 m -57.38 112.72 1.49 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.532 0.682 . . . . 71.31 111.42 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 115.286 -0.87 . . . . 74.2 112.265 -173.881 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.592 0.234 . . . . 71.1 110.461 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 7.4 m -97.86 127.0 43.52 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.793 0.33 . . . . 72.01 110.439 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.35 110.31 20.69 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 110.241 -0.281 . . . . 74.3 110.241 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -34.8 0.57 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.147 -0.549 . . . . 72.14 114.386 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 21.2 t -66.08 140.22 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.156 0.478 . . . . 74.54 112.2 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -89.65 107.95 19.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.279 -0.419 . . . . 73.14 111.546 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.3 m -144.65 138.88 27.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.258 -0.428 . . . . 72.32 111.333 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.24 -95.28 0.1 OUTLIER Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.486 -0.387 . . . . 73.54 112.336 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.12 111.18 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.368 2.046 . . . . 73.34 112.334 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.21 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.239 -0.505 . . . . 33.42 113.862 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.583 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.9 mtmt -129.51 160.59 32.72 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.474 0.637 . . . . 65.14 112.324 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.8 136.03 20.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.358 -0.837 . . . . 62.5 109.946 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.2 p -101.63 142.37 33.08 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.194 0.521 . . . . 63.42 111.648 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -132.76 143.92 49.92 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.971 -0.559 . . . . 63.55 110.629 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.25 101.92 9.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.996 0.427 . . . . 71.4 110.298 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HD3' ' A' ' 23' ' ' ARG . 77.8 mt -125.48 116.07 21.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.408 -0.36 . . . . 53.0 111.385 -175.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.42 32.75 82.18 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.297 -0.478 . . . . 64.4 113.019 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.02 77.03 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.429 -0.415 . . . . 72.0 113.077 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.88 135.68 24.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.6 -0.353 . . . . 74.1 111.548 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.93 98.22 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.444 2.096 . . . . 64.21 112.716 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 23' ' ' ARG . 37.3 mtp-105 -95.96 123.17 39.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.608 -0.269 . . . . 74.42 111.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 9.5 t -104.06 120.19 40.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.68 0.276 . . . . 74.45 110.398 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -129.7 160.89 31.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 74.44 111.415 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.08 125.01 23.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.156 -0.474 . . . . 75.13 111.556 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -109.13 132.98 20.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 111.909 0.337 . . . . 72.2 111.909 -176.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 16.5 Cg_exo -69.0 112.87 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.923 2.416 . . . . 63.34 112.899 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.32 133.79 38.68 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.024 0.44 . . . . 62.11 111.108 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.1 m -124.33 45.09 2.58 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.937 0.399 . . . . 54.21 111.424 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.9 m -77.01 -76.44 0.17 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.23 0.456 . . . . 72.51 112.23 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 52.01 3.97 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.247 -0.502 . . . . 71.41 114.158 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.694 HD11 ' SG ' ' A' ' 51' ' ' CYS . 4.6 pp -155.83 151.56 22.16 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.44 -0.447 . . . . 63.52 111.497 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 7.3 Cg_exo -73.63 137.7 25.48 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.594 2.196 . . . . 64.23 112.479 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.77 134.33 56.11 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.224 0.453 . . . . 54.14 112.224 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 63.59 15.65 9.05 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.828 0.677 . . . . 75.32 112.828 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.5 tm? -82.71 104.11 12.71 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.851 0.358 . . . . 70.35 110.84 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.408 ' O ' HD13 ' A' ' 37' ' ' LEU . 80.8 mt-30 -61.12 150.18 34.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.022 -0.535 . . . . 62.43 111.804 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 69' ' ' ARG . 25.5 m -141.52 159.16 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.952 0.353 . . . . 64.35 111.952 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.566 ' SG ' ' HA2' ' A' ' 44' ' ' GLY . 51.5 t -106.31 122.18 45.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.856 0.36 . . . . 72.44 111.57 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.38 176.86 54.55 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.327 -0.463 . . . . 52.02 113.224 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -58.51 -25.76 62.74 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.4 0.519 . . . . 71.32 112.4 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.01 -14.4 59.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.025 0.44 . . . . 63.31 111.688 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.566 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . 85.05 34.62 14.28 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.227 -0.511 . . . . 73.11 112.952 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.24 148.01 40.89 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.505 0.322 . . . . 51.22 111.405 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -93.76 115.35 27.77 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.012 0.434 . . . . 70.33 112.128 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.12 166.1 13.15 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.352 -0.386 . . . . 71.04 111.149 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -62.23 -38.06 87.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.948 0.404 . . . . 74.42 111.194 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -166.02 174.07 9.77 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.939 -0.573 . . . . 65.11 110.743 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HB3' HD22 ' A' ' 33' ' ' LEU . 33.9 tt0 -63.06 -29.48 70.84 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.779 0.323 . . . . 74.45 111.086 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.694 ' SG ' HD11 ' A' ' 33' ' ' LEU . 62.1 m -58.28 -43.0 87.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.873 0.368 . . . . 64.31 110.693 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.44 -36.67 76.87 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.216 -0.447 . . . . 73.05 111.688 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.4 tt -65.25 -49.29 70.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.883 0.373 . . . . 70.3 110.372 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -57.31 -46.67 82.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 73.14 110.29 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.29 87.26 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.778 -0.646 . . . . 35.25 111.534 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.12 77.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.802 0.334 . . . . 41.24 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 34.4 mtm180 -61.75 -43.32 99.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.392 0.615 . . . . 72.45 110.683 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.4 t -78.51 -21.4 48.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.358 -0.837 . . . . 53.13 111.605 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp85 -90.03 -29.0 18.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.604 0.594 . . . . 74.41 112.604 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.588 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . -169.9 -37.08 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 119.669 -1.253 . . . . 40.32 115.45 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 83.3 m-70 -110.28 81.78 2.4 Favored Pre-proline 0 N--CA 1.477 0.922 0 CA-C-N 118.059 0.929 . . . . 74.33 112.553 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 23.8 Cg_exo -64.37 -24.63 64.37 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.497 2.131 . . . . 74.14 113.405 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.38 -4.65 57.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.981 0.42 . . . . 74.2 111.609 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 61.4 tp -66.2 112.7 4.07 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.383 0.512 . . . . 72.32 112.383 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -105.95 151.79 24.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.395 -0.366 . . . . 72.44 111.166 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.86 127.66 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.846 0.355 . . . . 74.21 111.236 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.1 mtt -84.69 -55.06 4.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.947 0.403 . . . . 74.11 111.621 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -147.91 154.9 40.97 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.054 0.454 . . . . 51.3 111.779 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 39' ' ' VAL . 94.2 mtt180 -84.2 141.65 30.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.901 -0.59 . . . . 65.42 111.102 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.45 158.65 14.01 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.858 -0.61 . . . . 54.23 111.813 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.78 130.81 46.56 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 117.291 0.545 . . . . 70.22 110.612 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.06 142.84 56.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.942 0.349 . . . . 63.11 111.942 -172.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 112.209 0.448 . . . . 62.21 112.209 -174.416 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 m . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.72 0.295 . . . . 73.32 111.326 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.2 m -139.59 129.0 24.17 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 111.891 0.33 . . . . 72.34 111.891 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.9 112.26 22.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.056 0.391 . . . . 75.14 112.056 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.7 56.09 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 114.992 0.757 . . . . 73.4 114.992 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.4 t -107.24 120.97 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.103 -0.645 . . . . 74.11 111.004 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 0.3 OUTLIER -96.63 109.38 22.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.625 0.726 . . . . 71.01 111.543 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 95.8 m -148.47 139.67 23.27 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.842 -0.617 . . . . 61.32 110.415 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.9 -98.15 0.17 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.091 -0.576 . . . . 61.42 113.723 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.12 -62.76 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.672 2.248 . . . . 70.21 113.962 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.5 58.89 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.144 -0.551 . . . . 54.32 113.922 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 48.8 mtmt -133.81 139.89 46.57 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.304 -0.527 . . . . 71.44 111.763 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -115.17 137.65 51.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.684 -0.235 . . . . 64.02 110.396 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.681 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 19.0 p -99.68 140.57 33.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.121 0.486 . . . . 75.23 111.704 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.421 ' HD3' ' OE1' ' A' ' 25' ' ' GLU . 9.5 ptm180 -143.23 163.13 33.8 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.121 -0.49 . . . . 61.22 112.086 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.9 mmt -79.76 104.14 10.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.297 -0.411 . . . . 41.43 111.526 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 93.6 mt -120.69 119.09 31.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.67 -0.241 . . . . 75.3 110.8 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.46 26.36 56.65 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.152 -0.546 . . . . 72.13 113.554 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.55 82.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.453 -0.403 . . . . 40.21 113.64 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 18' ' ' LEU . 11.0 ptp180 -128.75 138.15 32.51 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 117.496 0.648 . . . . 62.12 111.558 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.95 111.59 3.31 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.777 2.318 . . . . 75.22 113.426 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 97.6 mtt180 -116.34 144.81 43.78 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.342 -0.39 . . . . 71.15 111.585 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 76.9 m -103.82 135.19 45.83 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.441 -0.345 . . . . 75.05 111.549 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' OE1' ' HD3' ' A' ' 16' ' ' ARG . 9.7 pt-20 -129.89 161.08 31.64 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.565 -0.289 . . . . 74.44 111.601 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.7 t -55.03 114.51 1.78 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.37 0.507 . . . . 64.11 112.37 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -97.2 118.43 64.63 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.452 -0.34 . . . . 73.11 111.078 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 2.6 Cg_endo -88.16 21.19 1.04 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.217 2.611 . . . . 63.13 113.944 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 55.74 36.41 27.2 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.903 0.382 . . . . 74.03 111.951 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HA ' HD21 ' A' ' 33' ' ' LEU . 60.4 m -65.52 78.62 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.458 0.647 . . . . 43.23 111.637 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -149.88 120.43 7.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.465 -0.788 . . . . 63.53 110.396 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.15 -40.11 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.134 -0.555 . . . . 63.0 112.679 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 30' ' ' CYS . 3.3 pp -66.09 153.35 92.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.592 -0.357 . . . . 64.5 111.263 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 17.0 Cg_exo -68.13 120.42 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.613 2.209 . . . . 31.44 113.081 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.41 141.17 29.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.061 -0.518 . . . . 75.41 111.023 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 63.3 10.86 4.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.134 0.791 . . . . 64.42 113.134 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . 3.3 tm? -103.27 110.64 22.69 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.169 -0.678 . . . . 74.34 109.169 174.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -54.18 153.94 4.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.804 0.668 . . . . 64.34 112.804 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.478 HG12 ' HG2' ' A' ' 69' ' ' ARG . 22.5 m -136.54 143.06 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.869 -0.605 . . . . 63.25 110.876 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.86 113.44 25.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 62.31 110.728 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.17 164.96 48.33 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.146 -0.479 . . . . 30.32 113.937 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 p -58.66 -20.98 52.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.307 0.643 . . . . 73.43 112.393 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.67 -14.31 60.35 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.989 0.424 . . . . 72.05 111.755 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.1 10.82 59.34 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.128 -0.558 . . . . 64.12 113.052 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.61 144.58 40.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.866 0.365 . . . . 43.24 111.416 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.0 m -96.23 129.41 43.55 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.502 -0.317 . . . . 70.0 111.226 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -109.89 168.89 9.09 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.626 0.251 . . . . 75.41 111.669 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -47.57 -54.92 10.4 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.573 0.583 . . . . 74.13 112.573 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -164.27 -178.91 5.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.696 0.284 . . . . 74.55 111.459 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 tp10 -55.37 -45.01 76.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.427 -0.351 . . . . 74.41 111.185 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.16 -43.08 82.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.098 0.475 . . . . 73.1 110.915 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.55 -43.23 97.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.967 -0.56 . . . . 72.42 111.052 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 64' ' ' LEU . 10.4 tt -62.4 -45.27 93.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.227 -0.442 . . . . 65.41 111.349 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.7 mmm180 -62.57 -37.82 87.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.395 0.617 . . . . 64.33 109.927 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.1 84.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 64.13 111.084 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.25 87.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.366 . . . . 65.52 111.424 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 66.5 ttt180 -64.79 -41.29 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.067 0.461 . . . . 75.21 110.601 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.53 -26.68 67.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.354 0.597 . . . . 52.44 110.686 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -89.51 58.12 4.23 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.723 -0.671 . . . . 73.13 111.299 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.78 36.24 93.06 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.926 0.73 . . . . 52.3 114.926 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 77.9 m80 -135.66 74.96 57.78 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 117.689 0.744 . . . . 71.12 111.607 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.04 -24.1 75.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.843 2.362 . . . . 53.52 114.114 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.16 -2.82 42.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.388 0.514 . . . . 74.53 112.388 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -77.72 111.59 13.67 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.241 0.543 . . . . 63.12 111.051 -175.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -142.92 152.07 41.65 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.005 -0.543 . . . . 74.42 110.706 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 53' ' ' LEU . 7.2 p -77.46 132.34 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 121.162 0.506 . . . . 61.15 112.257 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.9 mtt -92.51 -54.0 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.378 0.609 . . . . 61.32 110.25 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -143.36 150.49 39.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 75.13 109.909 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.478 ' HG2' HG12 ' A' ' 39' ' ' VAL . 77.2 mtt85 -92.18 148.15 22.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.964 0.888 . . . . 72.41 112.487 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.16 -163.21 12.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 114.977 -1.01 . . . . 53.11 110.878 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -90.42 142.91 27.26 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.486 0.643 . . . . 70.24 110.795 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.85 102.49 0.06 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.405 0.621 . . . . 72.34 112.578 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.4 ' HD3' HH11 ' A' ' 73' ' ' ARG . 3.5 ptm180 . . . . . 0 CA--C 1.54 0.585 0 CA-C-N 115.436 -0.802 . . . . 74.53 110.326 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 62.4 111.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 29.0 m -98.9 128.81 45.17 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.426 -0.352 . . . . 34.55 110.637 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.08 111.26 20.16 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.25 -0.282 . . . . 55.31 110.313 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.91 -39.62 0.97 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.373 -0.442 . . . . 65.21 113.932 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 6.2 t -66.62 146.06 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.397 0.517 . . . . 71.24 112.397 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -102.97 106.62 17.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.11 0.481 . . . . 65.02 110.554 176.186 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.26 178.78 8.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.719 0.637 . . . . 74.32 112.719 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.25 -82.88 0.29 Allowed Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.74 -0.664 . . . . 74.41 111.78 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.67 92.76 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.765 2.31 . . . . 71.31 112.854 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.4 -10.3 73.26 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.15 -0.547 . . . . 74.03 113.473 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 45.1 mtmt -135.29 136.3 41.5 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.273 -0.545 . . . . 72.2 111.761 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.81 133.52 55.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.206 -0.452 . . . . 70.13 110.132 173.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 23.8 p -97.92 119.71 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.299 0.571 . . . . 64.53 110.385 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.2 ttm-85 -124.67 143.8 50.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.73 -0.668 . . . . 64.04 110.577 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.411 ' HA ' ' CE ' ' A' ' 17' ' ' MET . 3.2 mmt -73.68 100.31 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.203 0.525 . . . . 60.11 110.694 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.561 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 83.9 mt -125.38 107.5 10.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.822 -0.626 . . . . 73.44 110.104 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.39 -64.89 4.09 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.958 -0.639 . . . . 51.11 112.532 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.55 -22.48 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.584 -0.817 . . . . 53.33 114.154 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -98.65 138.67 20.77 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.42 -0.459 . . . . 73.43 111.425 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.75 93.8 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.991 1.794 . . . . 75.24 112.093 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 11.5 ptm180 -106.1 142.55 35.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.889 -0.596 . . . . 70.21 111.022 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 93.9 m -103.29 138.85 39.51 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 64.34 111.757 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.5 mm-40 -106.45 156.69 18.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.232 -0.894 . . . . 54.31 110.061 -175.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.1 t -68.42 97.82 0.79 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.267 -0.642 . . . . 64.0 109.267 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.75 137.67 20.61 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.157 -0.474 . . . . 75.43 112.238 -171.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 7.7 Cg_exo -73.8 55.25 3.24 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.06 2.506 . . . . 74.12 112.59 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.51 127.01 18.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.819 0.342 . . . . 74.02 111.257 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.813 ' HB2' HD12 ' A' ' 33' ' ' LEU . 29.4 p -169.6 40.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.278 -0.419 . . . . 64.04 111.445 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.9 t -60.38 102.29 0.17 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.913 0.387 . . . . 64.21 111.705 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.31 -9.28 5.93 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.414 -0.422 . . . . 62.54 113.027 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 ' HB2' ' A' ' 30' ' ' CYS . 95.7 mt -95.32 126.08 47.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 O-C-N 122.64 -0.329 . . . . 63.04 111.325 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.87 125.15 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.501 2.134 . . . . 65.12 113.057 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.81 9.93 1.64 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.734 0.642 . . . . 64.2 112.734 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -113.18 9.66 18.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.961 0.41 . . . . 74.44 111.021 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 52.7 tp -106.83 97.91 7.64 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.755 0.312 . . . . 71.32 111.115 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.13 148.76 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.239 -0.437 . . . . 73.35 111.868 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 50' ' ' GLU . 25.0 m -137.21 161.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.359 . . . . 64.52 111.844 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.7 t -118.05 128.5 54.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.932 0.396 . . . . 71.44 110.627 173.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.33 177.54 37.91 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.103 -0.57 . . . . 74.44 114.207 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 p -63.78 -14.59 54.04 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.098 0.475 . . . . 71.32 111.74 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -81.95 -22.55 36.61 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.139 0.495 . . . . 65.32 111.093 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.54 -8.67 60.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.431 -0.414 . . . . 70.31 113.294 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.47 134.16 39.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.152 0.427 . . . . 52.32 112.152 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -86.72 116.25 24.69 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.248 -0.433 . . . . 63.33 110.626 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -100.65 159.68 14.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.036 0.446 . . . . 72.12 112.116 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -56.9 -35.96 69.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.723 -0.671 . . . . 73.13 111.163 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.0 p-10 -164.14 169.49 17.68 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.328 -0.851 . . . . 74.01 110.183 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HB3' HD13 ' A' ' 33' ' ' LEU . 34.4 tt0 -65.36 -33.02 74.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.043 -0.411 . . . . 70.25 111.552 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' HB2' ' OD2' ' A' ' 49' ' ' ASP . 28.2 m -65.41 -37.89 88.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.884 0.373 . . . . 72.21 110.435 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.99 -39.51 89.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.244 0.545 . . . . 51.11 110.603 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.97 -47.12 81.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.291 0.567 . . . . 61.45 110.31 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 54' ' ' ARG . 17.8 mtp180 -65.26 -22.09 66.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.813 -0.63 . . . . 71.23 111.03 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.59 -43.42 31.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.055 0.455 . . . . 74.34 110.876 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.32 64.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.133 0.492 . . . . 71.32 111.217 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 57' ' ' ARG . 16.0 tpp85 -54.18 -51.35 64.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.576 . . . . 74.53 110.273 170.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 62.2 m -68.58 -29.95 68.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.92 -0.582 . . . . 64.24 111.6 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.19 -32.32 73.68 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.903 0.382 . . . . 75.44 111.292 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.11 43.9 0.06 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.065 -0.588 . . . . 74.33 113.469 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.3 m-70 -135.33 82.07 41.79 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.345 -0.503 . . . . 74.3 111.646 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.04 -22.33 41.74 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.795 2.33 . . . . 63.23 113.415 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -84.23 -19.31 34.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.881 0.372 . . . . 75.51 111.805 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 43.6 tp -68.16 112.14 4.92 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.367 0.603 . . . . 71.13 112.521 -172.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.2 p -127.38 163.43 24.04 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.66 -0.7 . . . . 72.11 109.736 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.63 127.56 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.104 0.478 . . . . 70.42 111.814 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.4 mtt -90.62 -55.71 3.47 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.093 0.473 . . . . 75.44 111.406 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -148.46 157.15 43.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.864 0.364 . . . . 74.13 111.217 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -101.49 107.73 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.523 0.677 . . . . 74.13 111.782 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.88 -179.5 29.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.325 -0.852 . . . . 75.52 111.514 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -60.33 127.55 32.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.748 0.774 . . . . 62.21 109.95 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.89 97.96 0.06 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.437 0.637 . . . . 72.11 111.503 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 . . . . . 0 CA--C 1.537 0.473 0 CA-C-N 115.831 -0.622 . . . . 54.51 112.114 -175.128 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 120.732 0.301 . . . . 61.01 111.718 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.8 m -100.1 130.7 46.27 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.781 0.66 . . . . 61.45 112.781 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.06 124.87 32.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.327 -0.397 . . . . 72.2 111.445 173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.72 -31.42 2.48 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.689 0.636 . . . . 52.51 114.689 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 22' ' ' PRO . 36.2 t -66.16 139.69 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 117.276 0.538 . . . . 74.13 111.626 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.94 103.36 14.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.092 0.405 . . . . 73.35 112.092 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 57.9 m -152.13 138.84 18.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.369 -0.378 . . . . 52.31 111.266 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . -139.43 -106.32 0.68 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.737 -0.744 . . . . 63.44 113.977 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 13.5 Cg_exo -70.8 -49.82 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.843 2.362 . . . . 71.43 113.415 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.68 66.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.045 -0.598 . . . . 72.43 113.304 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 49.7 mtmt -128.47 141.26 51.45 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.622 -0.34 . . . . 74.04 110.985 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.36 133.82 52.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.494 -0.321 . . . . 74.12 110.169 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.0 t -100.42 136.52 40.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.339 . . . . 65.33 111.272 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -134.83 163.67 29.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.08 0.467 . . . . 75.14 111.465 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.8 mmm -89.85 101.5 14.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.199 0.523 . . . . 72.33 110.964 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.08 115.48 30.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.215 -0.448 . . . . 65.24 110.763 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.58 40.54 92.63 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.202 -0.523 . . . . 71.23 113.418 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 5.92 81.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.9 -0.667 . . . . 62.14 113.766 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -124.42 129.85 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 117.173 0.486 . . . . 72.32 111.517 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.524 ' HB2' HG21 ' A' ' 7' ' ' VAL . 61.1 Cg_endo -72.55 106.2 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.497 2.131 . . . . 62.41 112.787 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -115.33 142.81 46.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.881 0.372 . . . . 65.42 111.277 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 9.4 m -103.92 142.83 33.74 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.102 0.477 . . . . 72.11 112.203 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -143.6 153.38 42.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.74 -0.664 . . . . 73.03 110.684 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.6 t -52.83 128.23 26.13 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.176 0.512 . . . . 63.14 111.929 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.71 128.21 30.51 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.162 -0.472 . . . . 72.5 111.67 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.95 -2.84 12.39 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.264 1.976 . . . . 73.24 112.645 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' HB3' ' NH1' ' A' ' 54' ' ' ARG . 36.2 t70 62.14 7.22 2.08 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.633 0.73 . . . . 74.3 111.645 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' HD21 ' A' ' 33' ' ' LEU . 33.8 t -80.53 92.63 5.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.887 -0.597 . . . . 73.32 112.197 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 p -138.43 -83.01 0.3 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.205 -0.452 . . . . 70.14 111.1 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.19 49.52 2.71 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.966 -0.635 . . . . 72.32 113.123 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 30' ' ' CYS . 2.6 pp -132.71 159.05 74.11 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 122.46 0.304 . . . . 60.31 111.08 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.95 119.09 6.11 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.367 2.045 . . . . 64.22 113.502 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.17 66.35 8.46 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.886 -0.783 . . . . 74.05 108.886 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -143.87 -13.38 0.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.909 0.707 . . . . 73.32 112.909 -165.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 68.1 tp -128.05 116.83 20.61 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.712 0.634 . . . . 74.45 112.712 -168.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -58.57 154.74 13.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.156 -0.475 . . . . 72.53 111.405 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.6 m -140.79 148.5 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.236 0.541 . . . . 43.43 111.846 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.0 t -100.03 116.37 31.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.288 -0.414 . . . . 73.33 110.593 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.34 162.18 34.73 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.215 -0.517 . . . . 73.21 113.63 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.8 p -55.14 -28.0 49.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.117 0.484 . . . . 42.53 111.654 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.4 -47.47 83.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.869 -0.605 . . . . 74.32 111.817 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.13 -23.38 5.84 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.335 -0.459 . . . . 62.1 112.531 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.9 139.89 36.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.993 0.425 . . . . 74.1 111.824 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -86.68 122.75 31.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.008 0.432 . . . . 71.11 111.092 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.73 153.73 17.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.442 . . . . 73.21 111.331 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -62.16 -25.71 67.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.825 -0.625 . . . . 61.45 112.606 -173.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 25.0 t70 -170.45 159.89 7.19 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.595 -0.275 . . . . 73.44 110.782 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.67 -40.21 68.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.314 0.578 . . . . 62.51 110.538 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.8 t -52.99 -42.69 65.81 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.286 -0.87 . . . . 71.04 111.471 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.98 -43.73 57.11 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.336 -0.393 . . . . 54.11 111.336 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 66' ' ' VAL . 69.2 tp -55.17 -58.33 8.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.137 0.494 . . . . 72.23 112.208 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 78.3 mtp180 -70.69 -25.05 62.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.181 -0.463 . . . . 73.21 111.781 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 59' ' ' ARG . . . -72.76 -45.28 59.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 70.42 111.146 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.93 68.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.087 0.47 . . . . 73.24 110.771 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 54' ' ' ARG . 31.6 ttp180 -56.03 -50.02 72.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.579 -0.737 . . . . 73.04 110.642 171.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -66.28 -22.38 66.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.744 -0.662 . . . . 62.23 112.129 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 55' ' ' ALA . 29.5 mtp-105 -84.99 30.31 0.59 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.205 0.446 . . . . 73.33 112.205 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.75 6.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.965 -0.636 . . . . 64.51 114.279 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -134.46 77.54 59.16 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 117.294 0.547 . . . . 74.53 110.974 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.88 -21.15 38.18 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.872 2.382 . . . . 71.1 113.526 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.91 -17.64 52.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.989 0.423 . . . . 54.24 111.418 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 tp -72.26 112.0 7.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.195 0.521 . . . . 73.52 111.527 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -135.13 164.46 27.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.017 -0.538 . . . . 65.04 111.356 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.528 HG22 HD23 ' A' ' 53' ' ' LEU . 39.8 t -79.45 119.24 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.841 0.353 . . . . 71.21 111.862 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.3 mmt -81.92 -58.73 2.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.978 0.418 . . . . 73.05 110.579 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -161.58 160.91 29.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.801 -0.636 . . . . 64.0 111.2 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -77.78 137.59 38.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.271 -0.422 . . . . 75.13 111.569 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.61 172.27 30.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.264 -0.493 . . . . 72.52 113.127 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' ARG . 63.3 ttt180 -60.15 154.59 19.2 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.634 -0.333 . . . . 70.15 110.2 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.17 84.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 73.23 112.502 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' ARG . 57.8 mtp180 . . . . . 0 N--CA 1.469 0.524 0 C-N-CA 123.123 0.569 . . . . 64.44 111.319 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 120.999 0.428 . . . . 72.34 111.736 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.4 p -98.72 130.78 45.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.018 0.437 . . . . 63.01 112.169 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -80.51 126.46 31.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.081 0.467 . . . . 64.14 111.521 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.34 -2.2 16.05 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.002 -0.544 . . . . 73.13 113.945 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 10.9 t -107.17 145.83 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 117.118 0.459 . . . . 64.31 111.326 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.12 106.41 15.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.635 -0.506 . . . . 64.12 109.635 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 87.9 m -138.91 139.1 37.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.923 0.392 . . . . 75.43 111.048 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' LYS . . . 169.97 -64.05 0.17 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.393 -0.432 . . . . 63.32 113.076 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.36 42.83 1.3 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.154 2.569 . . . . 74.55 113.69 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.79 -45.01 0.43 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.158 -0.544 . . . . 73.41 112.424 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 36.8 mtmm -122.65 136.92 55.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.492 0.317 . . . . 75.14 110.263 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -107.23 134.35 50.45 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 122.381 -0.2 . . . . 42.34 111.108 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.88 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 31.5 p -114.77 139.64 49.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.668 0.618 . . . . 54.31 112.668 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.567 ' HG3' HH11 ' A' ' 16' ' ' ARG . 29.1 ttm-85 -142.5 160.52 40.13 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.958 -0.565 . . . . 72.2 111.152 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.2 mmt -82.53 107.91 15.53 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.577 0.584 . . . . 72.01 112.577 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HD2' ' A' ' 23' ' ' ARG . 6.3 mp -123.45 102.0 7.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.871 0.367 . . . . 75.2 110.938 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.65 52.57 52.22 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.403 -0.427 . . . . 43.53 114.018 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.45 -44.37 3.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.205 -0.521 . . . . 74.15 113.811 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.04 130.76 35.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 75.14 111.716 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.07 141.05 12.83 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.515 2.143 . . . . 52.32 112.922 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HD2' HD22 ' A' ' 18' ' ' LEU . 97.3 mtt180 -113.79 123.32 49.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.764 -0.198 . . . . 65.02 111.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.88 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 94.9 m -107.36 120.1 41.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.647 0.261 . . . . 75.0 110.988 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -119.74 159.23 24.9 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.341 -0.225 . . . . 75.52 111.525 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 58' ' ' CYS . 8.9 t -58.72 95.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.293 -0.412 . . . . 71.4 110.869 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.8 130.99 24.6 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.329 -0.396 . . . . 75.41 111.887 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -82.68 -158.87 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.672 2.248 . . . . 72.51 111.842 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.27 102.14 14.81 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.854 -0.529 . . . . 75.45 110.994 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.7 m -102.87 3.96 37.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.159 0.504 . . . . 73.25 110.56 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -81.37 -35.28 31.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.953 -0.567 . . . . 72.43 111.99 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.93 9.08 78.81 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.919 -0.658 . . . . 53.42 114.389 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 51' ' ' CYS . 4.1 pp -128.62 156.36 77.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 117.578 0.689 . . . . 74.32 112.087 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.56 123.19 2.49 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.677 2.251 . . . . 74.12 112.963 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.87 14.68 0.48 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.77 0.656 . . . . 72.04 112.77 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.01 10.04 13.85 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.11 -0.369 . . . . 72.52 111.78 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -111.06 100.19 8.92 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.205 -0.31 . . . . 73.21 110.798 -177.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.22 139.36 57.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.877 0.37 . . . . 73.02 111.974 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 69' ' ' ARG . 26.2 m -128.72 166.25 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.142 0.496 . . . . 72.33 111.811 -175.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.0 t -116.34 124.16 49.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.224 -0.444 . . . . 53.32 111.254 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.02 161.56 24.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.124 -0.56 . . . . 71.3 113.497 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 p -55.54 -24.13 30.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.404 0.52 . . . . 74.53 112.404 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.2 -2.5 28.22 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 120.877 0.37 . . . . 73.44 111.674 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.11 25.06 58.39 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.424 -0.417 . . . . 33.21 113.244 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.41 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.928 0.394 . . . . 71.54 111.832 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 71' ' ' ARG . 81.2 m -86.36 110.95 20.04 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.279 -0.419 . . . . 71.12 110.862 174.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -91.16 159.8 15.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 61.32 111.673 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 48' ' ' ARG . 3.9 mmp_? -53.04 -39.68 63.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.112 -0.494 . . . . 74.12 112.223 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 5.5 p-10 -163.93 -178.48 5.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.281 -0.418 . . . . 75.53 110.821 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.522 ' HB3' HD22 ' A' ' 33' ' ' LEU . 24.7 tt0 -68.85 -37.28 79.02 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.673 0.273 . . . . 75.25 111.589 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.627 ' HB2' HD11 ' A' ' 33' ' ' LEU . 25.3 t -65.5 -41.71 92.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.657 0.265 . . . . 64.42 110.667 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.25 -51.48 53.65 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.209 0.528 . . . . 63.24 111.122 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.4 -53.84 46.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.915 -0.584 . . . . 63.22 110.984 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.506 ' NH1' HD23 ' A' ' 33' ' ' LEU . 70.0 mtp180 -61.75 -29.86 70.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.115 -0.493 . . . . 74.22 111.977 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.32 -42.8 68.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.985 0.421 . . . . 63.33 110.812 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.35 88.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.862 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 36.8 ttt85 -63.39 -48.06 79.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.086 0.47 . . . . 52.43 111.236 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.486 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 5.6 t -55.47 -44.42 76.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.933 -0.576 . . . . 71.4 110.468 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -84.21 61.9 6.81 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.255 0.55 . . . . 64.45 112.147 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.05 25.28 49.51 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.58 0.992 . . . . 54.21 115.58 170.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.48 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 95.4 m-70 -134.81 74.88 63.27 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 118.222 1.011 . . . . 75.31 112.132 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.96 -19.76 17.64 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.608 2.206 . . . . 63.54 113.494 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.0 -22.52 42.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.083 0.468 . . . . 65.04 111.067 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.446 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 63.9 tp -75.12 111.74 10.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.184 -0.462 . . . . 62.2 111.264 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 p -124.75 141.97 51.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.003 0.43 . . . . 74.33 111.638 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.24 113.71 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.305 0.574 . . . . 75.33 111.289 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 28.0 mmt -77.01 -42.44 38.65 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.962 0.41 . . . . 72.03 111.416 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -169.03 163.0 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.085 -0.507 . . . . 75.23 111.217 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.646 ' HG3' HG12 ' A' ' 39' ' ' VAL . 1.3 mpp_? -93.34 153.72 18.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.387 -0.37 . . . . 72.55 111.336 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.99 49.69 2.42 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.366 -0.445 . . . . 34.41 113.514 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HA ' HG23 ' A' ' 46' ' ' THR . 59.7 mtp85 61.47 172.08 0.11 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.894 0.701 . . . . 75.4 112.894 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.2 m -81.32 112.28 18.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 72.51 111.646 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 . . . . . 0 CA--C 1.54 0.571 0 CA-C-N 116.053 -0.522 . . . . 74.21 110.765 178.104 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.832 0.348 . . . . 74.15 111.625 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 m -97.1 130.56 44.36 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.856 0.36 . . . . 65.41 111.173 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 7' ' ' VAL . 34.6 t70 -84.21 112.1 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.738 0.304 . . . . 75.54 111.454 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.28 0.01 9.6 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 114.67 0.628 . . . . 74.44 114.67 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' SG ' ' A' ' 9' ' ' CYS . 2.3 t -107.41 137.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 117.691 0.745 . . . . 51.34 111.819 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.46 106.03 18.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.797 0.332 . . . . 71.33 110.195 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.564 ' SG ' HG12 ' A' ' 7' ' ' VAL . 59.0 m -142.96 177.35 8.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.848 0.356 . . . . 74.11 111.908 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.87 -88.07 0.3 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.495 -0.383 . . . . 51.21 112.272 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.66 93.64 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.482 2.121 . . . . 64.44 112.925 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.0 10.89 82.26 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.034 -0.53 . . . . 72.13 113.432 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -146.98 136.29 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.386 -0.479 . . . . 74.42 111.484 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.1 140.21 52.28 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.594 -0.275 . . . . 73.34 110.802 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 15.8 p -100.1 106.24 17.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.402 0.62 . . . . 64.51 111.942 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -106.69 122.14 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.655 -0.702 . . . . 73.1 110.253 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 54.2 mtp -80.54 106.71 12.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.394 0.616 . . . . 64.13 111.883 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.68 HD12 ' HD2' ' A' ' 23' ' ' ARG . 92.9 mt -116.75 112.94 21.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.81 -0.632 . . . . 65.11 110.995 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.59 22.85 74.42 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.964 -0.636 . . . . 40.22 113.101 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.97 -21.12 44.86 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.337 -0.459 . . . . 71.31 113.627 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -106.08 131.78 21.45 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 117.22 0.51 . . . . 72.11 111.98 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 59.0 Cg_endo -73.36 111.6 3.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.436 2.091 . . . . 72.43 112.418 174.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.68 ' HD2' HD12 ' A' ' 18' ' ' LEU . 95.2 mtt180 -96.06 146.42 24.65 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.242 -0.286 . . . . 74.31 111.4 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 21.8 m -132.67 133.07 43.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.101 0.477 . . . . 53.31 111.191 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.16 161.23 37.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.015 -0.539 . . . . 71.24 110.11 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.8 t -54.05 95.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.033 0.444 . . . . 70.0 111.855 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -119.26 136.59 24.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.678 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 13.9 Cg_exo -68.45 90.84 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.421 2.081 . . . . 75.45 113.314 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.77 -70.5 0.25 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.921 0.391 . . . . 62.44 110.599 172.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.6 m 55.55 72.79 0.46 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.678 0.621 . . . . 65.21 112.678 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.8 m -85.28 -29.72 24.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.976 0.417 . . . . 64.54 110.893 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -65.52 1.54 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.28 -0.418 . . . . 62.44 113.333 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.3 pt? -74.13 141.78 78.21 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.989 0.423 . . . . 75.24 111.993 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 16.1 Cg_exo -70.49 120.8 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.776 2.318 . . . . 71.53 112.574 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.15 60.35 1.04 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.345 0.593 . . . . 71.31 111.089 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -151.24 -35.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.578 -0.737 . . . . 71.02 110.937 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 66.3 tp -67.76 107.99 2.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.278 -0.419 . . . . 73.22 111.744 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.63 149.82 38.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.5 0.666 . . . . 70.42 112.744 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.465 HG12 ' HG2' ' A' ' 69' ' ' ARG . 34.3 m -139.78 153.62 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 115.649 -0.705 . . . . 50.0 110.899 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.8 t -106.42 122.34 46.09 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.885 0.374 . . . . 74.21 111.256 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.6 165.12 40.21 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.05 -0.595 . . . . 60.24 113.648 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 p -53.53 -36.82 62.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.017 0.377 . . . . 71.21 112.017 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.06 -27.92 62.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 116.305 -0.407 . . . . 72.34 111.968 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.73 -3.0 34.05 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.174 -0.536 . . . . 55.14 113.099 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.28 142.73 27.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.98 0.419 . . . . 73.33 111.911 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.0 m -92.0 120.35 32.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.929 0.395 . . . . 71.15 110.33 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -97.12 148.55 22.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.529 -0.305 . . . . 64.14 111.11 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 19.9 ptp180 -49.51 -34.53 17.41 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.432 0.53 . . . . 73.25 112.432 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.2 p30 -160.75 176.69 11.22 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.885 0.374 . . . . 75.32 111.286 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HA ' HG21 ' A' ' 39' ' ' VAL . 35.2 tt0 -65.45 -33.61 76.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.412 -0.358 . . . . 73.05 111.885 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.32 -36.15 82.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.603 0.24 . . . . 61.01 111.1 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.63 -48.71 80.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.98 0.419 . . . . 74.01 110.818 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 53' ' ' LEU . 6.8 tt -59.6 -55.57 32.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.182 0.515 . . . . 74.51 110.397 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -58.8 -34.66 71.75 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.994 -0.548 . . . . 75.04 111.956 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.92 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.586 0.231 . . . . 73.24 111.485 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.57 86.09 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 73.44 111.348 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 1.6 tmt_? -59.42 -50.14 75.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.609 0.719 . . . . 73.25 109.99 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.76 -30.05 69.77 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.452 -0.794 . . . . 74.01 111.455 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.95 74.61 6.42 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.075 -0.512 . . . . 74.33 111.312 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.64 34.97 90.43 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 115.224 0.85 . . . . 73.42 115.224 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 77.8 m80 -135.04 89.05 25.07 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 117.96 0.88 . . . . 73.33 111.925 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.56 -18.18 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.01 2.473 . . . . 71.41 113.176 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -19.61 44.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.889 0.376 . . . . 74.22 111.916 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 tp -82.97 130.65 35.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.006 0.432 . . . . 74.52 112.001 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -146.72 161.26 40.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.283 -0.417 . . . . 74.5 110.78 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t -80.48 112.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 120.966 0.412 . . . . 64.04 111.372 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.18 -55.91 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.21 0.529 . . . . 71.11 110.668 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -159.51 152.93 22.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.917 -0.583 . . . . 74.21 110.706 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HG2' HG12 ' A' ' 39' ' ' VAL . 91.3 mtt180 -79.57 150.48 31.07 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.062 0.458 . . . . 73.43 111.195 177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.84 -178.34 29.64 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.978 -0.555 . . . . 21.51 112.177 -173.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -75.03 161.91 29.03 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.265 -0.55 . . . . 73.22 111.388 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.42 93.68 0.24 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.159 0.799 . . . . 74.15 113.159 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 . . . . . 0 CA--C 1.538 0.51 0 CA-C-N 115.413 -0.812 . . . . 71.54 110.88 176.624 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 110.268 -0.271 . . . . 54.14 110.268 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.0 m -120.56 131.13 54.52 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.276 0.472 . . . . 63.35 112.276 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 7' ' ' VAL . 9.5 m-20 -83.45 112.13 19.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.21 -0.45 . . . . 75.32 111.726 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.72 32.08 16.87 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.757 0.663 . . . . 74.2 114.757 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 22' ' ' PRO . 93.1 t -106.96 122.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.541 0.67 . . . . 62.22 111.542 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -99.26 105.97 18.05 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.329 0.585 . . . . 72.14 111.747 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 80.9 m -148.34 137.95 22.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.002 -0.545 . . . . 52.41 110.127 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.74 -86.9 0.06 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 119.897 -1.144 . . . . 73.43 114.635 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.56 -35.64 80.47 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.12 2.547 . . . . 74.22 113.901 -172.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.96 -45.35 1.39 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.988 -0.625 . . . . 65.12 113.634 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.8 mtmt -123.63 146.87 47.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.489 0.552 . . . . 71.51 112.489 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -116.67 145.94 43.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 53.1 110.494 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 26.8 p -104.03 133.99 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.154 0.502 . . . . 64.31 112.198 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.48 ' NH2' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -118.86 164.26 15.68 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.987 -0.551 . . . . 73.43 111.161 176.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 mmt -82.11 102.94 11.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.891 0.377 . . . . 64.12 111.274 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.83 103.41 12.66 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.871 0.367 . . . . 70.42 110.212 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.18 33.01 82.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.341 -0.457 . . . . 71.24 112.686 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.34 -12.97 57.27 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.369 -0.443 . . . . 52.2 113.047 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 94.9 mtt180 -99.19 129.31 29.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 O-C-N 122.616 -0.343 . . . . 72.2 111.602 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.682 ' HB2' HG21 ' A' ' 7' ' ' VAL . 1.9 Cg_endo -80.95 113.75 2.8 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.966 2.444 . . . . 73.11 112.877 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -123.14 140.62 52.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.789 0.328 . . . . 74.52 111.472 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.4 m -104.1 131.74 51.06 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.894 0.701 . . . . 62.0 112.894 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . 86.0 mt-10 -124.83 159.97 29.81 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.235 172.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.5 t -64.68 119.32 10.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.102 0.477 . . . . 62.21 111.415 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -108.82 138.38 20.31 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.794 0.664 . . . . 61.02 112.794 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.4 Cg_exo -77.74 130.69 10.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.952 2.435 . . . . 64.03 112.229 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 10.8 t0 -66.04 84.89 0.09 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.35 0.595 . . . . 71.33 110.816 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 87.4 m -105.18 39.66 1.68 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.19 -0.459 . . . . 75.35 112.074 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -69.12 83.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.12 0.486 . . . . 74.4 111.855 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.9 52.61 11.25 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.615 0.606 . . . . 64.22 114.615 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' A' ' 51' ' ' CYS . 4.4 pp -114.0 157.08 43.0 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 117.394 0.597 . . . . 61.43 111.258 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.81 119.92 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.264 1.976 . . . . 73.03 112.784 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.01 -9.96 59.37 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.297 0.48 . . . . 73.54 112.297 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -90.22 -9.63 47.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.538 -0.301 . . . . 72.45 111.795 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.3 tp -98.85 117.35 33.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.002 0.43 . . . . 62.34 112.113 -174.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 46.7 mt-30 -75.72 159.82 30.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 73.41 110.827 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.0 m -144.4 148.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 112.332 0.493 . . . . 73.13 112.332 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 34.2 m -104.67 126.7 52.01 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.347 -0.388 . . . . 42.22 111.676 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.27 162.91 22.84 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.174 -0.536 . . . . 74.54 112.711 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 t -57.36 -18.23 16.33 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.206 0.447 . . . . 71.51 112.206 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.4 -38.51 80.75 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.935 0.398 . . . . 53.44 111.607 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.0 4.3 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.106 -0.569 . . . . 73.11 113.041 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.82 148.5 29.96 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.123 0.487 . . . . 44.33 112.155 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.439 HG21 ' HG2' ' A' ' 71' ' ' ARG . 96.2 m -86.18 137.38 32.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.714 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -106.68 143.66 34.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.474 -0.33 . . . . 74.43 111.452 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 68.5 mtt180 -43.71 -39.29 3.6 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.031 0.752 . . . . 74.11 113.031 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 3.3 p30 -167.04 172.11 10.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.838 0.352 . . . . 75.13 111.278 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HG3' HD22 ' A' ' 33' ' ' LEU . 13.4 tp10 -58.16 -34.12 69.95 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.491 -0.322 . . . . 71.23 111.765 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 33' ' ' LEU . 62.9 m -71.05 -34.67 71.46 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.864 -0.523 . . . . 64.22 111.164 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.69 -46.86 87.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 73.13 110.65 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.82 -40.46 95.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 70.51 109.799 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -59.54 -24.76 63.97 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.706 -0.679 . . . . 65.11 111.084 175.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.09 -35.18 17.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.131 -0.486 . . . . 64.45 111.146 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.44 -29.41 69.0 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.191 0.441 . . . . 55.34 112.191 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 20.2 ptt180 -55.43 -29.09 57.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.524 0.678 . . . . 73.01 110.843 173.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.5 t -82.65 -18.8 39.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.396 -0.82 . . . . 70.22 111.174 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -107.03 89.42 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.062 0.458 . . . . 63.32 111.481 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.78 -17.13 1.29 Allowed Glycine 0 CA--C 1.536 1.35 0 N-CA-C 115.321 0.888 . . . . 71.53 115.321 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 61.4 m80 -122.83 74.89 47.2 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 118.243 1.021 . . . . 71.02 112.2 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.1 -23.0 29.72 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.255 1.97 . . . . 71.32 112.957 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -96.21 10.38 38.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.456 -0.338 . . . . 75.12 111.742 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 tp -62.96 115.55 4.5 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.342 0.497 . . . . 54.15 112.342 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.2 m -114.14 163.76 14.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.251 -0.431 . . . . 73.25 111.344 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 HD13 ' A' ' 53' ' ' LEU . 39.8 t -90.91 127.34 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.084 0.402 . . . . 73.32 112.084 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.3 mtt -73.16 -53.77 10.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 63.3 110.483 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -168.01 167.82 12.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.804 -0.634 . . . . 74.12 110.462 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 150.06 25.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.186 0.517 . . . . 75.52 111.388 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.48 -162.0 15.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.849 -0.614 . . . . 64.52 112.456 -176.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' HG21 ' A' ' 46' ' ' THR . 73.3 mtm180 -98.41 147.25 24.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.938 0.399 . . . . 75.04 111.201 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 73.3 m -62.93 106.97 0.9 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.885 0.698 . . . . 62.41 112.885 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 . . . . . 0 CA--C 1.539 0.548 0 CA-C-N 116.066 -0.516 . . . . 71.32 110.863 175.656 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.809 0.338 . . . . 32.12 111.351 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 54.5 m -140.43 140.44 35.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.203 0.445 . . . . 71.45 112.203 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 7' ' ' VAL . 22.5 t70 -50.77 111.83 0.61 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.415 0.524 . . . . 75.22 112.415 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.68 10.92 26.98 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.375 0.51 . . . . 65.21 114.375 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 22' ' ' PRO . 17.2 t -107.91 122.92 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 122.208 -0.583 . . . . 71.42 111.726 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.27 106.68 17.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.647 0.26 . . . . 75.51 110.416 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 7' ' ' VAL . 47.8 m -148.9 163.05 38.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.975 0.417 . . . . 63.13 111.655 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.92 -84.02 0.11 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.138 -0.483 . . . . 75.11 112.493 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.6 108.76 2.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.56 2.174 . . . . 75.21 112.52 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.69 6.38 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.88 -0.676 . . . . 75.33 113.109 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -142.85 136.9 29.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 117.164 0.482 . . . . 53.44 111.479 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.86 146.58 32.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.54 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 52.7 t -104.25 141.03 37.0 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.568 0.581 . . . . 73.21 112.568 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -142.46 132.86 24.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.008 -0.542 . . . . 74.4 110.393 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 67.9 mtp -86.75 121.1 28.78 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.133 0.492 . . . . 54.14 112.245 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.7 mt -112.8 118.1 34.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.806 -0.634 . . . . 75.05 110.58 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.06 30.61 67.16 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.045 -0.598 . . . . 61.31 113.384 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.18 -8.99 78.84 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.235 -0.507 . . . . 75.42 113.553 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.512 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 95.9 mtt180 -113.46 120.55 39.49 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 122.424 -0.456 . . . . 74.53 111.091 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.664 ' HB2' HG21 ' A' ' 7' ' ' VAL . 7.1 Cg_exo -75.29 143.69 28.45 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.037 2.491 . . . . 72.21 114.401 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 17.8 mmt180 -125.11 139.41 53.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.119 0.568 . . . . 73.14 110.814 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 89.4 m -122.28 118.97 29.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.986 0.422 . . . . 70.41 112.015 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -130.81 161.84 30.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.101 -0.5 . . . . 72.53 110.659 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 10.5 t -37.65 124.93 1.1 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.537 0.94 . . . . 72.55 113.537 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.02 143.84 27.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.779 -0.646 . . . . 74.04 111.306 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.15 52.7 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.469 2.113 . . . . 73.53 113.337 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.945 0.402 . . . . 52.5 110.456 173.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.551 ' HB2' HD21 ' A' ' 33' ' ' LEU . 24.8 p -134.37 23.4 3.76 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.795 0.665 . . . . 65.21 112.795 -171.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.2 t -65.19 106.38 1.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.874 0.368 . . . . 70.45 111.315 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.38 -42.87 0.92 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.758 -0.734 . . . . 73.41 113.499 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 50' ' ' GLU . 3.4 pp -67.66 152.51 96.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.359 0.503 . . . . 73.32 112.359 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 28.2 Cg_exo -62.77 137.67 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.677 2.251 . . . . 62.52 113.166 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 35.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.186 -0.461 . . . . 34.21 111.857 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 64.69 25.47 13.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.822 0.675 . . . . 70.12 112.822 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.1 tm? -84.85 102.8 13.37 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.672 -0.492 . . . . 75.13 109.672 174.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.662 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 64.2 mt-30 -66.26 145.89 55.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.726 0.639 . . . . 72.4 112.726 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.13 155.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.787 -0.642 . . . . 75.34 111.082 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.96 122.61 43.8 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.796 0.331 . . . . 62.51 111.603 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 47' ' ' TYR . . . -83.01 176.0 53.14 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.182 -0.532 . . . . 51.01 113.549 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.532 ' H ' HD12 ' A' ' 64' ' ' LEU . 40.1 t -54.8 -40.43 69.49 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.914 0.709 . . . . 70.23 112.914 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.53 -20.01 65.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.923 0.392 . . . . 75.12 111.995 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 14.76 42.8 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.439 -0.41 . . . . 70.13 112.53 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.33 142.66 28.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.901 0.381 . . . . 72.33 111.752 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -87.14 117.29 25.79 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.083 0.468 . . . . 73.43 111.452 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HE2' ' HA3' ' A' ' 41' ' ' GLY . 83.6 m-85 -94.65 138.78 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.248 -0.433 . . . . 72.41 109.971 174.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -66.42 -6.9 16.16 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.559 0.578 . . . . 62.52 112.559 -175.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 4.8 p-10 -174.5 155.91 2.35 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.914 0.485 . . . . 60.31 110.934 172.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 33' ' ' LEU . 41.7 tt0 -62.35 -30.79 71.43 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.172 0.434 . . . . 70.15 112.172 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.446 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 26.6 t -61.36 -40.19 93.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.223 0.535 . . . . 72.21 110.489 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -60.45 -44.01 96.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.675 -0.693 . . . . 71.12 110.784 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.56 -39.57 76.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.111 -0.495 . . . . 72.34 110.889 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -58.87 -49.43 77.79 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.989 0.423 . . . . 75.44 111.208 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.11 96.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.093 0.473 . . . . 72.21 111.211 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.3 96.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.143 -0.481 . . . . 74.03 111.548 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 23.2 ttt85 -61.82 -51.41 68.37 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.026 0.441 . . . . 72.41 111.342 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 74.7 m -75.47 -2.99 31.41 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.23 0.456 . . . . 64.24 112.23 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -78.88 -59.97 2.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.838 0.351 . . . . 73.43 110.112 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.47 27.31 0.32 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.962 -0.637 . . . . 63.33 113.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.704 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 37.8 m80 -134.53 76.33 61.61 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 122.233 -0.569 . . . . 72.43 111.668 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.34 -12.61 28.15 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.691 2.261 . . . . 63.02 113.45 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.82 8.07 26.49 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.843 0.312 . . . . 74.0 111.843 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.704 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 59.6 tp -73.44 111.34 8.48 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.154 0.502 . . . . 73.41 111.497 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.8 m -129.17 152.93 48.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 73.31 110.416 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.72 114.73 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.284 0.564 . . . . 64.43 111.579 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.3 mmt -65.9 -41.57 91.3 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.012 0.434 . . . . 72.25 111.186 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.62 150.55 6.0 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.053 -0.521 . . . . 54.44 111.689 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.18 140.84 43.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.981 -0.554 . . . . 75.24 111.865 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.25 170.35 20.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.187 -0.46 . . . . 43.4 112.509 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HG2' ' OE1' ' A' ' 38' ' ' GLN . 64.2 mtt-85 -61.0 132.11 52.79 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.612 -0.346 . . . . 73.24 110.454 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.49 96.99 0.73 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.197 0.522 . . . . 72.53 112.327 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 . . . . . 0 CA--C 1.539 0.544 0 CA-C-N 115.46 -0.791 . . . . 70.31 110.496 177.622 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.2 m . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 121.135 0.493 . . . . 61.13 111.734 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.7 m -98.68 130.73 45.19 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.18 -0.464 . . . . 65.31 111.388 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 7' ' ' VAL . 23.5 t70 -76.4 111.68 12.12 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.868 0.366 . . . . 54.52 111.191 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.76 -4.16 2.44 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.482 0.553 . . . . 24.41 114.482 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 14.1 t -97.49 126.25 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 117.408 0.604 . . . . 71.04 111.579 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.98 105.3 16.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.69 0.281 . . . . 73.03 110.985 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.0 m -149.05 158.78 44.45 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.374 0.509 . . . . 72.04 112.374 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.11 -107.67 0.2 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.107 -0.497 . . . . 71.43 112.758 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.83 102.69 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.323 2.015 . . . . 71.11 112.941 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.47 -3.88 56.57 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.958 -0.639 . . . . 62.55 113.813 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -143.22 136.12 27.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.316 0.579 . . . . 73.22 112.314 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -131.17 155.21 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.684 -0.689 . . . . 54.14 110.649 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.63 126.45 41.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.066 0.46 . . . . 50.42 111.209 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -123.5 137.32 54.8 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.138 -0.483 . . . . 53.52 110.465 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.9 mmm -85.79 102.58 13.79 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.113 0.483 . . . . 64.21 111.951 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 23' ' ' ARG . 4.1 mm? -109.11 115.69 30.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.2 -0.455 . . . . 64.43 110.303 174.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.8 27.67 67.03 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.157 -0.544 . . . . 74.11 113.261 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.51 85.14 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.483 -0.389 . . . . 55.43 113.696 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -109.55 126.68 28.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.517 -0.402 . . . . 53.52 111.439 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.44 104.36 1.73 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.42 2.08 . . . . 73.21 113.253 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.551 ' HG2' HD23 ' A' ' 18' ' ' LEU . 7.5 ptp180 -97.18 157.65 15.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.477 -0.328 . . . . 71.22 110.839 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 30.2 m -111.11 120.36 42.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.21 0.529 . . . . 72.33 112.093 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -107.02 160.17 15.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.691 -0.686 . . . . 64.43 109.959 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.22 95.87 0.14 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.057 0.456 . . . . 64.21 111.179 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.7 119.26 59.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.129 -0.487 . . . . 53.4 110.764 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 55' ' ' ALA . 22.4 Cg_endo -59.86 102.15 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.321 2.014 . . . . 62.54 112.932 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.46 100.34 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.001 0.429 . . . . 61.54 109.961 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.6 p -139.57 35.57 2.03 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.288 -0.415 . . . . 64.3 111.36 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.8 t -58.27 -37.89 75.88 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.242 -0.436 . . . . 74.43 111.842 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.41 43.16 1.75 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.365 -0.445 . . . . 40.21 113.151 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.454 HD11 ' NH2' ' A' ' 54' ' ' ARG . 87.9 mt -130.4 152.92 81.1 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.717 0.294 . . . . 73.11 111.428 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.09 119.94 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.211 1.941 . . . . 75.24 112.381 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.41 17.95 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.086 0.47 . . . . 60.42 111.65 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -120.84 -21.26 6.66 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.613 0.597 . . . . 71.44 112.613 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 69' ' ' ARG . 8.1 tt -93.2 120.84 33.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.832 0.349 . . . . 63.42 111.442 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.694 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 48.7 mt-30 -73.56 142.49 46.64 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.746 0.647 . . . . 74.2 112.746 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HB ' HG13 ' A' ' 66' ' ' VAL . 27.0 m -128.93 159.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.109 -0.496 . . . . 74.33 111.577 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 51.8 t -106.13 127.46 53.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.887 0.375 . . . . 62.21 111.775 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.54 155.91 32.81 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.168 -0.469 . . . . 75.14 113.257 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.51 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 43.8 t -53.79 -32.3 52.07 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.981 0.734 . . . . 72.12 112.981 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.78 -2.95 52.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.055 0.455 . . . . 74.24 112.135 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.38 20.91 39.68 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.199 -0.524 . . . . 72.43 113.136 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.9 132.52 42.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.789 0.328 . . . . 64.02 111.309 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -85.78 122.44 29.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.963 0.411 . . . . 71.42 111.703 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -112.84 147.35 37.15 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.998 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.694 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 31.2 mmt-85 -75.29 -20.33 59.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.359 -0.382 . . . . 54.42 111.739 -173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -163.99 161.65 22.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.061 -0.518 . . . . 64.2 111.092 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG2' HG21 ' A' ' 66' ' ' VAL . 1.7 tm-20 -57.61 -40.38 79.02 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.175 0.512 . . . . 70.43 110.701 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 25.7 t -59.64 -38.23 80.83 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.974 0.416 . . . . 53.34 111.461 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.11 -43.88 90.57 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.069 0.461 . . . . 71.2 111.05 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.65 HD13 HG22 ' A' ' 66' ' ' VAL . 10.3 tt -64.83 -47.25 78.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.991 -0.55 . . . . 75.21 110.99 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' NH2' HD11 ' A' ' 33' ' ' LEU . 19.0 ttm180 -55.14 -37.25 66.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.079 0.466 . . . . 74.22 111.13 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HB2' ' HG3' ' A' ' 28' ' ' PRO . . . -65.6 -47.65 74.96 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.179 -0.464 . . . . 71.32 111.262 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.91 -38.3 75.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.986 0.422 . . . . 62.24 111.633 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 76.2 ttt180 -60.74 -50.45 73.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.935 0.397 . . . . 75.21 111.085 175.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.27 -29.47 70.56 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.986 0.422 . . . . 75.32 111.664 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 59' ' ' ARG . 35.3 ttt-85 -61.8 -38.68 89.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.212 -0.449 . . . . 73.21 111.254 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.57 36.28 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.033 -0.603 . . . . 63.42 113.68 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.421 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 96.9 m-70 -134.31 78.13 58.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.297 -0.531 . . . . 70.21 111.507 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.62 -28.62 25.71 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.636 2.224 . . . . 71.32 113.186 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.24 -11.94 58.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.249 0.547 . . . . 64.33 111.328 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 5.8 tt -92.88 114.97 27.67 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.591 0.71 . . . . 74.32 111.331 -175.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.492 ' HA ' HD21 ' A' ' 53' ' ' LEU . 69.5 m -144.58 166.27 25.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.613 -0.721 . . . . 72.01 110.193 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.65 HG22 HD13 ' A' ' 53' ' ' LEU . 75.4 t -69.07 111.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.018 0.437 . . . . 63.42 111.65 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 42' ' ' SER . 66.1 mtm -81.69 -53.73 5.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.133 -0.485 . . . . 65.24 110.996 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.33 164.57 31.06 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.887 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.504 ' HB3' HD21 ' A' ' 37' ' ' LEU . 98.9 mtt180 -96.77 151.68 19.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.987 0.423 . . . . 72.44 111.639 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 47.85 1.74 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.185 -0.531 . . . . 62.22 112.549 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.61 -177.54 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.351 1.061 . . . . 73.11 113.364 -176.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.4 m -89.51 105.36 17.74 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.789 -0.569 . . . . 62.24 111.078 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 116.068 -0.514 . . . . 74.31 111.75 -174.294 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.995 0.426 . . . . 73.42 110.134 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.412 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.6 m -101.91 128.55 48.25 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.025 0.44 . . . . 74.11 111.721 -171.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.53 115.05 23.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.302 -0.408 . . . . 72.24 111.953 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.91 -31.74 1.07 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.217 -0.516 . . . . 70.42 113.538 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.562 HG21 ' HG2' ' A' ' 22' ' ' PRO . 12.1 t -67.94 105.07 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 122.545 -0.385 . . . . 72.34 110.985 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.8 105.78 17.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 71.41 110.844 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.1 m -133.33 137.33 45.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 74.33 111.396 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.16 -68.0 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.978 -0.555 . . . . 62.13 112.245 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.03 79.46 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.697 2.265 . . . . 63.12 112.408 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.77 54.99 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.356 -0.449 . . . . 73.33 113.68 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -145.53 148.87 33.67 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.627 0.713 . . . . 74.12 112.292 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.41 140.83 47.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.787 -0.642 . . . . 34.34 109.872 172.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.731 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 28.6 p -100.11 145.84 27.5 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.366 0.603 . . . . 64.24 111.422 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -129.78 133.74 47.17 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.629 -0.714 . . . . 65.33 110.826 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.86 103.13 4.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 70.15 111.325 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 98.0 mt -127.42 117.74 22.74 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.931 0.396 . . . . 65.14 111.788 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.6 26.34 66.52 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.562 -0.351 . . . . 73.11 113.826 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.07 -0.01 75.07 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.111 -0.566 . . . . 74.44 113.376 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -131.74 138.49 32.67 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 117.121 0.461 . . . . 73.41 112.014 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.562 ' HG2' HG21 ' A' ' 7' ' ' VAL . 97.1 Cg_endo -80.81 118.97 3.52 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.735 2.29 . . . . 52.3 113.571 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -109.23 137.26 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.26 -0.275 . . . . 62.12 110.365 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.731 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -103.82 139.9 38.39 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.847 0.684 . . . . 74.35 112.847 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.42 160.68 34.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.895 -0.593 . . . . 63.14 110.606 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -57.72 112.87 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.22 0.452 . . . . 65.32 112.22 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.36 119.71 55.48 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.131 -0.486 . . . . 61.31 110.916 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 86.84 1.09 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.384 2.056 . . . . 74.0 113.266 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.68 100.23 12.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.271 0.557 . . . . 65.54 110.368 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.4 p -98.68 134.38 41.68 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.278 -0.419 . . . . 63.14 111.907 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.3 p -99.49 -76.01 0.55 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.269 -0.423 . . . . 74.04 111.356 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.27 39.51 3.0 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.217 -0.516 . . . . 74.55 113.598 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 34.1 mt -120.34 135.71 24.69 Favored Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 122.395 -0.474 . . . . 65.24 110.6 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.45 139.65 31.96 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.46 2.106 . . . . 72.45 113.239 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.75 141.91 30.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.793 0.33 . . . . 74.24 111.408 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 64.29 6.23 2.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.253 0.621 . . . . 72.32 112.545 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 2.4 tm? -93.19 95.41 9.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.412 -0.588 . . . . 60.14 109.412 176.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -54.79 137.06 45.63 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.718 0.636 . . . . 74.25 112.718 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 35.7 m -129.96 156.76 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.149 -0.478 . . . . 71.43 111.439 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -100.55 118.13 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.295 -0.411 . . . . 71.54 110.941 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.79 168.44 39.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.396 -0.431 . . . . 73.43 113.793 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.7 t -49.86 -37.05 29.29 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.792 0.664 . . . . 45.21 112.792 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.24 -33.9 68.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.038 0.446 . . . . 74.11 112.037 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.89 18.94 18.76 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.724 -0.55 . . . . 52.24 111.724 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.66 146.81 40.44 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.981 0.419 . . . . 74.21 111.444 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.493 HG21 ' HG2' ' A' ' 71' ' ' ARG . 38.6 m -86.05 120.23 27.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.121 -0.49 . . . . 61.11 111.414 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.76 157.51 16.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.429 -0.351 . . . . 73.42 110.982 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -49.2 -42.59 40.66 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.047 0.388 . . . . 73.05 112.047 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 51' ' ' CYS . 1.5 p30 -173.42 175.49 3.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.08 -0.509 . . . . 74.05 111.122 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -62.25 -31.5 72.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.892 0.377 . . . . 64.13 111.677 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.477 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 42.1 t -66.86 -40.53 87.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.213 0.53 . . . . 74.41 110.408 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -68.85 -38.02 79.51 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.797 -0.638 . . . . 75.11 110.941 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 66' ' ' VAL . 10.4 tt -58.16 -43.4 87.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.872 0.368 . . . . 55.4 110.469 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -57.92 -38.77 76.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.383 -0.371 . . . . 74.45 111.227 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.99 44.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.382 . . . . 73.55 111.322 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.97 75.28 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.905 0.383 . . . . 74.13 111.54 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 46.3 ttt-85 -64.58 -50.37 67.5 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.934 0.397 . . . . 63.51 110.659 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 37.1 t -63.11 -33.09 74.71 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.181 -0.463 . . . . 72.1 111.857 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -65.81 -31.65 72.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.501 -0.318 . . . . 75.13 111.612 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.23 37.2 0.02 OUTLIER Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.84 -0.695 . . . . 64.31 113.995 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 85.1 m-70 -135.56 82.62 38.88 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.213 0.506 . . . . 53.2 112.168 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.28 -25.93 49.28 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.452 2.102 . . . . 71.53 112.976 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.3 -20.02 60.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.361 . . . . 72.24 111.683 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.5 tp -69.63 112.54 6.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.521 0.677 . . . . 75.21 112.664 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.4 p -131.15 164.22 25.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.674 -0.694 . . . . 71.51 110.753 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 53' ' ' LEU . 59.8 t -87.17 112.52 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.89 0.376 . . . . 64.44 111.544 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.0 mmt -81.16 -42.52 20.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.049 0.452 . . . . 72.14 110.979 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 45.9 p90 -169.4 156.75 6.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.021 -0.536 . . . . 52.22 110.812 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -82.82 125.54 31.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.023 0.44 . . . . 75.44 110.876 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.453 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 131.93 -175.79 19.58 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.134 -0.485 . . . . 74.33 112.105 -174.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.493 ' HG2' HG21 ' A' ' 46' ' ' THR . 96.1 mtt180 -86.03 140.2 30.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.613 -0.345 . . . . 64.53 111.186 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.428 ' HA ' ' OH ' ' A' ' 68' ' ' TYR . 96.4 m -59.79 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.261 0.467 . . . . 54.34 112.261 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 . . . . . 0 N--CA 1.469 0.483 0 CA-C-N 115.895 -0.593 . . . . 65.44 110.326 174.323 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.739 0.304 . . . . 52.42 110.401 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.0 m -98.31 127.23 44.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.963 0.411 . . . . 63.4 111.515 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.547 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 14.4 t70 -86.64 112.54 21.71 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.09 -0.505 . . . . 61.25 110.973 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.9 -32.92 0.74 Allowed Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.156 -0.545 . . . . 72.23 114.21 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 18.3 t -66.19 117.45 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.96 0.38 . . . . 54.3 111.708 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -106.73 106.88 17.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.831 0.348 . . . . 71.34 111.28 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 71.5 m -140.03 142.61 36.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.031 0.443 . . . . 62.33 111.758 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.97 -52.88 0.04 OUTLIER Glycine 0 CA--C 1.532 1.103 0 CA-C-N 115.729 -0.669 . . . . 60.04 113.273 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.63 87.09 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 60.2 112.983 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.49 15.46 79.12 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.386 -0.435 . . . . 71.1 113.778 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -146.26 135.76 23.04 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.575 -0.368 . . . . 64.25 110.97 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.95 137.77 53.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.595 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.0 p -100.65 122.78 43.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.91 0.386 . . . . 45.14 110.342 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HG3' ' HG ' ' A' ' 18' ' ' LEU . 10.7 ptm180 -129.2 160.55 32.57 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.079 0.4 . . . . 75.51 112.079 -172.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.9 mmt -76.25 101.89 5.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.88 0.371 . . . . 72.23 111.448 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HG ' ' HG3' ' A' ' 16' ' ' ARG . 94.5 mt -133.36 111.62 10.94 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.828 0.347 . . . . 75.35 110.579 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.41 44.91 82.8 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.913 -0.66 . . . . 73.45 112.678 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.29 -49.48 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.003 0.361 . . . . 71.14 114.003 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -92.92 137.87 23.66 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 121.032 0.444 . . . . 73.42 111.828 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 64.9 Cg_endo -72.51 129.74 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.516 2.144 . . . . 73.41 112.92 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -129.42 150.97 50.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.437 -0.347 . . . . 75.53 110.69 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 84.9 m -104.47 146.26 29.12 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.378 0.609 . . . . 63.43 112.262 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -143.94 161.44 38.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.881 -0.6 . . . . 73.35 110.535 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 12.7 t -64.17 84.04 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.209 0.528 . . . . 72.24 111.092 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.12 118.9 32.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 62.2 109.954 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.79 100.84 1.11 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.338 2.025 . . . . 70.2 114.276 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.21 98.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.546 -0.538 . . . . 63.44 109.546 166.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.65 ' HB2' HD11 ' A' ' 33' ' ' LEU . 6.3 p -121.87 91.82 3.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.444 0.535 . . . . 63.31 112.444 -172.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -107.98 166.11 10.96 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.921 -0.582 . . . . 71.33 110.861 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.97 -56.31 3.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.046 -0.597 . . . . 65.24 112.647 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 30' ' ' CYS . 4.5 pp -73.07 146.01 86.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.462 -0.434 . . . . 74.22 110.339 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.19 119.14 5.85 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 121.768 1.645 . . . . 50.21 113.509 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.23 15.22 6.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.829 0.347 . . . . 74.32 111.918 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -135.11 14.43 3.55 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.777 0.288 . . . . 74.22 111.777 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 38' ' ' GLN . 1.7 tm? -119.69 136.65 54.33 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.949 0.404 . . . . 74.15 110.645 -177.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.577 ' N ' HD13 ' A' ' 37' ' ' LEU . 37.6 mt-30 -63.74 137.67 58.17 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.352 0.501 . . . . 73.44 112.352 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 50' ' ' GLU . 34.6 m -128.6 152.38 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.126 0.488 . . . . 75.43 111.56 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.8 t -101.01 128.66 46.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.962 -0.563 . . . . 51.11 111.739 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.02 152.95 19.96 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.495 -0.383 . . . . 53.34 113.074 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.6 t -57.25 -31.88 66.0 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.942 0.401 . . . . 62.12 111.996 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.33 -20.49 65.55 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.152 0.427 . . . . 65.32 112.152 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.4 14.77 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.306 -0.474 . . . . 65.13 112.732 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.38 135.15 54.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.775 0.321 . . . . 72.25 111.547 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 m -94.81 128.58 41.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.863 0.363 . . . . 73.33 111.439 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.06 154.83 21.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.745 0.307 . . . . 55.24 111.363 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -66.59 -20.14 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.956 0.408 . . . . 55.41 111.575 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -165.49 155.59 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.714 -0.676 . . . . 75.42 110.071 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.627 ' HA ' HG21 ' A' ' 39' ' ' VAL . 31.3 tt0 -60.03 -34.43 73.38 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.044 0.45 . . . . 72.3 110.976 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -58.99 -37.33 76.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.293 -0.412 . . . . 73.43 110.729 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.97 -40.21 91.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.868 0.366 . . . . 71.24 110.852 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.86 -47.98 82.99 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.094 0.473 . . . . 65.11 110.301 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 50' ' ' GLU . 2.2 mpt_? -64.19 -39.43 93.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.235 -0.439 . . . . 75.15 111.222 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.997 0.427 . . . . 62.2 111.517 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -34.96 76.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.406 0.622 . . . . 51.21 110.833 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.11 92.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.912 -0.585 . . . . 71.34 110.446 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 73.4 m -64.22 -26.74 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 111.822 0.304 . . . . 74.04 111.822 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -64.24 -34.07 77.25 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.977 0.418 . . . . 72.34 111.27 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.66 35.17 0.05 OUTLIER Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.275 -0.488 . . . . 42.44 113.082 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -128.65 79.05 75.03 Favored Pre-proline 0 CA--C 1.539 0.533 0 O-C-N 122.37 -0.489 . . . . 71.24 111.44 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.22 -28.26 72.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.461 2.107 . . . . 75.42 112.21 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.33 -22.9 66.88 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.918 -0.583 . . . . 65.12 111.994 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.02 111.71 8.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.476 0.655 . . . . 72.44 112.044 -174.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -127.75 161.17 29.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.295 -0.866 . . . . 75.2 110.594 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p -88.8 134.76 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.203 0.525 . . . . 74.11 111.956 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 16.7 mmt -90.65 -59.05 2.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.363 -0.381 . . . . 74.35 110.974 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -164.52 164.34 21.81 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.099 0.476 . . . . 73.22 112.006 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -75.65 111.98 11.54 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.828 -0.624 . . . . 71.55 111.057 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 139.36 161.23 8.65 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.337 -0.392 . . . . 63.41 112.147 -174.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -72.58 134.85 45.39 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.249 0.525 . . . . 75.45 112.4 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.0 m -58.12 99.88 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.033 -0.53 . . . . 74.53 111.889 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 64.1 111.005 176.364 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.107 0.479 . . . . 71.11 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 33.7 m-20 -110.43 176.75 4.92 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.384 0.611 . . . . 60.42 112.492 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 66.6 m -142.59 146.03 34.15 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.471 -0.786 . . . . 71.42 110.771 176.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 72.4 m -100.03 172.99 6.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.862 0.319 . . . . 71.4 111.862 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.87 112.7 0.82 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.1 -0.5 . . . . 63.52 111.485 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.73 2.16 49.59 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.471 -0.395 . . . . 63.53 113.961 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' A' ' 22' ' ' PRO . 3.6 t -107.04 122.46 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 122.462 -0.434 . . . . 71.15 111.373 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.88 110.18 21.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.49 0.662 . . . . 64.44 111.421 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 55.1 m -136.14 180.0 6.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.195 -0.457 . . . . 75.11 111.09 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.57 -91.1 0.25 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 54.23 112.752 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.67 88.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.848 2.365 . . . . 74.34 112.839 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.621 ' H ' ' HB3' ' A' ' 29' ' ' ASP . . . 83.92 12.89 76.15 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.104 -0.498 . . . . 61.44 113.372 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.645 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 51.4 mtmt -141.3 136.67 31.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.376 0.51 . . . . 75.23 112.376 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.08 51.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.882 -0.599 . . . . 53.31 109.962 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 18.3 p -122.78 143.2 49.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.364 0.505 . . . . 74.23 112.364 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' HD3' HH11 ' A' ' 16' ' ' ARG . 40.2 ttp180 -143.74 148.8 36.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.086 -0.506 . . . . 71.51 110.259 173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 69.5 mtp -80.99 120.39 24.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.185 0.517 . . . . 62.33 112.072 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.6 106.14 18.27 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.952 -0.567 . . . . 75.44 109.664 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.57 -94.5 0.13 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.929 -0.653 . . . . 43.25 112.007 -174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.64 -8.2 12.63 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.177 -0.535 . . . . 51.14 113.881 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.459 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 27.3 ptt180 -121.04 133.27 24.12 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 117.573 0.687 . . . . 62.34 112.285 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 2.5 Cg_endo -81.89 128.82 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.143 2.562 . . . . 73.01 113.42 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -111.85 152.49 27.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.457 -0.338 . . . . 73.33 111.07 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 6.6 t -120.15 137.25 54.28 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.584 0.231 . . . . 63.51 110.465 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -131.82 146.14 51.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.75 0.31 . . . . 61.11 111.544 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 96.5 m -60.14 100.22 0.09 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.998 0.427 . . . . 52.22 111.141 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.24 155.29 53.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 64.21 111.359 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.71 107.75 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.372 2.048 . . . . 75.22 113.069 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.621 ' HB3' ' H ' ' A' ' 12' ' ' GLY . 10.7 p-10 -79.12 84.12 5.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.839 0.828 . . . . 74.32 110.81 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.4 m -83.74 84.5 7.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.526 -0.761 . . . . 51.32 112.226 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t -78.76 -145.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.903 -0.589 . . . . 73.44 110.487 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.66 80.84 0.12 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.863 -0.684 . . . . 71.51 112.997 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 51' ' ' CYS . 3.9 pp -155.33 148.59 18.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 122.609 -0.347 . . . . 75.34 111.758 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.94 120.33 3.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.554 2.169 . . . . 52.23 112.533 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.59 16.79 0.45 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.583 0.586 . . . . 61.4 112.583 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -115.21 -18.14 11.2 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.848 0.356 . . . . 74.33 111.735 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 61.6 tp -83.64 105.86 14.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.855 0.36 . . . . 55.44 111.757 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -59.86 160.09 8.14 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.032 -0.531 . . . . 61.22 112.132 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -157.58 144.66 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.331 -0.395 . . . . 53.12 111.963 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.2 128.52 46.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.907 0.384 . . . . 55.4 110.755 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 64' ' ' LEU . . . -90.35 177.52 42.55 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.257 -0.497 . . . . 73.23 113.541 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 m -60.82 -19.26 59.39 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.159 0.429 . . . . 73.14 112.159 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.54 -42.88 64.25 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.511 -0.313 . . . . 52.15 111.282 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.59 -0.27 8.62 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.25 -0.5 . . . . 72.4 113.895 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.27 146.19 27.21 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.218 -0.577 . . . . 65.11 111.891 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.3 m -86.3 108.32 18.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.088 0.471 . . . . 72.31 111.39 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -78.68 160.13 27.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.899 -0.591 . . . . 75.33 111.115 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -57.48 -34.85 69.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.371 0.508 . . . . 63.14 112.371 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.9 p30 -167.66 174.74 7.48 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.855 0.687 . . . . 72.55 112.855 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -46.99 -47.44 21.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.175 -0.92 . . . . 54.43 112.394 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.492 ' HB2' HD11 ' A' ' 33' ' ' LEU . 33.7 t -70.25 -40.24 74.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.058 -0.519 . . . . 62.14 111.028 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -54.25 -40.66 67.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.336 0.588 . . . . 64.51 111.203 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.91 -45.98 83.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.084 -0.507 . . . . 72.24 110.501 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -59.74 -27.54 66.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.138 -0.483 . . . . 72.35 111.765 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.09 -55.87 5.9 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 62.44 111.594 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . . . -53.35 -33.16 52.47 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.129 0.49 . . . . 60.44 111.198 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -48.97 -50.3 36.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.616 -0.72 . . . . 73.22 111.421 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 45.4 t -77.99 -23.54 48.33 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.04 0.448 . . . . 64.22 111.033 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 35.2 mmt180 -78.04 34.85 0.2 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.591 0.589 . . . . 63.45 112.591 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.66 23.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.226 -0.512 . . . . 74.13 114.118 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.403 ' HD2' ' HB1' ' A' ' 56' ' ' ALA . 27.9 m-70 -131.71 74.4 77.78 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.521 0.66 . . . . 74.3 111.055 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.05 -29.37 40.33 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.562 2.175 . . . . 61.12 112.608 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.53 -13.23 60.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.035 -0.53 . . . . 74.42 111.993 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -65.96 112.07 3.64 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.266 0.555 . . . . 72.41 111.948 -171.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -134.59 157.58 46.21 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.095 -0.502 . . . . 70.54 110.691 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.461 HG22 HD13 ' A' ' 53' ' ' LEU . 97.2 t -71.97 127.43 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.56 0.578 . . . . 72.31 112.56 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.4 mtt -94.81 -53.64 3.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.372 -0.377 . . . . 70.53 110.758 171.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -165.23 167.53 17.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.887 0.375 . . . . 74.22 111.568 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -85.8 172.02 11.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.649 0.611 . . . . 74.32 112.649 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.37 -154.22 53.13 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.549 -0.751 . . . . 41.55 113.863 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -70.2 138.78 52.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.847 0.356 . . . . 71.43 111.004 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.62 84.9 2.66 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.259 0.552 . . . . 72.02 110.29 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -88.73 136.43 33.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.923 0.712 . . . . 74.31 112.923 -173.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.693 -0.67 . . . . 54.53 110.536 172.929 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 120.411 0.148 . . . . 70.52 111.007 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.54 71.21 0.68 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.441 0.639 . . . . 73.15 110.478 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -166.04 -170.04 1.63 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.735 0.814 . . . . 73.45 110.485 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 15.1 m -129.6 126.89 39.51 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.144 -0.348 . . . . 75.12 111.014 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.43 112.13 23.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.852 -0.158 . . . . 72.22 111.338 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.95 49.0 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 114.463 0.545 . . . . 73.51 114.463 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 50.7 t -107.09 109.58 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 117.247 0.523 . . . . 64.34 110.887 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -91.5 106.5 18.53 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.349 0.5 . . . . 75.43 112.349 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 94.7 m -148.25 138.38 22.58 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.17 -0.468 . . . . 50.12 110.613 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 -121.27 0.9 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.913 -0.66 . . . . 65.42 113.519 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.39 107.84 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.597 2.198 . . . . 74.42 112.744 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 118.0 -54.96 0.59 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.095 -0.502 . . . . 75.34 112.255 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -135.39 134.95 40.24 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.802 0.334 . . . . 74.24 111.215 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.42 138.95 42.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.825 0.345 . . . . 74.12 110.476 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.595 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 20.2 p -100.15 125.21 46.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.124 0.488 . . . . 74.54 111.277 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -144.16 159.54 42.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 74.53 109.777 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 47.8 mtp -78.97 103.67 9.08 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.682 -0.636 . . . . 72.1 111.957 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.06 141.2 48.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.067 -0.515 . . . . 74.11 110.387 175.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.47 26.29 64.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.819 -0.705 . . . . 55.33 112.743 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.61 84.71 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.515 -0.374 . . . . 71.22 113.824 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -133.79 140.32 36.22 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 117.549 0.674 . . . . 74.32 111.676 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 27.5 Cg_endo -61.2 115.38 2.69 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.455 2.103 . . . . 65.53 113.455 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 35.4 mmt180 -118.05 156.53 28.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.869 0.467 . . . . 74.45 110.93 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 98.6 m -118.18 121.09 39.62 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.877 0.37 . . . . 63.21 111.77 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -133.85 161.36 34.96 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.468 -0.333 . . . . 60.02 111.058 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 37.0 t -55.26 130.15 41.13 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.421 0.897 . . . . 54.44 113.421 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.76 118.53 31.87 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.939 -0.573 . . . . 73.44 111.059 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.91 147.53 68.5 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.311 2.007 . . . . 71.24 112.75 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.41 31.7 0.12 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.35 0.5 . . . . 70.32 112.35 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.597 ' HA ' HD12 ' A' ' 33' ' ' LEU . 24.3 p -90.16 15.34 10.47 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.581 0.956 . . . . 71.54 113.581 -171.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -69.17 75.88 0.35 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.446 0.641 . . . . 52.55 110.527 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.16 6.39 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.034 -0.53 . . . . 63.25 112.97 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 30' ' ' CYS . 67.6 mt -94.42 151.14 39.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 122.474 -0.427 . . . . 72.41 111.467 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.29 119.32 6.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.335 2.023 . . . . 75.32 113.006 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.68 -4.56 53.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.129 0.49 . . . . 55.41 111.57 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -101.07 -1.0 35.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.203 -0.453 . . . . 71.44 112.024 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 58.1 tp -116.73 119.11 34.43 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.218 -0.301 . . . . 72.01 111.775 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -64.32 163.42 13.05 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.165 0.507 . . . . 62.34 112.188 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.581 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 10.0 p -150.51 144.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.019 0.378 . . . . 62.45 112.019 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 95.8 m -100.62 128.79 46.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.977 0.417 . . . . 52.11 111.122 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -101.62 177.65 27.06 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.241 -0.504 . . . . 65.55 113.467 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.9 p -61.88 -14.64 35.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.948 0.404 . . . . 72.23 111.839 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.36 -16.64 61.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.235 -0.439 . . . . 64.12 111.241 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.09 -14.44 62.56 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.435 -0.348 . . . . 74.14 113.494 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.04 153.68 19.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.667 0.617 . . . . 74.11 112.667 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -86.17 145.74 26.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.053 -0.522 . . . . 54.24 110.887 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.58 160.89 21.59 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.552 -0.295 . . . . 73.51 111.302 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 48' ' ' ARG . 1.5 tmm_? -51.39 -43.31 61.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.071 0.548 . . . . 74.22 111.857 -175.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' H ' ' HB3' ' A' ' 52' ' ' GLU . 4.7 p-10 -159.85 177.46 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.894 0.378 . . . . 64.32 111.469 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' HG11 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -57.94 -47.79 81.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.145 0.498 . . . . 72.34 111.453 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.4 t -65.81 -39.57 91.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.548 -0.296 . . . . 72.52 111.055 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.554 ' HB3' ' H ' ' A' ' 49' ' ' ASP . 5.8 tp10 -52.28 -41.17 62.66 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.318 -0.401 . . . . 53.02 111.246 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' HD21 ' A' ' 64' ' ' LEU . 9.7 tt -56.79 -56.01 27.0 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.205 0.526 . . . . 74.33 110.484 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -64.33 -29.55 70.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.118 -0.492 . . . . 74.15 111.211 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.85 71.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.94 0.4 . . . . 52.4 111.158 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.65 89.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 70.52 110.559 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 28.1 ttt180 -55.11 -50.28 69.61 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.523 -0.762 . . . . 63.1 111.808 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 84.9 m -81.0 6.33 13.74 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.223 0.453 . . . . 50.3 112.223 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -106.35 51.69 0.74 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.161 0.505 . . . . 73.25 111.279 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.0 69.54 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.551 0.58 . . . . 73.22 114.551 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 66.4 t60 -135.44 72.93 64.01 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 117.767 0.784 . . . . 54.13 111.721 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 16.6 Cg_exo -69.2 -7.46 20.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.03 2.486 . . . . 73.51 112.844 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -9.19 52.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 73.14 111.825 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' A' ' 41' ' ' GLY . 43.1 tp -85.49 129.05 34.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.002 0.741 . . . . 64.3 113.002 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -127.77 155.43 44.06 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.631 -0.713 . . . . 65.22 110.496 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.88 123.39 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.855 0.359 . . . . 71.35 111.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.6 mmt -100.48 -59.42 1.71 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.037 0.384 . . . . 72.3 112.037 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 53.1 p90 -154.43 145.46 22.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.001 0.429 . . . . 74.41 111.584 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.46 ' HE ' ' HG3' ' A' ' 50' ' ' GLU . 93.1 mtt180 -83.04 110.72 18.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.241 0.543 . . . . 71.33 111.664 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 151.82 179.24 27.31 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.84 -0.618 . . . . 63.44 112.028 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -83.24 140.78 32.32 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.64 -0.329 . . . . 72.12 111.266 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 91.3 m -61.78 104.92 0.49 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.233 0.539 . . . . 71.33 111.783 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -91.17 131.41 36.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 63.51 112.319 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.488 ' HB2' ' NZ ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.639 -0.696 . . . . 71.12 110.95 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.756 0.312 . . . . 71.44 110.375 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -60.26 97.5 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.636 0.732 . . . . 74.0 112.954 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m -152.06 121.97 7.06 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.248 -0.887 . . . . 75.45 109.484 172.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.76 130.45 45.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.049 0.452 . . . . 34.24 111.859 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.543 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 m-20 -69.91 112.16 6.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.182 -0.463 . . . . 75.41 112.239 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.24 37.39 38.4 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.09 0.396 . . . . 35.21 114.09 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -106.61 135.49 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.083 0.468 . . . . 73.41 112.004 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.18 106.64 14.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.096 0.474 . . . . 71.21 111.278 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -124.72 -179.92 4.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.089 -0.505 . . . . 62.01 111.02 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.38 -104.57 0.26 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 120.723 -0.751 . . . . 34.22 113.551 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.95 85.71 0.97 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.543 2.162 . . . . 63.31 113.106 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 102.07 2.74 51.7 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.194 -0.527 . . . . 44.45 113.559 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 48.4 mtmt -135.83 137.59 41.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.495 0.647 . . . . 73.04 112.03 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.04 142.13 49.46 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.719 -0.673 . . . . 43.43 110.072 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 23.2 p -105.5 136.46 45.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.133 0.492 . . . . 72.3 112.112 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -127.86 139.14 52.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.888 -0.597 . . . . 64.12 110.896 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.564 ' SD ' ' HB3' ' A' ' 22' ' ' PRO . 94.2 mmm -76.6 113.43 14.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.854 0.359 . . . . 72.01 111.409 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.795 HD12 ' HD3' ' A' ' 23' ' ' ARG . 88.6 mt -122.74 114.43 20.53 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.12 0.486 . . . . 62.44 111.304 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.65 30.74 75.61 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 116.231 -0.441 . . . . 40.14 113.77 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.25 -15.19 63.75 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 54.14 113.712 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 21' ' ' ARG . 43.0 mtt180 -122.14 137.42 27.47 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 117.25 0.525 . . . . 60.12 111.681 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 93.4 Cg_endo -83.28 145.29 12.02 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.725 2.283 . . . . 71.13 113.657 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.795 ' HD3' HD12 ' A' ' 18' ' ' LEU . 66.6 mtp85 -124.55 132.19 53.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.905 -0.589 . . . . 75.21 110.607 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 14.0 t -102.9 118.85 37.74 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.502 -0.555 . . . . 63.52 109.502 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.09 161.3 35.72 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 62.24 111.828 -171.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 97.5 m -54.26 108.55 0.38 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.137 0.791 . . . . 63.44 113.137 -174.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.72 120.82 56.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 115.889 -0.596 . . . . 65.31 110.754 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 83.3 Cg_endo -81.6 131.25 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.648 2.232 . . . . 75.45 113.535 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.816 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -67.86 82.5 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 116.303 -0.408 . . . . 65.4 111.019 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.8 p -148.96 123.07 9.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.399 0.619 . . . . 43.03 112.163 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -145.65 -53.9 0.28 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.844 -0.617 . . . . 53.3 110.197 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 51.63 1.96 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.176 -0.535 . . . . 73.22 113.385 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -156.64 145.07 14.52 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 122.584 -0.362 . . . . 73.31 110.8 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.94 120.02 4.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.247 1.965 . . . . 72.1 113.705 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.29 38.8 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.495 0.664 . . . . 44.41 110.792 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -129.9 8.05 5.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.819 -0.628 . . . . 73.2 111.551 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 64.9 tp -136.88 127.37 26.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.237 0.215 . . . . 64.21 111.064 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 50.7 mt-30 -66.48 148.27 52.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 74.24 112.047 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 32.6 m -131.15 146.77 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 71.22 111.493 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.5 t -100.9 113.66 26.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.388 -0.369 . . . . 64.41 110.822 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.14 170.37 49.2 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.266 -0.492 . . . . 31.41 114.239 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.9 m -54.9 -26.78 38.2 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.201 0.6 . . . . 70.03 112.111 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.54 -23.79 61.83 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.966 -0.561 . . . . 71.44 111.937 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.45 12.02 54.74 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.477 -0.392 . . . . 73.43 112.652 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.28 141.76 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.721 0.296 . . . . 75.41 111.764 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 m -86.65 107.35 18.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.466 -0.334 . . . . 54.11 111.434 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.01 147.16 24.43 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 110.151 -0.314 . . . . 71.23 110.151 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 39.9 ptt85 -59.83 -25.14 64.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.612 0.597 . . . . 73.51 112.612 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.0 p30 -166.86 172.25 10.53 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.043 0.449 . . . . 63.33 111.646 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 39' ' ' VAL . 29.6 tt0 -69.28 -26.7 64.88 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.147 -0.479 . . . . 74.32 112.135 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 48.6 t -74.72 -39.14 62.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.959 0.409 . . . . 73.21 110.206 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -59.14 -43.83 92.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.216 0.531 . . . . 74.43 110.583 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.59 -51.3 67.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.107 -0.497 . . . . 74.51 110.736 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.816 ' HD3' ' HB2' ' A' ' 29' ' ' ASP . 94.1 mtt180 -70.82 -17.01 62.77 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.32 0.489 . . . . 73.11 112.32 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.18 -34.05 63.66 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.328 0.585 . . . . 72.1 110.154 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.02 -25.62 52.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.701 -0.681 . . . . 75.3 112.091 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 54' ' ' ARG . 16.4 ptt85 -66.5 -20.08 65.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.045 0.45 . . . . 74.15 110.886 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.4 t -72.27 -16.83 61.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.297 0.57 . . . . 60.34 110.634 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -91.66 85.04 5.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.943 -0.571 . . . . 75.44 111.112 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.89 -52.68 4.5 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 114.737 0.655 . . . . 75.14 114.737 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 36.2 m80 -114.58 93.62 33.37 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 117.806 0.803 . . . . 75.24 112.978 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 61' ' ' HIS . 43.6 Cg_endo -67.44 -16.48 47.7 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.556 2.17 . . . . 64.2 112.55 177.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -82.14 0.0 42.84 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.352 0.501 . . . . 75.43 112.352 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.9 tp -57.2 111.97 1.23 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 71.0 110.792 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -115.59 164.2 14.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.262 -0.426 . . . . 44.45 111.339 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.67 127.79 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.095 0.474 . . . . 71.54 111.256 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -78.76 -45.32 21.34 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.307 0.575 . . . . 43.41 110.546 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -159.76 145.47 15.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.832 -0.622 . . . . 64.42 110.766 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.16 99.94 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.348 0.594 . . . . 72.32 110.925 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.53 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 164.57 -176.08 40.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.348 -0.842 . . . . 71.22 111.572 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -80.93 138.26 36.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.162 0.481 . . . . 54.35 111.3 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.9 m -61.9 94.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.208 0.528 . . . . 63.44 112.048 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.04 105.49 15.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.783 -0.644 . . . . 74.33 110.398 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.443 ' HB3' ' NZ ' ' A' ' 74' ' ' LYS . 4.3 ttpm? . . . . . 0 C--O 1.252 1.195 0 CA-C-O 118.696 -0.669 . . . . 61.42 111.072 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.723 0.296 . . . . 75.15 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.71 116.96 26.28 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.844 0.354 . . . . 74.44 111.069 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.5 p -102.31 108.55 19.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.754 0.312 . . . . 42.31 111.251 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.12 130.38 45.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.902 0.382 . . . . 61.3 111.837 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.19 114.85 20.29 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.355 0.502 . . . . 61.35 112.355 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.31 8.2 58.71 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 114.274 0.469 . . . . 72.33 114.274 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.58 109.78 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 O-C-N 122.617 -0.343 . . . . 74.23 110.741 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.85 108.96 16.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.98 0.419 . . . . 41.5 111.315 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -148.76 138.49 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.285 0.564 . . . . 51.02 111.341 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.44 -60.92 0.09 OUTLIER Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.616 -0.72 . . . . 40.4 111.625 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.51 90.35 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.474 2.116 . . . . 53.02 112.322 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 88.68 -5.69 84.38 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.19 -0.529 . . . . 74.33 114.051 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 49.6 mtmt -141.14 138.05 33.17 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.583 0.691 . . . . 72.03 112.202 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.84 140.11 50.51 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.145 -0.479 . . . . 75.14 110.005 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.3 t -98.33 135.74 39.5 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.099 0.476 . . . . 75.11 111.774 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 16' ' ' ARG . 12.5 ptm180 -142.62 137.03 29.73 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.824 -0.626 . . . . 64.41 110.808 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.9 mmm -76.46 104.55 7.03 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.009 0.433 . . . . 75.42 111.801 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 112.6 23.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.856 0.36 . . . . 61.43 111.02 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.05 31.7 72.51 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.448 -0.406 . . . . 30.33 112.882 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.81 -4.55 60.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.179 -0.534 . . . . 73.23 112.859 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -113.1 129.52 24.46 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.589 0.356 . . . . 42.15 111.053 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 115.52 4.28 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.493 2.129 . . . . 64.32 113.121 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -111.57 132.47 54.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.46 -0.336 . . . . 65.21 111.373 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 13' ' ' LYS . 87.0 m -103.28 119.98 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.993 0.425 . . . . 73.04 110.588 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -102.04 145.14 29.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.587 . . . . 73.22 110.006 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 20.4 p -80.48 123.2 27.87 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.142 0.496 . . . . 44.24 111.91 -175.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.05 134.28 24.03 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 52.04 110.962 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.71 152.33 47.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.411 2.074 . . . . 54.11 112.891 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -78.35 41.49 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.196 0.522 . . . . 73.1 111.483 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.758 ' HA ' HD21 ' A' ' 33' ' ' LEU . 25.1 p -77.49 89.79 3.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.189 0.519 . . . . 70.43 111.908 -174.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.3 t -138.79 132.49 30.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.954 -0.567 . . . . 63.2 110.857 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.35 39.42 51.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.187 -0.53 . . . . 73.54 112.9 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 30' ' ' CYS . 3.2 pp -151.8 163.6 23.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 122.7 0.4 . . . . 74.33 110.726 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 84.5 Cg_exo -49.9 118.96 4.26 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.526 2.151 . . . . 63.54 114.336 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.89 -10.43 14.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.678 -0.692 . . . . 75.13 110.818 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -125.55 -22.47 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 63.24 111.313 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 3.7 tt -90.19 119.83 30.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.767 0.318 . . . . 72.45 110.312 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 52.4 mt-30 -63.74 148.82 48.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.313 0.486 . . . . 64.12 112.313 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 34.0 m -129.81 151.91 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.213 0.53 . . . . 72.02 112.052 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.71 113.67 26.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.946 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.64 162.19 32.84 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.262 -0.494 . . . . 73.25 113.789 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.9 p -65.97 -9.43 29.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.336 0.495 . . . . 72.42 112.336 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' HD13 ' A' ' 64' ' ' LEU . 14.6 t70 -81.19 -4.98 57.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.149 0.5 . . . . 71.15 110.923 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 13.23 66.48 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.4 -0.429 . . . . 63.02 113.266 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.76 148.23 41.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.854 0.359 . . . . 74.34 111.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.687 HG21 ' HG2' ' A' ' 71' ' ' ARG . 69.7 m -99.62 116.57 32.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.959 0.409 . . . . 53.22 111.209 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -96.66 156.88 16.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.414 -0.357 . . . . 64.33 111.664 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 78.9 mtm180 -56.96 -32.88 66.48 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.518 0.562 . . . . 74.33 112.518 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -162.97 176.43 10.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.213 -0.449 . . . . 61.13 110.031 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.652 ' HB3' HD13 ' A' ' 33' ' ' LEU . 32.7 tt0 -74.99 -30.89 61.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.279 -0.569 . . . . 70.31 111.599 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 t -65.4 -37.41 86.88 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.834 -0.541 . . . . 63.22 109.806 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.56 -52.89 63.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.543 -0.753 . . . . 74.24 110.421 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.26 -52.03 54.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.034 -0.984 . . . . 73.43 111.675 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 41.4 mtp85 -70.46 -27.17 64.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.841 -0.618 . . . . 75.34 111.657 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.11 -49.27 62.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.188 0.518 . . . . 31.41 110.67 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.83 -32.01 71.4 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.078 -0.51 . . . . 74.43 110.969 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -58.37 -51.63 69.0 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.944 -0.571 . . . . 72.54 110.921 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 32.2 t -71.78 -31.74 66.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.746 0.308 . . . . 71.25 111.432 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -60.14 -50.5 73.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.401 0.519 . . . . 74.24 112.401 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.49 16.78 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.993 -1.098 . . . . 65.54 114.959 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.0 m-70 -135.69 75.16 57.16 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 117.806 0.803 . . . . 72.34 111.564 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.64 -23.18 74.59 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.358 2.038 . . . . 63.2 113.273 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.3 -14.26 47.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.008 0.373 . . . . 74.03 112.008 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 43' ' ' ASP . 55.0 tp -64.4 112.36 3.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.2 0.524 . . . . 73.34 112.144 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.1 m -132.73 162.04 32.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.486 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.31 129.98 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.172 0.511 . . . . 74.44 111.788 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 69.5 mtm -85.27 -55.33 4.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.277 0.56 . . . . 70.15 110.166 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.508 ' HE2' ' H ' ' A' ' 73' ' ' ARG . 16.6 p90 -151.5 140.03 20.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.714 -0.676 . . . . 74.21 110.743 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.51 125.52 29.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.272 0.558 . . . . 70.3 111.543 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.511 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 124.56 161.57 11.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.35 -0.841 . . . . 60.44 111.139 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.687 ' HG2' HG21 ' A' ' 46' ' ' THR . 65.4 mtt180 -63.14 138.82 58.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.747 0.774 . . . . 75.32 111.082 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.5 m -48.28 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.626 0.602 . . . . 62.02 112.626 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.508 ' H ' ' HE2' ' A' ' 68' ' ' TYR . 11.9 ptp180 -117.64 128.03 54.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.32 111.217 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 C--O 1.258 1.545 0 N-CA-C 112.497 0.554 . . . . 72.12 112.497 176.422 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.741 0.305 . . . . 51.54 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -101.41 151.79 21.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.327 0.585 . . . . 33.22 112.52 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.1 p -147.49 154.17 40.43 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.753 -0.658 . . . . 63.25 110.655 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 p -140.43 130.91 25.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.764 0.316 . . . . 63.24 111.794 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.66 114.15 22.42 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.154 0.502 . . . . 72.24 112.329 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.87 27.21 66.45 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.987 0.755 . . . . 61.33 114.987 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.524 HG12 ' SG ' ' A' ' 9' ' ' CYS . 49.9 t -107.15 126.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 117.358 0.579 . . . . 74.14 111.588 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 10.5 pt-20 -79.0 105.93 10.69 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.407 0.622 . . . . 75.32 111.664 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.524 ' SG ' HG12 ' A' ' 7' ' ' VAL . 58.7 m -149.61 155.99 41.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.101 -0.374 . . . . 64.41 111.42 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.7 -65.24 0.31 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.942 -0.647 . . . . 71.35 113.009 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.14 90.53 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.66 2.24 . . . . 71.31 112.83 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.31 0.78 84.48 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.053 -0.594 . . . . 70.04 113.634 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.32 136.04 41.26 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.0 -0.706 . . . . 74.11 111.964 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.27 143.95 41.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.076 -0.511 . . . . 74.21 110.353 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.698 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 30.9 p -101.88 128.52 48.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.79 0.663 . . . . 74.2 112.79 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -138.52 145.62 40.96 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.558 -0.746 . . . . 75.42 110.417 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 74.1 mtp -91.12 112.16 23.95 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.947 0.404 . . . . 44.01 111.8 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 18' ' ' LEU . 6.0 mp -103.09 112.19 24.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.243 -0.435 . . . . 40.05 110.634 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 36.11 58.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.375 -0.44 . . . . 72.52 113.861 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.28 70.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.168 -0.539 . . . . 52.14 113.51 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.6 111.26 63.66 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 117.346 0.573 . . . . 72.13 111.771 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.502 ' HB2' HG21 ' A' ' 7' ' ' VAL . 58.7 Cg_endo -71.86 106.99 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.218 1.945 . . . . 74.23 112.269 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -117.79 149.2 41.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.904 0.383 . . . . 75.42 111.534 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 91.2 m -129.0 125.55 37.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.017 0.437 . . . . 64.24 111.487 177.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -119.99 161.54 20.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.528 -0.305 . . . . 75.15 110.188 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.86 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.35 0.595 . . . . 64.44 111.072 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 120.0 60.27 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.479 -0.782 . . . . 32.42 110.493 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 11.0 Cg_endo -52.17 117.62 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.5 2.134 . . . . 60.03 112.499 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.66 36.22 0.13 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.233 0.539 . . . . 73.24 111.623 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 47.6 m -65.51 101.89 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.978 -0.556 . . . . 73.54 111.587 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -129.34 92.32 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 62.04 110.243 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.78 7.35 17.83 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.054 -0.521 . . . . 71.32 112.858 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.403 HD11 HH11 ' A' ' 54' ' ' ARG . 83.9 mt -100.83 114.89 65.84 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.619 -0.342 . . . . 73.45 111.142 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.63 153.09 26.34 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.761 2.308 . . . . 74.44 113.531 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.26 163.16 26.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.156 -0.475 . . . . 71.31 111.2 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 69.33 -15.2 0.29 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.793 0.664 . . . . 71.42 112.793 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 1.1 tm? -72.23 88.01 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.477 -0.564 . . . . 73.51 109.477 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.496 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 98.1 mt-30 -71.24 142.11 50.58 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.775 0.657 . . . . 75.44 112.775 -175.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 69' ' ' ARG . 33.4 m -137.02 157.28 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.819 -0.628 . . . . 64.13 111.003 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 90.7 m -101.12 132.01 46.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.89 -0.506 . . . . 65.3 111.839 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -82.85 173.5 52.46 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.918 -0.583 . . . . 64.31 113.422 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -64.38 -11.17 30.08 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.544 0.572 . . . . 43.11 112.544 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -87.17 -26.87 23.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.859 0.361 . . . . 73.23 111.094 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.26 -0.36 20.73 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.316 -0.469 . . . . 73.21 113.924 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.5 152.09 19.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.344 0.572 . . . . 74.42 112.268 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.8 m -90.91 120.08 31.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.051 -0.522 . . . . 73.11 111.975 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -87.49 140.64 29.33 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.283 -0.417 . . . . 75.24 110.814 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 18.0 ptp180 -59.65 -15.55 19.95 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.001 0.741 . . . . 73.41 113.001 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.5 p30 -167.26 160.68 13.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.556 0.343 . . . . 71.43 110.91 172.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -64.04 -30.83 71.87 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.088 0.403 . . . . 72.54 112.088 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.26 -33.99 72.26 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.031 0.444 . . . . 73.34 110.683 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -56.48 -50.9 70.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.985 -0.552 . . . . 75.4 110.662 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.574 HD11 ' HA2' ' A' ' 41' ' ' GLY . 6.5 tt -63.08 -46.7 86.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.818 -0.628 . . . . 54.32 110.328 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HD3' ' SG ' ' A' ' 30' ' ' CYS . 16.8 ttt180 -55.39 -33.69 63.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.832 -0.622 . . . . 73.24 111.288 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.11 -31.68 23.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.059 -0.519 . . . . 75.05 111.655 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.08 71.11 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.191 0.441 . . . . 71.02 112.191 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.57 -34.01 64.39 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.242 0.544 . . . . 75.12 111.45 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.3 m -88.66 14.16 10.67 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.434 0.531 . . . . 63.14 112.434 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -98.27 8.24 45.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.058 0.392 . . . . 75.52 112.058 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.1 0.81 5.05 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.756 -0.735 . . . . 72.35 114.429 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -133.98 88.53 31.75 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 117.655 0.727 . . . . 72.21 112.132 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.94 -20.92 69.27 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.505 2.136 . . . . 75.32 111.59 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -20.95 58.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.947 -1.024 . . . . 73.12 112.436 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.81 111.57 3.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.287 0.565 . . . . 63.13 111.653 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -129.67 163.48 26.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.0 -0.546 . . . . 74.31 111.242 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.84 126.28 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.106 0.479 . . . . 61.34 111.394 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 72.1 mtm -80.33 -43.79 20.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.006 0.373 . . . . 73.12 112.006 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 44.0 p90 -164.19 155.83 16.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.949 0.404 . . . . 74.13 111.876 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.676 ' HA ' HG12 ' A' ' 39' ' ' VAL . 8.6 mpt_? -80.5 104.87 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.168 0.509 . . . . 70.45 111.243 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.92 170.43 16.63 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 116.061 -0.518 . . . . 65.25 112.192 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -75.57 149.98 38.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.866 0.365 . . . . 74.3 111.424 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 71.5 m -58.77 113.78 2.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.113 -0.494 . . . . 52.32 111.934 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -97.85 143.62 28.27 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.706 -0.679 . . . . 74.13 112.131 -176.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 C--O 1.253 1.269 0 CA-C-O 118.67 -0.681 . . . . 62.02 110.816 172.875 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.924 0.393 . . . . 54.43 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 156.12 36.75 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.968 0.413 . . . . 60.43 111.614 175.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 p -94.69 120.12 34.41 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.106 0.41 . . . . 73.4 112.106 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.4 m -105.85 127.95 53.44 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.849 0.357 . . . . 73.3 111.605 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.646 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 11.5 m-20 -87.64 111.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.183 -0.323 . . . . 62.42 110.4 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.8 -39.78 0.79 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 121.004 -0.617 . . . . 53.14 114.016 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 10.7 t -66.08 146.28 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.962 0.505 . . . . 74.35 111.62 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -102.71 105.3 15.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.486 0.66 . . . . 75.24 110.218 177.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.632 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 97.9 m -149.52 179.41 7.99 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.502 0.556 . . . . 74.31 112.502 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.03 -67.54 0.56 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.259 -0.736 . . . . 63.01 111.259 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -93.01 131.1 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 73.21 111.96 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.37 -35.78 1.99 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.008 -0.615 . . . . 44.23 114.268 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HE3' ' SG ' ' A' ' 9' ' ' CYS . 48.5 mtmt -131.38 145.95 52.05 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.254 0.527 . . . . 74.21 111.286 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -122.09 132.04 54.28 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.455 -0.339 . . . . 74.42 110.634 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.2 p -100.12 121.83 42.02 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.479 0.657 . . . . 73.5 111.584 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -123.88 163.56 21.03 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.835 -0.62 . . . . 73.31 111.265 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -80.9 110.74 16.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.249 0.462 . . . . 74.42 112.249 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.699 HD22 ' HD2' ' A' ' 23' ' ' ARG . 6.8 mp -115.48 102.72 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.825 -0.435 . . . . 74.23 109.825 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.51 27.94 72.49 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.132 -0.556 . . . . 54.22 112.57 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.95 -16.62 56.51 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.483 -0.389 . . . . 64.54 113.633 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -93.11 137.25 23.77 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 122.321 -0.517 . . . . 72.13 111.804 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.646 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 90.4 Cg_endo -77.95 101.85 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.918 2.412 . . . . 45.33 113.409 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.699 ' HD2' HD22 ' A' ' 18' ' ' LEU . 53.9 mtt-85 -105.7 139.03 40.91 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.132 -0.321 . . . . 71.35 110.132 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 17.8 m -103.36 144.3 31.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 74.23 112.118 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' ' HD3' ' A' ' 16' ' ' ARG . 48.4 mt-10 -129.03 158.23 39.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 65.23 110.636 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.0 p -62.82 99.83 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.149 0.499 . . . . 63.52 112.278 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.82 125.59 41.68 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.874 -0.603 . . . . 71.22 111.45 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.9 Cg_exo -78.28 111.8 3.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.865 2.377 . . . . 65.5 112.848 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.36 94.22 0.16 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.788 0.328 . . . . 71.41 110.298 173.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.1 p -130.35 22.63 5.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.494 0.924 . . . . 63.55 113.494 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.1 p -70.93 -23.82 62.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.53 0.681 . . . . 63.42 109.965 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.61 27.83 14.08 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.56 -0.745 . . . . 31.42 113.017 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 78.6 mt -124.44 148.22 57.73 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 116.719 0.259 . . . . 52.12 111.688 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 13.6 Cg_exo -70.72 120.27 6.96 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.671 2.247 . . . . 73.13 112.629 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.28 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.992 0.367 . . . . 44.12 111.992 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -93.5 1.52 56.74 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.979 0.363 . . . . 72.11 111.979 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.3 mt -118.35 114.09 22.42 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.072 0.397 . . . . 71.2 112.072 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -67.34 146.75 53.78 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.503 -0.317 . . . . 71.33 110.375 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 69' ' ' ARG . 32.6 m -129.51 149.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.96 0.409 . . . . 71.33 111.603 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 61.3 m -100.53 128.58 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.385 -0.37 . . . . 70.31 110.796 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.516 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -72.89 164.3 54.88 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.253 -0.499 . . . . 43.41 113.068 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 t -58.97 -16.97 20.54 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.079 0.399 . . . . 71.54 112.079 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -82.11 -38.73 24.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.902 0.382 . . . . 74.03 110.931 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 -3.52 4.99 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.365 -0.445 . . . . 73.3 113.842 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.58 142.74 29.76 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.465 0.543 . . . . 62.54 112.465 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.583 HG21 ' HG3' ' A' ' 71' ' ' ARG . 32.1 m -90.19 113.12 24.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.446 -0.343 . . . . 54.12 111.478 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -97.62 167.59 10.87 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 71.5 111.745 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -44.2 87.21 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.647 0.61 . . . . 71.13 112.647 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -169.06 -179.29 3.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.63 0.252 . . . . 63.21 111.631 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -64.73 -36.22 83.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.752 0.31 . . . . 74.13 111.698 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 17.5 t -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.117 0.484 . . . . 64.24 109.974 174.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -56.92 -44.11 82.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.644 -0.707 . . . . 74.12 111.377 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.563 ' HG ' HG22 ' A' ' 66' ' ' VAL . 1.5 tm? -59.37 -50.05 75.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.735 0.302 . . . . 73.23 110.877 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -56.51 -41.83 77.36 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.867 0.365 . . . . 42.23 111.283 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -39.53 94.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.027 0.441 . . . . 54.12 110.741 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.786 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -66.24 -22.03 66.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 72.04 112.499 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -65.55 -47.31 76.29 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.542 0.687 . . . . 72.22 110.107 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.19 -30.59 65.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.464 0.649 . . . . 73.13 110.679 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.786 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 23.2 ttt180 -82.78 83.63 7.64 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.279 -0.873 . . . . 74.41 111.385 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . 88.72 -54.01 4.06 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 114.798 0.679 . . . . 73.11 114.798 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -115.04 90.94 25.04 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 113.673 0.99 . . . . 65.22 113.673 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 32.0 Cg_exo -61.71 -22.22 73.91 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.845 2.363 . . . . 71.33 113.072 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.05 -2.79 49.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.364 -0.38 . . . . 72.53 111.844 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.516 HD11 ' HA3' ' A' ' 41' ' ' GLY . 24.3 tp -77.71 118.08 19.74 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.554 0.576 . . . . 63.43 112.554 -172.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -125.87 164.63 20.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.856 -0.611 . . . . 60.44 110.607 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.563 HG22 ' HG ' ' A' ' 53' ' ' LEU . 44.0 t -80.13 128.57 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.955 0.354 . . . . 73.35 111.955 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 61.7 mtt -74.36 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.448 0.642 . . . . 72.3 110.273 171.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.45 161.17 24.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.409 -0.814 . . . . 75.51 110.841 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HA ' HG12 ' A' ' 39' ' ' VAL . 78.0 mtt180 -81.62 107.36 14.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.259 0.552 . . . . 61.14 110.655 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.32 143.91 3.79 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.688 -0.687 . . . . 73.13 112.076 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.583 ' HG3' HG21 ' A' ' 46' ' ' THR . 65.2 ttt180 -72.36 74.91 1.02 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.814 0.34 . . . . 73.41 111.819 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 85.7 m 34.84 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.747 1.017 . . . . 71.41 113.747 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -84.77 105.93 15.92 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.038 0.447 . . . . 75.23 110.905 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt . . . . . 0 C--O 1.251 1.137 0 CA-C-O 119.206 -0.426 . . . . 74.45 111.837 -176.732 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.592 0.234 . . . . 62.41 110.701 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -74.93 91.17 2.46 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.158 0.504 . . . . 62.24 111.573 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p -104.04 122.92 46.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.152 -0.476 . . . . 63.52 109.831 173.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 39.4 m -98.22 127.4 44.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 65.41 111.392 -173.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.501 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 13.3 t70 -85.77 111.1 19.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.455 . . . . 70.33 110.879 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 -23.01 0.3 Allowed Glycine 0 CA--C 1.535 1.285 0 N-CA-C 114.421 0.528 . . . . 73.15 114.421 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 23.6 t -73.98 125.32 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 117.043 0.421 . . . . 72.12 111.849 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -115.05 110.01 18.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.168 0.508 . . . . 62.41 111.895 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.3 m -149.1 139.24 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.492 -0.322 . . . . 74.44 110.878 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.19 -76.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.917 -0.658 . . . . 75.21 112.972 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.67 130.49 12.65 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.45 2.1 . . . . 62.44 112.692 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.34 -49.2 3.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.928 -0.653 . . . . 51.2 112.997 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -121.63 135.7 54.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.902 0.382 . . . . 74.3 111.433 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.92 145.57 41.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.784 -0.45 . . . . 62.43 109.784 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 31.9 p -99.08 113.38 25.56 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.41 0.624 . . . . 45.43 111.286 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -112.25 149.39 32.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.765 -0.652 . . . . 73.12 111.214 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.6 mtp -88.97 107.57 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 74.11 111.488 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.509 HD23 ' HG2' ' A' ' 23' ' ' ARG . 3.3 mm? -116.16 103.07 10.17 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.479 -0.328 . . . . 74.23 110.384 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.45 62.46 5.08 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 64.31 113.525 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.21 -46.4 3.39 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.203 -0.522 . . . . 64.33 113.953 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 21' ' ' ARG . 4.8 mpt_? -92.77 125.81 54.06 Favored Pre-proline 0 CA--C 1.541 0.611 0 O-C-N 122.328 -0.513 . . . . 70.05 111.969 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 96.5 Cg_endo -79.91 110.3 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.648 2.232 . . . . 73.33 112.094 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 33.6 ptt180 -99.11 158.28 15.78 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.164 -0.335 . . . . 73.32 111.079 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' CG1' ' A' ' 7' ' ' VAL . 78.2 m -103.14 120.69 41.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.081 0.467 . . . . 55.31 110.823 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.68 142.86 50.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.978 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' SG ' ' NH1' ' A' ' 59' ' ' ARG . 25.7 p -58.6 105.04 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.223 0.535 . . . . 73.35 111.562 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 135.9 19.35 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 51.22 111.174 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.906 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 74.2 Cg_endo -72.56 120.55 6.78 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.288 1.992 . . . . 63.42 112.486 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.6 -28.2 68.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.265 -0.425 . . . . 64.14 111.815 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HA ' HD11 ' A' ' 33' ' ' LEU . 79.2 m 73.4 -39.91 0.45 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.649 0.78 . . . . 61.13 112.609 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -54.12 112.62 1.0 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.109 -0.369 . . . . 72.44 111.797 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.07 -13.38 11.31 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.503 -0.38 . . . . 75.52 113.469 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 30' ' ' CYS . 2.5 pp -139.77 164.71 36.2 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 122.403 -0.469 . . . . 75.21 111.509 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 53.7 Cg_exo -53.96 119.61 6.56 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.548 2.165 . . . . 74.11 113.446 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.65 18.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.234 -0.439 . . . . 73.21 112.04 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.59 -39.08 3.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.849 0.315 . . . . 73.13 111.849 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -64.8 118.93 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.874 0.368 . . . . 62.34 110.671 -176.109 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.39 162.89 2.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.648 0.61 . . . . 64.31 112.648 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 66' ' ' VAL . 31.3 m -143.84 147.5 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.863 -0.608 . . . . 62.1 110.471 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.3 t -103.64 126.82 51.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.947 0.403 . . . . 72.22 110.829 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.47 165.52 44.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.257 -0.497 . . . . 62.04 113.686 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.2 m -50.61 -28.36 8.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.63 0.604 . . . . 65.5 112.63 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.82 -34.04 75.96 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.086 0.47 . . . . 73.05 111.947 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.31 -10.0 24.42 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.374 -0.441 . . . . 71.54 112.236 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.83 134.71 38.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.072 0.463 . . . . 70.02 111.621 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.0 m -86.66 112.6 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.332 -0.395 . . . . 71.54 111.337 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.66 160.95 16.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.796 0.332 . . . . 64.31 111.671 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -61.47 -40.32 94.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.142 -0.481 . . . . 71.41 111.783 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -165.91 174.52 9.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.058 -0.519 . . . . 74.2 110.552 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HA ' HG21 ' A' ' 39' ' ' VAL . 29.5 tt0 -71.74 -27.88 63.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.899 0.381 . . . . 70.4 111.498 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.906 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 9.1 t -67.56 -39.87 84.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.948 0.404 . . . . 75.31 110.262 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.42 -46.45 88.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.099 -0.5 . . . . 73.53 110.82 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -56.74 -42.2 78.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.377 -0.374 . . . . 72.21 110.739 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' A' ' 28' ' ' PRO . 29.6 ttt180 -57.16 -40.29 76.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.102 0.477 . . . . 75.23 110.899 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 59' ' ' ARG . . . -65.41 -50.41 65.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.283 -0.417 . . . . 64.42 111.019 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.35 -38.45 66.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.989 0.424 . . . . 63.2 111.728 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -52.9 -46.64 68.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.158 -0.474 . . . . 73.04 111.022 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.7 t -77.1 -34.01 56.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.349 0.5 . . . . 65.21 112.349 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 55' ' ' ALA . 37.8 mmt180 -58.33 -48.51 80.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.722 0.296 . . . . 75.14 111.555 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.14 32.31 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.221 -0.99 . . . . 73.13 114.26 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -132.39 81.93 59.06 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 117.216 0.508 . . . . 62.22 111.015 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.32 -34.8 26.06 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.614 2.209 . . . . 63.34 112.778 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.47 -11.59 60.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 111.978 0.362 . . . . 71.52 111.978 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.7 tp -77.21 110.35 11.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.518 0.562 . . . . 54.45 112.518 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -123.92 161.08 26.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.14 110.323 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 39' ' ' VAL . 2.7 p -88.34 111.3 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.001 0.429 . . . . 61.2 111.628 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.9 mtt -63.59 -58.82 5.75 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.112 0.482 . . . . 73.44 110.659 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.2 172.56 17.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.886 -0.597 . . . . 73.15 110.361 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 9.9 mpt_? -78.9 158.65 28.02 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.214 0.53 . . . . 74.04 111.564 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.4 54.72 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.951 -0.568 . . . . 75.23 112.562 -174.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -83.61 158.28 21.95 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.541 -0.387 . . . . 63.55 111.567 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.8 m -67.01 98.16 0.55 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.158 0.504 . . . . 62.15 111.078 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -94.94 123.32 38.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.993 -0.549 . . . . 74.12 111.046 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.8 pttt . . . . . 0 C--O 1.255 1.393 0 CA-C-O 118.244 -0.884 . . . . 62.32 112.016 -178.719 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.853 0.358 . . . . 70.03 111.203 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.75 132.68 43.16 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.835 0.35 . . . . 71.12 111.623 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 t -128.58 134.25 48.56 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.436 -0.347 . . . . 32.32 111.105 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.573 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 24.0 m -124.93 128.32 48.43 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.852 0.358 . . . . 62.41 111.956 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -87.42 110.66 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.442 -0.345 . . . . 72.25 110.429 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.26 -32.21 0.32 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.501 0.56 . . . . 72.12 114.501 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 38.5 t -65.61 131.7 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 117.194 0.497 . . . . 73.32 111.976 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -76.57 105.34 7.57 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.95 0.405 . . . . 54.12 111.648 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.543 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 65.7 m -138.3 179.49 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.932 0.396 . . . . 65.3 111.206 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.23 -85.3 0.39 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.161 -0.542 . . . . 70.51 112.574 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -61.23 92.13 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.358 2.038 . . . . 71.2 112.431 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.97 23.88 72.91 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 115.976 -0.556 . . . . 71.0 114.003 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.656 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.1 mtmt -144.26 146.66 32.77 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.655 0.728 . . . . 75.22 112.957 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.35 149.18 40.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.369 -0.832 . . . . 70.11 110.163 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 26.6 p -112.44 142.59 44.79 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.328 0.585 . . . . 73.11 112.499 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 15.2 mmt180 -129.1 163.22 25.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.974 -0.557 . . . . 74.41 111.332 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.7 mmm -85.68 102.33 13.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.964 0.411 . . . . 74.44 111.247 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.4 110.44 22.41 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.04 0.447 . . . . 45.34 110.536 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.85 71.75 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.133 -0.556 . . . . 52.55 113.188 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.36 -4.77 84.28 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.255 -0.497 . . . . 50.25 113.243 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 21' ' ' ARG . 9.1 mpt_? -114.97 126.24 28.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 122.383 -0.48 . . . . 74.22 111.361 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 70.9 Cg_endo -74.0 113.85 3.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.471 2.114 . . . . 72.11 112.901 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -120.77 152.28 38.52 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.121 -0.362 . . . . 64.03 110.941 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 2.0 t -103.41 140.05 37.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.633 0.605 . . . . 74.3 112.633 -169.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.54 160.51 33.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.679 -0.691 . . . . 73.03 109.874 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 p -76.16 140.7 41.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.028 0.442 . . . . 64.43 111.393 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -118.88 125.17 27.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.262 -0.426 . . . . 62.3 111.51 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 6.0 Cg_exo -79.59 24.45 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.269 2.646 . . . . 73.13 114.241 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 54.1 40.25 31.46 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.025 0.44 . . . . 71.32 111.859 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.462 ' HA ' HD21 ' A' ' 33' ' ' LEU . 27.3 m -70.4 88.64 0.66 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.217 0.532 . . . . 73.0 112.254 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.8 t -150.93 137.63 18.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.727 -0.67 . . . . 61.44 110.445 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 -50.32 4.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.04 -0.6 . . . . 61.14 113.367 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' ' 50' ' ' GLU . 1.8 pt? -66.98 151.87 96.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.821 -0.223 . . . . 73.22 111.304 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.45 119.3 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 74.04 112.912 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.85 8.99 11.19 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 73.23 111.373 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -129.26 15.12 6.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.119 0.485 . . . . 72.42 110.792 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 5.7 tt -125.64 125.4 43.05 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.07 -0.514 . . . . 72.42 110.025 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -63.55 147.73 50.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.897 0.702 . . . . 54.31 112.897 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 50' ' ' GLU . 35.4 m -138.62 146.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.301 -0.408 . . . . 72.24 110.676 176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 17.2 t -105.21 131.53 52.56 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.106 0.479 . . . . 74.51 111.853 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.91 177.82 40.31 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.127 -0.488 . . . . 63.45 114.015 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.1 m -55.29 -27.79 49.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.695 0.628 . . . . 63.31 112.695 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.87 8.0 11.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.43 0.53 . . . . 71.13 112.43 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.052 -0.594 . . . . 53.21 112.68 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 125.15 36.25 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.502 0.321 . . . . 52.54 111.072 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 61.7 m -91.38 104.91 17.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.161 0.505 . . . . 74.14 111.161 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -80.48 157.82 26.06 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.531 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 63.4 mtt180 -53.32 -33.43 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.66 0.615 . . . . 73.25 112.66 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.4 p30 -170.92 173.16 5.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.939 0.399 . . . . 50.52 111.54 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' HD12 ' A' ' 33' ' ' LEU . 11.8 tp10 -58.08 -43.6 87.1 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.07 -0.514 . . . . 73.24 111.63 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.55 -39.95 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.973 0.416 . . . . 71.24 110.599 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE1' ' HD2' ' A' ' 48' ' ' ARG . 7.5 tp10 -63.25 -44.27 95.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.826 -0.624 . . . . 75.13 110.866 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.94 -51.66 68.33 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.809 -0.632 . . . . 51.4 111.269 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.26 -33.27 75.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.714 0.292 . . . . 73.12 111.74 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.41 65.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.043 0.449 . . . . 74.2 110.689 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.2 76.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.982 0.42 . . . . 54.05 111.187 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -60.64 -50.24 74.28 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.079 -0.51 . . . . 74.52 110.404 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.77 -35.47 80.15 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.113 -0.494 . . . . 62.22 111.749 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -59.55 -58.68 7.53 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.506 -0.315 . . . . 74.11 111.575 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.44 24.92 0.19 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.543 -0.837 . . . . 74.23 114.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 42.2 m170 -122.38 78.81 45.35 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 122.139 -0.624 . . . . 73.53 111.144 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.51 -43.49 33.01 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.756 2.304 . . . . 70.34 113.552 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.53 2.82 39.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.57 0.581 . . . . 74.31 112.57 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 66.4 tp -76.64 127.43 32.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.015 0.436 . . . . 75.11 111.975 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -142.64 152.16 42.18 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.59 -0.277 . . . . 54.0 110.696 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -81.39 124.73 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.135 0.493 . . . . 52.15 111.748 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.36 -49.64 9.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.11 0.481 . . . . 72.34 110.783 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -159.84 164.29 33.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.916 -0.583 . . . . 73.3 111.258 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 39' ' ' VAL . 49.5 mtm180 -76.8 135.62 38.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 65.23 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.86 -172.88 20.4 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.271 -0.49 . . . . 65.14 112.71 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -86.72 149.34 24.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.56 -0.377 . . . . 75.44 111.675 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 35.3 m -66.08 83.78 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.622 0.725 . . . . 43.41 111.159 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -77.2 140.28 40.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.16 -0.927 . . . . 75.33 111.812 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--O 1.252 1.21 0 CA-C-N 115.919 -0.582 . . . . 73.24 110.565 176.764 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.795 0.331 . . . . 44.15 111.651 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -142.9 102.76 4.08 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.626 0.727 . . . . 74.22 112.332 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.412 ' H ' ' HG2' ' A' ' 17' ' ' MET . 58.8 m -157.09 166.31 33.64 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.826 0.85 . . . . 53.14 109.453 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.5 m -135.87 127.68 29.26 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.927 -0.483 . . . . 72.01 111.987 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 7' ' ' VAL . 29.0 t70 -86.67 111.42 20.65 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.676 0.25 . . . . 71.11 111.676 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 48.65 30.93 9.13 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 114.564 0.586 . . . . 72.14 114.564 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 5' ' ' ASP . 89.1 t -106.74 122.47 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 117.337 0.568 . . . . 74.15 111.77 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -92.07 106.73 18.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.612 -0.267 . . . . 72.11 111.202 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 96.1 m -148.84 138.54 21.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.648 0.261 . . . . 73.04 111.348 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.98 -141.42 4.33 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 120.894 -0.67 . . . . 41.1 113.932 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 -13.5 5.58 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.357 2.705 . . . . 72.24 114.81 -173.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.8 -30.17 9.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.99 -0.624 . . . . 53.33 113.155 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.7 mtmt -148.5 136.31 20.77 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.609 -0.347 . . . . 54.53 111.228 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.16 136.07 48.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.577 -0.283 . . . . 44.32 110.634 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.798 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 7.2 p -99.79 122.08 42.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.141 0.496 . . . . 62.02 111.714 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -119.95 158.84 25.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.144 -0.48 . . . . 75.54 111.345 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.412 ' HG2' ' H ' ' A' ' 3' ' ' SER . 3.8 mmt -79.73 102.62 9.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.468 -0.333 . . . . 73.21 111.597 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.578 HD13 ' HB2' ' A' ' 23' ' ' ARG . 6.6 mp -110.77 112.99 25.24 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.929 0.395 . . . . 42.11 110.118 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.39 29.84 75.77 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.84 -0.695 . . . . 71.21 112.252 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -0.12 69.17 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.522 -0.37 . . . . 41.3 113.721 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -115.1 138.44 23.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 72.22 111.502 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.71 124.33 7.47 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.949 2.432 . . . . 55.24 114.273 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 8.7 mtp180 -119.69 134.62 55.16 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.965 -0.561 . . . . 74.03 110.907 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.798 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.1 m -103.37 119.82 39.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.886 0.374 . . . . 60.2 110.987 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -123.07 160.38 26.49 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.935 -0.575 . . . . 63.05 111.117 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -52.18 106.74 0.16 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.84 0.352 . . . . 73.31 111.863 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.45 122.87 58.28 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 116.218 -0.447 . . . . 74.51 112.197 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 55' ' ' ALA . 72.8 Cg_endo -75.95 -18.81 16.47 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.366 2.044 . . . . 51.02 112.118 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.1 t70 63.36 96.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.693 0.797 . . . . 74.01 112.234 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.4 m -121.39 25.84 9.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.389 -0.823 . . . . 63.13 109.945 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -64.27 103.32 0.62 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.284 -0.871 . . . . 54.34 113.212 -171.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.75 2.1 88.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.355 0.902 . . . . 73.43 115.355 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 51' ' ' CYS . 3.7 pp -85.86 153.72 57.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 118.03 0.915 . . . . 75.31 111.396 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.08 119.4 6.43 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.317 2.011 . . . . 61.31 112.703 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 76.59 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.028 0.442 . . . . 71.34 111.06 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 177.51 15.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.991 -0.55 . . . . 74.21 111.561 -175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD21 ' HD3' ' A' ' 69' ' ' ARG . 50.9 tp -119.99 105.56 11.16 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.015 0.436 . . . . 52.3 111.867 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.35 145.18 56.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.029 -0.532 . . . . 52.13 111.984 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 50' ' ' GLU . 31.4 m -141.13 143.56 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.268 -0.424 . . . . 71.33 111.043 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -102.19 125.8 48.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 110.159 -0.312 . . . . 70.12 110.159 178.196 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -73.24 169.25 53.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.407 -0.425 . . . . 63.35 113.765 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 t -65.18 -6.39 9.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.155 0.428 . . . . 74.14 112.155 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.94 -31.15 14.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.356 0.262 . . . . 72.43 111.389 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.38 -11.39 7.18 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 121.357 -0.449 . . . . 50.41 113.778 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.98 134.58 36.26 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.014 0.435 . . . . 42.3 112.002 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.572 HG21 ' HG2' ' A' ' 71' ' ' ARG . 45.8 m -97.17 107.76 20.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.871 0.367 . . . . 42.43 111.1 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.52 151.62 24.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.395 -0.366 . . . . 74.22 111.705 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.52 -30.45 65.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.575 0.583 . . . . 71.14 112.575 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 34.5 t70 -155.29 159.81 40.29 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.758 0.313 . . . . 73.41 111.548 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' HG21 ' A' ' 39' ' ' VAL . 39.5 tt0 -58.92 -43.37 91.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.799 0.333 . . . . 64.53 110.994 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.507 ' HB2' HD11 ' A' ' 33' ' ' LEU . 36.1 t -57.23 -34.99 69.13 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.138 0.494 . . . . 64.52 111.032 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -65.66 -41.47 92.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.041 -0.527 . . . . 70.11 111.155 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.402 HD11 ' HA2' ' A' ' 41' ' ' GLY . 9.3 tt -65.03 -42.34 94.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.066 0.46 . . . . 52.53 110.172 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 54' ' ' ARG . 11.2 mmm180 -54.14 -49.72 68.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.294 0.569 . . . . 72.14 110.584 175.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . . . -61.13 -42.97 99.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.916 -0.584 . . . . 62.32 111.158 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -55.69 -36.94 67.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.052 -0.522 . . . . 73.34 111.938 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 76.3 ttt-85 -59.92 -38.16 81.56 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.104 0.478 . . . . 71.22 111.021 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.0 t -82.68 -15.68 51.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.06 0.457 . . . . 73.25 111.207 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.9 ttp180 -97.17 49.51 1.06 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.239 0.542 . . . . 74.13 111.619 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.46 58.97 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 115.068 0.787 . . . . 60.31 115.068 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 4.0 m-70 -126.76 77.74 73.9 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.144 0.972 . . . . 75.12 111.972 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.12 -22.87 61.12 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.67 2.247 . . . . 75.44 113.043 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.84 4.23 54.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.309 -0.405 . . . . 70.33 111.802 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 56.9 tp -80.46 125.77 30.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.27 0.557 . . . . 75.12 112.158 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.1 p -136.62 163.8 29.71 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.68 -0.691 . . . . 70.42 110.475 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.13 124.56 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.006 0.431 . . . . 63.32 111.194 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.5 mmt -89.59 -53.67 4.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.93 0.395 . . . . 74.55 111.044 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.98 152.66 42.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 73.25 111.276 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.649 ' HD3' HD21 ' A' ' 37' ' ' LEU . 96.7 mtt180 -82.55 134.73 35.19 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.189 0.519 . . . . 62.41 111.8 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 116.27 -161.82 12.83 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.944 -0.571 . . . . 71.41 112.422 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.572 ' HG2' HG21 ' A' ' 46' ' ' THR . 50.2 mtp180 -86.29 153.61 21.85 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.538 -0.39 . . . . 74.12 111.286 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.5 m -57.38 112.72 1.49 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.532 0.682 . . . . 71.31 111.42 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -118.98 141.12 48.95 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.286 -0.87 . . . . 74.2 112.265 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.3 tttm . . . . . 0 C--O 1.251 1.141 0 CA-C-O 119.069 -0.491 . . . . 65.33 111.151 170.678 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.819 0.342 . . . . 63.22 111.235 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -122.35 125.16 45.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.014 0.435 . . . . 72.44 111.677 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 t -144.21 179.42 7.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.123 -0.489 . . . . 71.1 110.461 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 7.4 m -97.86 127.0 43.52 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.793 0.33 . . . . 72.01 110.439 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.35 110.31 20.69 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 110.241 -0.281 . . . . 74.3 110.241 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -34.8 0.57 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.147 -0.549 . . . . 72.14 114.386 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 21.2 t -66.08 140.22 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.156 0.478 . . . . 74.54 112.2 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -89.65 107.95 19.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.279 -0.419 . . . . 73.14 111.546 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.3 m -144.65 138.88 27.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.258 -0.428 . . . . 72.32 111.333 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.24 -95.28 0.1 OUTLIER Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.486 -0.387 . . . . 73.54 112.336 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.12 111.18 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.368 2.046 . . . . 73.34 112.334 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.21 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.239 -0.505 . . . . 33.42 113.862 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.583 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.9 mtmt -129.51 160.59 32.72 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.474 0.637 . . . . 65.14 112.324 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.8 136.03 20.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.358 -0.837 . . . . 62.5 109.946 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.2 p -101.63 142.37 33.08 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.194 0.521 . . . . 63.42 111.648 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -132.76 143.92 49.92 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.971 -0.559 . . . . 63.55 110.629 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.25 101.92 9.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.996 0.427 . . . . 71.4 110.298 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HD3' ' A' ' 23' ' ' ARG . 77.8 mt -125.48 116.07 21.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.408 -0.36 . . . . 53.0 111.385 -175.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.42 32.75 82.18 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.297 -0.478 . . . . 64.4 113.019 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.02 77.03 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.429 -0.415 . . . . 72.0 113.077 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.88 135.68 24.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.6 -0.353 . . . . 74.1 111.548 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.93 98.22 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.444 2.096 . . . . 64.21 112.716 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 23' ' ' ARG . 37.3 mtp-105 -95.96 123.17 39.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.608 -0.269 . . . . 74.42 111.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 9.5 t -104.06 120.19 40.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.68 0.276 . . . . 74.45 110.398 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -129.7 160.89 31.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 74.44 111.415 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.08 125.01 23.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.156 -0.474 . . . . 75.13 111.556 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -109.13 132.98 20.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 111.909 0.337 . . . . 72.2 111.909 -176.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 16.5 Cg_exo -69.0 112.87 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.923 2.416 . . . . 63.34 112.899 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.32 133.79 38.68 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.024 0.44 . . . . 62.11 111.108 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.1 m -124.33 45.09 2.58 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.937 0.399 . . . . 54.21 111.424 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.9 m -77.01 -76.44 0.17 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.23 0.456 . . . . 72.51 112.23 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 52.01 3.97 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.247 -0.502 . . . . 71.41 114.158 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.694 HD11 ' SG ' ' A' ' 51' ' ' CYS . 4.6 pp -155.83 151.56 22.16 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.44 -0.447 . . . . 63.52 111.497 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 7.3 Cg_exo -73.63 137.7 25.48 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.594 2.196 . . . . 64.23 112.479 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.77 134.33 56.11 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.224 0.453 . . . . 54.14 112.224 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 63.59 15.65 9.05 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.828 0.677 . . . . 75.32 112.828 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.5 tm? -82.71 104.11 12.71 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.851 0.358 . . . . 70.35 110.84 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.408 ' O ' HD13 ' A' ' 37' ' ' LEU . 80.8 mt-30 -61.12 150.18 34.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.022 -0.535 . . . . 62.43 111.804 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 69' ' ' ARG . 25.5 m -141.52 159.16 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.952 0.353 . . . . 64.35 111.952 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.566 ' SG ' ' HA2' ' A' ' 44' ' ' GLY . 51.5 t -106.31 122.18 45.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.856 0.36 . . . . 72.44 111.57 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.38 176.86 54.55 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.327 -0.463 . . . . 52.02 113.224 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -58.51 -25.76 62.74 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.4 0.519 . . . . 71.32 112.4 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.01 -14.4 59.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.025 0.44 . . . . 63.31 111.688 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.566 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . 85.05 34.62 14.28 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.227 -0.511 . . . . 73.11 112.952 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.24 148.01 40.89 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.505 0.322 . . . . 51.22 111.405 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -93.76 115.35 27.77 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.012 0.434 . . . . 70.33 112.128 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.12 166.1 13.15 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.352 -0.386 . . . . 71.04 111.149 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -62.23 -38.06 87.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.948 0.404 . . . . 74.42 111.194 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -166.02 174.07 9.77 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.939 -0.573 . . . . 65.11 110.743 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HB3' HD22 ' A' ' 33' ' ' LEU . 33.9 tt0 -63.06 -29.48 70.84 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.779 0.323 . . . . 74.45 111.086 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.694 ' SG ' HD11 ' A' ' 33' ' ' LEU . 62.1 m -58.28 -43.0 87.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.873 0.368 . . . . 64.31 110.693 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.44 -36.67 76.87 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.216 -0.447 . . . . 73.05 111.688 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.4 tt -65.25 -49.29 70.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.883 0.373 . . . . 70.3 110.372 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -57.31 -46.67 82.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 73.14 110.29 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.29 87.26 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.778 -0.646 . . . . 35.25 111.534 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.12 77.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.802 0.334 . . . . 41.24 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 34.4 mtm180 -61.75 -43.32 99.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.392 0.615 . . . . 72.45 110.683 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.4 t -78.51 -21.4 48.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.358 -0.837 . . . . 53.13 111.605 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp85 -90.03 -29.0 18.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.604 0.594 . . . . 74.41 112.604 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.588 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . -169.9 -37.08 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 119.669 -1.253 . . . . 40.32 115.45 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 83.3 m-70 -110.28 81.78 2.4 Favored Pre-proline 0 N--CA 1.477 0.922 0 CA-C-N 118.059 0.929 . . . . 74.33 112.553 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 23.8 Cg_exo -64.37 -24.63 64.37 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.497 2.131 . . . . 74.14 113.405 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.38 -4.65 57.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.981 0.42 . . . . 74.2 111.609 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 61.4 tp -66.2 112.7 4.07 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.383 0.512 . . . . 72.32 112.383 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -105.95 151.79 24.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.395 -0.366 . . . . 72.44 111.166 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.86 127.66 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.846 0.355 . . . . 74.21 111.236 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.1 mtt -84.69 -55.06 4.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.947 0.403 . . . . 74.11 111.621 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -147.91 154.9 40.97 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.054 0.454 . . . . 51.3 111.779 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 39' ' ' VAL . 94.2 mtt180 -84.2 141.65 30.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.901 -0.59 . . . . 65.42 111.102 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.45 158.65 14.01 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.858 -0.61 . . . . 54.23 111.813 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.78 130.81 46.56 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 117.291 0.545 . . . . 70.22 110.612 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.06 142.84 56.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.942 0.349 . . . . 63.11 111.942 -172.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -113.39 105.72 13.73 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.209 0.448 . . . . 62.21 112.209 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.5 -0.762 . . . . 43.14 110.919 172.031 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.96 0.409 . . . . 51.34 111.406 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 10.3 m-20 -74.62 87.8 2.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.352 0.596 . . . . 71.12 111.295 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 m -95.15 161.01 14.29 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.737 -0.665 . . . . 73.32 111.326 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.2 m -139.59 129.0 24.17 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 111.891 0.33 . . . . 72.34 111.891 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.9 112.26 22.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.056 0.391 . . . . 75.14 112.056 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.7 56.09 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 114.992 0.757 . . . . 73.4 114.992 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.4 t -107.24 120.97 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.103 -0.645 . . . . 74.11 111.004 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 0.3 OUTLIER -96.63 109.38 22.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.625 0.726 . . . . 71.01 111.543 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 95.8 m -148.47 139.67 23.27 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.842 -0.617 . . . . 61.32 110.415 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.9 -98.15 0.17 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.091 -0.576 . . . . 61.42 113.723 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.12 -62.76 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.672 2.248 . . . . 70.21 113.962 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.5 58.89 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.144 -0.551 . . . . 54.32 113.922 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 48.8 mtmt -133.81 139.89 46.57 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.304 -0.527 . . . . 71.44 111.763 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -115.17 137.65 51.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.684 -0.235 . . . . 64.02 110.396 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.681 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 19.0 p -99.68 140.57 33.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.121 0.486 . . . . 75.23 111.704 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HA ' ' HB3' ' A' ' 2' ' ' ASP . 9.5 ptm180 -143.23 163.13 33.8 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.121 -0.49 . . . . 61.22 112.086 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.9 mmt -79.76 104.14 10.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.297 -0.411 . . . . 41.43 111.526 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 93.6 mt -120.69 119.09 31.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.67 -0.241 . . . . 75.3 110.8 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.46 26.36 56.65 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.152 -0.546 . . . . 72.13 113.554 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.55 82.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.453 -0.403 . . . . 40.21 113.64 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 18' ' ' LEU . 11.0 ptp180 -128.75 138.15 32.51 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 117.496 0.648 . . . . 62.12 111.558 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.95 111.59 3.31 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.777 2.318 . . . . 75.22 113.426 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 97.6 mtt180 -116.34 144.81 43.78 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.342 -0.39 . . . . 71.15 111.585 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 76.9 m -103.82 135.19 45.83 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.441 -0.345 . . . . 75.05 111.549 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' OE1' ' HD3' ' A' ' 16' ' ' ARG . 9.7 pt-20 -129.89 161.08 31.64 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.565 -0.289 . . . . 74.44 111.601 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.7 t -55.03 114.51 1.78 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.37 0.507 . . . . 64.11 112.37 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -97.2 118.43 64.63 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.452 -0.34 . . . . 73.11 111.078 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 2.6 Cg_endo -88.16 21.19 1.04 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.217 2.611 . . . . 63.13 113.944 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 55.74 36.41 27.2 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.903 0.382 . . . . 74.03 111.951 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HA ' HD21 ' A' ' 33' ' ' LEU . 60.4 m -65.52 78.62 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.458 0.647 . . . . 43.23 111.637 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -149.88 120.43 7.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.465 -0.788 . . . . 63.53 110.396 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.15 -40.11 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.134 -0.555 . . . . 63.0 112.679 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 30' ' ' CYS . 3.3 pp -66.09 153.35 92.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.592 -0.357 . . . . 64.5 111.263 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 17.0 Cg_exo -68.13 120.42 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.613 2.209 . . . . 31.44 113.081 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.41 141.17 29.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.061 -0.518 . . . . 75.41 111.023 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 63.3 10.86 4.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.134 0.791 . . . . 64.42 113.134 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . 3.3 tm? -103.27 110.64 22.69 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.169 -0.678 . . . . 74.34 109.169 174.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -54.18 153.94 4.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.804 0.668 . . . . 64.34 112.804 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.478 HG12 ' HG2' ' A' ' 69' ' ' ARG . 22.5 m -136.54 143.06 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.869 -0.605 . . . . 63.25 110.876 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.86 113.44 25.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 62.31 110.728 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.17 164.96 48.33 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.146 -0.479 . . . . 30.32 113.937 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 p -58.66 -20.98 52.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.307 0.643 . . . . 73.43 112.393 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.67 -14.31 60.35 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.989 0.424 . . . . 72.05 111.755 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.1 10.82 59.34 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.128 -0.558 . . . . 64.12 113.052 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.61 144.58 40.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.866 0.365 . . . . 43.24 111.416 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.0 m -96.23 129.41 43.55 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.502 -0.317 . . . . 70.0 111.226 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -109.89 168.89 9.09 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.626 0.251 . . . . 75.41 111.669 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -47.57 -54.92 10.4 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.573 0.583 . . . . 74.13 112.573 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -164.27 -178.91 5.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.696 0.284 . . . . 74.55 111.459 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 tp10 -55.37 -45.01 76.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.427 -0.351 . . . . 74.41 111.185 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.16 -43.08 82.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.098 0.475 . . . . 73.1 110.915 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.55 -43.23 97.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.967 -0.56 . . . . 72.42 111.052 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 64' ' ' LEU . 10.4 tt -62.4 -45.27 93.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.227 -0.442 . . . . 65.41 111.349 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.7 mmm180 -62.57 -37.82 87.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.395 0.617 . . . . 64.33 109.927 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.1 84.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 64.13 111.084 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.25 87.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.366 . . . . 65.52 111.424 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 66.5 ttt180 -64.79 -41.29 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.067 0.461 . . . . 75.21 110.601 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.53 -26.68 67.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.354 0.597 . . . . 52.44 110.686 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -89.51 58.12 4.23 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.723 -0.671 . . . . 73.13 111.299 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.78 36.24 93.06 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.926 0.73 . . . . 52.3 114.926 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 77.9 m80 -135.66 74.96 57.78 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 117.689 0.744 . . . . 71.12 111.607 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.04 -24.1 75.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.843 2.362 . . . . 53.52 114.114 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.16 -2.82 42.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.388 0.514 . . . . 74.53 112.388 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -77.72 111.59 13.67 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.241 0.543 . . . . 63.12 111.051 -175.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -142.92 152.07 41.65 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.005 -0.543 . . . . 74.42 110.706 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 53' ' ' LEU . 7.2 p -77.46 132.34 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 121.162 0.506 . . . . 61.15 112.257 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.9 mtt -92.51 -54.0 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.378 0.609 . . . . 61.32 110.25 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -143.36 150.49 39.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 75.13 109.909 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.478 ' HG2' HG12 ' A' ' 39' ' ' VAL . 77.2 mtt85 -92.18 148.15 22.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.964 0.888 . . . . 72.41 112.487 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.16 -163.21 12.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 114.977 -1.01 . . . . 53.11 110.878 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -90.42 142.91 27.26 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.486 0.643 . . . . 70.24 110.795 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.85 102.49 0.06 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.405 0.621 . . . . 72.34 112.578 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.4 ' HD3' HH11 ' A' ' 73' ' ' ARG . 3.5 ptm180 -118.6 110.96 17.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.436 -0.802 . . . . 74.53 110.326 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.254 1.302 0 CA-C-O 119.386 -0.34 . . . . 70.44 111.814 -173.761 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.771 0.32 . . . . 64.53 111.019 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.06 169.25 18.68 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.368 0.604 . . . . 74.21 112.336 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -88.29 128.95 35.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.799 -0.637 . . . . 62.4 111.881 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 29.0 m -98.9 128.81 45.17 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.426 -0.352 . . . . 34.55 110.637 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.08 111.26 20.16 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.25 -0.282 . . . . 55.31 110.313 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.91 -39.62 0.97 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.373 -0.442 . . . . 65.21 113.932 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 6.2 t -66.62 146.06 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.397 0.517 . . . . 71.24 112.397 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -102.97 106.62 17.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.11 0.481 . . . . 65.02 110.554 176.186 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.26 178.78 8.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.719 0.637 . . . . 74.32 112.719 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.25 -82.88 0.29 Allowed Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.74 -0.664 . . . . 74.41 111.78 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.67 92.76 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.765 2.31 . . . . 71.31 112.854 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.4 -10.3 73.26 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.15 -0.547 . . . . 74.03 113.473 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 45.1 mtmt -135.29 136.3 41.5 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.273 -0.545 . . . . 72.2 111.761 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.81 133.52 55.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.206 -0.452 . . . . 70.13 110.132 173.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 23.8 p -97.92 119.71 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.299 0.571 . . . . 64.53 110.385 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.2 ttm-85 -124.67 143.8 50.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.73 -0.668 . . . . 64.04 110.577 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.411 ' HA ' ' CE ' ' A' ' 17' ' ' MET . 3.2 mmt -73.68 100.31 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.203 0.525 . . . . 60.11 110.694 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.561 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 83.9 mt -125.38 107.5 10.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.822 -0.626 . . . . 73.44 110.104 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.39 -64.89 4.09 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.958 -0.639 . . . . 51.11 112.532 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.55 -22.48 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.584 -0.817 . . . . 53.33 114.154 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -98.65 138.67 20.77 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.42 -0.459 . . . . 73.43 111.425 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.75 93.8 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.991 1.794 . . . . 75.24 112.093 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 11.5 ptm180 -106.1 142.55 35.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.889 -0.596 . . . . 70.21 111.022 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 93.9 m -103.29 138.85 39.51 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 64.34 111.757 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.5 mm-40 -106.45 156.69 18.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.232 -0.894 . . . . 54.31 110.061 -175.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.1 t -68.42 97.82 0.79 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.267 -0.642 . . . . 64.0 109.267 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.75 137.67 20.61 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.157 -0.474 . . . . 75.43 112.238 -171.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 7.7 Cg_exo -73.8 55.25 3.24 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.06 2.506 . . . . 74.12 112.59 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.51 127.01 18.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.819 0.342 . . . . 74.02 111.257 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.813 ' HB2' HD12 ' A' ' 33' ' ' LEU . 29.4 p -169.6 40.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.278 -0.419 . . . . 64.04 111.445 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.9 t -60.38 102.29 0.17 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.913 0.387 . . . . 64.21 111.705 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.31 -9.28 5.93 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.414 -0.422 . . . . 62.54 113.027 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 ' HB2' ' A' ' 30' ' ' CYS . 95.7 mt -95.32 126.08 47.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 O-C-N 122.64 -0.329 . . . . 63.04 111.325 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.87 125.15 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.501 2.134 . . . . 65.12 113.057 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.81 9.93 1.64 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.734 0.642 . . . . 64.2 112.734 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -113.18 9.66 18.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.961 0.41 . . . . 74.44 111.021 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 52.7 tp -106.83 97.91 7.64 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.755 0.312 . . . . 71.32 111.115 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.13 148.76 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.239 -0.437 . . . . 73.35 111.868 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 50' ' ' GLU . 25.0 m -137.21 161.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.359 . . . . 64.52 111.844 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.7 t -118.05 128.5 54.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.932 0.396 . . . . 71.44 110.627 173.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.33 177.54 37.91 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.103 -0.57 . . . . 74.44 114.207 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 p -63.78 -14.59 54.04 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.098 0.475 . . . . 71.32 111.74 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -81.95 -22.55 36.61 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.139 0.495 . . . . 65.32 111.093 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.54 -8.67 60.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.431 -0.414 . . . . 70.31 113.294 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.47 134.16 39.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.152 0.427 . . . . 52.32 112.152 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -86.72 116.25 24.69 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.248 -0.433 . . . . 63.33 110.626 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -100.65 159.68 14.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.036 0.446 . . . . 72.12 112.116 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -56.9 -35.96 69.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.723 -0.671 . . . . 73.13 111.163 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.0 p-10 -164.14 169.49 17.68 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.328 -0.851 . . . . 74.01 110.183 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HB3' HD13 ' A' ' 33' ' ' LEU . 34.4 tt0 -65.36 -33.02 74.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.043 -0.411 . . . . 70.25 111.552 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' HB2' ' OD2' ' A' ' 49' ' ' ASP . 28.2 m -65.41 -37.89 88.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.884 0.373 . . . . 72.21 110.435 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.99 -39.51 89.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.244 0.545 . . . . 51.11 110.603 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.97 -47.12 81.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.291 0.567 . . . . 61.45 110.31 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 54' ' ' ARG . 17.8 mtp180 -65.26 -22.09 66.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.813 -0.63 . . . . 71.23 111.03 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.59 -43.42 31.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.055 0.455 . . . . 74.34 110.876 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.32 64.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.133 0.492 . . . . 71.32 111.217 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 57' ' ' ARG . 16.0 tpp85 -54.18 -51.35 64.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.576 . . . . 74.53 110.273 170.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 62.2 m -68.58 -29.95 68.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.92 -0.582 . . . . 64.24 111.6 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.19 -32.32 73.68 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.903 0.382 . . . . 75.44 111.292 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.11 43.9 0.06 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.065 -0.588 . . . . 74.33 113.469 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.3 m-70 -135.33 82.07 41.79 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.345 -0.503 . . . . 74.3 111.646 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.04 -22.33 41.74 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.795 2.33 . . . . 63.23 113.415 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -84.23 -19.31 34.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.881 0.372 . . . . 75.51 111.805 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 43.6 tp -68.16 112.14 4.92 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.367 0.603 . . . . 71.13 112.521 -172.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.2 p -127.38 163.43 24.04 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.66 -0.7 . . . . 72.11 109.736 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.63 127.56 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.104 0.478 . . . . 70.42 111.814 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.4 mtt -90.62 -55.71 3.47 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.093 0.473 . . . . 75.44 111.406 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -148.46 157.15 43.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.864 0.364 . . . . 74.13 111.217 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -101.49 107.73 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.523 0.677 . . . . 74.13 111.782 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.88 -179.5 29.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.325 -0.852 . . . . 75.52 111.514 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -60.33 127.55 32.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.748 0.774 . . . . 62.21 109.95 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.89 97.96 0.06 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.437 0.637 . . . . 72.11 111.503 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -83.03 135.25 34.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.831 -0.622 . . . . 54.51 112.114 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm . . . . . 0 C--O 1.25 1.119 0 CA-C-N 116.086 -0.506 . . . . 73.34 111.309 177.172 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.528 0.204 . . . . 55.02 111.298 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -164.03 151.96 12.71 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.463 0.305 . . . . 52.42 111.046 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p -144.46 155.22 43.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 120.732 0.301 . . . . 61.01 111.718 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.8 m -100.1 130.7 46.27 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.781 0.66 . . . . 61.45 112.781 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.06 124.87 32.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.327 -0.397 . . . . 72.2 111.445 173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.72 -31.42 2.48 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.689 0.636 . . . . 52.51 114.689 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 22' ' ' PRO . 36.2 t -66.16 139.69 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 117.276 0.538 . . . . 74.13 111.626 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.94 103.36 14.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.092 0.405 . . . . 73.35 112.092 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 57.9 m -152.13 138.84 18.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.369 -0.378 . . . . 52.31 111.266 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . -139.43 -106.32 0.68 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.737 -0.744 . . . . 63.44 113.977 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 13.5 Cg_exo -70.8 -49.82 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.843 2.362 . . . . 71.43 113.415 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.68 66.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.045 -0.598 . . . . 72.43 113.304 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 49.7 mtmt -128.47 141.26 51.45 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.622 -0.34 . . . . 74.04 110.985 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.36 133.82 52.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.494 -0.321 . . . . 74.12 110.169 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.0 t -100.42 136.52 40.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.339 . . . . 65.33 111.272 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -134.83 163.67 29.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.08 0.467 . . . . 75.14 111.465 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.8 mmm -89.85 101.5 14.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.199 0.523 . . . . 72.33 110.964 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.08 115.48 30.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.215 -0.448 . . . . 65.24 110.763 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.58 40.54 92.63 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.202 -0.523 . . . . 71.23 113.418 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 5.92 81.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.9 -0.667 . . . . 62.14 113.766 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -124.42 129.85 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 117.173 0.486 . . . . 72.32 111.517 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.524 ' HB2' HG21 ' A' ' 7' ' ' VAL . 61.1 Cg_endo -72.55 106.2 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.497 2.131 . . . . 62.41 112.787 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -115.33 142.81 46.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.881 0.372 . . . . 65.42 111.277 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 9.4 m -103.92 142.83 33.74 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.102 0.477 . . . . 72.11 112.203 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -143.6 153.38 42.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.74 -0.664 . . . . 73.03 110.684 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.6 t -52.83 128.23 26.13 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.176 0.512 . . . . 63.14 111.929 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.71 128.21 30.51 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.162 -0.472 . . . . 72.5 111.67 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.95 -2.84 12.39 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.264 1.976 . . . . 73.24 112.645 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' HB3' ' NH1' ' A' ' 54' ' ' ARG . 36.2 t70 62.14 7.22 2.08 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.633 0.73 . . . . 74.3 111.645 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' HD21 ' A' ' 33' ' ' LEU . 33.8 t -80.53 92.63 5.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.887 -0.597 . . . . 73.32 112.197 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 p -138.43 -83.01 0.3 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.205 -0.452 . . . . 70.14 111.1 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.19 49.52 2.71 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.966 -0.635 . . . . 72.32 113.123 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 30' ' ' CYS . 2.6 pp -132.71 159.05 74.11 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 122.46 0.304 . . . . 60.31 111.08 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.95 119.09 6.11 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.367 2.045 . . . . 64.22 113.502 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.17 66.35 8.46 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.886 -0.783 . . . . 74.05 108.886 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -143.87 -13.38 0.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.909 0.707 . . . . 73.32 112.909 -165.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 68.1 tp -128.05 116.83 20.61 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.712 0.634 . . . . 74.45 112.712 -168.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -58.57 154.74 13.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.156 -0.475 . . . . 72.53 111.405 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.6 m -140.79 148.5 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.236 0.541 . . . . 43.43 111.846 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.0 t -100.03 116.37 31.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.288 -0.414 . . . . 73.33 110.593 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.34 162.18 34.73 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.215 -0.517 . . . . 73.21 113.63 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.8 p -55.14 -28.0 49.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.117 0.484 . . . . 42.53 111.654 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.4 -47.47 83.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.869 -0.605 . . . . 74.32 111.817 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.13 -23.38 5.84 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.335 -0.459 . . . . 62.1 112.531 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.9 139.89 36.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.993 0.425 . . . . 74.1 111.824 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -86.68 122.75 31.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.008 0.432 . . . . 71.11 111.092 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.73 153.73 17.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.442 . . . . 73.21 111.331 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -62.16 -25.71 67.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.825 -0.625 . . . . 61.45 112.606 -173.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 25.0 t70 -170.45 159.89 7.19 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.595 -0.275 . . . . 73.44 110.782 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.67 -40.21 68.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.314 0.578 . . . . 62.51 110.538 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.8 t -52.99 -42.69 65.81 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.286 -0.87 . . . . 71.04 111.471 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.98 -43.73 57.11 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.336 -0.393 . . . . 54.11 111.336 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 66' ' ' VAL . 69.2 tp -55.17 -58.33 8.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.137 0.494 . . . . 72.23 112.208 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 78.3 mtp180 -70.69 -25.05 62.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.181 -0.463 . . . . 73.21 111.781 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 59' ' ' ARG . . . -72.76 -45.28 59.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 70.42 111.146 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.93 68.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.087 0.47 . . . . 73.24 110.771 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 54' ' ' ARG . 31.6 ttp180 -56.03 -50.02 72.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.579 -0.737 . . . . 73.04 110.642 171.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -66.28 -22.38 66.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.744 -0.662 . . . . 62.23 112.129 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 55' ' ' ALA . 29.5 mtp-105 -84.99 30.31 0.59 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.205 0.446 . . . . 73.33 112.205 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.75 6.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.965 -0.636 . . . . 64.51 114.279 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -134.46 77.54 59.16 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 117.294 0.547 . . . . 74.53 110.974 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.88 -21.15 38.18 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.872 2.382 . . . . 71.1 113.526 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.91 -17.64 52.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.989 0.423 . . . . 54.24 111.418 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 tp -72.26 112.0 7.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.195 0.521 . . . . 73.52 111.527 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -135.13 164.46 27.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.017 -0.538 . . . . 65.04 111.356 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.528 HG22 HD23 ' A' ' 53' ' ' LEU . 39.8 t -79.45 119.24 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.841 0.353 . . . . 71.21 111.862 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.3 mmt -81.92 -58.73 2.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.978 0.418 . . . . 73.05 110.579 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -161.58 160.91 29.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.801 -0.636 . . . . 64.0 111.2 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -77.78 137.59 38.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.271 -0.422 . . . . 75.13 111.569 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.61 172.27 30.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.264 -0.493 . . . . 72.52 113.127 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' ARG . 63.3 ttt180 -60.15 154.59 19.2 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.634 -0.333 . . . . 70.15 110.2 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.17 84.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 73.23 112.502 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' ARG . 57.8 mtp180 -119.25 142.86 47.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.123 0.569 . . . . 64.44 111.319 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.634 -0.698 . . . . 63.14 110.947 174.837 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 111.794 0.294 . . . . 73.41 111.794 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.414 ' OD2' ' HG3' ' A' ' 16' ' ' ARG . 10.0 p-10 -81.66 133.29 35.35 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.25 0.548 . . . . 61.53 111.578 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m -123.76 -166.41 1.48 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.999 0.428 . . . . 72.34 111.736 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.4 p -98.72 130.78 45.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.018 0.437 . . . . 63.01 112.169 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -80.51 126.46 31.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.081 0.467 . . . . 64.14 111.521 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.34 -2.2 16.05 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.002 -0.544 . . . . 73.13 113.945 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 10.9 t -107.17 145.83 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 117.118 0.459 . . . . 64.31 111.326 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.12 106.41 15.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.635 -0.506 . . . . 64.12 109.635 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 87.9 m -138.91 139.1 37.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.923 0.392 . . . . 75.43 111.048 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' LYS . . . 169.97 -64.05 0.17 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.393 -0.432 . . . . 63.32 113.076 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.36 42.83 1.3 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.154 2.569 . . . . 74.55 113.69 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.79 -45.01 0.43 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.158 -0.544 . . . . 73.41 112.424 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 36.8 mtmm -122.65 136.92 55.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.492 0.317 . . . . 75.14 110.263 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -107.23 134.35 50.45 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 122.381 -0.2 . . . . 42.34 111.108 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.88 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 31.5 p -114.77 139.64 49.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.668 0.618 . . . . 54.31 112.668 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.567 ' HG3' HH11 ' A' ' 16' ' ' ARG . 29.1 ttm-85 -142.5 160.52 40.13 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.958 -0.565 . . . . 72.2 111.152 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.2 mmt -82.53 107.91 15.53 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.577 0.584 . . . . 72.01 112.577 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HD2' ' A' ' 23' ' ' ARG . 6.3 mp -123.45 102.0 7.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.871 0.367 . . . . 75.2 110.938 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.65 52.57 52.22 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.403 -0.427 . . . . 43.53 114.018 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.45 -44.37 3.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.205 -0.521 . . . . 74.15 113.811 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.04 130.76 35.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 75.14 111.716 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.07 141.05 12.83 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.515 2.143 . . . . 52.32 112.922 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HD2' HD22 ' A' ' 18' ' ' LEU . 97.3 mtt180 -113.79 123.32 49.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.764 -0.198 . . . . 65.02 111.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.88 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 94.9 m -107.36 120.1 41.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.647 0.261 . . . . 75.0 110.988 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -119.74 159.23 24.9 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.341 -0.225 . . . . 75.52 111.525 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 58' ' ' CYS . 8.9 t -58.72 95.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.293 -0.412 . . . . 71.4 110.869 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.8 130.99 24.6 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.329 -0.396 . . . . 75.41 111.887 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -82.68 -158.87 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.672 2.248 . . . . 72.51 111.842 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.27 102.14 14.81 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.854 -0.529 . . . . 75.45 110.994 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.7 m -102.87 3.96 37.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.159 0.504 . . . . 73.25 110.56 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -81.37 -35.28 31.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.953 -0.567 . . . . 72.43 111.99 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.93 9.08 78.81 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.919 -0.658 . . . . 53.42 114.389 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 51' ' ' CYS . 4.1 pp -128.62 156.36 77.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 117.578 0.689 . . . . 74.32 112.087 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.56 123.19 2.49 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.677 2.251 . . . . 74.12 112.963 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.87 14.68 0.48 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.77 0.656 . . . . 72.04 112.77 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.01 10.04 13.85 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.11 -0.369 . . . . 72.52 111.78 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -111.06 100.19 8.92 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.205 -0.31 . . . . 73.21 110.798 -177.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.22 139.36 57.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.877 0.37 . . . . 73.02 111.974 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 69' ' ' ARG . 26.2 m -128.72 166.25 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.142 0.496 . . . . 72.33 111.811 -175.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.0 t -116.34 124.16 49.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.224 -0.444 . . . . 53.32 111.254 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.02 161.56 24.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.124 -0.56 . . . . 71.3 113.497 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 p -55.54 -24.13 30.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.404 0.52 . . . . 74.53 112.404 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.2 -2.5 28.22 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 120.877 0.37 . . . . 73.44 111.674 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.11 25.06 58.39 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.424 -0.417 . . . . 33.21 113.244 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.41 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.928 0.394 . . . . 71.54 111.832 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 71' ' ' ARG . 81.2 m -86.36 110.95 20.04 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.279 -0.419 . . . . 71.12 110.862 174.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -91.16 159.8 15.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 61.32 111.673 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 48' ' ' ARG . 3.9 mmp_? -53.04 -39.68 63.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.112 -0.494 . . . . 74.12 112.223 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 5.5 p-10 -163.93 -178.48 5.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.281 -0.418 . . . . 75.53 110.821 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.522 ' HB3' HD22 ' A' ' 33' ' ' LEU . 24.7 tt0 -68.85 -37.28 79.02 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.673 0.273 . . . . 75.25 111.589 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.627 ' HB2' HD11 ' A' ' 33' ' ' LEU . 25.3 t -65.5 -41.71 92.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.657 0.265 . . . . 64.42 110.667 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.25 -51.48 53.65 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.209 0.528 . . . . 63.24 111.122 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.4 -53.84 46.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.915 -0.584 . . . . 63.22 110.984 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.506 ' NH1' HD23 ' A' ' 33' ' ' LEU . 70.0 mtp180 -61.75 -29.86 70.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.115 -0.493 . . . . 74.22 111.977 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.32 -42.8 68.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.985 0.421 . . . . 63.33 110.812 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.35 88.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.862 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 36.8 ttt85 -63.39 -48.06 79.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.086 0.47 . . . . 52.43 111.236 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.486 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 5.6 t -55.47 -44.42 76.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.933 -0.576 . . . . 71.4 110.468 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -84.21 61.9 6.81 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.255 0.55 . . . . 64.45 112.147 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.05 25.28 49.51 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.58 0.992 . . . . 54.21 115.58 170.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.48 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 95.4 m-70 -134.81 74.88 63.27 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 118.222 1.011 . . . . 75.31 112.132 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.96 -19.76 17.64 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.608 2.206 . . . . 63.54 113.494 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.0 -22.52 42.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.083 0.468 . . . . 65.04 111.067 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.446 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 63.9 tp -75.12 111.74 10.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.184 -0.462 . . . . 62.2 111.264 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 p -124.75 141.97 51.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.003 0.43 . . . . 74.33 111.638 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.24 113.71 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.305 0.574 . . . . 75.33 111.289 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 28.0 mmt -77.01 -42.44 38.65 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.962 0.41 . . . . 72.03 111.416 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -169.03 163.0 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.085 -0.507 . . . . 75.23 111.217 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.646 ' HG3' HG12 ' A' ' 39' ' ' VAL . 1.3 mpp_? -93.34 153.72 18.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.387 -0.37 . . . . 72.55 111.336 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.99 49.69 2.42 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.366 -0.445 . . . . 34.41 113.514 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HA ' HG23 ' A' ' 46' ' ' THR . 59.7 mtp85 61.47 172.08 0.11 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.894 0.701 . . . . 75.4 112.894 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.2 m -81.32 112.28 18.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 72.51 111.646 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -118.22 105.08 11.42 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.053 -0.522 . . . . 74.21 110.765 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? . . . . . 0 C--O 1.253 1.261 0 CA-C-O 118.575 -0.726 . . . . 62.5 111.547 -175.079 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.922 0.392 . . . . 64.44 111.699 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -91.7 134.41 34.73 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.509 -0.314 . . . . 60.22 110.32 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -66.92 127.89 34.23 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.832 0.348 . . . . 74.15 111.625 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 m -97.1 130.56 44.36 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.856 0.36 . . . . 65.41 111.173 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 7' ' ' VAL . 34.6 t70 -84.21 112.1 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.738 0.304 . . . . 75.54 111.454 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.28 0.01 9.6 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 114.67 0.628 . . . . 74.44 114.67 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' SG ' ' A' ' 9' ' ' CYS . 2.3 t -107.41 137.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 117.691 0.745 . . . . 51.34 111.819 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.46 106.03 18.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.797 0.332 . . . . 71.33 110.195 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.564 ' SG ' HG12 ' A' ' 7' ' ' VAL . 59.0 m -142.96 177.35 8.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.848 0.356 . . . . 74.11 111.908 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.87 -88.07 0.3 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.495 -0.383 . . . . 51.21 112.272 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.66 93.64 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.482 2.121 . . . . 64.44 112.925 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.0 10.89 82.26 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.034 -0.53 . . . . 72.13 113.432 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -146.98 136.29 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.386 -0.479 . . . . 74.42 111.484 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.1 140.21 52.28 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.594 -0.275 . . . . 73.34 110.802 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 15.8 p -100.1 106.24 17.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.402 0.62 . . . . 64.51 111.942 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -106.69 122.14 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.655 -0.702 . . . . 73.1 110.253 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 54.2 mtp -80.54 106.71 12.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.394 0.616 . . . . 64.13 111.883 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.68 HD12 ' HD2' ' A' ' 23' ' ' ARG . 92.9 mt -116.75 112.94 21.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.81 -0.632 . . . . 65.11 110.995 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.59 22.85 74.42 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.964 -0.636 . . . . 40.22 113.101 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.97 -21.12 44.86 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.337 -0.459 . . . . 71.31 113.627 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -106.08 131.78 21.45 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 117.22 0.51 . . . . 72.11 111.98 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 59.0 Cg_endo -73.36 111.6 3.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.436 2.091 . . . . 72.43 112.418 174.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.68 ' HD2' HD12 ' A' ' 18' ' ' LEU . 95.2 mtt180 -96.06 146.42 24.65 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.242 -0.286 . . . . 74.31 111.4 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 21.8 m -132.67 133.07 43.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.101 0.477 . . . . 53.31 111.191 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.16 161.23 37.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.015 -0.539 . . . . 71.24 110.11 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.8 t -54.05 95.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.033 0.444 . . . . 70.0 111.855 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -119.26 136.59 24.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.678 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 13.9 Cg_exo -68.45 90.84 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.421 2.081 . . . . 75.45 113.314 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.77 -70.5 0.25 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.921 0.391 . . . . 62.44 110.599 172.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.6 m 55.55 72.79 0.46 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.678 0.621 . . . . 65.21 112.678 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.8 m -85.28 -29.72 24.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.976 0.417 . . . . 64.54 110.893 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -65.52 1.54 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.28 -0.418 . . . . 62.44 113.333 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.3 pt? -74.13 141.78 78.21 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.989 0.423 . . . . 75.24 111.993 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 16.1 Cg_exo -70.49 120.8 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.776 2.318 . . . . 71.53 112.574 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.15 60.35 1.04 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.345 0.593 . . . . 71.31 111.089 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -151.24 -35.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.578 -0.737 . . . . 71.02 110.937 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 66.3 tp -67.76 107.99 2.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.278 -0.419 . . . . 73.22 111.744 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.63 149.82 38.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.5 0.666 . . . . 70.42 112.744 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.465 HG12 ' HG2' ' A' ' 69' ' ' ARG . 34.3 m -139.78 153.62 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 115.649 -0.705 . . . . 50.0 110.899 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.8 t -106.42 122.34 46.09 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.885 0.374 . . . . 74.21 111.256 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.6 165.12 40.21 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.05 -0.595 . . . . 60.24 113.648 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 p -53.53 -36.82 62.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.017 0.377 . . . . 71.21 112.017 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.06 -27.92 62.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 116.305 -0.407 . . . . 72.34 111.968 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.73 -3.0 34.05 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.174 -0.536 . . . . 55.14 113.099 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.28 142.73 27.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.98 0.419 . . . . 73.33 111.911 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.0 m -92.0 120.35 32.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.929 0.395 . . . . 71.15 110.33 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -97.12 148.55 22.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.529 -0.305 . . . . 64.14 111.11 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 19.9 ptp180 -49.51 -34.53 17.41 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.432 0.53 . . . . 73.25 112.432 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.2 p30 -160.75 176.69 11.22 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.885 0.374 . . . . 75.32 111.286 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HA ' HG21 ' A' ' 39' ' ' VAL . 35.2 tt0 -65.45 -33.61 76.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.412 -0.358 . . . . 73.05 111.885 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.32 -36.15 82.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.603 0.24 . . . . 61.01 111.1 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.63 -48.71 80.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.98 0.419 . . . . 74.01 110.818 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 53' ' ' LEU . 6.8 tt -59.6 -55.57 32.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.182 0.515 . . . . 74.51 110.397 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -58.8 -34.66 71.75 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.994 -0.548 . . . . 75.04 111.956 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.92 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.586 0.231 . . . . 73.24 111.485 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.57 86.09 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 73.44 111.348 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 1.6 tmt_? -59.42 -50.14 75.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.609 0.719 . . . . 73.25 109.99 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.76 -30.05 69.77 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.452 -0.794 . . . . 74.01 111.455 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.95 74.61 6.42 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.075 -0.512 . . . . 74.33 111.312 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.64 34.97 90.43 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 115.224 0.85 . . . . 73.42 115.224 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 77.8 m80 -135.04 89.05 25.07 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 117.96 0.88 . . . . 73.33 111.925 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.56 -18.18 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.01 2.473 . . . . 71.41 113.176 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -19.61 44.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.889 0.376 . . . . 74.22 111.916 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 tp -82.97 130.65 35.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.006 0.432 . . . . 74.52 112.001 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -146.72 161.26 40.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.283 -0.417 . . . . 74.5 110.78 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t -80.48 112.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 120.966 0.412 . . . . 64.04 111.372 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.18 -55.91 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.21 0.529 . . . . 71.11 110.668 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -159.51 152.93 22.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.917 -0.583 . . . . 74.21 110.706 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HG2' HG12 ' A' ' 39' ' ' VAL . 91.3 mtt180 -79.57 150.48 31.07 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.062 0.458 . . . . 73.43 111.195 177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.84 -178.34 29.64 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.978 -0.555 . . . . 21.51 112.177 -173.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -75.03 161.91 29.03 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.265 -0.55 . . . . 73.22 111.388 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.42 93.68 0.24 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.159 0.799 . . . . 74.15 113.159 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -118.7 145.54 45.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.413 -0.812 . . . . 71.54 110.88 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.559 ' HB3' ' NZ ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.314 -0.851 . . . . 52.13 112.383 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 120.704 0.288 . . . . 52.23 110.665 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.53 118.19 18.11 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.35 0.5 . . . . 72.31 112.35 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 m -98.84 138.28 36.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.112 -0.495 . . . . 54.14 110.268 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.0 m -120.56 131.13 54.52 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.276 0.472 . . . . 63.35 112.276 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 7' ' ' VAL . 9.5 m-20 -83.45 112.13 19.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.21 -0.45 . . . . 75.32 111.726 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.72 32.08 16.87 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.757 0.663 . . . . 74.2 114.757 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 22' ' ' PRO . 93.1 t -106.96 122.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.541 0.67 . . . . 62.22 111.542 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -99.26 105.97 18.05 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.329 0.585 . . . . 72.14 111.747 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 80.9 m -148.34 137.95 22.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.002 -0.545 . . . . 52.41 110.127 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.74 -86.9 0.06 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 119.897 -1.144 . . . . 73.43 114.635 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.56 -35.64 80.47 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.12 2.547 . . . . 74.22 113.901 -172.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.96 -45.35 1.39 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.988 -0.625 . . . . 65.12 113.634 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.8 mtmt -123.63 146.87 47.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.489 0.552 . . . . 71.51 112.489 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -116.67 145.94 43.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 53.1 110.494 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 26.8 p -104.03 133.99 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.154 0.502 . . . . 64.31 112.198 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.48 ' NH2' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -118.86 164.26 15.68 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.987 -0.551 . . . . 73.43 111.161 176.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 mmt -82.11 102.94 11.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.891 0.377 . . . . 64.12 111.274 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.83 103.41 12.66 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.871 0.367 . . . . 70.42 110.212 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.18 33.01 82.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.341 -0.457 . . . . 71.24 112.686 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.34 -12.97 57.27 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.369 -0.443 . . . . 52.2 113.047 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 94.9 mtt180 -99.19 129.31 29.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 O-C-N 122.616 -0.343 . . . . 72.2 111.602 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.682 ' HB2' HG21 ' A' ' 7' ' ' VAL . 1.9 Cg_endo -80.95 113.75 2.8 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.966 2.444 . . . . 73.11 112.877 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -123.14 140.62 52.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.789 0.328 . . . . 74.52 111.472 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.4 m -104.1 131.74 51.06 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.894 0.701 . . . . 62.0 112.894 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . 86.0 mt-10 -124.83 159.97 29.81 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.235 172.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.5 t -64.68 119.32 10.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.102 0.477 . . . . 62.21 111.415 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -108.82 138.38 20.31 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.794 0.664 . . . . 61.02 112.794 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.4 Cg_exo -77.74 130.69 10.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.952 2.435 . . . . 64.03 112.229 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 10.8 t0 -66.04 84.89 0.09 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.35 0.595 . . . . 71.33 110.816 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 87.4 m -105.18 39.66 1.68 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.19 -0.459 . . . . 75.35 112.074 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -69.12 83.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.12 0.486 . . . . 74.4 111.855 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.9 52.61 11.25 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.615 0.606 . . . . 64.22 114.615 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' A' ' 51' ' ' CYS . 4.4 pp -114.0 157.08 43.0 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 117.394 0.597 . . . . 61.43 111.258 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.81 119.92 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.264 1.976 . . . . 73.03 112.784 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.01 -9.96 59.37 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.297 0.48 . . . . 73.54 112.297 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -90.22 -9.63 47.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.538 -0.301 . . . . 72.45 111.795 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.3 tp -98.85 117.35 33.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.002 0.43 . . . . 62.34 112.113 -174.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 46.7 mt-30 -75.72 159.82 30.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 73.41 110.827 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.0 m -144.4 148.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 112.332 0.493 . . . . 73.13 112.332 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 34.2 m -104.67 126.7 52.01 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.347 -0.388 . . . . 42.22 111.676 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.27 162.91 22.84 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.174 -0.536 . . . . 74.54 112.711 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 t -57.36 -18.23 16.33 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.206 0.447 . . . . 71.51 112.206 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.4 -38.51 80.75 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.935 0.398 . . . . 53.44 111.607 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.0 4.3 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.106 -0.569 . . . . 73.11 113.041 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.82 148.5 29.96 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.123 0.487 . . . . 44.33 112.155 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.439 HG21 ' HG2' ' A' ' 71' ' ' ARG . 96.2 m -86.18 137.38 32.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.714 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -106.68 143.66 34.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.474 -0.33 . . . . 74.43 111.452 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 68.5 mtt180 -43.71 -39.29 3.6 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.031 0.752 . . . . 74.11 113.031 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 3.3 p30 -167.04 172.11 10.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.838 0.352 . . . . 75.13 111.278 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HG3' HD22 ' A' ' 33' ' ' LEU . 13.4 tp10 -58.16 -34.12 69.95 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.491 -0.322 . . . . 71.23 111.765 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 33' ' ' LEU . 62.9 m -71.05 -34.67 71.46 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.864 -0.523 . . . . 64.22 111.164 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.69 -46.86 87.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 73.13 110.65 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.82 -40.46 95.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 70.51 109.799 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -59.54 -24.76 63.97 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.706 -0.679 . . . . 65.11 111.084 175.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.09 -35.18 17.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.131 -0.486 . . . . 64.45 111.146 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.44 -29.41 69.0 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.191 0.441 . . . . 55.34 112.191 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 20.2 ptt180 -55.43 -29.09 57.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.524 0.678 . . . . 73.01 110.843 173.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.5 t -82.65 -18.8 39.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.396 -0.82 . . . . 70.22 111.174 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -107.03 89.42 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.062 0.458 . . . . 63.32 111.481 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.78 -17.13 1.29 Allowed Glycine 0 CA--C 1.536 1.35 0 N-CA-C 115.321 0.888 . . . . 71.53 115.321 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 61.4 m80 -122.83 74.89 47.2 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 118.243 1.021 . . . . 71.02 112.2 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.1 -23.0 29.72 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.255 1.97 . . . . 71.32 112.957 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -96.21 10.38 38.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.456 -0.338 . . . . 75.12 111.742 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 tp -62.96 115.55 4.5 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.342 0.497 . . . . 54.15 112.342 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.2 m -114.14 163.76 14.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.251 -0.431 . . . . 73.25 111.344 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 HD13 ' A' ' 53' ' ' LEU . 39.8 t -90.91 127.34 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.084 0.402 . . . . 73.32 112.084 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.3 mtt -73.16 -53.77 10.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 63.3 110.483 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -168.01 167.82 12.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.804 -0.634 . . . . 74.12 110.462 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 150.06 25.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.186 0.517 . . . . 75.52 111.388 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.48 -162.0 15.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.849 -0.614 . . . . 64.52 112.456 -176.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' HG21 ' A' ' 46' ' ' THR . 73.3 mtm180 -98.41 147.25 24.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.938 0.399 . . . . 75.04 111.201 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 73.3 m -62.93 106.97 0.9 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.885 0.698 . . . . 62.41 112.885 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -118.03 131.72 56.44 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.066 -0.516 . . . . 71.32 110.863 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.599 -0.715 . . . . 73.32 111.665 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 81.0 p . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 112.252 0.464 . . . . 72.55 112.252 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -73.75 108.48 6.61 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.18 -0.325 . . . . 65.31 111.561 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 t -150.49 164.27 36.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.809 0.338 . . . . 32.12 111.351 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 54.5 m -140.43 140.44 35.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.203 0.445 . . . . 71.45 112.203 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 7' ' ' VAL . 22.5 t70 -50.77 111.83 0.61 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.415 0.524 . . . . 75.22 112.415 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.68 10.92 26.98 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.375 0.51 . . . . 65.21 114.375 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 22' ' ' PRO . 17.2 t -107.91 122.92 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 122.208 -0.583 . . . . 71.42 111.726 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.27 106.68 17.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.647 0.26 . . . . 75.51 110.416 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 7' ' ' VAL . 47.8 m -148.9 163.05 38.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.975 0.417 . . . . 63.13 111.655 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.92 -84.02 0.11 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.138 -0.483 . . . . 75.11 112.493 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.6 108.76 2.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.56 2.174 . . . . 75.21 112.52 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.69 6.38 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.88 -0.676 . . . . 75.33 113.109 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -142.85 136.9 29.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 117.164 0.482 . . . . 53.44 111.479 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.86 146.58 32.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.54 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 52.7 t -104.25 141.03 37.0 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.568 0.581 . . . . 73.21 112.568 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -142.46 132.86 24.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.008 -0.542 . . . . 74.4 110.393 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 67.9 mtp -86.75 121.1 28.78 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.133 0.492 . . . . 54.14 112.245 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.7 mt -112.8 118.1 34.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.806 -0.634 . . . . 75.05 110.58 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.06 30.61 67.16 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.045 -0.598 . . . . 61.31 113.384 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.18 -8.99 78.84 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.235 -0.507 . . . . 75.42 113.553 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.512 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 95.9 mtt180 -113.46 120.55 39.49 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 122.424 -0.456 . . . . 74.53 111.091 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.664 ' HB2' HG21 ' A' ' 7' ' ' VAL . 7.1 Cg_exo -75.29 143.69 28.45 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.037 2.491 . . . . 72.21 114.401 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 17.8 mmt180 -125.11 139.41 53.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.119 0.568 . . . . 73.14 110.814 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 89.4 m -122.28 118.97 29.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.986 0.422 . . . . 70.41 112.015 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -130.81 161.84 30.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.101 -0.5 . . . . 72.53 110.659 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 10.5 t -37.65 124.93 1.1 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.537 0.94 . . . . 72.55 113.537 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.02 143.84 27.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.779 -0.646 . . . . 74.04 111.306 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.15 52.7 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.469 2.113 . . . . 73.53 113.337 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.945 0.402 . . . . 52.5 110.456 173.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.551 ' HB2' HD21 ' A' ' 33' ' ' LEU . 24.8 p -134.37 23.4 3.76 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.795 0.665 . . . . 65.21 112.795 -171.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.2 t -65.19 106.38 1.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.874 0.368 . . . . 70.45 111.315 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.38 -42.87 0.92 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.758 -0.734 . . . . 73.41 113.499 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 50' ' ' GLU . 3.4 pp -67.66 152.51 96.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.359 0.503 . . . . 73.32 112.359 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 28.2 Cg_exo -62.77 137.67 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.677 2.251 . . . . 62.52 113.166 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 35.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.186 -0.461 . . . . 34.21 111.857 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 64.69 25.47 13.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.822 0.675 . . . . 70.12 112.822 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.1 tm? -84.85 102.8 13.37 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.672 -0.492 . . . . 75.13 109.672 174.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.662 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 64.2 mt-30 -66.26 145.89 55.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.726 0.639 . . . . 72.4 112.726 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.13 155.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.787 -0.642 . . . . 75.34 111.082 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.96 122.61 43.8 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.796 0.331 . . . . 62.51 111.603 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 47' ' ' TYR . . . -83.01 176.0 53.14 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.182 -0.532 . . . . 51.01 113.549 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.532 ' H ' HD12 ' A' ' 64' ' ' LEU . 40.1 t -54.8 -40.43 69.49 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.914 0.709 . . . . 70.23 112.914 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.53 -20.01 65.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.923 0.392 . . . . 75.12 111.995 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 14.76 42.8 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.439 -0.41 . . . . 70.13 112.53 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.33 142.66 28.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.901 0.381 . . . . 72.33 111.752 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -87.14 117.29 25.79 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.083 0.468 . . . . 73.43 111.452 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HE2' ' HA3' ' A' ' 41' ' ' GLY . 83.6 m-85 -94.65 138.78 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.248 -0.433 . . . . 72.41 109.971 174.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -66.42 -6.9 16.16 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.559 0.578 . . . . 62.52 112.559 -175.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 4.8 p-10 -174.5 155.91 2.35 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.914 0.485 . . . . 60.31 110.934 172.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 33' ' ' LEU . 41.7 tt0 -62.35 -30.79 71.43 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.172 0.434 . . . . 70.15 112.172 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.446 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 26.6 t -61.36 -40.19 93.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.223 0.535 . . . . 72.21 110.489 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -60.45 -44.01 96.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.675 -0.693 . . . . 71.12 110.784 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.56 -39.57 76.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.111 -0.495 . . . . 72.34 110.889 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -58.87 -49.43 77.79 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.989 0.423 . . . . 75.44 111.208 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.11 96.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.093 0.473 . . . . 72.21 111.211 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.3 96.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.143 -0.481 . . . . 74.03 111.548 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 23.2 ttt85 -61.82 -51.41 68.37 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.026 0.441 . . . . 72.41 111.342 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 74.7 m -75.47 -2.99 31.41 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.23 0.456 . . . . 64.24 112.23 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -78.88 -59.97 2.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.838 0.351 . . . . 73.43 110.112 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.47 27.31 0.32 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.962 -0.637 . . . . 63.33 113.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.704 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 37.8 m80 -134.53 76.33 61.61 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 122.233 -0.569 . . . . 72.43 111.668 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.34 -12.61 28.15 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.691 2.261 . . . . 63.02 113.45 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.82 8.07 26.49 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.843 0.312 . . . . 74.0 111.843 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.704 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 59.6 tp -73.44 111.34 8.48 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.154 0.502 . . . . 73.41 111.497 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.8 m -129.17 152.93 48.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 73.31 110.416 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.72 114.73 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.284 0.564 . . . . 64.43 111.579 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.3 mmt -65.9 -41.57 91.3 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.012 0.434 . . . . 72.25 111.186 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.62 150.55 6.0 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.053 -0.521 . . . . 54.44 111.689 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.18 140.84 43.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.981 -0.554 . . . . 75.24 111.865 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.25 170.35 20.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.187 -0.46 . . . . 43.4 112.509 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HG2' ' OE1' ' A' ' 38' ' ' GLN . 64.2 mtt-85 -61.0 132.11 52.79 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.612 -0.346 . . . . 73.24 110.454 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.49 96.99 0.73 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.197 0.522 . . . . 72.53 112.327 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -107.77 106.05 16.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.46 -0.791 . . . . 70.31 110.496 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? . . . . . 0 C--O 1.254 1.296 0 CA-C-O 119.114 -0.469 . . . . 63.44 110.734 -177.654 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.581 0.229 . . . . 62.32 111.27 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -109.66 174.55 5.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.845 0.355 . . . . 53.21 111.044 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.2 m -84.97 154.78 21.93 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.135 0.493 . . . . 61.13 111.734 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.7 m -98.68 130.73 45.19 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.18 -0.464 . . . . 65.31 111.388 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 7' ' ' VAL . 23.5 t70 -76.4 111.68 12.12 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.868 0.366 . . . . 54.52 111.191 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.76 -4.16 2.44 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.482 0.553 . . . . 24.41 114.482 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 14.1 t -97.49 126.25 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 117.408 0.604 . . . . 71.04 111.579 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.98 105.3 16.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.69 0.281 . . . . 73.03 110.985 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.0 m -149.05 158.78 44.45 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.374 0.509 . . . . 72.04 112.374 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.11 -107.67 0.2 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.107 -0.497 . . . . 71.43 112.758 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.83 102.69 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.323 2.015 . . . . 71.11 112.941 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.47 -3.88 56.57 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.958 -0.639 . . . . 62.55 113.813 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -143.22 136.12 27.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.316 0.579 . . . . 73.22 112.314 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -131.17 155.21 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.684 -0.689 . . . . 54.14 110.649 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.63 126.45 41.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.066 0.46 . . . . 50.42 111.209 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -123.5 137.32 54.8 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.138 -0.483 . . . . 53.52 110.465 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.9 mmm -85.79 102.58 13.79 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.113 0.483 . . . . 64.21 111.951 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 23' ' ' ARG . 4.1 mm? -109.11 115.69 30.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.2 -0.455 . . . . 64.43 110.303 174.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.8 27.67 67.03 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.157 -0.544 . . . . 74.11 113.261 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.51 85.14 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.483 -0.389 . . . . 55.43 113.696 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -109.55 126.68 28.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.517 -0.402 . . . . 53.52 111.439 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.44 104.36 1.73 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.42 2.08 . . . . 73.21 113.253 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.551 ' HG2' HD23 ' A' ' 18' ' ' LEU . 7.5 ptp180 -97.18 157.65 15.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.477 -0.328 . . . . 71.22 110.839 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 30.2 m -111.11 120.36 42.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.21 0.529 . . . . 72.33 112.093 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -107.02 160.17 15.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.691 -0.686 . . . . 64.43 109.959 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.22 95.87 0.14 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.057 0.456 . . . . 64.21 111.179 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.7 119.26 59.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.129 -0.487 . . . . 53.4 110.764 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 55' ' ' ALA . 22.4 Cg_endo -59.86 102.15 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.321 2.014 . . . . 62.54 112.932 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.46 100.34 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.001 0.429 . . . . 61.54 109.961 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.6 p -139.57 35.57 2.03 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.288 -0.415 . . . . 64.3 111.36 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.8 t -58.27 -37.89 75.88 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.242 -0.436 . . . . 74.43 111.842 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.41 43.16 1.75 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.365 -0.445 . . . . 40.21 113.151 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.454 HD11 ' NH2' ' A' ' 54' ' ' ARG . 87.9 mt -130.4 152.92 81.1 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.717 0.294 . . . . 73.11 111.428 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.09 119.94 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.211 1.941 . . . . 75.24 112.381 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.41 17.95 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.086 0.47 . . . . 60.42 111.65 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -120.84 -21.26 6.66 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.613 0.597 . . . . 71.44 112.613 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 69' ' ' ARG . 8.1 tt -93.2 120.84 33.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.832 0.349 . . . . 63.42 111.442 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.694 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 48.7 mt-30 -73.56 142.49 46.64 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.746 0.647 . . . . 74.2 112.746 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HB ' HG13 ' A' ' 66' ' ' VAL . 27.0 m -128.93 159.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.109 -0.496 . . . . 74.33 111.577 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 51.8 t -106.13 127.46 53.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.887 0.375 . . . . 62.21 111.775 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.54 155.91 32.81 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.168 -0.469 . . . . 75.14 113.257 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.51 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 43.8 t -53.79 -32.3 52.07 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.981 0.734 . . . . 72.12 112.981 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.78 -2.95 52.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.055 0.455 . . . . 74.24 112.135 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.38 20.91 39.68 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.199 -0.524 . . . . 72.43 113.136 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.9 132.52 42.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.789 0.328 . . . . 64.02 111.309 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -85.78 122.44 29.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.963 0.411 . . . . 71.42 111.703 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -112.84 147.35 37.15 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.998 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.694 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 31.2 mmt-85 -75.29 -20.33 59.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.359 -0.382 . . . . 54.42 111.739 -173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -163.99 161.65 22.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.061 -0.518 . . . . 64.2 111.092 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG2' HG21 ' A' ' 66' ' ' VAL . 1.7 tm-20 -57.61 -40.38 79.02 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.175 0.512 . . . . 70.43 110.701 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 25.7 t -59.64 -38.23 80.83 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.974 0.416 . . . . 53.34 111.461 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.11 -43.88 90.57 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.069 0.461 . . . . 71.2 111.05 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.65 HD13 HG22 ' A' ' 66' ' ' VAL . 10.3 tt -64.83 -47.25 78.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.991 -0.55 . . . . 75.21 110.99 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' NH2' HD11 ' A' ' 33' ' ' LEU . 19.0 ttm180 -55.14 -37.25 66.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.079 0.466 . . . . 74.22 111.13 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HB2' ' HG3' ' A' ' 28' ' ' PRO . . . -65.6 -47.65 74.96 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.179 -0.464 . . . . 71.32 111.262 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.91 -38.3 75.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.986 0.422 . . . . 62.24 111.633 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 76.2 ttt180 -60.74 -50.45 73.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.935 0.397 . . . . 75.21 111.085 175.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.27 -29.47 70.56 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.986 0.422 . . . . 75.32 111.664 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 59' ' ' ARG . 35.3 ttt-85 -61.8 -38.68 89.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.212 -0.449 . . . . 73.21 111.254 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.57 36.28 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.033 -0.603 . . . . 63.42 113.68 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.421 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 96.9 m-70 -134.31 78.13 58.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.297 -0.531 . . . . 70.21 111.507 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.62 -28.62 25.71 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.636 2.224 . . . . 71.32 113.186 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.24 -11.94 58.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.249 0.547 . . . . 64.33 111.328 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 5.8 tt -92.88 114.97 27.67 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.591 0.71 . . . . 74.32 111.331 -175.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.492 ' HA ' HD21 ' A' ' 53' ' ' LEU . 69.5 m -144.58 166.27 25.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.613 -0.721 . . . . 72.01 110.193 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.65 HG22 HD13 ' A' ' 53' ' ' LEU . 75.4 t -69.07 111.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.018 0.437 . . . . 63.42 111.65 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 42' ' ' SER . 66.1 mtm -81.69 -53.73 5.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.133 -0.485 . . . . 65.24 110.996 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.33 164.57 31.06 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.887 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.504 ' HB3' HD21 ' A' ' 37' ' ' LEU . 98.9 mtt180 -96.77 151.68 19.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.987 0.423 . . . . 72.44 111.639 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 47.85 1.74 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.185 -0.531 . . . . 62.22 112.549 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.61 -177.54 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.351 1.061 . . . . 73.11 113.364 -176.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.4 m -89.51 105.36 17.74 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.789 -0.569 . . . . 62.24 111.078 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -115.95 132.49 56.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.068 -0.514 . . . . 74.31 111.75 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.196 -0.907 . . . . 53.51 111.596 175.194 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.742 0.306 . . . . 74.13 111.169 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 9.0 m-20 -103.97 102.25 12.03 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.155 0.502 . . . . 72.42 112.063 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m -125.55 116.7 22.18 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.134 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.412 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.6 m -101.91 128.55 48.25 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.025 0.44 . . . . 74.11 111.721 -171.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.53 115.05 23.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.302 -0.408 . . . . 72.24 111.953 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.91 -31.74 1.07 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.217 -0.516 . . . . 70.42 113.538 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.562 HG21 ' HG2' ' A' ' 22' ' ' PRO . 12.1 t -67.94 105.07 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 122.545 -0.385 . . . . 72.34 110.985 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.8 105.78 17.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 71.41 110.844 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.1 m -133.33 137.33 45.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 74.33 111.396 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.16 -68.0 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.978 -0.555 . . . . 62.13 112.245 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.03 79.46 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.697 2.265 . . . . 63.12 112.408 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.77 54.99 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.356 -0.449 . . . . 73.33 113.68 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -145.53 148.87 33.67 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.627 0.713 . . . . 74.12 112.292 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.41 140.83 47.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.787 -0.642 . . . . 34.34 109.872 172.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.731 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 28.6 p -100.11 145.84 27.5 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.366 0.603 . . . . 64.24 111.422 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -129.78 133.74 47.17 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.629 -0.714 . . . . 65.33 110.826 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.417 ' HG3' ' HA ' ' A' ' 2' ' ' ASP . 0.5 OUTLIER -73.86 103.13 4.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 70.15 111.325 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 98.0 mt -127.42 117.74 22.74 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.931 0.396 . . . . 65.14 111.788 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.6 26.34 66.52 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.562 -0.351 . . . . 73.11 113.826 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.07 -0.01 75.07 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.111 -0.566 . . . . 74.44 113.376 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -131.74 138.49 32.67 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 117.121 0.461 . . . . 73.41 112.014 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.562 ' HG2' HG21 ' A' ' 7' ' ' VAL . 97.1 Cg_endo -80.81 118.97 3.52 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.735 2.29 . . . . 52.3 113.571 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -109.23 137.26 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.26 -0.275 . . . . 62.12 110.365 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.731 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -103.82 139.9 38.39 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.847 0.684 . . . . 74.35 112.847 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.42 160.68 34.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.895 -0.593 . . . . 63.14 110.606 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -57.72 112.87 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.22 0.452 . . . . 65.32 112.22 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.36 119.71 55.48 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.131 -0.486 . . . . 61.31 110.916 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 86.84 1.09 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.384 2.056 . . . . 74.0 113.266 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.68 100.23 12.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.271 0.557 . . . . 65.54 110.368 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.4 p -98.68 134.38 41.68 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.278 -0.419 . . . . 63.14 111.907 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.3 p -99.49 -76.01 0.55 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.269 -0.423 . . . . 74.04 111.356 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.27 39.51 3.0 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.217 -0.516 . . . . 74.55 113.598 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 34.1 mt -120.34 135.71 24.69 Favored Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 122.395 -0.474 . . . . 65.24 110.6 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.45 139.65 31.96 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.46 2.106 . . . . 72.45 113.239 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.75 141.91 30.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.793 0.33 . . . . 74.24 111.408 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 64.29 6.23 2.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.253 0.621 . . . . 72.32 112.545 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 2.4 tm? -93.19 95.41 9.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.412 -0.588 . . . . 60.14 109.412 176.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -54.79 137.06 45.63 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.718 0.636 . . . . 74.25 112.718 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 35.7 m -129.96 156.76 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.149 -0.478 . . . . 71.43 111.439 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -100.55 118.13 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.295 -0.411 . . . . 71.54 110.941 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.79 168.44 39.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.396 -0.431 . . . . 73.43 113.793 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.7 t -49.86 -37.05 29.29 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.792 0.664 . . . . 45.21 112.792 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.24 -33.9 68.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.038 0.446 . . . . 74.11 112.037 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.89 18.94 18.76 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.724 -0.55 . . . . 52.24 111.724 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.66 146.81 40.44 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.981 0.419 . . . . 74.21 111.444 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.493 HG21 ' HG2' ' A' ' 71' ' ' ARG . 38.6 m -86.05 120.23 27.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.121 -0.49 . . . . 61.11 111.414 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.76 157.51 16.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.429 -0.351 . . . . 73.42 110.982 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -49.2 -42.59 40.66 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.047 0.388 . . . . 73.05 112.047 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 51' ' ' CYS . 1.5 p30 -173.42 175.49 3.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.08 -0.509 . . . . 74.05 111.122 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -62.25 -31.5 72.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.892 0.377 . . . . 64.13 111.677 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.477 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 42.1 t -66.86 -40.53 87.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.213 0.53 . . . . 74.41 110.408 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -68.85 -38.02 79.51 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.797 -0.638 . . . . 75.11 110.941 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 66' ' ' VAL . 10.4 tt -58.16 -43.4 87.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.872 0.368 . . . . 55.4 110.469 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -57.92 -38.77 76.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.383 -0.371 . . . . 74.45 111.227 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.99 44.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.382 . . . . 73.55 111.322 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.97 75.28 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.905 0.383 . . . . 74.13 111.54 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 46.3 ttt-85 -64.58 -50.37 67.5 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.934 0.397 . . . . 63.51 110.659 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 37.1 t -63.11 -33.09 74.71 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.181 -0.463 . . . . 72.1 111.857 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -65.81 -31.65 72.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.501 -0.318 . . . . 75.13 111.612 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.23 37.2 0.02 OUTLIER Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.84 -0.695 . . . . 64.31 113.995 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 85.1 m-70 -135.56 82.62 38.88 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.213 0.506 . . . . 53.2 112.168 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.28 -25.93 49.28 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.452 2.102 . . . . 71.53 112.976 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.3 -20.02 60.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.361 . . . . 72.24 111.683 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.5 tp -69.63 112.54 6.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.521 0.677 . . . . 75.21 112.664 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.4 p -131.15 164.22 25.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.674 -0.694 . . . . 71.51 110.753 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 53' ' ' LEU . 59.8 t -87.17 112.52 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.89 0.376 . . . . 64.44 111.544 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.0 mmt -81.16 -42.52 20.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.049 0.452 . . . . 72.14 110.979 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 45.9 p90 -169.4 156.75 6.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.021 -0.536 . . . . 52.22 110.812 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -82.82 125.54 31.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.023 0.44 . . . . 75.44 110.876 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 131.93 -175.79 19.58 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.134 -0.485 . . . . 74.33 112.105 -174.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.493 ' HG2' HG21 ' A' ' 46' ' ' THR . 96.1 mtt180 -86.03 140.2 30.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.613 -0.345 . . . . 64.53 111.186 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.428 ' HA ' ' OH ' ' A' ' 68' ' ' TYR . 96.4 m -59.79 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.261 0.467 . . . . 54.34 112.261 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -119.36 123.52 44.36 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.895 -0.593 . . . . 65.44 110.326 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.403 -0.808 . . . . 73.35 110.572 -178.844 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.834 0.35 . . . . 75.41 111.126 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.34 80.73 0.37 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.402 0.62 . . . . 71.43 111.802 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m -99.47 123.89 44.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.703 -0.681 . . . . 52.42 110.401 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.0 m -98.31 127.23 44.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.963 0.411 . . . . 63.4 111.515 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.547 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 14.4 t70 -86.64 112.54 21.71 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.09 -0.505 . . . . 61.25 110.973 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.9 -32.92 0.74 Allowed Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.156 -0.545 . . . . 72.23 114.21 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 18.3 t -66.19 117.45 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.96 0.38 . . . . 54.3 111.708 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -106.73 106.88 17.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.831 0.348 . . . . 71.34 111.28 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 71.5 m -140.03 142.61 36.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.031 0.443 . . . . 62.33 111.758 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.97 -52.88 0.04 OUTLIER Glycine 0 CA--C 1.532 1.103 0 CA-C-N 115.729 -0.669 . . . . 60.04 113.273 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.63 87.09 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 60.2 112.983 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.49 15.46 79.12 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.386 -0.435 . . . . 71.1 113.778 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -146.26 135.76 23.04 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.575 -0.368 . . . . 64.25 110.97 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.95 137.77 53.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.595 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.0 p -100.65 122.78 43.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.91 0.386 . . . . 45.14 110.342 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HG3' ' HG ' ' A' ' 18' ' ' LEU . 10.7 ptm180 -129.2 160.55 32.57 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.079 0.4 . . . . 75.51 112.079 -172.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.9 mmt -76.25 101.89 5.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.88 0.371 . . . . 72.23 111.448 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HG ' ' HG3' ' A' ' 16' ' ' ARG . 94.5 mt -133.36 111.62 10.94 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.828 0.347 . . . . 75.35 110.579 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.41 44.91 82.8 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.913 -0.66 . . . . 73.45 112.678 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.29 -49.48 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.003 0.361 . . . . 71.14 114.003 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -92.92 137.87 23.66 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 121.032 0.444 . . . . 73.42 111.828 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 64.9 Cg_endo -72.51 129.74 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.516 2.144 . . . . 73.41 112.92 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -129.42 150.97 50.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.437 -0.347 . . . . 75.53 110.69 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 84.9 m -104.47 146.26 29.12 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.378 0.609 . . . . 63.43 112.262 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -143.94 161.44 38.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.881 -0.6 . . . . 73.35 110.535 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 12.7 t -64.17 84.04 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.209 0.528 . . . . 72.24 111.092 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.12 118.9 32.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 62.2 109.954 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.79 100.84 1.11 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.338 2.025 . . . . 70.2 114.276 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.21 98.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.546 -0.538 . . . . 63.44 109.546 166.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.65 ' HB2' HD11 ' A' ' 33' ' ' LEU . 6.3 p -121.87 91.82 3.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.444 0.535 . . . . 63.31 112.444 -172.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -107.98 166.11 10.96 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.921 -0.582 . . . . 71.33 110.861 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.97 -56.31 3.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.046 -0.597 . . . . 65.24 112.647 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 30' ' ' CYS . 4.5 pp -73.07 146.01 86.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.462 -0.434 . . . . 74.22 110.339 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.19 119.14 5.85 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 121.768 1.645 . . . . 50.21 113.509 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.23 15.22 6.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.829 0.347 . . . . 74.32 111.918 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -135.11 14.43 3.55 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.777 0.288 . . . . 74.22 111.777 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 38' ' ' GLN . 1.7 tm? -119.69 136.65 54.33 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.949 0.404 . . . . 74.15 110.645 -177.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.577 ' N ' HD13 ' A' ' 37' ' ' LEU . 37.6 mt-30 -63.74 137.67 58.17 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.352 0.501 . . . . 73.44 112.352 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 50' ' ' GLU . 34.6 m -128.6 152.38 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.126 0.488 . . . . 75.43 111.56 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.8 t -101.01 128.66 46.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.962 -0.563 . . . . 51.11 111.739 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.02 152.95 19.96 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.495 -0.383 . . . . 53.34 113.074 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.6 t -57.25 -31.88 66.0 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.942 0.401 . . . . 62.12 111.996 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.33 -20.49 65.55 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.152 0.427 . . . . 65.32 112.152 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.4 14.77 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.306 -0.474 . . . . 65.13 112.732 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.38 135.15 54.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.775 0.321 . . . . 72.25 111.547 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 m -94.81 128.58 41.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.863 0.363 . . . . 73.33 111.439 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.06 154.83 21.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.745 0.307 . . . . 55.24 111.363 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -66.59 -20.14 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.956 0.408 . . . . 55.41 111.575 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -165.49 155.59 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.714 -0.676 . . . . 75.42 110.071 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.627 ' HA ' HG21 ' A' ' 39' ' ' VAL . 31.3 tt0 -60.03 -34.43 73.38 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.044 0.45 . . . . 72.3 110.976 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -58.99 -37.33 76.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.293 -0.412 . . . . 73.43 110.729 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.97 -40.21 91.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.868 0.366 . . . . 71.24 110.852 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.86 -47.98 82.99 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.094 0.473 . . . . 65.11 110.301 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 50' ' ' GLU . 2.2 mpt_? -64.19 -39.43 93.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.235 -0.439 . . . . 75.15 111.222 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.997 0.427 . . . . 62.2 111.517 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -34.96 76.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.406 0.622 . . . . 51.21 110.833 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.11 92.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.912 -0.585 . . . . 71.34 110.446 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 73.4 m -64.22 -26.74 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 111.822 0.304 . . . . 74.04 111.822 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -64.24 -34.07 77.25 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.977 0.418 . . . . 72.34 111.27 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.66 35.17 0.05 OUTLIER Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.275 -0.488 . . . . 42.44 113.082 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -128.65 79.05 75.03 Favored Pre-proline 0 CA--C 1.539 0.533 0 O-C-N 122.37 -0.489 . . . . 71.24 111.44 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.22 -28.26 72.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.461 2.107 . . . . 75.42 112.21 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.33 -22.9 66.88 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.918 -0.583 . . . . 65.12 111.994 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.02 111.71 8.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.476 0.655 . . . . 72.44 112.044 -174.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -127.75 161.17 29.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.295 -0.866 . . . . 75.2 110.594 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p -88.8 134.76 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.203 0.525 . . . . 74.11 111.956 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 16.7 mmt -90.65 -59.05 2.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.363 -0.381 . . . . 74.35 110.974 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -164.52 164.34 21.81 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.099 0.476 . . . . 73.22 112.006 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -75.65 111.98 11.54 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.828 -0.624 . . . . 71.55 111.057 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 139.36 161.23 8.65 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.337 -0.392 . . . . 63.41 112.147 -174.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -72.58 134.85 45.39 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.249 0.525 . . . . 75.45 112.4 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.0 m -58.12 99.88 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.033 -0.53 . . . . 74.53 111.889 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -109.86 136.58 48.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 64.1 111.005 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.55 -0.738 . . . . 75.11 110.819 175.416 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 66.6 m . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.876 0.37 . . . . 71.420000000000002 110.771 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 72.4 m -100.03 172.99 6.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.862 0.319 . . . . 71.400000000000006 111.862 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.87 112.7 0.82 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.1 -0.5 . . . . 63.520000000000003 111.485 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.73 2.16 49.59 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.471 -0.395 . . . . 63.530000000000001 113.961 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' A' ' 22' ' ' PRO . 3.6 t -107.04 122.46 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 122.462 -0.434 . . . . 71.150000000000006 111.373 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.88 110.18 21.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.49 0.662 . . . . 64.439999999999998 111.421 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 55.1 m -136.14 180.0 6.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.09 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.57 -91.1 0.25 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 54.229999999999997 112.752 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.67 88.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.848 2.365 . . . . 74.340000000000003 112.839 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.621 ' H ' ' HB3' ' A' ' 29' ' ' ASP . . . 83.92 12.89 76.15 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.104 -0.498 . . . . 61.439999999999998 113.372 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.645 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 51.4 mtmt -141.3 136.67 31.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.376 0.51 . . . . 75.230000000000004 112.376 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.08 51.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.882 -0.599 . . . . 53.310000000000002 109.962 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 18.3 p -122.78 143.2 49.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.364 0.505 . . . . 74.230000000000004 112.364 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 16' ' ' ARG . 40.2 ttp180 -143.74 148.8 36.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.086 -0.506 . . . . 71.510000000000005 110.259 173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 69.5 mtp -80.99 120.39 24.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.185 0.517 . . . . 62.329999999999998 112.072 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.6 106.14 18.27 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.952 -0.567 . . . . 75.439999999999998 109.664 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.57 -94.5 0.13 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.929 -0.653 . . . . 43.25 112.007 -174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.64 -8.2 12.63 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.177 -0.535 . . . . 51.140000000000001 113.881 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.459 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 27.3 ptt180 -121.04 133.27 24.12 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 117.573 0.687 . . . . 62.340000000000003 112.285 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 2.5 Cg_endo -81.89 128.82 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.143 2.562 . . . . 73.010000000000005 113.42 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -111.85 152.49 27.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.457 -0.338 . . . . 73.329999999999998 111.07 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 6.6 t -120.15 137.25 54.28 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.584 0.231 . . . . 63.509999999999998 110.465 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -131.82 146.14 51.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.75 0.31 . . . . 61.109999999999999 111.544 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 96.5 m -60.14 100.22 0.09 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.998 0.427 . . . . 52.219999999999999 111.141 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.24 155.29 53.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 64.209999999999994 111.359 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.71 107.75 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.372 2.048 . . . . 75.219999999999999 113.069 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.621 ' HB3' ' H ' ' A' ' 12' ' ' GLY . 10.7 p-10 -79.12 84.12 5.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.839 0.828 . . . . 74.319999999999993 110.81 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.4 m -83.74 84.5 7.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.526 -0.761 . . . . 51.32 112.226 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t -78.76 -145.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.903 -0.589 . . . . 73.439999999999998 110.487 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.66 80.84 0.12 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.863 -0.684 . . . . 71.510000000000005 112.997 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 51' ' ' CYS . 3.9 pp -155.33 148.59 18.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 122.609 -0.347 . . . . 75.340000000000003 111.758 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.94 120.33 3.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.554 2.169 . . . . 52.229999999999997 112.533 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.59 16.79 0.45 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.583 0.586 . . . . 61.399999999999999 112.583 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -115.21 -18.14 11.2 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.848 0.356 . . . . 74.329999999999998 111.735 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 61.6 tp -83.64 105.86 14.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.855 0.36 . . . . 55.439999999999998 111.757 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -59.86 160.09 8.14 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.032 -0.531 . . . . 61.219999999999999 112.132 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -157.58 144.66 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.331 -0.395 . . . . 53.119999999999997 111.963 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.2 128.52 46.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.907 0.384 . . . . 55.399999999999999 110.755 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 64' ' ' LEU . . . -90.35 177.52 42.55 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.257 -0.497 . . . . 73.230000000000004 113.541 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 m -60.82 -19.26 59.39 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.159 0.429 . . . . 73.140000000000001 112.159 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.54 -42.88 64.25 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.511 -0.313 . . . . 52.149999999999999 111.282 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.59 -0.27 8.62 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.25 -0.5 . . . . 72.400000000000006 113.895 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.27 146.19 27.21 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.218 -0.577 . . . . 65.109999999999999 111.891 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.3 m -86.3 108.32 18.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.088 0.471 . . . . 72.310000000000002 111.39 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -78.68 160.13 27.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.899 -0.591 . . . . 75.329999999999998 111.115 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -57.48 -34.85 69.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.371 0.508 . . . . 63.140000000000001 112.371 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.9 p30 -167.66 174.74 7.48 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.855 0.687 . . . . 72.549999999999997 112.855 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -46.99 -47.44 21.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.175 -0.92 . . . . 54.43 112.394 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.492 ' HB2' HD11 ' A' ' 33' ' ' LEU . 33.7 t -70.25 -40.24 74.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.058 -0.519 . . . . 62.140000000000001 111.028 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -54.25 -40.66 67.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.336 0.588 . . . . 64.510000000000005 111.203 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.461 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.91 -45.98 83.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.084 -0.507 . . . . 72.239999999999995 110.501 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -59.74 -27.54 66.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.138 -0.483 . . . . 72.349999999999994 111.765 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.09 -55.87 5.9 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 62.439999999999998 111.594 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . . . -53.35 -33.16 52.47 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.129 0.49 . . . . 60.439999999999998 111.198 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -48.97 -50.3 36.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.616 -0.72 . . . . 73.219999999999999 111.421 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 45.4 t -77.99 -23.54 48.33 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.04 0.448 . . . . 64.219999999999999 111.033 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 35.2 mmt180 -78.04 34.85 0.2 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.591 0.589 . . . . 63.450000000000003 112.591 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.66 23.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.226 -0.512 . . . . 74.129999999999995 114.118 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.403 ' HD2' ' HB1' ' A' ' 56' ' ' ALA . 27.9 m-70 -131.71 74.4 77.78 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.521 0.66 . . . . 74.299999999999997 111.055 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.05 -29.37 40.33 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.562 2.175 . . . . 61.119999999999997 112.608 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.53 -13.23 60.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.035 -0.53 . . . . 74.420000000000002 111.993 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -65.96 112.07 3.64 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.266 0.555 . . . . 72.409999999999997 111.948 -171.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -134.59 157.58 46.21 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.095 -0.502 . . . . 70.540000000000006 110.691 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.461 HG22 HD13 ' A' ' 53' ' ' LEU . 97.2 t -71.97 127.43 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.56 0.578 . . . . 72.310000000000002 112.56 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.4 mtt -94.81 -53.64 3.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.372 -0.377 . . . . 70.530000000000001 110.758 171.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -165.23 167.53 17.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.887 0.375 . . . . 74.219999999999999 111.568 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -85.8 172.02 11.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.649 0.611 . . . . 74.319999999999993 112.649 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.37 -154.22 53.13 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.549 -0.751 . . . . 41.549999999999997 113.863 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -70.2 138.78 52.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.847 0.356 . . . . 71.430000000000007 111.004 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.62 84.9 2.66 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.259 0.552 . . . . 72.019999999999996 110.29 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 112.923 0.712 . . . . 74.310000000000002 112.923 -173.063 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.576 0.227 . . . . 73.450000000000003 110.485 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 15.1 m -129.6 126.89 39.51 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.144 -0.348 . . . . 75.120000000000005 111.014 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.43 112.13 23.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.852 -0.158 . . . . 72.219999999999999 111.338 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.95 49.0 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 114.463 0.545 . . . . 73.510000000000005 114.463 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 50.7 t -107.09 109.58 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 117.247 0.523 . . . . 64.340000000000003 110.887 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -91.5 106.5 18.53 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.349 0.5 . . . . 75.430000000000007 112.349 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 94.7 m -148.25 138.38 22.58 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.17 -0.468 . . . . 50.119999999999997 110.613 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 -121.27 0.9 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.913 -0.66 . . . . 65.420000000000002 113.519 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.39 107.84 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.597 2.198 . . . . 74.420000000000002 112.744 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 118.0 -54.96 0.59 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.095 -0.502 . . . . 75.340000000000003 112.255 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -135.39 134.95 40.24 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.802 0.334 . . . . 74.239999999999995 111.215 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.42 138.95 42.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 110.476 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.595 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 20.2 p -100.15 125.21 46.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.124 0.488 . . . . 74.540000000000006 111.277 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -144.16 159.54 42.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 74.530000000000001 109.777 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 47.8 mtp -78.97 103.67 9.08 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.682 -0.636 . . . . 72.099999999999994 111.957 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.06 141.2 48.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 110.387 175.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.47 26.29 64.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.819 -0.705 . . . . 55.329999999999998 112.743 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.61 84.71 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.515 -0.374 . . . . 71.219999999999999 113.824 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -133.79 140.32 36.22 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 117.549 0.674 . . . . 74.319999999999993 111.676 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 27.5 Cg_endo -61.2 115.38 2.69 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.455 2.103 . . . . 65.530000000000001 113.455 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 35.4 mmt180 -118.05 156.53 28.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.869 0.467 . . . . 74.450000000000003 110.93 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 98.6 m -118.18 121.09 39.62 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.877 0.37 . . . . 63.210000000000001 111.77 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -133.85 161.36 34.96 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.468 -0.333 . . . . 60.020000000000003 111.058 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 37.0 t -55.26 130.15 41.13 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.421 0.897 . . . . 54.439999999999998 113.421 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.76 118.53 31.87 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.939 -0.573 . . . . 73.439999999999998 111.059 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.91 147.53 68.5 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.311 2.007 . . . . 71.239999999999995 112.75 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.41 31.7 0.12 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.35 0.5 . . . . 70.319999999999993 112.35 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.597 ' HA ' HD12 ' A' ' 33' ' ' LEU . 24.3 p -90.16 15.34 10.47 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.581 0.956 . . . . 71.540000000000006 113.581 -171.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -69.17 75.88 0.35 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.446 0.641 . . . . 52.549999999999997 110.527 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.16 6.39 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.034 -0.53 . . . . 63.25 112.97 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 30' ' ' CYS . 67.6 mt -94.42 151.14 39.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 122.474 -0.427 . . . . 72.409999999999997 111.467 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.29 119.32 6.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.335 2.023 . . . . 75.319999999999993 113.006 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.68 -4.56 53.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.129 0.49 . . . . 55.409999999999997 111.57 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -101.07 -1.0 35.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.203 -0.453 . . . . 71.439999999999998 112.024 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 58.1 tp -116.73 119.11 34.43 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.218 -0.301 . . . . 72.010000000000005 111.775 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -64.32 163.42 13.05 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.165 0.507 . . . . 62.340000000000003 112.188 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.581 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 10.0 p -150.51 144.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.019 0.378 . . . . 62.450000000000003 112.019 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 95.8 m -100.62 128.79 46.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.977 0.417 . . . . 52.109999999999999 111.122 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -101.62 177.65 27.06 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.241 -0.504 . . . . 65.549999999999997 113.467 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.9 p -61.88 -14.64 35.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.948 0.404 . . . . 72.230000000000004 111.839 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.36 -16.64 61.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.235 -0.439 . . . . 64.120000000000005 111.241 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.09 -14.44 62.56 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.435 -0.348 . . . . 74.140000000000001 113.494 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.04 153.68 19.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.667 0.617 . . . . 74.109999999999999 112.667 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -86.17 145.74 26.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.053 -0.522 . . . . 54.240000000000002 110.887 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.58 160.89 21.59 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.552 -0.295 . . . . 73.510000000000005 111.302 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 48' ' ' ARG . 1.5 tmm_? -51.39 -43.31 61.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.071 0.548 . . . . 74.219999999999999 111.857 -175.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.554 ' H ' ' HB3' ' A' ' 52' ' ' GLU . 4.7 p-10 -159.85 177.46 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.894 0.378 . . . . 64.319999999999993 111.469 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' HG11 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -57.94 -47.79 81.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.145 0.498 . . . . 72.340000000000003 111.453 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.4 t -65.81 -39.57 91.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.548 -0.296 . . . . 72.519999999999996 111.055 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.554 ' HB3' ' H ' ' A' ' 49' ' ' ASP . 5.8 tp10 -52.28 -41.17 62.66 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.318 -0.401 . . . . 53.020000000000003 111.246 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' HD21 ' A' ' 64' ' ' LEU . 9.7 tt -56.79 -56.01 27.0 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.205 0.526 . . . . 74.329999999999998 110.484 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -64.33 -29.55 70.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.118 -0.492 . . . . 74.150000000000006 111.211 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.85 71.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.94 0.4 . . . . 52.399999999999999 111.158 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.65 89.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 70.519999999999996 110.559 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 28.1 ttt180 -55.11 -50.28 69.61 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.523 -0.762 . . . . 63.100000000000001 111.808 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 84.9 m -81.0 6.33 13.74 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.223 0.453 . . . . 50.299999999999997 112.223 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -106.35 51.69 0.74 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.161 0.505 . . . . 73.25 111.279 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.0 69.54 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.551 0.58 . . . . 73.219999999999999 114.551 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 66.4 t60 -135.44 72.93 64.01 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 117.767 0.784 . . . . 54.130000000000003 111.721 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 16.6 Cg_exo -69.2 -7.46 20.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.03 2.486 . . . . 73.510000000000005 112.844 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -9.19 52.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 73.140000000000001 111.825 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' A' ' 41' ' ' GLY . 43.1 tp -85.49 129.05 34.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.002 0.741 . . . . 64.299999999999997 113.002 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -127.77 155.43 44.06 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.631 -0.713 . . . . 65.219999999999999 110.496 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.88 123.39 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.855 0.359 . . . . 71.349999999999994 111.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.6 mmt -100.48 -59.42 1.71 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.037 0.384 . . . . 72.299999999999997 112.037 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 53.1 p90 -154.43 145.46 22.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.001 0.429 . . . . 74.409999999999997 111.584 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.46 ' HE ' ' HG3' ' A' ' 50' ' ' GLU . 93.1 mtt180 -83.04 110.72 18.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.241 0.543 . . . . 71.329999999999998 111.664 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 151.82 179.24 27.31 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.84 -0.618 . . . . 63.439999999999998 112.028 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -83.24 140.78 32.32 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.64 -0.329 . . . . 72.120000000000005 111.266 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 91.3 m -61.78 104.92 0.49 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.233 0.539 . . . . 71.329999999999998 111.783 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 63.509999999999998 112.319 -177.448 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 109.484 -0.561 . . . . 75.450000000000003 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.76 130.45 45.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.049 0.452 . . . . 34.240000000000002 111.859 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.543 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 m-20 -69.91 112.16 6.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 112.239 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.24 37.39 38.4 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.09 0.396 . . . . 35.210000000000001 114.09 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -106.61 135.49 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 112.004 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.18 106.64 14.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.096 0.474 . . . . 71.209999999999994 111.278 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -124.72 -179.92 4.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.089 -0.505 . . . . 62.009999999999998 111.02 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.38 -104.57 0.26 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 120.723 -0.751 . . . . 34.219999999999999 113.551 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.95 85.71 0.97 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.543 2.162 . . . . 63.310000000000002 113.106 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 102.07 2.74 51.7 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.194 -0.527 . . . . 44.450000000000003 113.559 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 48.4 mtmt -135.83 137.59 41.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.495 0.647 . . . . 73.040000000000006 112.03 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.04 142.13 49.46 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.719 -0.673 . . . . 43.43 110.072 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 23.2 p -105.5 136.46 45.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.133 0.492 . . . . 72.299999999999997 112.112 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -127.86 139.14 52.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.888 -0.597 . . . . 64.120000000000005 110.896 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.564 ' SD ' ' HB3' ' A' ' 22' ' ' PRO . 94.2 mmm -76.6 113.43 14.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.854 0.359 . . . . 72.010000000000005 111.409 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.795 HD12 ' HD3' ' A' ' 23' ' ' ARG . 88.6 mt -122.74 114.43 20.53 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.12 0.486 . . . . 62.439999999999998 111.304 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.65 30.74 75.61 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 116.231 -0.441 . . . . 40.140000000000001 113.77 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.25 -15.19 63.75 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 54.140000000000001 113.712 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 21' ' ' ARG . 43.0 mtt180 -122.14 137.42 27.47 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 117.25 0.525 . . . . 60.119999999999997 111.681 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 93.4 Cg_endo -83.28 145.29 12.02 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.725 2.283 . . . . 71.129999999999995 113.657 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.795 ' HD3' HD12 ' A' ' 18' ' ' LEU . 66.6 mtp85 -124.55 132.19 53.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.905 -0.589 . . . . 75.209999999999994 110.607 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 14.0 t -102.9 118.85 37.74 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.502 -0.555 . . . . 63.520000000000003 109.502 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.09 161.3 35.72 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 62.240000000000002 111.828 -171.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 97.5 m -54.26 108.55 0.38 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.137 0.791 . . . . 63.439999999999998 113.137 -174.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.72 120.82 56.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 115.889 -0.596 . . . . 65.310000000000002 110.754 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 83.3 Cg_endo -81.6 131.25 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.648 2.232 . . . . 75.450000000000003 113.535 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.816 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -67.86 82.5 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 116.303 -0.408 . . . . 65.400000000000006 111.019 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.8 p -148.96 123.07 9.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.399 0.619 . . . . 43.030000000000001 112.163 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -145.65 -53.9 0.28 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.844 -0.617 . . . . 53.299999999999997 110.197 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 51.63 1.96 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.176 -0.535 . . . . 73.219999999999999 113.385 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -156.64 145.07 14.52 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 122.584 -0.362 . . . . 73.310000000000002 110.8 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.94 120.02 4.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.247 1.965 . . . . 72.099999999999994 113.705 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.29 38.8 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.495 0.664 . . . . 44.409999999999997 110.792 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -129.9 8.05 5.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.819 -0.628 . . . . 73.200000000000003 111.551 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 64.9 tp -136.88 127.37 26.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.237 0.215 . . . . 64.209999999999994 111.064 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 50.7 mt-30 -66.48 148.27 52.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 74.239999999999995 112.047 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 32.6 m -131.15 146.77 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 71.219999999999999 111.493 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.5 t -100.9 113.66 26.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.388 -0.369 . . . . 64.409999999999997 110.822 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.14 170.37 49.2 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.266 -0.492 . . . . 31.41 114.239 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.9 m -54.9 -26.78 38.2 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.201 0.6 . . . . 70.030000000000001 112.111 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.54 -23.79 61.83 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.966 -0.561 . . . . 71.439999999999998 111.937 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.45 12.02 54.74 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.477 -0.392 . . . . 73.430000000000007 112.652 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.28 141.76 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.721 0.296 . . . . 75.409999999999997 111.764 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 m -86.65 107.35 18.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.466 -0.334 . . . . 54.109999999999999 111.434 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.01 147.16 24.43 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 110.151 -0.314 . . . . 71.230000000000004 110.151 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 39.9 ptt85 -59.83 -25.14 64.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.612 0.597 . . . . 73.510000000000005 112.612 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.0 p30 -166.86 172.25 10.53 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.043 0.449 . . . . 63.329999999999998 111.646 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 39' ' ' VAL . 29.6 tt0 -69.28 -26.7 64.88 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 112.135 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 48.6 t -74.72 -39.14 62.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.959 0.409 . . . . 73.209999999999994 110.206 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -59.14 -43.83 92.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.583 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.59 -51.3 67.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.107 -0.497 . . . . 74.510000000000005 110.736 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.816 ' HD3' ' HB2' ' A' ' 29' ' ' ASP . 94.1 mtt180 -70.82 -17.01 62.77 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.32 0.489 . . . . 73.109999999999999 112.32 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.18 -34.05 63.66 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.328 0.585 . . . . 72.099999999999994 110.154 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.02 -25.62 52.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.701 -0.681 . . . . 75.299999999999997 112.091 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 54' ' ' ARG . 16.4 ptt85 -66.5 -20.08 65.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.045 0.45 . . . . 74.150000000000006 110.886 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.4 t -72.27 -16.83 61.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.297 0.57 . . . . 60.340000000000003 110.634 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -91.66 85.04 5.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.943 -0.571 . . . . 75.439999999999998 111.112 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.89 -52.68 4.5 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 114.737 0.655 . . . . 75.140000000000001 114.737 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 36.2 m80 -114.58 93.62 33.37 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 117.806 0.803 . . . . 75.239999999999995 112.978 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 61' ' ' HIS . 43.6 Cg_endo -67.44 -16.48 47.7 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.556 2.17 . . . . 64.200000000000003 112.55 177.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -82.14 0.0 42.84 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.352 0.501 . . . . 75.430000000000007 112.352 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.9 tp -57.2 111.97 1.23 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 71.0 110.792 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -115.59 164.2 14.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.262 -0.426 . . . . 44.450000000000003 111.339 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.67 127.79 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.256 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -78.76 -45.32 21.34 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.307 0.575 . . . . 43.409999999999997 110.546 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -159.76 145.47 15.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.832 -0.622 . . . . 64.420000000000002 110.766 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.16 99.94 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.348 0.594 . . . . 72.319999999999993 110.925 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.53 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 164.57 -176.08 40.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.348 -0.842 . . . . 71.219999999999999 111.572 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -80.93 138.26 36.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.162 0.481 . . . . 54.350000000000001 111.3 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.9 m -61.9 94.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.208 0.528 . . . . 63.439999999999998 112.048 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.783 -0.644 . . . . 74.329999999999998 110.398 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.754 0.312 . . . . 42.310000000000002 111.251 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.12 130.38 45.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.902 0.382 . . . . 61.299999999999997 111.837 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.19 114.85 20.29 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.355 0.502 . . . . 61.350000000000001 112.355 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.31 8.2 58.71 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 114.274 0.469 . . . . 72.329999999999998 114.274 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.58 109.78 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 O-C-N 122.617 -0.343 . . . . 74.230000000000004 110.741 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.85 108.96 16.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.98 0.419 . . . . 41.5 111.315 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -148.76 138.49 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.285 0.564 . . . . 51.020000000000003 111.341 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.44 -60.92 0.09 OUTLIER Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.616 -0.72 . . . . 40.399999999999999 111.625 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.51 90.35 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.474 2.116 . . . . 53.020000000000003 112.322 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 88.68 -5.69 84.38 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.19 -0.529 . . . . 74.329999999999998 114.051 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 49.6 mtmt -141.14 138.05 33.17 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.583 0.691 . . . . 72.030000000000001 112.202 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.84 140.11 50.51 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.145 -0.479 . . . . 75.140000000000001 110.005 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.3 t -98.33 135.74 39.5 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.099 0.476 . . . . 75.109999999999999 111.774 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 16' ' ' ARG . 12.5 ptm180 -142.62 137.03 29.73 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.824 -0.626 . . . . 64.409999999999997 110.808 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.9 mmm -76.46 104.55 7.03 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.009 0.433 . . . . 75.420000000000002 111.801 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 112.6 23.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.856 0.36 . . . . 61.43 111.02 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.05 31.7 72.51 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.448 -0.406 . . . . 30.329999999999998 112.882 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.81 -4.55 60.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.179 -0.534 . . . . 73.230000000000004 112.859 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -113.1 129.52 24.46 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.589 0.356 . . . . 42.149999999999999 111.053 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 115.52 4.28 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.493 2.129 . . . . 64.319999999999993 113.121 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -111.57 132.47 54.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.46 -0.336 . . . . 65.209999999999994 111.373 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 13' ' ' LYS . 87.0 m -103.28 119.98 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.993 0.425 . . . . 73.040000000000006 110.588 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -102.04 145.14 29.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.587 . . . . 73.219999999999999 110.006 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 20.4 p -80.48 123.2 27.87 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.142 0.496 . . . . 44.240000000000002 111.91 -175.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.05 134.28 24.03 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 52.039999999999999 110.962 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.71 152.33 47.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.411 2.074 . . . . 54.109999999999999 112.891 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -78.35 41.49 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.483 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.758 ' HA ' HD21 ' A' ' 33' ' ' LEU . 25.1 p -77.49 89.79 3.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.189 0.519 . . . . 70.430000000000007 111.908 -174.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.3 t -138.79 132.49 30.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.954 -0.567 . . . . 63.200000000000003 110.857 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.35 39.42 51.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.187 -0.53 . . . . 73.540000000000006 112.9 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 30' ' ' CYS . 3.2 pp -151.8 163.6 23.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 122.7 0.4 . . . . 74.329999999999998 110.726 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 84.5 Cg_exo -49.9 118.96 4.26 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.526 2.151 . . . . 63.539999999999999 114.336 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.89 -10.43 14.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.678 -0.692 . . . . 75.129999999999995 110.818 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -125.55 -22.47 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 63.240000000000002 111.313 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 3.7 tt -90.19 119.83 30.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.767 0.318 . . . . 72.450000000000003 110.312 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 52.4 mt-30 -63.74 148.82 48.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.313 0.486 . . . . 64.120000000000005 112.313 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 34.0 m -129.81 151.91 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.213 0.53 . . . . 72.019999999999996 112.052 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.71 113.67 26.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.946 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.64 162.19 32.84 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.262 -0.494 . . . . 73.25 113.789 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.9 p -65.97 -9.43 29.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.336 0.495 . . . . 72.420000000000002 112.336 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' HD13 ' A' ' 64' ' ' LEU . 14.6 t70 -81.19 -4.98 57.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.149 0.5 . . . . 71.150000000000006 110.923 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 13.23 66.48 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.4 -0.429 . . . . 63.020000000000003 113.266 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.76 148.23 41.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 111.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.687 HG21 ' HG2' ' A' ' 71' ' ' ARG . 69.7 m -99.62 116.57 32.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.959 0.409 . . . . 53.219999999999999 111.209 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -96.66 156.88 16.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.414 -0.357 . . . . 64.329999999999998 111.664 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 78.9 mtm180 -56.96 -32.88 66.48 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.518 0.562 . . . . 74.329999999999998 112.518 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -162.97 176.43 10.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.213 -0.449 . . . . 61.130000000000003 110.031 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.652 ' HB3' HD13 ' A' ' 33' ' ' LEU . 32.7 tt0 -74.99 -30.89 61.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.279 -0.569 . . . . 70.310000000000002 111.599 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 t -65.4 -37.41 86.88 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.834 -0.541 . . . . 63.219999999999999 109.806 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.56 -52.89 63.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.543 -0.753 . . . . 74.239999999999995 110.421 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.26 -52.03 54.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.034 -0.984 . . . . 73.430000000000007 111.675 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 41.4 mtp85 -70.46 -27.17 64.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.841 -0.618 . . . . 75.340000000000003 111.657 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.11 -49.27 62.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.188 0.518 . . . . 31.41 110.67 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.83 -32.01 71.4 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.078 -0.51 . . . . 74.430000000000007 110.969 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -58.37 -51.63 69.0 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.944 -0.571 . . . . 72.540000000000006 110.921 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 32.2 t -71.78 -31.74 66.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.746 0.308 . . . . 71.25 111.432 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -60.14 -50.5 73.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.401 0.519 . . . . 74.239999999999995 112.401 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.49 16.78 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.993 -1.098 . . . . 65.540000000000006 114.959 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.0 m-70 -135.69 75.16 57.16 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 117.806 0.803 . . . . 72.340000000000003 111.564 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.64 -23.18 74.59 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.358 2.038 . . . . 63.200000000000003 113.273 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.3 -14.26 47.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.008 0.373 . . . . 74.030000000000001 112.008 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 43' ' ' ASP . 55.0 tp -64.4 112.36 3.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.2 0.524 . . . . 73.340000000000003 112.144 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.1 m -132.73 162.04 32.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.486 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.31 129.98 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.172 0.511 . . . . 74.439999999999998 111.788 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 69.5 mtm -85.27 -55.33 4.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.277 0.56 . . . . 70.150000000000006 110.166 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.508 ' HE2' ' H ' ' A' ' 73' ' ' ARG . 16.6 p90 -151.5 140.03 20.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.714 -0.676 . . . . 74.209999999999994 110.743 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.51 125.52 29.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.272 0.558 . . . . 70.299999999999997 111.543 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.511 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 124.56 161.57 11.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.35 -0.841 . . . . 60.439999999999998 111.139 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.687 ' HG2' HG21 ' A' ' 46' ' ' THR . 65.4 mtt180 -63.14 138.82 58.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.747 0.774 . . . . 75.319999999999993 111.082 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.5 m -48.28 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.626 0.602 . . . . 62.020000000000003 112.626 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.508 ' H ' ' HE2' ' A' ' 68' ' ' TYR . 11.9 ptp180 . . . . . 0 N--CA 1.468 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.319999999999993 111.217 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.68 0.276 . . . . 63.25 110.655 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 p -140.43 130.91 25.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.764 0.316 . . . . 63.240000000000002 111.794 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.66 114.15 22.42 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.154 0.502 . . . . 72.239999999999995 112.329 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.87 27.21 66.45 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.987 0.755 . . . . 61.329999999999998 114.987 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.524 HG12 ' SG ' ' A' ' 9' ' ' CYS . 49.9 t -107.15 126.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 117.358 0.579 . . . . 74.140000000000001 111.588 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 10.5 pt-20 -79.0 105.93 10.69 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.407 0.622 . . . . 75.319999999999993 111.664 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.524 ' SG ' HG12 ' A' ' 7' ' ' VAL . 58.7 m -149.61 155.99 41.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.101 -0.374 . . . . 64.409999999999997 111.42 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.7 -65.24 0.31 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.942 -0.647 . . . . 71.349999999999994 113.009 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.14 90.53 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.66 2.24 . . . . 71.310000000000002 112.83 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.31 0.78 84.48 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.053 -0.594 . . . . 70.040000000000006 113.634 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.32 136.04 41.26 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.0 -0.706 . . . . 74.109999999999999 111.964 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.27 143.95 41.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.076 -0.511 . . . . 74.209999999999994 110.353 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.698 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 30.9 p -101.88 128.52 48.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.79 0.663 . . . . 74.200000000000003 112.79 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -138.52 145.62 40.96 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.417 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 74.1 mtp -91.12 112.16 23.95 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.947 0.404 . . . . 44.009999999999998 111.8 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 18' ' ' LEU . 6.0 mp -103.09 112.19 24.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.243 -0.435 . . . . 40.049999999999997 110.634 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 36.11 58.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.375 -0.44 . . . . 72.519999999999996 113.861 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.28 70.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.168 -0.539 . . . . 52.140000000000001 113.51 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.6 111.26 63.66 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 117.346 0.573 . . . . 72.129999999999995 111.771 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.502 ' HB2' HG21 ' A' ' 7' ' ' VAL . 58.7 Cg_endo -71.86 106.99 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.218 1.945 . . . . 74.230000000000004 112.269 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -117.79 149.2 41.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.904 0.383 . . . . 75.420000000000002 111.534 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 91.2 m -129.0 125.55 37.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.017 0.437 . . . . 64.239999999999995 111.487 177.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -119.99 161.54 20.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.528 -0.305 . . . . 75.150000000000006 110.188 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.86 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.35 0.595 . . . . 64.439999999999998 111.072 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 120.0 60.27 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.479 -0.782 . . . . 32.420000000000002 110.493 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 11.0 Cg_endo -52.17 117.62 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.5 2.134 . . . . 60.030000000000001 112.499 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.66 36.22 0.13 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.233 0.539 . . . . 73.239999999999995 111.623 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 47.6 m -65.51 101.89 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.978 -0.556 . . . . 73.540000000000006 111.587 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -129.34 92.32 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 62.039999999999999 110.243 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.78 7.35 17.83 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.054 -0.521 . . . . 71.319999999999993 112.858 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.403 HD11 HH11 ' A' ' 54' ' ' ARG . 83.9 mt -100.83 114.89 65.84 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.619 -0.342 . . . . 73.450000000000003 111.142 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.63 153.09 26.34 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.761 2.308 . . . . 74.439999999999998 113.531 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.26 163.16 26.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.156 -0.475 . . . . 71.310000000000002 111.2 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 69.33 -15.2 0.29 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.793 0.664 . . . . 71.420000000000002 112.793 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 1.1 tm? -72.23 88.01 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.477 -0.564 . . . . 73.510000000000005 109.477 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.496 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 98.1 mt-30 -71.24 142.11 50.58 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.775 0.657 . . . . 75.439999999999998 112.775 -175.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 69' ' ' ARG . 33.4 m -137.02 157.28 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.819 -0.628 . . . . 64.129999999999995 111.003 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 90.7 m -101.12 132.01 46.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.89 -0.506 . . . . 65.299999999999997 111.839 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -82.85 173.5 52.46 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.918 -0.583 . . . . 64.310000000000002 113.422 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -64.38 -11.17 30.08 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.544 0.572 . . . . 43.109999999999999 112.544 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -87.17 -26.87 23.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.859 0.361 . . . . 73.230000000000004 111.094 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.26 -0.36 20.73 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.316 -0.469 . . . . 73.209999999999994 113.924 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.5 152.09 19.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.344 0.572 . . . . 74.420000000000002 112.268 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.8 m -90.91 120.08 31.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.051 -0.522 . . . . 73.109999999999999 111.975 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -87.49 140.64 29.33 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.283 -0.417 . . . . 75.239999999999995 110.814 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 18.0 ptp180 -59.65 -15.55 19.95 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.001 0.741 . . . . 73.409999999999997 113.001 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.5 p30 -167.26 160.68 13.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.556 0.343 . . . . 71.430000000000007 110.91 172.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -64.04 -30.83 71.87 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.088 0.403 . . . . 72.540000000000006 112.088 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.26 -33.99 72.26 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.031 0.444 . . . . 73.340000000000003 110.683 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -56.48 -50.9 70.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 110.662 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.574 HD11 ' HA2' ' A' ' 41' ' ' GLY . 6.5 tt -63.08 -46.7 86.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.818 -0.628 . . . . 54.32 110.328 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HD3' ' SG ' ' A' ' 30' ' ' CYS . 16.8 ttt180 -55.39 -33.69 63.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.832 -0.622 . . . . 73.239999999999995 111.288 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.11 -31.68 23.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.059 -0.519 . . . . 75.049999999999997 111.655 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.08 71.11 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.191 0.441 . . . . 71.019999999999996 112.191 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.57 -34.01 64.39 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.242 0.544 . . . . 75.120000000000005 111.45 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.3 m -88.66 14.16 10.67 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.434 0.531 . . . . 63.140000000000001 112.434 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -98.27 8.24 45.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.058 0.392 . . . . 75.519999999999996 112.058 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.1 0.81 5.05 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.756 -0.735 . . . . 72.349999999999994 114.429 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -133.98 88.53 31.75 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 117.655 0.727 . . . . 72.209999999999994 112.132 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.94 -20.92 69.27 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.505 2.136 . . . . 75.319999999999993 111.59 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -20.95 58.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.947 -1.024 . . . . 73.120000000000005 112.436 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.81 111.57 3.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.287 0.565 . . . . 63.130000000000003 111.653 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -129.67 163.48 26.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.0 -0.546 . . . . 74.310000000000002 111.242 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.84 126.28 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.106 0.479 . . . . 61.340000000000003 111.394 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 72.1 mtm -80.33 -43.79 20.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.006 0.373 . . . . 73.120000000000005 112.006 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 44.0 p90 -164.19 155.83 16.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.949 0.404 . . . . 74.129999999999995 111.876 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.676 ' HA ' HG12 ' A' ' 39' ' ' VAL . 8.6 mpt_? -80.5 104.87 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.168 0.509 . . . . 70.450000000000003 111.243 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.92 170.43 16.63 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 116.061 -0.518 . . . . 65.25 112.192 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -75.57 149.98 38.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.866 0.365 . . . . 74.299999999999997 111.424 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 71.5 m -58.77 113.78 2.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.113 -0.494 . . . . 52.32 111.934 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 115.706 -0.679 . . . . 74.129999999999995 112.131 -176.646 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 112.106 0.41 . . . . 73.400000000000006 112.106 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.4 m -105.85 127.95 53.44 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.849 0.357 . . . . 73.299999999999997 111.605 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.646 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 11.5 m-20 -87.64 111.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.183 -0.323 . . . . 62.420000000000002 110.4 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.8 -39.78 0.79 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 121.004 -0.617 . . . . 53.140000000000001 114.016 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 10.7 t -66.08 146.28 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.962 0.505 . . . . 74.349999999999994 111.62 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -102.71 105.3 15.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.486 0.66 . . . . 75.239999999999995 110.218 177.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.632 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 97.9 m -149.52 179.41 7.99 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.502 0.556 . . . . 74.310000000000002 112.502 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.03 -67.54 0.56 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.259 -0.736 . . . . 63.009999999999998 111.259 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -93.01 131.1 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 73.209999999999994 111.96 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.37 -35.78 1.99 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.008 -0.615 . . . . 44.229999999999997 114.268 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HE3' ' SG ' ' A' ' 9' ' ' CYS . 48.5 mtmt -131.38 145.95 52.05 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.254 0.527 . . . . 74.209999999999994 111.286 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -122.09 132.04 54.28 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.455 -0.339 . . . . 74.420000000000002 110.634 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.2 p -100.12 121.83 42.02 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.479 0.657 . . . . 73.5 111.584 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -123.88 163.56 21.03 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.835 -0.62 . . . . 73.310000000000002 111.265 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -80.9 110.74 16.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.249 0.462 . . . . 74.420000000000002 112.249 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.699 HD22 ' HD2' ' A' ' 23' ' ' ARG . 6.8 mp -115.48 102.72 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.825 -0.435 . . . . 74.230000000000004 109.825 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.51 27.94 72.49 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.132 -0.556 . . . . 54.219999999999999 112.57 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.95 -16.62 56.51 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.483 -0.389 . . . . 64.540000000000006 113.633 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -93.11 137.25 23.77 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 122.321 -0.517 . . . . 72.129999999999995 111.804 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.646 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 90.4 Cg_endo -77.95 101.85 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.918 2.412 . . . . 45.329999999999998 113.409 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.699 ' HD2' HD22 ' A' ' 18' ' ' LEU . 53.9 mtt-85 -105.7 139.03 40.91 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.132 -0.321 . . . . 71.349999999999994 110.132 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 17.8 m -103.36 144.3 31.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 74.230000000000004 112.118 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' ' HD3' ' A' ' 16' ' ' ARG . 48.4 mt-10 -129.03 158.23 39.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 65.230000000000004 110.636 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.0 p -62.82 99.83 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.149 0.499 . . . . 63.520000000000003 112.278 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.82 125.59 41.68 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.874 -0.603 . . . . 71.219999999999999 111.45 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.9 Cg_exo -78.28 111.8 3.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.865 2.377 . . . . 65.5 112.848 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.36 94.22 0.16 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.788 0.328 . . . . 71.409999999999997 110.298 173.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.1 p -130.35 22.63 5.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.494 0.924 . . . . 63.549999999999997 113.494 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.1 p -70.93 -23.82 62.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.53 0.681 . . . . 63.420000000000002 109.965 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.61 27.83 14.08 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.56 -0.745 . . . . 31.420000000000002 113.017 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 78.6 mt -124.44 148.22 57.73 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 116.719 0.259 . . . . 52.119999999999997 111.688 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 13.6 Cg_exo -70.72 120.27 6.96 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.671 2.247 . . . . 73.129999999999995 112.629 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.28 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.992 0.367 . . . . 44.119999999999997 111.992 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -93.5 1.52 56.74 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.979 0.363 . . . . 72.109999999999999 111.979 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.3 mt -118.35 114.09 22.42 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.072 0.397 . . . . 71.200000000000003 112.072 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.34 146.75 53.78 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.503 -0.317 . . . . 71.329999999999998 110.375 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 69' ' ' ARG . 32.6 m -129.51 149.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.96 0.409 . . . . 71.329999999999998 111.603 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 61.3 m -100.53 128.58 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.385 -0.37 . . . . 70.310000000000002 110.796 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.516 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -72.89 164.3 54.88 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.253 -0.499 . . . . 43.409999999999997 113.068 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 t -58.97 -16.97 20.54 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.079 0.399 . . . . 71.540000000000006 112.079 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -82.11 -38.73 24.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.902 0.382 . . . . 74.030000000000001 110.931 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 -3.52 4.99 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.365 -0.445 . . . . 73.299999999999997 113.842 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.58 142.74 29.76 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.465 0.543 . . . . 62.539999999999999 112.465 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.583 HG21 ' HG3' ' A' ' 71' ' ' ARG . 32.1 m -90.19 113.12 24.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.446 -0.343 . . . . 54.119999999999997 111.478 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -97.62 167.59 10.87 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 71.5 111.745 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -44.2 87.21 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.647 0.61 . . . . 71.129999999999995 112.647 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -169.06 -179.29 3.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.63 0.252 . . . . 63.210000000000001 111.631 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -64.73 -36.22 83.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.752 0.31 . . . . 74.129999999999995 111.698 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 17.5 t -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.117 0.484 . . . . 64.239999999999995 109.974 174.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -56.92 -44.11 82.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.644 -0.707 . . . . 74.120000000000005 111.377 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.563 ' HG ' HG22 ' A' ' 66' ' ' VAL . 1.5 tm? -59.37 -50.05 75.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.735 0.302 . . . . 73.230000000000004 110.877 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -56.51 -41.83 77.36 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.867 0.365 . . . . 42.229999999999997 111.283 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -39.53 94.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.027 0.441 . . . . 54.119999999999997 110.741 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.786 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -66.24 -22.03 66.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 72.040000000000006 112.499 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -65.55 -47.31 76.29 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.542 0.687 . . . . 72.219999999999999 110.107 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.19 -30.59 65.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.464 0.649 . . . . 73.129999999999995 110.679 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.786 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 23.2 ttt180 -82.78 83.63 7.64 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.279 -0.873 . . . . 74.409999999999997 111.385 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . 88.72 -54.01 4.06 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 114.798 0.679 . . . . 73.109999999999999 114.798 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -115.04 90.94 25.04 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 113.673 0.99 . . . . 65.219999999999999 113.673 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 32.0 Cg_exo -61.71 -22.22 73.91 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.845 2.363 . . . . 71.329999999999998 113.072 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.05 -2.79 49.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.364 -0.38 . . . . 72.530000000000001 111.844 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.516 HD11 ' HA3' ' A' ' 41' ' ' GLY . 24.3 tp -77.71 118.08 19.74 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.554 0.576 . . . . 63.43 112.554 -172.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -125.87 164.63 20.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.856 -0.611 . . . . 60.439999999999998 110.607 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.563 HG22 ' HG ' ' A' ' 53' ' ' LEU . 44.0 t -80.13 128.57 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.955 0.354 . . . . 73.349999999999994 111.955 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 61.7 mtt -74.36 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.448 0.642 . . . . 72.299999999999997 110.273 171.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.45 161.17 24.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.409 -0.814 . . . . 75.510000000000005 110.841 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HA ' HG12 ' A' ' 39' ' ' VAL . 78.0 mtt180 -81.62 107.36 14.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.259 0.552 . . . . 61.140000000000001 110.655 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.32 143.91 3.79 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.688 -0.687 . . . . 73.129999999999995 112.076 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.583 ' HG3' HG21 ' A' ' 46' ' ' THR . 65.2 ttt180 -72.36 74.91 1.02 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.814 0.34 . . . . 73.409999999999997 111.819 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 85.7 m 34.84 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.747 1.017 . . . . 71.409999999999997 113.747 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.038 0.447 . . . . 75.230000000000004 110.905 -178.261 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.831 -0.433 . . . . 63.520000000000003 109.831 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 39.4 m -98.22 127.4 44.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 65.409999999999997 111.392 -173.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.501 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 13.3 t70 -85.77 111.1 19.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.455 . . . . 70.329999999999998 110.879 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 -23.01 0.3 Allowed Glycine 0 CA--C 1.535 1.285 0 N-CA-C 114.421 0.528 . . . . 73.150000000000006 114.421 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 23.6 t -73.98 125.32 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 117.043 0.421 . . . . 72.120000000000005 111.849 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -115.05 110.01 18.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.168 0.508 . . . . 62.409999999999997 111.895 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.3 m -149.1 139.24 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.492 -0.322 . . . . 74.439999999999998 110.878 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.19 -76.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.917 -0.658 . . . . 75.209999999999994 112.972 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.67 130.49 12.65 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.45 2.1 . . . . 62.439999999999998 112.692 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.34 -49.2 3.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.928 -0.653 . . . . 51.200000000000003 112.997 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -121.63 135.7 54.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.902 0.382 . . . . 74.299999999999997 111.433 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.92 145.57 41.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.784 -0.45 . . . . 62.43 109.784 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 31.9 p -99.08 113.38 25.56 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.41 0.624 . . . . 45.43 111.286 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -112.25 149.39 32.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.765 -0.652 . . . . 73.120000000000005 111.214 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.6 mtp -88.97 107.57 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 74.109999999999999 111.488 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.509 HD23 ' HG2' ' A' ' 23' ' ' ARG . 3.3 mm? -116.16 103.07 10.17 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.479 -0.328 . . . . 74.230000000000004 110.384 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.45 62.46 5.08 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 64.310000000000002 113.525 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.21 -46.4 3.39 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.203 -0.522 . . . . 64.329999999999998 113.953 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 21' ' ' ARG . 4.8 mpt_? -92.77 125.81 54.06 Favored Pre-proline 0 CA--C 1.541 0.611 0 O-C-N 122.328 -0.513 . . . . 70.049999999999997 111.969 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 96.5 Cg_endo -79.91 110.3 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.648 2.232 . . . . 73.329999999999998 112.094 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 33.6 ptt180 -99.11 158.28 15.78 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.164 -0.335 . . . . 73.319999999999993 111.079 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' CG1' ' A' ' 7' ' ' VAL . 78.2 m -103.14 120.69 41.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.081 0.467 . . . . 55.310000000000002 110.823 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.68 142.86 50.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.978 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' SG ' ' NH1' ' A' ' 59' ' ' ARG . 25.7 p -58.6 105.04 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.223 0.535 . . . . 73.349999999999994 111.562 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 135.9 19.35 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 51.219999999999999 111.174 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.906 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 74.2 Cg_endo -72.56 120.55 6.78 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.288 1.992 . . . . 63.420000000000002 112.486 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.6 -28.2 68.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.265 -0.425 . . . . 64.140000000000001 111.815 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HA ' HD11 ' A' ' 33' ' ' LEU . 79.2 m 73.4 -39.91 0.45 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.649 0.78 . . . . 61.130000000000003 112.609 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -54.12 112.62 1.0 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.109 -0.369 . . . . 72.439999999999998 111.797 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.07 -13.38 11.31 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.503 -0.38 . . . . 75.519999999999996 113.469 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 30' ' ' CYS . 2.5 pp -139.77 164.71 36.2 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 122.403 -0.469 . . . . 75.209999999999994 111.509 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 53.7 Cg_exo -53.96 119.61 6.56 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.548 2.165 . . . . 74.109999999999999 113.446 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.65 18.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 112.04 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.59 -39.08 3.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.849 0.315 . . . . 73.129999999999995 111.849 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -64.8 118.93 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.874 0.368 . . . . 62.340000000000003 110.671 -176.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.39 162.89 2.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.648 0.61 . . . . 64.310000000000002 112.648 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 66' ' ' VAL . 31.3 m -143.84 147.5 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.863 -0.608 . . . . 62.100000000000001 110.471 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.3 t -103.64 126.82 51.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.947 0.403 . . . . 72.219999999999999 110.829 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.47 165.52 44.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.257 -0.497 . . . . 62.039999999999999 113.686 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.2 m -50.61 -28.36 8.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.63 0.604 . . . . 65.5 112.63 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.82 -34.04 75.96 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.086 0.47 . . . . 73.049999999999997 111.947 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.31 -10.0 24.42 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.374 -0.441 . . . . 71.540000000000006 112.236 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.83 134.71 38.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.072 0.463 . . . . 70.019999999999996 111.621 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.0 m -86.66 112.6 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.332 -0.395 . . . . 71.540000000000006 111.337 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.66 160.95 16.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.796 0.332 . . . . 64.310000000000002 111.671 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -61.47 -40.32 94.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 111.783 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -165.91 174.52 9.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.058 -0.519 . . . . 74.200000000000003 110.552 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HA ' HG21 ' A' ' 39' ' ' VAL . 29.5 tt0 -71.74 -27.88 63.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.899 0.381 . . . . 70.400000000000006 111.498 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.906 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 9.1 t -67.56 -39.87 84.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.948 0.404 . . . . 75.310000000000002 110.262 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.42 -46.45 88.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.099 -0.5 . . . . 73.530000000000001 110.82 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -56.74 -42.2 78.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.377 -0.374 . . . . 72.209999999999994 110.739 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' A' ' 28' ' ' PRO . 29.6 ttt180 -57.16 -40.29 76.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.102 0.477 . . . . 75.230000000000004 110.899 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 59' ' ' ARG . . . -65.41 -50.41 65.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.283 -0.417 . . . . 64.420000000000002 111.019 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.35 -38.45 66.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.989 0.424 . . . . 63.200000000000003 111.728 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -52.9 -46.64 68.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.158 -0.474 . . . . 73.040000000000006 111.022 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.7 t -77.1 -34.01 56.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.349 0.5 . . . . 65.209999999999994 112.349 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 55' ' ' ALA . 37.8 mmt180 -58.33 -48.51 80.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.722 0.296 . . . . 75.140000000000001 111.555 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.14 32.31 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.221 -0.99 . . . . 73.129999999999995 114.26 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -132.39 81.93 59.06 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 117.216 0.508 . . . . 62.219999999999999 111.015 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.32 -34.8 26.06 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.614 2.209 . . . . 63.340000000000003 112.778 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.47 -11.59 60.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 111.978 0.362 . . . . 71.519999999999996 111.978 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.7 tp -77.21 110.35 11.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.518 0.562 . . . . 54.450000000000003 112.518 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -123.92 161.08 26.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.140000000000001 110.323 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 39' ' ' VAL . 2.7 p -88.34 111.3 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.001 0.429 . . . . 61.200000000000003 111.628 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.9 mtt -63.59 -58.82 5.75 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 110.659 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.2 172.56 17.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.886 -0.597 . . . . 73.150000000000006 110.361 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 9.9 mpt_? -78.9 158.65 28.02 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.214 0.53 . . . . 74.040000000000006 111.564 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.4 54.72 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.951 -0.568 . . . . 75.230000000000004 112.562 -174.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -83.61 158.28 21.95 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.541 -0.387 . . . . 63.549999999999997 111.567 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.8 m -67.01 98.16 0.55 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.158 0.504 . . . . 62.149999999999999 111.078 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 . . . . . 0 CA--C 1.541 0.609 0 CA-C-N 115.993 -0.549 . . . . 74.120000000000005 111.046 -177.142 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 120.825 0.345 . . . . 32.32 111.105 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 24.0 m -124.93 128.32 48.43 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.852 0.358 . . . . 62.409999999999997 111.956 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -87.42 110.66 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.442 -0.345 . . . . 72.25 110.429 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.26 -32.21 0.32 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.501 0.56 . . . . 72.120000000000005 114.501 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 38.5 t -65.61 131.7 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 117.194 0.497 . . . . 73.319999999999993 111.976 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -76.57 105.34 7.57 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.95 0.405 . . . . 54.119999999999997 111.648 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.543 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 65.7 m -138.3 179.49 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.932 0.396 . . . . 65.299999999999997 111.206 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.23 -85.3 0.39 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.161 -0.542 . . . . 70.510000000000005 112.574 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -61.23 92.13 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.358 2.038 . . . . 71.200000000000003 112.431 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.97 23.88 72.91 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 115.976 -0.556 . . . . 71.0 114.003 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.656 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.1 mtmt -144.26 146.66 32.77 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.655 0.728 . . . . 75.219999999999999 112.957 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.35 149.18 40.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.369 -0.832 . . . . 70.109999999999999 110.163 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 26.6 p -112.44 142.59 44.79 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.328 0.585 . . . . 73.109999999999999 112.499 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 15.2 mmt180 -129.1 163.22 25.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.974 -0.557 . . . . 74.409999999999997 111.332 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.7 mmm -85.68 102.33 13.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.964 0.411 . . . . 74.439999999999998 111.247 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.4 110.44 22.41 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.04 0.447 . . . . 45.340000000000003 110.536 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.85 71.75 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.133 -0.556 . . . . 52.549999999999997 113.188 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.36 -4.77 84.28 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.255 -0.497 . . . . 50.25 113.243 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 21' ' ' ARG . 9.1 mpt_? -114.97 126.24 28.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 122.383 -0.48 . . . . 74.219999999999999 111.361 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 70.9 Cg_endo -74.0 113.85 3.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.471 2.114 . . . . 72.109999999999999 112.901 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -120.77 152.28 38.52 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.121 -0.362 . . . . 64.030000000000001 110.941 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 2.0 t -103.41 140.05 37.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.633 0.605 . . . . 74.299999999999997 112.633 -169.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.54 160.51 33.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.679 -0.691 . . . . 73.030000000000001 109.874 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 p -76.16 140.7 41.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.028 0.442 . . . . 64.430000000000007 111.393 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -118.88 125.17 27.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.262 -0.426 . . . . 62.299999999999997 111.51 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 6.0 Cg_exo -79.59 24.45 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.269 2.646 . . . . 73.129999999999995 114.241 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 54.1 40.25 31.46 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.025 0.44 . . . . 71.319999999999993 111.859 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.462 ' HA ' HD21 ' A' ' 33' ' ' LEU . 27.3 m -70.4 88.64 0.66 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.217 0.532 . . . . 73.0 112.254 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.8 t -150.93 137.63 18.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.727 -0.67 . . . . 61.439999999999998 110.445 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 -50.32 4.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.04 -0.6 . . . . 61.140000000000001 113.367 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' ' 50' ' ' GLU . 1.8 pt? -66.98 151.87 96.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.821 -0.223 . . . . 73.219999999999999 111.304 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.45 119.3 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 74.040000000000006 112.912 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.85 8.99 11.19 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 73.230000000000004 111.373 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -129.26 15.12 6.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.119 0.485 . . . . 72.420000000000002 110.792 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 5.7 tt -125.64 125.4 43.05 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.07 -0.514 . . . . 72.420000000000002 110.025 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -63.55 147.73 50.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.897 0.702 . . . . 54.310000000000002 112.897 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 50' ' ' GLU . 35.4 m -138.62 146.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.301 -0.408 . . . . 72.239999999999995 110.676 176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 17.2 t -105.21 131.53 52.56 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.106 0.479 . . . . 74.510000000000005 111.853 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.91 177.82 40.31 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.127 -0.488 . . . . 63.450000000000003 114.015 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.1 m -55.29 -27.79 49.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.695 0.628 . . . . 63.310000000000002 112.695 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.87 8.0 11.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.43 0.53 . . . . 71.129999999999995 112.43 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.052 -0.594 . . . . 53.210000000000001 112.68 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 125.15 36.25 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.502 0.321 . . . . 52.539999999999999 111.072 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 61.7 m -91.38 104.91 17.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.161 0.505 . . . . 74.140000000000001 111.161 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -80.48 157.82 26.06 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.531 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 63.4 mtt180 -53.32 -33.43 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.66 0.615 . . . . 73.25 112.66 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.4 p30 -170.92 173.16 5.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.939 0.399 . . . . 50.520000000000003 111.54 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' HD12 ' A' ' 33' ' ' LEU . 11.8 tp10 -58.08 -43.6 87.1 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.07 -0.514 . . . . 73.239999999999995 111.63 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.55 -39.95 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.973 0.416 . . . . 71.239999999999995 110.599 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE1' ' HD2' ' A' ' 48' ' ' ARG . 7.5 tp10 -63.25 -44.27 95.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.826 -0.624 . . . . 75.129999999999995 110.866 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.94 -51.66 68.33 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.809 -0.632 . . . . 51.399999999999999 111.269 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.26 -33.27 75.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.714 0.292 . . . . 73.120000000000005 111.74 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.41 65.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.043 0.449 . . . . 74.200000000000003 110.689 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.2 76.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.982 0.42 . . . . 54.049999999999997 111.187 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -60.64 -50.24 74.28 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.079 -0.51 . . . . 74.519999999999996 110.404 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.77 -35.47 80.15 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.113 -0.494 . . . . 62.219999999999999 111.749 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -59.55 -58.68 7.53 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.506 -0.315 . . . . 74.109999999999999 111.575 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.44 24.92 0.19 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.543 -0.837 . . . . 74.230000000000004 114.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 42.2 m170 -122.38 78.81 45.35 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 122.139 -0.624 . . . . 73.530000000000001 111.144 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.51 -43.49 33.01 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.756 2.304 . . . . 70.340000000000003 113.552 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.53 2.82 39.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.57 0.581 . . . . 74.310000000000002 112.57 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 66.4 tp -76.64 127.43 32.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.015 0.436 . . . . 75.109999999999999 111.975 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -142.64 152.16 42.18 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.59 -0.277 . . . . 54.0 110.696 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -81.39 124.73 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.135 0.493 . . . . 52.149999999999999 111.748 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.36 -49.64 9.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.11 0.481 . . . . 72.340000000000003 110.783 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -159.84 164.29 33.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.916 -0.583 . . . . 73.299999999999997 111.258 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 39' ' ' VAL . 49.5 mtm180 -76.8 135.62 38.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 65.230000000000004 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.86 -172.88 20.4 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.271 -0.49 . . . . 65.140000000000001 112.71 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -86.72 149.34 24.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.56 -0.377 . . . . 75.439999999999998 111.675 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 35.3 m -66.08 83.78 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.622 0.725 . . . . 43.409999999999997 111.159 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 115.16 -0.927 . . . . 75.329999999999998 111.812 -179.306 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 109.453 -0.573 . . . . 53.140000000000001 109.453 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.5 m -135.87 127.68 29.26 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.927 -0.483 . . . . 72.010000000000005 111.987 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 7' ' ' VAL . 29.0 t70 -86.67 111.42 20.65 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.676 0.25 . . . . 71.109999999999999 111.676 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 48.65 30.93 9.13 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 114.564 0.586 . . . . 72.140000000000001 114.564 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 5' ' ' ASP . 89.1 t -106.74 122.47 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 117.337 0.568 . . . . 74.150000000000006 111.77 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -92.07 106.73 18.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.612 -0.267 . . . . 72.109999999999999 111.202 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 96.1 m -148.84 138.54 21.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.648 0.261 . . . . 73.040000000000006 111.348 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.98 -141.42 4.33 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 120.894 -0.67 . . . . 41.100000000000001 113.932 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 -13.5 5.58 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.357 2.705 . . . . 72.239999999999995 114.81 -173.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.8 -30.17 9.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.99 -0.624 . . . . 53.329999999999998 113.155 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.7 mtmt -148.5 136.31 20.77 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.609 -0.347 . . . . 54.530000000000001 111.228 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.16 136.07 48.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.577 -0.283 . . . . 44.32 110.634 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.798 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 7.2 p -99.79 122.08 42.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.141 0.496 . . . . 62.020000000000003 111.714 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -119.95 158.84 25.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.144 -0.48 . . . . 75.540000000000006 111.345 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.8 mmt -79.73 102.62 9.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.468 -0.333 . . . . 73.209999999999994 111.597 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.578 HD13 ' HB2' ' A' ' 23' ' ' ARG . 6.6 mp -110.77 112.99 25.24 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.929 0.395 . . . . 42.109999999999999 110.118 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.39 29.84 75.77 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.84 -0.695 . . . . 71.209999999999994 112.252 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -0.12 69.17 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.522 -0.37 . . . . 41.299999999999997 113.721 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -115.1 138.44 23.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 72.219999999999999 111.502 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.71 124.33 7.47 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.949 2.432 . . . . 55.240000000000002 114.273 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 8.7 mtp180 -119.69 134.62 55.16 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.965 -0.561 . . . . 74.030000000000001 110.907 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.798 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.1 m -103.37 119.82 39.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.886 0.374 . . . . 60.200000000000003 110.987 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -123.07 160.38 26.49 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.935 -0.575 . . . . 63.049999999999997 111.117 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -52.18 106.74 0.16 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.84 0.352 . . . . 73.310000000000002 111.863 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.45 122.87 58.28 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 116.218 -0.447 . . . . 74.510000000000005 112.197 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 55' ' ' ALA . 72.8 Cg_endo -75.95 -18.81 16.47 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.366 2.044 . . . . 51.020000000000003 112.118 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.1 t70 63.36 96.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.693 0.797 . . . . 74.010000000000005 112.234 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.4 m -121.39 25.84 9.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.389 -0.823 . . . . 63.130000000000003 109.945 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -64.27 103.32 0.62 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.284 -0.871 . . . . 54.340000000000003 113.212 -171.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.75 2.1 88.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.355 0.902 . . . . 73.430000000000007 115.355 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 51' ' ' CYS . 3.7 pp -85.86 153.72 57.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 118.03 0.915 . . . . 75.310000000000002 111.396 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.08 119.4 6.43 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.317 2.011 . . . . 61.310000000000002 112.703 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 76.59 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.028 0.442 . . . . 71.340000000000003 111.06 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 177.51 15.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.991 -0.55 . . . . 74.209999999999994 111.561 -175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD21 ' HD3' ' A' ' 69' ' ' ARG . 50.9 tp -119.99 105.56 11.16 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.015 0.436 . . . . 52.299999999999997 111.867 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.35 145.18 56.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.029 -0.532 . . . . 52.130000000000003 111.984 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 50' ' ' GLU . 31.4 m -141.13 143.56 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.268 -0.424 . . . . 71.329999999999998 111.043 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -102.19 125.8 48.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 110.159 -0.312 . . . . 70.120000000000005 110.159 178.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -73.24 169.25 53.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.407 -0.425 . . . . 63.350000000000001 113.765 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 t -65.18 -6.39 9.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.155 0.428 . . . . 74.140000000000001 112.155 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.94 -31.15 14.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.356 0.262 . . . . 72.430000000000007 111.389 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.38 -11.39 7.18 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 121.357 -0.449 . . . . 50.409999999999997 113.778 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.98 134.58 36.26 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.014 0.435 . . . . 42.299999999999997 112.002 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.572 HG21 ' HG2' ' A' ' 71' ' ' ARG . 45.8 m -97.17 107.76 20.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.871 0.367 . . . . 42.43 111.1 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.52 151.62 24.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.395 -0.366 . . . . 74.219999999999999 111.705 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.52 -30.45 65.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.575 0.583 . . . . 71.140000000000001 112.575 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 34.5 t70 -155.29 159.81 40.29 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.758 0.313 . . . . 73.409999999999997 111.548 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' HG21 ' A' ' 39' ' ' VAL . 39.5 tt0 -58.92 -43.37 91.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.799 0.333 . . . . 64.530000000000001 110.994 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.507 ' HB2' HD11 ' A' ' 33' ' ' LEU . 36.1 t -57.23 -34.99 69.13 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.138 0.494 . . . . 64.519999999999996 111.032 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -65.66 -41.47 92.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.041 -0.527 . . . . 70.109999999999999 111.155 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.402 HD11 ' HA2' ' A' ' 41' ' ' GLY . 9.3 tt -65.03 -42.34 94.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.066 0.46 . . . . 52.530000000000001 110.172 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 54' ' ' ARG . 11.2 mmm180 -54.14 -49.72 68.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.294 0.569 . . . . 72.140000000000001 110.584 175.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . . . -61.13 -42.97 99.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.916 -0.584 . . . . 62.32 111.158 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -55.69 -36.94 67.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.052 -0.522 . . . . 73.340000000000003 111.938 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 76.3 ttt-85 -59.92 -38.16 81.56 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.104 0.478 . . . . 71.219999999999999 111.021 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.0 t -82.68 -15.68 51.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.06 0.457 . . . . 73.25 111.207 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.9 ttp180 -97.17 49.51 1.06 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.239 0.542 . . . . 74.129999999999995 111.619 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.46 58.97 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 115.068 0.787 . . . . 60.310000000000002 115.068 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 4.0 m-70 -126.76 77.74 73.9 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.144 0.972 . . . . 75.120000000000005 111.972 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.12 -22.87 61.12 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.67 2.247 . . . . 75.439999999999998 113.043 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.84 4.23 54.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.309 -0.405 . . . . 70.329999999999998 111.802 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 56.9 tp -80.46 125.77 30.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.27 0.557 . . . . 75.120000000000005 112.158 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.1 p -136.62 163.8 29.71 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.68 -0.691 . . . . 70.420000000000002 110.475 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.13 124.56 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.006 0.431 . . . . 63.32 111.194 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.5 mmt -89.59 -53.67 4.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.93 0.395 . . . . 74.549999999999997 111.044 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.98 152.66 42.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 73.25 111.276 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.649 ' HD3' HD21 ' A' ' 37' ' ' LEU . 96.7 mtt180 -82.55 134.73 35.19 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.189 0.519 . . . . 62.409999999999997 111.8 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 116.27 -161.82 12.83 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.944 -0.571 . . . . 71.409999999999997 112.422 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.572 ' HG2' HG21 ' A' ' 46' ' ' THR . 50.2 mtp180 -86.29 153.61 21.85 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.538 -0.39 . . . . 74.120000000000005 111.286 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.5 m -57.38 112.72 1.49 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.532 0.682 . . . . 71.310000000000002 111.42 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 115.286 -0.87 . . . . 74.200000000000003 112.265 -173.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.592 0.234 . . . . 71.099999999999994 110.461 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 7.4 m -97.86 127.0 43.52 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.793 0.33 . . . . 72.010000000000005 110.439 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.35 110.31 20.69 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 110.241 -0.281 . . . . 74.299999999999997 110.241 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -34.8 0.57 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.147 -0.549 . . . . 72.140000000000001 114.386 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 21.2 t -66.08 140.22 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.156 0.478 . . . . 74.540000000000006 112.2 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -89.65 107.95 19.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.279 -0.419 . . . . 73.140000000000001 111.546 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.3 m -144.65 138.88 27.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.258 -0.428 . . . . 72.319999999999993 111.333 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.24 -95.28 0.1 OUTLIER Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.486 -0.387 . . . . 73.540000000000006 112.336 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.12 111.18 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.368 2.046 . . . . 73.340000000000003 112.334 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.21 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.239 -0.505 . . . . 33.420000000000002 113.862 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.583 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.9 mtmt -129.51 160.59 32.72 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.474 0.637 . . . . 65.140000000000001 112.324 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.8 136.03 20.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.358 -0.837 . . . . 62.5 109.946 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.2 p -101.63 142.37 33.08 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.194 0.521 . . . . 63.420000000000002 111.648 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -132.76 143.92 49.92 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.971 -0.559 . . . . 63.549999999999997 110.629 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.25 101.92 9.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.996 0.427 . . . . 71.400000000000006 110.298 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HD3' ' A' ' 23' ' ' ARG . 77.8 mt -125.48 116.07 21.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.408 -0.36 . . . . 53.0 111.385 -175.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.42 32.75 82.18 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.297 -0.478 . . . . 64.400000000000006 113.019 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.02 77.03 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.429 -0.415 . . . . 72.0 113.077 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.88 135.68 24.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.6 -0.353 . . . . 74.099999999999994 111.548 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.93 98.22 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.444 2.096 . . . . 64.209999999999994 112.716 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 23' ' ' ARG . 37.3 mtp-105 -95.96 123.17 39.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.608 -0.269 . . . . 74.420000000000002 111.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 9.5 t -104.06 120.19 40.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.68 0.276 . . . . 74.450000000000003 110.398 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -129.7 160.89 31.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 74.439999999999998 111.415 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.08 125.01 23.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 111.556 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -109.13 132.98 20.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 111.909 0.337 . . . . 72.200000000000003 111.909 -176.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 16.5 Cg_exo -69.0 112.87 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.923 2.416 . . . . 63.340000000000003 112.899 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.32 133.79 38.68 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.024 0.44 . . . . 62.109999999999999 111.108 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.1 m -124.33 45.09 2.58 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.937 0.399 . . . . 54.210000000000001 111.424 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.9 m -77.01 -76.44 0.17 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.23 0.456 . . . . 72.510000000000005 112.23 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 52.01 3.97 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.247 -0.502 . . . . 71.409999999999997 114.158 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.694 HD11 ' SG ' ' A' ' 51' ' ' CYS . 4.6 pp -155.83 151.56 22.16 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.44 -0.447 . . . . 63.520000000000003 111.497 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 7.3 Cg_exo -73.63 137.7 25.48 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.594 2.196 . . . . 64.230000000000004 112.479 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.77 134.33 56.11 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.224 0.453 . . . . 54.140000000000001 112.224 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 63.59 15.65 9.05 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.828 0.677 . . . . 75.319999999999993 112.828 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.5 tm? -82.71 104.11 12.71 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.851 0.358 . . . . 70.349999999999994 110.84 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.408 ' O ' HD13 ' A' ' 37' ' ' LEU . 80.8 mt-30 -61.12 150.18 34.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.022 -0.535 . . . . 62.43 111.804 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 69' ' ' ARG . 25.5 m -141.52 159.16 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.952 0.353 . . . . 64.349999999999994 111.952 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.566 ' SG ' ' HA2' ' A' ' 44' ' ' GLY . 51.5 t -106.31 122.18 45.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.856 0.36 . . . . 72.439999999999998 111.57 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.38 176.86 54.55 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.327 -0.463 . . . . 52.020000000000003 113.224 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -58.51 -25.76 62.74 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.4 0.519 . . . . 71.319999999999993 112.4 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.01 -14.4 59.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.025 0.44 . . . . 63.310000000000002 111.688 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.566 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . 85.05 34.62 14.28 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.227 -0.511 . . . . 73.109999999999999 112.952 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.24 148.01 40.89 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.505 0.322 . . . . 51.219999999999999 111.405 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -93.76 115.35 27.77 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.012 0.434 . . . . 70.329999999999998 112.128 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.12 166.1 13.15 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.352 -0.386 . . . . 71.040000000000006 111.149 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -62.23 -38.06 87.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.948 0.404 . . . . 74.420000000000002 111.194 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -166.02 174.07 9.77 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.939 -0.573 . . . . 65.109999999999999 110.743 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HB3' HD22 ' A' ' 33' ' ' LEU . 33.9 tt0 -63.06 -29.48 70.84 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.779 0.323 . . . . 74.450000000000003 111.086 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.694 ' SG ' HD11 ' A' ' 33' ' ' LEU . 62.1 m -58.28 -43.0 87.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.873 0.368 . . . . 64.310000000000002 110.693 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.44 -36.67 76.87 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 111.688 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.4 tt -65.25 -49.29 70.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.883 0.373 . . . . 70.299999999999997 110.372 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -57.31 -46.67 82.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 73.140000000000001 110.29 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.29 87.26 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.778 -0.646 . . . . 35.25 111.534 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.12 77.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.802 0.334 . . . . 41.240000000000002 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 34.4 mtm180 -61.75 -43.32 99.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.392 0.615 . . . . 72.450000000000003 110.683 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.4 t -78.51 -21.4 48.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.358 -0.837 . . . . 53.130000000000003 111.605 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp85 -90.03 -29.0 18.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.604 0.594 . . . . 74.409999999999997 112.604 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.588 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . -169.9 -37.08 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 119.669 -1.253 . . . . 40.32 115.45 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 83.3 m-70 -110.28 81.78 2.4 Favored Pre-proline 0 N--CA 1.477 0.922 0 CA-C-N 118.059 0.929 . . . . 74.329999999999998 112.553 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 23.8 Cg_exo -64.37 -24.63 64.37 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.497 2.131 . . . . 74.140000000000001 113.405 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.38 -4.65 57.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.981 0.42 . . . . 74.200000000000003 111.609 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 61.4 tp -66.2 112.7 4.07 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.383 0.512 . . . . 72.319999999999993 112.383 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -105.95 151.79 24.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.395 -0.366 . . . . 72.439999999999998 111.166 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.86 127.66 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.846 0.355 . . . . 74.209999999999994 111.236 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.1 mtt -84.69 -55.06 4.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.947 0.403 . . . . 74.109999999999999 111.621 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -147.91 154.9 40.97 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.054 0.454 . . . . 51.299999999999997 111.779 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 39' ' ' VAL . 94.2 mtt180 -84.2 141.65 30.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.901 -0.59 . . . . 65.420000000000002 111.102 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.45 158.65 14.01 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.858 -0.61 . . . . 54.229999999999997 111.813 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.78 130.81 46.56 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 117.291 0.545 . . . . 70.219999999999999 110.612 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.06 142.84 56.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.942 0.349 . . . . 63.109999999999999 111.942 -172.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 112.209 0.448 . . . . 62.210000000000001 112.209 -174.416 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 m . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.72 0.295 . . . . 73.319999999999993 111.326 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.2 m -139.59 129.0 24.17 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 111.891 0.33 . . . . 72.340000000000003 111.891 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.9 112.26 22.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.056 0.391 . . . . 75.140000000000001 112.056 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.7 56.09 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 114.992 0.757 . . . . 73.400000000000006 114.992 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.4 t -107.24 120.97 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.103 -0.645 . . . . 74.109999999999999 111.004 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 0.3 OUTLIER -96.63 109.38 22.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.625 0.726 . . . . 71.010000000000005 111.543 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 95.8 m -148.47 139.67 23.27 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.842 -0.617 . . . . 61.32 110.415 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.9 -98.15 0.17 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.091 -0.576 . . . . 61.420000000000002 113.723 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.12 -62.76 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.672 2.248 . . . . 70.209999999999994 113.962 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.5 58.89 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.144 -0.551 . . . . 54.32 113.922 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 48.8 mtmt -133.81 139.89 46.57 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.304 -0.527 . . . . 71.439999999999998 111.763 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -115.17 137.65 51.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.684 -0.235 . . . . 64.019999999999996 110.396 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.681 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 19.0 p -99.68 140.57 33.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.121 0.486 . . . . 75.230000000000004 111.704 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.421 ' HD3' ' OE1' ' A' ' 25' ' ' GLU . 9.5 ptm180 -143.23 163.13 33.8 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.121 -0.49 . . . . 61.219999999999999 112.086 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.9 mmt -79.76 104.14 10.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.297 -0.411 . . . . 41.43 111.526 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 93.6 mt -120.69 119.09 31.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.67 -0.241 . . . . 75.299999999999997 110.8 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.46 26.36 56.65 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.152 -0.546 . . . . 72.129999999999995 113.554 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.55 82.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.453 -0.403 . . . . 40.210000000000001 113.64 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 18' ' ' LEU . 11.0 ptp180 -128.75 138.15 32.51 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 117.496 0.648 . . . . 62.119999999999997 111.558 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.95 111.59 3.31 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.777 2.318 . . . . 75.219999999999999 113.426 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 97.6 mtt180 -116.34 144.81 43.78 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.342 -0.39 . . . . 71.150000000000006 111.585 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 76.9 m -103.82 135.19 45.83 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.441 -0.345 . . . . 75.049999999999997 111.549 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' OE1' ' HD3' ' A' ' 16' ' ' ARG . 9.7 pt-20 -129.89 161.08 31.64 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.565 -0.289 . . . . 74.439999999999998 111.601 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.7 t -55.03 114.51 1.78 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.37 0.507 . . . . 64.109999999999999 112.37 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -97.2 118.43 64.63 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.452 -0.34 . . . . 73.109999999999999 111.078 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 2.6 Cg_endo -88.16 21.19 1.04 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.217 2.611 . . . . 63.130000000000003 113.944 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 55.74 36.41 27.2 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.903 0.382 . . . . 74.030000000000001 111.951 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HA ' HD21 ' A' ' 33' ' ' LEU . 60.4 m -65.52 78.62 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.458 0.647 . . . . 43.229999999999997 111.637 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -149.88 120.43 7.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.465 -0.788 . . . . 63.530000000000001 110.396 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.15 -40.11 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.134 -0.555 . . . . 63.0 112.679 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 30' ' ' CYS . 3.3 pp -66.09 153.35 92.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.592 -0.357 . . . . 64.5 111.263 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 17.0 Cg_exo -68.13 120.42 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.613 2.209 . . . . 31.440000000000001 113.081 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.41 141.17 29.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 111.023 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 63.3 10.86 4.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.134 0.791 . . . . 64.420000000000002 113.134 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . 3.3 tm? -103.27 110.64 22.69 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.169 -0.678 . . . . 74.340000000000003 109.169 174.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -54.18 153.94 4.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.804 0.668 . . . . 64.340000000000003 112.804 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.478 HG12 ' HG2' ' A' ' 69' ' ' ARG . 22.5 m -136.54 143.06 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.869 -0.605 . . . . 63.25 110.876 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.86 113.44 25.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 62.310000000000002 110.728 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.17 164.96 48.33 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.146 -0.479 . . . . 30.32 113.937 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 p -58.66 -20.98 52.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.307 0.643 . . . . 73.430000000000007 112.393 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.67 -14.31 60.35 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.989 0.424 . . . . 72.049999999999997 111.755 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.1 10.82 59.34 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.128 -0.558 . . . . 64.120000000000005 113.052 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.61 144.58 40.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.866 0.365 . . . . 43.240000000000002 111.416 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.0 m -96.23 129.41 43.55 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.502 -0.317 . . . . 70.0 111.226 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -109.89 168.89 9.09 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.626 0.251 . . . . 75.409999999999997 111.669 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -47.57 -54.92 10.4 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.573 0.583 . . . . 74.129999999999995 112.573 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -164.27 -178.91 5.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.696 0.284 . . . . 74.549999999999997 111.459 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 tp10 -55.37 -45.01 76.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.427 -0.351 . . . . 74.409999999999997 111.185 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.16 -43.08 82.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.098 0.475 . . . . 73.099999999999994 110.915 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.55 -43.23 97.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 111.052 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 64' ' ' LEU . 10.4 tt -62.4 -45.27 93.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.227 -0.442 . . . . 65.409999999999997 111.349 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.7 mmm180 -62.57 -37.82 87.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.395 0.617 . . . . 64.329999999999998 109.927 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.1 84.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 111.084 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.25 87.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.366 . . . . 65.519999999999996 111.424 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 66.5 ttt180 -64.79 -41.29 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.067 0.461 . . . . 75.209999999999994 110.601 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.53 -26.68 67.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.354 0.597 . . . . 52.439999999999998 110.686 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -89.51 58.12 4.23 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.723 -0.671 . . . . 73.129999999999995 111.299 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.78 36.24 93.06 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.926 0.73 . . . . 52.299999999999997 114.926 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 77.9 m80 -135.66 74.96 57.78 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 117.689 0.744 . . . . 71.120000000000005 111.607 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.04 -24.1 75.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.843 2.362 . . . . 53.520000000000003 114.114 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.16 -2.82 42.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.388 0.514 . . . . 74.530000000000001 112.388 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -77.72 111.59 13.67 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.241 0.543 . . . . 63.119999999999997 111.051 -175.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -142.92 152.07 41.65 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.005 -0.543 . . . . 74.420000000000002 110.706 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 53' ' ' LEU . 7.2 p -77.46 132.34 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 121.162 0.506 . . . . 61.149999999999999 112.257 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.9 mtt -92.51 -54.0 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.378 0.609 . . . . 61.32 110.25 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -143.36 150.49 39.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 109.909 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.478 ' HG2' HG12 ' A' ' 39' ' ' VAL . 77.2 mtt85 -92.18 148.15 22.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.964 0.888 . . . . 72.409999999999997 112.487 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.16 -163.21 12.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 114.977 -1.01 . . . . 53.109999999999999 110.878 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -90.42 142.91 27.26 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.486 0.643 . . . . 70.239999999999995 110.795 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.85 102.49 0.06 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.405 0.621 . . . . 72.340000000000003 112.578 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.4 ' HD3' HH11 ' A' ' 73' ' ' ARG . 3.5 ptm180 . . . . . 0 CA--C 1.54 0.585 0 CA-C-N 115.436 -0.802 . . . . 74.530000000000001 110.326 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 62.399999999999999 111.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 29.0 m -98.9 128.81 45.17 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.426 -0.352 . . . . 34.549999999999997 110.637 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.08 111.26 20.16 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.25 -0.282 . . . . 55.310000000000002 110.313 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.91 -39.62 0.97 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.373 -0.442 . . . . 65.209999999999994 113.932 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 6.2 t -66.62 146.06 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.397 0.517 . . . . 71.239999999999995 112.397 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -102.97 106.62 17.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.11 0.481 . . . . 65.019999999999996 110.554 176.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.26 178.78 8.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.719 0.637 . . . . 74.319999999999993 112.719 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.25 -82.88 0.29 Allowed Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.74 -0.664 . . . . 74.409999999999997 111.78 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.67 92.76 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.765 2.31 . . . . 71.310000000000002 112.854 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.4 -10.3 73.26 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.15 -0.547 . . . . 74.030000000000001 113.473 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 45.1 mtmt -135.29 136.3 41.5 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.273 -0.545 . . . . 72.200000000000003 111.761 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.81 133.52 55.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.206 -0.452 . . . . 70.129999999999995 110.132 173.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 23.8 p -97.92 119.71 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.299 0.571 . . . . 64.530000000000001 110.385 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.2 ttm-85 -124.67 143.8 50.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.73 -0.668 . . . . 64.040000000000006 110.577 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.411 ' HA ' ' CE ' ' A' ' 17' ' ' MET . 3.2 mmt -73.68 100.31 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.203 0.525 . . . . 60.109999999999999 110.694 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.561 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 83.9 mt -125.38 107.5 10.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.822 -0.626 . . . . 73.439999999999998 110.104 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.39 -64.89 4.09 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.958 -0.639 . . . . 51.109999999999999 112.532 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.55 -22.48 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.584 -0.817 . . . . 53.329999999999998 114.154 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -98.65 138.67 20.77 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.42 -0.459 . . . . 73.430000000000007 111.425 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.75 93.8 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.991 1.794 . . . . 75.239999999999995 112.093 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 11.5 ptm180 -106.1 142.55 35.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.889 -0.596 . . . . 70.209999999999994 111.022 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 93.9 m -103.29 138.85 39.51 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 64.340000000000003 111.757 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.5 mm-40 -106.45 156.69 18.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.232 -0.894 . . . . 54.310000000000002 110.061 -175.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.1 t -68.42 97.82 0.79 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.267 -0.642 . . . . 64.0 109.267 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.75 137.67 20.61 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.157 -0.474 . . . . 75.430000000000007 112.238 -171.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 7.7 Cg_exo -73.8 55.25 3.24 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.06 2.506 . . . . 74.120000000000005 112.59 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.51 127.01 18.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.819 0.342 . . . . 74.019999999999996 111.257 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.813 ' HB2' HD12 ' A' ' 33' ' ' LEU . 29.4 p -169.6 40.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.278 -0.419 . . . . 64.040000000000006 111.445 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.9 t -60.38 102.29 0.17 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.913 0.387 . . . . 64.209999999999994 111.705 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.31 -9.28 5.93 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.414 -0.422 . . . . 62.539999999999999 113.027 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 ' HB2' ' A' ' 30' ' ' CYS . 95.7 mt -95.32 126.08 47.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 O-C-N 122.64 -0.329 . . . . 63.039999999999999 111.325 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.87 125.15 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.501 2.134 . . . . 65.120000000000005 113.057 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.81 9.93 1.64 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.734 0.642 . . . . 64.200000000000003 112.734 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -113.18 9.66 18.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.961 0.41 . . . . 74.439999999999998 111.021 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 52.7 tp -106.83 97.91 7.64 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.755 0.312 . . . . 71.319999999999993 111.115 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.13 148.76 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.239 -0.437 . . . . 73.349999999999994 111.868 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 50' ' ' GLU . 25.0 m -137.21 161.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.359 . . . . 64.519999999999996 111.844 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.7 t -118.05 128.5 54.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.932 0.396 . . . . 71.439999999999998 110.627 173.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.33 177.54 37.91 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.103 -0.57 . . . . 74.439999999999998 114.207 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 p -63.78 -14.59 54.04 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.098 0.475 . . . . 71.319999999999993 111.74 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -81.95 -22.55 36.61 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.139 0.495 . . . . 65.319999999999993 111.093 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.54 -8.67 60.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.431 -0.414 . . . . 70.310000000000002 113.294 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.47 134.16 39.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.152 0.427 . . . . 52.32 112.152 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -86.72 116.25 24.69 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.248 -0.433 . . . . 63.329999999999998 110.626 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -100.65 159.68 14.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.036 0.446 . . . . 72.120000000000005 112.116 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -56.9 -35.96 69.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.723 -0.671 . . . . 73.129999999999995 111.163 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.0 p-10 -164.14 169.49 17.68 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.328 -0.851 . . . . 74.010000000000005 110.183 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HB3' HD13 ' A' ' 33' ' ' LEU . 34.4 tt0 -65.36 -33.02 74.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.043 -0.411 . . . . 70.25 111.552 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' HB2' ' OD2' ' A' ' 49' ' ' ASP . 28.2 m -65.41 -37.89 88.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.884 0.373 . . . . 72.209999999999994 110.435 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.99 -39.51 89.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.244 0.545 . . . . 51.109999999999999 110.603 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.97 -47.12 81.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.291 0.567 . . . . 61.450000000000003 110.31 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 54' ' ' ARG . 17.8 mtp180 -65.26 -22.09 66.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.813 -0.63 . . . . 71.230000000000004 111.03 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.59 -43.42 31.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.055 0.455 . . . . 74.340000000000003 110.876 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.32 64.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.133 0.492 . . . . 71.319999999999993 111.217 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 57' ' ' ARG . 16.0 tpp85 -54.18 -51.35 64.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.576 . . . . 74.530000000000001 110.273 170.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 62.2 m -68.58 -29.95 68.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.92 -0.582 . . . . 64.239999999999995 111.6 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.19 -32.32 73.68 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.903 0.382 . . . . 75.439999999999998 111.292 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.11 43.9 0.06 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.065 -0.588 . . . . 74.329999999999998 113.469 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.3 m-70 -135.33 82.07 41.79 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.345 -0.503 . . . . 74.299999999999997 111.646 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.04 -22.33 41.74 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.795 2.33 . . . . 63.229999999999997 113.415 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -84.23 -19.31 34.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.881 0.372 . . . . 75.510000000000005 111.805 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 43.6 tp -68.16 112.14 4.92 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.367 0.603 . . . . 71.129999999999995 112.521 -172.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.2 p -127.38 163.43 24.04 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.66 -0.7 . . . . 72.109999999999999 109.736 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.63 127.56 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.104 0.478 . . . . 70.420000000000002 111.814 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.4 mtt -90.62 -55.71 3.47 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.093 0.473 . . . . 75.439999999999998 111.406 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -148.46 157.15 43.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.864 0.364 . . . . 74.129999999999995 111.217 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -101.49 107.73 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.523 0.677 . . . . 74.129999999999995 111.782 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.88 -179.5 29.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.325 -0.852 . . . . 75.519999999999996 111.514 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -60.33 127.55 32.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.748 0.774 . . . . 62.210000000000001 109.95 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.89 97.96 0.06 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.437 0.637 . . . . 72.109999999999999 111.503 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 . . . . . 0 CA--C 1.537 0.473 0 CA-C-N 115.831 -0.622 . . . . 54.509999999999998 112.114 -175.128 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 120.732 0.301 . . . . 61.009999999999998 111.718 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.8 m -100.1 130.7 46.27 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.781 0.66 . . . . 61.450000000000003 112.781 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.06 124.87 32.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.327 -0.397 . . . . 72.200000000000003 111.445 173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.72 -31.42 2.48 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.689 0.636 . . . . 52.509999999999998 114.689 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 22' ' ' PRO . 36.2 t -66.16 139.69 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 117.276 0.538 . . . . 74.129999999999995 111.626 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.94 103.36 14.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.092 0.405 . . . . 73.349999999999994 112.092 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 57.9 m -152.13 138.84 18.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.369 -0.378 . . . . 52.310000000000002 111.266 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . -139.43 -106.32 0.68 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.737 -0.744 . . . . 63.439999999999998 113.977 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 13.5 Cg_exo -70.8 -49.82 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.843 2.362 . . . . 71.430000000000007 113.415 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.68 66.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.045 -0.598 . . . . 72.430000000000007 113.304 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 49.7 mtmt -128.47 141.26 51.45 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.622 -0.34 . . . . 74.040000000000006 110.985 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.36 133.82 52.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.494 -0.321 . . . . 74.120000000000005 110.169 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.0 t -100.42 136.52 40.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.339 . . . . 65.329999999999998 111.272 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -134.83 163.67 29.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.08 0.467 . . . . 75.140000000000001 111.465 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.8 mmm -89.85 101.5 14.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.199 0.523 . . . . 72.329999999999998 110.964 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.08 115.48 30.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.215 -0.448 . . . . 65.239999999999995 110.763 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.58 40.54 92.63 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.202 -0.523 . . . . 71.230000000000004 113.418 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 5.92 81.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.9 -0.667 . . . . 62.140000000000001 113.766 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -124.42 129.85 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 117.173 0.486 . . . . 72.319999999999993 111.517 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.524 ' HB2' HG21 ' A' ' 7' ' ' VAL . 61.1 Cg_endo -72.55 106.2 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.497 2.131 . . . . 62.409999999999997 112.787 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -115.33 142.81 46.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.881 0.372 . . . . 65.420000000000002 111.277 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 9.4 m -103.92 142.83 33.74 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.102 0.477 . . . . 72.109999999999999 112.203 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -143.6 153.38 42.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.74 -0.664 . . . . 73.030000000000001 110.684 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.6 t -52.83 128.23 26.13 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.176 0.512 . . . . 63.140000000000001 111.929 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.71 128.21 30.51 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.162 -0.472 . . . . 72.5 111.67 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.95 -2.84 12.39 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.264 1.976 . . . . 73.239999999999995 112.645 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' HB3' ' NH1' ' A' ' 54' ' ' ARG . 36.2 t70 62.14 7.22 2.08 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.633 0.73 . . . . 74.299999999999997 111.645 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' HD21 ' A' ' 33' ' ' LEU . 33.8 t -80.53 92.63 5.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.887 -0.597 . . . . 73.319999999999993 112.197 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 p -138.43 -83.01 0.3 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.205 -0.452 . . . . 70.140000000000001 111.1 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.19 49.52 2.71 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.966 -0.635 . . . . 72.319999999999993 113.123 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 30' ' ' CYS . 2.6 pp -132.71 159.05 74.11 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 122.46 0.304 . . . . 60.310000000000002 111.08 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.95 119.09 6.11 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.367 2.045 . . . . 64.219999999999999 113.502 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.17 66.35 8.46 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.886 -0.783 . . . . 74.049999999999997 108.886 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -143.87 -13.38 0.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.909 0.707 . . . . 73.319999999999993 112.909 -165.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 68.1 tp -128.05 116.83 20.61 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.712 0.634 . . . . 74.450000000000003 112.712 -168.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -58.57 154.74 13.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.156 -0.475 . . . . 72.530000000000001 111.405 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.6 m -140.79 148.5 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.236 0.541 . . . . 43.43 111.846 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.0 t -100.03 116.37 31.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.288 -0.414 . . . . 73.329999999999998 110.593 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.34 162.18 34.73 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.215 -0.517 . . . . 73.209999999999994 113.63 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.8 p -55.14 -28.0 49.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.117 0.484 . . . . 42.530000000000001 111.654 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.4 -47.47 83.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.869 -0.605 . . . . 74.319999999999993 111.817 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.13 -23.38 5.84 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.335 -0.459 . . . . 62.100000000000001 112.531 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.9 139.89 36.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.993 0.425 . . . . 74.099999999999994 111.824 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -86.68 122.75 31.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.008 0.432 . . . . 71.109999999999999 111.092 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.73 153.73 17.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.442 . . . . 73.209999999999994 111.331 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -62.16 -25.71 67.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.825 -0.625 . . . . 61.450000000000003 112.606 -173.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 25.0 t70 -170.45 159.89 7.19 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.595 -0.275 . . . . 73.439999999999998 110.782 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.67 -40.21 68.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.314 0.578 . . . . 62.509999999999998 110.538 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.8 t -52.99 -42.69 65.81 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.286 -0.87 . . . . 71.040000000000006 111.471 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.98 -43.73 57.11 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.336 -0.393 . . . . 54.109999999999999 111.336 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 66' ' ' VAL . 69.2 tp -55.17 -58.33 8.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.137 0.494 . . . . 72.230000000000004 112.208 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 78.3 mtp180 -70.69 -25.05 62.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 111.781 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 59' ' ' ARG . . . -72.76 -45.28 59.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 70.420000000000002 111.146 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.93 68.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.087 0.47 . . . . 73.239999999999995 110.771 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 54' ' ' ARG . 31.6 ttp180 -56.03 -50.02 72.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.579 -0.737 . . . . 73.040000000000006 110.642 171.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -66.28 -22.38 66.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.744 -0.662 . . . . 62.229999999999997 112.129 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 55' ' ' ALA . 29.5 mtp-105 -84.99 30.31 0.59 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.205 0.446 . . . . 73.329999999999998 112.205 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.75 6.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.965 -0.636 . . . . 64.510000000000005 114.279 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -134.46 77.54 59.16 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 117.294 0.547 . . . . 74.530000000000001 110.974 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.88 -21.15 38.18 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.872 2.382 . . . . 71.099999999999994 113.526 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.91 -17.64 52.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.989 0.423 . . . . 54.240000000000002 111.418 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 tp -72.26 112.0 7.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.195 0.521 . . . . 73.519999999999996 111.527 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -135.13 164.46 27.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.017 -0.538 . . . . 65.040000000000006 111.356 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.528 HG22 HD23 ' A' ' 53' ' ' LEU . 39.8 t -79.45 119.24 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.841 0.353 . . . . 71.209999999999994 111.862 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.3 mmt -81.92 -58.73 2.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.978 0.418 . . . . 73.049999999999997 110.579 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -161.58 160.91 29.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.801 -0.636 . . . . 64.0 111.2 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -77.78 137.59 38.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.271 -0.422 . . . . 75.129999999999995 111.569 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.61 172.27 30.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.264 -0.493 . . . . 72.519999999999996 113.127 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' ARG . 63.3 ttt180 -60.15 154.59 19.2 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.634 -0.333 . . . . 70.150000000000006 110.2 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.17 84.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 73.230000000000004 112.502 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' ARG . 57.8 mtp180 . . . . . 0 N--CA 1.469 0.524 0 C-N-CA 123.123 0.569 . . . . 64.439999999999998 111.319 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 120.999 0.428 . . . . 72.340000000000003 111.736 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.4 p -98.72 130.78 45.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.018 0.437 . . . . 63.009999999999998 112.169 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -80.51 126.46 31.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.081 0.467 . . . . 64.140000000000001 111.521 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.34 -2.2 16.05 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.002 -0.544 . . . . 73.129999999999995 113.945 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 10.9 t -107.17 145.83 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 117.118 0.459 . . . . 64.310000000000002 111.326 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.12 106.41 15.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.635 -0.506 . . . . 64.120000000000005 109.635 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 87.9 m -138.91 139.1 37.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.923 0.392 . . . . 75.430000000000007 111.048 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' LYS . . . 169.97 -64.05 0.17 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.393 -0.432 . . . . 63.32 113.076 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.36 42.83 1.3 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.154 2.569 . . . . 74.549999999999997 113.69 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.79 -45.01 0.43 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.158 -0.544 . . . . 73.409999999999997 112.424 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 36.8 mtmm -122.65 136.92 55.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.492 0.317 . . . . 75.140000000000001 110.263 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -107.23 134.35 50.45 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 122.381 -0.2 . . . . 42.340000000000003 111.108 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.88 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 31.5 p -114.77 139.64 49.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.668 0.618 . . . . 54.310000000000002 112.668 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.567 HH11 ' HG3' ' A' ' 16' ' ' ARG . 29.1 ttm-85 -142.5 160.52 40.13 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.958 -0.565 . . . . 72.200000000000003 111.152 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.2 mmt -82.53 107.91 15.53 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.577 0.584 . . . . 72.010000000000005 112.577 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HD2' ' A' ' 23' ' ' ARG . 6.3 mp -123.45 102.0 7.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.871 0.367 . . . . 75.200000000000003 110.938 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.65 52.57 52.22 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.403 -0.427 . . . . 43.530000000000001 114.018 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.45 -44.37 3.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.205 -0.521 . . . . 74.150000000000006 113.811 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.04 130.76 35.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 75.140000000000001 111.716 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.07 141.05 12.83 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.515 2.143 . . . . 52.32 112.922 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HD2' HD22 ' A' ' 18' ' ' LEU . 97.3 mtt180 -113.79 123.32 49.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.764 -0.198 . . . . 65.019999999999996 111.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.88 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 94.9 m -107.36 120.1 41.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.647 0.261 . . . . 75.0 110.988 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -119.74 159.23 24.9 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.341 -0.225 . . . . 75.519999999999996 111.525 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 58' ' ' CYS . 8.9 t -58.72 95.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.293 -0.412 . . . . 71.400000000000006 110.869 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.8 130.99 24.6 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.329 -0.396 . . . . 75.409999999999997 111.887 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -82.68 -158.87 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.672 2.248 . . . . 72.510000000000005 111.842 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.27 102.14 14.81 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.854 -0.529 . . . . 75.450000000000003 110.994 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.7 m -102.87 3.96 37.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.159 0.504 . . . . 73.25 110.56 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -81.37 -35.28 31.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.953 -0.567 . . . . 72.430000000000007 111.99 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.93 9.08 78.81 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.919 -0.658 . . . . 53.420000000000002 114.389 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 51' ' ' CYS . 4.1 pp -128.62 156.36 77.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 117.578 0.689 . . . . 74.319999999999993 112.087 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.56 123.19 2.49 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.677 2.251 . . . . 74.120000000000005 112.963 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.87 14.68 0.48 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.77 0.656 . . . . 72.040000000000006 112.77 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.01 10.04 13.85 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.11 -0.369 . . . . 72.519999999999996 111.78 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -111.06 100.19 8.92 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.205 -0.31 . . . . 73.209999999999994 110.798 -177.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.22 139.36 57.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.877 0.37 . . . . 73.019999999999996 111.974 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 69' ' ' ARG . 26.2 m -128.72 166.25 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.142 0.496 . . . . 72.329999999999998 111.811 -175.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.0 t -116.34 124.16 49.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.224 -0.444 . . . . 53.32 111.254 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.02 161.56 24.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.124 -0.56 . . . . 71.299999999999997 113.497 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 p -55.54 -24.13 30.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.404 0.52 . . . . 74.530000000000001 112.404 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.2 -2.5 28.22 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 120.877 0.37 . . . . 73.439999999999998 111.674 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.11 25.06 58.39 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.424 -0.417 . . . . 33.210000000000001 113.244 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.41 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.928 0.394 . . . . 71.540000000000006 111.832 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 71' ' ' ARG . 81.2 m -86.36 110.95 20.04 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.279 -0.419 . . . . 71.120000000000005 110.862 174.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -91.16 159.8 15.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 61.32 111.673 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 3.9 mmp_? -53.04 -39.68 63.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.112 -0.494 . . . . 74.120000000000005 112.223 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 5.5 p-10 -163.93 -178.48 5.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.281 -0.418 . . . . 75.530000000000001 110.821 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.522 ' HB3' HD22 ' A' ' 33' ' ' LEU . 24.7 tt0 -68.85 -37.28 79.02 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.673 0.273 . . . . 75.25 111.589 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.627 ' HB2' HD11 ' A' ' 33' ' ' LEU . 25.3 t -65.5 -41.71 92.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.657 0.265 . . . . 64.420000000000002 110.667 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.25 -51.48 53.65 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.209 0.528 . . . . 63.240000000000002 111.122 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.4 -53.84 46.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.915 -0.584 . . . . 63.219999999999999 110.984 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.506 ' NH1' HD23 ' A' ' 33' ' ' LEU . 70.0 mtp180 -61.75 -29.86 70.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 111.977 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.32 -42.8 68.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.985 0.421 . . . . 63.329999999999998 110.812 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.35 88.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.862 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 36.8 ttt85 -63.39 -48.06 79.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.086 0.47 . . . . 52.43 111.236 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.486 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 5.6 t -55.47 -44.42 76.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.933 -0.576 . . . . 71.400000000000006 110.468 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -84.21 61.9 6.81 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.255 0.55 . . . . 64.450000000000003 112.147 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.05 25.28 49.51 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.58 0.992 . . . . 54.210000000000001 115.58 170.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.48 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 95.4 m-70 -134.81 74.88 63.27 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 118.222 1.011 . . . . 75.310000000000002 112.132 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.96 -19.76 17.64 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.608 2.206 . . . . 63.539999999999999 113.494 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.0 -22.52 42.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.083 0.468 . . . . 65.040000000000006 111.067 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.446 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 63.9 tp -75.12 111.74 10.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.184 -0.462 . . . . 62.200000000000003 111.264 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 p -124.75 141.97 51.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.003 0.43 . . . . 74.329999999999998 111.638 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.24 113.71 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.305 0.574 . . . . 75.329999999999998 111.289 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 28.0 mmt -77.01 -42.44 38.65 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.962 0.41 . . . . 72.030000000000001 111.416 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -169.03 163.0 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.085 -0.507 . . . . 75.230000000000004 111.217 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.646 ' HG3' HG12 ' A' ' 39' ' ' VAL . 1.3 mpp_? -93.34 153.72 18.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.387 -0.37 . . . . 72.549999999999997 111.336 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.99 49.69 2.42 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.366 -0.445 . . . . 34.409999999999997 113.514 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HA ' HG23 ' A' ' 46' ' ' THR . 59.7 mtp85 61.47 172.08 0.11 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.894 0.701 . . . . 75.400000000000006 112.894 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.2 m -81.32 112.28 18.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 72.510000000000005 111.646 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 . . . . . 0 CA--C 1.54 0.571 0 CA-C-N 116.053 -0.522 . . . . 74.209999999999994 110.765 178.104 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.832 0.348 . . . . 74.150000000000006 111.625 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 m -97.1 130.56 44.36 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.856 0.36 . . . . 65.409999999999997 111.173 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 7' ' ' VAL . 34.6 t70 -84.21 112.1 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.738 0.304 . . . . 75.540000000000006 111.454 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.28 0.01 9.6 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 114.67 0.628 . . . . 74.439999999999998 114.67 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' SG ' ' A' ' 9' ' ' CYS . 2.3 t -107.41 137.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 117.691 0.745 . . . . 51.340000000000003 111.819 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.46 106.03 18.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.797 0.332 . . . . 71.329999999999998 110.195 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.564 ' SG ' HG12 ' A' ' 7' ' ' VAL . 59.0 m -142.96 177.35 8.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.848 0.356 . . . . 74.109999999999999 111.908 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.87 -88.07 0.3 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.495 -0.383 . . . . 51.210000000000001 112.272 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.66 93.64 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.482 2.121 . . . . 64.439999999999998 112.925 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.0 10.89 82.26 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.034 -0.53 . . . . 72.129999999999995 113.432 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -146.98 136.29 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.386 -0.479 . . . . 74.420000000000002 111.484 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.1 140.21 52.28 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.594 -0.275 . . . . 73.340000000000003 110.802 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 15.8 p -100.1 106.24 17.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.402 0.62 . . . . 64.510000000000005 111.942 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -106.69 122.14 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.655 -0.702 . . . . 73.099999999999994 110.253 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 54.2 mtp -80.54 106.71 12.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.394 0.616 . . . . 64.129999999999995 111.883 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.68 HD12 ' HD2' ' A' ' 23' ' ' ARG . 92.9 mt -116.75 112.94 21.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.81 -0.632 . . . . 65.109999999999999 110.995 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.59 22.85 74.42 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.964 -0.636 . . . . 40.219999999999999 113.101 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.97 -21.12 44.86 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.337 -0.459 . . . . 71.310000000000002 113.627 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -106.08 131.78 21.45 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 117.22 0.51 . . . . 72.109999999999999 111.98 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 59.0 Cg_endo -73.36 111.6 3.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.436 2.091 . . . . 72.430000000000007 112.418 174.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.68 ' HD2' HD12 ' A' ' 18' ' ' LEU . 95.2 mtt180 -96.06 146.42 24.65 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.242 -0.286 . . . . 74.310000000000002 111.4 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 21.8 m -132.67 133.07 43.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.101 0.477 . . . . 53.310000000000002 111.191 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.16 161.23 37.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.015 -0.539 . . . . 71.239999999999995 110.11 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.8 t -54.05 95.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.033 0.444 . . . . 70.0 111.855 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -119.26 136.59 24.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.678 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 13.9 Cg_exo -68.45 90.84 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.421 2.081 . . . . 75.450000000000003 113.314 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.77 -70.5 0.25 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.921 0.391 . . . . 62.439999999999998 110.599 172.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.6 m 55.55 72.79 0.46 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.678 0.621 . . . . 65.209999999999994 112.678 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.8 m -85.28 -29.72 24.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.976 0.417 . . . . 64.540000000000006 110.893 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -65.52 1.54 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.28 -0.418 . . . . 62.439999999999998 113.333 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.663 HD23 ' H ' ' A' ' 33' ' ' LEU . 2.3 pt? -74.13 141.78 78.21 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.989 0.423 . . . . 75.239999999999995 111.993 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 16.1 Cg_exo -70.49 120.8 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.776 2.318 . . . . 71.530000000000001 112.574 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.15 60.35 1.04 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.345 0.593 . . . . 71.310000000000002 111.089 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -151.24 -35.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.578 -0.737 . . . . 71.019999999999996 110.937 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 66.3 tp -67.76 107.99 2.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.278 -0.419 . . . . 73.219999999999999 111.744 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.63 149.82 38.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.5 0.666 . . . . 70.420000000000002 112.744 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.465 HG12 ' HG2' ' A' ' 69' ' ' ARG . 34.3 m -139.78 153.62 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 115.649 -0.705 . . . . 50.0 110.899 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.8 t -106.42 122.34 46.09 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.885 0.374 . . . . 74.209999999999994 111.256 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.6 165.12 40.21 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.05 -0.595 . . . . 60.240000000000002 113.648 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 p -53.53 -36.82 62.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.017 0.377 . . . . 71.209999999999994 112.017 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.06 -27.92 62.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 116.305 -0.407 . . . . 72.340000000000003 111.968 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.73 -3.0 34.05 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.174 -0.536 . . . . 55.140000000000001 113.099 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.28 142.73 27.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.98 0.419 . . . . 73.329999999999998 111.911 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.0 m -92.0 120.35 32.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.929 0.395 . . . . 71.150000000000006 110.33 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -97.12 148.55 22.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.529 -0.305 . . . . 64.140000000000001 111.11 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 19.9 ptp180 -49.51 -34.53 17.41 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.432 0.53 . . . . 73.25 112.432 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.2 p30 -160.75 176.69 11.22 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.885 0.374 . . . . 75.319999999999993 111.286 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HA ' HG21 ' A' ' 39' ' ' VAL . 35.2 tt0 -65.45 -33.61 76.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.412 -0.358 . . . . 73.049999999999997 111.885 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.32 -36.15 82.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.603 0.24 . . . . 61.009999999999998 111.1 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.63 -48.71 80.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.98 0.419 . . . . 74.010000000000005 110.818 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 53' ' ' LEU . 6.8 tt -59.6 -55.57 32.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.182 0.515 . . . . 74.510000000000005 110.397 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -58.8 -34.66 71.75 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.994 -0.548 . . . . 75.040000000000006 111.956 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.92 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.586 0.231 . . . . 73.239999999999995 111.485 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.57 86.09 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 73.439999999999998 111.348 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 1.6 tmt_? -59.42 -50.14 75.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.609 0.719 . . . . 73.25 109.99 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.76 -30.05 69.77 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.452 -0.794 . . . . 74.010000000000005 111.455 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.95 74.61 6.42 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.075 -0.512 . . . . 74.329999999999998 111.312 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.64 34.97 90.43 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 115.224 0.85 . . . . 73.420000000000002 115.224 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 77.8 m80 -135.04 89.05 25.07 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 117.96 0.88 . . . . 73.329999999999998 111.925 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.56 -18.18 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.01 2.473 . . . . 71.409999999999997 113.176 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -19.61 44.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.889 0.376 . . . . 74.219999999999999 111.916 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 tp -82.97 130.65 35.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.006 0.432 . . . . 74.519999999999996 112.001 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -146.72 161.26 40.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.283 -0.417 . . . . 74.5 110.78 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t -80.48 112.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 120.966 0.412 . . . . 64.040000000000006 111.372 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.18 -55.91 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.21 0.529 . . . . 71.109999999999999 110.668 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -159.51 152.93 22.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.917 -0.583 . . . . 74.209999999999994 110.706 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HG2' HG12 ' A' ' 39' ' ' VAL . 91.3 mtt180 -79.57 150.48 31.07 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.062 0.458 . . . . 73.430000000000007 111.195 177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.84 -178.34 29.64 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.978 -0.555 . . . . 21.510000000000002 112.177 -173.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -75.03 161.91 29.03 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.265 -0.55 . . . . 73.219999999999999 111.388 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.42 93.68 0.24 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.159 0.799 . . . . 74.150000000000006 113.159 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 . . . . . 0 CA--C 1.538 0.51 0 CA-C-N 115.413 -0.812 . . . . 71.540000000000006 110.88 176.624 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 110.268 -0.271 . . . . 54.140000000000001 110.268 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.0 m -120.56 131.13 54.52 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.276 0.472 . . . . 63.350000000000001 112.276 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 7' ' ' VAL . 9.5 m-20 -83.45 112.13 19.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.21 -0.45 . . . . 75.319999999999993 111.726 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.72 32.08 16.87 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.757 0.663 . . . . 74.200000000000003 114.757 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 22' ' ' PRO . 93.1 t -106.96 122.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.541 0.67 . . . . 62.219999999999999 111.542 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -99.26 105.97 18.05 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.329 0.585 . . . . 72.140000000000001 111.747 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 80.9 m -148.34 137.95 22.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.002 -0.545 . . . . 52.409999999999997 110.127 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.74 -86.9 0.06 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 119.897 -1.144 . . . . 73.430000000000007 114.635 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.56 -35.64 80.47 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.12 2.547 . . . . 74.219999999999999 113.901 -172.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.96 -45.35 1.39 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.988 -0.625 . . . . 65.120000000000005 113.634 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.8 mtmt -123.63 146.87 47.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.489 0.552 . . . . 71.510000000000005 112.489 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -116.67 145.94 43.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 53.100000000000001 110.494 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 26.8 p -104.03 133.99 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.154 0.502 . . . . 64.310000000000002 112.198 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.48 ' NH2' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -118.86 164.26 15.68 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.987 -0.551 . . . . 73.430000000000007 111.161 176.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 mmt -82.11 102.94 11.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.891 0.377 . . . . 64.120000000000005 111.274 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.83 103.41 12.66 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.871 0.367 . . . . 70.420000000000002 110.212 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.18 33.01 82.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.341 -0.457 . . . . 71.239999999999995 112.686 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.34 -12.97 57.27 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.369 -0.443 . . . . 52.200000000000003 113.047 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 94.9 mtt180 -99.19 129.31 29.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 O-C-N 122.616 -0.343 . . . . 72.200000000000003 111.602 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.682 ' HB2' HG21 ' A' ' 7' ' ' VAL . 1.9 Cg_endo -80.95 113.75 2.8 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.966 2.444 . . . . 73.109999999999999 112.877 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -123.14 140.62 52.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.789 0.328 . . . . 74.519999999999996 111.472 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.4 m -104.1 131.74 51.06 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.894 0.701 . . . . 62.0 112.894 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . 86.0 mt-10 -124.83 159.97 29.81 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.252 -0.431 . . . . 74.310000000000002 110.235 172.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.5 t -64.68 119.32 10.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.102 0.477 . . . . 62.210000000000001 111.415 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -108.82 138.38 20.31 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.794 0.664 . . . . 61.020000000000003 112.794 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.4 Cg_exo -77.74 130.69 10.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.952 2.435 . . . . 64.030000000000001 112.229 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 10.8 t0 -66.04 84.89 0.09 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.35 0.595 . . . . 71.329999999999998 110.816 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 87.4 m -105.18 39.66 1.68 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.19 -0.459 . . . . 75.349999999999994 112.074 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -69.12 83.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.12 0.486 . . . . 74.400000000000006 111.855 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.9 52.61 11.25 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.615 0.606 . . . . 64.219999999999999 114.615 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' A' ' 51' ' ' CYS . 4.4 pp -114.0 157.08 43.0 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 117.394 0.597 . . . . 61.43 111.258 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.81 119.92 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.264 1.976 . . . . 73.030000000000001 112.784 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.01 -9.96 59.37 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.297 0.48 . . . . 73.540000000000006 112.297 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -90.22 -9.63 47.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.538 -0.301 . . . . 72.450000000000003 111.795 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.3 tp -98.85 117.35 33.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.002 0.43 . . . . 62.340000000000003 112.113 -174.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 46.7 mt-30 -75.72 159.82 30.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 73.409999999999997 110.827 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.0 m -144.4 148.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 112.332 0.493 . . . . 73.129999999999995 112.332 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 34.2 m -104.67 126.7 52.01 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.347 -0.388 . . . . 42.219999999999999 111.676 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.27 162.91 22.84 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.174 -0.536 . . . . 74.540000000000006 112.711 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 t -57.36 -18.23 16.33 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.206 0.447 . . . . 71.510000000000005 112.206 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.4 -38.51 80.75 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.935 0.398 . . . . 53.439999999999998 111.607 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.0 4.3 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.106 -0.569 . . . . 73.109999999999999 113.041 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.82 148.5 29.96 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.123 0.487 . . . . 44.329999999999998 112.155 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.439 HG21 ' HG2' ' A' ' 71' ' ' ARG . 96.2 m -86.18 137.38 32.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.714 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -106.68 143.66 34.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.474 -0.33 . . . . 74.430000000000007 111.452 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 68.5 mtt180 -43.71 -39.29 3.6 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.031 0.752 . . . . 74.109999999999999 113.031 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 3.3 p30 -167.04 172.11 10.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.838 0.352 . . . . 75.129999999999995 111.278 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HG3' HD22 ' A' ' 33' ' ' LEU . 13.4 tp10 -58.16 -34.12 69.95 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.491 -0.322 . . . . 71.230000000000004 111.765 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 33' ' ' LEU . 62.9 m -71.05 -34.67 71.46 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.864 -0.523 . . . . 64.219999999999999 111.164 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.69 -46.86 87.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 73.129999999999995 110.65 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.82 -40.46 95.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 70.510000000000005 109.799 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -59.54 -24.76 63.97 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.706 -0.679 . . . . 65.109999999999999 111.084 175.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.09 -35.18 17.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.131 -0.486 . . . . 64.450000000000003 111.146 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.44 -29.41 69.0 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.191 0.441 . . . . 55.340000000000003 112.191 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 20.2 ptt180 -55.43 -29.09 57.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.843 173.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.5 t -82.65 -18.8 39.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.396 -0.82 . . . . 70.219999999999999 111.174 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -107.03 89.42 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.062 0.458 . . . . 63.32 111.481 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.78 -17.13 1.29 Allowed Glycine 0 CA--C 1.536 1.35 0 N-CA-C 115.321 0.888 . . . . 71.530000000000001 115.321 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 61.4 m80 -122.83 74.89 47.2 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 118.243 1.021 . . . . 71.019999999999996 112.2 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.1 -23.0 29.72 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.255 1.97 . . . . 71.319999999999993 112.957 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -96.21 10.38 38.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.456 -0.338 . . . . 75.120000000000005 111.742 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 tp -62.96 115.55 4.5 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.342 0.497 . . . . 54.149999999999999 112.342 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.2 m -114.14 163.76 14.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.251 -0.431 . . . . 73.25 111.344 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 HD13 ' A' ' 53' ' ' LEU . 39.8 t -90.91 127.34 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.084 0.402 . . . . 73.319999999999993 112.084 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.3 mtt -73.16 -53.77 10.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 63.299999999999997 110.483 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -168.01 167.82 12.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.804 -0.634 . . . . 74.120000000000005 110.462 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 150.06 25.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.186 0.517 . . . . 75.519999999999996 111.388 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.48 -162.0 15.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.849 -0.614 . . . . 64.519999999999996 112.456 -176.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' HG21 ' A' ' 46' ' ' THR . 73.3 mtm180 -98.41 147.25 24.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.938 0.399 . . . . 75.040000000000006 111.201 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 73.3 m -62.93 106.97 0.9 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.885 0.698 . . . . 62.409999999999997 112.885 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 . . . . . 0 CA--C 1.539 0.548 0 CA-C-N 116.066 -0.516 . . . . 71.319999999999993 110.863 175.656 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.809 0.338 . . . . 32.119999999999997 111.351 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 54.5 m -140.43 140.44 35.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.203 0.445 . . . . 71.450000000000003 112.203 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 7' ' ' VAL . 22.5 t70 -50.77 111.83 0.61 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.415 0.524 . . . . 75.219999999999999 112.415 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.68 10.92 26.98 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.375 0.51 . . . . 65.209999999999994 114.375 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 22' ' ' PRO . 17.2 t -107.91 122.92 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 122.208 -0.583 . . . . 71.420000000000002 111.726 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.27 106.68 17.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.647 0.26 . . . . 75.510000000000005 110.416 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 7' ' ' VAL . 47.8 m -148.9 163.05 38.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.975 0.417 . . . . 63.130000000000003 111.655 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.92 -84.02 0.11 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.138 -0.483 . . . . 75.109999999999999 112.493 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.6 108.76 2.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.56 2.174 . . . . 75.209999999999994 112.52 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.69 6.38 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.88 -0.676 . . . . 75.329999999999998 113.109 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -142.85 136.9 29.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 117.164 0.482 . . . . 53.439999999999998 111.479 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.86 146.58 32.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.194 -0.457 . . . . 71.319999999999993 110.54 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 52.7 t -104.25 141.03 37.0 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.568 0.581 . . . . 73.209999999999994 112.568 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -142.46 132.86 24.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.008 -0.542 . . . . 74.400000000000006 110.393 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 67.9 mtp -86.75 121.1 28.78 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.133 0.492 . . . . 54.140000000000001 112.245 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.7 mt -112.8 118.1 34.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.806 -0.634 . . . . 75.049999999999997 110.58 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.06 30.61 67.16 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.045 -0.598 . . . . 61.310000000000002 113.384 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.18 -8.99 78.84 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.235 -0.507 . . . . 75.420000000000002 113.553 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.512 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 95.9 mtt180 -113.46 120.55 39.49 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 122.424 -0.456 . . . . 74.530000000000001 111.091 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.664 ' HB2' HG21 ' A' ' 7' ' ' VAL . 7.1 Cg_exo -75.29 143.69 28.45 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.037 2.491 . . . . 72.209999999999994 114.401 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 17.8 mmt180 -125.11 139.41 53.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.119 0.568 . . . . 73.140000000000001 110.814 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 89.4 m -122.28 118.97 29.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.986 0.422 . . . . 70.409999999999997 112.015 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -130.81 161.84 30.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.101 -0.5 . . . . 72.530000000000001 110.659 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 10.5 t -37.65 124.93 1.1 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.537 0.94 . . . . 72.549999999999997 113.537 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.02 143.84 27.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.779 -0.646 . . . . 74.040000000000006 111.306 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.15 52.7 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.469 2.113 . . . . 73.530000000000001 113.337 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.945 0.402 . . . . 52.5 110.456 173.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.551 ' HB2' HD21 ' A' ' 33' ' ' LEU . 24.8 p -134.37 23.4 3.76 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.795 0.665 . . . . 65.209999999999994 112.795 -171.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.2 t -65.19 106.38 1.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.874 0.368 . . . . 70.450000000000003 111.315 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.38 -42.87 0.92 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.758 -0.734 . . . . 73.409999999999997 113.499 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 50' ' ' GLU . 3.4 pp -67.66 152.51 96.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.359 0.503 . . . . 73.319999999999993 112.359 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 28.2 Cg_exo -62.77 137.67 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.677 2.251 . . . . 62.520000000000003 113.166 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 35.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.186 -0.461 . . . . 34.210000000000001 111.857 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 64.69 25.47 13.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.822 0.675 . . . . 70.120000000000005 112.822 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.1 tm? -84.85 102.8 13.37 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.672 -0.492 . . . . 75.129999999999995 109.672 174.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.662 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 64.2 mt-30 -66.26 145.89 55.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.726 0.639 . . . . 72.400000000000006 112.726 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.13 155.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.787 -0.642 . . . . 75.340000000000003 111.082 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.96 122.61 43.8 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.796 0.331 . . . . 62.509999999999998 111.603 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 47' ' ' TYR . . . -83.01 176.0 53.14 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.182 -0.532 . . . . 51.009999999999998 113.549 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.532 ' H ' HD12 ' A' ' 64' ' ' LEU . 40.1 t -54.8 -40.43 69.49 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.914 0.709 . . . . 70.230000000000004 112.914 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.53 -20.01 65.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.923 0.392 . . . . 75.120000000000005 111.995 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 14.76 42.8 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.439 -0.41 . . . . 70.129999999999995 112.53 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.33 142.66 28.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.901 0.381 . . . . 72.329999999999998 111.752 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -87.14 117.29 25.79 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.083 0.468 . . . . 73.430000000000007 111.452 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HE2' ' HA3' ' A' ' 41' ' ' GLY . 83.6 m-85 -94.65 138.78 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 109.971 174.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -66.42 -6.9 16.16 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.559 0.578 . . . . 62.520000000000003 112.559 -175.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 4.8 p-10 -174.5 155.91 2.35 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.914 0.485 . . . . 60.310000000000002 110.934 172.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 33' ' ' LEU . 41.7 tt0 -62.35 -30.79 71.43 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.172 0.434 . . . . 70.150000000000006 112.172 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.446 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 26.6 t -61.36 -40.19 93.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.223 0.535 . . . . 72.209999999999994 110.489 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -60.45 -44.01 96.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.675 -0.693 . . . . 71.120000000000005 110.784 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.56 -39.57 76.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 110.889 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -58.87 -49.43 77.79 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.989 0.423 . . . . 75.439999999999998 111.208 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.11 96.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.093 0.473 . . . . 72.209999999999994 111.211 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.3 96.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.143 -0.481 . . . . 74.030000000000001 111.548 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 23.2 ttt85 -61.82 -51.41 68.37 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.026 0.441 . . . . 72.409999999999997 111.342 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 74.7 m -75.47 -2.99 31.41 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.23 0.456 . . . . 64.239999999999995 112.23 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -78.88 -59.97 2.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.838 0.351 . . . . 73.430000000000007 110.112 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.47 27.31 0.32 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.962 -0.637 . . . . 63.329999999999998 113.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.704 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 37.8 m80 -134.53 76.33 61.61 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 122.233 -0.569 . . . . 72.430000000000007 111.668 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.34 -12.61 28.15 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.691 2.261 . . . . 63.020000000000003 113.45 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.82 8.07 26.49 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.843 0.312 . . . . 74.0 111.843 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.704 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 59.6 tp -73.44 111.34 8.48 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.154 0.502 . . . . 73.409999999999997 111.497 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.8 m -129.17 152.93 48.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 73.310000000000002 110.416 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.72 114.73 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.284 0.564 . . . . 64.430000000000007 111.579 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.3 mmt -65.9 -41.57 91.3 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.012 0.434 . . . . 72.25 111.186 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.62 150.55 6.0 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.053 -0.521 . . . . 54.439999999999998 111.689 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.18 140.84 43.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.981 -0.554 . . . . 75.239999999999995 111.865 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.25 170.35 20.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.187 -0.46 . . . . 43.399999999999999 112.509 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HG2' ' OE1' ' A' ' 38' ' ' GLN . 64.2 mtt-85 -61.0 132.11 52.79 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.612 -0.346 . . . . 73.239999999999995 110.454 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.49 96.99 0.73 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.197 0.522 . . . . 72.530000000000001 112.327 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 . . . . . 0 CA--C 1.539 0.544 0 CA-C-N 115.46 -0.791 . . . . 70.310000000000002 110.496 177.622 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.2 m . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 121.135 0.493 . . . . 61.130000000000003 111.734 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.7 m -98.68 130.73 45.19 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.18 -0.464 . . . . 65.310000000000002 111.388 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 7' ' ' VAL . 23.5 t70 -76.4 111.68 12.12 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.868 0.366 . . . . 54.520000000000003 111.191 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.76 -4.16 2.44 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.482 0.553 . . . . 24.41 114.482 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 14.1 t -97.49 126.25 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 117.408 0.604 . . . . 71.040000000000006 111.579 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.98 105.3 16.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.69 0.281 . . . . 73.030000000000001 110.985 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.0 m -149.05 158.78 44.45 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.374 0.509 . . . . 72.040000000000006 112.374 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.11 -107.67 0.2 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.107 -0.497 . . . . 71.430000000000007 112.758 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.83 102.69 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.323 2.015 . . . . 71.109999999999999 112.941 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.47 -3.88 56.57 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.958 -0.639 . . . . 62.549999999999997 113.813 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -143.22 136.12 27.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.316 0.579 . . . . 73.219999999999999 112.314 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -131.17 155.21 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.684 -0.689 . . . . 54.140000000000001 110.649 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.63 126.45 41.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.066 0.46 . . . . 50.420000000000002 111.209 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -123.5 137.32 54.8 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.138 -0.483 . . . . 53.520000000000003 110.465 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.9 mmm -85.79 102.58 13.79 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.113 0.483 . . . . 64.209999999999994 111.951 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 23' ' ' ARG . 4.1 mm? -109.11 115.69 30.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.2 -0.455 . . . . 64.430000000000007 110.303 174.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.8 27.67 67.03 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.157 -0.544 . . . . 74.109999999999999 113.261 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.51 85.14 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.483 -0.389 . . . . 55.43 113.696 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -109.55 126.68 28.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.517 -0.402 . . . . 53.520000000000003 111.439 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.44 104.36 1.73 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.42 2.08 . . . . 73.209999999999994 113.253 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.551 ' HG2' HD23 ' A' ' 18' ' ' LEU . 7.5 ptp180 -97.18 157.65 15.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.477 -0.328 . . . . 71.219999999999999 110.839 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 30.2 m -111.11 120.36 42.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.21 0.529 . . . . 72.329999999999998 112.093 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -107.02 160.17 15.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.691 -0.686 . . . . 64.430000000000007 109.959 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.22 95.87 0.14 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.057 0.456 . . . . 64.209999999999994 111.179 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.7 119.26 59.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.129 -0.487 . . . . 53.399999999999999 110.764 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 55' ' ' ALA . 22.4 Cg_endo -59.86 102.15 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.321 2.014 . . . . 62.539999999999999 112.932 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.46 100.34 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.001 0.429 . . . . 61.539999999999999 109.961 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.6 p -139.57 35.57 2.03 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.288 -0.415 . . . . 64.299999999999997 111.36 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.8 t -58.27 -37.89 75.88 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.242 -0.436 . . . . 74.430000000000007 111.842 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.41 43.16 1.75 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.365 -0.445 . . . . 40.210000000000001 113.151 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.454 HD11 ' NH2' ' A' ' 54' ' ' ARG . 87.9 mt -130.4 152.92 81.1 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.717 0.294 . . . . 73.109999999999999 111.428 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.09 119.94 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.211 1.941 . . . . 75.239999999999995 112.381 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.41 17.95 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.086 0.47 . . . . 60.420000000000002 111.65 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -120.84 -21.26 6.66 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.613 0.597 . . . . 71.439999999999998 112.613 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 69' ' ' ARG . 8.1 tt -93.2 120.84 33.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.832 0.349 . . . . 63.420000000000002 111.442 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.694 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 48.7 mt-30 -73.56 142.49 46.64 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.746 0.647 . . . . 74.200000000000003 112.746 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HB ' HG13 ' A' ' 66' ' ' VAL . 27.0 m -128.93 159.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.109 -0.496 . . . . 74.329999999999998 111.577 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 51.8 t -106.13 127.46 53.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.887 0.375 . . . . 62.210000000000001 111.775 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.54 155.91 32.81 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 113.257 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.51 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 43.8 t -53.79 -32.3 52.07 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.981 0.734 . . . . 72.120000000000005 112.981 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.78 -2.95 52.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.055 0.455 . . . . 74.239999999999995 112.135 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.38 20.91 39.68 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.199 -0.524 . . . . 72.430000000000007 113.136 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.9 132.52 42.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.789 0.328 . . . . 64.019999999999996 111.309 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -85.78 122.44 29.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.963 0.411 . . . . 71.420000000000002 111.703 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -112.84 147.35 37.15 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.998 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.694 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 31.2 mmt-85 -75.29 -20.33 59.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.359 -0.382 . . . . 54.420000000000002 111.739 -173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -163.99 161.65 22.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.061 -0.518 . . . . 64.200000000000003 111.092 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG2' HG21 ' A' ' 66' ' ' VAL . 1.7 tm-20 -57.61 -40.38 79.02 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.175 0.512 . . . . 70.430000000000007 110.701 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 25.7 t -59.64 -38.23 80.83 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.974 0.416 . . . . 53.340000000000003 111.461 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.11 -43.88 90.57 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.069 0.461 . . . . 71.200000000000003 111.05 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.65 HD13 HG22 ' A' ' 66' ' ' VAL . 10.3 tt -64.83 -47.25 78.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.991 -0.55 . . . . 75.209999999999994 110.99 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' NH2' HD11 ' A' ' 33' ' ' LEU . 19.0 ttm180 -55.14 -37.25 66.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.079 0.466 . . . . 74.219999999999999 111.13 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HB2' ' HG3' ' A' ' 28' ' ' PRO . . . -65.6 -47.65 74.96 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 111.262 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.91 -38.3 75.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.986 0.422 . . . . 62.240000000000002 111.633 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 76.2 ttt180 -60.74 -50.45 73.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.935 0.397 . . . . 75.209999999999994 111.085 175.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.27 -29.47 70.56 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.986 0.422 . . . . 75.319999999999993 111.664 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 59' ' ' ARG . 35.3 ttt-85 -61.8 -38.68 89.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.254 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.57 36.28 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.033 -0.603 . . . . 63.420000000000002 113.68 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.421 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 96.9 m-70 -134.31 78.13 58.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.297 -0.531 . . . . 70.209999999999994 111.507 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.62 -28.62 25.71 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.636 2.224 . . . . 71.319999999999993 113.186 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.24 -11.94 58.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.249 0.547 . . . . 64.329999999999998 111.328 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 5.8 tt -92.88 114.97 27.67 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.591 0.71 . . . . 74.319999999999993 111.331 -175.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.492 ' HA ' HD21 ' A' ' 53' ' ' LEU . 69.5 m -144.58 166.27 25.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.613 -0.721 . . . . 72.010000000000005 110.193 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.65 HG22 HD13 ' A' ' 53' ' ' LEU . 75.4 t -69.07 111.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.018 0.437 . . . . 63.420000000000002 111.65 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 42' ' ' SER . 66.1 mtm -81.69 -53.73 5.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.133 -0.485 . . . . 65.239999999999995 110.996 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.33 164.57 31.06 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 110.887 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.504 ' HB3' HD21 ' A' ' 37' ' ' LEU . 98.9 mtt180 -96.77 151.68 19.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.987 0.423 . . . . 72.439999999999998 111.639 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 47.85 1.74 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.185 -0.531 . . . . 62.219999999999999 112.549 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.61 -177.54 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.351 1.061 . . . . 73.109999999999999 113.364 -176.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.4 m -89.51 105.36 17.74 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.789 -0.569 . . . . 62.240000000000002 111.078 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 116.068 -0.514 . . . . 74.310000000000002 111.75 -174.294 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.995 0.426 . . . . 73.420000000000002 110.134 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.412 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.6 m -101.91 128.55 48.25 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.025 0.44 . . . . 74.109999999999999 111.721 -171.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.53 115.05 23.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.302 -0.408 . . . . 72.239999999999995 111.953 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.91 -31.74 1.07 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.217 -0.516 . . . . 70.420000000000002 113.538 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.562 HG21 ' HG2' ' A' ' 22' ' ' PRO . 12.1 t -67.94 105.07 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 122.545 -0.385 . . . . 72.340000000000003 110.985 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.8 105.78 17.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 71.409999999999997 110.844 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.1 m -133.33 137.33 45.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 74.329999999999998 111.396 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.16 -68.0 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.978 -0.555 . . . . 62.130000000000003 112.245 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.03 79.46 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.697 2.265 . . . . 63.119999999999997 112.408 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.77 54.99 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.356 -0.449 . . . . 73.329999999999998 113.68 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -145.53 148.87 33.67 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.627 0.713 . . . . 74.120000000000005 112.292 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.41 140.83 47.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.787 -0.642 . . . . 34.340000000000003 109.872 172.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.731 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 28.6 p -100.11 145.84 27.5 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.366 0.603 . . . . 64.239999999999995 111.422 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -129.78 133.74 47.17 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.629 -0.714 . . . . 65.329999999999998 110.826 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.86 103.13 4.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 70.150000000000006 111.325 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 98.0 mt -127.42 117.74 22.74 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.931 0.396 . . . . 65.140000000000001 111.788 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.6 26.34 66.52 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.562 -0.351 . . . . 73.109999999999999 113.826 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.07 -0.01 75.07 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.111 -0.566 . . . . 74.439999999999998 113.376 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -131.74 138.49 32.67 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 117.121 0.461 . . . . 73.409999999999997 112.014 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.562 ' HG2' HG21 ' A' ' 7' ' ' VAL . 97.1 Cg_endo -80.81 118.97 3.52 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.735 2.29 . . . . 52.299999999999997 113.571 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -109.23 137.26 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.26 -0.275 . . . . 62.119999999999997 110.365 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.731 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -103.82 139.9 38.39 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.847 0.684 . . . . 74.349999999999994 112.847 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.42 160.68 34.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.895 -0.593 . . . . 63.140000000000001 110.606 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -57.72 112.87 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.22 0.452 . . . . 65.319999999999993 112.22 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.36 119.71 55.48 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.131 -0.486 . . . . 61.310000000000002 110.916 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 86.84 1.09 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.384 2.056 . . . . 74.0 113.266 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.68 100.23 12.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.271 0.557 . . . . 65.540000000000006 110.368 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.4 p -98.68 134.38 41.68 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.278 -0.419 . . . . 63.140000000000001 111.907 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.3 p -99.49 -76.01 0.55 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.269 -0.423 . . . . 74.040000000000006 111.356 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.27 39.51 3.0 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.217 -0.516 . . . . 74.549999999999997 113.598 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 34.1 mt -120.34 135.71 24.69 Favored Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 122.395 -0.474 . . . . 65.239999999999995 110.6 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.45 139.65 31.96 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.46 2.106 . . . . 72.450000000000003 113.239 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.75 141.91 30.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.793 0.33 . . . . 74.239999999999995 111.408 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 64.29 6.23 2.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.253 0.621 . . . . 72.319999999999993 112.545 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 2.4 tm? -93.19 95.41 9.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.412 -0.588 . . . . 60.140000000000001 109.412 176.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -54.79 137.06 45.63 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.718 0.636 . . . . 74.25 112.718 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 35.7 m -129.96 156.76 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.149 -0.478 . . . . 71.430000000000007 111.439 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -100.55 118.13 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.295 -0.411 . . . . 71.540000000000006 110.941 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.79 168.44 39.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.396 -0.431 . . . . 73.430000000000007 113.793 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.7 t -49.86 -37.05 29.29 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.792 0.664 . . . . 45.210000000000001 112.792 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.24 -33.9 68.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.038 0.446 . . . . 74.109999999999999 112.037 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.89 18.94 18.76 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.724 -0.55 . . . . 52.240000000000002 111.724 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.66 146.81 40.44 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.981 0.419 . . . . 74.209999999999994 111.444 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.493 HG21 ' HG2' ' A' ' 71' ' ' ARG . 38.6 m -86.05 120.23 27.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.121 -0.49 . . . . 61.109999999999999 111.414 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.76 157.51 16.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.429 -0.351 . . . . 73.420000000000002 110.982 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -49.2 -42.59 40.66 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.047 0.388 . . . . 73.049999999999997 112.047 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 51' ' ' CYS . 1.5 p30 -173.42 175.49 3.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.08 -0.509 . . . . 74.049999999999997 111.122 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -62.25 -31.5 72.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.892 0.377 . . . . 64.129999999999995 111.677 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.477 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 42.1 t -66.86 -40.53 87.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.213 0.53 . . . . 74.409999999999997 110.408 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -68.85 -38.02 79.51 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.797 -0.638 . . . . 75.109999999999999 110.941 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 66' ' ' VAL . 10.4 tt -58.16 -43.4 87.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.872 0.368 . . . . 55.399999999999999 110.469 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -57.92 -38.77 76.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.383 -0.371 . . . . 74.450000000000003 111.227 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.99 44.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.382 . . . . 73.549999999999997 111.322 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.97 75.28 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 111.54 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 46.3 ttt-85 -64.58 -50.37 67.5 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.934 0.397 . . . . 63.509999999999998 110.659 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 37.1 t -63.11 -33.09 74.71 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 111.857 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -65.81 -31.65 72.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.501 -0.318 . . . . 75.129999999999995 111.612 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.23 37.2 0.02 OUTLIER Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.84 -0.695 . . . . 64.310000000000002 113.995 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 85.1 m-70 -135.56 82.62 38.88 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.213 0.506 . . . . 53.200000000000003 112.168 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.28 -25.93 49.28 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.452 2.102 . . . . 71.530000000000001 112.976 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.3 -20.02 60.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.361 . . . . 72.239999999999995 111.683 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.5 tp -69.63 112.54 6.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.521 0.677 . . . . 75.209999999999994 112.664 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.4 p -131.15 164.22 25.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.674 -0.694 . . . . 71.510000000000005 110.753 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 53' ' ' LEU . 59.8 t -87.17 112.52 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.89 0.376 . . . . 64.439999999999998 111.544 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.0 mmt -81.16 -42.52 20.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.049 0.452 . . . . 72.140000000000001 110.979 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 45.9 p90 -169.4 156.75 6.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.021 -0.536 . . . . 52.219999999999999 110.812 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -82.82 125.54 31.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.023 0.44 . . . . 75.439999999999998 110.876 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.453 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 131.93 -175.79 19.58 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 112.105 -174.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.493 ' HG2' HG21 ' A' ' 46' ' ' THR . 96.1 mtt180 -86.03 140.2 30.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.613 -0.345 . . . . 64.530000000000001 111.186 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.428 ' HA ' ' OH ' ' A' ' 68' ' ' TYR . 96.4 m -59.79 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.261 0.467 . . . . 54.340000000000003 112.261 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 . . . . . 0 N--CA 1.469 0.483 0 CA-C-N 115.895 -0.593 . . . . 65.439999999999998 110.326 174.323 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.739 0.304 . . . . 52.420000000000002 110.401 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.0 m -98.31 127.23 44.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.963 0.411 . . . . 63.399999999999999 111.515 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.547 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 14.4 t70 -86.64 112.54 21.71 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.09 -0.505 . . . . 61.25 110.973 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.9 -32.92 0.74 Allowed Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.156 -0.545 . . . . 72.230000000000004 114.21 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 18.3 t -66.19 117.45 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.96 0.38 . . . . 54.299999999999997 111.708 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -106.73 106.88 17.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.831 0.348 . . . . 71.340000000000003 111.28 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 71.5 m -140.03 142.61 36.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.031 0.443 . . . . 62.329999999999998 111.758 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.97 -52.88 0.04 OUTLIER Glycine 0 CA--C 1.532 1.103 0 CA-C-N 115.729 -0.669 . . . . 60.039999999999999 113.273 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.63 87.09 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 60.200000000000003 112.983 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.49 15.46 79.12 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.386 -0.435 . . . . 71.099999999999994 113.778 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -146.26 135.76 23.04 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.575 -0.368 . . . . 64.25 110.97 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.95 137.77 53.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.595 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.0 p -100.65 122.78 43.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.91 0.386 . . . . 45.140000000000001 110.342 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HG3' ' HG ' ' A' ' 18' ' ' LEU . 10.7 ptm180 -129.2 160.55 32.57 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.079 0.4 . . . . 75.510000000000005 112.079 -172.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.9 mmt -76.25 101.89 5.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.88 0.371 . . . . 72.230000000000004 111.448 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HG ' ' HG3' ' A' ' 16' ' ' ARG . 94.5 mt -133.36 111.62 10.94 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.828 0.347 . . . . 75.349999999999994 110.579 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.41 44.91 82.8 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.913 -0.66 . . . . 73.450000000000003 112.678 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.29 -49.48 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.003 0.361 . . . . 71.140000000000001 114.003 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -92.92 137.87 23.66 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.828 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 64.9 Cg_endo -72.51 129.74 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.516 2.144 . . . . 73.409999999999997 112.92 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -129.42 150.97 50.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.437 -0.347 . . . . 75.530000000000001 110.69 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 84.9 m -104.47 146.26 29.12 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.378 0.609 . . . . 63.43 112.262 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -143.94 161.44 38.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.881 -0.6 . . . . 73.349999999999994 110.535 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 12.7 t -64.17 84.04 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.209 0.528 . . . . 72.239999999999995 111.092 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.12 118.9 32.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 62.200000000000003 109.954 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.79 100.84 1.11 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.338 2.025 . . . . 70.200000000000003 114.276 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.21 98.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.546 -0.538 . . . . 63.439999999999998 109.546 166.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.65 ' HB2' HD11 ' A' ' 33' ' ' LEU . 6.3 p -121.87 91.82 3.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.444 0.535 . . . . 63.310000000000002 112.444 -172.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -107.98 166.11 10.96 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.921 -0.582 . . . . 71.329999999999998 110.861 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.97 -56.31 3.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.046 -0.597 . . . . 65.239999999999995 112.647 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 30' ' ' CYS . 4.5 pp -73.07 146.01 86.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.462 -0.434 . . . . 74.219999999999999 110.339 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.19 119.14 5.85 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 121.768 1.645 . . . . 50.210000000000001 113.509 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.23 15.22 6.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.829 0.347 . . . . 74.319999999999993 111.918 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -135.11 14.43 3.55 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.777 0.288 . . . . 74.219999999999999 111.777 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 38' ' ' GLN . 1.7 tm? -119.69 136.65 54.33 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.949 0.404 . . . . 74.150000000000006 110.645 -177.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.577 ' N ' HD13 ' A' ' 37' ' ' LEU . 37.6 mt-30 -63.74 137.67 58.17 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.352 0.501 . . . . 73.439999999999998 112.352 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 50' ' ' GLU . 34.6 m -128.6 152.38 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.126 0.488 . . . . 75.430000000000007 111.56 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.8 t -101.01 128.66 46.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.962 -0.563 . . . . 51.109999999999999 111.739 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.02 152.95 19.96 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.495 -0.383 . . . . 53.340000000000003 113.074 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.6 t -57.25 -31.88 66.0 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.942 0.401 . . . . 62.119999999999997 111.996 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.33 -20.49 65.55 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.152 0.427 . . . . 65.319999999999993 112.152 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.4 14.77 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.306 -0.474 . . . . 65.129999999999995 112.732 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.38 135.15 54.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.775 0.321 . . . . 72.25 111.547 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 m -94.81 128.58 41.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.863 0.363 . . . . 73.329999999999998 111.439 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.06 154.83 21.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.745 0.307 . . . . 55.240000000000002 111.363 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -66.59 -20.14 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.956 0.408 . . . . 55.409999999999997 111.575 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -165.49 155.59 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.714 -0.676 . . . . 75.420000000000002 110.071 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.627 ' HA ' HG21 ' A' ' 39' ' ' VAL . 31.3 tt0 -60.03 -34.43 73.38 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.044 0.45 . . . . 72.299999999999997 110.976 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -58.99 -37.33 76.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.293 -0.412 . . . . 73.430000000000007 110.729 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.97 -40.21 91.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.868 0.366 . . . . 71.239999999999995 110.852 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.86 -47.98 82.99 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.094 0.473 . . . . 65.109999999999999 110.301 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 50' ' ' GLU . 2.2 mpt_? -64.19 -39.43 93.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.235 -0.439 . . . . 75.150000000000006 111.222 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.997 0.427 . . . . 62.200000000000003 111.517 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -34.96 76.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.406 0.622 . . . . 51.210000000000001 110.833 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.11 92.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.912 -0.585 . . . . 71.340000000000003 110.446 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 73.4 m -64.22 -26.74 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 111.822 0.304 . . . . 74.040000000000006 111.822 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -64.24 -34.07 77.25 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.977 0.418 . . . . 72.340000000000003 111.27 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.66 35.17 0.05 OUTLIER Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.275 -0.488 . . . . 42.439999999999998 113.082 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -128.65 79.05 75.03 Favored Pre-proline 0 CA--C 1.539 0.533 0 O-C-N 122.37 -0.489 . . . . 71.239999999999995 111.44 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.22 -28.26 72.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.461 2.107 . . . . 75.420000000000002 112.21 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.33 -22.9 66.88 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.918 -0.583 . . . . 65.120000000000005 111.994 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.02 111.71 8.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.476 0.655 . . . . 72.439999999999998 112.044 -174.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -127.75 161.17 29.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.295 -0.866 . . . . 75.200000000000003 110.594 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p -88.8 134.76 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.203 0.525 . . . . 74.109999999999999 111.956 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 16.7 mmt -90.65 -59.05 2.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.363 -0.381 . . . . 74.349999999999994 110.974 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -164.52 164.34 21.81 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.099 0.476 . . . . 73.219999999999999 112.006 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -75.65 111.98 11.54 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.828 -0.624 . . . . 71.549999999999997 111.057 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 139.36 161.23 8.65 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.337 -0.392 . . . . 63.409999999999997 112.147 -174.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -72.58 134.85 45.39 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.249 0.525 . . . . 75.450000000000003 112.4 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.0 m -58.12 99.88 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.033 -0.53 . . . . 74.530000000000001 111.889 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 64.099999999999994 111.005 176.364 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.107 0.479 . . . . 71.109999999999999 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 33.7 m-20 -110.43 176.75 4.92 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.384 0.611 . . . . 60.420000000000002 112.492 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 66.6 m -142.59 146.03 34.15 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.471 -0.786 . . . . 71.420000000000002 110.771 176.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 72.4 m -100.03 172.99 6.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.862 0.319 . . . . 71.400000000000006 111.862 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.87 112.7 0.82 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.1 -0.5 . . . . 63.520000000000003 111.485 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.73 2.16 49.59 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.471 -0.395 . . . . 63.530000000000001 113.961 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' A' ' 22' ' ' PRO . 3.6 t -107.04 122.46 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 122.462 -0.434 . . . . 71.150000000000006 111.373 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.88 110.18 21.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.49 0.662 . . . . 64.439999999999998 111.421 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 55.1 m -136.14 180.0 6.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.09 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.57 -91.1 0.25 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 54.229999999999997 112.752 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.67 88.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.848 2.365 . . . . 74.340000000000003 112.839 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.621 ' H ' ' HB3' ' A' ' 29' ' ' ASP . . . 83.92 12.89 76.15 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.104 -0.498 . . . . 61.439999999999998 113.372 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.645 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 51.4 mtmt -141.3 136.67 31.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.376 0.51 . . . . 75.230000000000004 112.376 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.08 51.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.882 -0.599 . . . . 53.310000000000002 109.962 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 18.3 p -122.78 143.2 49.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.364 0.505 . . . . 74.230000000000004 112.364 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 16' ' ' ARG . 40.2 ttp180 -143.74 148.8 36.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.086 -0.506 . . . . 71.510000000000005 110.259 173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 69.5 mtp -80.99 120.39 24.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.185 0.517 . . . . 62.329999999999998 112.072 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.6 106.14 18.27 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.952 -0.567 . . . . 75.439999999999998 109.664 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.57 -94.5 0.13 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.929 -0.653 . . . . 43.25 112.007 -174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.64 -8.2 12.63 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.177 -0.535 . . . . 51.140000000000001 113.881 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.459 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 27.3 ptt180 -121.04 133.27 24.12 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 117.573 0.687 . . . . 62.340000000000003 112.285 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 2.5 Cg_endo -81.89 128.82 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.143 2.562 . . . . 73.010000000000005 113.42 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -111.85 152.49 27.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.457 -0.338 . . . . 73.329999999999998 111.07 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 6.6 t -120.15 137.25 54.28 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.584 0.231 . . . . 63.509999999999998 110.465 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -131.82 146.14 51.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.75 0.31 . . . . 61.109999999999999 111.544 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 96.5 m -60.14 100.22 0.09 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.998 0.427 . . . . 52.219999999999999 111.141 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.24 155.29 53.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 64.209999999999994 111.359 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.71 107.75 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.372 2.048 . . . . 75.219999999999999 113.069 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.621 ' HB3' ' H ' ' A' ' 12' ' ' GLY . 10.7 p-10 -79.12 84.12 5.13 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.839 0.828 . . . . 74.319999999999993 110.81 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.4 m -83.74 84.5 7.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.526 -0.761 . . . . 51.32 112.226 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t -78.76 -145.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.903 -0.589 . . . . 73.439999999999998 110.487 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.66 80.84 0.12 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.863 -0.684 . . . . 71.510000000000005 112.997 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 51' ' ' CYS . 3.9 pp -155.33 148.59 18.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 O-C-N 122.609 -0.347 . . . . 75.340000000000003 111.758 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.94 120.33 3.01 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.554 2.169 . . . . 52.229999999999997 112.533 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.59 16.79 0.45 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.583 0.586 . . . . 61.399999999999999 112.583 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -115.21 -18.14 11.2 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.848 0.356 . . . . 74.329999999999998 111.735 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 61.6 tp -83.64 105.86 14.89 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.855 0.36 . . . . 55.439999999999998 111.757 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -59.86 160.09 8.14 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.032 -0.531 . . . . 61.219999999999999 112.132 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -157.58 144.66 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.331 -0.395 . . . . 53.119999999999997 111.963 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.2 128.52 46.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.907 0.384 . . . . 55.399999999999999 110.755 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 64' ' ' LEU . . . -90.35 177.52 42.55 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.257 -0.497 . . . . 73.230000000000004 113.541 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 m -60.82 -19.26 59.39 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.159 0.429 . . . . 73.140000000000001 112.159 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.54 -42.88 64.25 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.511 -0.313 . . . . 52.149999999999999 111.282 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.59 -0.27 8.62 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.25 -0.5 . . . . 72.400000000000006 113.895 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.27 146.19 27.21 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.218 -0.577 . . . . 65.109999999999999 111.891 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.3 m -86.3 108.32 18.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.088 0.471 . . . . 72.310000000000002 111.39 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -78.68 160.13 27.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.899 -0.591 . . . . 75.329999999999998 111.115 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -57.48 -34.85 69.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.371 0.508 . . . . 63.140000000000001 112.371 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.9 p30 -167.66 174.74 7.48 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.855 0.687 . . . . 72.549999999999997 112.855 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -46.99 -47.44 21.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.175 -0.92 . . . . 54.43 112.394 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.492 ' HB2' HD11 ' A' ' 33' ' ' LEU . 33.7 t -70.25 -40.24 74.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.058 -0.519 . . . . 62.140000000000001 111.028 -175.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -54.25 -40.66 67.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.336 0.588 . . . . 64.510000000000005 111.203 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.91 -45.98 83.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.084 -0.507 . . . . 72.239999999999995 110.501 176.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -59.74 -27.54 66.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.138 -0.483 . . . . 72.349999999999994 111.765 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.09 -55.87 5.9 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 62.439999999999998 111.594 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . . . -53.35 -33.16 52.47 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.129 0.49 . . . . 60.439999999999998 111.198 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -48.97 -50.3 36.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.616 -0.72 . . . . 73.219999999999999 111.421 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 45.4 t -77.99 -23.54 48.33 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.04 0.448 . . . . 64.219999999999999 111.033 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 35.2 mmt180 -78.04 34.85 0.2 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.591 0.589 . . . . 63.450000000000003 112.591 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.66 23.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.226 -0.512 . . . . 74.129999999999995 114.118 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.403 ' HD2' ' HB1' ' A' ' 56' ' ' ALA . 27.9 m-70 -131.71 74.4 77.78 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.521 0.66 . . . . 74.299999999999997 111.055 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.05 -29.37 40.33 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.562 2.175 . . . . 61.119999999999997 112.608 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.53 -13.23 60.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.035 -0.53 . . . . 74.420000000000002 111.993 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -65.96 112.07 3.64 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.266 0.555 . . . . 72.409999999999997 111.948 -171.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -134.59 157.58 46.21 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.095 -0.502 . . . . 70.540000000000006 110.691 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.461 HG22 HD13 ' A' ' 53' ' ' LEU . 97.2 t -71.97 127.43 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.56 0.578 . . . . 72.310000000000002 112.56 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.4 mtt -94.81 -53.64 3.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.372 -0.377 . . . . 70.530000000000001 110.758 171.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -165.23 167.53 17.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.887 0.375 . . . . 74.219999999999999 111.568 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -85.8 172.02 11.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.649 0.611 . . . . 74.319999999999993 112.649 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.37 -154.22 53.13 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.549 -0.751 . . . . 41.549999999999997 113.863 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -70.2 138.78 52.04 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.847 0.356 . . . . 71.430000000000007 111.004 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.62 84.9 2.66 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.259 0.552 . . . . 72.019999999999996 110.29 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -88.73 136.43 33.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.923 0.712 . . . . 74.310000000000002 112.923 -173.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.693 -0.67 . . . . 54.530000000000001 110.536 172.929 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 120.411 0.148 . . . . 70.519999999999996 111.007 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.54 71.21 0.68 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.441 0.639 . . . . 73.150000000000006 110.478 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -166.04 -170.04 1.63 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.735 0.814 . . . . 73.450000000000003 110.485 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 15.1 m -129.6 126.89 39.51 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.144 -0.348 . . . . 75.120000000000005 111.014 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.43 112.13 23.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.852 -0.158 . . . . 72.219999999999999 111.338 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.95 49.0 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 114.463 0.545 . . . . 73.510000000000005 114.463 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 50.7 t -107.09 109.58 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 117.247 0.523 . . . . 64.340000000000003 110.887 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -91.5 106.5 18.53 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.349 0.5 . . . . 75.430000000000007 112.349 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 94.7 m -148.25 138.38 22.58 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.17 -0.468 . . . . 50.119999999999997 110.613 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 -121.27 0.9 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.913 -0.66 . . . . 65.420000000000002 113.519 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.39 107.84 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.597 2.198 . . . . 74.420000000000002 112.744 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 118.0 -54.96 0.59 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.095 -0.502 . . . . 75.340000000000003 112.255 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -135.39 134.95 40.24 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.802 0.334 . . . . 74.239999999999995 111.215 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.42 138.95 42.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 110.476 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.595 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 20.2 p -100.15 125.21 46.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.124 0.488 . . . . 74.540000000000006 111.277 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -144.16 159.54 42.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.08 -0.509 . . . . 74.530000000000001 109.777 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 47.8 mtp -78.97 103.67 9.08 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.682 -0.636 . . . . 72.099999999999994 111.957 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.06 141.2 48.33 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 110.387 175.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.47 26.29 64.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.819 -0.705 . . . . 55.329999999999998 112.743 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.61 84.71 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.515 -0.374 . . . . 71.219999999999999 113.824 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -133.79 140.32 36.22 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 117.549 0.674 . . . . 74.319999999999993 111.676 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 27.5 Cg_endo -61.2 115.38 2.69 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.455 2.103 . . . . 65.530000000000001 113.455 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 35.4 mmt180 -118.05 156.53 28.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.869 0.467 . . . . 74.450000000000003 110.93 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 98.6 m -118.18 121.09 39.62 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.877 0.37 . . . . 63.210000000000001 111.77 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -133.85 161.36 34.96 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.468 -0.333 . . . . 60.020000000000003 111.058 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 37.0 t -55.26 130.15 41.13 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.421 0.897 . . . . 54.439999999999998 113.421 -171.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.76 118.53 31.87 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.939 -0.573 . . . . 73.439999999999998 111.059 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.91 147.53 68.5 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.311 2.007 . . . . 71.239999999999995 112.75 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.41 31.7 0.12 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.35 0.5 . . . . 70.319999999999993 112.35 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.597 ' HA ' HD12 ' A' ' 33' ' ' LEU . 24.3 p -90.16 15.34 10.47 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.581 0.956 . . . . 71.540000000000006 113.581 -171.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -69.17 75.88 0.35 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.446 0.641 . . . . 52.549999999999997 110.527 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.16 6.39 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.034 -0.53 . . . . 63.25 112.97 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 30' ' ' CYS . 67.6 mt -94.42 151.14 39.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 O-C-N 122.474 -0.427 . . . . 72.409999999999997 111.467 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.29 119.32 6.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.335 2.023 . . . . 75.319999999999993 113.006 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.68 -4.56 53.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.129 0.49 . . . . 55.409999999999997 111.57 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -101.07 -1.0 35.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.203 -0.453 . . . . 71.439999999999998 112.024 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 58.1 tp -116.73 119.11 34.43 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.218 -0.301 . . . . 72.010000000000005 111.775 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -64.32 163.42 13.05 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.165 0.507 . . . . 62.340000000000003 112.188 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.581 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 10.0 p -150.51 144.04 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.019 0.378 . . . . 62.450000000000003 112.019 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 95.8 m -100.62 128.79 46.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.977 0.417 . . . . 52.109999999999999 111.122 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -101.62 177.65 27.06 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.241 -0.504 . . . . 65.549999999999997 113.467 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.9 p -61.88 -14.64 35.76 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.948 0.404 . . . . 72.230000000000004 111.839 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.36 -16.64 61.34 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.235 -0.439 . . . . 64.120000000000005 111.241 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.09 -14.44 62.56 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.435 -0.348 . . . . 74.140000000000001 113.494 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.04 153.68 19.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.667 0.617 . . . . 74.109999999999999 112.667 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -86.17 145.74 26.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.053 -0.522 . . . . 54.240000000000002 110.887 175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -119.58 160.89 21.59 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.552 -0.295 . . . . 73.510000000000005 111.302 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 48' ' ' ARG . 1.5 tmm_? -51.39 -43.31 61.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.071 0.548 . . . . 74.219999999999999 111.857 -175.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' H ' ' HB3' ' A' ' 52' ' ' GLU . 4.7 p-10 -159.85 177.46 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.894 0.378 . . . . 64.319999999999993 111.469 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' HG11 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -57.94 -47.79 81.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.145 0.498 . . . . 72.340000000000003 111.453 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.4 t -65.81 -39.57 91.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.548 -0.296 . . . . 72.519999999999996 111.055 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.554 ' HB3' ' H ' ' A' ' 49' ' ' ASP . 5.8 tp10 -52.28 -41.17 62.66 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.318 -0.401 . . . . 53.020000000000003 111.246 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' HD21 ' A' ' 64' ' ' LEU . 9.7 tt -56.79 -56.01 27.0 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.205 0.526 . . . . 74.329999999999998 110.484 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -64.33 -29.55 70.62 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.118 -0.492 . . . . 74.150000000000006 111.211 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.85 71.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.94 0.4 . . . . 52.399999999999999 111.158 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.65 89.57 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.333 0.587 . . . . 70.519999999999996 110.559 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 28.1 ttt180 -55.11 -50.28 69.61 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.523 -0.762 . . . . 63.100000000000001 111.808 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 84.9 m -81.0 6.33 13.74 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.223 0.453 . . . . 50.299999999999997 112.223 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -106.35 51.69 0.74 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.161 0.505 . . . . 73.25 111.279 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.0 69.54 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.551 0.58 . . . . 73.219999999999999 114.551 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 66.4 t60 -135.44 72.93 64.01 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 117.767 0.784 . . . . 54.130000000000003 111.721 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 16.6 Cg_exo -69.2 -7.46 20.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.03 2.486 . . . . 73.510000000000005 112.844 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -9.19 52.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.084 -0.507 . . . . 73.140000000000001 111.825 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' A' ' 41' ' ' GLY . 43.1 tp -85.49 129.05 34.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.002 0.741 . . . . 64.299999999999997 113.002 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 m -127.77 155.43 44.06 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.631 -0.713 . . . . 65.219999999999999 110.496 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.88 123.39 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.855 0.359 . . . . 71.349999999999994 111.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.6 mmt -100.48 -59.42 1.71 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.037 0.384 . . . . 72.299999999999997 112.037 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.419 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 53.1 p90 -154.43 145.46 22.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.001 0.429 . . . . 74.409999999999997 111.584 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.46 ' HE ' ' HG3' ' A' ' 50' ' ' GLU . 93.1 mtt180 -83.04 110.72 18.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.241 0.543 . . . . 71.329999999999998 111.664 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 151.82 179.24 27.31 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.84 -0.618 . . . . 63.439999999999998 112.028 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -83.24 140.78 32.32 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.64 -0.329 . . . . 72.120000000000005 111.266 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 91.3 m -61.78 104.92 0.49 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.233 0.539 . . . . 71.329999999999998 111.783 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -91.17 131.41 36.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 63.509999999999998 112.319 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.639 -0.696 . . . . 71.120000000000005 110.95 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.756 0.312 . . . . 71.439999999999998 110.375 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -60.26 97.5 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.636 0.732 . . . . 74.0 112.954 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 m -152.06 121.97 7.06 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.248 -0.887 . . . . 75.450000000000003 109.484 172.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.76 130.45 45.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.049 0.452 . . . . 34.240000000000002 111.859 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.543 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 m-20 -69.91 112.16 6.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 112.239 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.24 37.39 38.4 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.09 0.396 . . . . 35.210000000000001 114.09 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.7 t -106.61 135.49 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 112.004 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.18 106.64 14.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.096 0.474 . . . . 71.209999999999994 111.278 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -124.72 -179.92 4.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.089 -0.505 . . . . 62.009999999999998 111.02 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.38 -104.57 0.26 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 120.723 -0.751 . . . . 34.219999999999999 113.551 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.95 85.71 0.97 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.543 2.162 . . . . 63.310000000000002 113.106 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 102.07 2.74 51.7 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.194 -0.527 . . . . 44.450000000000003 113.559 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 48.4 mtmt -135.83 137.59 41.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.495 0.647 . . . . 73.040000000000006 112.03 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.04 142.13 49.46 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.719 -0.673 . . . . 43.43 110.072 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 23.2 p -105.5 136.46 45.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.133 0.492 . . . . 72.299999999999997 112.112 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -127.86 139.14 52.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.888 -0.597 . . . . 64.120000000000005 110.896 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.564 ' SD ' ' HB3' ' A' ' 22' ' ' PRO . 94.2 mmm -76.6 113.43 14.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.854 0.359 . . . . 72.010000000000005 111.409 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.795 HD12 ' HD3' ' A' ' 23' ' ' ARG . 88.6 mt -122.74 114.43 20.53 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.12 0.486 . . . . 62.439999999999998 111.304 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.65 30.74 75.61 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 116.231 -0.441 . . . . 40.140000000000001 113.77 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.25 -15.19 63.75 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.074 -0.584 . . . . 54.140000000000001 113.712 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 21' ' ' ARG . 43.0 mtt180 -122.14 137.42 27.47 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 117.25 0.525 . . . . 60.119999999999997 111.681 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 93.4 Cg_endo -83.28 145.29 12.02 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.725 2.283 . . . . 71.129999999999995 113.657 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.795 ' HD3' HD12 ' A' ' 18' ' ' LEU . 66.6 mtp85 -124.55 132.19 53.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.905 -0.589 . . . . 75.209999999999994 110.607 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 14.0 t -102.9 118.85 37.74 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.502 -0.555 . . . . 63.520000000000003 109.502 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.09 161.3 35.72 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 62.240000000000002 111.828 -171.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 97.5 m -54.26 108.55 0.38 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.137 0.791 . . . . 63.439999999999998 113.137 -174.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.72 120.82 56.38 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 115.889 -0.596 . . . . 65.310000000000002 110.754 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 83.3 Cg_endo -81.6 131.25 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.648 2.232 . . . . 75.450000000000003 113.535 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.816 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -67.86 82.5 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 116.303 -0.408 . . . . 65.400000000000006 111.019 178.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.8 p -148.96 123.07 9.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.399 0.619 . . . . 43.030000000000001 112.163 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.9 m -145.65 -53.9 0.28 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.844 -0.617 . . . . 53.299999999999997 110.197 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 51.63 1.96 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.176 -0.535 . . . . 73.219999999999999 113.385 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -156.64 145.07 14.52 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 122.584 -0.362 . . . . 73.310000000000002 110.8 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.94 120.02 4.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.247 1.965 . . . . 72.099999999999994 113.705 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.29 38.8 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.495 0.664 . . . . 44.409999999999997 110.792 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -129.9 8.05 5.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.819 -0.628 . . . . 73.200000000000003 111.551 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 64.9 tp -136.88 127.37 26.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.237 0.215 . . . . 64.209999999999994 111.064 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 50.7 mt-30 -66.48 148.27 52.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 74.239999999999995 112.047 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 32.6 m -131.15 146.77 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 71.219999999999999 111.493 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.5 t -100.9 113.66 26.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.388 -0.369 . . . . 64.409999999999997 110.822 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.14 170.37 49.2 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.266 -0.492 . . . . 31.41 114.239 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.9 m -54.9 -26.78 38.2 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.201 0.6 . . . . 70.030000000000001 112.111 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.54 -23.79 61.83 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.966 -0.561 . . . . 71.439999999999998 111.937 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.45 12.02 54.74 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.477 -0.392 . . . . 73.430000000000007 112.652 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.28 141.76 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.721 0.296 . . . . 75.409999999999997 111.764 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 m -86.65 107.35 18.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.466 -0.334 . . . . 54.109999999999999 111.434 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.01 147.16 24.43 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 110.151 -0.314 . . . . 71.230000000000004 110.151 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 39.9 ptt85 -59.83 -25.14 64.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.612 0.597 . . . . 73.510000000000005 112.612 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.0 p30 -166.86 172.25 10.53 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.043 0.449 . . . . 63.329999999999998 111.646 174.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 39' ' ' VAL . 29.6 tt0 -69.28 -26.7 64.88 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 112.135 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 48.6 t -74.72 -39.14 62.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.959 0.409 . . . . 73.209999999999994 110.206 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -59.14 -43.83 92.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.583 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.59 -51.3 67.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.107 -0.497 . . . . 74.510000000000005 110.736 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.816 ' HD3' ' HB2' ' A' ' 29' ' ' ASP . 94.1 mtt180 -70.82 -17.01 62.77 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.32 0.489 . . . . 73.109999999999999 112.32 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.18 -34.05 63.66 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.328 0.585 . . . . 72.099999999999994 110.154 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.02 -25.62 52.8 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.701 -0.681 . . . . 75.299999999999997 112.091 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 54' ' ' ARG . 16.4 ptt85 -66.5 -20.08 65.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.045 0.45 . . . . 74.150000000000006 110.886 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.4 t -72.27 -16.83 61.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.297 0.57 . . . . 60.340000000000003 110.634 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -91.66 85.04 5.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.943 -0.571 . . . . 75.439999999999998 111.112 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.89 -52.68 4.5 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 114.737 0.655 . . . . 75.140000000000001 114.737 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 36.2 m80 -114.58 93.62 33.37 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 117.806 0.803 . . . . 75.239999999999995 112.978 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 61' ' ' HIS . 43.6 Cg_endo -67.44 -16.48 47.7 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.556 2.17 . . . . 64.200000000000003 112.55 177.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -82.14 0.0 42.84 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.352 0.501 . . . . 75.430000000000007 112.352 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.9 tp -57.2 111.97 1.23 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 71.0 110.792 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -115.59 164.2 14.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.262 -0.426 . . . . 44.450000000000003 111.339 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.67 127.79 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.256 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -78.76 -45.32 21.34 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.307 0.575 . . . . 43.409999999999997 110.546 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -159.76 145.47 15.69 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.832 -0.622 . . . . 64.420000000000002 110.766 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.16 99.94 4.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.348 0.594 . . . . 72.319999999999993 110.925 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.53 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 164.57 -176.08 40.48 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.348 -0.842 . . . . 71.219999999999999 111.572 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -80.93 138.26 36.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.162 0.481 . . . . 54.350000000000001 111.3 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.9 m -61.9 94.86 0.05 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.208 0.528 . . . . 63.439999999999998 112.048 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.04 105.49 15.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.783 -0.644 . . . . 74.329999999999998 110.398 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' A' ' 74' ' ' LYS . 4.3 ttpm? . . . . . 0 C--O 1.252 1.195 0 CA-C-O 118.696 -0.669 . . . . 61.420000000000002 111.072 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.723 0.296 . . . . 75.150000000000006 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.71 116.96 26.28 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.844 0.354 . . . . 74.439999999999998 111.069 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.5 p -102.31 108.55 19.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.754 0.312 . . . . 42.310000000000002 111.251 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -99.12 130.38 45.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.902 0.382 . . . . 61.299999999999997 111.837 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.19 114.85 20.29 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.355 0.502 . . . . 61.350000000000001 112.355 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.31 8.2 58.71 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 114.274 0.469 . . . . 72.329999999999998 114.274 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.58 109.78 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 O-C-N 122.617 -0.343 . . . . 74.230000000000004 110.741 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -82.85 108.96 16.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.98 0.419 . . . . 41.5 111.315 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -148.76 138.49 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.285 0.564 . . . . 51.020000000000003 111.341 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.44 -60.92 0.09 OUTLIER Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.616 -0.72 . . . . 40.399999999999999 111.625 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.51 90.35 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.474 2.116 . . . . 53.020000000000003 112.322 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' CYS . . . 88.68 -5.69 84.38 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.19 -0.529 . . . . 74.329999999999998 114.051 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 49.6 mtmt -141.14 138.05 33.17 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.583 0.691 . . . . 72.030000000000001 112.202 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.84 140.11 50.51 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.145 -0.479 . . . . 75.140000000000001 110.005 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.3 t -98.33 135.74 39.5 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.099 0.476 . . . . 75.109999999999999 111.774 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 16' ' ' ARG . 12.5 ptm180 -142.62 137.03 29.73 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.824 -0.626 . . . . 64.409999999999997 110.808 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.9 mmm -76.46 104.55 7.03 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.009 0.433 . . . . 75.420000000000002 111.801 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 112.6 23.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.856 0.36 . . . . 61.43 111.02 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.05 31.7 72.51 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.448 -0.406 . . . . 30.329999999999998 112.882 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.81 -4.55 60.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.179 -0.534 . . . . 73.230000000000004 112.859 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -113.1 129.52 24.46 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.589 0.356 . . . . 42.149999999999999 111.053 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.84 115.52 4.28 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.493 2.129 . . . . 64.319999999999993 113.121 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -111.57 132.47 54.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.46 -0.336 . . . . 65.209999999999994 111.373 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 13' ' ' LYS . 87.0 m -103.28 119.98 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.993 0.425 . . . . 73.040000000000006 110.588 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -102.04 145.14 29.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.587 . . . . 73.219999999999999 110.006 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 20.4 p -80.48 123.2 27.87 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.142 0.496 . . . . 44.240000000000002 111.91 -175.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.05 134.28 24.03 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 52.039999999999999 110.962 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.71 152.33 47.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.411 2.074 . . . . 54.109999999999999 112.891 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -78.35 41.49 0.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.483 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.758 ' HA ' HD21 ' A' ' 33' ' ' LEU . 25.1 p -77.49 89.79 3.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.189 0.519 . . . . 70.430000000000007 111.908 -174.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.3 t -138.79 132.49 30.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.954 -0.567 . . . . 63.200000000000003 110.857 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.35 39.42 51.37 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.187 -0.53 . . . . 73.540000000000006 112.9 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 30' ' ' CYS . 3.2 pp -151.8 163.6 23.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 122.7 0.4 . . . . 74.329999999999998 110.726 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 84.5 Cg_exo -49.9 118.96 4.26 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.526 2.151 . . . . 63.539999999999999 114.336 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.89 -10.43 14.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.678 -0.692 . . . . 75.129999999999995 110.818 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -125.55 -22.47 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 63.240000000000002 111.313 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 3.7 tt -90.19 119.83 30.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.767 0.318 . . . . 72.450000000000003 110.312 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 52.4 mt-30 -63.74 148.82 48.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.313 0.486 . . . . 64.120000000000005 112.313 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 34.0 m -129.81 151.91 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.213 0.53 . . . . 72.019999999999996 112.052 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.71 113.67 26.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.946 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.64 162.19 32.84 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.262 -0.494 . . . . 73.25 113.789 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.9 p -65.97 -9.43 29.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.336 0.495 . . . . 72.420000000000002 112.336 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' HD13 ' A' ' 64' ' ' LEU . 14.6 t70 -81.19 -4.98 57.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.149 0.5 . . . . 71.150000000000006 110.923 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 13.23 66.48 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.4 -0.429 . . . . 63.020000000000003 113.266 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.76 148.23 41.33 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 111.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.687 HG21 ' HG2' ' A' ' 71' ' ' ARG . 69.7 m -99.62 116.57 32.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.959 0.409 . . . . 53.219999999999999 111.209 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -96.66 156.88 16.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.414 -0.357 . . . . 64.329999999999998 111.664 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 78.9 mtm180 -56.96 -32.88 66.48 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.518 0.562 . . . . 74.329999999999998 112.518 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -162.97 176.43 10.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.213 -0.449 . . . . 61.130000000000003 110.031 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.652 ' HB3' HD13 ' A' ' 33' ' ' LEU . 32.7 tt0 -74.99 -30.89 61.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.279 -0.569 . . . . 70.310000000000002 111.599 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 t -65.4 -37.41 86.88 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.834 -0.541 . . . . 63.219999999999999 109.806 176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.56 -52.89 63.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.543 -0.753 . . . . 74.239999999999995 110.421 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.26 -52.03 54.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.034 -0.984 . . . . 73.430000000000007 111.675 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 41.4 mtp85 -70.46 -27.17 64.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.841 -0.618 . . . . 75.340000000000003 111.657 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.11 -49.27 62.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.188 0.518 . . . . 31.41 110.67 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.83 -32.01 71.4 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.078 -0.51 . . . . 74.430000000000007 110.969 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -58.37 -51.63 69.0 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.944 -0.571 . . . . 72.540000000000006 110.921 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 32.2 t -71.78 -31.74 66.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.746 0.308 . . . . 71.25 111.432 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -60.14 -50.5 73.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.401 0.519 . . . . 74.239999999999995 112.401 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.49 16.78 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.993 -1.098 . . . . 65.540000000000006 114.959 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.0 m-70 -135.69 75.16 57.16 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 117.806 0.803 . . . . 72.340000000000003 111.564 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.64 -23.18 74.59 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.358 2.038 . . . . 63.200000000000003 113.273 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.3 -14.26 47.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.008 0.373 . . . . 74.030000000000001 112.008 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 43' ' ' ASP . 55.0 tp -64.4 112.36 3.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.2 0.524 . . . . 73.340000000000003 112.144 -175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.1 m -132.73 162.04 32.47 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.486 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.31 129.98 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.172 0.511 . . . . 74.439999999999998 111.788 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 69.5 mtm -85.27 -55.33 4.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.277 0.56 . . . . 70.150000000000006 110.166 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.508 ' HE2' ' H ' ' A' ' 73' ' ' ARG . 16.6 p90 -151.5 140.03 20.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.714 -0.676 . . . . 74.209999999999994 110.743 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.51 125.52 29.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.272 0.558 . . . . 70.299999999999997 111.543 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.511 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 124.56 161.57 11.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.35 -0.841 . . . . 60.439999999999998 111.139 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.687 ' HG2' HG21 ' A' ' 46' ' ' THR . 65.4 mtt180 -63.14 138.82 58.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.747 0.774 . . . . 75.319999999999993 111.082 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.5 m -48.28 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.626 0.602 . . . . 62.020000000000003 112.626 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.508 ' H ' ' HE2' ' A' ' 68' ' ' TYR . 11.9 ptp180 -117.64 128.03 54.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.999 -0.546 . . . . 73.319999999999993 111.217 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 C--O 1.258 1.545 0 N-CA-C 112.497 0.554 . . . . 72.120000000000005 112.497 176.422 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.741 0.305 . . . . 51.539999999999999 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -101.41 151.79 21.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.327 0.585 . . . . 33.219999999999999 112.52 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.1 p -147.49 154.17 40.43 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.753 -0.658 . . . . 63.25 110.655 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 p -140.43 130.91 25.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.764 0.316 . . . . 63.240000000000002 111.794 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.66 114.15 22.42 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.154 0.502 . . . . 72.239999999999995 112.329 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.87 27.21 66.45 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.987 0.755 . . . . 61.329999999999998 114.987 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.524 HG12 ' SG ' ' A' ' 9' ' ' CYS . 49.9 t -107.15 126.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 117.358 0.579 . . . . 74.140000000000001 111.588 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 10.5 pt-20 -79.0 105.93 10.69 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.407 0.622 . . . . 75.319999999999993 111.664 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.524 ' SG ' HG12 ' A' ' 7' ' ' VAL . 58.7 m -149.61 155.99 41.18 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.101 -0.374 . . . . 64.409999999999997 111.42 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.7 -65.24 0.31 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.942 -0.647 . . . . 71.349999999999994 113.009 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.14 90.53 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.66 2.24 . . . . 71.310000000000002 112.83 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.31 0.78 84.48 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.053 -0.594 . . . . 70.040000000000006 113.634 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.32 136.04 41.26 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.0 -0.706 . . . . 74.109999999999999 111.964 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.27 143.95 41.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.076 -0.511 . . . . 74.209999999999994 110.353 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.698 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 30.9 p -101.88 128.52 48.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.79 0.663 . . . . 74.200000000000003 112.79 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -138.52 145.62 40.96 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.417 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 74.1 mtp -91.12 112.16 23.95 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.947 0.404 . . . . 44.009999999999998 111.8 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 18' ' ' LEU . 6.0 mp -103.09 112.19 24.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.243 -0.435 . . . . 40.049999999999997 110.634 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.56 36.11 58.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.375 -0.44 . . . . 72.519999999999996 113.861 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.28 70.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.168 -0.539 . . . . 52.140000000000001 113.51 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.6 111.26 63.66 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 117.346 0.573 . . . . 72.129999999999995 111.771 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.502 ' HB2' HG21 ' A' ' 7' ' ' VAL . 58.7 Cg_endo -71.86 106.99 2.11 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.218 1.945 . . . . 74.230000000000004 112.269 175.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -117.79 149.2 41.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.904 0.383 . . . . 75.420000000000002 111.534 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 91.2 m -129.0 125.55 37.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.017 0.437 . . . . 64.239999999999995 111.487 177.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -119.99 161.54 20.75 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.528 -0.305 . . . . 75.150000000000006 110.188 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.86 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.35 0.595 . . . . 64.439999999999998 111.072 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 120.0 60.27 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.479 -0.782 . . . . 32.420000000000002 110.493 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 11.0 Cg_endo -52.17 117.62 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.5 2.134 . . . . 60.030000000000001 112.499 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.66 36.22 0.13 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.233 0.539 . . . . 73.239999999999995 111.623 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 47.6 m -65.51 101.89 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.978 -0.556 . . . . 73.540000000000006 111.587 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -129.34 92.32 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 62.039999999999999 110.243 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.78 7.35 17.83 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.054 -0.521 . . . . 71.319999999999993 112.858 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.403 HD11 HH11 ' A' ' 54' ' ' ARG . 83.9 mt -100.83 114.89 65.84 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 122.619 -0.342 . . . . 73.450000000000003 111.142 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.63 153.09 26.34 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.761 2.308 . . . . 74.439999999999998 113.531 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.26 163.16 26.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.156 -0.475 . . . . 71.310000000000002 111.2 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 69.33 -15.2 0.29 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.793 0.664 . . . . 71.420000000000002 112.793 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 1.1 tm? -72.23 88.01 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.477 -0.564 . . . . 73.510000000000005 109.477 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.496 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 98.1 mt-30 -71.24 142.11 50.58 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.775 0.657 . . . . 75.439999999999998 112.775 -175.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 69' ' ' ARG . 33.4 m -137.02 157.28 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.819 -0.628 . . . . 64.129999999999995 111.003 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 90.7 m -101.12 132.01 46.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.89 -0.506 . . . . 65.299999999999997 111.839 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -82.85 173.5 52.46 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.918 -0.583 . . . . 64.310000000000002 113.422 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -64.38 -11.17 30.08 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.544 0.572 . . . . 43.109999999999999 112.544 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -87.17 -26.87 23.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.859 0.361 . . . . 73.230000000000004 111.094 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.26 -0.36 20.73 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.316 -0.469 . . . . 73.209999999999994 113.924 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.5 152.09 19.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.344 0.572 . . . . 74.420000000000002 112.268 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.8 m -90.91 120.08 31.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.051 -0.522 . . . . 73.109999999999999 111.975 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -87.49 140.64 29.33 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.283 -0.417 . . . . 75.239999999999995 110.814 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 18.0 ptp180 -59.65 -15.55 19.95 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.001 0.741 . . . . 73.409999999999997 113.001 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.5 p30 -167.26 160.68 13.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.556 0.343 . . . . 71.430000000000007 110.91 172.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -64.04 -30.83 71.87 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.088 0.403 . . . . 72.540000000000006 112.088 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.26 -33.99 72.26 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.031 0.444 . . . . 73.340000000000003 110.683 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -56.48 -50.9 70.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 110.662 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.574 HD11 ' HA2' ' A' ' 41' ' ' GLY . 6.5 tt -63.08 -46.7 86.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.818 -0.628 . . . . 54.32 110.328 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HD3' ' SG ' ' A' ' 30' ' ' CYS . 16.8 ttt180 -55.39 -33.69 63.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.832 -0.622 . . . . 73.239999999999995 111.288 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.11 -31.68 23.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.059 -0.519 . . . . 75.049999999999997 111.655 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.08 71.11 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.191 0.441 . . . . 71.019999999999996 112.191 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.57 -34.01 64.39 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.242 0.544 . . . . 75.120000000000005 111.45 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.3 m -88.66 14.16 10.67 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.434 0.531 . . . . 63.140000000000001 112.434 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -98.27 8.24 45.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.058 0.392 . . . . 75.519999999999996 112.058 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.1 0.81 5.05 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.756 -0.735 . . . . 72.349999999999994 114.429 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -133.98 88.53 31.75 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 117.655 0.727 . . . . 72.209999999999994 112.132 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.94 -20.92 69.27 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.505 2.136 . . . . 75.319999999999993 111.59 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -20.95 58.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.947 -1.024 . . . . 73.120000000000005 112.436 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.81 111.57 3.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.287 0.565 . . . . 63.130000000000003 111.653 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -129.67 163.48 26.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.0 -0.546 . . . . 74.310000000000002 111.242 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.84 126.28 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.106 0.479 . . . . 61.340000000000003 111.394 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 72.1 mtm -80.33 -43.79 20.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.006 0.373 . . . . 73.120000000000005 112.006 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 44.0 p90 -164.19 155.83 16.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.949 0.404 . . . . 74.129999999999995 111.876 177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.676 ' HA ' HG12 ' A' ' 39' ' ' VAL . 8.6 mpt_? -80.5 104.87 11.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.168 0.509 . . . . 70.450000000000003 111.243 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.92 170.43 16.63 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 116.061 -0.518 . . . . 65.25 112.192 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -75.57 149.98 38.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.866 0.365 . . . . 74.299999999999997 111.424 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 71.5 m -58.77 113.78 2.21 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.113 -0.494 . . . . 52.32 111.934 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -97.85 143.62 28.27 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.706 -0.679 . . . . 74.129999999999995 112.131 -176.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 C--O 1.253 1.269 0 CA-C-O 118.67 -0.681 . . . . 62.020000000000003 110.816 172.875 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.924 0.393 . . . . 54.43 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 156.12 36.75 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.968 0.413 . . . . 60.43 111.614 175.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 p -94.69 120.12 34.41 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.106 0.41 . . . . 73.400000000000006 112.106 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 29.4 m -105.85 127.95 53.44 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.849 0.357 . . . . 73.299999999999997 111.605 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.646 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 11.5 m-20 -87.64 111.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.183 -0.323 . . . . 62.420000000000002 110.4 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.8 -39.78 0.79 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 121.004 -0.617 . . . . 53.140000000000001 114.016 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 10.7 t -66.08 146.28 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.962 0.505 . . . . 74.349999999999994 111.62 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -102.71 105.3 15.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.486 0.66 . . . . 75.239999999999995 110.218 177.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.632 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 97.9 m -149.52 179.41 7.99 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.502 0.556 . . . . 74.310000000000002 112.502 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.03 -67.54 0.56 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.259 -0.736 . . . . 63.009999999999998 111.259 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -93.01 131.1 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 73.209999999999994 111.96 168.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.37 -35.78 1.99 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.008 -0.615 . . . . 44.229999999999997 114.268 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HE3' ' SG ' ' A' ' 9' ' ' CYS . 48.5 mtmt -131.38 145.95 52.05 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.254 0.527 . . . . 74.209999999999994 111.286 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -122.09 132.04 54.28 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.455 -0.339 . . . . 74.420000000000002 110.634 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.2 p -100.12 121.83 42.02 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.479 0.657 . . . . 73.5 111.584 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -123.88 163.56 21.03 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.835 -0.62 . . . . 73.310000000000002 111.265 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -80.9 110.74 16.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.249 0.462 . . . . 74.420000000000002 112.249 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.699 HD22 ' HD2' ' A' ' 23' ' ' ARG . 6.8 mp -115.48 102.72 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.825 -0.435 . . . . 74.230000000000004 109.825 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.51 27.94 72.49 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.132 -0.556 . . . . 54.219999999999999 112.57 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.95 -16.62 56.51 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.483 -0.389 . . . . 64.540000000000006 113.633 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -93.11 137.25 23.77 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 122.321 -0.517 . . . . 72.129999999999995 111.804 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.646 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 90.4 Cg_endo -77.95 101.85 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.918 2.412 . . . . 45.329999999999998 113.409 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.699 ' HD2' HD22 ' A' ' 18' ' ' LEU . 53.9 mtt-85 -105.7 139.03 40.91 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.132 -0.321 . . . . 71.349999999999994 110.132 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 17.8 m -103.36 144.3 31.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 74.230000000000004 112.118 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' ' HD3' ' A' ' 16' ' ' ARG . 48.4 mt-10 -129.03 158.23 39.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 65.230000000000004 110.636 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.0 p -62.82 99.83 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.149 0.499 . . . . 63.520000000000003 112.278 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.82 125.59 41.68 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.874 -0.603 . . . . 71.219999999999999 111.45 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.9 Cg_exo -78.28 111.8 3.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.865 2.377 . . . . 65.5 112.848 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.36 94.22 0.16 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.788 0.328 . . . . 71.409999999999997 110.298 173.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.1 p -130.35 22.63 5.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.494 0.924 . . . . 63.549999999999997 113.494 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.1 p -70.93 -23.82 62.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.53 0.681 . . . . 63.420000000000002 109.965 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.61 27.83 14.08 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.56 -0.745 . . . . 31.420000000000002 113.017 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 78.6 mt -124.44 148.22 57.73 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-N 116.719 0.259 . . . . 52.119999999999997 111.688 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 13.6 Cg_exo -70.72 120.27 6.96 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.671 2.247 . . . . 73.129999999999995 112.629 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.28 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.992 0.367 . . . . 44.119999999999997 111.992 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -93.5 1.52 56.74 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.979 0.363 . . . . 72.109999999999999 111.979 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.3 mt -118.35 114.09 22.42 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.072 0.397 . . . . 71.200000000000003 112.072 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.34 146.75 53.78 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.503 -0.317 . . . . 71.329999999999998 110.375 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 69' ' ' ARG . 32.6 m -129.51 149.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.96 0.409 . . . . 71.329999999999998 111.603 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 61.3 m -100.53 128.58 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.385 -0.37 . . . . 70.310000000000002 110.796 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.516 ' HA3' HD11 ' A' ' 64' ' ' LEU . . . -72.89 164.3 54.88 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.253 -0.499 . . . . 43.409999999999997 113.068 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 t -58.97 -16.97 20.54 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.079 0.399 . . . . 71.540000000000006 112.079 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -82.11 -38.73 24.37 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.902 0.382 . . . . 74.030000000000001 110.931 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 -3.52 4.99 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.365 -0.445 . . . . 73.299999999999997 113.842 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.58 142.74 29.76 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.465 0.543 . . . . 62.539999999999999 112.465 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.583 HG21 ' HG3' ' A' ' 71' ' ' ARG . 32.1 m -90.19 113.12 24.85 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.446 -0.343 . . . . 54.119999999999997 111.478 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -97.62 167.59 10.87 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 71.5 111.745 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -44.2 87.21 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.647 0.61 . . . . 71.129999999999995 112.647 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -169.06 -179.29 3.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.63 0.252 . . . . 63.210000000000001 111.631 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -64.73 -36.22 83.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.752 0.31 . . . . 74.129999999999995 111.698 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 17.5 t -60.7 -46.7 89.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.117 0.484 . . . . 64.239999999999995 109.974 174.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -56.92 -44.11 82.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.644 -0.707 . . . . 74.120000000000005 111.377 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.563 ' HG ' HG22 ' A' ' 66' ' ' VAL . 1.5 tm? -59.37 -50.05 75.46 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.735 0.302 . . . . 73.230000000000004 110.877 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -56.51 -41.83 77.36 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.867 0.365 . . . . 42.229999999999997 111.283 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.08 -39.53 94.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.027 0.441 . . . . 54.119999999999997 110.741 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.786 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -66.24 -22.03 66.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 72.040000000000006 112.499 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -65.55 -47.31 76.29 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.542 0.687 . . . . 72.219999999999999 110.107 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.19 -30.59 65.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.464 0.649 . . . . 73.129999999999995 110.679 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.786 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 23.2 ttt180 -82.78 83.63 7.64 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.279 -0.873 . . . . 74.409999999999997 111.385 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . 88.72 -54.01 4.06 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 114.798 0.679 . . . . 73.109999999999999 114.798 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -115.04 90.94 25.04 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 113.673 0.99 . . . . 65.219999999999999 113.673 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 32.0 Cg_exo -61.71 -22.22 73.91 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.845 2.363 . . . . 71.329999999999998 113.072 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.05 -2.79 49.53 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.364 -0.38 . . . . 72.530000000000001 111.844 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.516 HD11 ' HA3' ' A' ' 41' ' ' GLY . 24.3 tp -77.71 118.08 19.74 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.554 0.576 . . . . 63.43 112.554 -172.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -125.87 164.63 20.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.856 -0.611 . . . . 60.439999999999998 110.607 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.563 HG22 ' HG ' ' A' ' 53' ' ' LEU . 44.0 t -80.13 128.57 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.955 0.354 . . . . 73.349999999999994 111.955 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 61.7 mtt -74.36 -58.95 2.96 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.448 0.642 . . . . 72.299999999999997 110.273 171.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.45 161.17 24.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.409 -0.814 . . . . 75.510000000000005 110.841 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HA ' HG12 ' A' ' 39' ' ' VAL . 78.0 mtt180 -81.62 107.36 14.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.259 0.552 . . . . 61.140000000000001 110.655 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.32 143.91 3.79 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.688 -0.687 . . . . 73.129999999999995 112.076 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.583 ' HG3' HG21 ' A' ' 46' ' ' THR . 65.2 ttt180 -72.36 74.91 1.02 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.814 0.34 . . . . 73.409999999999997 111.819 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 85.7 m 34.84 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.747 1.017 . . . . 71.409999999999997 113.747 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -84.77 105.93 15.92 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.038 0.447 . . . . 75.230000000000004 110.905 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt . . . . . 0 C--O 1.251 1.137 0 CA-C-O 119.206 -0.426 . . . . 74.450000000000003 111.837 -176.732 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.592 0.234 . . . . 62.409999999999997 110.701 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -74.93 91.17 2.46 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.158 0.504 . . . . 62.240000000000002 111.573 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.7 p -104.04 122.92 46.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.152 -0.476 . . . . 63.520000000000003 109.831 173.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 39.4 m -98.22 127.4 44.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.022 0.439 . . . . 65.409999999999997 111.392 -173.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.501 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 13.3 t70 -85.77 111.1 19.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.455 . . . . 70.329999999999998 110.879 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 -23.01 0.3 Allowed Glycine 0 CA--C 1.535 1.285 0 N-CA-C 114.421 0.528 . . . . 73.150000000000006 114.421 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 23.6 t -73.98 125.32 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 117.043 0.421 . . . . 72.120000000000005 111.849 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -115.05 110.01 18.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.168 0.508 . . . . 62.409999999999997 111.895 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.3 m -149.1 139.24 22.2 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.492 -0.322 . . . . 74.439999999999998 110.878 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.19 -76.73 0.02 OUTLIER Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.917 -0.658 . . . . 75.209999999999994 112.972 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.67 130.49 12.65 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.45 2.1 . . . . 62.439999999999998 112.692 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.34 -49.2 3.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.928 -0.653 . . . . 51.200000000000003 112.997 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -121.63 135.7 54.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.902 0.382 . . . . 74.299999999999997 111.433 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.92 145.57 41.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.784 -0.45 . . . . 62.43 109.784 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 31.9 p -99.08 113.38 25.56 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.41 0.624 . . . . 45.43 111.286 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -112.25 149.39 32.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.765 -0.652 . . . . 73.120000000000005 111.214 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.6 mtp -88.97 107.57 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 74.109999999999999 111.488 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.509 HD23 ' HG2' ' A' ' 23' ' ' ARG . 3.3 mm? -116.16 103.07 10.17 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.479 -0.328 . . . . 74.230000000000004 110.384 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.45 62.46 5.08 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 64.310000000000002 113.525 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.21 -46.4 3.39 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.203 -0.522 . . . . 64.329999999999998 113.953 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 21' ' ' ARG . 4.8 mpt_? -92.77 125.81 54.06 Favored Pre-proline 0 CA--C 1.541 0.611 0 O-C-N 122.328 -0.513 . . . . 70.049999999999997 111.969 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 96.5 Cg_endo -79.91 110.3 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.648 2.232 . . . . 73.329999999999998 112.094 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 33.6 ptt180 -99.11 158.28 15.78 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.164 -0.335 . . . . 73.319999999999993 111.079 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' CG1' ' A' ' 7' ' ' VAL . 78.2 m -103.14 120.69 41.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.081 0.467 . . . . 55.310000000000002 110.823 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.68 142.86 50.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.978 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' SG ' ' NH1' ' A' ' 59' ' ' ARG . 25.7 p -58.6 105.04 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.223 0.535 . . . . 73.349999999999994 111.562 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 135.9 19.35 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 51.219999999999999 111.174 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.906 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 74.2 Cg_endo -72.56 120.55 6.78 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.288 1.992 . . . . 63.420000000000002 112.486 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.6 -28.2 68.31 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.265 -0.425 . . . . 64.140000000000001 111.815 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HA ' HD11 ' A' ' 33' ' ' LEU . 79.2 m 73.4 -39.91 0.45 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.649 0.78 . . . . 61.130000000000003 112.609 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -54.12 112.62 1.0 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.109 -0.369 . . . . 72.439999999999998 111.797 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.07 -13.38 11.31 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.503 -0.38 . . . . 75.519999999999996 113.469 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 30' ' ' CYS . 2.5 pp -139.77 164.71 36.2 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 122.403 -0.469 . . . . 75.209999999999994 111.509 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 53.7 Cg_exo -53.96 119.61 6.56 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.548 2.165 . . . . 74.109999999999999 113.446 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.92 -25.65 18.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 112.04 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.59 -39.08 3.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.849 0.315 . . . . 73.129999999999995 111.849 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -64.8 118.93 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.874 0.368 . . . . 62.340000000000003 110.671 -176.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.39 162.89 2.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.648 0.61 . . . . 64.310000000000002 112.648 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 66' ' ' VAL . 31.3 m -143.84 147.5 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.863 -0.608 . . . . 62.100000000000001 110.471 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.3 t -103.64 126.82 51.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.947 0.403 . . . . 72.219999999999999 110.829 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.47 165.52 44.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.257 -0.497 . . . . 62.039999999999999 113.686 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.2 m -50.61 -28.36 8.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.63 0.604 . . . . 65.5 112.63 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.82 -34.04 75.96 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.086 0.47 . . . . 73.049999999999997 111.947 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.31 -10.0 24.42 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.374 -0.441 . . . . 71.540000000000006 112.236 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.83 134.71 38.97 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.072 0.463 . . . . 70.019999999999996 111.621 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.0 m -86.66 112.6 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.332 -0.395 . . . . 71.540000000000006 111.337 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.66 160.95 16.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.796 0.332 . . . . 64.310000000000002 111.671 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -61.47 -40.32 94.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 111.783 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -165.91 174.52 9.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.058 -0.519 . . . . 74.200000000000003 110.552 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HA ' HG21 ' A' ' 39' ' ' VAL . 29.5 tt0 -71.74 -27.88 63.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.899 0.381 . . . . 70.400000000000006 111.498 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.906 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 9.1 t -67.56 -39.87 84.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.948 0.404 . . . . 75.310000000000002 110.262 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.42 -46.45 88.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.099 -0.5 . . . . 73.530000000000001 110.82 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -56.74 -42.2 78.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.377 -0.374 . . . . 72.209999999999994 110.739 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' A' ' 28' ' ' PRO . 29.6 ttt180 -57.16 -40.29 76.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.102 0.477 . . . . 75.230000000000004 110.899 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 59' ' ' ARG . . . -65.41 -50.41 65.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.283 -0.417 . . . . 64.420000000000002 111.019 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.35 -38.45 66.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.989 0.424 . . . . 63.200000000000003 111.728 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -52.9 -46.64 68.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.158 -0.474 . . . . 73.040000000000006 111.022 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.7 t -77.1 -34.01 56.88 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.349 0.5 . . . . 65.209999999999994 112.349 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 55' ' ' ALA . 37.8 mmt180 -58.33 -48.51 80.32 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.722 0.296 . . . . 75.140000000000001 111.555 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.14 32.31 0.02 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.221 -0.99 . . . . 73.129999999999995 114.26 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -132.39 81.93 59.06 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 117.216 0.508 . . . . 62.219999999999999 111.015 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.32 -34.8 26.06 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.614 2.209 . . . . 63.340000000000003 112.778 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.47 -11.59 60.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 111.978 0.362 . . . . 71.519999999999996 111.978 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.7 tp -77.21 110.35 11.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.518 0.562 . . . . 54.450000000000003 112.518 -173.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -123.92 161.08 26.11 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.140000000000001 110.323 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 39' ' ' VAL . 2.7 p -88.34 111.3 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.001 0.429 . . . . 61.200000000000003 111.628 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.9 mtt -63.59 -58.82 5.75 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 110.659 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.2 172.56 17.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.886 -0.597 . . . . 73.150000000000006 110.361 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 9.9 mpt_? -78.9 158.65 28.02 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.214 0.53 . . . . 74.040000000000006 111.564 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.4 54.72 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.951 -0.568 . . . . 75.230000000000004 112.562 -174.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -83.61 158.28 21.95 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.541 -0.387 . . . . 63.549999999999997 111.567 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.8 m -67.01 98.16 0.55 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.158 0.504 . . . . 62.149999999999999 111.078 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -94.94 123.32 38.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.993 -0.549 . . . . 74.120000000000005 111.046 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.8 pttt . . . . . 0 C--O 1.255 1.393 0 CA-C-O 118.244 -0.884 . . . . 62.32 112.016 -178.719 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.853 0.358 . . . . 70.030000000000001 111.203 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.75 132.68 43.16 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.835 0.35 . . . . 71.120000000000005 111.623 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.2 t -128.58 134.25 48.56 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.436 -0.347 . . . . 32.32 111.105 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.573 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 24.0 m -124.93 128.32 48.43 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.852 0.358 . . . . 62.409999999999997 111.956 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -87.42 110.66 20.44 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.442 -0.345 . . . . 72.25 110.429 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.26 -32.21 0.32 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.501 0.56 . . . . 72.120000000000005 114.501 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 38.5 t -65.61 131.7 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 117.194 0.497 . . . . 73.319999999999993 111.976 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -76.57 105.34 7.57 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 120.95 0.405 . . . . 54.119999999999997 111.648 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.543 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 65.7 m -138.3 179.49 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.932 0.396 . . . . 65.299999999999997 111.206 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.23 -85.3 0.39 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.161 -0.542 . . . . 70.510000000000005 112.574 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -61.23 92.13 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.358 2.038 . . . . 71.200000000000003 112.431 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.97 23.88 72.91 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 115.976 -0.556 . . . . 71.0 114.003 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.656 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.1 mtmt -144.26 146.66 32.77 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.655 0.728 . . . . 75.219999999999999 112.957 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.35 149.18 40.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.369 -0.832 . . . . 70.109999999999999 110.163 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 26.6 p -112.44 142.59 44.79 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.328 0.585 . . . . 73.109999999999999 112.499 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 15.2 mmt180 -129.1 163.22 25.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.974 -0.557 . . . . 74.409999999999997 111.332 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.7 mmm -85.68 102.33 13.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.964 0.411 . . . . 74.439999999999998 111.247 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.4 110.44 22.41 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.04 0.447 . . . . 45.340000000000003 110.536 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.85 71.75 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.133 -0.556 . . . . 52.549999999999997 113.188 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.36 -4.77 84.28 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.255 -0.497 . . . . 50.25 113.243 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 21' ' ' ARG . 9.1 mpt_? -114.97 126.24 28.08 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 122.383 -0.48 . . . . 74.219999999999999 111.361 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 70.9 Cg_endo -74.0 113.85 3.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.471 2.114 . . . . 72.109999999999999 112.901 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -120.77 152.28 38.52 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.121 -0.362 . . . . 64.030000000000001 110.941 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 2.0 t -103.41 140.05 37.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.633 0.605 . . . . 74.299999999999997 112.633 -169.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.54 160.51 33.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.679 -0.691 . . . . 73.030000000000001 109.874 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 p -76.16 140.7 41.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.028 0.442 . . . . 64.430000000000007 111.393 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -118.88 125.17 27.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.262 -0.426 . . . . 62.299999999999997 111.51 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 6.0 Cg_exo -79.59 24.45 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.269 2.646 . . . . 73.129999999999995 114.241 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 54.1 40.25 31.46 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.025 0.44 . . . . 71.319999999999993 111.859 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.462 ' HA ' HD21 ' A' ' 33' ' ' LEU . 27.3 m -70.4 88.64 0.66 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.217 0.532 . . . . 73.0 112.254 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.8 t -150.93 137.63 18.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.727 -0.67 . . . . 61.439999999999998 110.445 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 -50.32 4.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.04 -0.6 . . . . 61.140000000000001 113.367 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' ' 50' ' ' GLU . 1.8 pt? -66.98 151.87 96.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.821 -0.223 . . . . 73.219999999999999 111.304 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.45 119.3 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.359 2.039 . . . . 74.040000000000006 112.912 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.85 8.99 11.19 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.221 -0.445 . . . . 73.230000000000004 111.373 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -129.26 15.12 6.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.119 0.485 . . . . 72.420000000000002 110.792 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 5.7 tt -125.64 125.4 43.05 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.07 -0.514 . . . . 72.420000000000002 110.025 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -63.55 147.73 50.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.897 0.702 . . . . 54.310000000000002 112.897 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 50' ' ' GLU . 35.4 m -138.62 146.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.301 -0.408 . . . . 72.239999999999995 110.676 176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 17.2 t -105.21 131.53 52.56 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.106 0.479 . . . . 74.510000000000005 111.853 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.91 177.82 40.31 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.127 -0.488 . . . . 63.450000000000003 114.015 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.1 m -55.29 -27.79 49.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.695 0.628 . . . . 63.310000000000002 112.695 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.87 8.0 11.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.43 0.53 . . . . 71.129999999999995 112.43 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.052 -0.594 . . . . 53.210000000000001 112.68 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 125.15 36.25 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.502 0.321 . . . . 52.539999999999999 111.072 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 61.7 m -91.38 104.91 17.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.161 0.505 . . . . 74.140000000000001 111.161 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -80.48 157.82 26.06 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.531 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 63.4 mtt180 -53.32 -33.43 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.66 0.615 . . . . 73.25 112.66 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.4 p30 -170.92 173.16 5.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.939 0.399 . . . . 50.520000000000003 111.54 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' HD12 ' A' ' 33' ' ' LEU . 11.8 tp10 -58.08 -43.6 87.1 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.07 -0.514 . . . . 73.239999999999995 111.63 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.55 -39.95 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.973 0.416 . . . . 71.239999999999995 110.599 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' OE1' ' HD2' ' A' ' 48' ' ' ARG . 7.5 tp10 -63.25 -44.27 95.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.826 -0.624 . . . . 75.129999999999995 110.866 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.94 -51.66 68.33 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.809 -0.632 . . . . 51.399999999999999 111.269 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.26 -33.27 75.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.714 0.292 . . . . 73.120000000000005 111.74 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.75 -51.41 65.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.043 0.449 . . . . 74.200000000000003 110.689 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.2 76.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.982 0.42 . . . . 54.049999999999997 111.187 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -60.64 -50.24 74.28 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.079 -0.51 . . . . 74.519999999999996 110.404 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.77 -35.47 80.15 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.113 -0.494 . . . . 62.219999999999999 111.749 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -59.55 -58.68 7.53 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.506 -0.315 . . . . 74.109999999999999 111.575 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.44 24.92 0.19 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.543 -0.837 . . . . 74.230000000000004 114.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 42.2 m170 -122.38 78.81 45.35 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 122.139 -0.624 . . . . 73.530000000000001 111.144 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.51 -43.49 33.01 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.756 2.304 . . . . 70.340000000000003 113.552 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.53 2.82 39.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.57 0.581 . . . . 74.310000000000002 112.57 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 66.4 tp -76.64 127.43 32.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.015 0.436 . . . . 75.109999999999999 111.975 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.0 m -142.64 152.16 42.18 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.59 -0.277 . . . . 54.0 110.696 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -81.39 124.73 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.135 0.493 . . . . 52.149999999999999 111.748 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.36 -49.64 9.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.11 0.481 . . . . 72.340000000000003 110.783 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -159.84 164.29 33.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.916 -0.583 . . . . 73.299999999999997 111.258 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 39' ' ' VAL . 49.5 mtm180 -76.8 135.62 38.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.141 -0.481 . . . . 65.230000000000004 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.86 -172.88 20.4 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.271 -0.49 . . . . 65.140000000000001 112.71 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -86.72 149.34 24.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.56 -0.377 . . . . 75.439999999999998 111.675 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 35.3 m -66.08 83.78 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.622 0.725 . . . . 43.409999999999997 111.159 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -77.2 140.28 40.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.16 -0.927 . . . . 75.329999999999998 111.812 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--O 1.252 1.21 0 CA-C-N 115.919 -0.582 . . . . 73.239999999999995 110.565 176.764 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.795 0.331 . . . . 44.149999999999999 111.651 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -142.9 102.76 4.08 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.626 0.727 . . . . 74.219999999999999 112.332 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.412 ' H ' ' HG2' ' A' ' 17' ' ' MET . 58.8 m -157.09 166.31 33.64 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.826 0.85 . . . . 53.140000000000001 109.453 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.5 m -135.87 127.68 29.26 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.927 -0.483 . . . . 72.010000000000005 111.987 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 7' ' ' VAL . 29.0 t70 -86.67 111.42 20.65 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.676 0.25 . . . . 71.109999999999999 111.676 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 48.65 30.93 9.13 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 114.564 0.586 . . . . 72.140000000000001 114.564 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 5' ' ' ASP . 89.1 t -106.74 122.47 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 117.337 0.568 . . . . 74.150000000000006 111.77 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -92.07 106.73 18.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.612 -0.267 . . . . 72.109999999999999 111.202 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 96.1 m -148.84 138.54 21.98 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.648 0.261 . . . . 73.040000000000006 111.348 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.98 -141.42 4.33 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 120.894 -0.67 . . . . 41.100000000000001 113.932 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 -13.5 5.58 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.357 2.705 . . . . 72.239999999999995 114.81 -173.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.8 -30.17 9.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.99 -0.624 . . . . 53.329999999999998 113.155 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.7 mtmt -148.5 136.31 20.77 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.609 -0.347 . . . . 54.530000000000001 111.228 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.16 136.07 48.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.577 -0.283 . . . . 44.32 110.634 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.798 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 7.2 p -99.79 122.08 42.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.141 0.496 . . . . 62.020000000000003 111.714 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -119.95 158.84 25.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.144 -0.48 . . . . 75.540000000000006 111.345 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.412 ' HG2' ' H ' ' A' ' 3' ' ' SER . 3.8 mmt -79.73 102.62 9.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.468 -0.333 . . . . 73.209999999999994 111.597 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.578 HD13 ' HB2' ' A' ' 23' ' ' ARG . 6.6 mp -110.77 112.99 25.24 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.929 0.395 . . . . 42.109999999999999 110.118 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.39 29.84 75.77 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.84 -0.695 . . . . 71.209999999999994 112.252 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -0.12 69.17 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.522 -0.37 . . . . 41.299999999999997 113.721 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -115.1 138.44 23.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 72.219999999999999 111.502 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.71 124.33 7.47 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.949 2.432 . . . . 55.240000000000002 114.273 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 8.7 mtp180 -119.69 134.62 55.16 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.965 -0.561 . . . . 74.030000000000001 110.907 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.798 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.1 m -103.37 119.82 39.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.886 0.374 . . . . 60.200000000000003 110.987 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -123.07 160.38 26.49 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.935 -0.575 . . . . 63.049999999999997 111.117 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -52.18 106.74 0.16 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.84 0.352 . . . . 73.310000000000002 111.863 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.45 122.87 58.28 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 116.218 -0.447 . . . . 74.510000000000005 112.197 -175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 55' ' ' ALA . 72.8 Cg_endo -75.95 -18.81 16.47 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.366 2.044 . . . . 51.020000000000003 112.118 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.1 t70 63.36 96.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.693 0.797 . . . . 74.010000000000005 112.234 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.4 m -121.39 25.84 9.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.389 -0.823 . . . . 63.130000000000003 109.945 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -64.27 103.32 0.62 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.284 -0.871 . . . . 54.340000000000003 113.212 -171.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.75 2.1 88.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.355 0.902 . . . . 73.430000000000007 115.355 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 51' ' ' CYS . 3.7 pp -85.86 153.72 57.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 118.03 0.915 . . . . 75.310000000000002 111.396 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.08 119.4 6.43 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.317 2.011 . . . . 61.310000000000002 112.703 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 76.59 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.028 0.442 . . . . 71.340000000000003 111.06 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 177.51 15.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.991 -0.55 . . . . 74.209999999999994 111.561 -175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD21 ' HD3' ' A' ' 69' ' ' ARG . 50.9 tp -119.99 105.56 11.16 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.015 0.436 . . . . 52.299999999999997 111.867 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.35 145.18 56.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.029 -0.532 . . . . 52.130000000000003 111.984 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 50' ' ' GLU . 31.4 m -141.13 143.56 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.268 -0.424 . . . . 71.329999999999998 111.043 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -102.19 125.8 48.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 110.159 -0.312 . . . . 70.120000000000005 110.159 178.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' HA2' HD11 ' A' ' 53' ' ' LEU . . . -73.24 169.25 53.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.407 -0.425 . . . . 63.350000000000001 113.765 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 t -65.18 -6.39 9.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.155 0.428 . . . . 74.140000000000001 112.155 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.94 -31.15 14.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.356 0.262 . . . . 72.430000000000007 111.389 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.38 -11.39 7.18 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 121.357 -0.449 . . . . 50.409999999999997 113.778 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.98 134.58 36.26 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.014 0.435 . . . . 42.299999999999997 112.002 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.572 HG21 ' HG2' ' A' ' 71' ' ' ARG . 45.8 m -97.17 107.76 20.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.871 0.367 . . . . 42.43 111.1 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.52 151.62 24.46 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.395 -0.366 . . . . 74.219999999999999 111.705 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -57.52 -30.45 65.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.575 0.583 . . . . 71.140000000000001 112.575 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 34.5 t70 -155.29 159.81 40.29 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.758 0.313 . . . . 73.409999999999997 111.548 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' HG21 ' A' ' 39' ' ' VAL . 39.5 tt0 -58.92 -43.37 91.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.799 0.333 . . . . 64.530000000000001 110.994 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.507 ' HB2' HD11 ' A' ' 33' ' ' LEU . 36.1 t -57.23 -34.99 69.13 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.138 0.494 . . . . 64.519999999999996 111.032 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -65.66 -41.47 92.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.041 -0.527 . . . . 70.109999999999999 111.155 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.402 HD11 ' HA2' ' A' ' 41' ' ' GLY . 9.3 tt -65.03 -42.34 94.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.066 0.46 . . . . 52.530000000000001 110.172 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 54' ' ' ARG . 11.2 mmm180 -54.14 -49.72 68.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.294 0.569 . . . . 72.140000000000001 110.584 175.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . . . -61.13 -42.97 99.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.916 -0.584 . . . . 62.32 111.158 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . . . -55.69 -36.94 67.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.052 -0.522 . . . . 73.340000000000003 111.938 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 76.3 ttt-85 -59.92 -38.16 81.56 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.104 0.478 . . . . 71.219999999999999 111.021 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.0 t -82.68 -15.68 51.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.06 0.457 . . . . 73.25 111.207 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.9 ttp180 -97.17 49.51 1.06 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.239 0.542 . . . . 74.129999999999995 111.619 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.57 1.46 58.97 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 115.068 0.787 . . . . 60.310000000000002 115.068 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 4.0 m-70 -126.76 77.74 73.9 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.144 0.972 . . . . 75.120000000000005 111.972 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.12 -22.87 61.12 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.67 2.247 . . . . 75.439999999999998 113.043 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.84 4.23 54.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.309 -0.405 . . . . 70.329999999999998 111.802 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 56.9 tp -80.46 125.77 30.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.27 0.557 . . . . 75.120000000000005 112.158 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.1 p -136.62 163.8 29.71 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.68 -0.691 . . . . 70.420000000000002 110.475 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.13 124.56 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.006 0.431 . . . . 63.32 111.194 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.5 mmt -89.59 -53.67 4.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.93 0.395 . . . . 74.549999999999997 111.044 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.98 152.66 42.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.995 0.426 . . . . 73.25 111.276 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.649 ' HD3' HD21 ' A' ' 37' ' ' LEU . 96.7 mtt180 -82.55 134.73 35.19 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.189 0.519 . . . . 62.409999999999997 111.8 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 116.27 -161.82 12.83 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.944 -0.571 . . . . 71.409999999999997 112.422 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.572 ' HG2' HG21 ' A' ' 46' ' ' THR . 50.2 mtp180 -86.29 153.61 21.85 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.538 -0.39 . . . . 74.120000000000005 111.286 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.5 m -57.38 112.72 1.49 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.532 0.682 . . . . 71.310000000000002 111.42 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -118.98 141.12 48.95 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.286 -0.87 . . . . 74.200000000000003 112.265 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.3 tttm . . . . . 0 C--O 1.251 1.141 0 CA-C-O 119.069 -0.491 . . . . 65.329999999999998 111.151 170.678 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.819 0.342 . . . . 63.219999999999999 111.235 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -122.35 125.16 45.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.014 0.435 . . . . 72.439999999999998 111.677 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 t -144.21 179.42 7.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.123 -0.489 . . . . 71.099999999999994 110.461 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 7.4 m -97.86 127.0 43.52 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.793 0.33 . . . . 72.010000000000005 110.439 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.35 110.31 20.69 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 110.241 -0.281 . . . . 74.299999999999997 110.241 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -34.8 0.57 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.147 -0.549 . . . . 72.140000000000001 114.386 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 21.2 t -66.08 140.22 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.156 0.478 . . . . 74.540000000000006 112.2 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -89.65 107.95 19.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.279 -0.419 . . . . 73.140000000000001 111.546 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.3 m -144.65 138.88 27.66 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.258 -0.428 . . . . 72.319999999999993 111.333 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.24 -95.28 0.1 OUTLIER Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.486 -0.387 . . . . 73.540000000000006 112.336 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.12 111.18 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.368 2.046 . . . . 73.340000000000003 112.334 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.21 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.239 -0.505 . . . . 33.420000000000002 113.862 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.583 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 52.9 mtmt -129.51 160.59 32.72 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.474 0.637 . . . . 65.140000000000001 112.324 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.8 136.03 20.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.358 -0.837 . . . . 62.5 109.946 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.2 p -101.63 142.37 33.08 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.194 0.521 . . . . 63.420000000000002 111.648 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -132.76 143.92 49.92 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.971 -0.559 . . . . 63.549999999999997 110.629 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.25 101.92 9.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.996 0.427 . . . . 71.400000000000006 110.298 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HD3' ' A' ' 23' ' ' ARG . 77.8 mt -125.48 116.07 21.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.408 -0.36 . . . . 53.0 111.385 -175.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.42 32.75 82.18 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.297 -0.478 . . . . 64.400000000000006 113.019 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.02 77.03 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.429 -0.415 . . . . 72.0 113.077 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -120.88 135.68 24.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.6 -0.353 . . . . 74.099999999999994 111.548 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.93 98.22 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.444 2.096 . . . . 64.209999999999994 112.716 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 23' ' ' ARG . 37.3 mtp-105 -95.96 123.17 39.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.608 -0.269 . . . . 74.420000000000002 111.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 9.5 t -104.06 120.19 40.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.68 0.276 . . . . 74.450000000000003 110.398 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -129.7 160.89 31.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 74.439999999999998 111.415 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.08 125.01 23.11 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 111.556 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -109.13 132.98 20.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 111.909 0.337 . . . . 72.200000000000003 111.909 -176.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 16.5 Cg_exo -69.0 112.87 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.923 2.416 . . . . 63.340000000000003 112.899 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.32 133.79 38.68 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.024 0.44 . . . . 62.109999999999999 111.108 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.1 m -124.33 45.09 2.58 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.937 0.399 . . . . 54.210000000000001 111.424 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.9 m -77.01 -76.44 0.17 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.23 0.456 . . . . 72.510000000000005 112.23 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 52.01 3.97 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.247 -0.502 . . . . 71.409999999999997 114.158 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.694 HD11 ' SG ' ' A' ' 51' ' ' CYS . 4.6 pp -155.83 151.56 22.16 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 122.44 -0.447 . . . . 63.520000000000003 111.497 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 7.3 Cg_exo -73.63 137.7 25.48 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.594 2.196 . . . . 64.230000000000004 112.479 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.77 134.33 56.11 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.224 0.453 . . . . 54.140000000000001 112.224 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 63.59 15.65 9.05 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.828 0.677 . . . . 75.319999999999993 112.828 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.5 tm? -82.71 104.11 12.71 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.851 0.358 . . . . 70.349999999999994 110.84 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.408 ' O ' HD13 ' A' ' 37' ' ' LEU . 80.8 mt-30 -61.12 150.18 34.92 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.022 -0.535 . . . . 62.43 111.804 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 69' ' ' ARG . 25.5 m -141.52 159.16 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.952 0.353 . . . . 64.349999999999994 111.952 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.566 ' SG ' ' HA2' ' A' ' 44' ' ' GLY . 51.5 t -106.31 122.18 45.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.856 0.36 . . . . 72.439999999999998 111.57 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.38 176.86 54.55 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.327 -0.463 . . . . 52.020000000000003 113.224 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -58.51 -25.76 62.74 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.4 0.519 . . . . 71.319999999999993 112.4 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.01 -14.4 59.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.025 0.44 . . . . 63.310000000000002 111.688 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.566 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . 85.05 34.62 14.28 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.227 -0.511 . . . . 73.109999999999999 112.952 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.24 148.01 40.89 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.505 0.322 . . . . 51.219999999999999 111.405 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -93.76 115.35 27.77 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.012 0.434 . . . . 70.329999999999998 112.128 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.12 166.1 13.15 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.352 -0.386 . . . . 71.040000000000006 111.149 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -62.23 -38.06 87.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.948 0.404 . . . . 74.420000000000002 111.194 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -166.02 174.07 9.77 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.939 -0.573 . . . . 65.109999999999999 110.743 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HB3' HD22 ' A' ' 33' ' ' LEU . 33.9 tt0 -63.06 -29.48 70.84 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.779 0.323 . . . . 74.450000000000003 111.086 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.694 ' SG ' HD11 ' A' ' 33' ' ' LEU . 62.1 m -58.28 -43.0 87.82 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.873 0.368 . . . . 64.310000000000002 110.693 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.44 -36.67 76.87 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 111.688 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.4 tt -65.25 -49.29 70.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.883 0.373 . . . . 70.299999999999997 110.372 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -57.31 -46.67 82.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 73.140000000000001 110.29 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.29 87.26 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.778 -0.646 . . . . 35.25 111.534 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.12 77.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.802 0.334 . . . . 41.240000000000002 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 34.4 mtm180 -61.75 -43.32 99.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.392 0.615 . . . . 72.450000000000003 110.683 175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.4 t -78.51 -21.4 48.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.358 -0.837 . . . . 53.130000000000003 111.605 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp85 -90.03 -29.0 18.7 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.604 0.594 . . . . 74.409999999999997 112.604 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.588 ' O ' ' HD3' ' A' ' 62' ' ' PRO . . . -169.9 -37.08 0.03 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 119.669 -1.253 . . . . 40.32 115.45 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 83.3 m-70 -110.28 81.78 2.4 Favored Pre-proline 0 N--CA 1.477 0.922 0 CA-C-N 118.059 0.929 . . . . 74.329999999999998 112.553 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 60' ' ' GLY . 23.8 Cg_exo -64.37 -24.63 64.37 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.497 2.131 . . . . 74.140000000000001 113.405 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.38 -4.65 57.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.981 0.42 . . . . 74.200000000000003 111.609 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . 61.4 tp -66.2 112.7 4.07 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.383 0.512 . . . . 72.319999999999993 112.383 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 m -105.95 151.79 24.14 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.395 -0.366 . . . . 72.439999999999998 111.166 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.86 127.66 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.846 0.355 . . . . 74.209999999999994 111.236 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.1 mtt -84.69 -55.06 4.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.947 0.403 . . . . 74.109999999999999 111.621 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -147.91 154.9 40.97 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.054 0.454 . . . . 51.299999999999997 111.779 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 39' ' ' VAL . 94.2 mtt180 -84.2 141.65 30.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.901 -0.59 . . . . 65.420000000000002 111.102 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.45 158.65 14.01 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.858 -0.61 . . . . 54.229999999999997 111.813 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.78 130.81 46.56 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 117.291 0.545 . . . . 70.219999999999999 110.612 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.06 142.84 56.34 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.942 0.349 . . . . 63.109999999999999 111.942 -172.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -113.39 105.72 13.73 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.209 0.448 . . . . 62.210000000000001 112.209 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.5 -0.762 . . . . 43.140000000000001 110.919 172.031 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.96 0.409 . . . . 51.340000000000003 111.406 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 10.3 m-20 -74.62 87.8 2.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.352 0.596 . . . . 71.120000000000005 111.295 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 m -95.15 161.01 14.29 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.737 -0.665 . . . . 73.319999999999993 111.326 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.2 m -139.59 129.0 24.17 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 111.891 0.33 . . . . 72.340000000000003 111.891 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.9 112.26 22.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.056 0.391 . . . . 75.140000000000001 112.056 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.7 56.09 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 114.992 0.757 . . . . 73.400000000000006 114.992 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.4 t -107.24 120.97 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 122.103 -0.645 . . . . 74.109999999999999 111.004 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 0.3 OUTLIER -96.63 109.38 22.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.625 0.726 . . . . 71.010000000000005 111.543 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 95.8 m -148.47 139.67 23.27 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.842 -0.617 . . . . 61.32 110.415 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.9 -98.15 0.17 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.091 -0.576 . . . . 61.420000000000002 113.723 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.12 -62.76 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.672 2.248 . . . . 70.209999999999994 113.962 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.5 58.89 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.144 -0.551 . . . . 54.32 113.922 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 48.8 mtmt -133.81 139.89 46.57 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.304 -0.527 . . . . 71.439999999999998 111.763 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -115.17 137.65 51.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.684 -0.235 . . . . 64.019999999999996 110.396 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.681 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 19.0 p -99.68 140.57 33.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.121 0.486 . . . . 75.230000000000004 111.704 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HA ' ' HB3' ' A' ' 2' ' ' ASP . 9.5 ptm180 -143.23 163.13 33.8 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.121 -0.49 . . . . 61.219999999999999 112.086 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.9 mmt -79.76 104.14 10.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.297 -0.411 . . . . 41.43 111.526 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 93.6 mt -120.69 119.09 31.81 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.67 -0.241 . . . . 75.299999999999997 110.8 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.46 26.36 56.65 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.152 -0.546 . . . . 72.129999999999995 113.554 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.55 82.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.453 -0.403 . . . . 40.210000000000001 113.64 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 18' ' ' LEU . 11.0 ptp180 -128.75 138.15 32.51 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 117.496 0.648 . . . . 62.119999999999997 111.558 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.95 111.59 3.31 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.777 2.318 . . . . 75.219999999999999 113.426 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 97.6 mtt180 -116.34 144.81 43.78 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.342 -0.39 . . . . 71.150000000000006 111.585 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 76.9 m -103.82 135.19 45.83 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.441 -0.345 . . . . 75.049999999999997 111.549 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' OE1' ' HD3' ' A' ' 16' ' ' ARG . 9.7 pt-20 -129.89 161.08 31.64 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.565 -0.289 . . . . 74.439999999999998 111.601 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.7 t -55.03 114.51 1.78 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.37 0.507 . . . . 64.109999999999999 112.37 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -97.2 118.43 64.63 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.452 -0.34 . . . . 73.109999999999999 111.078 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 2.6 Cg_endo -88.16 21.19 1.04 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.217 2.611 . . . . 63.130000000000003 113.944 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 55.74 36.41 27.2 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.903 0.382 . . . . 74.030000000000001 111.951 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.495 ' HA ' HD21 ' A' ' 33' ' ' LEU . 60.4 m -65.52 78.62 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.458 0.647 . . . . 43.229999999999997 111.637 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -149.88 120.43 7.46 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.465 -0.788 . . . . 63.530000000000001 110.396 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.15 -40.11 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.134 -0.555 . . . . 63.0 112.679 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 30' ' ' CYS . 3.3 pp -66.09 153.35 92.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.592 -0.357 . . . . 64.5 111.263 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 17.0 Cg_exo -68.13 120.42 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.613 2.209 . . . . 31.440000000000001 113.081 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.41 141.17 29.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 111.023 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 63.3 10.86 4.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.134 0.791 . . . . 64.420000000000002 113.134 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . 3.3 tm? -103.27 110.64 22.69 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.169 -0.678 . . . . 74.340000000000003 109.169 174.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -54.18 153.94 4.77 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.804 0.668 . . . . 64.340000000000003 112.804 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.478 HG12 ' HG2' ' A' ' 69' ' ' ARG . 22.5 m -136.54 143.06 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.869 -0.605 . . . . 63.25 110.876 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.86 113.44 25.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.059 0.457 . . . . 62.310000000000002 110.728 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.17 164.96 48.33 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.146 -0.479 . . . . 30.32 113.937 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.9 p -58.66 -20.98 52.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.307 0.643 . . . . 73.430000000000007 112.393 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.67 -14.31 60.35 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.989 0.424 . . . . 72.049999999999997 111.755 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.1 10.82 59.34 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.128 -0.558 . . . . 64.120000000000005 113.052 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.61 144.58 40.63 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.866 0.365 . . . . 43.240000000000002 111.416 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.0 m -96.23 129.41 43.55 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.502 -0.317 . . . . 70.0 111.226 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -109.89 168.89 9.09 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.626 0.251 . . . . 75.409999999999997 111.669 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -47.57 -54.92 10.4 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.573 0.583 . . . . 74.129999999999995 112.573 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -164.27 -178.91 5.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.696 0.284 . . . . 74.549999999999997 111.459 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 tp10 -55.37 -45.01 76.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.427 -0.351 . . . . 74.409999999999997 111.185 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.16 -43.08 82.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.098 0.475 . . . . 73.099999999999994 110.915 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.55 -43.23 97.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 111.052 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 64' ' ' LEU . 10.4 tt -62.4 -45.27 93.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.227 -0.442 . . . . 65.409999999999997 111.349 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 8.7 mmm180 -62.57 -37.82 87.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.395 0.617 . . . . 64.329999999999998 109.927 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.1 84.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 111.084 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.25 87.02 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.366 . . . . 65.519999999999996 111.424 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 66.5 ttt180 -64.79 -41.29 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.067 0.461 . . . . 75.209999999999994 110.601 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.53 -26.68 67.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.354 0.597 . . . . 52.439999999999998 110.686 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -89.51 58.12 4.23 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.723 -0.671 . . . . 73.129999999999995 111.299 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.78 36.24 93.06 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.926 0.73 . . . . 52.299999999999997 114.926 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 77.9 m80 -135.66 74.96 57.78 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 117.689 0.744 . . . . 71.120000000000005 111.607 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.04 -24.1 75.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.843 2.362 . . . . 53.520000000000003 114.114 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -97.16 -2.82 42.19 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.388 0.514 . . . . 74.530000000000001 112.388 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -77.72 111.59 13.67 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.241 0.543 . . . . 63.119999999999997 111.051 -175.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -142.92 152.07 41.65 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.005 -0.543 . . . . 74.420000000000002 110.706 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 53' ' ' LEU . 7.2 p -77.46 132.34 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 121.162 0.506 . . . . 61.149999999999999 112.257 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.9 mtt -92.51 -54.0 3.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.378 0.609 . . . . 61.32 110.25 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -143.36 150.49 39.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 109.909 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.478 ' HG2' HG12 ' A' ' 39' ' ' VAL . 77.2 mtt85 -92.18 148.15 22.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.964 0.888 . . . . 72.409999999999997 112.487 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.16 -163.21 12.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 114.977 -1.01 . . . . 53.109999999999999 110.878 -168.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -90.42 142.91 27.26 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.486 0.643 . . . . 70.239999999999995 110.795 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.85 102.49 0.06 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.405 0.621 . . . . 72.340000000000003 112.578 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.4 ' HD3' HH11 ' A' ' 73' ' ' ARG . 3.5 ptm180 -118.6 110.96 17.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.436 -0.802 . . . . 74.530000000000001 110.326 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.254 1.302 0 CA-C-O 119.386 -0.34 . . . . 70.439999999999998 111.814 -173.761 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.771 0.32 . . . . 64.530000000000001 111.019 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.06 169.25 18.68 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.368 0.604 . . . . 74.209999999999994 112.336 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -88.29 128.95 35.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.799 -0.637 . . . . 62.399999999999999 111.881 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 29.0 m -98.9 128.81 45.17 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.426 -0.352 . . . . 34.549999999999997 110.637 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.08 111.26 20.16 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 122.25 -0.282 . . . . 55.310000000000002 110.313 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.91 -39.62 0.97 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.373 -0.442 . . . . 65.209999999999994 113.932 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 6.2 t -66.62 146.06 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.397 0.517 . . . . 71.239999999999995 112.397 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -102.97 106.62 17.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.11 0.481 . . . . 65.019999999999996 110.554 176.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.26 178.78 8.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.719 0.637 . . . . 74.319999999999993 112.719 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.25 -82.88 0.29 Allowed Glycine 0 CA--C 1.524 0.642 0 CA-C-N 115.74 -0.664 . . . . 74.409999999999997 111.78 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.67 92.76 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.765 2.31 . . . . 71.310000000000002 112.854 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.4 -10.3 73.26 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.15 -0.547 . . . . 74.030000000000001 113.473 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 24' ' ' CYS . 45.1 mtmt -135.29 136.3 41.5 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.273 -0.545 . . . . 72.200000000000003 111.761 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.81 133.52 55.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.206 -0.452 . . . . 70.129999999999995 110.132 173.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 23.8 p -97.92 119.71 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.299 0.571 . . . . 64.530000000000001 110.385 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.2 ttm-85 -124.67 143.8 50.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.73 -0.668 . . . . 64.040000000000006 110.577 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.411 ' HA ' ' CE ' ' A' ' 17' ' ' MET . 3.2 mmt -73.68 100.31 3.34 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.203 0.525 . . . . 60.109999999999999 110.694 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.561 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 83.9 mt -125.38 107.5 10.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.822 -0.626 . . . . 73.439999999999998 110.104 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.39 -64.89 4.09 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.958 -0.639 . . . . 51.109999999999999 112.532 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.55 -22.48 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.584 -0.817 . . . . 53.329999999999998 114.154 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -98.65 138.67 20.77 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.42 -0.459 . . . . 73.430000000000007 111.425 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.75 93.8 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.991 1.794 . . . . 75.239999999999995 112.093 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 11.5 ptm180 -106.1 142.55 35.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.889 -0.596 . . . . 70.209999999999994 111.022 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 93.9 m -103.29 138.85 39.51 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.435 0.636 . . . . 64.340000000000003 111.757 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.5 mm-40 -106.45 156.69 18.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.232 -0.894 . . . . 54.310000000000002 110.061 -175.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.1 t -68.42 97.82 0.79 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.267 -0.642 . . . . 64.0 109.267 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -98.75 137.67 20.61 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.157 -0.474 . . . . 75.430000000000007 112.238 -171.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 7.7 Cg_exo -73.8 55.25 3.24 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.06 2.506 . . . . 74.120000000000005 112.59 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.51 127.01 18.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.819 0.342 . . . . 74.019999999999996 111.257 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.813 ' HB2' HD12 ' A' ' 33' ' ' LEU . 29.4 p -169.6 40.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.278 -0.419 . . . . 64.040000000000006 111.445 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.9 t -60.38 102.29 0.17 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.913 0.387 . . . . 64.209999999999994 111.705 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.31 -9.28 5.93 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.414 -0.422 . . . . 62.539999999999999 113.027 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD12 ' HB2' ' A' ' 30' ' ' CYS . 95.7 mt -95.32 126.08 47.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 O-C-N 122.64 -0.329 . . . . 63.039999999999999 111.325 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.87 125.15 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.501 2.134 . . . . 65.120000000000005 113.057 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.81 9.93 1.64 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.734 0.642 . . . . 64.200000000000003 112.734 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -113.18 9.66 18.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.961 0.41 . . . . 74.439999999999998 111.021 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 52.7 tp -106.83 97.91 7.64 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.755 0.312 . . . . 71.319999999999993 111.115 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.13 148.76 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.239 -0.437 . . . . 73.349999999999994 111.868 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 50' ' ' GLU . 25.0 m -137.21 161.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.359 . . . . 64.519999999999996 111.844 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.7 t -118.05 128.5 54.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.932 0.396 . . . . 71.439999999999998 110.627 173.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.33 177.54 37.91 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.103 -0.57 . . . . 74.439999999999998 114.207 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 p -63.78 -14.59 54.04 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.098 0.475 . . . . 71.319999999999993 111.74 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -81.95 -22.55 36.61 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.139 0.495 . . . . 65.319999999999993 111.093 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.54 -8.67 60.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.431 -0.414 . . . . 70.310000000000002 113.294 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.47 134.16 39.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.152 0.427 . . . . 52.32 112.152 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -86.72 116.25 24.69 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.248 -0.433 . . . . 63.329999999999998 110.626 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -100.65 159.68 14.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.036 0.446 . . . . 72.120000000000005 112.116 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -56.9 -35.96 69.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.723 -0.671 . . . . 73.129999999999995 111.163 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.0 p-10 -164.14 169.49 17.68 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.328 -0.851 . . . . 74.010000000000005 110.183 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HB3' HD13 ' A' ' 33' ' ' LEU . 34.4 tt0 -65.36 -33.02 74.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.043 -0.411 . . . . 70.25 111.552 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' HB2' ' OD2' ' A' ' 49' ' ' ASP . 28.2 m -65.41 -37.89 88.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.884 0.373 . . . . 72.209999999999994 110.435 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.99 -39.51 89.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.244 0.545 . . . . 51.109999999999999 110.603 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.97 -47.12 81.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.291 0.567 . . . . 61.450000000000003 110.31 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 54' ' ' ARG . 17.8 mtp180 -65.26 -22.09 66.81 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.813 -0.63 . . . . 71.230000000000004 111.03 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.59 -43.42 31.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.055 0.455 . . . . 74.340000000000003 110.876 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.32 64.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.133 0.492 . . . . 71.319999999999993 111.217 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 57' ' ' ARG . 16.0 tpp85 -54.18 -51.35 64.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.576 . . . . 74.530000000000001 110.273 170.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 62.2 m -68.58 -29.95 68.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.92 -0.582 . . . . 64.239999999999995 111.6 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.19 -32.32 73.68 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.903 0.382 . . . . 75.439999999999998 111.292 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.11 43.9 0.06 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.065 -0.588 . . . . 74.329999999999998 113.469 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 87.3 m-70 -135.33 82.07 41.79 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.345 -0.503 . . . . 74.299999999999997 111.646 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.04 -22.33 41.74 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.795 2.33 . . . . 63.229999999999997 113.415 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -84.23 -19.31 34.16 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.881 0.372 . . . . 75.510000000000005 111.805 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 43.6 tp -68.16 112.14 4.92 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.367 0.603 . . . . 71.129999999999995 112.521 -172.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.2 p -127.38 163.43 24.04 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.66 -0.7 . . . . 72.109999999999999 109.736 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.63 127.56 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.104 0.478 . . . . 70.420000000000002 111.814 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.4 mtt -90.62 -55.71 3.47 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.093 0.473 . . . . 75.439999999999998 111.406 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -148.46 157.15 43.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.864 0.364 . . . . 74.129999999999995 111.217 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -101.49 107.73 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.523 0.677 . . . . 74.129999999999995 111.782 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.88 -179.5 29.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.325 -0.852 . . . . 75.519999999999996 111.514 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -60.33 127.55 32.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.748 0.774 . . . . 62.210000000000001 109.95 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.89 97.96 0.06 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.437 0.637 . . . . 72.109999999999999 111.503 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -83.03 135.25 34.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.831 -0.622 . . . . 54.509999999999998 112.114 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm . . . . . 0 C--O 1.25 1.119 0 CA-C-N 116.086 -0.506 . . . . 73.340000000000003 111.309 177.172 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.528 0.204 . . . . 55.020000000000003 111.298 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -164.03 151.96 12.71 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.463 0.305 . . . . 52.420000000000002 111.046 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p -144.46 155.22 43.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 120.732 0.301 . . . . 61.009999999999998 111.718 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.8 m -100.1 130.7 46.27 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.781 0.66 . . . . 61.450000000000003 112.781 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.06 124.87 32.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.327 -0.397 . . . . 72.200000000000003 111.445 173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.72 -31.42 2.48 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.689 0.636 . . . . 52.509999999999998 114.689 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 22' ' ' PRO . 36.2 t -66.16 139.69 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 117.276 0.538 . . . . 74.129999999999995 111.626 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.94 103.36 14.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.092 0.405 . . . . 73.349999999999994 112.092 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 57.9 m -152.13 138.84 18.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.369 -0.378 . . . . 52.310000000000002 111.266 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . -139.43 -106.32 0.68 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.737 -0.744 . . . . 63.439999999999998 113.977 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 13.5 Cg_exo -70.8 -49.82 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.843 2.362 . . . . 71.430000000000007 113.415 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.68 66.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.045 -0.598 . . . . 72.430000000000007 113.304 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 49.7 mtmt -128.47 141.26 51.45 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.622 -0.34 . . . . 74.040000000000006 110.985 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.36 133.82 52.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.494 -0.321 . . . . 74.120000000000005 110.169 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.0 t -100.42 136.52 40.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.339 . . . . 65.329999999999998 111.272 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -134.83 163.67 29.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.08 0.467 . . . . 75.140000000000001 111.465 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 95.8 mmm -89.85 101.5 14.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.199 0.523 . . . . 72.329999999999998 110.964 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.08 115.48 30.29 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.215 -0.448 . . . . 65.239999999999995 110.763 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.58 40.54 92.63 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.202 -0.523 . . . . 71.230000000000004 113.418 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.1 5.92 81.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.9 -0.667 . . . . 62.140000000000001 113.766 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -124.42 129.85 24.53 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 117.173 0.486 . . . . 72.319999999999993 111.517 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.524 ' HB2' HG21 ' A' ' 7' ' ' VAL . 61.1 Cg_endo -72.55 106.2 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.497 2.131 . . . . 62.409999999999997 112.787 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -115.33 142.81 46.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.881 0.372 . . . . 65.420000000000002 111.277 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 9.4 m -103.92 142.83 33.74 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.102 0.477 . . . . 72.109999999999999 112.203 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -143.6 153.38 42.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.74 -0.664 . . . . 73.030000000000001 110.684 176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.6 t -52.83 128.23 26.13 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.176 0.512 . . . . 63.140000000000001 111.929 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.71 128.21 30.51 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.162 -0.472 . . . . 72.5 111.67 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.95 -2.84 12.39 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.264 1.976 . . . . 73.239999999999995 112.645 173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' HB3' ' NH1' ' A' ' 54' ' ' ARG . 36.2 t70 62.14 7.22 2.08 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.633 0.73 . . . . 74.299999999999997 111.645 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' HD21 ' A' ' 33' ' ' LEU . 33.8 t -80.53 92.63 5.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.887 -0.597 . . . . 73.319999999999993 112.197 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 p -138.43 -83.01 0.3 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.205 -0.452 . . . . 70.140000000000001 111.1 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.19 49.52 2.71 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.966 -0.635 . . . . 72.319999999999993 113.123 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 30' ' ' CYS . 2.6 pp -132.71 159.05 74.11 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 122.46 0.304 . . . . 60.310000000000002 111.08 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.95 119.09 6.11 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.367 2.045 . . . . 64.219999999999999 113.502 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.17 66.35 8.46 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.886 -0.783 . . . . 74.049999999999997 108.886 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -143.87 -13.38 0.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.909 0.707 . . . . 73.319999999999993 112.909 -165.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 68.1 tp -128.05 116.83 20.61 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.712 0.634 . . . . 74.450000000000003 112.712 -168.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -58.57 154.74 13.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.156 -0.475 . . . . 72.530000000000001 111.405 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.6 m -140.79 148.5 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.236 0.541 . . . . 43.43 111.846 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.0 t -100.03 116.37 31.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.288 -0.414 . . . . 73.329999999999998 110.593 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.34 162.18 34.73 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.215 -0.517 . . . . 73.209999999999994 113.63 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.8 p -55.14 -28.0 49.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.117 0.484 . . . . 42.530000000000001 111.654 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.4 -47.47 83.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.869 -0.605 . . . . 74.319999999999993 111.817 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.13 -23.38 5.84 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.335 -0.459 . . . . 62.100000000000001 112.531 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.9 139.89 36.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.993 0.425 . . . . 74.099999999999994 111.824 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -86.68 122.75 31.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.008 0.432 . . . . 71.109999999999999 111.092 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -94.73 153.73 17.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.442 . . . . 73.209999999999994 111.331 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -62.16 -25.71 67.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.825 -0.625 . . . . 61.450000000000003 112.606 -173.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 25.0 t70 -170.45 159.89 7.19 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.595 -0.275 . . . . 73.439999999999998 110.782 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.67 -40.21 68.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.314 0.578 . . . . 62.509999999999998 110.538 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.8 t -52.99 -42.69 65.81 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.286 -0.87 . . . . 71.040000000000006 111.471 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -73.98 -43.73 57.11 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.336 -0.393 . . . . 54.109999999999999 111.336 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 66' ' ' VAL . 69.2 tp -55.17 -58.33 8.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.137 0.494 . . . . 72.230000000000004 112.208 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 78.3 mtp180 -70.69 -25.05 62.79 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 111.781 -175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 59' ' ' ARG . . . -72.76 -45.28 59.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.843 0.354 . . . . 70.420000000000002 111.146 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.93 68.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.087 0.47 . . . . 73.239999999999995 110.771 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 54' ' ' ARG . 31.6 ttp180 -56.03 -50.02 72.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.579 -0.737 . . . . 73.040000000000006 110.642 171.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 81.6 m -66.28 -22.38 66.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.744 -0.662 . . . . 62.229999999999997 112.129 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 55' ' ' ALA . 29.5 mtp-105 -84.99 30.31 0.59 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.205 0.446 . . . . 73.329999999999998 112.205 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.75 6.34 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.965 -0.636 . . . . 64.510000000000005 114.279 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -134.46 77.54 59.16 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 117.294 0.547 . . . . 74.530000000000001 110.974 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.88 -21.15 38.18 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.872 2.382 . . . . 71.099999999999994 113.526 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.91 -17.64 52.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.989 0.423 . . . . 54.240000000000002 111.418 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 tp -72.26 112.0 7.96 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.195 0.521 . . . . 73.519999999999996 111.527 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.0 m -135.13 164.46 27.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.017 -0.538 . . . . 65.040000000000006 111.356 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.528 HG22 HD23 ' A' ' 53' ' ' LEU . 39.8 t -79.45 119.24 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.841 0.353 . . . . 71.209999999999994 111.862 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.3 mmt -81.92 -58.73 2.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.978 0.418 . . . . 73.049999999999997 110.579 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -161.58 160.91 29.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.801 -0.636 . . . . 64.0 111.2 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -77.78 137.59 38.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.271 -0.422 . . . . 75.129999999999995 111.569 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.61 172.27 30.62 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.264 -0.493 . . . . 72.519999999999996 113.127 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' ARG . 63.3 ttt180 -60.15 154.59 19.2 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.634 -0.333 . . . . 70.150000000000006 110.2 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.17 84.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 73.230000000000004 112.502 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' ARG . 57.8 mtp180 -119.25 142.86 47.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.123 0.569 . . . . 64.439999999999998 111.319 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.634 -0.698 . . . . 63.140000000000001 110.947 174.837 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 111.794 0.294 . . . . 73.409999999999997 111.794 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.414 ' OD2' ' HG3' ' A' ' 16' ' ' ARG . 10.0 p-10 -81.66 133.29 35.35 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.25 0.548 . . . . 61.530000000000001 111.578 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m -123.76 -166.41 1.48 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.999 0.428 . . . . 72.340000000000003 111.736 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.4 p -98.72 130.78 45.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.018 0.437 . . . . 63.009999999999998 112.169 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -80.51 126.46 31.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.081 0.467 . . . . 64.140000000000001 111.521 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.34 -2.2 16.05 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.002 -0.544 . . . . 73.129999999999995 113.945 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 10.9 t -107.17 145.83 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 117.118 0.459 . . . . 64.310000000000002 111.326 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -111.12 106.41 15.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.635 -0.506 . . . . 64.120000000000005 109.635 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 87.9 m -138.91 139.1 37.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.923 0.392 . . . . 75.430000000000007 111.048 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' LYS . . . 169.97 -64.05 0.17 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.393 -0.432 . . . . 63.32 113.076 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.36 42.83 1.3 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.154 2.569 . . . . 74.549999999999997 113.69 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.79 -45.01 0.43 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.158 -0.544 . . . . 73.409999999999997 112.424 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 36.8 mtmm -122.65 136.92 55.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.492 0.317 . . . . 75.140000000000001 110.263 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -107.23 134.35 50.45 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 122.381 -0.2 . . . . 42.340000000000003 111.108 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.88 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 31.5 p -114.77 139.64 49.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.668 0.618 . . . . 54.310000000000002 112.668 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.567 HH11 ' HG3' ' A' ' 16' ' ' ARG . 29.1 ttm-85 -142.5 160.52 40.13 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.958 -0.565 . . . . 72.200000000000003 111.152 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.2 mmt -82.53 107.91 15.53 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.577 0.584 . . . . 72.010000000000005 112.577 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HD2' ' A' ' 23' ' ' ARG . 6.3 mp -123.45 102.0 7.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.871 0.367 . . . . 75.200000000000003 110.938 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.65 52.57 52.22 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.403 -0.427 . . . . 43.530000000000001 114.018 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.45 -44.37 3.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.205 -0.521 . . . . 74.150000000000006 113.811 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.04 130.76 35.04 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 75.140000000000001 111.716 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.07 141.05 12.83 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.515 2.143 . . . . 52.32 112.922 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HD2' HD22 ' A' ' 18' ' ' LEU . 97.3 mtt180 -113.79 123.32 49.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.764 -0.198 . . . . 65.019999999999996 111.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.88 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 94.9 m -107.36 120.1 41.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.647 0.261 . . . . 75.0 110.988 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -119.74 159.23 24.9 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.341 -0.225 . . . . 75.519999999999996 111.525 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 58' ' ' CYS . 8.9 t -58.72 95.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.293 -0.412 . . . . 71.400000000000006 110.869 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.8 130.99 24.6 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.329 -0.396 . . . . 75.409999999999997 111.887 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -82.68 -158.87 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.672 2.248 . . . . 72.510000000000005 111.842 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.27 102.14 14.81 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.854 -0.529 . . . . 75.450000000000003 110.994 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.7 m -102.87 3.96 37.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.159 0.504 . . . . 73.25 110.56 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -81.37 -35.28 31.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.953 -0.567 . . . . 72.430000000000007 111.99 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.93 9.08 78.81 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.919 -0.658 . . . . 53.420000000000002 114.389 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 51' ' ' CYS . 4.1 pp -128.62 156.36 77.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 117.578 0.689 . . . . 74.319999999999993 112.087 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.56 123.19 2.49 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.677 2.251 . . . . 74.120000000000005 112.963 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.87 14.68 0.48 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.77 0.656 . . . . 72.040000000000006 112.77 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -117.01 10.04 13.85 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.11 -0.369 . . . . 72.519999999999996 111.78 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -111.06 100.19 8.92 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.205 -0.31 . . . . 73.209999999999994 110.798 -177.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.22 139.36 57.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.877 0.37 . . . . 73.019999999999996 111.974 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 69' ' ' ARG . 26.2 m -128.72 166.25 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.142 0.496 . . . . 72.329999999999998 111.811 -175.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.0 t -116.34 124.16 49.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.224 -0.444 . . . . 53.32 111.254 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.02 161.56 24.6 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.124 -0.56 . . . . 71.299999999999997 113.497 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 p -55.54 -24.13 30.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.404 0.52 . . . . 74.530000000000001 112.404 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.2 -2.5 28.22 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 120.877 0.37 . . . . 73.439999999999998 111.674 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.11 25.06 58.39 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.424 -0.417 . . . . 33.210000000000001 113.244 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.4 134.41 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.928 0.394 . . . . 71.540000000000006 111.832 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 71' ' ' ARG . 81.2 m -86.36 110.95 20.04 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.279 -0.419 . . . . 71.120000000000005 110.862 174.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -91.16 159.8 15.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.773 0.321 . . . . 61.32 111.673 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 3.9 mmp_? -53.04 -39.68 63.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.112 -0.494 . . . . 74.120000000000005 112.223 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 5.5 p-10 -163.93 -178.48 5.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.281 -0.418 . . . . 75.530000000000001 110.821 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.522 ' HB3' HD22 ' A' ' 33' ' ' LEU . 24.7 tt0 -68.85 -37.28 79.02 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.673 0.273 . . . . 75.25 111.589 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.627 ' HB2' HD11 ' A' ' 33' ' ' LEU . 25.3 t -65.5 -41.71 92.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.657 0.265 . . . . 64.420000000000002 110.667 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.25 -51.48 53.65 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.209 0.528 . . . . 63.240000000000002 111.122 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.4 -53.84 46.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.915 -0.584 . . . . 63.219999999999999 110.984 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.506 ' NH1' HD23 ' A' ' 33' ' ' LEU . 70.0 mtp180 -61.75 -29.86 70.4 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 111.977 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.32 -42.8 68.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.985 0.421 . . . . 63.329999999999998 110.812 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.35 88.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.862 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 36.8 ttt85 -63.39 -48.06 79.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.086 0.47 . . . . 52.43 111.236 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.486 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 5.6 t -55.47 -44.42 76.42 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.933 -0.576 . . . . 71.400000000000006 110.468 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -84.21 61.9 6.81 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.255 0.55 . . . . 64.450000000000003 112.147 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.05 25.28 49.51 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 115.58 0.992 . . . . 54.210000000000001 115.58 170.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.48 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 95.4 m-70 -134.81 74.88 63.27 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 118.222 1.011 . . . . 75.310000000000002 112.132 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.96 -19.76 17.64 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.608 2.206 . . . . 63.539999999999999 113.494 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.0 -22.52 42.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.083 0.468 . . . . 65.040000000000006 111.067 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.446 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 63.9 tp -75.12 111.74 10.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.184 -0.462 . . . . 62.200000000000003 111.264 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 p -124.75 141.97 51.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.003 0.43 . . . . 74.329999999999998 111.638 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.24 113.71 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.305 0.574 . . . . 75.329999999999998 111.289 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 28.0 mmt -77.01 -42.44 38.65 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.962 0.41 . . . . 72.030000000000001 111.416 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -169.03 163.0 11.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.085 -0.507 . . . . 75.230000000000004 111.217 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.646 ' HG3' HG12 ' A' ' 39' ' ' VAL . 1.3 mpp_? -93.34 153.72 18.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.387 -0.37 . . . . 72.549999999999997 111.336 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.99 49.69 2.42 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.366 -0.445 . . . . 34.409999999999997 113.514 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HA ' HG23 ' A' ' 46' ' ' THR . 59.7 mtp85 61.47 172.08 0.11 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.894 0.701 . . . . 75.400000000000006 112.894 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.2 m -81.32 112.28 18.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 72.510000000000005 111.646 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -118.22 105.08 11.42 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.053 -0.522 . . . . 74.209999999999994 110.765 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? . . . . . 0 C--O 1.253 1.261 0 CA-C-O 118.575 -0.726 . . . . 62.5 111.547 -175.079 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.922 0.392 . . . . 64.439999999999998 111.699 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -91.7 134.41 34.73 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.509 -0.314 . . . . 60.219999999999999 110.32 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -66.92 127.89 34.23 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.832 0.348 . . . . 74.150000000000006 111.625 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 m -97.1 130.56 44.36 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.856 0.36 . . . . 65.409999999999997 111.173 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 7' ' ' VAL . 34.6 t70 -84.21 112.1 19.97 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.738 0.304 . . . . 75.540000000000006 111.454 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.28 0.01 9.6 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 114.67 0.628 . . . . 74.439999999999998 114.67 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' SG ' ' A' ' 9' ' ' CYS . 2.3 t -107.41 137.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 117.691 0.745 . . . . 51.340000000000003 111.819 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.46 106.03 18.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.797 0.332 . . . . 71.329999999999998 110.195 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.564 ' SG ' HG12 ' A' ' 7' ' ' VAL . 59.0 m -142.96 177.35 8.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.848 0.356 . . . . 74.109999999999999 111.908 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.87 -88.07 0.3 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.495 -0.383 . . . . 51.210000000000001 112.272 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.66 93.64 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.482 2.121 . . . . 64.439999999999998 112.925 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.0 10.89 82.26 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.034 -0.53 . . . . 72.129999999999995 113.432 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -146.98 136.29 22.68 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.386 -0.479 . . . . 74.420000000000002 111.484 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.1 140.21 52.28 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.594 -0.275 . . . . 73.340000000000003 110.802 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 15.8 p -100.1 106.24 17.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.402 0.62 . . . . 64.510000000000005 111.942 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -106.69 122.14 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.655 -0.702 . . . . 73.099999999999994 110.253 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 54.2 mtp -80.54 106.71 12.75 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.394 0.616 . . . . 64.129999999999995 111.883 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.68 HD12 ' HD2' ' A' ' 23' ' ' ARG . 92.9 mt -116.75 112.94 21.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.81 -0.632 . . . . 65.109999999999999 110.995 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.59 22.85 74.42 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.964 -0.636 . . . . 40.219999999999999 113.101 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.97 -21.12 44.86 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.337 -0.459 . . . . 71.310000000000002 113.627 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -106.08 131.78 21.45 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 117.22 0.51 . . . . 72.109999999999999 111.98 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 59.0 Cg_endo -73.36 111.6 3.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.436 2.091 . . . . 72.430000000000007 112.418 174.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.68 ' HD2' HD12 ' A' ' 18' ' ' LEU . 95.2 mtt180 -96.06 146.42 24.65 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.242 -0.286 . . . . 74.310000000000002 111.4 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 21.8 m -132.67 133.07 43.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.101 0.477 . . . . 53.310000000000002 111.191 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.16 161.23 37.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.015 -0.539 . . . . 71.239999999999995 110.11 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.8 t -54.05 95.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.033 0.444 . . . . 70.0 111.855 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -119.26 136.59 24.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.678 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 13.9 Cg_exo -68.45 90.84 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.421 2.081 . . . . 75.450000000000003 113.314 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.77 -70.5 0.25 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.921 0.391 . . . . 62.439999999999998 110.599 172.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.6 m 55.55 72.79 0.46 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.678 0.621 . . . . 65.209999999999994 112.678 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.8 m -85.28 -29.72 24.36 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.976 0.417 . . . . 64.540000000000006 110.893 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -65.52 1.54 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.28 -0.418 . . . . 62.439999999999998 113.333 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.663 HD23 ' H ' ' A' ' 33' ' ' LEU . 2.3 pt? -74.13 141.78 78.21 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.989 0.423 . . . . 75.239999999999995 111.993 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 33' ' ' LEU . 16.1 Cg_exo -70.49 120.8 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.776 2.318 . . . . 71.530000000000001 112.574 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.15 60.35 1.04 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.345 0.593 . . . . 71.310000000000002 111.089 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -151.24 -35.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.578 -0.737 . . . . 71.019999999999996 110.937 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 66.3 tp -67.76 107.99 2.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.278 -0.419 . . . . 73.219999999999999 111.744 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.63 149.82 38.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.5 0.666 . . . . 70.420000000000002 112.744 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.465 HG12 ' HG2' ' A' ' 69' ' ' ARG . 34.3 m -139.78 153.62 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 115.649 -0.705 . . . . 50.0 110.899 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.8 t -106.42 122.34 46.09 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.885 0.374 . . . . 74.209999999999994 111.256 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.6 165.12 40.21 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.05 -0.595 . . . . 60.240000000000002 113.648 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 p -53.53 -36.82 62.22 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.017 0.377 . . . . 71.209999999999994 112.017 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.06 -27.92 62.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 116.305 -0.407 . . . . 72.340000000000003 111.968 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.73 -3.0 34.05 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.174 -0.536 . . . . 55.140000000000001 113.099 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.28 142.73 27.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.98 0.419 . . . . 73.329999999999998 111.911 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.0 m -92.0 120.35 32.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.929 0.395 . . . . 71.150000000000006 110.33 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -97.12 148.55 22.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.529 -0.305 . . . . 64.140000000000001 111.11 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 19.9 ptp180 -49.51 -34.53 17.41 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.432 0.53 . . . . 73.25 112.432 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.2 p30 -160.75 176.69 11.22 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.885 0.374 . . . . 75.319999999999993 111.286 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HA ' HG21 ' A' ' 39' ' ' VAL . 35.2 tt0 -65.45 -33.61 76.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.412 -0.358 . . . . 73.049999999999997 111.885 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.32 -36.15 82.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.603 0.24 . . . . 61.009999999999998 111.1 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.63 -48.71 80.57 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.98 0.419 . . . . 74.010000000000005 110.818 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 53' ' ' LEU . 6.8 tt -59.6 -55.57 32.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.182 0.515 . . . . 74.510000000000005 110.397 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -58.8 -34.66 71.75 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.994 -0.548 . . . . 75.040000000000006 111.956 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.92 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.586 0.231 . . . . 73.239999999999995 111.485 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.57 86.09 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 73.439999999999998 111.348 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' A' ' 61' ' ' HIS . 1.6 tmt_? -59.42 -50.14 75.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.609 0.719 . . . . 73.25 109.99 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.76 -30.05 69.77 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.452 -0.794 . . . . 74.010000000000005 111.455 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.95 74.61 6.42 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.075 -0.512 . . . . 74.329999999999998 111.312 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.64 34.97 90.43 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 115.224 0.85 . . . . 73.420000000000002 115.224 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 57' ' ' ARG . 77.8 m80 -135.04 89.05 25.07 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 117.96 0.88 . . . . 73.329999999999998 111.925 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.56 -18.18 13.87 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.01 2.473 . . . . 71.409999999999997 113.176 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -19.61 44.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.889 0.376 . . . . 74.219999999999999 111.916 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 tp -82.97 130.65 35.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.006 0.432 . . . . 74.519999999999996 112.001 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m -146.72 161.26 40.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.283 -0.417 . . . . 74.5 110.78 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t -80.48 112.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 120.966 0.412 . . . . 64.040000000000006 111.372 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -84.18 -55.91 3.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.21 0.529 . . . . 71.109999999999999 110.668 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -159.51 152.93 22.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.917 -0.583 . . . . 74.209999999999994 110.706 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HG2' HG12 ' A' ' 39' ' ' VAL . 91.3 mtt180 -79.57 150.48 31.07 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.062 0.458 . . . . 73.430000000000007 111.195 177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.84 -178.34 29.64 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.978 -0.555 . . . . 21.510000000000002 112.177 -173.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -75.03 161.91 29.03 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.265 -0.55 . . . . 73.219999999999999 111.388 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.42 93.68 0.24 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.159 0.799 . . . . 74.150000000000006 113.159 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -118.7 145.54 45.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.413 -0.812 . . . . 71.540000000000006 110.88 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.559 ' NZ ' ' HB3' ' A' ' 74' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.314 -0.851 . . . . 52.130000000000003 112.383 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 120.704 0.288 . . . . 52.229999999999997 110.665 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -75.53 118.19 18.11 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.35 0.5 . . . . 72.310000000000002 112.35 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 m -98.84 138.28 36.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.112 -0.495 . . . . 54.140000000000001 110.268 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.0 m -120.56 131.13 54.52 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.276 0.472 . . . . 63.350000000000001 112.276 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 7' ' ' VAL . 9.5 m-20 -83.45 112.13 19.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.21 -0.45 . . . . 75.319999999999993 111.726 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.72 32.08 16.87 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.757 0.663 . . . . 74.200000000000003 114.757 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 22' ' ' PRO . 93.1 t -106.96 122.71 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.541 0.67 . . . . 62.219999999999999 111.542 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -99.26 105.97 18.05 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.329 0.585 . . . . 72.140000000000001 111.747 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 80.9 m -148.34 137.95 22.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.002 -0.545 . . . . 52.409999999999997 110.127 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.74 -86.9 0.06 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 119.897 -1.144 . . . . 73.430000000000007 114.635 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.56 -35.64 80.47 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.12 2.547 . . . . 74.219999999999999 113.901 -172.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.96 -45.35 1.39 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.988 -0.625 . . . . 65.120000000000005 113.634 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 9' ' ' CYS . 52.8 mtmt -123.63 146.87 47.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.489 0.552 . . . . 71.510000000000005 112.489 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -116.67 145.94 43.09 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 53.100000000000001 110.494 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 26.8 p -104.03 133.99 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.154 0.502 . . . . 64.310000000000002 112.198 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.48 ' NH2' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -118.86 164.26 15.68 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.987 -0.551 . . . . 73.430000000000007 111.161 176.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 mmt -82.11 102.94 11.37 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.891 0.377 . . . . 64.120000000000005 111.274 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.83 103.41 12.66 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.871 0.367 . . . . 70.420000000000002 110.212 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.18 33.01 82.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.341 -0.457 . . . . 71.239999999999995 112.686 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.34 -12.97 57.27 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.369 -0.443 . . . . 52.200000000000003 113.047 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 94.9 mtt180 -99.19 129.31 29.68 Favored Pre-proline 0 CA--C 1.538 0.489 0 O-C-N 122.616 -0.343 . . . . 72.200000000000003 111.602 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.682 ' HB2' HG21 ' A' ' 7' ' ' VAL . 1.9 Cg_endo -80.95 113.75 2.8 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.966 2.444 . . . . 73.109999999999999 112.877 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -123.14 140.62 52.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.789 0.328 . . . . 74.519999999999996 111.472 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 73.4 m -104.1 131.74 51.06 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.894 0.701 . . . . 62.0 112.894 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' ' NH2' ' A' ' 16' ' ' ARG . 86.0 mt-10 -124.83 159.97 29.81 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.252 -0.431 . . . . 74.310000000000002 110.235 172.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.5 t -64.68 119.32 10.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.102 0.477 . . . . 62.210000000000001 111.415 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -108.82 138.38 20.31 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.794 0.664 . . . . 61.020000000000003 112.794 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 4.4 Cg_exo -77.74 130.69 10.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.952 2.435 . . . . 64.030000000000001 112.229 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 10.8 t0 -66.04 84.89 0.09 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.35 0.595 . . . . 71.329999999999998 110.816 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 87.4 m -105.18 39.66 1.68 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.19 -0.459 . . . . 75.349999999999994 112.074 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -69.12 83.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.12 0.486 . . . . 74.400000000000006 111.855 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.9 52.61 11.25 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.615 0.606 . . . . 64.219999999999999 114.615 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.767 HD11 ' SG ' ' A' ' 51' ' ' CYS . 4.4 pp -114.0 157.08 43.0 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-N 117.394 0.597 . . . . 61.43 111.258 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.81 119.92 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.264 1.976 . . . . 73.030000000000001 112.784 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.01 -9.96 59.37 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.297 0.48 . . . . 73.540000000000006 112.297 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -90.22 -9.63 47.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.538 -0.301 . . . . 72.450000000000003 111.795 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.3 tp -98.85 117.35 33.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.002 0.43 . . . . 62.340000000000003 112.113 -174.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 46.7 mt-30 -75.72 159.82 30.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 73.409999999999997 110.827 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.0 m -144.4 148.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 112.332 0.493 . . . . 73.129999999999995 112.332 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 72' ' ' CYS . 34.2 m -104.67 126.7 52.01 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.347 -0.388 . . . . 42.219999999999999 111.676 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.27 162.91 22.84 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.174 -0.536 . . . . 74.540000000000006 112.711 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 t -57.36 -18.23 16.33 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.206 0.447 . . . . 71.510000000000005 112.206 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.4 -38.51 80.75 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 120.935 0.398 . . . . 53.439999999999998 111.607 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.0 4.3 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.106 -0.569 . . . . 73.109999999999999 113.041 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.82 148.5 29.96 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.123 0.487 . . . . 44.329999999999998 112.155 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.439 HG21 ' HG2' ' A' ' 71' ' ' ARG . 96.2 m -86.18 137.38 32.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.714 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -106.68 143.66 34.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.474 -0.33 . . . . 74.430000000000007 111.452 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 68.5 mtt180 -43.71 -39.29 3.6 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.031 0.752 . . . . 74.109999999999999 113.031 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 3.3 p30 -167.04 172.11 10.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.838 0.352 . . . . 75.129999999999995 111.278 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HG3' HD22 ' A' ' 33' ' ' LEU . 13.4 tp10 -58.16 -34.12 69.95 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.491 -0.322 . . . . 71.230000000000004 111.765 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.767 ' SG ' HD11 ' A' ' 33' ' ' LEU . 62.9 m -71.05 -34.67 71.46 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.864 -0.523 . . . . 64.219999999999999 111.164 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.69 -46.86 87.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 73.129999999999995 110.65 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 66' ' ' VAL . 9.0 tt -64.82 -40.46 95.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 70.510000000000005 109.799 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -59.54 -24.76 63.97 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.706 -0.679 . . . . 65.109999999999999 111.084 175.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.09 -35.18 17.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.131 -0.486 . . . . 64.450000000000003 111.146 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.44 -29.41 69.0 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.191 0.441 . . . . 55.340000000000003 112.191 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 20.2 ptt180 -55.43 -29.09 57.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.843 173.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.5 t -82.65 -18.8 39.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.396 -0.82 . . . . 70.219999999999999 111.174 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -107.03 89.42 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.062 0.458 . . . . 63.32 111.481 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.78 -17.13 1.29 Allowed Glycine 0 CA--C 1.536 1.35 0 N-CA-C 115.321 0.888 . . . . 71.530000000000001 115.321 173.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ARG . 61.4 m80 -122.83 74.89 47.2 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 118.243 1.021 . . . . 71.019999999999996 112.2 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.1 -23.0 29.72 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.255 1.97 . . . . 71.319999999999993 112.957 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -96.21 10.38 38.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.456 -0.338 . . . . 75.120000000000005 111.742 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 tp -62.96 115.55 4.5 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.342 0.497 . . . . 54.149999999999999 112.342 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.2 m -114.14 163.76 14.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.251 -0.431 . . . . 73.25 111.344 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 HD13 ' A' ' 53' ' ' LEU . 39.8 t -90.91 127.34 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.084 0.402 . . . . 73.319999999999993 112.084 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.3 mtt -73.16 -53.77 10.15 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.066 0.46 . . . . 63.299999999999997 110.483 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -168.01 167.82 12.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.804 -0.634 . . . . 74.120000000000005 110.462 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 150.06 25.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.186 0.517 . . . . 75.519999999999996 111.388 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.48 -162.0 15.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.849 -0.614 . . . . 64.519999999999996 112.456 -176.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' HG21 ' A' ' 46' ' ' THR . 73.3 mtm180 -98.41 147.25 24.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.938 0.399 . . . . 75.040000000000006 111.201 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 40' ' ' CYS . 73.3 m -62.93 106.97 0.9 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.885 0.698 . . . . 62.409999999999997 112.885 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -118.03 131.72 56.44 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.066 -0.516 . . . . 71.319999999999993 110.863 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 74' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.599 -0.715 . . . . 73.319999999999993 111.665 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 81.0 p . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 112.252 0.464 . . . . 72.549999999999997 112.252 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -73.75 108.48 6.61 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.18 -0.325 . . . . 65.310000000000002 111.561 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 t -150.49 164.27 36.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.809 0.338 . . . . 32.119999999999997 111.351 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 54.5 m -140.43 140.44 35.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.203 0.445 . . . . 71.450000000000003 112.203 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 7' ' ' VAL . 22.5 t70 -50.77 111.83 0.61 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.415 0.524 . . . . 75.219999999999999 112.415 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.68 10.92 26.98 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.375 0.51 . . . . 65.209999999999994 114.375 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 22' ' ' PRO . 17.2 t -107.91 122.92 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 122.208 -0.583 . . . . 71.420000000000002 111.726 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.27 106.68 17.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.647 0.26 . . . . 75.510000000000005 110.416 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 7' ' ' VAL . 47.8 m -148.9 163.05 38.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.975 0.417 . . . . 63.130000000000003 111.655 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.92 -84.02 0.11 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.138 -0.483 . . . . 75.109999999999999 112.493 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.6 108.76 2.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.56 2.174 . . . . 75.209999999999994 112.52 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.87 -33.69 6.38 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.88 -0.676 . . . . 75.329999999999998 113.109 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -142.85 136.9 29.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 117.164 0.482 . . . . 53.439999999999998 111.479 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.86 146.58 32.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.194 -0.457 . . . . 71.319999999999993 110.54 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 52.7 t -104.25 141.03 37.0 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.568 0.581 . . . . 73.209999999999994 112.568 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -142.46 132.86 24.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.008 -0.542 . . . . 74.400000000000006 110.393 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 67.9 mtp -86.75 121.1 28.78 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.133 0.492 . . . . 54.140000000000001 112.245 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.7 mt -112.8 118.1 34.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.806 -0.634 . . . . 75.049999999999997 110.58 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.06 30.61 67.16 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.045 -0.598 . . . . 61.310000000000002 113.384 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.18 -8.99 78.84 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.235 -0.507 . . . . 75.420000000000002 113.553 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.512 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 95.9 mtt180 -113.46 120.55 39.49 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 122.424 -0.456 . . . . 74.530000000000001 111.091 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.664 ' HB2' HG21 ' A' ' 7' ' ' VAL . 7.1 Cg_exo -75.29 143.69 28.45 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.037 2.491 . . . . 72.209999999999994 114.401 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 17.8 mmt180 -125.11 139.41 53.8 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.119 0.568 . . . . 73.140000000000001 110.814 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 89.4 m -122.28 118.97 29.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.986 0.422 . . . . 70.409999999999997 112.015 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -130.81 161.84 30.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.101 -0.5 . . . . 72.530000000000001 110.659 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 10.5 t -37.65 124.93 1.1 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.537 0.94 . . . . 72.549999999999997 113.537 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.02 143.84 27.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.779 -0.646 . . . . 74.040000000000006 111.306 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.15 52.7 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.469 2.113 . . . . 73.530000000000001 113.337 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.75 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.945 0.402 . . . . 52.5 110.456 173.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.551 ' HB2' HD21 ' A' ' 33' ' ' LEU . 24.8 p -134.37 23.4 3.76 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.795 0.665 . . . . 65.209999999999994 112.795 -171.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.2 t -65.19 106.38 1.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.874 0.368 . . . . 70.450000000000003 111.315 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.38 -42.87 0.92 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.758 -0.734 . . . . 73.409999999999997 113.499 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 50' ' ' GLU . 3.4 pp -67.66 152.51 96.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.359 0.503 . . . . 73.319999999999993 112.359 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 28.2 Cg_exo -62.77 137.67 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.677 2.251 . . . . 62.520000000000003 113.166 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 35.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.186 -0.461 . . . . 34.210000000000001 111.857 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 64.69 25.47 13.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.822 0.675 . . . . 70.120000000000005 112.822 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 2.1 tm? -84.85 102.8 13.37 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.672 -0.492 . . . . 75.129999999999995 109.672 174.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.662 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 64.2 mt-30 -66.26 145.89 55.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.726 0.639 . . . . 72.400000000000006 112.726 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.13 155.68 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.787 -0.642 . . . . 75.340000000000003 111.082 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.96 122.61 43.8 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.796 0.331 . . . . 62.509999999999998 111.603 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 47' ' ' TYR . . . -83.01 176.0 53.14 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.182 -0.532 . . . . 51.009999999999998 113.549 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.532 ' H ' HD12 ' A' ' 64' ' ' LEU . 40.1 t -54.8 -40.43 69.49 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.914 0.709 . . . . 70.230000000000004 112.914 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.53 -20.01 65.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.923 0.392 . . . . 75.120000000000005 111.995 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 14.76 42.8 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.439 -0.41 . . . . 70.129999999999995 112.53 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.33 142.66 28.93 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.901 0.381 . . . . 72.329999999999998 111.752 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.0 m -87.14 117.29 25.79 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.083 0.468 . . . . 73.430000000000007 111.452 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HE2' ' HA3' ' A' ' 41' ' ' GLY . 83.6 m-85 -94.65 138.78 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 109.971 174.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -66.42 -6.9 16.16 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.559 0.578 . . . . 62.520000000000003 112.559 -175.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 4.8 p-10 -174.5 155.91 2.35 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.914 0.485 . . . . 60.310000000000002 110.934 172.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 33' ' ' LEU . 41.7 tt0 -62.35 -30.79 71.43 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.172 0.434 . . . . 70.150000000000006 112.172 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.446 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 26.6 t -61.36 -40.19 93.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.223 0.535 . . . . 72.209999999999994 110.489 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -60.45 -44.01 96.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.675 -0.693 . . . . 71.120000000000005 110.784 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.56 -39.57 76.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 110.889 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -58.87 -49.43 77.79 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.989 0.423 . . . . 75.439999999999998 111.208 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.11 96.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.093 0.473 . . . . 72.209999999999994 111.211 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -41.3 96.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.143 -0.481 . . . . 74.030000000000001 111.548 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 23.2 ttt85 -61.82 -51.41 68.37 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.026 0.441 . . . . 72.409999999999997 111.342 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 74.7 m -75.47 -2.99 31.41 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.23 0.456 . . . . 64.239999999999995 112.23 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -78.88 -59.97 2.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.838 0.351 . . . . 73.430000000000007 110.112 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.47 27.31 0.32 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.962 -0.637 . . . . 63.329999999999998 113.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.704 ' HB3' ' HB2' ' A' ' 64' ' ' LEU . 37.8 m80 -134.53 76.33 61.61 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 122.233 -0.569 . . . . 72.430000000000007 111.668 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.34 -12.61 28.15 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.691 2.261 . . . . 63.020000000000003 113.45 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.82 8.07 26.49 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.843 0.312 . . . . 74.0 111.843 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.704 ' HB2' ' HB3' ' A' ' 61' ' ' HIS . 59.6 tp -73.44 111.34 8.48 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.154 0.502 . . . . 73.409999999999997 111.497 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.8 m -129.17 152.93 48.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 73.310000000000002 110.416 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.72 114.73 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.284 0.564 . . . . 64.430000000000007 111.579 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.3 mmt -65.9 -41.57 91.3 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.012 0.434 . . . . 72.25 111.186 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.62 150.55 6.0 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.053 -0.521 . . . . 54.439999999999998 111.689 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.18 140.84 43.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.981 -0.554 . . . . 75.239999999999995 111.865 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.25 170.35 20.59 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.187 -0.46 . . . . 43.399999999999999 112.509 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HG2' ' OE1' ' A' ' 38' ' ' GLN . 64.2 mtt-85 -61.0 132.11 52.79 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.612 -0.346 . . . . 73.239999999999995 110.454 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.49 96.99 0.73 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.197 0.522 . . . . 72.530000000000001 112.327 -171.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -107.77 106.05 16.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.46 -0.791 . . . . 70.310000000000002 110.496 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? . . . . . 0 C--O 1.254 1.296 0 CA-C-O 119.114 -0.469 . . . . 63.439999999999998 110.734 -177.654 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.581 0.229 . . . . 62.32 111.27 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -109.66 174.55 5.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.845 0.355 . . . . 53.210000000000001 111.044 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.2 m -84.97 154.78 21.93 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.135 0.493 . . . . 61.130000000000003 111.734 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.7 m -98.68 130.73 45.19 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.18 -0.464 . . . . 65.310000000000002 111.388 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 7' ' ' VAL . 23.5 t70 -76.4 111.68 12.12 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.868 0.366 . . . . 54.520000000000003 111.191 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.76 -4.16 2.44 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.482 0.553 . . . . 24.41 114.482 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 14.1 t -97.49 126.25 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 117.408 0.604 . . . . 71.040000000000006 111.579 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.98 105.3 16.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.69 0.281 . . . . 73.030000000000001 110.985 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.0 m -149.05 158.78 44.45 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.374 0.509 . . . . 72.040000000000006 112.374 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.11 -107.67 0.2 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 116.107 -0.497 . . . . 71.430000000000007 112.758 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.83 102.69 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.323 2.015 . . . . 71.109999999999999 112.941 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.47 -3.88 56.57 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.958 -0.639 . . . . 62.549999999999997 113.813 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -143.22 136.12 27.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.316 0.579 . . . . 73.219999999999999 112.314 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -131.17 155.21 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.684 -0.689 . . . . 54.140000000000001 110.649 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.63 126.45 41.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.066 0.46 . . . . 50.420000000000002 111.209 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -123.5 137.32 54.8 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.138 -0.483 . . . . 53.520000000000003 110.465 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.9 mmm -85.79 102.58 13.79 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.113 0.483 . . . . 64.209999999999994 111.951 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 23' ' ' ARG . 4.1 mm? -109.11 115.69 30.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.2 -0.455 . . . . 64.430000000000007 110.303 174.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.8 27.67 67.03 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.157 -0.544 . . . . 74.109999999999999 113.261 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.51 85.14 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.483 -0.389 . . . . 55.43 113.696 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -109.55 126.68 28.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.517 -0.402 . . . . 53.520000000000003 111.439 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.44 104.36 1.73 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.42 2.08 . . . . 73.209999999999994 113.253 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.551 ' HG2' HD23 ' A' ' 18' ' ' LEU . 7.5 ptp180 -97.18 157.65 15.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.477 -0.328 . . . . 71.219999999999999 110.839 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 14' ' ' ALA . 30.2 m -111.11 120.36 42.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.21 0.529 . . . . 72.329999999999998 112.093 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -107.02 160.17 15.74 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.691 -0.686 . . . . 64.430000000000007 109.959 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -64.22 95.87 0.14 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.057 0.456 . . . . 64.209999999999994 111.179 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.7 119.26 59.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.129 -0.487 . . . . 53.399999999999999 110.764 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 55' ' ' ALA . 22.4 Cg_endo -59.86 102.15 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.321 2.014 . . . . 62.539999999999999 112.932 -178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.46 100.34 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.001 0.429 . . . . 61.539999999999999 109.961 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.6 p -139.57 35.57 2.03 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.288 -0.415 . . . . 64.299999999999997 111.36 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.8 t -58.27 -37.89 75.88 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.242 -0.436 . . . . 74.430000000000007 111.842 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.41 43.16 1.75 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.365 -0.445 . . . . 40.210000000000001 113.151 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.454 HD11 ' NH2' ' A' ' 54' ' ' ARG . 87.9 mt -130.4 152.92 81.1 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 120.717 0.294 . . . . 73.109999999999999 111.428 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.09 119.94 6.32 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.211 1.941 . . . . 75.239999999999995 112.381 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.41 17.95 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.086 0.47 . . . . 60.420000000000002 111.65 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -120.84 -21.26 6.66 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.613 0.597 . . . . 71.439999999999998 112.613 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 69' ' ' ARG . 8.1 tt -93.2 120.84 33.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.832 0.349 . . . . 63.420000000000002 111.442 -175.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.694 ' HG2' ' HA ' ' A' ' 48' ' ' ARG . 48.7 mt-30 -73.56 142.49 46.64 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.746 0.647 . . . . 74.200000000000003 112.746 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HB ' HG13 ' A' ' 66' ' ' VAL . 27.0 m -128.93 159.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.109 -0.496 . . . . 74.329999999999998 111.577 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 51.8 t -106.13 127.46 53.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.887 0.375 . . . . 62.210000000000001 111.775 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.54 155.91 32.81 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 113.257 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.51 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 43.8 t -53.79 -32.3 52.07 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.981 0.734 . . . . 72.120000000000005 112.981 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.78 -2.95 52.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.055 0.455 . . . . 74.239999999999995 112.135 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.38 20.91 39.68 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.199 -0.524 . . . . 72.430000000000007 113.136 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.9 132.52 42.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.789 0.328 . . . . 64.019999999999996 111.309 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 m -85.78 122.44 29.86 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.963 0.411 . . . . 71.420000000000002 111.703 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -112.84 147.35 37.15 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.998 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.694 ' HA ' ' HG2' ' A' ' 38' ' ' GLN . 31.2 mmt-85 -75.29 -20.33 59.18 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.359 -0.382 . . . . 54.420000000000002 111.739 -173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -163.99 161.65 22.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.061 -0.518 . . . . 64.200000000000003 111.092 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG2' HG21 ' A' ' 66' ' ' VAL . 1.7 tm-20 -57.61 -40.38 79.02 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.175 0.512 . . . . 70.430000000000007 110.701 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 28' ' ' PRO . 25.7 t -59.64 -38.23 80.83 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.974 0.416 . . . . 53.340000000000003 111.461 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -65.11 -43.88 90.57 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.069 0.461 . . . . 71.200000000000003 111.05 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.65 HD13 HG22 ' A' ' 66' ' ' VAL . 10.3 tt -64.83 -47.25 78.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.991 -0.55 . . . . 75.209999999999994 110.99 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' NH2' HD11 ' A' ' 33' ' ' LEU . 19.0 ttm180 -55.14 -37.25 66.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.079 0.466 . . . . 74.219999999999999 111.13 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HB2' ' HG3' ' A' ' 28' ' ' PRO . . . -65.6 -47.65 74.96 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 111.262 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.91 -38.3 75.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.986 0.422 . . . . 62.240000000000002 111.633 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 76.2 ttt180 -60.74 -50.45 73.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.935 0.397 . . . . 75.209999999999994 111.085 175.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.27 -29.47 70.56 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.986 0.422 . . . . 75.319999999999993 111.664 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 59' ' ' ARG . 35.3 ttt-85 -61.8 -38.68 89.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.254 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.57 36.28 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.033 -0.603 . . . . 63.420000000000002 113.68 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.421 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 96.9 m-70 -134.31 78.13 58.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.297 -0.531 . . . . 70.209999999999994 111.507 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.62 -28.62 25.71 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.636 2.224 . . . . 71.319999999999993 113.186 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.24 -11.94 58.37 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.249 0.547 . . . . 64.329999999999998 111.328 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 5.8 tt -92.88 114.97 27.67 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.591 0.71 . . . . 74.319999999999993 111.331 -175.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.492 ' HA ' HD21 ' A' ' 53' ' ' LEU . 69.5 m -144.58 166.27 25.64 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.613 -0.721 . . . . 72.010000000000005 110.193 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.65 HG22 HD13 ' A' ' 53' ' ' LEU . 75.4 t -69.07 111.42 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.018 0.437 . . . . 63.420000000000002 111.65 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 42' ' ' SER . 66.1 mtm -81.69 -53.73 5.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.133 -0.485 . . . . 65.239999999999995 110.996 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.33 164.57 31.06 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 110.887 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.504 ' HB3' HD21 ' A' ' 37' ' ' LEU . 98.9 mtt180 -96.77 151.68 19.41 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.987 0.423 . . . . 72.439999999999998 111.639 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 47.85 1.74 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.185 -0.531 . . . . 62.219999999999999 112.549 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.61 -177.54 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.351 1.061 . . . . 73.109999999999999 113.364 -176.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.4 m -89.51 105.36 17.74 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.789 -0.569 . . . . 62.240000000000002 111.078 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -115.95 132.49 56.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.068 -0.514 . . . . 74.310000000000002 111.75 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.196 -0.907 . . . . 53.509999999999998 111.596 175.194 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.742 0.306 . . . . 74.129999999999995 111.169 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 9.0 m-20 -103.97 102.25 12.03 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.155 0.502 . . . . 72.420000000000002 112.063 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.2 m -125.55 116.7 22.18 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.134 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.412 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 61.6 m -101.91 128.55 48.25 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.025 0.44 . . . . 74.109999999999999 111.721 -171.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -85.53 115.05 23.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.302 -0.408 . . . . 72.239999999999995 111.953 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.91 -31.74 1.07 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.217 -0.516 . . . . 70.420000000000002 113.538 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.562 HG21 ' HG2' ' A' ' 22' ' ' PRO . 12.1 t -67.94 105.07 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 122.545 -0.385 . . . . 72.340000000000003 110.985 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.8 105.78 17.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 71.409999999999997 110.844 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.1 m -133.33 137.33 45.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 74.329999999999998 111.396 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.16 -68.0 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.978 -0.555 . . . . 62.130000000000003 112.245 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.03 79.46 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.697 2.265 . . . . 63.119999999999997 112.408 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.96 0.77 54.99 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.356 -0.449 . . . . 73.329999999999998 113.68 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -145.53 148.87 33.67 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.627 0.713 . . . . 74.120000000000005 112.292 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.41 140.83 47.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.787 -0.642 . . . . 34.340000000000003 109.872 172.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.731 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 28.6 p -100.11 145.84 27.5 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.366 0.603 . . . . 64.239999999999995 111.422 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -129.78 133.74 47.17 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.629 -0.714 . . . . 65.329999999999998 110.826 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.417 ' HG3' ' HA ' ' A' ' 2' ' ' ASP . 0.5 OUTLIER -73.86 103.13 4.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 70.150000000000006 111.325 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 98.0 mt -127.42 117.74 22.74 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.931 0.396 . . . . 65.140000000000001 111.788 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.6 26.34 66.52 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.562 -0.351 . . . . 73.109999999999999 113.826 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.07 -0.01 75.07 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.111 -0.566 . . . . 74.439999999999998 113.376 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -131.74 138.49 32.67 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 117.121 0.461 . . . . 73.409999999999997 112.014 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.562 ' HG2' HG21 ' A' ' 7' ' ' VAL . 97.1 Cg_endo -80.81 118.97 3.52 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.735 2.29 . . . . 52.299999999999997 113.571 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -109.23 137.26 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.26 -0.275 . . . . 62.119999999999997 110.365 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.731 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -103.82 139.9 38.39 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.847 0.684 . . . . 74.349999999999994 112.847 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.42 160.68 34.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.895 -0.593 . . . . 63.140000000000001 110.606 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.5 t -57.72 112.87 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.22 0.452 . . . . 65.319999999999993 112.22 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.36 119.71 55.48 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.131 -0.486 . . . . 61.310000000000002 110.916 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.22 86.84 1.09 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.384 2.056 . . . . 74.0 113.266 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.68 100.23 12.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.271 0.557 . . . . 65.540000000000006 110.368 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.4 p -98.68 134.38 41.68 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.278 -0.419 . . . . 63.140000000000001 111.907 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.3 p -99.49 -76.01 0.55 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.269 -0.423 . . . . 74.040000000000006 111.356 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.27 39.51 3.0 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.217 -0.516 . . . . 74.549999999999997 113.598 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 34.1 mt -120.34 135.71 24.69 Favored Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 122.395 -0.474 . . . . 65.239999999999995 110.6 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.45 139.65 31.96 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.46 2.106 . . . . 72.450000000000003 113.239 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.75 141.91 30.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.793 0.33 . . . . 74.239999999999995 111.408 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 64.29 6.23 2.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.253 0.621 . . . . 72.319999999999993 112.545 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' ASP . 2.4 tm? -93.19 95.41 9.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.412 -0.588 . . . . 60.140000000000001 109.412 176.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -54.79 137.06 45.63 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.718 0.636 . . . . 74.25 112.718 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' H ' ' A' ' 70' ' ' GLY . 35.7 m -129.96 156.76 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.149 -0.478 . . . . 71.430000000000007 111.439 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -100.55 118.13 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.295 -0.411 . . . . 71.540000000000006 110.941 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.79 168.44 39.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.396 -0.431 . . . . 73.430000000000007 113.793 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.7 t -49.86 -37.05 29.29 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.792 0.664 . . . . 45.210000000000001 112.792 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.24 -33.9 68.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.038 0.446 . . . . 74.109999999999999 112.037 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.89 18.94 18.76 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.724 -0.55 . . . . 52.240000000000002 111.724 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.66 146.81 40.44 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.981 0.419 . . . . 74.209999999999994 111.444 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.493 HG21 ' HG2' ' A' ' 71' ' ' ARG . 38.6 m -86.05 120.23 27.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.121 -0.49 . . . . 61.109999999999999 111.414 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.76 157.51 16.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.429 -0.351 . . . . 73.420000000000002 110.982 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -49.2 -42.59 40.66 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.047 0.388 . . . . 73.049999999999997 112.047 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 51' ' ' CYS . 1.5 p30 -173.42 175.49 3.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.08 -0.509 . . . . 74.049999999999997 111.122 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -62.25 -31.5 72.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.892 0.377 . . . . 64.129999999999995 111.677 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.477 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 42.1 t -66.86 -40.53 87.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.213 0.53 . . . . 74.409999999999997 110.408 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -68.85 -38.02 79.51 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.797 -0.638 . . . . 75.109999999999999 110.941 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 66' ' ' VAL . 10.4 tt -58.16 -43.4 87.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.872 0.368 . . . . 55.399999999999999 110.469 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -57.92 -38.77 76.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.383 -0.371 . . . . 74.450000000000003 111.227 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.99 44.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.382 . . . . 73.549999999999997 111.322 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.97 75.28 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 111.54 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 61' ' ' HIS . 46.3 ttt-85 -64.58 -50.37 67.5 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.934 0.397 . . . . 63.509999999999998 110.659 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 37.1 t -63.11 -33.09 74.71 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 111.857 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -65.81 -31.65 72.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.501 -0.318 . . . . 75.129999999999995 111.612 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.23 37.2 0.02 OUTLIER Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.84 -0.695 . . . . 64.310000000000002 113.995 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 85.1 m-70 -135.56 82.62 38.88 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.213 0.506 . . . . 53.200000000000003 112.168 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.28 -25.93 49.28 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.452 2.102 . . . . 71.530000000000001 112.976 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.3 -20.02 60.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.361 . . . . 72.239999999999995 111.683 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.5 tp -69.63 112.54 6.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.521 0.677 . . . . 75.209999999999994 112.664 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.4 p -131.15 164.22 25.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.674 -0.694 . . . . 71.510000000000005 110.753 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 53' ' ' LEU . 59.8 t -87.17 112.52 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.89 0.376 . . . . 64.439999999999998 111.544 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.0 mmt -81.16 -42.52 20.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.049 0.452 . . . . 72.140000000000001 110.979 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 72' ' ' CYS . 45.9 p90 -169.4 156.75 6.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.021 -0.536 . . . . 52.219999999999999 110.812 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -82.82 125.54 31.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.023 0.44 . . . . 75.439999999999998 110.876 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 131.93 -175.79 19.58 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 112.105 -174.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.493 ' HG2' HG21 ' A' ' 46' ' ' THR . 96.1 mtt180 -86.03 140.2 30.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.613 -0.345 . . . . 64.530000000000001 111.186 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.428 ' HA ' ' OH ' ' A' ' 68' ' ' TYR . 96.4 m -59.79 95.01 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.261 0.467 . . . . 54.340000000000003 112.261 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -119.36 123.52 44.36 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.895 -0.593 . . . . 65.439999999999998 110.326 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.403 -0.808 . . . . 73.349999999999994 110.572 -178.844 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.834 0.35 . . . . 75.409999999999997 111.126 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.34 80.73 0.37 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.402 0.62 . . . . 71.430000000000007 111.802 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m -99.47 123.89 44.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.703 -0.681 . . . . 52.420000000000002 110.401 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.0 m -98.31 127.23 44.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.963 0.411 . . . . 63.399999999999999 111.515 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.547 ' H ' ' HG3' ' A' ' 22' ' ' PRO . 14.4 t70 -86.64 112.54 21.71 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.09 -0.505 . . . . 61.25 110.973 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.9 -32.92 0.74 Allowed Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.156 -0.545 . . . . 72.230000000000004 114.21 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 4' ' ' CYS . 18.3 t -66.19 117.45 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.96 0.38 . . . . 54.299999999999997 111.708 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -106.73 106.88 17.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.831 0.348 . . . . 71.340000000000003 111.28 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 71.5 m -140.03 142.61 36.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.031 0.443 . . . . 62.329999999999998 111.758 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.97 -52.88 0.04 OUTLIER Glycine 0 CA--C 1.532 1.103 0 CA-C-N 115.729 -0.669 . . . . 60.039999999999999 113.273 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.63 87.09 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 60.200000000000003 112.983 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.49 15.46 79.12 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.386 -0.435 . . . . 71.099999999999994 113.778 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -146.26 135.76 23.04 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.575 -0.368 . . . . 64.25 110.97 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 24' ' ' CYS . . . -118.95 137.77 53.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.595 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 27.0 p -100.65 122.78 43.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.91 0.386 . . . . 45.140000000000001 110.342 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HG3' ' HG ' ' A' ' 18' ' ' LEU . 10.7 ptm180 -129.2 160.55 32.57 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.079 0.4 . . . . 75.510000000000005 112.079 -172.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.9 mmt -76.25 101.89 5.61 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.88 0.371 . . . . 72.230000000000004 111.448 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HG ' ' HG3' ' A' ' 16' ' ' ARG . 94.5 mt -133.36 111.62 10.94 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.828 0.347 . . . . 75.349999999999994 110.579 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.41 44.91 82.8 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.913 -0.66 . . . . 73.450000000000003 112.678 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.29 -49.48 2.98 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.003 0.361 . . . . 71.140000000000001 114.003 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -92.92 137.87 23.66 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.828 -175.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 64.9 Cg_endo -72.51 129.74 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.516 2.144 . . . . 73.409999999999997 112.92 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -129.42 150.97 50.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.437 -0.347 . . . . 75.530000000000001 110.69 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 84.9 m -104.47 146.26 29.12 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.378 0.609 . . . . 63.43 112.262 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -143.94 161.44 38.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.881 -0.6 . . . . 73.349999999999994 110.535 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 12.7 t -64.17 84.04 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.209 0.528 . . . . 72.239999999999995 111.092 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.12 118.9 32.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.614 . . . . 62.200000000000003 109.954 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.79 100.84 1.11 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.338 2.025 . . . . 70.200000000000003 114.276 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.21 98.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.546 -0.538 . . . . 63.439999999999998 109.546 166.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.65 ' HB2' HD11 ' A' ' 33' ' ' LEU . 6.3 p -121.87 91.82 3.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.444 0.535 . . . . 63.310000000000002 112.444 -172.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -107.98 166.11 10.96 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.921 -0.582 . . . . 71.329999999999998 110.861 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.97 -56.31 3.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.046 -0.597 . . . . 65.239999999999995 112.647 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 30' ' ' CYS . 4.5 pp -73.07 146.01 86.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 122.462 -0.434 . . . . 74.219999999999999 110.339 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.19 119.14 5.85 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 121.768 1.645 . . . . 50.210000000000001 113.509 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.23 15.22 6.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.829 0.347 . . . . 74.319999999999993 111.918 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -135.11 14.43 3.55 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.777 0.288 . . . . 74.219999999999999 111.777 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 38' ' ' GLN . 1.7 tm? -119.69 136.65 54.33 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.949 0.404 . . . . 74.150000000000006 110.645 -177.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.577 ' N ' HD13 ' A' ' 37' ' ' LEU . 37.6 mt-30 -63.74 137.67 58.17 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.352 0.501 . . . . 73.439999999999998 112.352 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 50' ' ' GLU . 34.6 m -128.6 152.38 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.126 0.488 . . . . 75.430000000000007 111.56 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 47.8 t -101.01 128.66 46.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.962 -0.563 . . . . 51.109999999999999 111.739 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.02 152.95 19.96 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.495 -0.383 . . . . 53.340000000000003 113.074 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.6 t -57.25 -31.88 66.0 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.942 0.401 . . . . 62.119999999999997 111.996 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.33 -20.49 65.55 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.152 0.427 . . . . 65.319999999999993 112.152 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.53 21.4 14.77 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.306 -0.474 . . . . 65.129999999999995 112.732 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.38 135.15 54.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.775 0.321 . . . . 72.25 111.547 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 m -94.81 128.58 41.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.863 0.363 . . . . 73.329999999999998 111.439 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.06 154.83 21.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.745 0.307 . . . . 55.240000000000002 111.363 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -66.59 -20.14 65.94 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.956 0.408 . . . . 55.409999999999997 111.575 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -165.49 155.59 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.714 -0.676 . . . . 75.420000000000002 110.071 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.627 ' HA ' HG21 ' A' ' 39' ' ' VAL . 31.3 tt0 -60.03 -34.43 73.38 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.044 0.45 . . . . 72.299999999999997 110.976 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -58.99 -37.33 76.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.293 -0.412 . . . . 73.430000000000007 110.729 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.97 -40.21 91.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.868 0.366 . . . . 71.239999999999995 110.852 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.86 -47.98 82.99 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.094 0.473 . . . . 65.109999999999999 110.301 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 50' ' ' GLU . 2.2 mpt_? -64.19 -39.43 93.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.235 -0.439 . . . . 75.150000000000006 111.222 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.997 0.427 . . . . 62.200000000000003 111.517 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -34.96 76.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.406 0.622 . . . . 51.210000000000001 110.833 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.11 92.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.912 -0.585 . . . . 71.340000000000003 110.446 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 73.4 m -64.22 -26.74 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 111.822 0.304 . . . . 74.040000000000006 111.822 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -64.24 -34.07 77.25 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.977 0.418 . . . . 72.340000000000003 111.27 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.66 35.17 0.05 OUTLIER Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.275 -0.488 . . . . 42.439999999999998 113.082 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -128.65 79.05 75.03 Favored Pre-proline 0 CA--C 1.539 0.533 0 O-C-N 122.37 -0.489 . . . . 71.239999999999995 111.44 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.22 -28.26 72.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.461 2.107 . . . . 75.420000000000002 112.21 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.33 -22.9 66.88 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.918 -0.583 . . . . 65.120000000000005 111.994 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 tp -73.02 111.71 8.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.476 0.655 . . . . 72.439999999999998 112.044 -174.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -127.75 161.17 29.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.295 -0.866 . . . . 75.200000000000003 110.594 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p -88.8 134.76 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.203 0.525 . . . . 74.109999999999999 111.956 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 16.7 mmt -90.65 -59.05 2.28 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.363 -0.381 . . . . 74.349999999999994 110.974 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -164.52 164.34 21.81 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.099 0.476 . . . . 73.219999999999999 112.006 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -75.65 111.98 11.54 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.828 -0.624 . . . . 71.549999999999997 111.057 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 39' ' ' VAL . . . 139.36 161.23 8.65 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.337 -0.392 . . . . 63.409999999999997 112.147 -174.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -72.58 134.85 45.39 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.249 0.525 . . . . 75.450000000000003 112.4 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.0 m -58.12 99.88 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.033 -0.53 . . . . 74.530000000000001 111.889 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -109.86 136.58 48.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 64.099999999999994 111.005 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.55 -0.738 . . . . 75.109999999999999 110.819 175.416 . . . . . . . . 0 0 . 1 stop_ save_